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Preface
 
Since 1988 
 
Australia’s Health
 
 has reported on the health status of Australians,
determinants of health, risk factors affecting health, and services and resources applied
within the healthcare system. This 2002 edition follows the framework agreed by
Australian Health Ministers in 2001, and includes reporting on the six National Health
Priority Areas.
The health of most Australians is very good and continues to improve, although
regrettably there is still no evidence of improvement for Indigenous Australians. Health
services are widely available and accessible, and of high quality. There are pressures at
all levels of the health system, with around 640,000 people being employed in the sector
to deliver a complex and demanding array of services. Together these account for 8.5%
of Gross Domestic Product. 
 
Australia’s Health 2002
 
 describes a wide array of factors that affect demand for, and
supply of health interventions and services, which in turn contribute to overall health
expenditure. Most interventions have an immediate effect, but for some, particularly
those that impact on risk factors, the effects may not be obvious for some years. Thus
evaluation of our success means examining changes in risk factor prevalence as well as
Þnal outcomes. In this light, as a nation we have been successful in reducing smoking
rates, with only 19.5% of adults now smoking daily. Vaccination coverage has expanded
and there has been an overall reduction in high blood pressure within the community.
But there is still more to do, especially in areas such as physical inactivity, obesity and
motor vehicle accidents. 
On the treatment side, our cancer survival results are world class, and heart disease
survival is also excellent. Again, there are areas of potential improvement. For example,
by supporting better prescribing practices we may be able to reduce the incidence of
pharmaceutical adverse events. 
The authors of this report have provided excellent material for thoughtful reßection and
analysis. Readers can develop an informed view of the pressures acting on the health
system now, and likely future developments. The complex interactions among such a
large number of factors makes summary difÞcult. But make sense of it we must, as
there is no doubt that todayÕs decisions on service provision, Þnancing, infrastructure
and training will have substantial effects on the nationÕs future health, the health
system and its overall cost.
As always, feedback from you, our readers, is welcome.
The 
 
Australia’s Health 2002
 
 author team was led by Geoff Sims, and then Ching Choi.
I would particularly like to thank the whole team and the members of the Editorial
Committee for another landmark report to continue the series proudly produced by the
AIHW since 1988.
Richard Madden
Director
 xii 
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 Introduction
 
As we enter a new millennium, Australians can expect their health and wellbeing to
improve: death rates continue to fall, and access to treatment and other services is
generally improving. Overall, the nature of illness and disability has dramatically
shifted away from infectious diseases to chronic conditions, especially those inßuenced
by lifestyle and behaviour. However, rates of disability in the population have remained
stable.
This reportÑthe eighth in the series of biennial reports on health in Australia produced
by the Australian Institute of Health and Welfare (AIHW)Ñis a compilation of key
health statistics and analysis based mainly on the work of the AIHW. Many of the topics
covered in the report are more fully treated in separate AIHW publications, all of which
are freely available on the AIHW web site (www.aihw.gov.au). Also available on the
AIHW web site are interactive data matrices on a range of topics, currently including
hospital episodes, cancer incidence, general practice and disability services.
 
1.1 Structure and highlights of the report
 
The report is broadly structured along the lines of the conceptual schema for health
shown in Figure 1.1. This shows health and wellbeing as the outcome of many causes
and processes modiÞed by intervention activities that are supported by human and
material resources. 
This Þrst chapter discusses what health is, what determines it, and the role of health
information in supporting the needs of service users, providers and administrators in
the system. It also includes an overview of the Australian health system. 
Chapter 2 reports on the health status of Australians and describes the major diseases
and conditions that have an impact on their health. It shows the following:
¥ Australians enjoy one of the highest life expectancies in the worldÑ82.1 years for
females and 76.6 years for males in 2000. 
¥ Death rates from cancer as a whole have been falling over the past 20 years, although
slowly. Five-year cancer survival increased between 1982Ð86 and 1992Ð94 from 43.8%
to 56.8% for males and from 55.3% to 63.4% for females.
¥ Despite continuing gains in life expectancy during the late twentieth century, the rate
of severe or profound disability (through activity limitation) appears to have been
relatively stable over the past decade.
Chapter 3 focuses on the individual and environmental factors that determine health. It
highlights the important role of the so-called SNAP set of risk factors in chronic disease
(i.e. 
 
s
 
moking, poor 
 
n
 
utrition, 
 
a
 
lcohol misuse and 
 
p
 
hysical inactivity). Key Þndings
include:
¥ Smoking rates have continued to decline, with less than 20% of Australians aged 14
or over smoking tobacco daily.
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¥ Average energy intake increased by over 10% for boys and girls aged 10Ð15 years,
and by around 4% for adults, between the mid-1980s and 1990s.
¥ In a new analysis of alcohol risk, the AIHW estimates that 35% of adult Australians
drink at levels which are risky for short-term harm, and around 10% drink at levels
which put them at risk of harm in the long term.
¥ Adult participation in sufÞcient physical activity for a health beneÞt declined from
62% in 1997 to 57% in 2000.
¥ Overweight and obesity remains a serious problem, affecting around 65% of men,
45% of women and 22% of children aged 2Ð17 years.
Chapter 4 discusses the health of particular population groups. It shows that although
most Australians enjoy good health today, some groups in the population continue to
suffer poor health, in particular Aboriginal and Torres Strait Islander peoples. Other
Þndings in this chapter are:
¥ There are important differences in health status, health risk factors and health service
access between urban and rural populations. 
¥ Injury and poisoning are leading causes of child deaths, and asthma is the leading
cause of disease burden among children; a concern for future health patterns is the
high prevalence of tobacco smoking among young people.
¥ A clear trend is emerging in the analysis of age-speciÞc fertility: among women aged
less than 30 years the birth rates are in a long-term decline; this is partly offset by
women in their late thirties and early forties whose birth rates are increasing.
 
Box 1.1: Australia at a glance
 
• 19 million people, including about 400,000 Indigenous people (2% of total)
• Average life expectancy at birth is 82 years for women, 77 for men
• Life expectancy for Indigenous people is much lower, at 63 years for women and 56
for men
• Fertility rate well below replacement level, middle-ranked among developed countries
• Climate varied but mainly continental and dry; highly urbanised, most people live in
south-east seaboard region, high exposure to sun radiation
• Many cultural backgrounds, 23% of residents born overseas
• 78% of 15–19-year-olds are at school or other educational institutions
• Per capita income high, gross domestic product (GDP) 12th among 30 OECD countries
• Services sector main contributor to GDP (63%)
• Unemployment under 7% in early 2002
• Health expenditure 8.5% of GDP in 1999–00
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Chapter 5 examines the cost of health services, employment in the health industry and
the provision and use of health services. Highlights of this chapter include:
¥ In 1999Ð00, $53.7 billion was spent on health services in Australia. About 71.2% was
funded by governmentsÑ48.0% by the Commonwealth Government (up from 44.2%
in 1996Ð97), and 23.2% by State, Territory and local governments (up from 23.0%).
¥ There were 5.9 million separations from public and private hospitals in 1999Ð00, and
a total of 22.6 million days spent in hospital. Separation rates for private hospitals
rose by 19% between 1995Ð96 and 1999Ð00, and by 1.7% for public acute hospitals.
¥ Medicare provided beneÞts for 213.9 million services in 2000Ð01, 3.7% more than in
1998Ð99. The Pharmaceutical BeneÞts Scheme subsidised 148.1 million community
prescriptions, 18.4% more than the 125.1 million in 1989Ð99.
Chapter 6 outlines the need for health information for a better understanding of current
and emerging health issues, and the structures and processes involved. It describes key
achievements and challenges for the health information system. One achievement has
been the adoption of a framework for health system performance measurement (the
National Health Performance Framework) and a set of criteria for the selection of
performance indicators. In the past 2 years there has also been considerable expansion
in health survey capacity across the country. The National Health Survey will be
conducted on a 3-yearly basis from 2001, including substantial supplementation for
Aboriginal and Torres Strait Islander peoples.
Statistical tables covering a range of topics are included after chapter 6. These tables
contain data on population and fertility as well as health-related information. Many of
the tables provide time series information, as well as comparing Australia with other
countries.
 
1.2 Health and its determinants
 
What is health?
 
In 1946 the World Health Organization (WHO) described health as Ôa state of complete
physical, mental and social well-being and not merely the absence of disease or inÞrmityÕ
(WHO 1946). A more recent dictionary deÞnition of health is Ôthe general condition of the
body or mind with reference to soundness and vigourÕ (Macquarie 1997). 
Together these two deÞnitions convey the ideas that: 
¥ health is an important part of wellbeing, of how people feel and function, and also
contributes to social and economic wellbeing
¥ health is not simply the absence of illness or injury, and there are degrees of good
health as well as of bad health
¥ health should be seen in a broad social context.
In short, healthy people feel and function well in body and mind and are in a position
to keep doing so for as long as possible.
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Despite the longevity and status of the WHO deÞnition, it remains a challenge to fully
measure the concepts contained in it. Most of the measures that are currently used
relate to ill health (e.g. deaths, hospital episodes, incidence of disease). WHO now
focuses on health outcomes as much as on health problems (WHO 2001).
In the last two decades, the effort has expanded to include measuring determinants of
health (factors inßuencing health), functioning and disability, and describing the
context in which health is assessed and managed. For each aspect of health that is
measured, equity issues must also be addressed. 
 
What determines and influences health?
 
Many things determine and inßuence health. Indeed, the dominant view presently is a
ÔmulticausalÕ one, in which disease, disability and (ultimately) death are to be seen as
the result of the interaction of human biology, lifestyle and environmental (including
social) factors, modiÞed by healthcare interventions.
Figure 1.1 presents a conceptual framework for health. Disability, disease and death are
aspects of health and wellbeing, and all can be seen as the result of a complex interplay
of many determinants described as individual or environmental. These causes and
effects can be modiÞed to various degrees by health protection, prevention and
promotion, or by treatment and rehabilitation; in the end stages of life, palliation
services feature. Such interventions are supported by human and material resources,
including essential information via research, monitoring and evaluation.
Determinants of health include those that can be measured in an individual, although
the measures of these determinants are often aggregated to population groups.
Environmental factors can be physical, as in landscape and climate; biological, as in
vegetation, the food supply, infectious agents and other animal life; and socioeconomic,
as in politics, culture, standard of living and other economic factors, and interactions
within and among communities. 
Figure 1.1: A conceptual framework for health
Determinants of health
Individual
Biomedical factors
Lifestyle and behaviour
Attitudes and beliefs
Genetic contribution
Environmental
Physical
Chemical
Biological
Social
Economic
Cultural
Political
Health, functioning and wellbeing Resources
Research 
Evaluation 
Monitoring 
Other information
Financial
Material
Human
Prevention and health promotion
Treatment and care
Rehabilitation
Palliation
Disease,
impairments,
problems,
injuries
Disability 
(active and 
participation)
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Environmental factors in turn overlap one another in many ways and are also
inßuenced by the actions of individuals and groups.
In assessing interventions, the following are important:
¥ availability of and access to appropriate health services
¥ the responsiveness of the health system to a personÕs needs
¥ the quality of the services provided.
 
Implications for improving health
 
Health interventions can occur at many levels. These can range from clinical and
preventive attention to individuals through to efforts to improve the physical, social
and economic environment for special groups or the community as a whole. As well as
seeking to reduce peopleÕs exposure to risks, some strategies aim to help people
develop personal skills to exercise more control over their own health and
environments, and to make healthy choices.
Given the great range of inßuences on health, many major improvements require a
strong partnership between public health and clinical care, and also that the health
sector work with other sectors to make the best use of limited resources. This further
requires that other sectors take into account the possible health impact of their
decisions. 
Improvements have occurred among all the major Australian socioeconomic groups,
even though there are continuing large inequalities between them in their levels of
health. However, to achieve the full scope of improvement also requires signiÞcant
social changes such as reducing educational and economic disadvantage. 
Solving these major issues often involves value judgments, and often includes political
processes because of competing interests. Along with limited resources, the challenge
requires choices, priority setting and trade-offs between the health sector and other
sectors, between prevention and treatment services, and between the short term and
longer term.
 
1.3 The role of health information
 
Health information is fundamental to developing effective health policies and
programs, to coordinating treatment and care, and to empowering consumers. 
Again using the structure of Figure 1.1, health information is about:
¥ quantifying the inputs to the health system
¥ monitoring and evaluating health programs
¥ extending and reÞning knowledge
¥ measuring the extent and distribution of health determinants and risk factors
¥ assessing the effectiveness (outcomes) of the system
¥ understanding the relationships among all of the above. 
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Australia has for the last decade given substantial attention to coordinating and
structuring health information to support decision making. The National Health
Information Agreement, made in 1993 between Commonwealth, State and Territory
health agencies, the Australian Bureau of Statistics and the AIHW, now includes the
Health Insurance Commission. A major product of this agreement is the 
 
National Health
Data Dictionary
 
, which is updated annually to provide standards for national health
information and generally to be a guide for gathering health data.
There is also a burgeoning collection of information frameworks, indicator sets and
national minimum data sets (i.e. an agreed set of data items on a particular topic that
are collected in a uniform manner and collated for national reporting). Much effort in
the past 2 years has gone into developing the National Health Performance Framework,
under the auspices of the Australian Health MinistersÕ Advisory Council. This
framework proposes a number of indicators to comprehensively cover aspects of
performance at the organisational level and at the system level, while keeping a focus
on equity issues and encompassing the role of health determinants (more detail can be
found in Chapter 6).
With increasing electronic availability of clinical information, opportunities are growing
to improve heath information for populations and system-wide purposes. Provided
personal privacy and conÞdentiality are properly protected richer data sets will become
possible to improve health and health services.
 
1.4 The Australian health system
 
The Australian health system is widely regarded as being world-class, in terms of both
its effectiveness and efÞciency. This is largely achieved as a result of partnerships
between individual Australians and families and healthcare professionals. PeopleÕs
decisions about lifestyle, self-care, and seeking and acting on professional help, and
their participation in the development of public policy at many levels, all contribute to
shaping the Australian health system. Increasingly, detailed information is available to
and accessed by individuals, especially via the Internet.
The system is complex, with many types and providers of services and a range of
funding and regulatory mechanisms. Those who provide services include medical
practitioners, other health professionals, hospitals, and other government and non-
government agencies. Funding is provided by the Commonwealth (federal)
Government, State and Territory governments, health insurers, individual Australians
and a range of other sources.
The CommonwealthÕs funding includes two major national subsidy schemes, Medicare
and the Pharmaceutical BeneÞts Scheme. These schemes cover all Australians and
subsidise their payments for private medical services and for a high proportion of
prescription medications bought from pharmacies. The Commonwealth and State
governments also jointly fund public hospital services so they are provided free of
charge to patients. Between them, these three funding provisions aim to give all
Australians, regardless of their personal circumstances, access to adequate health care
at an affordable cost or no cost. These arrangements, with minor modiÞcations, have
been supported by successive governments for almost 30 years.
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Many patientsÕ Þrst contact with the health system is through a general medical
practitioner (GP). Patients can choose their own GP and are reimbursed for all or part of
the GPÕs fee by Medicare, depending on the GPÕs billing arrangements. For specialised
care, patients can be referred to specialist medical practitioners, other health
professionals, hospitals or community-based healthcare organisations. Community-
based services, some of which can also be accessed directly by patients, provide mental
health, family planning and other specialised care and treatment, usually funded
through Medicare or other government programs.
Patients can access public hospitals through emergency departments, where they may
present on their own initiative, or via the ambulance services, or after referral from a
medical practitioner. Admitted patients are charged nothing for their treatment or
accommodation, unless they choose private treatment. Emergency department and
outpatient services are free.
Australians may also choose to be treated in a private hospital, or be treated as private
patients in a public hospital. Private patients can choose their own doctor, and they
must pay for the hospitalÕs services, with or without the support of private health
insurance, or through other arrangements such as compensation. Medicare subsidises
the fees charged by doctors for services provided to private patients in hospitals, and
private health insurance funds also contribute towards medical fees for insured
patients. No-gap or known-gap arrangements are increasingly being agreed on between
hospitals and insurers.
Since the late 1990s, various Commonwealth incentives encouraged people to take up
and retain private health insurance. There are virtually no employer-based health
insurance schemes in Australia.
Australians also visit dentists and other private sector health professionals of their
choice. Charges are met by the patients themselves, or with support of private health
insurance. Limited provision of these services is available from the public sector on a
needs-tested basis.
The health service system is regulated in various ways. Private hospitals are licensed by
State and Territory governments. Medical practitioners and other health professionals
are registered for practice in each State and Territory. The CommonwealthÕs regulatory
roles include overseeing the safety and quality of pharmaceutical and therapeutic
goods and appliances, and regulating the private health insurance industry.
Commonwealth and State policies also regulate food safety and product labelling, and
encourage quality across the health system.
An important addition to the services outlined above is the provision of public health
services, community health services and ambulance services, largely funded by
Commonwealth, State and Territory, and local governments. Public health services
include:
¥ activities to ensure food quality
¥ immunisation services and other communicable disease control (including
biosecurity)
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¥ public health education campaigns (including health promotion in the areas of
nutrition and physical activity)
¥ injury prevention activities
¥ programs to reduce the use of tobacco, alcohol and illicit drugs, and their harmful
effects on individuals and communities
¥ environmental monitoring and control
¥ screening programs for diseases such as breast cancer.
Essential support to the health service system is given by many other agencies.
Research is fostered and funded through the National Health and Medical Research
Council. Statistical agencies provide the information needed for prevention, detection,
diagnosis, treatment, care and associated policy. Consumer and advocacy groups
contribute to public discussion and policy. Professional associations for medical
practitioners and other health professionals help set professional standards and clinical
guidelines. Universities and hospitals undertake training of undergraduate and
postgraduate health professionals. Voluntary agencies contribute in various ways,
including raising funds for research, running education and health promotion
programs, and coordinating voluntary care.
Although they are not seen as part of the health system, many other government and
non-government organisations play a role because of their inßuence on health.
Departments of transport and the environment, the media and the food industry are
just a few examples. 
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2
 
 Health of Australians
 
This chapter provides an overview of the health of the Australian population as a
whole, drawing on the most recent available data. It covers major dimensions of health
status, highlights areas of importance and, where possible, provides trends over time to
show whether there has been improvement or not. 
The chapter is divided into six sections: 
¥
 
Health
 
 
 
covers components such as life expectancy, self-reported health, oral health,
immunological health and sexual health.
¥
 
Functioning and disability
 
 describes disability and provides information on the level
and types of disability in the Australian population.
¥
 
Mortality
 
 documents the leading causes of death for Australia as a whole and for
various age groups, the proportion of total deaths that occur among those age
groups, and longer term trends in death rates for a range of major diseases. 
¥
 
Non-communicable diseases and conditions
 
 covers a range of important diseases
and conditions, including injuries, that have a signiÞcant impact in Australia through
illness, disability or death.
¥
 
Communicable diseases
 
 provides information on acute respiratory infections,
bloodborne diseases such as viral hepatitis and HIV/AIDS, non-HIV sexually
transmitted infections, vaccine-preventable diseases, and topical problems such as
meningococcal and Creutzfeldt-Jakob diseases.
¥
 
National Health Priority Areas diseases and conditions
 
 summarises data on the
combined impact of six major diseases and conditions, namely cardiovascular
diseases, cancers, injuries, mental problems, diabetes mellitus and asthma. These
have been chosen for special focus as National Health Priority Areas by the
Commonwealth, State and Territory governments.
 
2.1 Health
 
Life expectancy and longevity
 
Life expectancy
 
In 2000, life expectancy at birth was 76.6 years for Australian males and 82.1 years for
females. In contrast, in the 1901Ð1910 period a male could expect to live 47.2 years and
a female 58.8 years. These are increases in expected years of life of almost 30 years (60%)
for males and of 23 years (40%) for females during the twentieth century.
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Figure 2.1: Life expectancy, females, 1901 to 2001
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Figure 2.2: Life expectancy, males, 1901 to 2001 
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Over the long term, reductions in infant and child mortality have been the greatest
contributors to this improvement. However, signiÞcant gains have also occurred
through reductions in death rates among the middle-aged and the elderly, especially for
diseases of the circulatory system (heart disease and stroke) over the past few decades.
Males aged 30 in 2001 could expect to live to 78.0 years and females to 82.8 years. This
is about 12 years more than the respective life expectancies in the period 1901Ð1910.
Males aged 65 years in 2001 could expect to live to 81.6 years and females to 85.2 years,
about 6 years more than for those in 1901Ð1910.
These trends have important consequences. Not only do they increase the proportion of
the population reaching an advanced age, but they also inßuence health, disease, and
disability patterns in a population.
 
Life expectancy for population groups
 
Life expectancy is not uniform across population groups within Australia. Aboriginal
and Torres Strait Islander peoples have a much lower life expectancy at birth than the
national average. Indigenous people born in the period 1998Ð00 are expected to live
about 20 years less than the rest of the Australian population, Indigenous males to
about 56 years and females to about 63 years (ABS 2001a). Among broad socioeconomic
groups in 1996, males in the most disadvantaged Þfth were expected to live 3.6 years
less than those in the most advantaged Þfth, and for corresponding females the
difference was 1.9 years (AIHW: Mathers et al. 1999b). 
Life expectancy also shows regional variation. Life expectancy at birth in the Northern
Territory is lower by 5.3 and 6.5 years for males and females respectively, compared
with the national average. These differences reßect the higher death rates of the
Indigenous populations, which make up close to 30% of the Northern Territory
population (AIHW: Mathers et al. 1999a).
 
International comparisons
 
Overall, Australians enjoy one of the highest life expectancies in the world. In 2000, the
male life expectancy of 76.6 years can be compared with the highest recorded, in Japan
(77.5) and Sweden (77.3). The highest female life expectancies were recorded in Japan
(84.7 years) and France (83.1), compared with AustraliaÕs 82.1. Australian life expectancy
is a little higher than that of countries such as Canada, Norway and Spain, and
signiÞcantly higher than that of countries such as New Zealand, the United Kingdom
and the United States (Table 2.1). 
Most of the countries compared in Table 2.1 are from the more developed regions of the
world. The life expectancies of less developed countries are considerably lower. Regions
deÞned by the United Nations as being made up of less developed countries (i.e.
countries outside Europe, North America, Australia, Japan and New Zealand) have an
overall life expectancy of about 64 years, compared with 75 years for developed
regions. The African continent has the lowest life expectancy at birth (less than
50 years). 
Australia is part of the Asia and the PaciÞc region, whose average life expectancy in
2000 was only 66 years for males and 69 years for females. However, life expectancy in
the region varies greatly, including 63 years for males and 64 for females in India and
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corresponding Þgures of 64 and 68 for Indonesia, 69 and 73 for China, 75 and 80 for
Singapore and 76 and 82 for Hong Kong SAR (ESCAP 2000).
 
‘Healthy life expectancy’
 
As part of the measure of overall life expectancy, the World Health Organization
(WHO) has proposed Ôhealthy life expectancyÕ (HALE) as a measure of the expected
number of years to be lived without reduced functioning. HALE calculations adjust the
overall life expectancy by the years of life lived with reduced functioning because of ill
health (WHO 2002).
AustraliaÕs Ôhealthy life expectancyÕ is among the highest in the world. Australian males
can expect to live 69.6 years of life without reduced functioning, ranking them sixth in
the world, and females 73.3 years, making them third. These Þgures represent a very 
 
Table 2.1: ÔHealthy life expectancyÕ, selected countries, 2000
 
Males Females
‘Healthy life 
expectancy’
‘Healthy life 
expectancy’
Country
Life
expectancy Years Per cent
 
(a)
 
Country
Life
expectancy Years Per cent
 
(a)
 
Japan 77.5 71.2 91.9 Japan 84.7 76.3 90.1
Switzerland 76.7 70.4 91.9 Switzerland 82.5 73.7 89.3
Sweden 77.3 70.1 90.7
 
Australia 82.1 73.3 89.3
 
Iceland 77.1 69.8 90.5 France 83.1 72.9 87.8
Greece 75.4 69.7 92.4 Italy 82.4 72.8 88.4
 
Australia 76.6 69.6 90.9
 
Sweden 82.0 72.7 88.7
New Zealand 75.9 69.5 91.5 Iceland 81.8 72.6 88.7
Italy 76.0 69.5 91.5 Austria 81.4 72.5 89.1
Denmark 74.2 68.9 92.8 Spain 82.3 72.5 88.1
Norway 75.7 68.8 90.8 Greece 80.8 72.3 89.5
Spain 75.4 68.7 91.2 Norway 81.4 72.3 88.8
France 75.2 68.5 91.1 New Zealand 80.9 72.1 89.0
UK 74.8 68.3 91.3 Canada 81.5 71.7 88.0
Canada 76.0 68.3 89.8 Germany 80.6 71.5 88.6
Austria 74.9 68.1 91.0 Finland 80.9 71.5 88.3
Ireland 74.1 67.8 91.5 UK 79.9 71.4 89.4
Belgium 74.6 67.7 90.8 Belgium 80.9 71.0 87.8
Germany 74.3 67.4 90.7 Ireland 79.7 70.9 89.0
Singapore 75.4 66.8 88.6 Denmark 78.5 70.1 89.3
Finland 73.7 66.1 89.7 Singapore 80.2 68.9 85.9
USA 73.9 65.7 88.9 USA 79.5 68.8 86.6
Portugal 71.7 63.9 89.1 Portugal 79.3 68.6 86.5
Poland 69.2 59.3 85.6 Poland 77.7 64.3 82.8
Russia 59.4 50.3 84.7 Russia 72.0 60.6 84.2
South Africa 49.6 43.0 86.7 South Africa 52.1 43.5 83.5
 
(a) Per cent of life expectancy spent without loss of functioning capacity.
 
Source:
 
 WHO 2002.
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high proportion of life with full functioning capacity. Australian males and females can
expect to live 90.9% and 89.3% of their lives with full functioning capacity. This
compares very favourably with other countries that have high life expectancies.
Australian males lie twelfth behind Danish males who have a proportion of 92.8%, and
Australian females lie fourth behind Japanese females who have a 90.1% proportion
(WHO 2002) (Table 2.1).
 
Self-reported health
 
PeopleÕs perception of their own health has been shown to be a powerful, independent
predictor of their future health care use and survival (Miilunpalo et al. 1997; Idler &
Benyamini 1997). 
This section discusses how Australians rate their own health and wellbeing, based on
self-assessed health status data from the 1989Ð90 and 1995 National Health Surveys,
and the 1997 National Survey of Mental Health and Wellbeing of Adults, all conducted
by the Australian Bureau of Statistics (ABS).
 
Self-assessed health status
 
Just over half (57%) of people aged 18 years and over reported their overall health as
excellent or very good in 1997, and a further 28% reported that they were in good
health. Proportions were similar for the two sexes. The remaining 15% rated their health
as either fair or poor. In interpreting these Þndings, note that some people in poorer
health were not included in the surveyÑfor example, people living in institutions such
as hospitals and nursing homes.
18–24 25–34 35–44 45–54 55–64 65–74 75+
0
10
20
30
40
50
60
70
80
Excellent/very good
Good
Fair/poor
Age (years)
Per cent of persons
Source: AIHW analysis of National Survey of Mental Health and Wellbeing.
Figure 2.3: Self-assessed health status, 1997
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Self-assessed health status is strongly related to age. In the 1997 survey the proportions
reporting excellent or very good, good, and fair or poor health remained relatively
unchanged up to the age group 35Ð44 years. At ages over 44 years, the proportion
reporting excellent or very good health declined with increasing age, from 66% at ages
35Ð44 to 37% at ages 75 and over, and the corresponding proportion reporting fair or
poor health increased from 10% to 33% (Figure 2.3).
 
Self-reported health and socioeconomic status
 
The link between health and socioeconomic status has been clearly shown in studies
both in Australia and overseas (Wilkinson & Marmot 1998), with lower socioeconomic
status generally being associated with poorer overall health.
As expected, the proportion of people who report their health as only fair or poor
shows a marked trend across socioeconomic groups. People who are less educated,
unemployed or living in households with low income all report poorer health
(Table 2.2).
Also, as the 1990s progressed, the proportion reporting good health increased across
most socioeconomic groups. The only exception was among the unemployed, with 21%
reporting fair or poor health in 1997Ñup slightly from 19% in 1995 but still lower than
25% in 1989Ð90.
 
Table 2.2: Adults who say their health is only ÔfairÕ or ÔpoorÕ, 1989Ð90 to 1997
 
Socioeconomic group 1989–90 1995 1997
Sex
 
Men
 
20.5 17.3 15.6
 
Women
 
21.1 16.6 13.5
 
Smoking
 
Smoker
 
26.2 22.5 n.a.
 
Non-smoker
 
18.4 15.0 n.a.
 
Education
 
Secondary
 
24.4 19.6 17.8
 
Post-secondary
 
18.4 14.5 13.4
 
Bachelor’s degree and higher
 
11.3 9.2 6.8
 
Employment
 
Unemployed
 
24.9 19.4 21.3
 
Employed
 
12.7 9.3 7.8
 
Income
 
Low 
 
32.1 24.3 n.a.
 
Middle 
 
20.4 25.2 n.a.
 
High 
 
14.1 13.0 n.a.
 
Notes
 
1. The age groups for the different categories for self-reported health are: 18 years and over for sex, smoking and income; 
20 years and over for education; and 18–64 years for employment.
2. All proportions have been age-standardised using the 1991 total Australian population.
 
Source: 
 
AIHW analysis of 1989–90 and 1995 ABS National Health Surveys, and 1997 ABS National Survey of Mental 
Health and Wellbeing of Adults.
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Oral health
 
Dental decay and gum diseases remain among the most prevalent illnesses for Australians.
Oral diseases are a largely silent epidemic, but one which causes widespread infection and
disability.
Australia enjoys a high level of oral health among most children. Using the
internationally accepted comparison age and indicator for child oral health reveals that,
among OECD countries, Australian 12-year-old children have the second lowest
number of permanent teeth with some dental decay. Whereas health policy aimed at
improving child oral health (such as ßuoridation of water supplies) has been largely
successful, there are some concerning signs. First, the time-series information available
indicates that improvements in child oral health may have peaked and even begun to
reverse. Second, there is a substantial social gradient in child oral disease that indicates
a small disadvantaged group of children who experience a disproportionate share of
dental decay. 
However, these problems are overshadowed by persistent high levels of oral disease,
particularly dental caries, among adults. Only some of the improved oral health of
children has been carried through to adulthood. By mid-life, decay experience is
extensive and as yet has shown only modest improvements over recent decades. Older
adults have surprisingly high levels of current decay, despite the loss (extraction) of
many more susceptible teeth earlier in life.
 
Child dental health
 
The following data on child oral health are based on information collected in the Child
Dental Health Survey, a surveillance activity undertaken by the Australian Institute of
Health and Welfare (AIHW) Dental Statistics and Research Unit.
After a continuing improvement in primary and secondary school childrenÕs oral health
from the 1970s, it now appears that the declines in dental decay have slowed and, in
some cases, levels of decay are beginning to increase. Oral health in children is most
often assessed by their dental decay experience, expressed as a count of the number of
teeth currently decayed, the number that have been extracted as a result of having been
decayed, and the number that have received Þllings. The average number of decayed,
missing or Þlled teeth in the deciduous dentition (ÔbabyÕ or primary teeth) of children
aged between 5 and 10 years declined markedly between 1989 and 1996, but has since
increased for children aged 5, 6 and 8 while reducing only slightly for the other age
groups (Table 2.3) (ArmÞeld et al. 2001).
Dental caries experience in the permanent dentition (ÔadultÕ teeth) shows a similar
pattern, declining between 1989 and 1996 but then increasing for children aged 7, 8, 9
and 10 (Table 2.4). Between 1996 and 1998 only 12-year-olds showed any appreciable
reductions in decay experience. Although the caries experience of children is improved
over levels Þrst observed in 1977, it is now becoming apparent that improvements have
stalled or that the caries experience of children may be beginning to increase once again.
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Oral health of Australian adults
 
Historically, increasingly high percentages of older adults were edentulous (having lost
their natural teeth), leading to a diminishing burden of oral disease due to fewer teeth
exposed to disease processes. Complete tooth loss has been declining rapidly over recent
decades. Improved treatment options that encourage the retention of teeth and improved
community expectations to keep teeth for life may result in further decreases in tooth loss.
For instance, among Australian adults aged 65 years and over the percentage edentulous
has decreased from 66% in 1979 to 51% in 1989 to 38% in 1999.
Despite this great improvement, some population groups appear to be left behind in this
decline. These include lower income adults and those who hold a health concession card
conferring eligibility for public dental care.
 
Table 2.3: Primary teeth with caries experience(a), students 5 to 10 years old, 1989 to 1998 
(average number of teeth)
Age (years)
5 6 7 8 9 10
1989 2.07 2.15 2.38 2.31 2.26 1.88
1990 1.85 2.06 2.20 2.31 2.28 1.78
1991 1.78 1.94 2.13 2.24 2.22 1.81
1992 1.80 1.95 1.93 2.21 2.11 1.74
1993 1.76 1.90 2.01 2.15 2.13 1.73
1994 1.56 1.79 1.95 2.13 2.01 1.71
1995 1.49 1.73 1.87 2.05 1.97 1.61
1996 1.26 1.45 1.66 1.68 1.72 1.47
1997 1.28 1.50 1.63 1.78 1.75 1.47
1998 1.37 1.51 1.62 1.81 1.70 1.40
(a) As measured by dmft index (number of decayed, missing and filled primary teeth).
Source: AIHW DSRU Child Dental Health Survey, Australia 1989–98.
Table 2.4: Permanent teeth with caries experience(a), students 6 to 12 years old, 1989 to 1998 
(average number of teeth)
Age (years)
6 7 8 9 10 11 12
1989 0.09 0.26 0.46 0.65 0.83 1.37 1.56
1990 0.10 0.24 0.42 0.63 0.76 1.00 1.44
1991 0.09 0.24 0.40 0.56 0.83 0.91 1.29
1992 0.09 0.21 0.38 0.53 0.69 0.90 1.22
1993 0.08 0.22 0.36 0.51 0.66 0.90 1.10
1994 0.11 0.23 0.37 0.47 0.65 0.88 1.09
1995 0.10 0.20 0.36 0.46 0.57 0.79 1.01
1996 0.07 0.18 0.30 0.38 0.49 0.66 0.90
1997 0.07 0.17 0.30 0.42 0.52 0.65 0.86
1998 0.07 0.21 0.32 0.41 0.58 0.64 0.83
(a) As measured by DMFT index (number of decayed, missing and filled permanent teeth).
Source: AIHW DSRU Child Dental Health Survey, Australia 1989–98.
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Tooth loss is unequally distributed socially, with progressively greater impact evident
among lower income groups. Figure 2.4 presents the percentage of edentulous people
aged 45 years and over within income groups. 
Complete tooth loss decreased sharply across income in both the age groups 45Ð64
years and 65 years and over. Cardholders had a higher rate of complete tooth loss than
non-cardholders with the difference evident in both age groups (Figure 2.4). 
Indigenous adult oral health
Data on Indigenous adults are available only from sporadic surveys. The National Oral
Health Survey of Australia in 1987Ð88 did not collect data on Indigenous status,
although a special supplementary survey was undertaken on 35Ð44-year-olds in Central
Australia.
Data from the National Dental Telephone Interview Survey 1994Ð96 indicated that a
higher proportion of Indigenous Australians than other Australians were edentulous,
particularly over the age of 65 years (72% with no natural teeth compared with 28%).
Figure 2.5 shows the average number of teeth with caries experience by age group for
Indigenous people in remote communities in South Australia and the Northern
Territory (1999), an Indigenous metropolitan clinic (2000) and those who were seen in
public clinics in the period 1994Ð96, compared with other Australians seen across the
same period. Caries levels of the remote communities are lowest of the four groups and
the caries experience in the metropolitan clinic is the highest in all age groups.
<$12 $12–$20 $20–$30 $30–$40 $40–$50 $50+ Cardholder Non-
cardholder
0
10
20
30
40
50
45–64 years
65+ years
Annual income ($’000) and cardholder status
Per cent of endentulous persons
Source: AIHW Dental Statistics and Research Unit National Dental Telephone Interview Survey 1999.
Figure 2.4: Complete tooth loss among adults aged 45 years and over, 1999
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Figure 2.6 shows the average number of decayed, missing or Þlled teeth of Indigenous
Australians in remote areas in 1999. In the youngest age group, untreated decay accounts
for over 70% of the caries experience. Levels of Þlled teeth and teeth with untreated
decay are comparable in the 18Ð24 age group. By the 25Ð44 age group, the largest
component is missing teeth, which is absolutely dominant in the oldest age group.
The substantial increase in missing teeth in the older age groups of Indigenous adults in
remote communities may reßect a predominance of tooth extraction as a treatment for
caries or the contribution to tooth loss of other oral diseases. Gum disease is regarded as
the second most frequent cause of tooth extraction, although for most Australians this
contributes to less than 20% of all tooth loss.
The Indigenous population is known to have higher levels of Type 2 diabetes than other
Australians, and diabetes and gum diseases have been shown to be associated. This
relationship was investigated. When the average number of missing teeth was
examined by diabetic status (Figure 2.7), people with diabetes were found to have
signiÞcantly more missing teeth, indicating that gum disease known to be associated
with diabetes may have contributed to tooth loss.
18–24 25–44 45+
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16
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20
Remote Indigenous (1999)
Metro Indigenous (2000)
Public dental care Indigenous (1994–96)
Public dental care other Australians (1994–96)
Age (years)
Average DMFT
Note: Indigenous figures based on oral health data processed by the Dental Statistics and Research Unit in 
collaboration with participating Indigenous communities.
Sources: AIHW Dental Statistics and Research Unit surveys: oral health survey of Indigenous persons — remote 1999; 
oral health survey of Indigenous persons — metro 2000; Adult Dental Programs Survey 1994–96.
Figure 2.5: Caries experience (DMFT) of Indigenous persons
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Note: Indigenous figures based on oral health data processed by the Dental Statistics and Research Unit in 
collaboration with participating Indigenous communities.
Source: AIHW Dental Statistics and Research Unit oral health survey of Indigenous persons — remote 1999.
Figure 2.6: Average number of teeth with caries experience among Indigenous adults in 
remote communities, 1999
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Note: Indigenous figures based on oral health data processed by the Dental Statistics and Research Unit in 
collaboration with participating Indigenous communities.
Source: AIHW Dental Statistics and Research Unit oral health survey of Indigenous persons — remote 1999.
Figure 2.7: Average number of missing teeth by diabetic status among Indigenous adults 
in remote communities, 1999
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Knowledge about the risk factors and effective treatments of gum diseases among
Indigenous adults is currently rudimentary. However, control of levels of dental plaque
and cessation of smoking are two of the factors thought to be important. In remote
communities the practice of brushing teeth is not common. In addition, smoking is a
recognised risk factor for gum disease and higher numbers of Indigenous people smoke
than other Australians. Both of these factors may increase the risk of gum disease.
In remote areas the prevalence of diabetes and other chronic diseases has increased
substantially over the past 20 years. Increased levels of tooth loss seem to be related to
these general health changes.
Immunological health
The immunological health of an individual depends upon the ability of their body to
rapidly recognise and effectively protect itself against infection. An infection does not
necessarily lead to signiÞcant illness. The great majority of microorganisms to which
people are exposed cause only mild symptoms or discomfort. There are, however, a
minority of organisms, such as those which cause measles or legionnaireÕs disease,
which can lead to severe illness or death if introduced into the body. 
Without a functioning immune system, humans can be quickly overwhelmed by
infections. The immune system also contributes to a range of other health outcomes. A
number of primary disease-prevention strategies take advantage of the human immune
system to prevent or reduce the severity of diseases in individuals and the community.
Paramount among these is vaccination.
Although it greatly strengthens the immune response, vaccination is not without risks.
An extremely small number of people may have a severe reaction to a vaccination.
However, the risks of becoming ill with a childhood disease and of suffering severe side
effects or death as a result are very much higher than the risk of an adverse reaction to
a vaccination. The rates of adverse reactions to the vaccines on the National Health and
Medical Research Council (NHMRC) schedule (recommended for routine vaccination
for Australian children) compared with the known effects of various diseases are shown
in Table 2.5. 
Vaccines currently used in the standard schedule of childhood immunisation in
Australia are diphtheria, tetanus, pertussis, measles, mumps, rubella, polio,
Haemophilus influenzae type b (Hib) and hepatitis B (NHMRC 2000). All these vaccines
are highly effective, ranging from 84% to 95% (MacIntyre & Gidding 2001).
Monitoring immunisation levels
The level of immunity of a population can be monitored in several different ways. The
most useful indicator is examination of antibody levels in the blood. This type of
information is currently not collected for the Australian population. Another indicator
of the level of immunity is the extent of vaccination coverage. Although Australia Þrst
instituted a childhood vaccination program in the 1920s, information on coverage was
less than satisfactory until the establishment of the National NotiÞable Diseases
Surveillance Scheme (NNDSS) in 1991 and the Australian Childhood Immunisation
Register (ACIR) in 1996 (Lister et al. 1999).
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The ACIR was set up as part of the National Childhood Immunisation Program to
collect information on the vaccination status of children under 7 years. It was
developed in response to a decline in childhood immunisation in Australia and the
resulting increase in the incidence of vaccine-preventable diseases in childhood. In 1997,
as part of the ÔImmunise AustraliaÕ program, a number of incentives were introduced to
improve vaccination coverage in Australia comprising incentives for parents to improve
compliance with the vaccination schedule and incentives for general practitioners who
monitor, promote and provide age-appropriate immunisation services for children.
Table 2.5: Comparison of the effects of diseases for which the NHMRC recommends 
vaccination of children with the side effects of those vaccinations
Disease Effects of disease Side effects of vaccination
Diphtheria Death in 6.6% of cases. Paralysis 
and heart failure.
Local inflammation or fever in 10%. 
Very rare other adverse effects.
Hepatitis B Liver cancer or cirrhosis in 33% of 
chronic cases.
Pain and fever in between 1% and 
7%. Anaphylactic shock in 1 in 
600,000 or 0.00016%.
Haemophilus influenzae 
type b
Death in 5%, permanent brain 
damage in 25% of cases.
Local discomfort or inflammation in 
5%, fever in 2%.
Measles Pneumonia in 4%, encephalitis in 
0.05%, death in 0.005% and brain 
damage in 0.02% of cases. Brain 
degeneration, which is always fatal, 
in 0.004% of cases.
Discomfort, local inflammation or 
fever in 10%. Non-infectious rash in 
1%. Encephalitis in 1 per 1 million 
vaccinations.
Mumps Encephalitis in 0.5% of cases, 
inflammation of testicles in 20% of 
post-pubescent males.
Swelling of salivary glands in 1%. 
Mild encephalitis in 1 in 3 million 
vaccinations.
Pertussis (whooping cough) Death in 0.5% of cases aged under 
6 months from pneumonia or brain 
damage.
Local inflammation or fever in 10%. 
Very rare other adverse effects.
Polio Death in 5% and permanent 
paralysis in 50% of hospitalised 
cases.
Diarrhoea, headache and/or 
muscular pain in less than 1%. 
Paralysis of recipient or close 
contact in 1 in 2.5 million 
vaccinations.
Rubella 90% of infants whose mothers are 
infected 10 weeks after conception 
are born with major congenital 
abnormalities (deafness, blindness, 
brain damage, heart defects).
Discomfort, local inflammation and 
fever in 10%. Swollen glands, stiff 
neck or joint pains in 5%. Non-
infectious rash in 1% and bruising 
or bleeding after first dose of MMR 
vaccine in 0.003%.
Tetanus Death in 10% of cases. Local inflammation or fever in 10%. 
Very rare other adverse effects.
Source: NHMRC 2000.
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According to the Australian Standard Vaccination Schedule, a child who is fully
immunised at 1 year of age has received three doses of diptheria/tetanus/pertussis
(DTP) vaccine, three doses of oral polio vaccine and two or three doses of Hib vaccine
(depending on the particular Hib vaccine used) (NHMRC 1997a, 2000). Full
immunisation at 2 years of age requires a booster dose of DTP, a Hib booster and a dose
of measles/mumps/rubella vaccine (MMR). Since the establishment of the ACIR and
the ÔImmunise AustraliaÕ program, the overall age-appropriate vaccination coverage for
children at 1 year of age increased from 74.9% in 1997 to 91.2% in 2001 and that for
children at 2 years increased from 63.8% in 1997 to 84.7% in 2000 (ACIR, Health
Insurance Commission, unpublished data, 12 July 2001). 
Allergies, auto-immunity and immunodeficiency
In certain circumstances the immune system of some people may overreact to some
antigens so they suffer from allergies. In other cases, and for reasons not yet well
understood, the immune system may fail to recognise the difference between its own
body and foreign agents, and will attack cells in its own body. This is thought to be a
major cause of a number of diseases, such as Type 1 diabetes and rheumatoid arthritis,
that are understood as auto-immune diseases. In still other cases, foreign agents attack
the bodyÕs immune system, leaving a person liable to suffer severe illnesses from other
infectious agents, such as commonly occurring bacteria that normally cause only mild
illnesses. The best known of these foreign agents is the human immunodeÞciency virus
(HIV), the virus that causes acquired immunodeÞciency syndrome (AIDS).
There is a growing body of evidence that physical and emotional stress, including
depression, can reduce immunity. Psychological stress inhibits many aspects of the
immune response. For example, acute stress was found to suppress the immune
response to hepatitis B vaccine and to the common cold (Cohen et al. 1991; Glaser et al.
1992, 1998). This suppression of the immune system can happen through direct
transmission of signals from the nervous system to the immune system, or through
hormones produced during stress which can adversely affect the immune system. It
would appear that a sense of wellbeing and security, including good mental health,
mediated through the immune system has beneÞcial effects for health in general. 
Allergies
Allergic reactions can occur to such things as wasp and bee venom, particular drugs,
certain foods, grass and tree pollen, and dust mites. For example, hay fever occurs after
the immune system reacts to pollen allergens and becomes sensitised to them. Later
exposure to the same allergen will cause a rapid and vigorous immune response that
includes the release of histamines and other chemicals. Asthma is an increasingly
serious disease in Australia (Robertson et al. 1991) and allergies are also believed to be
involved in its development as well as in triggering attacks. The rapid increase in
asthma in developed countries has led to the suggestion that the reduced rate of
infections in infancy and childhood, due to improved hygiene, is responsible for the
persistence of an immature immune response. This would particularly be the case in
genetically prone individuals (Abramson & Walters 2000). 
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Auto-immunity
The failure of the immune system to distinguish between its own body and foreign
agents leads to a variety of auto-immune diseases, including:
¥ systemic lupus erythematosus, which involves an immune reaction to nucleic acids
normally occurring in body cells (Bach & Koutouzov 1997) 
¥ rheumatoid arthritis, a crippling disease in which the immune system attacks the joints 
¥ Type 1 diabetes, which results from the destruction of the insulin-producing cells of
the pancreas 
¥ rheumatic fever, where antibodies against the bacterium streptococcus also react with
heart muscle, damaging heart valves 
¥ multiple sclerosis, believed to be caused by auto-immune responses to certain parts
of the nervous system.
Auto-immune diseases are responsible for signiÞcant illness, disability and activity
restriction in Australia (AIHW: Mathers et al. 1999a). Most of the disease burden for the
auto-immune diseases shown in Figure 2.8, with the exception of rheumatic heart
disease, was due to disability. With the exception of Type 1 diabetes, the auto-immune
diseases shown are more prevalent among females than males, and this difference is
reßected in both hospital and mortality statistics (Table 2.6).
Rheumatoid arthritis
Type 1 diabetes
Multiple sclerosis
Rheumatic heart disease
0 3,000 6,000 9,000 12,000
Years of life lost due to
premature mortality
Years of life lost due to
disability
Disability-adjusted life years
Note: A disability-adjusted life year is a year of healthy life lost through premature death or living with disability due to 
illness or injury.
Source: AIHW: Mathers et al. 1999a.
Figure 2.8: Total burden of disease from selected auto-immune diseases, 1996
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The incidence and prevalence of these auto-immune diseases and the morbidity and
mortality associated with them are difÞcult to establish. These diseases may share a
common origin, but are expressed in a diverse number of illnesses and outcomes. A
wide range of information is collected on epidemiological aspects of these diseases;
however, the degree to which they are classiÞed as auto-immune in administrative
collections varies. No consistent categorisation of auto-immune diseases occurs, and
this may result in an underestimate of their burden on the community. 
Immunodeficiency
ImmunodeÞciency arises through a variety of mechanisms. Some people are born with
defective immune systems. In others, disease may suppress or damage the immune
system. Some microorganisms attack the immune system itself, leaving it unable to
protect the body against other microorganisms. A good example of the latter is infection
with HIV, which causes weakness of the immune system leading to AIDS. If damage to
the immune system reaches a certain point in people with HIV, cellular immunity
collapses and opportunistic infections and diseases such as KaposiÕs sarcoma and
pneumocystis pneumonia can cause death.
Sexual health
Sexual and reproductive health is described as a state of complete mental, physical and
social wellbeing in all matters relating to the reproductive system and to its functions
and processes (United Nations 1994). It is affected by, and affects, a broad range of
attitudes and social values.
Improved methods of contraception over the past half-century, and greater access to
those methods, have contributed to changes in attitudes both to sexuality and to
reproduction. In addition, various social and economic factors inßuence decisions about
marriage and the timing, spacing and numbers of children within a family.
The appearance of HIV/AIDS in the 1980s gave greater prominence to all sexually
transmitted diseases and inßuenced approaches to public education and awareness.
Greater recognition of the scope of sexual and reproductive health, particularly since the
UN International Conference on Population and Development in 1994, has encouraged
concern over reproductive health problems and issues such as female genital mutilation.
Table 2.6: Selected auto-immune diseases and conditions: estimated hospitalisations (1997Ð98) 
and mortality (1998)
Condition
Hospital separations Mortality
Males Females Males Females
Type 1 diabetes 5,691 5,454 192 154
Rheumatic heart disease 827 1,364 101 164
Rheumatoid arthritis 1,507 4,111 50 131
Multiple sclerosis 949 2,381 35 78
Systemic lupus 227 948 8 37
Sources: AIHW National Hospital Morbidity and Mortality Databases.
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This section provides an overview of the sexual health of Australians, relating to
reproduction, fertility control, sexually transmitted diseases and sexual health
problems. Section 2.5 on communicable diseases later in this chapter provides
additional information on sexually transmitted infections (STIs). 
Fertility
Since 1961, when each woman on average had 3.6 babies, total fertility rates have
declined to 1.75 births per woman in 2000 (ABS 2000a). This is notably below the
replacement level of 2.1 babies per woman, and reßects a trend in fertility to drop below
the replacement level in the developed, and even in some developing, countries.
Aided by effective and available methods of fertility control, Australian women are
increasingly delaying or avoiding marriage and postponing childbearing. The reasons
for such choices are beyond the scope of this report but have been widely discussed
elsewhere (e.g. McDonald 2000 and Hugo 2000).
The median age of Þrst marriage in 2000 was 26.7 years for women and 28.5 for men
(ABS 2000b) compared with 21 years for women and 23.3 for men in 1971 (BIR 1992).
Almost half (48%) of all childbearing now takes place at age 30 and over. Some 30% of
births occur outside marriage, although in most cases the paternity is acknowledged
(ABS 2000a).
Of the generation of women born in the mid-1960sÑthose currently reaching the end of
their reproductive yearsÑit has been estimated that more than one-Þfth will remain
childless (Carmichael 1998). For many such women, childlessness is a deliberate choice.
Others may have fertility problems, either innate or due to causes such as pelvic
infections. In addition there are increasing numbers for whom the postponement of
child-bearing results in age-related infertility. Demand for medical assistance such as in-
vitro fertilisation (IVF) and gamete intra-fallopian transfer is increasing; in 2000Ð01
there were 135,657 infertility services for which Medicare beneÞts were paid
(Department of Health and Ageing, pers. comm.). Chances of pregnancy with each IVF
treatment cycle have doubled in the past decade to 18% in 2000. More than 4,300 babies
were born after IVF in 1999, accounting for 1.7% of all births (AIHW NPSU 2001).
Contraception
Contraceptive methods may be non-medical, medical or surgical. The Þrst category
includes withdrawal or periodic abstinence (rhythm or calendar techniques), douches,
spermicides, and male and female condoms. In Australia, diaphragms, oral
contraceptives, intra-uterine devices, injectables and tubal occlusion devices as well as
post-coital or ÔemergencyÕ contraception require medical prescription or other medical
intervention. Tubal ligation or (occasionally) hysterectomy for women and vasectomy
for men are surgical procedures. In 2000Ð01, Medicare fee-for-service beneÞts were paid
for 6,417 tubal ligations and 27,518 vasectomies (Department of Health and Ageing,
pers. comm.). These Þgures exclude services to public patients in hospitals and through
other publicly funded programs. The exclusions are probably not very signiÞcant in the
case of tubal ligation but may considerably underestimate the total number of
vasectomies. However, the Medicare data do demonstrate the continuing trend to male,
rather than female, sterilisation.
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The 1995 National Health Survey (ABS 1998c) found that two-thirds of Australian
women aged 18Ð49 years were using contraception in 1995, the most recent year for
which data are available. Almost 40% of 18Ð49-year-old women that were currently
using contraception took an oral contraceptive, 19% were sterilised, and in 18% of cases
their partners used condoms.
A further 18% of 18Ð49-year-old women interviewed in the 1995 National Health Survey
were either not sexually active, or were trying to become or had become pregnant. The
remaining 15% did not use contraception, although they were presumably at risk and
trying to avoid pregnancy.
Data from the 1997 Survey of Australian Secondary Students indicated that 67% of
students of both sexes had begun sexual intercourse before the age of 18. However, in
1998 the Young WomenÕs Pregnancy Survey in New South Wales and the Australian
Capital Territory of women who had given birth or had a pregnancy termination in the
previous year showed that only 72% had used contraception at the time of Þrst
intercourse, and that proportion included those who used withdrawal and other less
reliable methods (Evans 2000).
Termination of pregnancy
National information on induced abortions is lacking. Only South Australia, the
Northern Territory and Western Australia collect population-based data on induced
abortions. In 2000Ð01, Medicare fee-for-service beneÞts were paid for 76,603
terminations of pregnancy; this Þgure excludes services to public patients in hospital
and through other publicly funded programs. Mathers and colleagues (AIHW: Mathers
et al. 1999a) estimated that in 1996 total terminations were some 90,700, a rate of 19 per
1,000 women aged 15Ð49. Of those terminations, about 93% or more than 84,000 may
have involved unwanted pregnancy (Adelson et al. 1995).
Sexually transmitted infections
Many STIs are notiÞable on a national basis, which means that any diagnosis of the
infection must be reported to the relevant State/Territory authorities. These reports are
then provided to the Commonwealth through the NNDSS. The infections classiÞed as
sexually transmissible for surveillance in the NNDSS are chlamydial infection,
donovanosis, gonococcal infection and syphilis.
Trends in the annual number of notiÞcations for chlamydia, gonococcal infection and
syphilis are shown in Figure 2.9. Chlamydia is the highest reported STI and is among
the top Þve notiÞable diseases in Australia.
In 2000, a total of 16,770 notiÞcations for chlamydial infection were received, a rate of
87.5 cases per 100,000 population compared with a rate of 23.4 per 100,000 population
in 1991. Part of this increase may reßect increased rates of testing and notiÞcation rather
than a genuine rise in incidence.
NotiÞcations of gonococcal infection have doubled over the same period, from 2,530 (a
rate of 14.6 per 100,000) in 1991 to 5,708 (29.8 per 100,000) in 2000. Antibiotic-resistant
strains of gonorrhoea present an increasing problem throughout the AsiaÐPaciÞc region. 
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In Australia in 2000, the Gonococcal Antimicrobial Surveillance Programme found that
19.5% of isolates were penicillin-resistant, whereas 9.6% were less sensitive and 8.2%
were resistant to quiriolene (GASP 2000).
The number of cases of syphilis has ßuctuated but the overall trend shows a slight
decrease. The highest number of reported cases was 2,695 in 1992 and the lowest 1,313
in 1997. In 2000 there were 1,780 cases, giving a rate of 9.3 per 100,000 population.
HIV/AIDS and hepatitis B and C are discussed later in this chapter (page 93).
Other important infections which are commonly or usually spread by sexual contact
include genital herpes, genital warts, trichomoniasis and some parasitic infestations
such as pubic lice. However, these infections are not subject to national notiÞcation and
no information on their incidence is available.
Health of reproductive organs and pregnancy
In 2000Ð01, the Bettering the Evaluation and Care of Health (BEACH) survey found that
female genital system problems accounted for 4.2 per cent of the total number of health
problems managed by general practitioners (GPs) (AIHW: Britt et al. 2001a). Most of
these visits were for genital check-ups or Pap smears (24%), or for menopausal
problems (23%). A further 13% involved menstrual problems, but this underestimates
their actual frequency. Of the young women in the WomenÕs Health Australia survey
who complained of menstrual problems, fewer than half had sought help from a doctor
(WomenÕs Health Australia 1997).
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Figure 2.9: Trends in sexually transmitted infection notifications, 1991 to 2000
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Consultations relating to pregnancy and family planning accounted for 2.7% of all health
issues in the BEACH survey. Male genital problems accounted for 1% of all health issues
managed by GPs.
Statistics on hospital separations (Table 2.7) provide some information on morbidity
related to reproductive organs (male and female) as well as complications of pregnancy
(AIHW 2001a).
Further indicators of reproductive health include female genital mutilation and male
erectile dysfunction. Most States and Territories now have legislation speciÞcally
banning female genital mutilation. However, in the 1990s an estimated 120,000 women
living in Australia came from countries where some form of female circumcision is
traditional. The proportion of women from those countries actually affected by these
practices remains unknown.
Erectile dysfunction among men may result from both physical and psychological
causes, including diabetes and cardiovascular disorders, treatments for prostate or
bladder cancer, and drug and alcohol abuse. A study in Perth of adult males attending
GPs found that 39 per cent of respondents reported erectile dysfunction and 18.6 per
cent experienced such dysfunction all the time. Only 11.4% had received any medical
treatment for the condition (Chew et al. 1997).
2.2 Functioning and disability 
Functioning and disability are important aspects of health in its broadest sense.
Disability can include an impairment in body structure or function, a limitation in
activities (such as mobility and communication) or a restriction in participation
(involvement in life situations such as social interaction and work). The experience and
degree of disability are inßuenced by environmental factors, such as social attitudes,
physical access or technical equipment. This conceptualisation of disability reßects that
of the new International ClassiÞcation of Functioning, Disability and Health (ICF),
which was endorsed by the World Health Assembly in May 2001 (WHO 2001b). The
Table 2.7: Hospital separations by principal diagnosis, 1999Ð00
Diagnosis
Separations % total separations
Males Females Males Females
Diseases of the male genital organs 42,835 . . 1.6 . .
Diseases of the breast 1,731 13,264 0.06 0.4
Diseases of the female pelvic organs 
and genital tract . . 167,282 . . 5.3
Complications relating to pregnancy . . 55,612 . . 1.8
Complications relating to labour/
delivery . . 268,861 . . 8.5
Complications relating to the 
puerperium . . 30,770 . . 1.0
Pregnancy with abortive outcome . . 72,151 . . 2.3
. . Not applicable.
Source: AIHW National Hospital Morbidity Database.
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ICF is a core member of the WHO family of health-related classiÞcations,
complementary to the other core member, the International ClassiÞcation of Diseases
(ICD), which focuses on diseases and health conditions.
Statistically, disability can be measured along a continuum, and estimates of the level of
disability in the community vary with the particular deÞnition. At the broadest level,
the ABS 1998 Survey of Disability, Ageing and Carers estimated that 3,610,300 people
(19.3% of the Australian population) had a ÔdisabilityÕ (Table 2.8). This reßected the
proportion of people in the survey who reported at least one of a list of limitations,
health conditions or impairments that had lasted, or were likely to last, for at least
6 months and which restricted everyday activities. The proportions of males and
females with a disability were approximately equal.
The 1998 survey also collected information about ÔspeciÞc activity restrictionsÕ, of which
there are Þve categories: restrictions in the three ÔcoreÕ activities of daily living (self-care,
mobility and communication), in schooling or in employment (Box 2.1). Of those with
disability, an estimated 3,155,900 people had at least one speciÞc activity restriction,
16.9% of the Australian population. Based on self-reports, an estimated 1,135,900 people
or 6.1% of Australians had a Ôsevere or profound core activity restrictionÕ, meaning that
they sometimes or always needed personal assistance or supervision with the ÔcoreÕ
activities of daily living.
Box 2.1: ABS 1998 Survey of Disability, Ageing and Carers: restrictions and their 
severity
Specific restrictions are:
• core activity restrictions
• schooling or employment restrictions.
Core activities are:
• self-care—bathing or showering, dressing, eating, using the toilet and managing incon-
tinence
• mobility—moving around at home and away from home, getting into or out of a bed or
chair and using public transport
• communication—understanding and being understood by others: strangers, family and
friends.
A core activity restriction may be:
• profound—unable to perform a core activity or always needing assistance
• severe—sometimes needing assistance to perform a core activity
• moderate—not needing assistance but having difficulty performing a core activity
• mild—having no difficulty performing a core activity but using aids or equipment
because of disability.
Note: In the text of this chapter, ‘a severe or profound core activity restriction’ is sometimes referred to as ‘severe or 
profound restriction’.
Source: ABS 1999c.
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Table 2.8: People with a disability, by disability status and severity, 1998
Core activity restriction Schooling or
employment
restriction
only(a)
Total with
specific
restrictions
Without
specific
restrictions
Total with a
disabilityProfound Severe Moderate Mild
Number (’000)
Males 218.8 286.6 338.6 534.3 188.4 1,566.7 254.4 1,821.1
Females 318.9 311.6 321.7 497.5 139.5 1,589.2 200.0 1,789.2
Persons 537.7 598.2 660.3 1,031.8 327.9 3,155.9 454.4 3,610.3
Per cent(b)
Males 2.4 3.1 3.6 5.8 2.3 16.9 2.7 19.6
Females 3.4 3.3 3.4 5.3 1.7 16.9 2.1 19.1
Persons 2.9 3.2 3.5 5.5 2.0 16.9 2.4 19.3
(a) Schooling or employment restriction related to people aged under 65 years.
(b) Percentage of the Australian population of that sex.
Source: ABS 1998 Survey of Disability, Ageing and Carers, unpublished data tables; AIHW 2001b.
Table 2.9: People with a disability as a percentage of the Australian population, 1998
Main disabling condition All disabling conditions
Condition type Number (’000) Per cent Number (’000) Per cent
Psychiatric(a) 258.2 1.4 609.6 3.3
Intellectual and other mental(b) 262.2 1.4 407.8 2.2
Sensory 393.8 2.1 n.a. n.a.
Diseases of eye 113.2 0.6 281.2 1.5
Diseases of ear 280.6 1.5 985.2 5.3
Physical 2,695.8 14.4 n.a. n.a.
Nervous system diseases 182.3 1.0 343.7 1.8
Stroke 63.6 0.3 230.3 1.2
Other circulatory diseases 246.6 1.3 1,004.1 5.4
Respiratory diseases 260.9 1.4 592.1 3.2
Arthritis 497.1 2.7 1,107.5 5.9
Other musculoskeletal 
disorder 744.3 4.0 1,212.9 6.5
Head injury/any other brain 
damage 39.2 0.2 169.6 0.9
All other diseases and 
conditions(c) 661.9 3.5 1,601.2 8.6
Total population 18,659.7 100.0 n.a. n.a.
n.a. Not available.
(a) Includes the groups entitled ‘Psychoses/mood affective disorders’ and ‘Neurotic/stress-related/somatoform disorders’ in 
ABS publications. This definition has changed since the 1993 survey (see AIHW 1997).
(b) Includes the groups entitled ‘Intellectual and developmental disorders’ and ‘Other mental and behavioural disorders’. 
This definition has changed since the 1993 survey and now includes Down syndrome (see AIHW 1997).
(c) Includes other physical diseases and conditions such as spina bifida, neoplasms and diseases of urinary system, 
genital organs and breast.
Source: AIHW analysis of ABS 1998 Survey of Disability, Ageing and Carers confidentialised unit record file.
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Most reported disabilities in the 1998 survey were associated with a physical Ômain
conditionÕ (14.4% of the population); i.e. the Ôlong-term condition identiÞed by a person
as the one causing the most problemsÕ (ABS 1999c). The most common physical Ômain
conditionsÕ were arthritis (2.7%) and other musculoskeletal disorders (4.0%). The next
most frequent group was sensory (2.1%), followed by intellectual (1.4%) and psychiatric
(1.4%) conditions (Table 2.9).
The possibility of multiple disabilities or conditions complicates the estimation of
prevalence. Table 2.9 compares the prevalence of various conditions, according to
whether they were reported as the main condition or among a number of disabling
conditions. Reported prevalence is higher when all conditions are considered,
suggesting the common occurrence of multiple conditions in the population with a
disability. In particular, head injury and brain damage, stroke and other circulatory
diseases were frequently reported in combination with another condition.
Recent studies from the United States and some European countries have suggested
that disability prevalence rates among older people have started to decline and that the
improvements have mainly occurred through reduced levels of moderate or mild
disability. On the other hand, no evidence of a decline in disability rates was reported
for Australia, the United Kingdom and some other developed countries (AIHW 2001b).
Indeed, between 1993 and 1998 the estimated rate of severe or profound restriction in
Australia, as reported by the ABS, increased to 6.1% of the population after being stable
during the decade or so before, at around 4%. However, almost all of this reported
increase can be attributed to the changes in design and methods of the 1998 disability
survey which ÔcapturedÕ a larger number of people with a severe or profound
restriction than the 1993 survey (AIHW 2001b).
2.3 Mortality
This section describes the patterns of mortality in the Australian population, examining
causes of death, age and sex patterns, and recent and longer term trends over time. 
Leading causes of death 
In 2000, there were 128,291 deaths recorded in Australia, consisting of 66,817 male
deaths (712 deaths per 100,000 males) and 61,474 female deaths (450 deaths per 100,000
females). The top ten individual causes of death were responsible for about 60% of all
deaths in 2000 (Table 2.10). Coronary heart disease (also known as ischaemic heart
disease: heart attack and related disorders) and cerebrovascular disease (stroke)
accounted for more than 30% of all deaths. All cancers combined accounted for almost
another 30%.
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Death rates over the last century
Death rates fell considerably over the last century. The age-standardised rates for males
have fallen by 62% from a high of 1,887 deaths per 100,000 males in the early 1900s to
712 deaths per 100,000 in 2000. The rates for females fell by 70% from 1,516 deaths per
100,000 during the early 1900s to 450 deaths per 100,000 females in the year 2000
(Figure 2.10). This has been attributed to a combination of better living conditions,
improved public health and safety initiatives, and improved medical treatments.
Trends in death rates for the major causes from 1907 to 2000 are shown in Figures 2.11
and 2.12.
Table 2.10: Leading causes of death, 2000
Males Females
Cause
Number
of deaths
% of all
deaths Cause 
Number
of deaths
% of all
deaths
1 Ischaemic heart disease 
(I20–I25)
14,052 21.0 1 Ischaemic heart disease 
(I20–I25)
12,469 21.3
2 Cerebrovascular disease 
(I60–I69)
4,913 7.3 2 Cerebrovascular disease 
(I60–I69)
7,387 12.0
3 Lung cancer (C34) 4,587 6.9 3 Breast cancer 
(C50)
2,511 4.1
4 Chronic obstructive 
pulmonary disease 
(J41–J44)
3,281 4.9 4 Lung cancer (C34) 2,291 3.7
5 Prostate cancer 
(C61)
2,663 4.0 5 Colorectal cancer 
(C18–C21)
2,179 3.5
6 Colorectal cancer 
(C18–C21)
2,533 3.8 6 Chronic obstructive 
pulmonary disease 
(J41–J44)
2,015 3.3
7 Suicide (X60–X84) 1,860 2.8 7 Dementia and related 
disorders (G30–G32, 
F01–F03)
1,698 2.8
8 Diabetes (E10–E14) 1,594 2.4 8 Pneumonia & influenza 
(J10–J18)
1,625 2.6
9 Land transport accidents 
(V00–V89)
1,374 2.0 9 Diabetes (E10–E14) 1,412 2.3
10 Pneumonia & influenza 
(J10–J18)
1,312 2.0 10 Diseases of arteries, 
arterioles and capillaries (I7)
1,296 2.1
Total leading causes 38,169 57.1 Total leading causes 34,883 56.7
All deaths 66,817 100 All deaths 61,474  100
Note: Codes refer to the International Classification of Diseases, 10th Revision (ICD-10).
Source: AIHW National Mortality Database.
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Box 2.2: Comparing death rates: age-standardisation
Statistics relating to deaths are sometimes presented as crude death rates, i.e. the number of
deaths in a year divided by the number of individuals in the corresponding population. For
example, the crude death rate in Australia in 2000 was 669 deaths per 100,000 population.
However, since the risk of dying varies greatly with age, even small differences in the age
structure of populations may affect crude death rates. This may make comparisons between
different populations and analysis of time trends in the same population misleading. One
way around this difficulty is to compare age-specific death rates, i.e. mortality at particular
ages, but this requires that separate comparisons be made for each age group. However,
variations in age structure, between populations or over time, can be adjusted by a simple
statistical procedure called age-standardisation. 
In this report, unless otherwise specified, death rates have been directly age-standardised to
the Australian population as at 30 June 1991 (ABS 1993). Both the AIHW and the ABS
agreed to adopt this as the national standard until population estimates for 30 June 2001
become available. The population at 30 June 1991 was the standard used in the 1996, 1998
and 2000 editions of AustraliaÕs Health, whereas the 1992 and 1994 editions used the
population as at 30 June 1988. For this reason, age-standardised death rates in this publi-
cation cannot be directly compared with those in the 1992 and 1994 editions.
The major causes of death are coded to the International Classification of Diseases (ICD)
system, Version 10 (WHO 1992). The ICD-10 classification categorises diseases into 21
broad groupings or chapters on the basis of type of condition or body system. Causes of
death can be further disaggregated either on the basis of similar disease causation (e.g. infec-
tious diseases or cancers), or into specific entities (e.g. tuberculosis, breast cancer or AIDS).
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Note: Age standardised to the Australian population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 2.10: Trends in mortality, 1907 to 2000
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Trends over the last century for selected conditions
 
Coronary heart disease
 
 (also known as
 
 
 
ischaemic heart disease, and comprising heart
attack and related disorders) is the single biggest cause of death in Australia. In 2000,
there were 150 deaths per 100,000 males and 84 deaths per 100,000 females with coronary
heart disease as the underlying cause of death. Coronary heart disease death rates
climbed steadily from 1940 to 1968 (AIHW: dÕEspaignet 1993). Since then, the rates have
declined steadily. During the 5 years 1996Ð00, death rates declined annually by 6.3% in
males and 5.6% in females. The reduction in coronary heart disease death rates is believed
to be due both to prevention and to improved medical management of the disease.
 
Cerebrovascular disease
 
 
 
(stroke) is the second largest cause of death for both sexes,
with 53 deaths per 100,000 males and 48 deaths per 100,000 females in 2000. Death
rates increased over the Þrst half of the century, but began to slow down between 1950
and 1970. Since 1970, death rates for stroke have declined annually by over 4.5% in
males and 4.9% in females. As with CHD, changes in lifestyle and improvements in
disease management are considered to have contributed to the decline in death rates.
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1
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Prostate cancer
Chronic obstructive 
pulmonary disease
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heart disease
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Lung cancer
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Deaths per 100,000 population
Notes
1. Age standardised to the Australian population at 30 June 1991.
2. Death rates presented on logarithmic scale.
3. The time series for ischaemic heart disease begins in 1968 due to coding changes between ICD-8 and previous 
versions of the ICD.
Source: AIHW National Mortality Database.
Figure 2.11: Trends in major causes of death, males, 1907 to 2000
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Lung cancer
 
 is the leading cause of cancer deaths in Australia, with 48 deaths per
100,000 in males and 19.6 deaths per 100,000 in females in 2000. Between 1940 (when
lung cancer was Þrst listed as a speciÞc cause of death) and 1982, the annual death rate
for males increased steadily. Since 1982 the male rate has been declining steadily. During
the 5 years 1996Ð00, the rate declined annually by 3.1%. The lung cancer death rate for
females also increased from 1940 to 1967, but the female rate was a third of the rate for
males. The lung cancer death rate for females, unlike that for males, continued to rise
beyond 1982 (Figures 2.11 and 2.12), reßecting trends in smoking among females. During
the period 1982Ð95 the death rate rose at 1.8% annually. Since 1995, the death rate for
lung cancer in females has continued to rise, but more slowly at about 0.2% per year.
 
Colorectal cancer
 
 is the second most common cause of cancer deaths, with rates of 26.5
per 100,000 males and 17.5 per 100,000 females in 2000. Colorectal cancer death rates
have ßuctuated over the last few decades. The rates increased in both sexes from 1921
to the early 1940s. For males, the rate continued to climb to a high of 32.4 deaths per
100,000 in 1983. Since then the rate has been falling steadily and during the 5 years
1996Ð00 it declined at 2.5%. The rate for females has fallen since 1942, and during the
5 years 1996Ð00 it fell at 2.5% per year.
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Female breast cancer Cerebrovascular
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Deaths per 100,000  population
Chronic obstructive 
pulmonary disease
Notes
1. Age standardised to the Australian population at 30 June 1991.
2. Death rates presented on logarithmic scale.
3. The time series for ischaemic heart disease begins in 1968 due to coding changes between ICD-8 and previous 
versions of the ICD.
Source: AIHW National Mortality Database.
Figure 2.12: Trends in major causes of death, females, 1907 to 2000
 
AH2002 body 26-6  Page 35  Wednesday, June 26, 2002  7:07 PM
 36 
 
 Australia’s Health 2002
 
TRIM SIZE 175 mm Wide x 250 mm Deep
 
Breast cancer 
 
is the fourth leading cause of cancer deaths, and the most common cause
of cancer deaths among females. In 2000, there were 21.5 deaths per 100,000 females.
The death rate for breast cancer peaked in the early 1940s, having increased slowly
since 1921. The rate decreased between 1940 and 1950, after which it remained
relatively stable until 1993, ßuctuating between 25 and 27 deaths per 100,000 females.
Since 1993, the rate has fallen at about 3.0% per year.
 
Prostate cancer
 
 is the second most common cause of cancer death in males, with 83% of
prostate cancer deaths occurring among those over the age of 70. In 2000 the death rate
for prostate cancer was 28.8 deaths per 100,000 males. Since 1921, the death rate for
prostate cancer has been increasing slowly. The early 1990s saw a marked increase in
the death rate, reaching a high of 35.1 deaths per 100,000 males in 1993. However,
between 1993 and 2000 the rate decreased by 3.1% per year.
 
Chronic obstructive pulmonary disease
 
 (COPD) is the fourth most common cause of
death in males and the sixth most common in females. The two main diseases in this
group, chronic bronchitis and emphysema, are usually caused by smoking. In 2000,
there were 35.5 deaths per 100,000 males and 15.6 deaths per 100,000 females with
COPD as the underlying cause of death. Death rates for COPD have followed a pattern
similar to those for deaths from lung cancer in both males and females. COPD death
rates in males increased steadily from the early 1950s, peaking in 1970. In the period
1970Ð00, the male death rate declined by 1.1% per year and since 1995 the decline has
been 5.2%. In females, the COPD death rate increased between 1960 and 1995 at about
4.5% per year, again related to trends in female smoking. However, since 1995 there has
been a 4.2% annual decline in the COPD death rate among females. 
 
Suicide
 
 statistics began in 1907 when the rates were 24.4 and 5.0 deaths per 100,000
population for males and females respectively. The suicide rate for males has ßuctuated
between 15 and 25 deaths per 100,000 during the twentieth century, except for the
World War II years when the rate fell to 11 deaths per 100,000. The rate in 2000 was 19.4
deaths per 100,000 males. The suicide rate for females was relatively constant over the
twentieth century, ßuctuating between 4 and 6 deaths per 100,000 except during the
period from 1960 to the late 1970s. During this period the rate rose, reaching 12.2 deaths
per 100,000 females in 1967, after which it declined. By the 1980s the rate had fallen to
about 5 deaths per 100,000 females and in 2000 it was 5.2.
 
Major causes of death by life stage
 
Of the 128,291 deaths recorded in Australia in 2000 (Table 2.11): 
¥ more than 70% of all male deaths and more than 80% of female deaths were in people
aged 65 or older
¥ about 23% of male deaths and 14% of female deaths were in people aged 25Ð64
¥ about 3% of male deaths and 2% of female deaths were in people aged less than 25 years.
Injuries and poisoning are the most common causes of death for males and females in
age groups 1Ð14 and 15Ð24 and for males aged 25Ð44. Cancer is the most common cause
of death for females aged 25Ð44, and for males and females aged 45Ð64. Cardiovascular
disease, which includes ischaemic heart disease and stroke, is the prominent cause of
death for people aged over 65 years. The major causes of death in various age groups in
2000 are presented in Table 2.12.
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Table 2.11: Numbers of deaths, 2000
Age group Males Per cent Females Per cent
0 725 1.1 565 0.9
1–14 377 0.6 264 0.4
15–24 1,201 1.8 463 0.7
25–44 4,311 6.5 2,006 3.3
45–64 11,173 16.7 6,712 10.9
65–84 36,303 54.3 27,798 45.2
85+ 12,709 19.0 23,644 38.5
Missing 18 — 2 —
Total 66,817 100.0 61,474 100.0
Source: AIHW National Mortality Database.
Table 2.12: Leading causes of death, 2000
Males Females
Age group Cause of death % deaths(a) Cause of death % deaths(a)
Infants (less 
than 1 year
Conditions emerging from the 
perinatal period 
Congenital anomalies
Sudden death
Injury and poisoning
49.0
25.0
13.0
3.4
Conditions emerging from the 
perinatal period 
Congenital anomalies
Sudden death
Injury and poisoning
49.7
25.1
9.7
4.1
1–14 Injury and poisoning
Cancer
Nervous system disease
Congenital anomalies
50.7
14.3
10.3
6.4
Injury and poisoning
Cancer
Congenital anomalies
Nervous system diseases
35.6
17.4
11.4
9.8
15–24 Injury and poisoning
Mental disorders
Cancer
Nervous system diseases
72.8
7.2
5.3
4.5
Injury and poisoning
Cancer
Mental disorders
Endocrine disorders
61.3
11.7
6.7
4.1
25–44 Injury and poisoning
Cancer
Cardiovascular disease
Digestive disorders
51.8
12.4
13.1
7.6
Cancer
Injury and poisoning
Cardiovascular disease
Mental disorders
33.2
31.5
12.0
4.2
45–64 Cancer
Cardiovascular disease
Injury and poisoning
Respiratory system diseases
41.4
28.5
9.5
4.8
Cancer
Cardiovascular disease
Respiratory system diseases
Injury and poisoning
55.2
17.8
5.7
5.7
65–84 Cardiovascular disease
Cancer
Respiratory system diseases
Endocrine
38.2
34.6
10.1
3.4
Cardiovascular disease
Cancer
Respiratory system diseases
Endocrine
40.7
29.9
8.7
3.9
85+ Cardiovascular disease
Cancer
Respiratory system diseases
Genitourinary diseases
47.9
18.3
12.7
3.4
Cardiovascular disease
Cancer
Respiratory system diseases
Mental disorders
55.6
11.4
8.9
4.3
(a) Percentage within age group.
Source: AIHW National Mortality Database.
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2.4 Non-communicable diseases and conditions
Cardiovascular disease
The term Ôcardiovascular diseaseÕ is used to cover all diseases and conditions involving
the heart and blood vessels. It includes coronary heart disease, stroke, peripheral
vascular disease and heart failure. The main underlying problem in cardiovascular
disease is atherosclerosis, a process that clogs blood vessels with deposits of fat,
cholesterol and other substances that have built up in the inner lining of the vessels. It
is most serious when it affects the blood supply to the heart (causing angina, heart
attack or sudden death) or to the brain (which can lead to a stroke).
Cardiovascular disease is AustraliaÕs largest health problem. Despite great declines in
death rates from it over the past few decades, the health and economic burden of
cardiovascular disease exceeds that of any other disease and it kills more people than
any other disease (accounting for 39% of all deaths). Coronary heart disease is the
greatest single cause of death among Australians and stroke is the second largest.
Based on the 1995 National Health Survey, an estimated 2.8 million Australians, or 16%
of the population, had cardiovascular conditions. High blood pressure was the most
common condition for both males and females (AIHW 2001c).
Much of the death, disability and illness caused by cardiovascular disease is
preventable. Many Australians remain at higher risk of the disease through tobacco
smoking, being physically inactive, eating a diet high in saturated fats or being
overweight. Many Australians have high blood pressure or high blood cholesterol. It is
important to note that there have been declines in physical activity participation and
that the proportion of overweight and obese Australians has dramatically increased
over the past 20 years (see Chapter 3). 
Coronary heart disease (ischaemic heart disease)
Coronary heart disease is the most common cause of sudden death in Australia. It
consists mainly of acute myocardial infarction (heart attack) and angina. A heart attack
is a life-threatening emergency that occurs when a vessel supplying blood to the heart
muscle suddenly becomes blocked by a blood clot. Angina is temporary chest pain or
discomfort when the heartÕs own blood supply is inadequate to meet extra needs.
There are no national data on the incidence of coronary heart disease in Australia.
However, the Universities of Newcastle and Western Australia and the Queensland
Department of Health have developed a method to estimate the rate of coronary events
among people aged 35Ð69 years (AIHW 2001c). Using this method, it is estimated that
there were 18,817 coronary events (mainly heart attacks) among people aged 35Ð69 in
1997Ð98. Of these coronary events, almost two-thirds (12,457 cases) were non-fatal heart
attacks. 
The rates of non-fatal heart attacks have declined signiÞcantly between 1993Ð94 and
1997Ð98, by 13% for men and 20% for women.
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Stroke
Stroke (also known as cerebrovascular disease) occurs when an artery supplying blood
to the brain suddenly becomes blocked or bleeds, often causing paralysis of parts of the
body or speech problems. It includes ischaemic stroke (blockage), haemorrhagic stroke
(bleeding), transient ischaemic attack and other cerebrovascular diseases. 
Each year, around 40,000 Australians have a stroke, with 70% of these being Þrst-ever
strokes. Strokes are more common among older Australians, with around 50% of all
strokes occurring in those aged 75 years and over. Under the age of 85 years, the
incidence of stroke is higher in males than in females. For 45-year-olds, the risk of
having a stroke before age 85 is 1 in 4 for males and 1 in 5 for females (NHMRC 1997b).
Stroke is a leading cause of disability. From the 1998 Survey of Disability, Ageing and
Carers there were an estimated 63,530 Australians with a disability resulting from a
stroke. Over 75% of these needed assistance with self-care, mobility or communication
(ABS 1999c).
Rheumatic fever and rheumatic heart disease
Rheumatic fever is caused by group A streptococcus bacteria associated with infections
of the throat and skin. This occurs mainly in children and young adults and may affect
the heart valves, the heart muscle and its lining, the brain and the joints. Recurrences of
rheumatic fever lead to cumulative heart damage and can be almost completely
prevented by strict follow-up and monthly injections of penicillin. Rheumatic heart
disease is the longer term damage done to the heart muscle and heart valves by acute
rheumatic fever.
Although this type of cardiovascular disease is rare among the Australian population
overall, its prevalence among Indigenous Australians living in remote areas is very
high. Since the 1950s acute rheumatic fever and rheumatic heart disease have largely
become diseases of economically disadvantaged people. Poverty and overcrowding,
poor sanitary conditions, lack of education and limited access to medical care for
diagnosis and treatment are contributing factors to this disease in Australia.
A register of people with known or suspected rheumatic fever and rheumatic heart
disease operates in the Top End of the Northern Territory. The following data come
from the Northern Territory Rheumatic Heart Disease Register (Angela Kelly, pers.
comm.). In 2001, Indigenous children aged 5Ð14 years accounted for 62% of all cases of
acute rheumatic fever among Indigenous Australians in the Northern Territory (13
cases). There were 143 cases for every 100,000 Indigenous children aged 5Ð14. In
contrast, there were no reported cases of acute rheumatic fever among other Australian
children living in the area.
In 2001, there were 660 people with rheumatic heart disease in the Top End of
AustraliaÕs Northern Territory, of whom 93% were Aboriginal and Torres Strait Islander
peoples (617 cases). Rheumatic heart disease was present in 57 children aged 5Ð14 (9%
of all cases), all of whom were Indigenous Australians. The prevalence of rheumatic
heart disease among Indigenous Australians in the Top End was 1,640 per 100,000 in
2001. In contrast, among other Australians in the area the rate was 38 per 100,000.
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Health services
General practice
A survey of general practice activity found that in 2000Ð01 cardiovascular problems
represented 11% of all problems managed by GPs (AIHW: Britt et al. 2001a).
Hypertension (high blood pressure) was the most common cardiovascular problem
managed and was the most frequent problem seen in general practice overall,
accounting for 6.0% of all problems. Lipid disorders (abnormal levels of cholesterol or
related substances in the blood) rated highly as well, accounting for 2.0% of problems
managed. Other common cardiovascular problems managed were coronary heart
disease (0.9%) and heart failure (0.5%).
Several classes of drugs to lower blood pressure or blood lipids were among the top 30
drug groups prescribed by GPs, reßecting the large number of high blood pressure
and/or lipid problems managed. Lipids accounted for the highest number of chemistry
pathology tests ordered, and represented 11.3% of all pathology tests ordered by GPs.
The two problems accounting for the highest number of pathology tests ordered overall
were lipid disorder (6.4% of these problems were managed with a pathology order) and
hypertension (6.2% of these problems were managed with a pathology order).
Comparison of 2000Ð01 survey results with those of a similar study conducted in
1990Ð91 showed that although hypertension remained the most common problem
managed by GPs, the rate per 100 encounters fell from 9.5 to 8.6. In contrast, the
management rate for lipid disorders increased from 1.8 to 2.9 per 100 encounters.
Hospitalisation
In 1999Ð00, cardiovascular disease accounted for 443,068 hospital separations (7.5% of
all hospitalisations) from all public acute and private hospitals in Australia. Of these,
36% were attributed to coronary heart disease, 12% to stroke, 11% to heart rhythm
disorders, 9% to heart failure, 3% to peripheral vascular disease and 2% to hypertensive
disease.
Across all age groups, there were likely to be more males in hospital for cardiovascular
disease than females. The sex differential was particularly marked for coronary heart
disease and peripheral vascular disease, where there were twice as many males in
hospital for these diseases as females. Hospitalisations associated with stroke and heart
failure were similar for the two sexes, whereas for hypertensive disease, rheumatic
fever and rheumatic heart disease, females had more hospital separations than males.
Hospitalisation for cardiovascular disease increased rapidly with age. Although those
aged 55 years and over represent only 21% of the total population, they accounted for
over three-quarters of hospital separations for cardiovascular disease. In the case of
stroke, peripheral vascular disease and heart failure, over 88% of hospitalisations were
for those aged 55 years and over. 
The average length of stay in hospital for cardiovascular disease declined from 7.6 days
in 1993Ð94 to 5.4 days in 1999Ð00. Over this period, there was an increase in the
proportion of same-day patients, particularly for coronary heart disease, largely
reßecting the much greater use of investigations in recent years. On average, those in
hospital for stroke in 1999Ð00 tended to stay the longest (9.7 days), followed by heart
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failure (8.4), peripheral vascular disease (7.6), rheumatic fever and rheumatic heart
disease (7.6), and hypertensive disease (4.4). Those in hospital for coronary heart
disease tended to stay for a shorter period (on average 4.5 days) than those in hospital
for other major cardiovascular diseases, diabetes, most cancers and mental disorders.
The average length of stay for non-cardiovascular diseases was 3.7 days.
Although males were more likely than females to be in hospital for cardiovascular
disease, females tended to stay in hospital longer (5.8 days compared with 5.2 days)
(Figure 2.13). Length of stay in hospital for cardiovascular disease increased with age
after age 30, with those aged 85 and over staying in hospital for 9.1 days on average
compared with 2.8 days for 30Ð34-year-olds.
In 1999Ð00, there were 18,276 hospitalisations for cardiovascular disease where the
patient died in hospital (4.1% of cardiovascular disease hospitalisations). Females in
hospital for cardiovascular disease were more likely to die in hospital than males (4.6%
compared with 3.7%) (Figure 2.14). 
The in-hospital death rate for coronary heart disease was 2.8% of hospital separations
for this disease; for heart attacks (a major form of coronary heart disease) the rate was
over three times as high at 9.8% in 1999Ð00 (3,523 hospitalisations). Females in hospital
for heart attacks were more likely to die than males (14.2% compared with 7.4%). Of the
patients in hospital for stroke, 10.5% died in hospital, with females more likely to die in
hospital than males (11.9% compared with 9.2%).
Hypertensive disease
Coronary heart disease
All cardiovascular disease
Heart attack
Peripheral vascular disease
Rheumatic heart disease
Heart failure
Stroke
0 2 4 6 8 10 12
Male
Female
Average length of stay (days)
Source: AIHW National Hospital Morbidity Database.
Figure 2.13: Average length of stay for cardiovascular conditions, 1999Ð00
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Cardiovascular procedures
There is a range of procedures to diagnose and treat cardiovascular disease (the main
procedures are explained in Box 2.3).
Coronary angiography (also known as coronary arteriography) is a diagnostic
procedure for coronary heart disease and provides an X-ray picture of the heartÕs
arteries. In 1999Ð00 there were 77,158 angiograms.
Cardiac surgery and coronary angioplasty are the most common cardiac procedures
undertaken in Australia. There has been a progressive increase in coronary artery
bypass grafting since the 1960s. Coronary angioplasty was introduced in Australia in
the 1980s and has grown rapidly since then. Coronary stenting, widespread in Australia
since 1995, was developed to reduce the risk of early closure of the coronary artery
following coronary angioplasty. In 1998, coronary angioplasty replaced coronary artery
bypass grafting as the most common procedure in the treatment of coronary heart
disease (Figure 2.15).
In 1999, there were 19,444 coronary angioplasty procedures with an in-hospital death rate
of 1%. Of these procedures, 86% involved the placing of a coronary stent (16,626
procedures). The average length of stay for a coronary angioplasty procedure was 3.7 days.
In 1999, there were 17,321 coronary artery bypass grafting procedures, with 2.6% of
patients dying in hospital. The average length of stay for this procedure was 11.8 days.
In addition, during 1999Ð00 there were 27,764 computerised tomographic (CT) scans of
the brain for a diagnosis of stroke and 3,834 carotid endarterectomies to assist in
making a diagnosis of stroke.
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Source: AIHW National Hospital Morbidity Database.
Figure 2.14: In-hospital mortality rate for cardiovascular conditions, 1999Ð00
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Box 2.3: Cardiovascular procedures
Coronary angiography gives a picture of the heart’s arteries, known as the coronary
arteries. The procedure is used to diagnose coronary heart disease and is essential before
either coronary artery bypass surgery or coronary angioplasty.
Coronary angioplasty involves inserting a catheter with a balloon into a major artery
via the skin. The catheter is threaded through the circulation back towards the heart and
into the coronary arteries to the area of the vessel blockage. The balloon is then inflated
against the blocked area to create a wider passage for blood flow.
Coronary stenting involves expanding a metal mesh tube within the artery to form a
supporting structure to hold the artery open at the point where there is narrowing. The
development of this catheter-based technique was due to the risk of early acute closure of
the coronary artery and a high rate of reblockage from coronary angioplasty. 
Coronary artery bypass grafting (CABG) entails opening a patient’s chest and using
blood vessel grafts to bypass blockages in the coronary arteries and restore adequate blood
supply to the heart muscle. CABG is not a cure for coronary artery disease, and there is a
risk of blockage recurrence.
Computerised tomographic (CT) scans of the brain are used to guide treatment in acute
stroke by distinguishing between major stroke types (either blocked blood supply to the
brain, or bleeding within the brain or on its surface). The test is also done to confirm a
clinical diagnosis of stroke.
1970 1972 1974 1976 1978 1980 1982 1984 1986 1988 1990 1992 1994 1996 1998
0
2
4
6
8
10
12
14
16
18
20
Coronary artery bypass grafts
Coronary angioplasty
Coronary stenting
Number of procedures (’000)
Year
Note: Coronary angioplasty includes procedures with or without stents.
Source: AIHW/NHF National Cardiac Surgery and Coronary Angioplasty Registers.
Figure 2.15: Trends in coronary revascularisation procedures, 1970 to 1999
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Mortality
Cardiovascular disease was the leading cause of death among Australians in 2000,
accounting for 49,741 deaths or 39% of all deaths. Coronary heart disease was the major
cardiovascular cause of death accounting for 53% of all such deaths, followed by stroke
(25%), heart failure (5%) and peripheral vascular disease (5%). Cardiovascular mortality
is higher among Indigenous Australians, in rural areas of the country and among
socioeconomically disadvantaged groups (AIHW 2001c) (see Chapter 4).
Over the last three decades there has been a considerable decline (around 68%) in
cardiovascular death rates. These declines are substantial, especially when compared
with a decline of around 24% in the death rate for non-cardiovascular diseases. During
the period 1989 to 2000, death rates for cardiovascular diseases fell 4.2% per year for
males and 4.0% per year for females, a faster decline than for all causes combined
(Table 2.13). Coronary heart disease death rates have been declining faster than death
rates from stroke.
Declines in death rates for coronary heart disease and stroke have been inßuenced by
reductions in the prevalence of some risk factors (high levels of blood pressure, tobacco
smoking and saturated fat intake) and in medical interventions such as counselling,
drug use, emergency care, medical and surgical treatment, and follow-up care. These
gains have been achieved despite a signiÞcant increase in the prevalence of overweight
and declines in physical activity levels (see Chapter 3).
Table 2.13: Deaths from cardiovascular diseases, 2000
Cause of death 
(ICD-10 code)
Males Females
Number Rate(a)
Annual
rate of
change(b)
(per cent) Number Rate(a)
Annual
rate of
change(b)
(per cent)
All cardiovascular disease
(I00–I99) 23,774 255.7 –4.2 25,967 172.9 –4.0
Coronary heart disease
(I20–I25) 14,052 150.2 –4.8 12,469 84.0 –4.7
Stroke
(I60–I69 and G45, G46) 4,931 53.7 –2.9 7,423 48.5 –3.1
Heart failure
(I50) 982 10.9 –5.3 1,662 10.0 –5.3
Peripheral vascular disease
(I71–I74) 1,108 11.9 –3.8 938 6.5 –1.8
Hypertensive disease
(I10–I15) 449 4.9 –2.7 753 5.0 –2.3
Rheumatic fever and rheumatic 
heart disease
(I00–I09) 101 1.1 –3.0 164 1.3 –3.0
All causes of death 66,817 712.7 –2.5 61,474 450.7 –2.0
(a) Age-standardised rate per 100,000 population.
(b) Annual change in the age-standardised death rate over the period 1989 to 2000.
Source: AIHW National Mortality Database.
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Males were more likely to die from cardiovascular disease than females across almost
all age groups, with death rates among males aged 25Ð74 two to three times those of
females in 2000. For coronary heart disease, the sex differential (difference between the
sexes) was more marked than for cardiovascular disease overall, particularly in the
25Ð64 age group where death rates among males were three to four times those of
females. For stroke, the sex differential was not as large as for coronary heart disease,
with death rates across most age groups marginally higher for males than for females
(Figure 2.16). 
Death rates for cardiovascular disease increased dramatically with age, with over 80%
of all such deaths occurring among those aged 70 years and over, compared with less
than 5% for those aged under 60.
International comparisons
Cardiovascular disease is a major health and economic burden throughout the world,
especially in developed countries. However, rates of cardiovascular disease are
increasing dramatically in developing countries. It is estimated that coronary heart
disease will become the single leading public health problem for the world by 2020
(AIHW 2001c).
Australian cardiovascular disease death rates ranked towards the lower end of the 28
countries compared in Figure 2.17 (sixth lowest for males and Þfth lowest for females).
Despite this, the Australian cardiovascular death rates for males and females were
respectively 1.4 and 1.5 times the lowest ratesÑthose of Japanese males and females.
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Source: AIHW National Mortality Database.
Figure 2.16: Death rates for major cardiovascular diseases, 2000
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The relative ranking of Australian death rates varies for the major components of
cardiovascular disease. For coronary heart disease, Australian death rates ranked
towards the middle of those compared (eleventh lowest for males and twelfth lowest
for females), whereas for stroke Australian death rates were among the lowest of those
compared (fourth lowest for both males and females).
Burden of cardiovascular disease
Cardiovascular disease was estimated to account for 22% of the disease burden in
Australia in 1996, 33% of premature mortality and 9% of years of equivalent ÔhealthyÕ
life lost through disease, impairment and disability (AIHW: Mathers et al. 1999a).
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Source: WHO 2001c; AIHW National Mortality Database.
Figure 2.17: Death rates for cardiovascular disease in selected countries, latest available 
year
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In 1993Ð94, cardiovascular disease accounted for the largest proportion of health system
costs in Australia, $3.7 billion or 12% of total health system costs (AIHW: Mathers &
Penm 1999a). 
Cancers
Cancer is a diverse group of diseases in which some of the bodyÕs cells become defective,
begin to multiply out of control, can invade and damage the area around them, and can
also spread (metastasise) to other parts of the body to cause further damage. 
In 2000, there were 35,628 deaths in Australia from cancer (malignant neoplasms),
accounting for 27.8% of all deaths, with the proportion as high as 55.9% of deaths among
45Ð54-year-old females and 45.0% of deaths among 55Ð64-year-old males. The death rate
for cancers as a whole peaked in the 1980s and has been declining slowly since then. 
Information on cancers is collected by State and Territory cancer registries, and
compiled by the AIHW in the National Cancer Statistics Clearing House (see Box 2.4).
With current knowledge of cancer risk factors, incidence and death rates for several major
cancers can be greatly reduced. It has been estimated that 30% of cancers can be attributed
to tobacco smoking, 30% to dietary inßuences, 2% to radiation exposure, 5Ð15% to
infectious agents, and the remainder to other risk factors (Trichopoulos et al. 1996). The
AIHW has estimated that 7,068 cancer deaths in 1998 were smoking-related and a further
307 were due to excessive alcohol consumption (AIHW & AACR 2001a). Many of the 979
deaths from melanoma can be attributed to excessive exposure to the sun.
Box 2.4: Cancer surveillance and monitoring in Australia
The registration of cancer is required by law in each of the States and Territories, usually
under the Public Health Acts, where the data are collated by cancer registries. These regis-
tries collect clinical and demographic information about people with newly diagnosed
cancer. This information is collected from hospitals, pathologists, radiation oncologists
(cancer specialists), cancer treatment centres and nursing homes. 
Agreement was reached in 1990 for all State and Territory cancer registries to supply the
AIHW with records of all new cases of cancer from 1982 onwards, excluding non-
melanoma skin cancer. This national collection is called the National Cancer Statistics
Clearing House (NCSCH) and is operated by the AIHW under the supervision of the Aus-
tralasian Association of Cancer Registries (AACR). Both the Australian Institute of
Health and Welfare Act and Commonwealth privacy law provide for the protection of con-
fidentiality of records supplied to the AIHW. As well as national statistics, the NCSCH
also enables data to be released to researchers after a strict scientific and ethical review
process which involves the AACR executive, the AIHW Ethics Committee and the State
and Territory cancer registries. In December 2001 data for incidence were available to
1998 and for mortality to 2000. 
In addition, the Registrars of Births, Deaths and Marriages collect information related to
deaths from cancer. By combining information from these sources, statistics can be pro-
duced of cancer incidence, survival and mortality. These have disclosed high-risk groups
and emerging incidence trends that have warranted a public health response.
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Some risk factors are modiÞable through lifestyle changes whereas others are inherited.
Although some risk factors are unavoidable, risks of particular cancers may be reduced
through clinical monitoring of people and their risk factors, and diagnosing and
treating new cases early in their development.
Each year, approximately 350,000 new cancer cases are diagnosed in Australia. A large
proportion of these, approximately 270,000, are non-melanoma skin cancers (NMSC)
which, if treated early, are much less life-threatening than most other cancers. Most of
AustraliaÕs cancer registries do not record details of NMSC as most cases are not
conÞrmed by histology, or not reported. These skin cancers are often self-detected and
are usually removed in doctorsÕ surgeries. 
Cancer incidence
Excluding NMSC, there were 43,595 new cancers in males and 37,269 new cancers in
females in Australia in 1998. This represented age-standardised incidence rates of 475
per 100,000 males and 347 per 100,000 females. At these incidence rates, it would be
expected that 1 in 3 males and 1 in 4 females in Australia would be diagnosed with
cancer in the Þrst 75 years of life (AIHW & AACR 2001a).
In 1998 prostate cancer was the most common registrable cancer in males, with 9,869
cases diagnosed. It was followed by bowel cancer (6,131 new cases), lung cancer (5,307
new cases) and melanoma (4,398 new cases). Together these four cancers accounted for
59% of all registrable cancers in males. In females, breast cancer (10,665) was the most
common registrable cancer, followed by bowel cancer (5,158), melanoma (3,493) and
lung cancer (2,488), which in total accounted for 59% of all registrable cancers in
females (Figure 2.18).
The overall incidence of cancer is lowest in late childhood. In adult life it increases with
age (Figure 2.19). Males have a higher incidence than females beyond 55 years of age.
Females have a higher overall incidence than males between ages 25 and 54 years
because cancers of the cervix, uterus, ovary and breast have an incidence almost seven
times that of cancers speciÞc to males in this age range.
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Source: AIHW & AACR 2001a.
Figure 2.18: Number of new cases and deaths from the most frequently occurring cancers 
(excluding non-melanoma skin cancer), 1998
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Between 1993 and 1998, age-standardised incidence rates for all registrable cancers
combined declined for males by an average of 1.9% per year and rose for females by an
average of 0.6% per year. These incidence rates have been strongly inßuenced by the
steady rise in breast cancer incidence in females and the rise and fall of prostate cancer
incidence during this period. Changes in prostate cancer incidence have been
inßuenced by changes in diagnostic testing.
Cancers in males that showed an average annual increase for the period 1993 to 1998
include melanoma (2.1%), testis (3.4%) and kidney (1.6%). Lung cancer has shown a
consistent decline since 1983, with an average annual decline for the period 1993 to 1998
of 1.8%. Other cancers in males recording an average decline during that period were
stomach (Ð2.7%) and pancreas (Ð1.0%). 
Among females, melanoma incidence had an average annual rise of 1.7% from 1993 to
1998. Non-HodgkinÕs lymphoma (1.8% per year) and cancers of the kidney (1.7%), bladder
(1.2%), pancreas (1.0%), breast (0.9%) and lung (0.8%) all showed an increase for this
period. On the other hand, for the same period, cervical cancer showed the largest average
annual decline in age-standardised incidence rate (Ð6.9%); cancer of the oesophagus
(Ð1.5%) and leukaemia (Ð0.6%) also showed a decline for the period 1993 to 1998. Changes
in cervical cancer incidence can be attributed to the national cervical screening program
introduced in the early 1990s.
Improvements in detection of various cancers through the introduction and more
widespread use of medical technologies has increased the number of cancers reported
and improved the accuracy of determining their site of origin in the body.
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Figure 2.19: Age-specific incidence and death rates for cancers (excluding non-melanoma 
skin cancer), 1998
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Survival following cancer diagnosis
Survival after a diagnosis of cancer is an important measure in assessing the broad
impacts of early detection methods such as screening and of treatment. Relative
survival is the method commonly used by population-based cancer registries to
measure and assess survival. It is the ratio between what actually happened to a group
of people with cancer and what would normally have occurred to them in the absence
of cancer. This discussion focuses on the 5-year relative survival proportion. This is the
relative survival over the Þrst 5 years following a diagnosis of cancer. A relative
survival of 100% indicates that the disease has made no difference to survival of the
group over this period. A survival proportion of less than 100% indicates that fewer
members of the group survived for 5 years than would have been expected for similar
people in the general population.
The average 5-year relative survival proportion for all registrable cancers diagnosed in
Australia from 1992 to 1994 was 56.8% for males and 63.4% for females (Table 2.14). The
cancers with the highest relative survival in males were cancer of the testis (95.4%) and
melanoma (90.0%), and in females were cancer of the thyroid (95.6%) and melanoma
(94.6%). Cancers with the lowest relative survival in both males and females were
cancers of the pancreas (5.4% for males and 5.2% for females), and the lung (11.0% and
14.0%).
Relating to the diagnosis periods 1982Ð86 and 1992Ð94, 5-year relative survival for all
registrable cancers increased on average from 43.8% to 56.8% respectively for males and
from 55.3% to 63.4% for females. Most individual cancer sites showed an increase in
relative survival over this period. The largest increases for males were in cancer of the
prostate (59.3% to 82.7%) and cancer of the kidney (50.8% to 59.9%), and for females
were in cancer of the breast (72.3% to 84.0%) and HodgkinÕs lymphoma (73.8% to
84.4%). Cancers of the brain and bladder showed small decreases in relative survival
over this period for both males and females, but these decreases were not statistically
signiÞcant.
Mortality from cancer
In 2000, there were 20,153 deaths among males from cancer and 15,475 cancer deaths
among females. This represented 30.2% of all deaths in males and 25.2% of all deaths in
females. The age-standardised cancer death rates in 2000 were 211 per 100,000 males
and 128 per 100,000 females. At these death rates, it would be expected that 1 in 7 males
and 1 in 11 females would die from cancer by age 75 or younger. 
Lung cancer accounted for 22.8% of cancer deaths among males in 2000, while prostate
cancer accounted for 13.2% and bowel cancer accounted for 12.6%. The major causes of
cancer death in females were breast cancer (16.2% of all cancer deaths), lung cancer
(14.8%) and bowel cancer (14.1%).
From the age of 15, death rates for cancer increase with age. Further, AustraliaÕs ageing
population has meant that older people make up a higher proportion of those dying
from cancer. For example, in 1983, approximately 30% of all cancer deaths occurred in
persons aged 75 years and over, but by 2000 this proportion was around 45%.
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Table 2.14: Five-year relative survival ratios for all registrable cancers and selected individual 
cancer sites, Australia
Cancer site
Diagnosis period
1982–86 1987–91 1992–94
Males (per cent)
Testis 91.1 95.2 *95.4
Melanoma 83.0 87.2 *90.0
Thyroid 81.0 82.6 87.9
Prostate 59.3 64.3 *82.7
Hodgkin’s lymphoma 74.1 79.1 *82.6
Bladder 71.2 71.6 70.8
Kidney 50.8 53.7 *59.9
Colon 50.2 54.7 *58.3
Rectum 48.7 51.2 *56.6
Non-Hodgkin’s lymphoma 49.6 51.1 *54.6
Leukaemia 39.4 43.3 41.2
Brain 24.8 24.3 23.8
Stomach 19.2 21.6 *22.6
Unknown primary 11.7 13.0 13.4
Lung 9.3 10.7 *11.0
Pancreas 4.2 4.4 5.4
All registrable cancers 43.8 48.1 *56.8
Females (per cent)
Thyroid 87.8 91.9 *95.6
Melanoma 90.9 93.5 *94.6
Hodgkin’s lymphoma 73.8 79.9 *84.4
Breast 72.3 77.8 *84.0
Uterus 76.1 78.5 *81.4
Cervix 69.6 72.0 *74.6
Bladder 67.2 65.2 64.7
Rectum 52.3 56.0 *60.6
Colon 51.3 54.7 *58.7
Kidney 49.4 52.7 *57.5
Non-Hodgkin’s lymphoma 49.9 54.6 *55.8
Leukaemia 39.4 44.2 *43.2
Ovary 34.4 37.7 *42.0
Stomach 21.1 21.8 *24.8
Brain 24.1 25.3 23.8
Lung 11.8 11.9 *14.0
Unknown primary 10.4 10.9 11.5
Pancreas 4.1 5.4 5.2
All registrable cancers 55.3 59.1 *63.4
* Change between 1982–86 and 1992–94 is statistically significant at the 95% level.
Source: AIHW & AACR 2001b.
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Males have similar or higher cancer death rates than females before age 35 and higher
rates from age 55 onwards. The higher death rates among females aged 35Ð54 years
reßect the impact of female breast cancer and the female-only cancers. However, the
difference between the male and female death rates in this age group is not as large as
that observed for incidence.
Between 1993 and 2000, total cancer death rates declined for both males and females by
an annual average of 1.8% and 2% respectively. The decline in male lung cancer and
prostate cancer deaths was the main contributor to the falling death rate for males.
Specific cancers
Lung cancer, breast cancer, bowel cancer and prostate cancer are among the most
commonly diagnosed cancers and have a signiÞcant impact on morbidity, mortality and
health service use. Other common cancers, such as melanoma, have been the focus of
discussion in previous editions of Australia’s Health.
Lung cancer
Lung cancer is the leading cause of cancer death in Australia. There were 5,307 new
cases of lung cancer diagnosed in males in 1998 (58 new cases per 100,000 population)
and 2,488 new cases diagnosed in females (23 new cases per 100,000). In the same year,
there were 4,817 deaths (53.2 per 100,000) for males and 2,076 for females (14.0 per
100,000), with only a slight fall to 4,587 (48.0 per 100,000) for males and an increase to
2,291 (19.6 per 100,000) for females in 2000. Lung cancer currently accounts for 12% of
all new cancer registrations in males and 7% in females, but for 22.8% of all male cancer
deaths and 14.8% of all female cancer deaths. The 5-year relative survival proportion for
people diagnosed with lung cancer during the period 1992Ð97 was 11% for males and
14% for females. 
Smoking is responsible for approximately 90% of new cases of lung cancer in males and
65% in females (AIHW: Ridolfo & Stevenson 2001). Twenty-Þve years ago, smoking
rates in males were almost double those in females. However, this is no longer the case,
with the estimates for 2001 indicating that 21% of males and 18% of females aged
14 years or over are daily smokers (see Chapter 3). Current patterns of lung cancer
incidence largely reßect smoking behaviour approximately 20 years ago, due to the
time lag between exposure to cancer-causing agents in tobacco smoke and the onset of
cancer. The changing prevalence of smoking in males compared with females is
reßected in the trends for lung cancer incidence and mortality (Figure 2.20). Between
1993 and 1998, the incidence and mortality of lung cancer among males fell by an
average of 1.8% and 1.9% respectively per year. The mortality falls in the years 1999 and
2000 followed a similar trend. In contrast, lung cancer incidence among females
increased at an average rate of 0.8% per year from 1993 to 1998 and lung cancer
mortality rose at an average rate of 0.4% per year from 1993 to 2000. This reßects rising
levels of smoking among females during the 1970s, whereas male smoking levels were
declining. The increase in lung cancer incidence is mainly in females aged 65 and over,
whereas rates in younger females have generally remained stable or fallen. Despite
these patterns, age-standardised male lung cancer incidence rates are still more than 2.5
times the female rates.
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Source: AIHW & AACR 2001a; AIHW National Mortality Database.
Figure 2.20: Age-standardised incidence and death rates for lung cancer, 1983 to 2000
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Figure 2.21: Age-standardised incidence and death rates for breast cancer in females, 
1983 to 2000 
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Breast cancer
Apart from NMSCs, breast cancer is the most common cancer detected in Australian
females, for which the lifetime risk of developing this disease before age 75 is 1 in 11. In
1998, 10,665 new cases of breast cancer were diagnosed in Australia. Breast cancer is
also the most common cause of death from cancer in females with 2,511 deaths in 2000. 
The incidence of breast cancer has been on the rise since the early 1980s. However,
death rates due to breast cancer have remained relatively stable over the same period,
at around 22 deaths per 100,000 females (Figure 2.21).
The 5-year relative survival proportion for females diagnosed with breast cancer during
the period 1992Ð94 was 84%. The relative survival proportion increased over time, with
those diagnosed in the 1980s having a relative survival proportion of 72%. Females
aged between 40 and 69 years diagnosed with breast cancer during the period 1992Ð94
had the best relative survival proportion (86%).
Prostate cancer 
Apart from NMSCs, prostate cancer is the most common cancer detected in Australian
males, for which the lifetime risk of developing this disease before age 75 is 1 in 11. In
1998, there were 9,869 new cases of prostate cancer diagnosed. Prostate cancer is the
second most common cause of death from cancer in males, after lung cancer, with 2,663
deaths in 2000. 
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Source: AIHW & AACR 2001a; AIHW National Mortality Database.
Figure 2.22: Age-standardised incidence and death rates for prostate cancer, 1983 to 2000
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Between 1989 and 1994, there was a dramatic rise in the number of new cases of
prostate cancer registered (Figure 2.22). Reported incidence rates have fallen
substantially since then, although not to pre-1989 levels. The rise and then fall in
prostate cancer incidence rates has been attributed to increased detection of the disease
through increased investigation, particularly the introduction of prostate-speciÞc
antigen (PSA) testing around 1990. PSA tests are speciÞcally designed to identify
cancers before the onset of clinical symptoms. Many of these prevalent cancers may not
show any symptoms, and therefore would not be detected except for PSA testing. The
recent decline in the incidence rate indicates a return towards the underlying rate,
removing the catch-up effect from previously undetected cases. The incidence rate is
also declining because the number of PSA tests conducted is falling.
The 5-year relative survival proportion for males diagnosed with prostate cancer in the
period 1992Ð94 was 83%.
Bowel cancer
Apart from NMSCs, bowel (colorectal) cancer is the second most common cancer in
both Australian males and females. The lifetime risk of developing this cancer before
the age of 75 is 1 in 17 for males and 1 in 26 for females. In 1998, there were 6,131 new
cases of bowel cancer diagnosed in males and 5,158 new cases in females. Bowel cancer
is the third most common cause of death from cancer in males, after lung and prostate
cancers, and the third most common in females, after breast and lung cancers. In 2000
there were 2,533 bowel cancer deaths of males and 2,179 of females.
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Figure 2.23: Age-standardised incidence and death rates for bowel cancer, 1983 to 2000
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For bowel cancer, both the male and female incidence rates have remained largely
unchanged since 1993 while mortality rates have fallen steadilyÑthe male rate decreased
by 1.9% per year between 1993 and 2000, and the female rate by 2.3% per year (Figure
2.23). The bowel comprises the colon and the rectum. The 5-year relative survival
proportion for both males and females diagnosed with colon cancer in the period
1992Ð94 was around 58%. For cancer of the rectum, the 5-year relative survival
proportion for males diagnosed in the 1992Ð94 period was 57% and for females was 61%.
Injuries
Injury (used here to mean both injury and poisoning) is a signiÞcant cause of mortality
and morbidity in Australia. It is the leading cause of death among young people and
accounts for a range of physical, intellectual and psychological disabilities that affect
the quality of life of injured people and their families, often seriously. Injury is a
considerable source of healthcare cost, estimated to account for approximately 8% of the
total direct cost of all diseases (DHFS & AIHW 1998).
Deaths
In 1999, injury was the Þfth leading cause of death in Australia. A total of 8,361 deaths
(5,868 males and 2,493 females) were the result of an external cause of injury,
accounting for 6.5% of all deaths registered in that year. For people under 45 years,
injury was the main cause of death, representing 51.3% of all deaths for people in that
age group. Injury death rates are highest among young males and for both sexes in old
age. Of all injury deaths, almost one-third were of males aged between 20 and 39 years.
Suicide accounted for the largest proportion of injury deaths (2,492 deaths or 29.8%) in
1999, followed by deaths due to road crashes (2,011 or 24.1%). Despite the large
reduction in death rates from road crashes since 1970, they remain a major cause of
injury-related deaths.
Trends in injury-related deaths
Over the past 20 years, age-standardised death rates due to injury decreased
signiÞcantly but still less than overall death rates. Furthermore, during the middle and
late 1990s, injury death rates remained more or less static, while all-cause death rates
continued to decline. There was a 4% increase in the rates of injury deaths registered in
1999 compared with those registered in 1998. This apparent increase is likely to be
largely a reßection of the introduction of the tenth revision of the International
ClassiÞcation of Diseases (ICD-10). This is because more deaths are generally coded as
being due to external causes under ICD-10 than under ICD-9 (about 3% more when
applied to 1998).
Trends in injury deaths differ for major types of external causes (Figure 2.24). A
considerable increase in the suicide rate occurred in the 1960s when the rates due to the
use of pharmaceutical substances (especially barbiturates) increased. Also, there was an
increase in the all-ages male suicide rate from the early 1990s, although the rate has
declined since 1997 from 23.4 per 100,000 males to 19.4 in 2000. Suicide (also see next
page) has become a more common cause of male death than transport-related injuries
in recent years. In the mid-twentieth century, deaths due to motor vehicle crashes
accounted for a large proportion of injury deaths in Australia because of the emergence
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of this mode of transport. Since the early 1970s, road injury death rates and the actual
number of deaths have declined signiÞcantly, even though vehicle numbers and the
distance travelled have continued to increase. The reductions in deaths due to road
injury may be attributed to a range of interventions designed to improve road safety
(DHFS & AIHW 1998).
Suicide
Suicide is a signiÞcant cause of death in Australia, responsible for 2,363 deaths registered
in 2000 (1,860 males, 503 females) and 2,492 deaths in 1999 (2,002 males, 490 females). In
both these years, the male suicide rate was considerably higher than the female rate
across all age groups. Although the rate for adult females varied little by age, the male
rate in 2000 was highest between ages 30 and 39 and at age 80 and over (Figure 2.25). For
males, excluding deaths from road crashes, suicide deaths in 1997 exceeded those from
all other injuries combined (Steenkamp & Harrison 2000). It has been reported that about
one-third of those who committed suicide, and 40% of those who attempted suicide,
were receiving psychiatric treatment before the episode (DHAC 1998).
Suicide became a matter of national public health concern in Australia during the 1990s.
A focus on youth suicide was prompted by the observation that the rate for young
males (i.e. 15Ð24 years) had risen about threefold during the 30 years to 1990, whereas
the rates at older ages had tended to decline. During the 1990s, the rate for males aged
15Ð24 did not rise further and declined each year after 1997. In contrast, the rate for
males aged 25Ð39 rose through most of the 1990s and remains markedly higher than
that for males aged 15Ð24 or 40 and over (Figure 2.26).
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Source: AIHW National Injury Surveillance Unit using mortality and population data from ABS.
Figure 2.24: Injury mortality, 1924 to 1999
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Figure 2.25: Age-specific suicide rates, 2000
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Figure 2.26: Suicide rates for selected male age groups, 1981 to 2000
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Death by hanging, strangulation or suffocation was the main method of suicide in
Australia in 1999 and 2000, for both males and females (Table 2.15). Hanging has been
the most common method of suicide for males since the early 1990s and for females
since 1997. In 2000, along with strangulation and suffocation it accounted for 42% of all
suicides. The use of Þrearms as a method of suicide, although less common than in the
1980s, is still very much a male phenomenon, accounting for 11.5% of male suicides in
2000 compared with 2% of female suicides.
More than three-and-a-half times as many males as females committed suicide in 2000. In
1999 the ratio was about four to one. On the other hand, females accounted for about 58%
of hospital separations for attempted suicide and intentional self-harm attempts in
1999Ð00 (AIHW 2001a). A similar situation exists in the United States. The greater suicide
rate among males may therefore reßect more violent methods, such as Þrearm use.
Hospital care 
Injury is a major cause of hospitalisation. In 1998Ð99, injury or poisoning was the
principal diagnosis recorded for 401,723 hospital separations, accounting for about 7%
of all hospital separations. The age-standardised hospital separation rate for injury was
2,104 per 100,000 population and the rates for males and females were 2,505 and 1,671,
respectively, for this period.
Accidental falls were the leading single cause of injury-related hospital admissions
representing 28.6% of injury separations. These separations accounted for the largest
proportion of bed-days (647,307 bed-days or 38.1%) with an average length of stay of
5.6 days. Falls were the reason for more than half of injury separations of people aged
65 years and over (52,125 bed-days), and for more than one-third of injury separations
of children aged 0Ð14 years (25,668 bed-days).
About 12% of injury-related hospitalisations were due to transport-related incidents. Other
unintentional injuries accounted for 26.9% of injury separations and for 14.0% of bed-days.
Table 2.15: Mode of suicide, 1999 and 2000 (number)
Mode of suicide
1999 2000
Males Females Males Females
Intentional self-poisoning (excluding carbon 
monoxide, motor vehicle exhaust, utility gas) 177 125 175 134
Exposure to carbon monoxide, motor vehicle 
exhaust, utility gas 473 98 441 97
Hanging, strangulation and suffocation 868 160 807 182
Firearm discharge and explosive material 257 13 213 10
Drowning and submersion 18 19 29 18
Sharp object 30 13 30 6
Jumping from a high place 73 25 56 16
Other specified and unspecified methods 106 37 109 40
Total 2,002 490 1,860 503
Source: AIHW National Mortality Database.
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Medical misadventure, complications and so on were another common cause of injury-
related hospital admissions in 1998Ð99, representing 16.7% of all injury separations and
accounting for 428,146 patient bed-days (25.2% of all injury bed-days) with an average
length of stay of 6.4 days. The 1994 Quality in Australian Health Care Study reported
that 16.6% of admissions to 28 hospitals in New South Wales and South Australia were
associated with an Ôadverse eventÕ caused by healthcare management and that 4.9% of
these events resulted in death (Wilson et al. 1995).
Injuries to the head were a common principal diagnosis of injury-related hospital
separations (60,366 cases or 15.0% of all injury hospitalisations). They were the most
common principal diagnosis among injury-related hospital separations for children aged
0Ð14 years, representing 23.1% of injury separations in that age group. Head injury was
the main diagnosis for 20.1% of injury separations of people aged 15Ð34 years.
Injuries to the wrist or hand were the main diagnosis for 10.4% of injury
hospitalisations. Injuries to the elbow and forearm also made up 23.1% of injury
separations among children aged 0Ð14 years. Injuries to the hip or thigh were the most
frequent principal diagnosis of injury-related hospital care for females aged 65 years
and over in 1998Ð99, accounting for 26.7% of female hospitalisations due to injury
within this age group.
Mental health problems and disorders 
A mental disorder is a disturbance of mood or thought that can affect behaviour and
distress the person or those around them, so that the person cannot function normally.
Mental disorders such as depression, anxiety and schizophrenia are common, affecting
about one million Australians (ABS 1997a). They impose a heavy burden of human
suffering including stigmatisation of those affected; they account for much disability, and
contribute to the death of many Australians per year. For example, studies in Australia
and overseas suggest that some form of mental disorder is a component in many suicides
(see page 58). Mental disorders are also responsible for a large number of hospitalisations
and incur high health system costs. Mental health has consequently been included as a
National Health Priority Area for focused attention (AIHW & DHFS 1997).
Prevalence
Information on the national prevalence and types of mental health problems and disorders
may be gathered from three major sources: the National Survey of Mental Health and
Wellbeing, hospital separation data, and general practitioner consultation data.
Table 2.16: Prevalence of mental disorders in adults, 1997 (per cent)
Type of disorder Males Females
Any affective disorder 4.2 7.4
Any anxiety disorder 7.1 12.0
Any substance use disorder 11.1 4.5
Any mental disorder 17.4 18.0
Source: Andrews et al. 1999.
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National Survey of Mental Health and Wellbeing
The National Survey of Mental Health and Wellbeing was conducted between 1997 and
1998 and had three components: adults, children and adolescents, and people with Ôlow
prevalenceÕ (psychotic) disorders. From the adult component of the National Survey of
Mental Health and Wellbeing, an estimated 17.7% of adults in Australia had an anxiety,
affective or substance use disorder, or a combination of these, in the 12 months
preceding the survey (Table 2.16). Given the limited scope of the survey (disorders such
as schizophrenia and dementia were not included, homeless people were not surveyed)
and the 78% survey response rate, the overall prevalence of mental disorders among
adults is likely to be higher. However, the pattern of mental disorder revealed by the
survey is consistent with survey Þndings from Canada, the United States and the
United Kingdom, despite differing methods (Andrews et al. 1999).
The Ôlow-prevalence disordersÕ component of the National Survey of Mental Health and
Wellbeing was a study of people living with psychotic disorders in Ôcatchment areasÕ in
the Australian Capital Territory, Queensland, Victoria and Western Australia. Although
less common than disorders such as anxiety and depression, psychotic disorders such
as schizophrenia represent a very serious group of illnesses that affect brain
functioning, perceptions, emotions and communication. Overall, the prevalence of
psychotic disorders in the urban adult population was estimated to be in the range of 4
to 7 per 1,000, depending on the area under study (Jablensky et al. 1999). The 1-month
and 12-month prevalence rates by sex are shown in Table 2.17.
Of the participants in the child and adolescent component of the National Survey of
Mental Health and Wellbeing, 14% were found to have mental health problems (Sawyer
et al. 2000). A mental health problem was considered to exist if the number of emotional
and behavioural problems experienced by an individual was in the range typically
reported for children and adolescents attending mental health clinics. The prevalence of
speciÞc areas of mental health problems, expressed as a percentage of the sample, is
shown in Table 2.18.
Table 2.17: Estimated 1-month and 12-month prevalence of psychoses in mainstream services, 
1997 (per 1,000 estimated resident population)
Area
Prevalence period ACT Qld Vic WA
Males
1-month rate 3.12 3.43 4.56 5.94
12-month rate 4.49 4.08 5.53 6.74
Females
1-month rate 2.63 2.20 3.00 4.23
12-month rate 3.71 2.55 3.52 4.78
Persons
1-month rate 2.88 2.81 3.75 5.10
12-month rate 4.10 3.31 4.49 5.78
Source: Jablensky et al. 1999.
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In addition to mental health problems, the child and adolescent component of the survey
also looked at the prevalence of three mental disorders (with ÔdisordersÕ being deÞned
differently from ÔproblemsÕ). The prevalence of attention deÞcit/hyperactivity disorder
was 11.2% in all adolescents and children compared with 3.7% for depressive disorder
and 3% for conduct disorder. In adolescents aged 13Ð17 years, depressive disorder was
found in 4.8% of males and 4.9% of females.
Hospital separations
Hospital separations reßect the more severe end of the spectrum of mental health
problems and disorders. In 1999Ð00, mental disorders accounted for 244,857 hospital
separations (Table 2.19). People diagnosed with depressive disorders, neurotic and
stress-related disorders, and schizophrenia accounted for the highest proportion of
separations for mental disorders in 1999Ð00 (24.6%, 17.9% and 11.1% respectively).
Professional consultations
Visits to GPs, psychologists, and psychiatrists are another source of information that may
relate to the prevalence of mental health problems and disorders in Australia. The
majority of mental health care in Australia is delivered through general practice.
Furthermore, a person with a mental disorder, especially depression, is more likely to
seek help from a GP than from any other health care provider (ABS 1998a). 
According to the BEACH survey of general practice activity 1999Ð00, depression
accounted for 2.3% of total problems and was the fourth most commonly managed
health problem (340 per 1,000 encounters with a GP). Anxiety accounted for 1.2% of the
total problems managed (170 per 1,000 encounters). The fourth most common scripts
written (8% of the total) were for medications related to psychological problems
(AIHW: Britt et al. 2000). 
Co-morbidity
Co-morbidity refers to the occurrence of more than one disorder at the same time, and
is common among people with mental disorders. An affected person may have one or
more coexisting mental disorders, physical disorders, or a combination of these. Such
co-morbidity may lead to a serious complication for the affected person. Failure to take
Table 2.18: Prevalence of mental health problems in specific areas, 1998 (per cent)
Problem
4–12 years 13–17 years
All children Males Females Males Females
Somatic complaints 7.3 7.2 5.6 10.6 6.8
Delinquent behaviour 7.1 7.4 7.8 6.4 5.9
Attention problems 6.1 7.4 6.2 4.8 4.6
Aggressive behaviour 5.2 5.9 5.2 5.0 4.0
Social problems 4.6 6.5 3.9 3.8 3.0
Withdrawn 4.3 5.4 2.9 4.8 4.2
Anxious/depressed 3.5 4.1 2.9 3.6 3.6
Thought problems 3.1 3.2 2.7 3.4 3.1
Total problems 14.1 15.0 14.4 13.4 12.8
Source: Sawyer et al. 2000.
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medication is common and can also lead to serious complications. Co-morbidity tends
to be the rule in the case of mental disorders rather than the exception (Hall et al. 2001).
In young people, drug and alcohol problems often coexist with other mental disorders
(Raphael 2000).
Medication non-compliance among people with schizophrenia is associated with an
increased risk of rehospitalisation, emergency room visits, homelessness and symptom
worsening (Olfson et al. 2000). Violence and aggression have also been associated with
schizophrenics who misuse substances (Soyka 2000). Asthma sufferers who develop
depressive symptoms are at risk of medication non-compliance and even sudden death
(Nejtek et al. 2001). In people with diabetes, depression is associated with poor control
of blood sugar levels and may increase the risk of diabetic complications (Lustman et al.
2000). Co-morbidity involving alcohol or drug use is widespread and associated with
poor treatment outcomes, severe illness course and high service use.
Table 2.19: Mental disorder hospital separations, 1999Ð00
Principal diagnosis or external cause Separations Per cent
Separations
per 10,000
population
F00–F03 Dementia 6,911 2.8 3.63
F04–F09 Other organic mental disorders 5,058 2.1 2.65
F10 Mental, behavioural disorders due to use of 
alcohol 23,865 9.7 12.53
F11–F19 Mental, behavioural disorders due to other 
psychoactive substances use 15,829 6.5 8.31
F20 Schizophrenia 27,175 11.1 14.26
F21–F29 Other schizophrenic, schizotypal, delusional 
disorders 15,302 6.2 8.03
F30 Manic episode 1,150 0.5 0.60
F31 Bipolar affective disorders 15,104 6.2 7.93
F32–F33 Depressive disorders 60,314 24.6 31.66
F34–F39 Other mood (affective) disorders 4,084 1.7 2.14
F40–F48 Neurotic, stress-related and somatoform 
disorders 43,738 17.9 22.96
F50 Eating disorders 5,957 2.4 3.13
F51–F59 Other behavioural syndromes associated with 
physiological disturbances, physical factors 4,352 1.8 2.28
F60–F69 Disorders of adult personality and behaviour 9,255 3.8 4.86
F70–F79 Mental retardation 402 0.2 0.21
F80–F89 Disorders of psychological development 1,024 0.4 0.54
F90–F98 Disorders onset usually occurring in 
childhood, adolescence 4,979 2.0 2.61
F99 Mental disorder not otherwise specified 217 0.1 0.11
Z03.2 Observation for suspected mental and 
behavioural disorder 140 0.1 0.07
Z81, Z86.5 Personal or family history of mental and 
behavioural disorder 1 0.0 <0.01
Mental disorders total 244,857 100 128.53
Source: AIHW Hospital Morbidity Database 1999–00.
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The adult component of the National Survey of Mental Health and Wellbeing reported
that 61% of those with an affective disorder (e.g. depression) and 45% with an anxiety
disorder also had one or more other mental disorders. Also, about 43% of people with a
mental disorder had one or more physical conditions such as a heart problem, diabetes
or cancer (ABS 1998a). 
The National Survey of Mental Health and Wellbeing also examined co-morbidity in
people with psychotic disorders. A common and serious problem among such people is
the use of psychoactive drugs (substances that act on the brain) other than those
medically prescribed. 
Disability
Among participants of the adult component of the National Survey of Mental Health and
Wellbeing, people with depression were unable to carry out their usual activities fully for
an average 2.7 days in the previous month. For people with both a depressive disorder
and a physical condition, the corresponding Þgure was 6.3 days (Andrews et al. 1999).
The National Survey of Mental Health and Wellbeing also found considerable disability
among people with psychotic disorders. Only 38.2% of this group had carried out an
occupational role (e.g. job, housework, study) in the previous 12 months and almost
half (46.2%) of those had experienced dysfunction in their role. Among participants
living with a family or household, 49.1% experienced obvious or severe dysfunction in
daily family or household activities. Almost 30% of this sample exhibited problems
with self-care, including personal hygiene, care for their own appearance and efforts to
keep physically Þt (Jablensky et al. 1999).
Mortality
Excluding dementia and suicide, a total of 978 deaths occurred in 2000 and 897 in 1999
where a mental disorder was listed as the underlying cause of death. Most of these deaths
(853 in 2000 and 713 in 1999) were due to mental and behavioural disorders attributed to
the use of one or more psychoactive substances, such as alcohol or heroin (Table 2.20).
Table 2.20: Deaths due to mental and behavioural disorders attributed to psychoactive 
substance use (ICD-10 F10ÐF19), 1999 and 2000
Substance 1999 2000
Alcohol 237 255
Opioids 272 296
Tobacco 90 70
Cannabinoids 3 2
Sedatives or hypnotics 1 6
Cocaine 2 2
Other stimulants, including caffeine 1 3
Volatile solvents 2 0
Other psychoactive substances 105 219
Total 713 853
Source: AIHW National Mortality Database.
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Among males, the age-standardised death rate (deaths per 100,000 population)
attributed to mental and behavioural disorders due to substance abuse was 6.9 in 2000,
compared with 5.9 in 1999 and 8.0 in 1998. The rate among females was 2.0 per 100,000
population in 2000, 1.7 in 1999, and 2.0 in 1998.
Diabetes
Diabetes is a long-term (chronic) condition in which blood glucose levels become too
high because the body produces little or no insulin or cannot use insulin properly.
Insulin is a hormone produced by the pancreas that helps the body to use glucose. 
Diabetes is the sixth leading cause of death in Australia (ABS 2001b), and contributes to
signiÞcant illness, disability, poor quality of life and premature mortality. Over the
course of the disease, diabetes can lead to long-term damage to various parts of the
body, especially the heart and blood vessels, eyes, kidneys and nerves. Diabetes also
contributes to many pregnancy-related complications for the mother and the baby, both
before and after birth.
Types of diabetes
Because the common feature of diabetes is high blood glucose, it is often mistakenly
thought to be a single disease. There are actually several types of diabetes, with
different causal mechanisms. The three main types of diabetes are Type 1, Type 2 and
gestational diabetes.
Type 1 diabetes is marked by a total or near-total lack of insulin. It results from the body
destroying its insulin-producing cells in the pancreas. People with this form of diabetes
require daily insulin therapy to survive. It is the most common cause of childhood
diabetes and accounts for 10Ð15% of all people with diabetes. 
Type 2 diabetes is marked by reduced levels of insulin, or the inability of the body to use
insulin properly (insulin resistance). The disease is most common among people aged
40 years and over and accounts for 85Ð90% of all people with diabetes. Many people with
this form of diabetes eventually need insulin therapy to control their blood glucose levels.
Gestational diabetes occurs during pregnancy in about 3Ð8% of females not previously
diagnosed with diabetes. Screening tests for gestational diabetes are usually performed
in weeks 24Ð28 of pregnancy. It is a temporary form of diabetes and usually disappears
after the baby is born. However, it is a marker of increased risk of developing Type 2
diabetes later in life. 
Diabetes shares several of the risk factors with, and is itself a risk factor for,
cardiovascular disease. Both genetic and environmental factors contribute to the onset
of diabetes. Type 1 diabetes is believed to be caused by particular biological interactions
and exposure to environmental triggers in people genetically predisposed. In addition
to ageing and genetic predisposition, the risk of developing Type 2 diabetes increases
with body fatness. Regular physical activity, however, plays a protective role against the
development of Type 2 diabetes (Manson et al. 1992; Perry et al. 1995). The risk factors
for gestational diabetes are mostly similar to those for Type 2 diabetes and include the
age of the mother, body fatness and ethnicity. 
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Box 2.5: How is diabetes detected?
The diagnostic test for diabetes is measurement of the plasma glucose level. This is
expressed as the concentration of glucose in plasma (the fluid part of blood after blood cells
are removed). The test may be performed in people with classical symptoms of diabetes,
such as excessive thirst and urination. However, it is also used for screening for Type 2
diabetes among people identified as at higher risk of the disease.
A plasma glucose sample taken after fasting is preferred, but a random sample may be used
if fasting is impractical. Diabetes is likely in people with a fasting plasma glucose concen-
tration of at least 7.0 millimoles/litre (mmol/L), or more than 11.1 mmol/L based on a
random sample.
An oral glucose tolerance test (OGTT) should be done if fasting results fall between 5.5
and 6.9 mmol/L or random results are between 5.5 and 11.0 mmol/L. In the OGTT an ini-
tial plasma glucose measurement is taken after a period of fasting. A second measurement
is then taken 2 hours after consuming 75 g of glucose. The glucose levels should have
returned to normal by then but they will remain high in a person with diabetes. The
results of the OGTT should be interpreted using the 1999 WHO criteria (WHO 1999).
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Figure 2.27: Age-specific prevalence of diabetes, 1999Ð00
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Incidence and prevalence 
From a national survey in 1999Ð00, the Australian Diabetes, Obesity and Lifestyle Study
(AusDiab, see Box 3.4, Chapter 3) estimated that 938,700 Australians aged 25 or over
had diabetes, 7.5% of the population. About half of these people were not aware that
they had diabetes.
Among males aged 25 and over, the estimated prevalence of diabetes in 1999Ð00 was
8.0%, and among females of the same age it was 7.0%. The prevalence increased with
age, from 0.3% among people aged 25Ð34 to 23.7% among those aged 75 years and over
(Dunstan et al. 2001). This increase in prevalence occurs faster and earlier among males
than among females (Figure 2.27).
There is a marked difference in the age proÞle of people with various types of diabetes.
Type 1 diabetes is the most common form among children and young adults, because of
its early onset, whereas Type 2 diabetes is the predominant form among middle-aged
and elderly people because of the rapid increase in its prevalence after the age of 45.
Although the prevalence of gestational diabetes is generally not high, it may be as high
as 20% in high-risk populations such as Aboriginal and Torres Strait Islander females. 
Type 2 diabetes is more common in certain population groups, including Aboriginal
and Torres Strait Islander peoples and people of Chinese, Vietnamese, Indian and Arab
origin (Dowse et al. 1990; FECCA 1997). On the other hand, Type 1 diabetes is more
common in populations of European origin.
Among the 1995 National Health Survey respondents who reported ever having had
diabetes, 19% reported Type 1 diabetes, 42% reported Type 2 diabetes, and 6% reported
gestational diabetes. Among the remaining third, i.e. those who did not report the type
of diabetes, the majority were determined as having Type 2 diabetes (ABS 1997c). 
There are no national data on trends in the prevalence of diabetes in Australia based on
measurements. However, a comparison of the 1981 Busselton Population Survey and
the 1999Ð00 AusDiab study suggests that the prevalence rate of diabetes in Australia
Box 2.6: National Diabetes Register
The National Diabetes Register was established in 1999 as part of the National Diabetes
Strategy to collect information about Australians who have insulin-treated diabetes. The
register is operated by the AIHW using data from the National Diabetes Services Scheme
and the Australasian Paediatric Endocrine Group.
The register collects information about people who have been diagnosed with diabetes and
who required insulin treatment since 1 January 1999. The first report on the register was
released in October 2001 and gives a statistical profile of the people who consented to be on
the register and began using insulin between 1 January 1999 and 31 December 2000.
Information contained in the register will help to monitor the incidence of insulin-treated
diabetes in Australia (including Type 1, Type 2 and gestational diabetes). Researchers are
now able to use the register as an important source of information for clinical and epidemi-
ological studies of the causes and complications of diabetes.
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may have doubled over the 20-year period (Dunstan et al. 2001). Dunstan et al. (2001)
suggest that the increased prevalence of obesity in Australia has been a signiÞcant
contributing factor in the increasing prevalence of diabetes, in particular Type 2
diabetes. 
The AIHW has established the National Diabetes Register of people diagnosed with
diabetes who require insulin treatment (see Box 2.6). In 2000, based on the register, the
incidence of diabetes (predominantly Type 1) among people less than 15 years of age
was estimated to be 18.9 new cases per 100,000 population (AIHW 2001d). 
Among Aboriginal people in central Australia it has been estimated that the incidence
rate of diabetes is 20.3 cases per 1,000 person-years (Daniel et al. 1999), which is among
the highest in the world.
Diabetes-related complications
Diabetes can lead to a range of complications, including diseases of the large blood vessels
(macrovascular disease) such as coronary heart disease, stroke and peripheral vascular
disease as well as diseases of the small blood vessels (microvascular disease) such as
kidney disease, nerve damage (possibly leading to limb amputation) and loss of vision.
Macrovascular complications are more common in people with Type 2 diabetes whereas
the risk of microvascular complications is similar in both Type 1 and Type 2 diabetes. 
All types of diabetes are known to be associated with complications in pregnancy and
childbirth. Poorly managed diabetes in pregnancy can lead to spontaneous abortions,
stillbirths or difÞcult births.
Several factors are known to contribute to the risk of developing complications in
diabetes. In addition to poorly controlled glucose levels, duration of the disease and
age, these risk factors include obesity, high blood pressure, high blood cholesterol,
tobacco smoking and genetic predisposition. Avoiding or reducing risk-increasing
behaviours and conditions can delay the onset or slow the progression of complications.
According to the 1999Ð00 AusDiab study, the proportion of Australians aged 25 or over
with diabetes who also had high blood pressure (69.3%) was 2.7 times that of people
without diabetes (25.8%). Similarly, the proportions of people with diabetes who had
ever been told that they had angina (16.9%), heart attack (11.8%) or stroke (9.3%) were
4.5, 4.3 and 5.5 times, respectively, those of people without diabetes (corresponding
proportions were 3.8%, 2.7% and 1.7%).
Of those Australians aged 25 or over who reported ever having been told they had
diabetes, 30.0% had been treated for or suffered from heart disease, 24.0% from poor
circulation, 18.8% from retinopathy, 11.2% from kidney disease and 8.4% from nerve
damage. Also, of those males who reported ever having been told they had diabetes,
30.2% had been treated for or suffered from impotence.
Evidence of the burden of kidney complications caused by diabetes is found in the
Australia and New Zealand Dialysis and Transplant Registry, a register of people
requiring kidney dialysis or a kidney transplant. In Australia during 2000, diabetic
kidney disease (diabetic nephropathy) was the second most common cause of kidney
failure, accounting for more than one in Þve kidney failure registrants (22%) (Russ 2001). 
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Data from the 2000 National Association of Diabetes Centres survey agree with the
Þndings above. People attending specialist diabetes services (diabetes centres and
specialist endocrinologists in private practice) have a wide range of complications
including erectile dysfunction, nerve damage, kidney problems, eye damage,
circulatory problems in the limbs, heart attack and stroke.
Health services use
People with diabetes are more than twice as likely as those without diabetes to consult
health professionals or use hospital services (ABS 1997c). This higher rate is related to
treatment for blood glucose control, as well as for complications associated with diabetes.
GP consultations
In 2000Ð01, according to the BEACH survey, non-gestational diabetes represented 1.9%
of all problems managed by GPs and was managed at a rate of 2.8 per 100 encounters
(AIHW: Britt et al. 2001a). For people being managed for diabetes, the other main
problems being managed were high blood pressure, lipid disorders and osteoarthritis
(Table 2.21). Coronary heart disease was also a common problem managed for males,
whereas depression was commonly managed for females with diabetes.
Hospital separations
In 1999Ð00, diabetes was the principal diagnosis in 24,417 hospital separations or 0.4%
of all hospital separations for that period. Diabetes is often not reported as the principal
diagnosis because the condition responsible for the hospitalisation, rather than diabetes,
is recorded as the principal diagnosis even when it is a complication of diabetes.
Diabetes is often reported as an additional diagnosis, particularly in association with
primary diagnoses of coronary heart disease, stroke and kidney disease. When
separations for diabetes as the principal diagnosis and as an additional diagnosis are
combined, the total number of such separations rises to 336,976 or 5.7% of all hospital
separations. This higher number better reßects the extent of diabetes-related morbidity
in the population, and the need to manage it in a hospital setting. 
The impact of diabetes on the health system is magniÞed by the long periods that
patients with diabetes spend in hospital. The average length of hospital stay for people
with diabetes as the principal diagnosis was 6.6 days in 1999Ð00. In comparison, the
Table 2.21: GP consultations: top five ÔotherÕ problems managed at encounters where diabetes 
was managed, 2000Ð01
Males Per cent(a) Females Per cent(a)
Hypertension 22.4 Hypertension 23.5
Lipid disorder 7.3 Lipid disorder 6.6
Coronary heart disease 4.1 Osteoarthritis 3.4
Immunisation(b) 2.9 Depression 3.4
Osteoarthritis 2.8 Immunisation(b) 2.9
Total number of complications 1,682 Total number of complications 1,717
(a) Listed condition as a proportion of all complications.
(b) Includes preventive immunisation medication for hepatitis, tetanus, influenza, and other non-specific conditions.
Source: AIHW: GPSCU unpublished.
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average length of stay for all people without diabetes as the principal diagnosis was 3.8
days. Diabetes also contributes to extended hospital stays for other related or non-
related conditions. When separations for diabetes as an additional diagnosis were taken
into account, the average length of hospital stay for people with diabetes increased to
7.0 days compared with 3.6 days for people without diabetes. 
Mortality 
On death certiÞcates diabetes was listed as the underlying cause of 3,006 deaths, or
2.3% of all deaths in 2000. In addition, diabetes was listed as an associated cause of
7,124 deaths (ABS 2001b).
Diabetes is rarely listed as the only cause of death on death certiÞcates. In 2000, where
diabetes was listed as the underlying cause of death it was the only cause listed in less
than 1.5% of such cases; conditions listed as associated causes of death included
coronary heart disease (in 51.0% of the cases), kidney-related diseases (22.6%), stroke
(21.4%) and heart failure (18.6%). 
Of the deaths in 2000 where diabetes was listed as an associated cause of death,
coronary heart disease was recorded as the underlying cause of death in 35.2% of cases.
Other prominent underlying causes of death with which diabetes was associated
included cancer (20.0%) and stroke (11.3%). 
The death rate for diabetes (as an underlying cause of death) has shown an increase in
recent years for males, with an average annual increase of 1.2% between 1989 and 2000.
There has, however, been no consistent trend for females over this same period. 
Burden of diabetes
In terms of premature mortality, diabetes was estimated to be responsible for almost
70,000 years of life lost in 1996Ñalmost 5.3% of the estimated years of life lost for all
causes. Diabetes and its complications were also responsible for much disability, with
more than 53,000 years of equivalent ÔhealthyÕ life lost to disability in 1996, or 4.6% of
the total years lost due to disability. Although the effect of diabetes on premature
mortality was similar in both sexes, males lost more years of Ôhealthy lifeÕ to disability
than females did (AIHW: Mathers et al. 1999a).
As a result of the high impact of the disease, a substantial proportion of healthcare
expenditure goes on diabetes and its complications. The direct costs of diabetes and its
complications in 1993Ð94 have been estimated at $681 million, or 2.2% of total health
system costs that year (AIHW: Mathers & Penm 1999a). 
Asthma
Asthma is an inßammatory disease of the lungÕs air passages that makes them prone to
narrow too easily and too much in response to ÔtriggersÕ, causing episodes of shortness
of breath and wheezing or coughing. The symptoms are usually reversible,
spontaneously or with treatment. However, death can occasionally result if the
asthmatic episode is severe enough and not managed properly (NHLBI 1992).
People with asthma can experience reduced quality of life and require a range of health
services, from general practitioner care to emergency department visits or hospital
in-patient care.
AH2002 body 26-6  Page 71  Wednesday, June 26, 2002  6:28 PM
72  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
Morbidity
Prevalence
Asthma is highly prevalent in Australia. Based on self-reports in the 1995 National
Health Survey, an estimated 11.3% of people had asthma as a recent or long-term
condition. This is equivalent to approximately 2 million Australians (ABS 1997b).
Asthma prevalence was the highest among 5Ð14-year-olds at 19.2%. Prevalence was
also high among 15Ð24-year-olds at 14.9%. Up to 15 years of age, asthma was more
common among males than among females. In older age groups, however, asthma was
more common among females than among males.
The age-related distribution of asthma was similar in the 1989Ð90 and 1995 National
Health Surveys. However, between the two surveys there was a marked increase in the
proportion reporting asthma in all age groups and among both adults and children
(Figure 2.28).
The proportion of Australians who had asthma (as a recent illness or as a long-term
condition) increased by one-third, from 85 per 1,000 in 1989Ð90 to 113 per 1,000 in 1995.
(ABS 1997b). The increase in self-reported asthma was greater among adults aged 15
and over (41.4%) than among children aged 0Ð14 (17.3%). For both adults and children,
the increase was greater among females than males (ABS 1999a).
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Figure 2.28: Age-specific prevalence of asthma, 1989Ð90 and 1995
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Compared with other countries, the prevalence of asthma among school-age children in
Australia is high. The International Study of Asthma and Allergies in Childhood, which
administered standardised questionnaires to school children in 56 countries, ranked
Australia third highest in the prevalence of current wheeze (a symptom of asthma)
among 13Ð14-year-olds and second highest among 6Ð7-year-olds (ISAAC Steering
Committee 1998).
Hospital separations
In 1999Ð00, asthma was the principal diagnosis for 47,008 hospital separations, or 0.8%
of all hospital separations, with an average length of stay of 2.7 days (AIHW 2001a). It
was one of the most frequent reasons for hospitalisation among children aged 0Ð14. For
example, the asthma hospital separation rate in early childhood (0Ð4 years) was 1,339
per 100,000 males and 765 per 100,000 females. After age 14, the hospital separation
rates in both sexes decreased, reaching the lowest rates in the 35Ð44 age group
(Figure 2.29).
Asthma is often reported as an additional diagnosis in hospital separations, notably
with principal diagnoses of pneumonia, cataract and heart conditions such as angina.
Making a diagnosis of asthma can be problematic in very young children (0Ð4 years)
and in adults aged over 50 years. In both these age groups, other breathing disorders
may be difÞcult to distinguish from asthma. For this reason, hospital separation data in
these age ranges should be treated with caution.
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Figure 2.29: Age-specific hospital separation rates for asthma, 1999Ð00
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Emergency department visits
Asthma is one of the more common reasons for visits to a casualty/emergency
department. In the 1995 National Health Survey, an estimated 8,870 people visited a
hospital emergency department for their asthma in the 2 weeks before interview (or
6.4% of all visits); of these, 349 (3.9%) had more than one visit. Admission to a hospital
emergency department was more common among the young, with about half (49.7%) of
admissions for asthma occurring in those aged 0Ð9 years.
Doctor consultations
Asthma is a major problem managed in the primary healthcare setting, being the sixth
most frequently managed problem by GPs. A survey of general practice in 2000Ð01
found that asthma was managed at a rate of 2.8 problems per 100 encounters, with
females (55.0%) presenting more often than males (45.0%). The survey also found about
two-Þfths (41.4%) of asthma patients were aged under 25 (AIHW: Britt et al. 2001a). 
Medications were by far the most common treatment for asthma prescribed by GPs, at
a rate of 153 medications per 100 asthma encounters. Salbutamol was the most frequent
medication prescribed at 52 prescriptions per 100 asthma encounters. Overall, it was the
sixth most frequently prescribed medication by GPs (AIHW: Britt et al. 2001a).
Referrals for asthma were low (2.7 per 100 asthma problems) compared with other
problems (7.2 per 100 problems). Referral to a respiratory physician (0.7 per 100
problems) was the most common referral type for asthma in 2000Ð01. Less than one
(0.4) in 100 asthma problems was referred to a hospital (AIHW: Britt et al. 2001a).
Health-related actions
From self-reports in the 1995 National Health Survey, an estimated 1.1 million people
cited asthma as the reason for taking health-related actions, such as medications, days
away from work or school, medical consultation or hospital episodes. This represented
just over half (56%) of people who reported the disease (ABS 1997b).
Episodes of asthma often lead to interruptions in schooling and work. Based on the self-
reports from the 1995 National Health Survey, approximately 12% of people who had
asthma took days off from work or school in the 2 weeks preceding the survey
compared with about 4% of the rest of the population (ABS 1997b). Asthma appears to
have caused less disruption to the usual activities of adults than of children, with fewer
than 1% of 25Ð64-year-olds with asthma taking a day off work (ABS 1999). 
Disability
Asthma is a signiÞcant cause of disability and it can have a large impact on quality of
life. From the 1998 Survey of Disability, Ageing and Carers, it was estimated that more
than 400,000 people had asthma as one of the health conditions causing disability,
resulting in restriction of daily living activities such as attendance at work or school. Of
these, an estimated 170,902 had asthma as their main disabling condition. Furthermore,
approximately 131,400 Australians had difÞculties in undertaking speciÞc activities
related to self-care, mobility and communication due to their asthma (ABS 1999c and
unpublished data).
AH2002 body 26-6  Page 74  Wednesday, June 26, 2002  6:28 PM
2 Health of Australians  75
TRIM SIZE 175 mm Wide x 250 mm Deep
Mortality
In 2000, asthma was the underlying cause of 454 deaths, less than 1% of all deaths
(128,291) in Australia that year.
The number of deaths attributed to asthma increases with age. Very few deaths in
childhood are attributed to asthma. In 2000, the death rates among children aged 0Ð4,
5Ð9 and 10Ð14 years were less than 1 per 100,000. The rate remains low during early and
middle adult life, then increases markedly after the age of 50, peaking at 32.2 deaths per
100,000 in the 85 and over age group. However, death from asthma among older people
is often complicated by the presence of chronic obstructive pulmonary disease and
hence attribution to asthma in this group may be problematic.
The difference between the male and female death rates for asthma was largest in the 65
and over age groups, with the rate higher among females. However, the death rates
were very similar in both sexes aged under 55 years, with slightly higher rates among
females in the 35Ð39 and 45Ð49 age groups (Figure 2.30).
Asthma was also recorded as an associated cause in a further 920 deaths. Of these
deaths, 325 (35.3%) had ischaemic heart condition as the underlying cause of death. A
further 63 deaths (6.8%) had cerebrovascular disease as the underlying cause, and 34
deaths (3.7%) had chronic obstructive pulmonary disease.
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Figure 2.30: Age-specific death rates for asthma, 2000
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Death rates for asthma in the total population ßuctuated considerably from 1970 to 2000.
The death rate for males decreased in the 1970s, whereas the rate for females remained
steady. Both rates increased between 1980 and 1989, followed by a marked decline in the
1990s. The death rates in 2000 were 1.8 per 100,000 males and 2.4 per 100,000 females, the
lowest male rate and third lowest female rate recorded in those three decades (Figure 2.31).
Similar to trends shown by males and females in the total population, the asthma death
rate among those aged 5Ð34 years decreased by about half between 1986 and 1996 and
gradually after 1998 (Figure 2.31). This is supporting evidence that deaths attributable to
asthma fell during the period, because the accuracy of reporting asthma as the
underlying cause of death on death certiÞcates outside this age range is often questioned.
Chronic obstructive pulmonary disease
COPD is a permanent and typically progressive disease, where damage to the lungs
obstructs oxygen intake and causes breathlessness with exertion and limitation of exercise
capacity. In severe cases, breathlessness may occur with little or no exertion. COPD is a
cause of substantial morbidity, disability and mortality in Australia. Smoking is the major
risk factor for COPD.
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Figure 2.31: Death rates for asthma, 1970 to 2000
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Chronic bronchitis and emphysema are the two main components of COPD. Each
condition can occur on its own, but they usually coexist in an individual (GOLD 2001).
Morbidity
COPD is a large source of morbidity. This is shown by its prevalence in the population
and the large amount of hospital use and primary care required by sufferers.
Prevalence
The Australian Burden of Disease and Injury Study estimated that in 1996 there were
almost 300,000 people with COPD in Australia, representing about 1.6% of the population,
with more than 20,000 new cases every year (AIHW: Mathers et al. 1999a). The prevalence
was higher in males than in females: 1,940 per 100,000 compared with 1,300.
It is difÞcult to obtain prevalence estimates for COPD that allow valid comparisons of
rates over time and between population groups. There are major differences in how the
disease is deÞned, the only consensus being the inclusion of chronic bronchitis and
emphysema. Also, COPD prevalence based on self-reporting is underestimated because
the disease is usually not diagnosed until it begins to restrict a personÕs lifestyle and is
moderately advanced.
Hospital separations
COPD is one of the major causes for hospitalisation, especially among the elderly. In
1999Ð00, COPD was the principal diagnosis in 48,583 hospital separations, accounting
for 0.8% of all separations. Hospital separations for COPD among the elderly, those
aged 65 and over (37,024 separations), accounted for more than three-quarters of all
COPD separations and 1.9% of all separations in the 65 and over age group. Male
COPD separations were double those of females.
The average length of stay for COPD separations was 7.8 days during 1999Ð00.
Doctor consultations
COPD (deÞned in a way that excludes chronic bronchitis) is not among the top 30
problems managed by GPs. According to the 2000Ð01 BEACH survey of general practice
activity, COPD was managed at a rate of 0.7 problems per 100 encounters (or 0.5% of all
problems managed). It was the eighth most frequently managed disease of the respiratory
system, accounting for 3.2% of all respiratory problems (AIHW: Britt et al. 2001a).
People in middle age or older with COPD required the most care by GPs. The survey
showed that people aged 45 and over accounted for a large proportion of the COPD
problems managed by GPs, some 96.5% of COPD problems managed.
Males accounted for 60.1% of COPD problems managed.
Disability
COPD is a signiÞcant contributor to disability, particularly among the elderly.
According to the 1998 ABS Survey of Disability, Ageing and Carers, an estimated 52,906
people had COPD (emphysema or bronchitis/bronchiolitis) as their main disabling
condition; two-thirds were males.
Older people (aged 65 and over) accounted for two-thirds (65.5%) of those reporting
COPD as their main disabling condition (Figure 2.32).
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Mortality
COPD is a major cause of mortality in Australia, being the fourth leading cause of death
among males and sixth among females. In 2000, there were 5,296 deaths (24 per 100,000
people) with COPD recorded as the underlying cause. The age-standardised death rate
was higher among males, with 35 deaths per 100,000 compared with 16 per 100,000
females.
COPD deaths occur mostly among older people, in particular those aged 70 and over
(80.6% of deaths), mostly reßecting lifelong exposure to tobacco smoking.
The death rate for COPD has declined in Australia over the last three decades, reßecting
changes in cigarette smoking. Almost all of the decrease is accounted for by reductions
in male deaths. Death rates for COPD have also converged between the two sexes
because, as the male rate decreased from 1970, the female rate increased between 1970
and 1990 and remained steady thereafter (Figure 2.33).
Risk factors
Tobacco smoking is the major known risk factor for COPD. It has been estimated that
77% of deaths from COPD are attributable to smoking (AIHW: Mathers et al. 1999a).
Accordingly, about 4,080 COPD deaths in 2000 can be attributed to smoking alone. In
addition, COPD may be a contributing factor in deaths from other smoking-associated
causes. 
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Figure 2.32: Persons with COPD (emphysema or bronchitis/bronchiolitis) as their main 
disabling condition, 1998
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Exposure to agents in the environment, including air pollutants and occupational dusts
and chemicals, is also known to contribute to the risk of developing COPD, either
independently or in addition to tobacco smoking (Krzyzanowski & Kauffmann 1988;
Goldring et al. 1993).
COPD symptoms can be aggravated by chest and viral infections, particularly the
common cold, inßuenza and pneumonia.
Musculoskeletal disorders
Disorders of the musculoskeletal system (joints, muscles and bones) are among the
most common health conditions and have a substantial inßuence on quality of life and
use of resources. They affect almost every individual at some time in their lifetime.
Many of these conditions are minor or transient, but some can cause lifelong disability.
However, they are not immediately life threatening and have low associated mortality.
The WHO (1998) has declared the Þrst decade of the twenty-Þrst century to be the Bone
and Joint Decade in order to raise awareness of the impact of musculoskeletal disorders
and encourage further research and development.
More than 100 diseases make up the spectrum of musculoskeletal disorders. Most of
them are of unknown cause and allow little opportunity for prevention. 
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Figure 2.33: Death rates for COPD, 1970 to 2000
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A major subgroup is arthritis, which refers broadly to inßammation of the joints with
associated stiffness, pain and deformity. Arthritis imposes a heavy economic burden on
the community, including in-patient and outpatient care, residential aged care,
medications and lost productivity. From self-reported information obtained in the 1995
ABS National Health Survey, it has been estimated that over 2.6 million Australians, or
nearly 15% of the population, have some form of arthritis, with about 60% of these
being females. Arthritic conditions are among the most frequently managed problems
in general practice, representing 2.4% of all problems managed in 1999Ð00.
Two signiÞcant musculoskeletal disorders, osteoarthritis and osteoporosis, are
discussed in some detail below. Other musculoskeletal disorders were discussed in
Australia’s Health 2000. 
Osteoarthritis
Osteoarthritis, the most common form of arthritis, is a degenerative condition due
mainly to accumulated wear. It affects mainly the hands, spine and weight-bearing
joints such as hips, knees and ankles. Based on self-reported information in the 1995
ABS National Health Survey, almost 1.2 million Australians had osteoarthritis, a
prevalence rate of 64 per 1,000. Osteoarthritis constituted 1.5% of all problems managed
by GPs in 2000, ranking it as the tenth most frequently managed problem (AIHW: Britt
et al. 2000). Osteoarthritis is also the third most common problem for which imaging is
ordered by GPs, after back pain and fracture, accounting for 4.1% of all imaging orders
(AIHW: Britt et al. 2001b).
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Figure 2.34: Age-specific prevalence of osteoarthritis, 1995
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Hospital separations for osteoarthritis have increased 42% over the past 7 years, from
39,186 in 1993Ð94 to 55,758 in 1999Ð00. Average length of stay in hospital in 1999Ð00 was
more than 6 days. Health system costs in 1993Ð94 were estimated to be $624 million,
nearly half (48%) of which was for hospital services. A further 19% was for nursing
home care, 13% for medical care (mainly GPs) and 9% for pharmaceuticals (AIHW:
Mathers & Penm 1999b).
The prevalence of osteoarthritis increases sharply with age, and is greater in females at
nearly all ages (Figure 2.34). By age 65, nearly 30% of females and 18% of males report
having osteoarthritis.
Although it is known that increasing age and genetic factors predispose people to most
forms of arthritis, behavioural risk factors have been identiÞed only for osteoarthritis.
The major modiÞable risk factors are joint trauma, obesity and repetitive joint usage. A
history of joint trauma is the strongest risk factor for osteoarthritis at either the knee or
the hip. Obesity has been shown to be a weight-bearing factor in osteoarthritis of the
knee. Occupations requiring knee-bending have been associated with knee
osteoarthritis, and farming has been associated with hip osteoarthritis. Recreational
activities, including running and other sports, have not been associated with the
development of osteoarthritis among people who have not had previous joint injuries
(Scott & Hochberg 1998).
On the basis of current knowledge, avoiding joint trauma, preventing obesity,
exercising to strengthen bones and muscles, and modifying occupational-related joint
stress through ergonomic approaches can all help prevent osteoarthritis (Scott &
Hochberg 1998).
A number of drugs are used in the treatment of osteoarthritis. In advanced cases not
responding to treatment, surgical joint replacement is a cost-effective intervention.
Osteoporosis
Osteoporosis, the progressive thinning of bone tissue, is a common condition among
the elderly and a major contributor to fractures in this age group. An Australian study
that used information obtained from radiology services, the Dubbo Osteoporosis
Epidemiology Study, estimated that after age 60 about 56% of females and 29% of males
suffer a fracture due to osteoporosis (Wark 1996). Osteoporotic limb fractures are
usually precipitated by falls, whereas the precipitating factor in vertebral fracture is
often being lifted or lifting a heavy weight. Back pain from compression fractures of the
thoracic vertebrae is a common problem among the elderly. 
Hip fractures are a particularly serious outcome of osteoporosis, as virtually all people
with a hip fracture are hospitalised for treatment. The number of hospital separations
for hip fractures from a fall among people aged 50 years and over, many of which
would be due to osteoporosis, has increased steadily from 14,007 in 1993Ð94 to 18,351 in
1999Ð00. Two-thirds of people who fracture a hip do not return to their pre-fracture
level of functioning, with many of these requiring nursing home care. Studies in
Australia and the United States suggest that mortality within a year of hip fracture is
24%, and in the Australian study this was about Þve times higher than in an age-
matched group who did not suffer a hip fracture (ANCC 1997; US CDCP 2001).
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The prevalence of osteoporosis is difÞcult to estimate, because most people with the
condition are not aware of it until suffering a fracture. Based on self-reports in the 1995
ABS National Health Survey, an estimated 248,000 people had osteoporosis.
Osteoporosis is more common among females and the elderly. From the 1995 National
Health Survey, the rate of osteoporosis among females was 105 per 1,000 for those aged
65Ð74, and 123 per 1,000 for those aged 75 and over (Figure 2.35). Comparable rates for
males were 12 and 15 per 1,000.
Only a small number of deaths (93 in 1998) are recorded as being caused by
osteoporosis. However, the number of deaths due to falls among the elderly, many of
which can be attributed to osteoporosis, is large. The Burden of Disease and Injury
Study, using attributable fractions by age and sex for six fracture sites, estimated that
523 Australian deaths in 1996 were attributable to osteoporosis (AIHW: Mathers et al.
1999a). 
The two main causes of osteoporosis are an inadequate build-up of bone mass during
growth and a rapid loss of bone mass with ageing. Although genetic factors account for
much of the individual variation in these two phases, it is possible to increase peak
bone mass and reduce bone loss by lifestyle changes. Adequate calcium intake and
exercise are important in achieving a higher level of bone mass during growth and
minimising loss of bone mass among the aged. Osteoporosis may also occur as a result
of corticosteroid drug treatments, tobacco smoking and alcohol abuse.
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Figure 2.35: Age-specific prevalence of osteoporosis, 1995
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A number of drug treatments, including hormone replacement therapy (HRT), are
available to reduce loss of bone mass. For females, oestrogen replacement started at the
time of menopause seems to retard or prevent bone loss and reduce fracture risk for as
long as the oestrogen is taken. According to the 1995 ABS National Health Survey, 25%
of females aged 45Ð54 and 30% of those aged 55Ð64 were using HRT (ABS 1997a).
Testosterone replacement is appropriate for males with osteoporosis caused by
hypogonadism (OÕNeill 1997). 
Diseases of the liver
Diseases of the liver are a signiÞcant cause of mostly preventable morbidity and mortality
in Australia. The liver is a versatile production, processing and storage ÔfactoryÕ, with
over 200 different functions. These include processing carbohydrates, proteins, fats,
vitamins and minerals, and the disposal of poisonous waste products, toxins and drugs.
There are four main types of liver disease: cirrhosis, hepatitis, fatty liver and other or
unspeciÞed forms of liver disease. Major risk factors for liver disease are excess alcohol
use and viral infections that cause hepatitis (DOH 2001; Stroup et al. 1993). This report
focuses on cirrhosis, hepatitis and fatty liver.
Fatty liver is a condition of fat accumulation within the liver cells. It is often preventable
and may be reversible. The major risk factor for fatty liver disease is alcohol misuse,
with alcoholic fatty liver being present in nearly all heavy drinkers. Other important
causes are obesity, diabetes, poor diet and illness. Typically symptomless, fatty liver
may lead to inßammation and progress to cirrhosis. 
Hepatitis is inßammation of the liver. Some types of hepatitis are reversible, but some
can lead to cirrhosis. Risk factors for hepatitis include viruses, excess alcohol, certain
drugs and chemicals, and auto-immune and inherited conditions. 
Cirrhosis, the Þnal outcome for many types of liver disease, is a serious and irreversible
form of liver damage. In people with cirrhosis, liver cells are progressively destroyed
and replaced by scarred tissue. As the disease develops, the liver hardens, becomes
distorted, and loses size. The major risk factor for cirrhosis is alcohol misuse; other risk
factors include infections, toxins and other liver diseases.
Incidence and prevalence
Determining the incidence and prevalence of cirrhosis and other chronic liver diseases
is difÞcult as most cases show no signs or symptoms until late in the development of
the disease. The prevalence in 1996 has been estimated at about 70 per 100,000 males
and 50 per 100,000 females (AIHW: Mathers et al. 1999a), indicating that more than
10,000 people in Australia were living with some form of liver disease. At the same
time, the number of new cases was estimated to be 1,000 per year.
Hospital separations
In 1999Ð00, diseases of the liver were the principal diagnosis in 9,614 separations (6,199
males and 3,415 females). The hospitalisation rate for diseases of the liver was 61.7 per
100,000 males and 32.9 per 100,000 females. There were 63,903 patient-days for liver
disease as a principal diagnosis, with the average length of hospital stay being 6.6 days.
Alcoholic liver disease was the principal diagnosis in 40% of separations for liver disease.
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Mortality
Liver disease is an important cause of death and illness. In 2000, diseases of the liver
were the underlying cause of 1,162 deaths (805 males and 357 females). The death rates
were 8 per 100,000 males and 3 per 100,000 females. Mortality due to liver disease rises
with age in both sexes to a high in those aged 85 and over.
The death rate for diseases of the liver is declining in both sexes. After rising
consistently for several decades, the combined rate peaked in the late 1970s (Figure
2.36). Since the early 1980s, the age-standardised death rates have declined from 14.7
and 5.7 per 100,000 males and females respectively, to 8 and 3.1 per 100,000 respectively
in 2000. There has been a corresponding trend in per capita consumption of alcoholic
beverages in Australia. Per capita consumption peaked in 1981, at 9.7 litres of pure
alcohol per person, and has since declined to 7.5 litres per person in 1999.
Kidney (renal) failure
Kidney failure, where much or all of the kidney function is lost, is a large source of
morbidity, disability and mortality. The condition may be acute (caused suddenly and
typically reversible), or chronic and long-term (where kidney function is progressively
and irreversibly lost). End-stage renal disease (ESRD) is the Þnal stage in the
progressive worsening of kidney function. Thereafter, dialysis or kidney transplantation
is necessary to maintain life. 
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1. Age standardised to the Australian population at 30 June 1991.
2. The mortality rates for 1970–96 (ICD-9) have been adjusted by a factor of 1.02 to be comparable with the ICD-10 
classifications and 1997–00 rates.
Source: AIHW National Mortality Database.
Figure 2.36: Trends in mortality for liver disease, 1970 to 2000
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Statistical information on various stages of kidney failure and associated signs and
symptoms is variable in quality. The proÞle of the disease described below relates
mostly to ESRD, mainly because of the availability of suitable information.
Causes and risk factors
Several factors and conditions damage the kidneys and affect their functioning.
Although some may cause short-term, acute damage which may be reversed if
managed correctly, others cause long-term irreversible damage. Risk factors include
infections, diabetes, high blood pressure, heredity, injury, excess weight, tobacco
smoking, and use of certain analgesic compounds and related agents.
In Australia, a major cause of kidney failure is glomerulonephritis. This is a term for a
group of kidney diseases in which there is inßammation of the glomeruli, a key part of
each of the kidneyÕs approximately one million Þltering units. Diabetic kidney disease
is another common cause of kidney failure. 
The Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), which
maintains a database of all people who begin treatment for ESRD, also records the main
(primary) kidney disease for all new cases. In the registry, the cause of 30% of the new
cases in 2000 was glomerulonephritis (Table 2.22). Diabetic kidney disease was the
cause of 22% of new cases.
Between 1993 and 2000, glomerulonephritis remained the main cause of ESRD, but
diabetic kidney disease and high blood pressure assumed more prominence as causes.
Analgesic kidney disease declined as a cause of ESRD.
Prevalence
The prevalence of kidney failure is difÞcult to estimate, although some national
information on the indicators of kidney disease, such as elevated blood creatinine levels
and protein or blood present in the urine, has become available recently. According to
the Australian Diabetes, Obesity and Lifestyle report, in 1999Ð00 elevated blood
creatinine was present in approximately 1.1% of the population, urinary protein in 2.5%,
and 6.4% were estimated to have detectable blood in the urine (Dunstan et al. 2001).
Table 2.22: Main kidney disease in new cases of end-stage renal disease, 1993 and 2000
Cause
1993 2000
Number Per cent Number Per cent
Glomerulonephritis 380 33 518 30
Diabetic kidney disease 181 16 381 22
Analgesic kidney disease 124 11 79 5
Long-term high blood pressure 105 9 239 14
Other 370 32 506 29
Total 1,160 100 1,723 100
Note: The data reported here have been supplied by the Australia and New Zealand Dialysis and Transplant Registry 
(ANZDATA). The interpretation and reporting of these data are the responsibility of the authors and in no way should be 
seen as an official policy or interpretation of ANZDATA.
Source: Russ 2001.
AH2002 body 26-6  Page 85  Wednesday, June 26, 2002  6:28 PM
86  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
In addition, ANZDATA provides a proxy source for estimating the prevalence of the
severe end of the spectrum of kidney failure. As at December 2001, there were 11,597
people (61 per 100,000 population) being treated for ESRD (Russ 2001). According to
ANZDATA, 54% of these people (6,362) depended on regular dialysis and 46% (5,235)
lived with functioning kidney transplants.
Using ANZDATA information, the number of people living with ESRD in Australia
appears to be rising. Between 1989 and 2000, the number of cases in the ANZDATA
registry increased from 30 to 61 per 100,000 persons. Although some of this increase
may be due to increasing incidence of the disease, it is also thought to be due to longer
survival of cases, improved management and technologies, and an increase in the
number of older people undertaking treatment for ESRD. 
Incidence
ANZDATA also publishes the number of new cases of kidney failure registered with it
in Australia. This is only a proxy measure of the incidence of kidney failure, as not all
people with kidney failure progress to ESRD; also, some of those with ESRD are not
able to begin treatment, or choose not to, and are therefore not recorded with
ANZDATA. In 2000, there were 1,723 new ESRD cases (983 males and 740 females)
registered with ANZDATA, an incidence rate of 9 per 100,000 population (Figure 2.37). 
The average age of people beginning treatment for ESRD in 2000 was 61 years. In all
age groups there were more males than females beginning treatment for ESRD. In both
sexes, incidence of ESRD increased with age.
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Note: Age standardised to the Australian population at 30 June 1991.
Source: Russ 2001.
Figure 2.37: Trends in new cases of end-stage renal disease, 1981 to 2000
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Mortality
Kidney failure contributes signiÞcantly to mortality. In 2000, there were 1,715 deaths for
which kidney failure was recorded as the underlying cause of death (803 males and 913
females). Death rates rise with age in both sexes, and are highest among those aged 75
and over.
Deaths following kidney failure have risen over the past 20 years. In 2000, age-adjusted
death rates were 8.8 and 6.0 per 100,000 for males and females respectively, up from 7.0
and 3.7 two decades earlier (Figure 2.38).
Morbidity
Hospital separations
Kidney failure is a major reason for hospital visits. Most of these are for maintenance
dialysis or kidney transplantation procedures.
In 1999Ð00, kidney failure was the principal diagnosis in 7,394 hospital separations.
Males were more likely than females to have a separation for kidney failure, 42 per
100,000 males in comparison to 31.4 per 100,000 females. The average length of hospital
stay was 8.6 days (8.4 days for males and 8.9 days for females).
In addition, in 1999Ð00, there were 535,451 separations for dialysis, up from 480,606 in
1998Ð99, and accounting for an estimated 10% of all hospital separations. Note that
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1. Age standardised to the Australian population at 30 June 1991.
2. The mortality rates for 1980–96 (ICD-9) have been adjusted by a factor of 1.05 to be comparable with the ICD-10 
classification and 1997–00 rates.
Source: AIHW National Mortality Database.
Figure 2.38: Trends in mortality for kidney failure, 1980 to 2000
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these represent a relatively small number of patients having multiple hospital
admissions. Dialysis was the most common principal diagnosis in public hospitals in
1999Ð00 and the second most common in private hospitals. Males accounted for 58% of
these separations, most of which were same-day separations.
Kidney failure among Indigenous Australians
Kidney failure among Indigenous Australians, in particular in the Northern Territory, is
high and has been described as an epidemic (Spencer et al. 1998). 
According to ANZDATA, new cases of ESRD in Indigenous Australians rose from 42
cases to 143 between 1991 and 2000. The rise has been most dramatic in the Northern
Territory, where more than 80% of new cases in 2000 were in Indigenous Australians.
Currently, about 6% of ESRD registrants with ANZDATA are Indigenous Australians,
who account for just 2% of the total population. In 2000, 710 Indigenous people were
receiving dialysis or living with kidney transplants.
A signiÞcant difference between the Indigenous and other Australian populations is in
the age of ESRD development. Indigenous people typically need treatment for ESRD at
an earlier age than other Australians. More than 85% of new Indigenous patients are
aged 64 or under. This contrasts with 55% of new patients in this age group among the
rest of the Australian population.
The incidence of kidney failure in Indigenous people has been attributed to a number of
factors, including high levels of glomerulonephritis following streptococcal infections
and increasing prevalence of the Ômetabolic syndromeÕ (e.g. high blood pressure, Type 2
diabetes, obesity and heart disease). Better ascertainment and greater acceptance of
ESRD therapy by the Aboriginal community may also contribute to the increase in
reported numbers (Thomas 1998).
Nervous system disorders
Introduction
Disorders of the nervous system are responsible for a signiÞcant proportion of the
burden of disability in Australia. The Burden of Disease and Injury Study found that
nervous system disorders (not including sense organ disorders) accounted for over 8%
of years of life lost due to disability in Australia (AIHW: Mathers et al. 1999a). Nervous
system disorders include dementia, epilepsy, ParkinsonÕs disease, multiple sclerosis,
motor neurone disease, HuntingtonÕs disease, muscular dystrophy and many others.
Nervous disorders are distinguished from mental disorders partly through the presence
of objective markers in the former, such as X-ray or laboratory abnormalities. However,
the distinction becomes blurred with conditions such as dementia.
Information about incidence, prevalence, mortality, hospitalisations and health system
costs for some of these has been given previously in Australia’s Health 2000. This edition
features a more detailed discussion of AlzheimerÕs disease, the main form of dementia.
Alzheimer’s disease
AlzheimerÕs disease is the most common form of dementia. Dementia is the progressive
impairment of brain functions, including language, memory, perception, personality
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and cognitive skills. In 2000, there were an estimated 146,800 Australians aged 65 and
over with dementia (AIHW 2001b), with over half of these having AlzheimerÕs disease
(AIHW 2000). 
The cause of AlzheimerÕs disease is not known, but it is not considered a part of normal
ageing. Previous theories about the accumulation of aluminium, lead, mercury and
other substances in the brain have been disproved. A diagnosis of AlzheimerÕs disease
is based on characteristic symptoms and on excluding other causes of dementia. It can
be conÞrmed by microscopic examination of a sample of brain tissue after death. 
By causing both structural and chemical problems in the brain, AlzheimerÕs disease
appears to disconnect areas of the brain that normally work together. Currently there is
no proven way to prevent or cure AlzheimerÕs disease, and the impaired functions
cannot be restored. The progression can be slowed but not stopped. Total disablement is
common. The average length of life after diagnosis is 8 to 10 years, although some
individuals live with the disease for 20 years or more (Hime 2001).
About 10% of all people aged over 70 have signiÞcant memory problems and about half
of such cases are due to AlzheimerÕs disease. Because women usually live longer than
men, they are more likely to develop AlzheimerÕs disease (US National Library of
Medicine 2001). 
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1. Age standardised to the Australian population at 30 June 1991.
2. ICD-9 code 331.0 used for 1979–96; ICD-10 code G30 used for 1997–00. Rates for 1979–96 adjusted by a factor 
of 1.48 to be comparable with 1997–00 rates.
Source: AIHW National Mortality Database.
Figure 2.39: Trends in death rates for AlzheimerÕs disease, 1979 to 2000
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Through the 1980s the number of deaths attributed to AlzheimerÕs disease increased
rapidly because of heightened awareness among medical practitioners (Hime 2001). In
2000, there were 1,559 deaths in Australia attributed to AlzheimerÕs disease; over 50% of
these were of people aged 85 years and over, and over 70% were of females. These
Þgures have been relatively stable over the past 10 years. 
The death rates for AlzheimerÕs disease have been fairly equal for males and females,
and have been declining since peaking at around 8 per 100,000 in 1993 for males and in
1995 for females (Figure 2.39). This decline may be due to the coding of some deaths
from AlzheimerÕs disease to pneumonia (AIHW 2000).
 
2.5 Communicable diseases
 
Communicable or infectious diseases are illnesses due to speciÞc infectious organisms
or their toxic products (Benenson 1995). The agent or toxic product can be transmitted
(communicated) to humans by direct or indirect contact with other humans, animals or
environments that carry the organism. This section begins with a brief overview giving
summary statistics on the major groups of communicable diseases in Australia,
followed by information on a range of speciÞc categories. 
 
Overview
 
This section discusses two major groups of communicable diseases, as classiÞed in the
International ClassiÞcation of Diseases: 
¥ infectious or parasitic diseases (ICD-10 codes A00ÐB99)
¥ acute respiratory infections which include inßuenza, pneumonia and other acute
upper/lower respiratory tract infections (ICD-10 codes J00ÐJ22).
 
Infectious and parasitic diseases
 
Deaths:
 
 In 2000, an infectious or parasitic disease was recorded as the underlying cause in
867 male and 779 female deaths in Australia, with age-standardised death rates of 9.2 and
5.8 per 100,000 respectively. In addition, there were 3,009 (12.2 per 100,000) deaths from an
acute respiratory infection in Australia (see more detailed information later in this section).
Figure 2.40 shows death rates for infectious and parasitic diseases between 1980 and
2000. The apparent increase in rates for both males and females warrants further
investigation, taking the following into account. First, AIDS was transferred to the
infectious and parasitic disease category in 1996, adding more than 400 male deaths in
that year. Second, the introductions of ICD-10 in 1997 and of automated coding of
deaths have increased the identiÞcation of communicable disease deaths (AIHW 2002).
(To allow analysis of trends, the ABS has introduced an adjustment method for these
changes.)
 
Hospitalisations:
 
 In 1999Ð00, infectious and parasitic diseases were the principal
diagnosis in 86,675 hospital separations; some 28,772 (33%) of these were for children
0Ð4 years of age. In addition, there were 125,724 hospital separations for inßuenza,
pneumonia and acute upper/lower respiratory tract infections.
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Notifications:
 
 
 
In 2000, there were 89,788 notiÞcations of communicable diseases to the
National NotiÞable Diseases Surveillance System (NNDSS), which is maintained by the
Commonwealth Department of Health and Ageing and receives data from State and
Territory health departments on more than 50 communicable diseases (Lin et al. 2002).
The most commonly notiÞed diseases were bloodborne diseases, followed by sexually
transmitted diseases and gastrointestinal diseases.
 
Acute respiratory infections 
 
Acute respiratory infections (ARIs) (ICD-10 J00ÐJ22) are usually divided into upper
respiratory tract infections affecting the mouth and nose, and lower respiratory tract
infections affecting the trachea and lungs. This section presents summary data on ARIs
and then more detailed information on inßuenza and pneumonia.
 
Deaths:
 
 
 
ARIs contributed signiÞcantly to mortality during 2000 and were the underlying
cause in 3,009 deaths, 1,339 male and 1,670 female with age-standardised death rates of
14.8 and 10.4 per 100,000 respectively. Deaths were concentrated in the older age groups
with the average age being 82.5 years for males and 80.7 years for females. 
 
Hospitalisations:
 
 In 1999Ð00, there were 125,724 hospitalisations for inßuenza,
pneumonia and acute upper/lower respiratory tract infections. Hospitalisations are
concentrated among the young aged 0Ð4 years (43,832 separations) and those over
50 years (52,849 separations).
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1. Age standardised to the Australian population at June 1991.
2. Infectious or parasitic disease was classified using ICD-9 codes 0001 to 139 with additional codes for 
compatibility to ICD-10 of 48283, 67004, 7713 and ICD-10 A00-B99. A 1.25 comparability factor was applied to 
the source data from 1980–96.
Source: AIHW National Mortality Database.
Figure 2.40: Death rates for infectious and parasitic diseases, 1980 to 2000
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General practice:
 
 ARIs were the major contributor to respiratory problems, which were
the most frequently managed problem by general practitioners in the BEACH survey of
2000Ð01 (22.5 per 100 encounters). Upper respiratory tract infection (4.4 per 100
encounters) and acute bronchitis (1.6 per 100 encounters) were also the most frequently
managed new conditions (AIHW: Britt et al. 2001a).
 
Influenza and pneumonia
 
Inßuenza causes fever, sore throat, cough, headache, muscle pain and malaise lasting
some days. Complications most commonly include lower respiratory tract infection,
especially in people with pre-existing heart or lung illness (NHMRC 2000). Laboratory-
conÞrmed cases of inßuenza became nationally notiÞable from 1 January 2001.
 
Deaths:
 
 There were 67 deaths (40 males and 27 females) during 2000 with inßuenza as
an underlying cause, compared with an average of 58 per year over the previous
3 years. The inßuenza age-standardised death rate was 0.3 per 100,000 for both males
and females. Inßuenza and pneumonia often occur together (NHMRC 2000) and in 2000
there were 2,937 deaths (1,312 males and 1,625 females) with an underlying cause of
death of either inßuenza or pneumonia. This was considerably higher than the previous
3-year period (average 2,055 per year). The age-standardised death rate in 2000 was 11.9
per 100,000 (14.5 per 100,000 for males and 10.1 for females). The vast majority of these
deaths (93%) occurred in people aged 65 years and over. The average age at death was
78.6 years for males and 82.6 years for females.
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Source: AIHW National Hospital Morbidity Database.
Figure 2.41: Age-specific hospitalisation rates for influenza, 1999Ð00
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Hospitalisations:
 
 The number of hospital separations in 1999Ð00 with a principal
diagnosis of inßuenza was 2,591 (1,202 males and 1,389 females), compared with an
average of 3158 per year over the previous 3 years. Hospital separations were
distributed evenly over most age groups (Figure 2.41) with a greater number in children
aged 0Ð4 years (573, 22%) and in adults aged 65 years and over (725, 28%). The
combined number of hospital separations caused by inßuenza and pneumonia in 2000
were 62,581 (33,155 males and 29,426 females). Half of these hospitalisations occurred in
people aged 65 years and over, 16,048 males (48.4%) and 14,617 (49.7%) females.
 
Vaccination:
 
 
 
Older Australians are at greater risk of illness from diseases such as
inßuenza. In 1999, the federal government began funding the Inßuenza Vaccine
Program for Older Australians. The program was designed to remove cost and physical
barriers that had prevented older people from having inßuenza vaccines. Telephone
surveys of Australians aged 65 years and over reported that inßuenza vaccination in
Australia increased from 60.7% in that age group in 1998 to 74.1% in 2000. This increase
occurred across all States and Territories. The survey shows no clear pattern in the
relationship between an individualÕs highest education obtained or annual household
income and the likelihood of being vaccinated to prevent inßuenza (Table 2.23). In New
South Wales, Victoria, Queensland and the Australian Capital Territory, the highest
vaccination coverage was observed for those with a secondary education, whereas in
South Australia, Tasmania and the Northern Territory the highest coverage was
observed in tertiary-educated respondents.
 
Bloodborne diseases
 
HIV/AIDS
 
The human immunodeÞciency virus (HIV) causes a chronic infection that can be
initially ÔsilentÕ in those infected. However, in time it usually leads to the clinical illness
known as acquired immunodeÞciency syndrome (AIDS), through destruction of key
 
Table 2.23: Coverage of influenza vaccine in people age 65 years and over, 2000
 
Vaccination coverage NSW Vic Qld WA SA Tas ACT NT Aust
Per cent
Highest education obtained
 
Secondary 74.6 76.6 70.0 74.9 80.9 78.1 85.0 65.8 74.9
Trade/diploma 74.2 73.4 68.5 75.2 77.8 78.2 78.7 63.9 73.3
Degree or higher 67.1 65.8 68.4 65.7 83.6 83.8 80.6 66.7 69.0
 
Annual household income
 
Up to $20,000 72.9 76.2 68.6 76.0 77.8 78.1 86.9 65.2 73.8
$20,001 to $50,000 73.5 73.8 69.3 75.9 82.3 79.2 81.6 67.6 73.9
$50,001 to $80,000 75.5 62.8 75.2 63.1 85.0 79.7 76.0 53.6 71.6
More than $80,000
 
(a)
 
n.a n.a n.a n.a n.a n.a n.a n.a n.a
Not stated/don’t know 80.9 78.9 73.7 73.6 87.4 77.7 75.2 64.5 78.4
 
n.a. Not available.
(a) Sample too small to provide reliable data.
 
Source:
 
 Taylor et al. 2000.
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cells of the immune system. At the end of 2000, an estimated 12,730 people were living
with HIV infection in Australia, including 2,700 who had developed AIDS. 
Most cases of HIV infection in Australia (over 80% of those diagnosed in 2000) were
transmitted by sexual contact between men, with relatively little transmission through
other sources of exposure. HIV prevalence in Australian injecting drug users continues
to be low, with the most recent estimated prevalence being 0.7% among people tested
through needle and syringe programs in 2000 (NCHECR 2001).
For most cases of HIV there is a lag between infection and diagnosis. In other words,
most newly diagnosed cases will not, in fact, be newly acquired. The National Centre in
HIV Epidemiology and Clinical Research, allowing for such factors, estimates that the
incidence of HIV infections declined rapidly from more than 2,500 new HIV infections
in 1984 to around 500 per year in recent years. This is corroborated by a decline in the
number of people newly diagnosed with HIV from a peak of over 1,700 in 1985 to
around 650 in 2000 (Figure 2.42).
Illness and mortality associated with HIV infection have been dramatically reduced
since 1996 in many countries by effective drug therapies. Of all people living with HIV
infection in Australia, an estimated half received treatment with combination therapies
in 2000. Even among those with AIDS, survival has increased from under 20 months for
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Note: Adjusted for multiple reporting delay.
Source: State and Territory health authority reports to National Centre in HIV Epidemiology and Clinical Research.
Figure 2.42: HIV/AIDS diagnoses, 1981 to 2000
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cases diagnosed in 1994 to 38 months for cases diagnosed in 1997. The number of
reported AIDS diagnoses and deaths in Australia peaked in 1994, at 955 and 737
respectively, and had fallen to 255 (a 73% fall) and 157 (79% fall) by 2000 (Figure 2.42).
With generally low levels of HIV transmission, and an improved treatment outlook,
AustraliaÕs epidemic of HIV infection and AIDS represents less of an immediate public
threat than it did a decade ago. Nevertheless some population groups remain
vulnerable. Surveys of homosexual men in several cities suggest that anal intercourse
with casual partners has become more frequent since the mid-1990s and rates of
sexually transmitted infections are increasing in this population. High rates of
hepatitis C spread among people who inject drugs and widespread bacterial sexually
transmitted infections in some Indigenous communities also suggest the potential for
further HIV spread (NCHECR 2001).
Chronic viral hepatitis
Information on hepatitis B and C is given below. For both diseases, incident cases (new,
recently occurring) can be diagnosed by speciÞc blood tests. Incident cases are also
determined when the symptoms are compatible with viral hepatitis and other causes
have been excluded. NotiÞcations of hepatitis B and C that do not meet the deÞnition of
an incident case are recorded as ÔunspeciÞedÕ.
Hepatitis B
Hepatitis B is transmitted through sexual contact, blood contact or from mother to baby.
It can cause chronic infection leading to liver disease, mainly when exposure occurs at a
young age. The number of new cases of hepatitis B reported to the NNDSS has
increased from 213 cases in 1996 (a crude rate of 1.2 per 100,000) to 395 cases in 2000 (a
crude rate of 2.1 per 100,000). The highest rate of new cases occurred in the 20Ð24 age
group (7.6 cases per 100,000 population), constituting 26% of all cases. Overall, the male
to female ratio was 1.6:1. NotiÞcations of unspeciÞed hepatitis B have been relatively
stable over the period 1996Ð00 at approximately 40 cases per 100,000 annually (Lin et al.
2002; NNDSS 2002; Roche et al. 2001b).
Hepatitis C
Hepatitis C virus is transmitted mainly by blood contact and causes chronic infection in
around 70% of cases. In Australia an estimated 90% of newly acquired hepatitis C cases
are related to injecting drug use. Hepatitis C continues to be the most frequently
reported notiÞable infection in Australia. During 2000, 20,048 newly or previously
acquired cases were notiÞed to the NNDSS, bringing the total number of notiÞed cases
of hepatitis C in Australia to more than 160,000 since antibody testing became available
in 1990. NotiÞcations of hepatitis C between 1996 and 2000 remained relatively stable in
the range of 18,000Ð22,000 per year. NotiÞcations of hepatitis C include newly acquired
(incident) cases, or unspeciÞed cases, where the timing of infection is unknown.
Rates of hepatitis C notiÞcation between 1996 and 2000 doubled among people aged
15Ð19 years, from 54 per 100,000 in 1996 to 108 per 100,000 in 2000. Overall, the male to
female ratio of notiÞcations in 2000 was almost double. In the 15Ð19 year age group,
however, approximately equal numbers of male and female cases were notiÞed (Lin et
al. 2002).
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The number of notiÞcations of newly acquired hepatitis C increased from 346 cases in
1998 to 441 cases in 2000 (Lin et al. 2002). Yet this number remains a small fraction of the
estimated 11,000 cases of newly acquired hepatitis C infections that occur in Australia
each year (Law 1999). In contrast to HIV, the hepatitis C prevalence in injecting drug
users has remained high in Australia. Over the period 1996Ð00 the prevalence was
relatively stable at approximately 50%, based on an annual survey of people attending
needle and syringe program sites across Australia (NCHECR 2001).
Sexually transmissible infections other than HIV
The two most common sexually transmissible infections (STIs) in Australia are believed
to be human papillomavirus and genital herpes, both of which are chronic viral
infections. Their occurrence is difÞcult to monitor, as they are not notiÞable. 
The main bacterial STIs are reported through the NNDSS. Over the past 5 years, the rate
of chlamydia diagnosis doubled, from 46 per 100,000 population in 1996 to 88 in 2000.
The rate of gonorrhoea diagnosis has increased more gradually from 23 per 100 000 in
1996 to 30 in 2000 (Lin et al. 2002). The rates of notiÞcation of chlamydia and
gonorrhoea in the Northern Territory were substantially higher (10 to 100-fold) than in
other States or Territories. Increases in these STIs may be partly due to the increasing
use of more sensitive diagnostic tests, more acceptable specimen collection methods
and the introduction of screening programs. 
In 2000 the rate of syphilis diagnosis was also substantially higher in the Northern
Territory (90 cases per 100,000 population) compared with the national rate (9.2 cases
per 100,000 population). In 2000, the male to female ratio of notiÞcations was 0.7:1 for
chlamydia, 2.1:1 for gonorrhoea and 1.2:1 for syphilis. In New South Wales and Victoria,
there has been a steady increase over the past 5 years in the rates of gonorrhoea
diagnosis among homosexual men. The national number of donovanosis cases
diagnosed has declined over time, from 84 in 1995 to 12 in 2000. 
NotiÞcations of STIs for the Indigenous population during 1998 to 2000 combined were
taken from data for South Australia, Western Australia and the Northern Territory.
These rates were substantially higher than the rates for the total population (reported
above). The notiÞcation rates for Indigenous persons per 100,000 were chlamydia 983.2,
gonorrhoea 1,405.0, syphilis 233.2 and donovanosis 10.4 (ABS & AIHW 2001).
Gastrointestinal infections
Gastrointestinal infections are a major cause of morbidity in the developed world. In
2000, there were 21,304 notiÞcations to the NNDSS of gastrointestinal infections. The
majority of these notiÞcations were for campylobacteriosis (13,595) and salmonellosis
(6,151), although there were many notiÞcations of other more serious illnesses
potentially from food, including haemolytic uraemic syndrome. It is widely recognised
that notiÞed cases of gastrointestinal illness represent a small fraction of all
gastrointestinal infections that occur in the community.
Attributing the causes of gastrointestinal infection to different sources is difÞcult, due to
the unknown contribution from different modes of transmission. People may contract
gastrointestinal infections via food, water, other people, the environment or animals.
Despite the difÞculties in identifying the causes, transmission from food is estimated to
account for millions of cases of gastroenteritis each year in Australia (Veitch & Hogg 1997). 
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Although gastrointestinal infections are often mild and self-limiting, foodborne
illnesses can result in hospitalisations and death. For example, listeriosis can cause
septicaemia and meningitis in pregnant women, newborn infants and
immunocompromised people. State and Territory health departments notiÞed 33 cases
of listeriosis in the Þrst 6 months of 2001. There have been 19 deaths recorded due to
listeriosis for the years 1997 to 2000. These Þgures are likely to be signiÞcant
underestimates, due to coding issues and the opportunistic nature of the infections. 
To obtain better estimates of the burden of foodborne disease in Australia, the
Department of Health and Ageing established OzFoodNet in 2000. This is a
collaborative program to enhance surveillance of gastrointestinal infections and
conduct research. 
 
Vectorborne diseases
 
This section presents NNDSS notiÞcations of diseases transmitted by mosquitoes in
Australia. The nationally notiÞable vectorborne diseases include two caused by alpha
viruses (Barmah Forest virus disease and Ross River virus disease), a ßavivirus
(dengue), malaria and a category for all other arboviruses (includes Murray Valley
encephalitis, Kunjin viruses and Japanese encephalitis). 
 
Ross River virus (RRV) disease:
 
 Ross River virus infection was the most commonly
notiÞed vectorborne disease in Australia in 2000, with 4,200 notiÞcations (crude rate of
21.9 per 100,000 population). Crude rates were highest in the Northern Territory and
Queensland. Ross River virus disease shows a seasonal pattern, with peak notiÞcations
in the Þrst two quarters of every year.
 
Barmah Forest virus disease:
 
 There were 634 notiÞcations (crude rate of 3.3 per 100,000
population) of Barmah Forest virus disease in 2000. The rates were highest in the
Northern Territory and Queensland. 
 
Dengue fever:
 
 A total of 215 cases were notiÞed in 2000 (crude rate of 1.1 per 100,000
population) with the majority occurring in the Northern Territory and Queensland.
Dengue is not endemic in Australia despite periodic outbreaks and the main vector
being present in northern Queensland.
 
Malaria:
 
 Australia has been free of endemic malaria since 1981. Cases notiÞed in
Australia are from travellers returning from malaria-prone areas. NotiÞcations
remained stable in the period 1994Ð00 with 951 notiÞcations in 2000 (Lin et al. 2002).
 
Tuberculosis 
 
Australia has one of the lowest rates for tuberculosis (TB) notiÞcation internationally,
with little change over the last 10 years. People born overseas account for more than
80% of all notiÞed cases (Roche et al. 2001a). 
 
Deaths:
 
 TB death rates have decreased over the past 20 years (Figure 2.43). The age-
standardised death rates in 2000 of 0.2 per 100,000 males (33 cases) and 0.1 per 100,000
females (22 cases) were the lowest recorded.
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Hospitalisations:
 
 Between 1995Ð96 and 1999Ð00 there were 4,560 hospital separations
with the principal diagnosis of TB, an annual average of 912 hospital separations. There
were slightly more hospital separations for males (53%) than females (47%).
 
Notifications:
 
 
 
In 2000, 1,024 cases (crude rate of 5.3 per 100,000 population) of TB were
notiÞed. Cases were more common among males (crude rate of 5.3 per 100,000) than
females (4.8) and most were in the older age groups (Lin et al. 2002). The Australian
Mycobacterium Reference Laboratory Network continues to report cases of drug-
resistant TB but at a low prevalence (Dawson 2001).
 
Invasive meningococcal disease
 
Invasive meningococcal disease is due to an infection with the meningococcus bacterium
(
 
Neisseria meningitidis
 
) that causes septicaemia and meningitis. The risk of invasive
disease is increased if a person has had a recent upper respiratory tract illness or exposure
to cigarette smoke. Australia does not have a vaccination program due to the relatively
low risk of acquiring the disease and because the currently available vaccines target only
some of the thirteen different types of the organism. There is no effective vaccination
against meningococcal type B, which represented 56% of the infections in 2000 (Tapsall
2001).
1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000
0
0.5
1
1.5
2
Males
Females
Deaths per 100,000 population
Year
Notes
1. Age standardised to the Australian population at 30 June 1991.
2. Comparability factor of 1.21 applied to data before 1997. ICD-9 codes 010 to 018, 137 and ICD-10 A15-A19 and B90.
Source: AIHW National Mortality Database.
Figure 2.43: Death rates for tuberculosis, 1980 to 2000
 
AH2002 body 26-6  Page 98  Wednesday, June 26, 2002  7:18 PM
 2
 
 Health of Australians  
 
99
 
TRIM SIZE 175 mm Wide x 250 mm Deep
 
Notifications:
 
 
 
In 1999, there were 568 notiÞcations (crude rate of 3.0 per 100,000) and in
2000 there were 621 (crude rate of 3.2 per 100,000). NotiÞcation rates in both years were
highest in the 0Ð4 and 15Ð24 year age groups. In 2000 the rate was 15.8 per 100,000 for
0Ð4-year-olds and 7.2 per 100,000 for 15Ð24-year-olds.
 
Hospitalisations:
 
 In 1999Ð00, there were 730 hospital separations for meningococcal
disease. Over 90% of these hospitalisations were for meningitis or septicaemia.
 
Deaths:
 
 There were 29 deaths from meningococcal disease in 2000, 17 males and 12
females. Six of the deaths were from meningitis.
 
Vaccine-preventable diseases
 
Certain communicable diseases are regarded as Ôvaccine preventableÕ and are therefore
recommended by the NHMRC for routine vaccination/immunisation for children in
Australia. The resulting Australian Standard Vaccination Schedule is implemented by
the National Immunisation Committee. Recent changes occurred in May 2000, when
universal immunisation against hepatitis B (at birth and in the Þrst year of life) was
added to the schedule. In October 2001 a vaccine was introduced for children at high
risk of invasive pneumococcal disease, for those of Aboriginal or Torres Strait Islander
descent or those with medical conditions predisposing to this disease.
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Source: National Notifiable Diseases Surveillance System.
Figure 2.44: Notification rates for whooping cough, 1993 to 2000
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Whooping cough (pertussis)
 
Notifications:
 
 
 
Whooping cough remains the most frequently reported vaccine-
preventable disease. There were 4,397 notiÞcations (a crude rate of 23.2 per 100,000) in
1999 and 5,942 (a crude rate of 31.0) in 2000. The increase in 2000 represents the largest
number of cases reported since 1997 (10,941 cases). In both years, the 10Ð14 age group
had the highest rates, whereas in previous years the rates were highest in children under
1 year (Figure 2.44). Improved vaccination coverage for the Þrst four doses of diphtheria,
tetanus, pertussis (DTP) vaccine and the inclusion of a Þfth dose at 4 years of age (in
1994) may explain the low rates for 1Ð9-year-olds in 1999 and 2000 compared with
previous years. 
 
Hospitalisations:
 
 The number of hospital separations with a principal diagnosis of
pertussis was considerably lower in 1998Ð99 and 1999Ð00 (average of 302 per year)
compared with the previous 5-year period (average 806 per year) (AIHW 2000;
McIntyre et al. 2000). As in the past, the majority of hospitalisations (61%) were in
children less than 1 year of age.
 
Deaths: 
 
One death from whooping cough was reported during 2000, in a child less than
1 year old.
 
Tetanus
 
Notifications:
 
 Since 1995 there have been fewer than 10 cases of tetanus notiÞed each
year in Australia, with two cases in 1999 and six in 2000. Six of these cases were female
and seven were in people aged 50 years or older. To improve immunity in those most at
risk, a tetanus booster is now recommended at age 50 unless one was received in the
last 10 years (NHMRC 2000).
 
Hospitalisations:
 
 
 
Over the 2 years 1998Ð99 to 1999Ð00 there were 36 separations with a
principal diagnosis of tetanus, a similar number per year to the previous period
(1993Ð94 to 1997Ð98) (AIHW 2000). The majority of separations (72%) were of people
aged 50 years or over and there were fewer males than females (1:1.8). There were no
separations for neonatal tetanus. 
 
Deaths:
 
 There were no deaths in 1999 and two in 2000. Both were female and over 85.
 
Diphtheria
 
No cases of diphtheria have been notiÞed in Australia since 1993. Despite this,
diphtheria has the potential to re-emerge, as shown by a recent case in New Zealand
(Baker et al. 1998) and an extensive outbreak in the former Soviet Union in the 1990s
(Vitek & Wharton 1998).
 
Polio
 
The last conÞrmed case of polio arising in Australia was in 1967, with three possible
cases notiÞed in 1972 (DHAC 2000a). In October 2000, the WHO certiÞed the Western
PaciÞc Region, which includes Australia, polio-free (WHO 2000). The absence of natural
polio from the region and the rare but deÞnite risk of vaccine-associated poliomyelitis
has prompted governments to consider following the United States in changing to an
inactivated rather than live-oral vaccine. The inactivated vaccine does not cause
vaccine-associated poliomyelitis.
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Invasive 
 
Haemophilus influenzae
 
 type b disease 
 
Invasive 
 
Haemophilus influenzae
 
 type b (Hib) disease can cause meningitis, epiglottitis or
other illness (NHMRC 2000). 
 
Notifications:
 
 
 
The number of notiÞed cases of invasive Hib disease has continued to
decline following the inclusion of the Hib vaccine on the childhood vaccination
schedule in 1993 (see Chapter 3, page 152). In 1999 there were 40 cases notiÞed and in
2000 there were 28, the lowest number of notiÞcations recorded since national
surveillance began in 1991. In 1999 and 2000 there was a similar distribution of cases to
previous years and cases occurred most commonly in the 0Ð4 age group (45%).
Although rates have declined in all age groups since the introduction of the vaccine, the
most dramatic decreases have been in those aged under 2 years. Even so, infants aged
under 1 year continued to have the highest rate in 2000 (crude rate of 2.4 per 100,000).
Note that there are no speciÞc hospital separation or death codes for Hib. Cases of
 
H. influenzae
 
 meningitis and acute epiglottitis (unspeciÞed cause) have been used as a
measure of Hib morbidity. Before routine Hib vaccination began in late 1993, most of
these cases were presumed to be caused by type b. However, this may no longer be
valid and this should be considered when interpreting the following information.
 
Hospitalisations:
 
 In the 2-year period between 1998Ð99 and 1999Ð00 there were a total
of 56 hospital separations with a principal diagnosis of 
 
H. influenzae
 
 meningitis and 273
for acute epiglottitis. Most separations for meningitis were of infants under 2 years
(64%). Separations for acute epiglottitis were spread across all age groups with 83%
being adults (aged at least 15 years).
 
Deaths:
 
 There was one death in 1999 and one in 2000. 
 
Measles
 
Notifications:
 
 There has been a decline in the measles notiÞcation rate for Australia.
This followed the introduction of a two-dose vaccination schedule in 1994 (Gidding et
al. 2001), the Measles Control Campaign conducted in 1998 (Turnbull et al. 2001), and
improved coverage as part of the routine childhood vaccination schedule. In 2000 there
were 107 notiÞcations (crude rate of 0.6 per 100,000), the lowest number since national
surveillance began in 1991. 
As in past years, rates were highest for 0Ð4-year-olds (crude rate of 6.1 per 100,000 in
1999 and 2.5 for 2000). In both 1999 and 2000, young adults aged 20Ð24 years accounted
for 20% of all measles notiÞcations and had the second highest notiÞcation rate (crude
rate of 4.0 and 1.7 per 100,000 respectively). 
Many outbreaks in 1999 and 2000 involved young adults (Lambert et al. 2000, Holland
& Hall 2000) and a recent blood survey indicated that 11% of 18Ð22-year-olds were not
immune to measles (Gidding & Gilbert 2001). In response, free vaccinations were
provided to 18Ð30-year-olds from 2001 (Campbell 2000).
 
Hospitalisations:
 
 Hospitalisations due to measles have been declining since 1993Ð94. In
1998Ð99 there were 61 separations with a principal diagnosis of measles and in 1999Ð00
there were 50. The youngest age group (0Ð4) continued to have the highest
hospitalisation rates in these 2 years (1.6 per 100,000 and 1.7). However, in 1998Ð99
there was a secondary peak in young adults aged 20Ð24 years (1.3 per 100,000).
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Deaths:
 
 
 
There were no deaths during 1999 and 2000.
 
Subacute sclerosing panencephalitis (SSPE):
 
 SSPE is a delayed complication of
measles causing brain damage and invariably death, usually 10Ð15 years after the initial
measles episode (NHMRC 1997a). Surveillance of SSPE by Australian paediatricians
between 1995 and 1998 identiÞed 6 cases aged less than 15 years (APSU 1999). From
1999 onwards, however, SSPE was no longer reported by this system. Over the 2-year
period 1998Ð99 to 1999Ð00, there were 8 individual hospital separations with a principal
diagnosis of SSPE. All were for people in the age range 13Ð18 years.
 
Mumps
 
Notifications:
 
 
 
In 2000 there were 212 notiÞcations of mumps (1.4 per 100,000) a slight
increase on the 184 cases (1.1 per 100,000) reported in 1999. Although the notiÞcation
rate overall has changed very little since 1997, rates for children (0Ð14 years of age) have
been declining whereas those for adults (15 years and over) have been increasing. In
2000, 71% of notiÞcations were from people aged at least 15 years.
 
Hospitalisations:
 
 In 1998Ð99 and 1999Ð00 there were 83 hospital separations with a
principal diagnosis of mumps. The average annual rate over this 2-year period was 0.2
per 100,000. In 1999Ð00 rates were highest in the 0Ð4 (0.7 per 100,000) and 20Ð24 (0.7 per
100,000) age groups, with 67% of the admissions in people aged 15 years and over.
The increased mumps notiÞcation rate in young adults is important as adults can
experience a higher rate of complications from infection with the mumps virus. This is
evidenced by the high rate of hospitalisations in the 20Ð24 age group in 1999Ð00.
 
Rubella
 
Notifications:
 
 Cases of rubella have been declining each year since 1995. In 1999 there
were 379 notiÞcations (crude rate of 2.0 per 100,000) and in 2000 there were 322
notiÞcations (crude rate of 1.7 per 100,000), the lowest number on record. As in most
years, the highest rates in 2000 were for young adult males aged 15Ð24 (crude rate of 8.9
per 100,000). However, rates for this group have been decreasing in recent years due to
the replacement of the schoolgirl rubella program with adolescent vaccination of both
males and females between 1994 and 1998. 
 
Hospitalisations:
 
 In 1998Ð99 and 1999Ð00 there were 38 hospital separations with a
principal diagnosis of rubella (annual rate for 2-year period of 0.1 per 100,000). As in
past years, the majority of hospitalisations (61%) were in children under the age of
5 years, especially infants under 2 years old.
 
Deaths:
 
 There were no rubella deaths in 1999 or 2000.
 
Congenital rubella:
 
 The major consequence of rubella infection in the community is
children born with congenital rubella abnormalities due to maternal rubella during
pregnancy. One case of congenital rubella infection was identiÞed in 1999 and none in
2000. Between May 1993 and December 2000, 27 cases of congenital rubella infection
were identiÞed in Australian live-born children, an average annual rate of 1.3 per
100,000. The incidence of congenital rubella infection causing defects over this time was
an average annual rate of 1.1 per 100,000 (APSU 2001).
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Transmissible spongiform encephalopathies
Transmissible spongiform encephalopathies (TSEs) are a group of transmissible diseases
in humans and animals marked by a spongy (spongiform) deterioration of the brain
(encephalus). TSEs cause severe neurological symptoms and death. The most accepted
scientiÞc theory is that TSEs are caused by a self-replicating protein known as a prion. 
The most important forms of TSEs are: 
¥ Creutzfeldt-Jakob disease (CJD)
¥ variant CJD (vCJD)
¥ bovine spongiform encephalopathy (BSE, affecting cows).
Australia is free of BSE and other animal TSEs that affect sheep, goats, mink and cats.
CJD is a unique communicable disease because it can occur sporadically (90.4% of
cases) and is also caused by genetic mutation (7.4% of cases) or transmitted by infection
through medical care, such as through treatment with human brain tissue (2.2% of
cases) (Boyd et al. 2001). The Australian National CJD Registry undertakes surveillance
and diagnosis of CJD and monitors other human forms of TSEs. At the time of writing
the registry had recorded 479 cases of CJD since 1970 (Masters et al. 2002).
Variant CJD (vCJD) was Þrst recognised in the United Kingdom in 1995 and is linked to
eating BSE-infected beef. No cases of vCJD have been reported in Australia and
stringent measures have been taken to restrict the import of products that may have
been exposed to BSE.
2.6 National Health Priority Areas diseases and 
conditions 
Several diseases and conditions have been chosen for special attention by the Australian
Health Ministers under the National Health Priority Areas (NHPA) initiative. The
NHPA diseases and conditions are cardiovascular diseases, cancers, injuries, mental
problems, diabetes mellitus and asthma. The NHPA initiative is a collaborative effort
involving Commonwealth, State and Territory governments. It seeks to focus public
attention and health policy on those areas that are known to contribute signiÞcantly to
the burden of disease in Australia, and for which there is potential for health gain. The
NHPA initiative recognises that in order to reduce the burden of disease, strategies
need to be holistic, and to encompass the continuum of care from prevention through to
treatment and management (AIHW & DHFS 1997). 
This section provides a joint overview of the six NHPAs in terms of their prevalence,
morbidity, disability and mortality towards the end of the twentieth century.
Information is also provided on burden and costs to the health system. Time-series
information for the NHPA indicators is contained in Tables S58 to S63.
The NHPAs account for much morbidity, disability and mortality in Australia. They
also account for high health system costs. 
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¥ In 1995, over 40% of the Australian population suffered from an NHPA disease or
condition.
¥ Over one in four problems managed by general practitioners relate to NHPA
conditions. 
¥ The six NHPAs accounted for about 1.8 million hospital separations, over 9 million
patient-days, in 1999Ð00.
¥ The NHPA diseases and conditions were the cause of disability in almost 1.4 million
people.
¥ NHPA-related diseases and conditions accounted for almost 78% of all deaths in
2000.
¥ Using the summary measure disability-adjusted life years, it is estimated that 70% of
the burden of disease in Australia is attributable to the six NHPAs.
Morbidity
Prevalence
Population-based information on disease prevalence in Australia is based on various
surveys, such as the National Health Survey and the National Survey of Mental Health
and Wellbeing, both conducted by the ABS; and the AusDiab study. The 1995 National
Health Survey estimated that over 40% of Australians suffer from an NHPA disease or
condition, as either a recent or long-term health condition. In particular:
¥ From self-report, an estimated 2.8 million Australians, 15.5% of the population (Table
2.24), had a cardiovascular problem or condition in 1995, with high blood pressure
the most common cardiovascular condition reported (ABS 1997a). 
¥ Asthma was the second most common NHPA disease or condition reported, followed
by injury and poisoning. 
¥ The 1997 National Survey of Mental Health and Wellbeing revealed that approximately
one in Þve adult Australians suffer from a mental disorder (ABS 1998b). 
¥ From self-reports in the 1995 National Health Survey, over 430,000 Australians, 2.4%
of the population, had been told they had diabetes. In addition, a similar number
may have had the condition and been unaware of it (DHAC & AIHW 1999). The
AusDiab survey, using biomedical measurements, estimated that in 1999Ð00 over
Table 2.24: Prevalence of NHPA diseases and conditions, 1995
Priority area Number (’000) Per cent of total population
Cardiovascular disease or condition 2,795.5 15.5
Asthma 2,041.4 11.3
Injury and poisoning 1,153.9 6.4
Mental disorders 1,047.6 5.8
Diabetes 430.7 2.4
Cancer 379.6 2.1
Source: ABS 1997a.
AH2002 body 26-6  Page 104  Wednesday, June 26, 2002  6:28 PM
2 Health of Australians  105
TRIM SIZE 175 mm Wide x 250 mm Deep
930,000 people aged 25 years and over (around 7% of that population) had diabetes,
again about half of these unaware of their disease (Dunstan et al. 2001).
Problems managed by general practitioners
Another perspective of the impact of NHPA diseases and conditions is provided by
visits to GPs. In Australia, GPs are usually the Þrst point of healthcare contact.
Consulting a doctor is actually the second most common action related to health care
taken by Australians, after the use of medications (ABS 1997a). 
According to the 2000Ð01 BEACH survey, over one in four problems managed by GPs
relate to NHPA conditions, although the frequency of consultations varies with disease
severity and condition (AIHW: Britt et al. 2001a). Circulatory and psychological
problems are the most common NHPAs that GPs manage. Over the 12-month period
(2000Ð01), out of a total of 143,528 problems managed by 999 GPs during 99,307
encounters: 
¥ 11.1% were for circulatory problems
¥ 7.2% were for psychological problems
¥ 5.2% were for injuries
¥ 2.0% were for asthma
¥ 1.9% were for diabetes
¥ 0.6% were for malignant skin cancers.
Four of the top ten problems managed by GPs in 2000Ð01 were in relation to an NHPA.
Hypertension was the problem most frequently managed in general practice overall,
accounting for 6.0% of all problems managed. Depression was the fourth most common
problem managed (2.5%). Asthma and diabetes were the sixth and seventh problems
most commonly managed. 
Hospitalisation
Hospitalisation represents a different part of the spectrum of morbidity associated with
various NHPA diseases and conditions. In 1999Ð00, principal diagnoses within the six
NHPAs accounted for about 1.8 million hospital separations or around 30% of all
separations, and about 9 million patient-days (41% of the total). Cancers (33% of the
NHPAs), cardiovascular diseases (25%), injuries (24%) and mental disorders (14%) were
the major contributors to NHPA-related hospital separations. 
Over the period 1993Ð94 to 1999Ð00 the number of hospital separations increased for all
NHPAs except asthma. The largest increases in separations were for mental disorders
and cancers. Conversely, over the same period the average length of stay decreased for
all NHPAs except mental disorders. The largest decreases in lengths of stay were for
cardiovascular diseases, diabetes and cancers.
The average length of hospital stay for NHPA diseases and conditions in 1999Ð00 was
5.3 days, compared to 3.8 days for all hospital separations, probably reßecting the more
serious nature of these conditions. Mental disorders and diabetes place the greatest
burden on the hospital system in terms of hospital days per separation, with lengths of
stays averaging 12.0 days and 6.6 days respectively in 1999Ð00.
AH2002 body 26-6  Page 105  Wednesday, June 26, 2002  6:28 PM
106  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
Many of the NHPA diseases and conditions, as well as being the main reason for
hospitalisation (principal diagnosis), may be contributors to separations for other causes;
i.e. they were additional diagnoses (Figure 2.45). Diabetes in particular accounts for a
much larger proportion of additional diagnoses than principal diagnoses, especially in
relation to cardiovascular diseases. In almost 23% of separations with a principal
diagnosis of cardiovascular disease, diabetes was listed as an additional diagnosis.
Disability
NHPA diseases and conditions entail signiÞcant disability. According to the 1998
Survey of Disability, Ageing and Carers, in almost 1.4 million cases (38% of people with
a disability), NHPA diseases and conditions were the main reason for the disability
(ABS 1999c). Over 36% of these people had profound or severe core activity restriction,
and 27% had only mild core activity restriction.
Among the NHPAs, mental and behavioural disorders were the most common cause of
disability (38% of NHPA disability), followed by cardiovascular diseases (23%), and
injury and poisoning (18%). According to the survey, around 740,000 Australian males
and 620,000 females had an NHPA disease or condition as their main disabling
condition (Figure 2.46). As the main disabling conditions, mental and behavioural
disorders, cardiovascular disease, injury and poisoning, and cancer were more common
causes among males than females compared with the other NHPA conditions, whereas
diabetes and asthma more common among females.
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Source: AIHW National Hospital Morbidity Database.
Figure 2.45: Hospital separations for NHPA diseases and conditions, 1999Ð00
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NHPA-associated disability occurs throughout the life cycle although the impact is
more disease-speciÞc. Over 68% of people with cardiovascular disease as their main
disabling condition were over the age of 65. In contrast, over 50% of people with
asthma as their main disabling condition were under the age of 30, and about 50% of
people with diabetes as their main disabling condition were between 50 and 70 years.
Disability associated with mental disorders was relatively common among children,
whereas disability associated with injury was most common among middle-aged
people.
Mortality
Although signiÞcant reductions have occurred in death rates for some NHPA diseases
and conditions over the past several decades, they still are the primary cause of death in
more than three out of four deaths in Australia. NHPA-related deaths accounted for
about 100,000 or 78% of all deaths in 2000. 
Cardiovascular diseases (50% of NHPA conditions) and cancers (36%) were the major
causes of NHPA-related deaths, followed by injuries, mental disorders, diabetes and
asthma. Diabetes accounted for a much smaller proportion as the underlying cause of
death. However, in addition to being the underlying cause of death, it is considered to
contribute indirectly to mortality associated with other diseases, particularly
cardiovascular diseases.
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Figure 2.46: Disability associated with NHPA diseases and conditions, 1998
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Figure 2.47 presents trends in death rates for NHPA diseases and conditions over two
decades, 1980 to 2000. Death rates from cardiovascular diseases decreased by over 50%
over the period, and deaths from injury and poisoning fell by a third. In contrast, death
rates for diabetes and mental disorders increased over the period, with rates for the
latter increasing by over 4%, on average, annually.
The declines in death rates for cardiovascular diseases and cancers were greater among
males than females, whereas females had greater reductions than males in death rates
for injury and poisoning. Interestingly, although there were large increases in diabetes
death rates for males over the two decades, no change in rate was noted among
females.
Overall burden of NHPAs
Figure 2.48 presents a comparison of the burden of disease and injury across the six
NHPAs in 1996. The six NHPAs accounted for 70% of the total burden of disease and
injury in Australia in terms of disability-adjusted life years. The three largest
contributors were cardiovascular diseases, cancers and mental disorders. Together, they
accounted for around 77% of the burden associated with the six NHPAs.
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Source: AIHW National Mortality Database.
Figure 2.47: Trends in death rates for NHPA diseases and conditions, 1980 to 2000
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NHPAs accounted for 81% of the years of life lost to premature mortality and 57% of
the equivalent years of ÔhealthyÕ life lost due to disability (AIHW: Mathers et al. 1999a).
The main burden of cardiovascular diseases, cancers and injuries was due to premature
mortality, whereas for mental disorders and asthma the burden was mostly in the form
of years of ÔhealthyÕ life lost due to disability. For diabetes, the two components made
similar contributions.
Mental disorders were the leading cause of years of ÔhealthyÕ life lost due to disability in
1996, accounting for nearly 30% of the total years of healthyÕ life lost due to disability in
Australia, and they were the third leading cause of overall burden (14% of the total)
after cardiovascular diseases (20%) and cancers (19%).
Health system costs
Data on health system costs provide an indication of the relative impact of the different
priority areas in comparison to one another and to total health system costs.
Figure 2.49 presents a comparison of the direct health system costs associated with the
health priority areas. Although the information is slightly dated, the Þgures provide a
useful account of the impact of various NHPAs. The six NHPAs accounted for an
estimated 40% of total health expenditure in 1993Ð94 (AIHW: Mathers et al. 1999a). The
three largest contributors to health expenditure were cardiovascular diseases, mental
illness and injuries. Together, those amounted to over $9.5 billion in health system costs
in 1993Ð94 or around 30% of total health expenditure and 76% of expenditure associated
with the six priority areas.
All other causes
Asthma
Diabetes mellitus
Injuries
Mental disorders
Cancers
Cardiovascular diseases
0 100 200 300 400 500 600 700 800
Years of life lost to premature mortality
Life lost due to disability
Disability-adjusted life years (’000)
Source: AIHW: Mathers et al. 1999b.
Figure 2.48: Disability-adjusted life years attributable to NHPA diseases and conditions, 
1996
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Most health system expenditure for the six NHPAs was in the hospital sector (47% of all
NHPA expenditure). This proportion is higher than that for health system expenditure
overall. The proportion of NHPA expenditure that occurred in the medical sector (15%),
which includes consultations with GPs and specialists as well as pathology tests and
screening and diagnostic imaging services, was lower than that for the whole health
system. Expenditure on NHPAs for pharmaceuticals was about the same.
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3
 
 Determinants of health
 
The health of individuals and populations is inßuenced by many factors that may act
alone or in conjunction with others (see Chapter 1). Information on the determinants of
health is particularly important because it can help explain trends in health and why
some groups have better or worse health than others. This knowledge can then guide
the nature and focus of preventive activities. Prevention can occur through the efforts of
individuals acting on their own behalf, through health professionals, and through
governments and other agencies. 
The health determinants outlined in this chapter relate to factors that can be measured
in an individual (biomedical; lifestyle and behaviour; knowledge, attitudes and beliefs;
genetic) or to broader environmental factors. 
¥
 
Biomedical factors
 
. Body weight, blood pressure, blood cholesterol and impaired
glucose tolerance are among the important biomedical factors that affect health
(Box 3.1). The levels of these factors in a person are the result of a complex
interplay between the various inßuences on health described below. For example,
within the context of a personÕs physical and social environment, knowledge of a
family history of heart disease may induce behaviour change (e.g. improved diet,
cessation of smoking, increasing physical activity) that may lower biomedical risks
(e.g. high blood pressure and cholesterol levels).
¥
 
Lifestyle and behaviour.
 
 Use of tobacco and other drugs, patterns of eating and
drinking, physical activity, sexual practice and other behaviours can all contribute to
a personÕs health (Box 3.1). Along with genetic factors, lifestyle and behaviour
inßuence biomedical factors that affect health. 
¥
 
Knowledge, attitudes and beliefs.
 
 Knowledge, attitudes and beliefs inßuence a
personÕs lifestyle and behaviour and so affect biomedical factors and health. They are
inßuenced by broad social, economic and cultural factors.
¥
 
Genetic factors
 
. Some diseases, such as muscular dystrophy, result entirely from a
personÕs genetic make-up whereas many other diseases reßect the interaction
between that make-up, environmental factors and behavioural factors.
¥
 
Environmental factors
 
. These include physical, chemical, biological, social, economic,
cultural and political factors. Physical, chemical and biological factors affect the
quality and safety of air, water, soil and food by, for example, chemical pollution and
waste disposal methods. Larger scale environmental disruptions, such as human-
induced climate change, can have major health implications. The social environment
is inßuenced by cultural customs, language, and religious, spiritual and personal
beliefs. Socioeconomic factors such as education and employment can affect a
personÕs ability and opportunity to make healthy choices and to sustain health-
promoting behaviours.
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Box 3.1: Some biomedical and behavioural risk factors associated with major 
causes of ill health, disability and death 
In the health context, a risk factor is any factor that represents a greater risk of ill health,
disability, disease or death. The risk factors included in this report are those which have
been consistently found to meet accepted public health criteria of causation. Although they
are presented separately, these factors often co-exist and interact. Although some factors
may play an overwhelming role in some diseases, such as smoking and lung cancer, most
diseases have many contributory causes.
Risk factors Associated cause of disease, disorder, disability, and
death
Biomedical
Overweight and obesity Coronary heart disease, Type 2 diabetes, breast cancer, gall-
stones, degenerative joint disease, obstructive sleep apnoea
High blood pressure Coronary heart disease, stroke
Raised blood cholesterol level Coronary heart disease, stroke
Impaired glucose tolerance Type 2 diabetes
Behavioural
Smoking Coronary heart disease; several cancers including lung,
mouth and cervical cancers; stroke; chronic lung disease
Poor diet and nutrition Coronary heart disease, stroke, breast and digestive system
cancers, Type 2 diabetes, gallstones, osteoporosis, malnutri-
tion, dental conditions
Excess alcohol consumption Coronary heart disease, liver and pancreatic disease, stroke,
high blood pressure, cancers of the digestive system, acci-
dents, mental illness, violence
Inadequate physical activity Coronary heart disease, stroke, Type 2 diabetes, colon cancer,
osteoporosis, bone fractures, falls, mental illness, obesity
Other drug abuse HIV/AIDS, hepatitis, renal failure, mental illness, suicide,
violence, accidents
Not vaccinated Measles, diphtheria, tetanus, pertussis, poliomyelitis,
Haemophilus influenzae type b
Excessive sun exposure(a) Melanoma and other skin cancers, premature ageing of the
skin
Unprotected sexual 
activity(a)
HIV/AIDS, hepatitis, cervical cancer, infertility, pelvic
infection, venereal disease
 (a) These risk factors are not reported in this edition of AustraliaÕs Health but have been reported in previous editions. 
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3.1 Biomedical factors
Body weight
The association between excess body weight and numerous health problems is well
documented. People who are overweight or obese have higher mortality and morbidity
rates for a number of diseases and conditions such as Type 2 diabetes, coronary heart
disease, respiratory disease and some types of cancers. Other conditions associated
with excess body weight are gall bladder disease, osteoporosis and ischaemic stroke.
Among those who are overweight, weight loss reduces the incidence and severity of
high blood pressure, high blood cholesterol, diabetes, osteoarthritis and some types of
cancers (NHLBI 1998). In terms of overall disease burden, overweight and obesity has
been estimated to account for over 4% of the total burden of disease in Australia in 1996
(AIHW: Mathers et al. 1999). 
Being underweight is also associated with poor health, including conditions such as
osteoporosis, ulcers, mental conditions such as depression, and eating disorders
(Gilmore 1999). 
Overweight and obesity is caused by an energy imbalance, where energy intake (diet)
exceeds energy expenditure (physical activity) over a considerable period. Hence diet
and physical activity are important in both weight loss and weight maintenance. Aside
from underlying genetic factors, the physical environment, and social, economic and
cultural factors can also affect overweight and obesity through their inßuence on
dietary behaviours and physical activity patterns. 
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Source: AIHW analysis of the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (see Box 3.4).
Figure 3.1: Proportion of people who are overweight or obese, 1999Ð2000
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Children and adolescents who are overweight or obese are at greater risk of becoming
overweight or obese adults. They are also at greater risk of encountering obesity-related
health problems usually associated with adult obesity. For example, it has recently been
observed that the increase in Type 2 diabetes among children is due to the increasing
prevalence of overweight and obesity among children (Ludwig & Ebbling 2001). 
Body mass index (BMI) is the most common method used to estimate the prevalence of
underweight, normal weight, overweight and obesity in a population. A personÕs BMI
is assessed by dividing weight (kilograms) by height (metres) squared. For adults, a
BMI less than 18.5 is considered underweight, 18.5 and less than 25 is healthy, 25 to less
than 30 is overweight, and 30 or more is considered to be obese. 
The 1999Ð2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab) (see Box 3.4,
page 127) estimated that 7.5 million Australians aged 25 years and over (60%) were
overweight or obese (BMI 25 and over). Of these, over 2.6 million (or 21% of the
population aged 25 years and over) were obese (BMI 30 and over). Men (67%) were
more likely to be overweight or obese than were women (52%). The proportion of
overweight or obese people increased with age and peaked at 55Ð74 years for men
(74%) and 65Ð74 years for women (71%) (Figure 3.1) (AIHW 2001).
There have been signiÞcant increases in the proportions of overweight or obese
Australians over the last 20 years. Among urban adults aged 25Ð64 years, the
prevalence of overweight or obese women increased from 26% in 1980 to 46% in 1995.
This trend was also seen among urban men, where the prevalence of overweight and
obesity increased from 47% in 1980 to 66% in 1995. AusDiab results in 1999Ð2000 were
consistent with the 1995 estimates (44% for women and 64% for men) (Figure 3.2)
(AIHW 2001).
In 1995, the proportion of overweight or obese children and adolescents aged 2Ð17
years was 21% for boys and 23% for girls (Booth et al. 2001). There have also been
signiÞcant increases in childhood obesity in recent years. The prevalence of overweight
or obese girls aged 7Ð15 years increased from 12% in 1985 to 16% in 1995. Similarly, the
proportion of overweight or obese boys increased from 11% to 15% over this period.
The proportion of obese girls aged 7Ð15 years increased dramatically from 1.2% in 1985
to 5.5% in 1995 and the proportion of obese boys increased from 1.4% to 4.7% (Magarey
et al. 2001). 
In 1999Ð2000, the proportion of underweight (BMI less than 18.5) men was less than 1%,
and the proportion of underweight women was less than 2%, among people aged
25 years and over. Data from the 1995 National Nutrition Survey showed that
underweight is more common among women aged 18Ð24 years, where the prevalence
was over 6%. In 1995, the proportion of underweight children and adolescents aged
2Ð17 years was 6% for boys and 5% for girls. 
Waist circumference is also a useful measure of increased disease risk due to
overweight and obesity (NHLBI 1998). Fat located in the abdominal region is associated
with greater risk of diabetes, coronary heart disease and high blood pressure,
independent of BMI (Albu et al. 1997; Lemieux et al. 1996).
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Although there are currently no standard cut-offs for waist circumferences to indicate
increased risk of obesity-related complications, current evidence suggests that, for
Caucasians, waist circumferences greater than 94 cm in men and greater than 80 cm in
women indicate increased risk (WHO 1997). Waist circumferences greater than 102 cm
(men) and 88 cm (women) indicate substantially increased risk. In 1999Ð2000, 55% of
men had a waist circumference greater than 94 cm and 57% of women had a waist
circumference greater than 80 cm. Almost 27% of men had a waist circumference
greater than 102 cm and 34% of women had a waist circumference greater than 88 cm.
For both men and women, waist circumferences generally increased with age
(FigureÊ3.3) (Dunstan et al. 2001). 
Excess body weight is more prevalent among Aboriginal and Torres Strait Islander
peoples than among other Australians. From data collected in 1994 (Aboriginal and
Torres Strait Islander peoples) and 1995 (all Australians), there was little difference
between the age-adjusted proportion of overweight or obese Aboriginal and Torres
Strait Islander men and all Australian men (62% compared with 63%). However, almost
25% of Aboriginal and Torres Strait Islander men were obese, a rate somewhat higher
than that for all Australian men (18%) (AIHW 2001). 
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Sources: AIHW analysis of the 1980, 1983, 1989 Risk Factor Prevalence Surveys; 1995 National Nutrition Survey; 
1999–2000 Australian Diabetes, Obesity and Lifestyle Study.
Figure 3.2: Proportion of people who are overweight or obese, 1980 to 1999Ð2000
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Almost 60% of Aboriginal and Torres Strait Islander women were overweight or obese,
a rate much higher than that seen among all Australian women (49%). Rates of obesity
among Aboriginal and Torres Strait Islander women were also much higher than
among all Australian women (28% compared with 18%) (AIHW 2001).
Women in lower socioeconomic groups are also more likely to be overweight or obese.
In 1995, around 53% of women in the lowest socioeconomic group were overweight or
obese, compared with 44% of women in the highest socioeconomic group (AIHW 2001).
Of women in the lowest socioeconomic group, 24% were obese, compared with 14% of
women in the highest group. For men, there was no signiÞcant difference in the rate of
overweight or obesity in the highest and lowest socioeconomic groups (around 61% for
both groups). Similarly, there was no signiÞcant difference in the rate of obese men
(around 18% for both the highest and lowest socioeconomic groups) (AIHW 2001). 
In 1995, 53% of women living in remote areas were overweight or obese, compared with
around 47% of women living in urban and rural areas. Of women living in remote
areas, 22% were obese, compared with around 18% of women living in urban or rural
regions. For men, there was no signiÞcant difference, with 65% of men living in remote
and rural areas being overweight or obese, compared with 62% in urban areas. Of men
living in rural and remote regions, 20% were obese compared with 18% of men living in
urban areas (AIHW 2001).
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Source: 1999–2000 Australian Diabetes, Obesity and Lifestyle Study.
Figure 3.3: Proportion of people with waist circumference > 94 cm for men 
and > 80 cm for women, 1999Ð2000
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Blood pressure
High blood pressure (often referred to as hypertension, see Box 3.2) is a major risk
factor for coronary heart disease, stroke, heart failure, peripheral vascular disease and
renal failure. The risk of disease increases as the level of blood pressure increases. When
high blood pressure is controlled by medication, the risk of disease is reduced, but not
to the levels of unaffected people (Kannel 1991). High blood pressure is more likely to
develop among people who are overweight or physically inactive, or have high dietary
salt intakes. Acute mental or emotional stress can cause a temporary rise in blood
pressure (see Box 3.3). 
High blood pressure was the most commonly managed problem by general
practitioners in 2000Ð01, accounting for 6% of all conditions managed (AIHW: Britt et
al. 2001). The burden of disease in Australia that can be attributed to high blood
pressure is estimated to be more than 5% of the total burden of disease among
Australians (AIHW: Mathers et al. 1999). 
Although high blood pressure can be deÞned as being above a particular level, there is
in fact no threshold level of risk. Starting from quite low levels, as blood pressure
increases so does the risk of stroke, heart attack and heart failure. In terms of predicting
ill health, both systolic blood pressure (SBP) and diastolic blood pressure (DBP) are
predictors of cardiovascular disease. Each reduction of 10Ð14 mmHg in SBP and 5Ð6
mmHg in DBP reduces the occurrence of stroke by two-Þfths, of coronary heart disease
by one-sixth, and of cardiovascular disease by one-third (Chalmers 1999).
Box 3.2: High blood pressure
Blood pressure represents the forces exerted by blood on the wall of the arteries and is
written as systolic/diastolic, e.g. 120/80 mmHg, stated as ‘120 over 80’ (AIHW 2001).
The continuous relationship between blood pressure levels and cardiovascular disease risk,
and the ‘arbitrary’ nature of the definition of high blood pressure, has contributed to the
variation in the definitions issued by various national and international authorities for
population surveys and clinical guidelines.
New classifications for the clinical management of high blood pressure have recently been
released by the World Health Organization (WHO 1999). These new guidelines define
high blood pressure as:
• systolic blood pressure (SBP) greater than or equal to 140 mmHg; and/or
• diastolic blood pressure (DBP) greater than or equal to 90 mmHg; and/or
• receiving medication for high blood pressure.
For the purposes of this report, high blood pressure is defined using these guidelines.
Previously, in Australia, high blood pressure was defined as an SBP of 160 mmHg or
greater and/or a DBP of 95 mmHg or greater and/or receiving medication for high blood
pressure. Data published using this classification should not be compared with data using
the new guidelines.
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Box 3.3: ‘Stress’ as a risk factor for cardiovascular disease
The American Heart Association reports a growing body of scientific evidence identifying
‘stress’ as a factor contributing to the risk of cardiovascular disease. However, too little is
known of the possible mechanisms involved. One reason for this is the difficulty in meas-
uring stress in the individual, particularly how, what and when it should be measured.
The use of differing definitions or measures of ‘stress’ between studies also makes it diffi-
cult to compare results. 
What is ‘stress’? 
All people feel ‘stress’, but each individual’s reaction may be different. Physiologically, an
acute stress response, or the ‘fight or flight’ response as it is commonly known, activates
release of the hormones adrenaline, noradrenaline and cortisol. These hormones increase
blood flow to the heart, muscles and brain and cause nutrients stored in muscles to become
available to provide energy so that the threat, or perceived threat, can be dealt with.
Most people are well adapted to dealing with acute stress such as occurs in the ‘fight or
flight’ response. However, the health implications of chronic stress, resulting in activation
of the acute stress response repeatedly over long periods, are not well understood. 
How might psychological stress contribute to cardiovascular disease? 
In a recent study of patients in Melbourne, most study participants reported a recent
stressful event before their heart attacks, although the majority of those involved were suf-
fering from undiagnosed heart problems before their heart attack (Baker Medical Research
Institute 2001). Whether chronic stress causes heart disease or just affects the timing of
adverse events (as was observed in the Melbourne study), or both, remains uncertain. 
The possible association between stress and cardiovascular disease appears to be related to
the impact of emotional stress on some of the established major risk factors. For example,
when people are stressed, the increased levels of adrenaline and noradrenaline circulating
in the bloodstream cause blood pressure to increase and blood vessels to constrict. This may
disrupt plaque in the artery walls and lead to restricted blood flow in vessels such as those
supplying blood to the heart or brain. People under stress may also overeat, find it difficult
to stop smoking or smoke more than they otherwise would (American Heart Association
2000).
Does reducing stress reduce your risk?
The answer is uncertain at this stage. Most of the evidence relating stress to cardiovas-
cular disease is based on studies involving people who already have cardiovascular disease,
so identifying causal mechanisms relies on the ability of participants to recall past events
and behaviours. What is needed are studies involving large samples of healthy people fol-
lowed over time (and using a standard measure of ‘stress’), to clarify the role of stress in
cardiovascular disease risk.
Source: American Heart Association 2000. 
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Box 3.4: Australian Diabetes, Obesity and Lifestyle Study
The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) has been an important
element of the Commonwealth Government’s actions under the National Diabetes
Strategy, which was endorsed by Australian Health Ministers in 1999.
The study was conducted during 1999 and 2000 to determine the prevalence of diabetes,
obesity and other cardiovascular disease risk factors including behavioural and biomedical
risk factors, such as high blood pressure and abnormal lipid profiles. It is the first nation-
wide survey to collect blood lipid data since the National Heart Foundation conducted its
Risk Factor Prevalence Survey in 1989. 
AusDiab collected data from about 11,250 Australians aged 25 years or over, residing in
42 randomly selected urban and non-urban areas (Census Collector Districts) of the six
States of Australia and the Northern Territory. 
Approximately 50% of eligible households participated in the household interview, and
55.2% of eligible adults in these households took part in the physical examination. The
effect of any non-response bias on estimates from AusDiab is yet to be determined. 
The study has been used in this report to provide the latest data for biomedical risk factors
and to contribute some estimates of disease prevalence in Chapter 2.
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Source: AIHW analysis of the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study.
Figure 3.4 Proportion of people with high blood pressure, 1999Ð2000
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Data from the 1999Ð2000 Australian Diabetes, Obesity and Lifestyle Study (see Box 3.4)
suggest that 29% or 3.6 million Australians over the age of 25 had high blood pressure
or were on medication for that conditionÑ31% of men and 26% of women (AIHW
2001). The proportion of men and women with high blood pressure increases with age
(Figure 3.4). 
Since 1980 the prevalence of high blood pressure has decreased signiÞcantly for both
males and females (Figure 3.5). The proportion of men (aged 25Ð64 years) with high
blood pressure has more than halved from 45% in 1980 to 22% in 1999Ð2000 and has
almost halved for women from 29% in 1980 to around 16% in 1999Ð2000. There has also
been a substantial reduction in average blood pressure levels in this time. 
At a population level, this decline has occurred among those not on medication for high
blood pressure as well as those on treatment. The reason is not certain but is consistent
with the greater availability of low-salt products in the food supply. 
In 1995, there was no signiÞcant difference in the prevalence of high blood pressure
between people in the lowest socioeconomic group and those in the highest (AIHW
2001).
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Figure 3.5: Proportion of people with high blood pressure, 1980 to 1999Ð2000
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There are no national data to assess the prevalence of high blood pressure among
Aboriginal and Torres Strait Islander peoples. However, data from the Kimberley region
of Northern Australia suggest that high blood pressure is up to three times as common
among Indigenous people living there than among other Australians (Smith et al. 1992).
Biomedical and lifestyle factors that are major causes of high blood pressure include
excess body fat, excessive alcohol consumption, physical inactivity, dietary salt intake
and complex dietary patterns marked by a low intake of fruit and vegetables and a high
intake of saturated fat. Stress raises blood pressure transiently but in the long term may
have indirect effects by inßuencing eating, drinking, smoking and physical activity
patterns (Beilin 1997). Cigarette smoking increases the risk of heart attack and stroke
threefold in people with high blood pressure.
For high blood pressure to be managed, lifestyle modiÞcations are essential. This is the
case whether anti-hypertensive drugs are used or not. ModiÞcation of lifestyle can
successfully diminish or eliminate the need for these drugs (NHF 1999).
Blood cholesterol
High blood cholesterol is a major risk factor for coronary heart disease and possibly for
some types of stroke. It is one of the main causes of the process by which blood vessels
become clogged (see Box 3.5). High blood cholesterol has been estimated to cause
nearly 3% of the total burden of disease of Australians (AIHW: Mathers et al. 1999). 
Box 3.5: High blood cholesterol
Cholesterol is a fatty substance produced by the liver and carried by the blood to the rest of
the body. Its natural function is to provide material for cell walls and for steroid hormones.
If levels in the blood are too high, this can lead to the artery clogging process known as
atherosclerosis that can bring on heart attacks, angina or stroke. The risk of heart disease
increases steadily from a low base with increasing blood cholesterol levels.
A total cholesterol level of 5.5 mmol/L or above is considered ‘high’, although a person’s
risk of cardiovascular disease also depends on other factors such as blood pressure levels
and smoking.
Total cholesterol has several parts. They include
LDL cholesterol, which is often known as ‘bad’ cholesterol. Excess levels of LDL cho-
lesterol are the main way that cholesterol contributes to atherosclerosis. 
HDL cholesterol, which is often known as ‘good’ cholesterol. High levels can have a
protective effect against heart disease by helping to reduce atherosclerosis. 
Triglyceride (TG) is another form of blood fat that is made by the body and can fluctuate
according to dietary fat intake. Under some conditions excess levels may contribute to
atherosclerosis. 
Sources: Barter P 2001; National Heart Foundation of Australia 1995.
AH2002 body 26-6  Page 129  Wednesday, June 26, 2002  6:28 PM
130  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
For most people, saturated fat in the diet is regarded as the main factor that raises blood
cholesterol levels. Cholesterol in foods can also raise blood cholesterol levels, but less
than saturated fat does. Genetic factors can affect blood cholesterolÑsome people have
high cholesterol levels regardless of their saturated fat and cholesterol intake and are at
increased risk from coronary heart disease.
The 1999Ð2000 AusDiab study (see Box 3.4) assessed blood cholesterol levels in
Australia. It was estimated that around 50% of both men and women had blood
cholesterol levels greater than or equal to 5.5 mmol/L (see Box 3.5), i.e. over 6 million
Australian adults aged 25 years and over. The prevalence increased with age, to age 74
in women and 64 in men (Figure 3.6) (AIHW 2001). In terms of people at high risk of
coronary heart disease, 18% of men and women aged 20Ð69 years had blood cholesterol
levels of 6.5 mmol/L or more. 
Average blood cholesterol levels in 1999Ð2000 are very similar to those 20 years earlier
for men and for women (Table 3.1). Although average cholesterol levels in Australia in
1999Ð2000 are 5.6 mmol/L for men and 5.5 mmol/L for women, it is biologically
achievable for people to have lower cholesterol levels. Cholesterol levels in societies
that follow a more traditional diet are much lower, as are their rates of cardiovascular
disease (Forge 1999).
There has been no marked reduction in the prevalence of people with high blood
cholesterol since 1980, when nationwide monitoring began (Figure 3.7) (AIHW 2001).
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Source: AIHW analysis of the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study.
Figure 3.6: Proportion of people with high blood cholesterol, 1999Ð2000
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In 1989, there were no strong associations between cholesterol levels and socioeconomic
status. However, a blood cholesterol level of 6.5 mmol/L or more (used in previous
studies to indicate high risk) was more common among unemployed women (25Ð64
years) than among women in full-time employment. Men (25Ð64 years) living alone or
previously married had around one-and-a-half-times the rate of high-risk blood
cholesterol (6.5 mmol/L and above) than men with partners or dependants (AIHW
2001).
Table 3.1: Average blood cholesterol levels, 1980 to 1999Ð2000
Sex 1980 1983 1989 1999–2000
mmol/L
Men 5.6 5.7 5.6 5.6
Women 5.5 5.6 5.5 5.5
Notes
1. Age-standardised to the 1991 Australian population. 
2. Includes persons aged 25–64.
3. For capital cities only.
Sources: AIHW analysis of the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (see Box 3.4); 1980, 1983 and 
1989 Risk Factor Prevalence Surveys.
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Figure 3.7: Proportion of people with high blood cholesterol, 1980 to 1999Ð2000
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There are no national data on blood cholesterol levels among Aboriginal and Torres
Strait Islander peoples. A New South Wales survey on cardiovascular risk factors
showed that a greater proportion of Indigenous women in Wilcannia had cholesterol
levels above 6.5 mmol/L compared with other Australian women. However, other
studies have shown no difference in cholesterol levels between Indigenous Australians
and other Australians (AIHW 2001).
Impaired glucose tolerance
Impaired glucose tolerance (IGT) is a metabolic stage between normal glucose tolerance
and diabetes. As well as being a risk factor for Type 2 diabetes, IGT is linked to a greater
risk of heart disease. 
In people with IGT, blood glucose levels are higher than normal but less than the level
required for a diagnosis of diabetes (see diagnostic criteria in Box 3.6). Blood glucose
levels normally rise after eating a meal then gradually fall as the meal is digested, but in
people with IGT these levels remain elevated. This is a result of reduced sensitivity of
the bodyÕs cells to insulin with or without a reduction of insulin production by the
pancreas (insulin is the hormone that enables the body to convert glucose to energy).
Although many people with IGT may revert to normal glucose tolerance, one in three
people with IGT are likely to develop Type 2 diabetes within 10 years (Harris & Zimmet
1992).
IGT is common in people who are physically inactive and obese, particularly with high
fat deposits in the abdominal region, and is more common in older people because such
risk factors are more widespread. With increasing age, the cells in the pancreas that make
insulinÑbeta cellsÑbecome less efÞcient. This, combined with decreased physical
activity and increased body weight, contribute to higher prevalence among older people
(Table 3.2). Indeed, for similar reasons, Type 2 diabetes is also more common among older
people. Genetic factors are also important; people who have a family history of diabetes
are more likely to suffer from impaired glucose tolerance and to develop diabetes. 
Table 3.2: Age-specific prevalence of impaired glucose tolerance, 1999Ð2000
Age (years) Men Women
Per cent
25–34 2.1 4.9
35–44 4.8 8.5
45–54 8.4 11.2
55–64 14.8 15.2
65–74 20.4 22.9
75+ 25.5 20.7
Source: Dunstan et al. 2001.
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The 1999Ð2000 AusDiab study (see Box 3.4) found that 10.6% of Australians aged
25 years and over had impaired glucose tolerance (Dunstan et al. 2001). The condition
was more common in women (12.0%) than in men (9.2%). The only earlier estimate of
prevalence is based on the 1981 Busselton Population Survey (Welborn et al. 1989).
Using the Busselton survey criteria for IGT, Dunstan et al. (2001) estimated that the
prevalence of IGT has trebled (Table 3.3).
Dunstan et al. (2001) suggest that a corresponding increase in the prevalence of obesity
in Australia has been a signiÞcant contributing factor to the increasing prevalence of
diabetes. Given the links between obesity and IGT, this trend may also contribute to the
escalating prevalence of IGT. 
Poor glucose control can also lead to cardiovascular disease, particularly when a person
has IGT in combination with cardiovascular risk factors such as obesity and high blood
pressure. This clustering of inter-related risk factors is known as the Metabolic
Syndrome (see Box 3.7).
Box 3.6: How is impaired glucose tolerance diagnosed?
Impaired glucose tolerance (IGT) is normally detected through an oral glucose tolerance
test. In this test a blood glucose measurement is taken after a period of fasting, then an
additional measurement is taken 2 hours after consuming 75 g of glucose. The blood glu-
cose levels in a person with normal metabolism should have returned to normal by this
time. In a person with IGT or diabetes mellitus, blood glucose levels will remain elevated.
The blood glucose measurement is expressed as the concentration of glucose in plasma,
which is the fluid component of blood after blood cells are removed. People with IGT will
have a fasting plasma glucose concentration of less than 7.0 mmol/L and between 7.8 and
11.1 mmol/L 2 hours after the oral glucose load. 
For a diagnosis of diabetes, symptoms of diabetes are likely to be present and the plasma
glucose concentrations greater than or equal to 7.0 mmol/L after fasting or greater than or
equal to 11.1 mmol/L 2 hours after the glucose load. 
Recently, a new category—’Impaired fasting glucose’—also considered to be predictive of
diabetes, was introduced by the Australasian Working Party on Diagnostic Criteria for
Diabetes Mellitus (Colman et al. 1999). This category is based on an abnormal blood glu-
cose measurement after fasting. The impaired fasting glucose category covers fasting
plasma glucose levels between 6.1 mmol/L and 7 mmol/L.
Table 3.3: Trends in the age-standardised prevalence of impaired glucose 
tolerance, 1981 to 2000
Survey Males Females
Per cent
Busselton 1981 3.2 3.0
AusDiab 1999–2000 9.8 12.3
Note: Age-standardised to the 1998 Australian population.
Source: Dunstan et al. 2001.
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As with many risk factors for Type 2 diabetes and heart disease, IGT is potentially
avoidable. Improvements in glucose tolerance can be achieved through participation in
regular physical activity and weight reduction. Clinical studies have shown that
physical activity and physical Þtness can increase insulin sensitivity and improve
glucose tolerance (Takemura et al. 1999; Tuomilehto et al. 2001). In addition to
controlling weight, physical activity also improves the bodyÕs sensitivity to insulin,
helping to lower blood sugar. Even a single bout of vigorous physical activity will have
an immediate effect on insulin sensitivity.
3.2 Lifestyle and behaviour
Tobacco smoking
Tobacco smoking contributes to more drug-related hospital separations and deaths than
alcohol and illicit drug use combined. In addition, of all risk factors for disease, tobacco
smoking is responsible for the greatest burden on the health of Australians. Although
the number of deaths attributed to tobacco smoking has declined in recent yearsÑfrom
around 19,900 in 1996 to 19,000 in 1998Ñthe number of hospital separations has
increased from 126,000 in 1995Ð96 to 143,000 in 1997Ð98 (AIHW: Miller & Draper 2001).
Tobacco smoking is a major risk factor for coronary heart disease, stroke, peripheral
vascular disease, numerous cancers and a variety of other diseases and conditions. It
has been estimated that in 1996 tobacco smoking was responsible for around 12% of the
total burden of disease in males and 7% in females (AIHW: Mathers et al. 1999).
Estimates from the 2001 National Drug Strategy Household Survey (NDSHS) indicate
that around 3.1 million Australians (19.5% of people aged 14 years and over) smoke
tobacco on a daily basis. 
A further 0.6 million (3.6%) smoke occasionally (not on a daily basis). These two
categories combined were referred to as current smokers in Australia’s Health 2000.
Males are more likely to be daily smokers (21%) than females (18%). The proportion of
daily smokers was highest among males aged 20Ð29 (29%) and females aged 20Ð39
(24%) (Figure 3.8).
The same survey estimated that 26% are former smokers (30% of males and 23% of
females) and 51% have never smoked (45% of males and 55% of females).
Box 3.7: The Metabolic Syndrome
The World Health Organization has classified a specific clustering of risk factors as the
Metabolic Syndrome (Syndrome X). Insulin resistance—either impaired glucose tolerance,
impaired fasting glucose or diabetes—is thought to be the underlying defect in this syn-
drome. In addition to insulin resistance, a person with the Metabolic Syndrome will usu-
ally have one or more of the following risk factors: high cholesterol, high blood pressure or
central obesity. The syndrome vastly increases a person’s risk of developing Type 2 diabetes
or cardiovascular disease. 
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Figure 3.8: Proportion of people who are daily smokers, 2001
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Figure 3.9: Proportion of people who are daily smokers, 1985 to 2001
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In Australia, smoking rates have been declining since the 1950s, when it was estimated
that around 70% of males and 30% of females smoked. Since 1985, smoking rates have
continued to decline and reached an important milestone in 2001, falling below 20% for
the Þrst time (Figure 3.9). 
There were no statistically signiÞcant changes in daily smoking rates among
adolescents, when compared with 1998. This is consistent with a 1999 study of school
students that reported that smoking rates among male and female students aged 16Ð17
had not changed when compared with 1996, and had declined among students aged
12Ð15 years (Hill et al. 2002). The authors concluded that the rise in the prevalence of
smoking among younger secondary students seen in the 1990s seems to have stopped.
Smoking is more common among Indigenous Australians than among other
Australians. In the 2001 NDSHS, almost half of the Indigenous population surveyed
reported that they smoked on a daily basis. In contrast, around one in Þve of the other
Australian population reported that they smoked on a daily basis. Indigenous
Australians were also less likely than other Australians to be former smokers or to have
never smoked (Figure 3.10).
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Source: 2001 National Drug Strategy Household Survey.
Figure 3.10: Smoking status, Indigenous and other Australians, 2001 
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Smoking status appears to be strongly related to socioeconomic status, with those from
lower socioeconomic backgrounds more likely to smoke than their higher ranked
counterparts. In the 2001 NDSHS, about 24% of people from the most disadvantaged
socioeconomic group smoked tobacco on a daily basis, compared with about 14% of
those from the most advantaged group (Figure 3.11). Individuals from the most
advantaged group were also more likely to never have smoked (55%) than were the
most disadvantaged socioeconomic group (48%).
Dietary behaviour
There is considerable evidence linking dietary behaviours with protection against or
reduced risk of developing many of the chronic diseases and their risk factors. Dietary
guidelines developed by the National Health and Medical Research Council (NHMRC)
(2001a, 2001b) recommend a high intake of plant foods (such as cereals, fruit,
vegetables, legumes and nuts) and to limit saturated fat and moderate total fat intake to
reduce the risk of coronary heart disease, several of the common cancers, and
overweight and obesity. Other common diseases and risk factors where good nutrition
may be protective or reduce risk include stroke, Type 2 diabetes, osteoporosis, tooth
decay, high blood pressure and raised blood cholesterol (Table 3.4). 
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Figure 3.11: Smoking status by index of relative socioeconomic disadvantage, 2001
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The effect of good nutrition on health begins early in life. It has been known for many
years that insufÞcient folate or folic acid (a B vitamin) in the diets of women of child-
bearing age increases the risk of having a foetus develop spina biÞda or other neural
tube defects. The NHMRC (1994) recommends that women capable of becoming
pregnant consume 400 µg per day of folate. Based on analysis of data from the 1995
National Nutrition Survey, only 1% of women aged 15Ð49 years consumed the
recommended level from naturally occurring sources (excluding supplements)
(Abraham & Webb 2000). To increase folate intakes, particularly among women of
child-bearing age, voluntary (i.e. at the discretion of food manufacturers) fortiÞcation of
selected staple foods with folate was introduced in 1995. However, by late 1998, it was
estimated that voluntary fortiÞcation had had little effect on dietary folate intakes
among the target population, due largely to the small number of foods that were
fortiÞed with folate (Abraham & Webb 2000).
Breastfeeding is an important contributor to infant health and inßuences health status
as an adult. Evidence is accumulating that breastfeeding has a protective role in several
chronic diseases including Type 1 diabetes, inßammatory bowel disease, allergic
diseases and obesity (NHMRC 2001b). The World Health Organization (WHO)
recommends that babies be exclusively breastfed for 6 months, with the introduction of
complementary foods and continued breastfeeding thereafter (WHO 2001a). Although
Australian breastfeeding rates were quite high at discharge from hospital (82% in 1995),
only 57% were exclusively breastfed at 3 months (includes water and water-based
drinks such as fruit juice) and just 19% were exclusively breastfed at 6 months (Donath
& Amir 2000). 
Although nutritional deÞciency is uncommon among the Australian population in
general, it remains a concern for some groups considered to be more vulnerable to poor
nutrition such as the frail aged, people with disabilities, some Aboriginal and Torres
Strait Islander communities, people on low incomes, the homeless, and those who
Table 3.4: Components of food which may provide protection against diseases and conditions 
of public health importance
Food
Diseases (or conditions) against which protection may be 
provided or for which risk may be reduced
High intake of plant foods, low intake of fat 
and saturated fat, high intake of dietary 
fibre
Coronary heart disease; angina; cancers of the colon, bowel, 
breast and prostate; overweight; obesity; high blood 
cholesterol
High intake of plant foods, low intake of salt High blood pressure; stroke
High intake of plant foods Type 2 diabetes; constipation; gastrointestinal cancers 
(including cancers of the colon, rectum, stomach, pancreas 
and oesophagus); lung cancer; cancers of the breast, 
prostate, cervix and bladder
Low intake of fat and saturated fat Colorectal cancer
Low intake of alcohol Most cancers; liver cirrhosis; brain damage; foetal alcohol 
syndrome
Adequate to high intake of calcium Osteoporosis
Infrequent and low intake of sugar Tooth decay
Source: Adapted from The Australian Guide to Healthy Eating (DHFS 1998).
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suffer from alcoholism and some chronic diseases (SIGNAL 2001). Poor nutrition early
in life has been associated with various health outcomes in adults. In particular,
undernutrition (a deÞciency of energy or nutrients) during pregnancy may contribute
to an increased risk of coronary heart disease and the related disorders stroke, Type 2
diabetes and high blood pressure in adult life (Godfrey & Barker 2000). 
In contrast, overnutrition and the rising prevalence of overweight and obesity in both
children and adults is of concern (see section on body weight). A comparison of food
and nutrient intake among Australian children aged 10Ð15 years showed that mean
intake of energy (Table 3.5) and most nutrients (except fat, cholesterol and calcium)
increased by 10% or more between 1985 and 1995 (the most recent national data) for
both boys and girls (Cook et al. 2001). Intake of vitamin C decreased for both boys and
girls between 1985 and 1995 but the decrease was statistically signiÞcant for girls only.
The increases in energy intake were attributable mainly to an increased intake of
carbohydrate from a range of foods including cereals and cereal-based foods,
confectionery, non-alcoholic beverages, and sugar products and dishes. Children or
adolescents who are overweight or obese are more likely in the short-term to develop
gastrointestinal, endocrine or certain orthopaedic problems than children of normal
weight and more likely in the longer-term to develop cardiovascular disease (Must &
Strauss 1999).
Although changes in food and nutrient intakes among adults living in State capital
cities followed similar patterns to those for children, they were generally of smaller
magnitude. Between 1983 and 1995, intake of energy (Table 3.5) and most nutrients
increased signiÞcantly, although protein intake remained unchanged, and fat,
cholesterol and vitamin C decreased signiÞcantly (Cook et al. 2001).
The decrease in vitamin C intake among both children and adults between the mid-
1980s and the mid-1990s is unexpected. The decline is largely due to a fall in fruit
consumption in adults and fruit juice consumption in children (Cook et al. 2001). The
Table 3.5: Mean daily intake of energy among older children and adults, 1983, 1985 and 1995
Age (years) 1983 1985 1995
Energy (kJ)
Boys 10–15 . . 9,670 11,088
Girls 10–15 . . 7,586 8,488
Men 25–64 10,824 . . 11,195
Women 25–64 7,299 . . 7,624
Notes
1. Analysis of data for children: Adjustments for changes in the food composition database were made to enable 
estimates of ‘real change’ in food and nutrient intakes to be better assessed. However, adjustments could not be made 
for differences in the dietary methods between surveys, sample design differences (such as season and day of week) 
or demographic changes between the 1985 and 1995 surveys.
2. Analysis of data for adults: Adjustments were made for changes in survey design (relating to age, geographical 
coverage, season and day of week), changes in the food composition database and changes in the Australian 
population profile between 1983 and 1995 to enable estimates of ‘real change’ in food and nutrient intakes to be 
assessed.
3. Difference between estimated means for 1985 and 1995 (children) and 1983 and 1995 (adults) are statistically 
significant at the 0.01 level.
4. Adult data for State capital cities only.
Source: Cook et al. 2001.
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NHMRC Core Food Groups guide recommends that Australian adults aged 19 years
and over (excluding pregnant and lactating women) consume at least 300 g of
vegetables (including legumes) and 300 g of fruit per day (Cashel & Jeffreson 1995) to
meet recommended dietary intakes of nutrients largely derived from fruit and
vegetables (Box 3.8). 
Analysis by Baghurst et al. (1999) of data from the 1995 National Nutrition Survey
showed that 42% of adults did not eat any fruit on the day of the survey and only 17%
met the daily recommendation of 300 g (two serves, excluding fruit juice). About 16% of
adults did not eat any vegetables (including potatoes) on the day of the survey and just
32% had over 300 g (four serves), the lower end of the range recommended by the
NHMRC Core Food Groups guide.
It is estimated that inadequate fruit and vegetable consumption (less than Þve serves)
was responsible for 3% of the total burden of disease and 11% of total cancer burden in
Australia in 1996 (AIHW: Mathers et al. 1999). By comparison, the net harm associated
with alcohol consumption in 1996 was around 2.2% of the total burden of disease. The
effects of alcohol consumption on health are discussed later in this chapter. 
High intakes of fat, especially saturated fats, are associated with elevated blood
cholesterol levels, overweight and increased risk of heart attack. Total fat (including
saturated, mono-unsaturated and polyunsaturated) accounts for about 33% of the total
energy intake of Australian adults (ABS & DHFS 1997). Although total dietary fat intake
has decreased from about 37% in the 1980s, the current level is still above the NHMRCÕs
recommended level of 30% (NHMRC 1991). 
Among Australian adults, saturated fat accounts for around 13% of total energy intake,
higher than the recommended maximum level of 10% (AIHW 2001). The major sources
of saturated fatty acids in the adult diet are dairy milk, meat, pastries, cheese, potatoes
(due to added fats) and butter (ABS & DHAC 1999). 
In some people, high salt consumption is associated with an increase in blood pressure
and possibly cardiovascular illness and death. No national data exist to assess levels of
salt consumption among Australians. However, in one study conducted in Hobart, only
6% of men and 36% of women were below the recommended maximum intake of 100
mmol per day (Beard et al. 1997).
Box 3.8: Definition of recommended dietary intakes
Recommended dietary intakes (RDIs) are the levels of intake of essential nutrients consid-
ered, in the judgement of the NHMRC, on the basis of available scientific knowledge to be
adequate to meet the known nutritional needs of practically all healthy people. The RDIs
are derived from estimates of requirements for each age/sex category and incorporate gen-
erous factors to accommodate variations in absorption and metabolism. They therefore
apply to group needs. RDIs exceed the actual nutrient requirements of practically all
healthy persons and are not synonymous with individual requirements.
Source: NHMRC 1991.
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The evidence linking diet with preventable disease is recognised in Australia and
internationally to provide sufÞcient reason for including improved nutrition as a major
component of public health initiatives. The Strategic Inter-Governmental Nutrition
Alliance (SIGNAL) was established in 1997 as part of a strategic plan to further the
implementation of the National Food and Nutrition Policy (DHCS 1992). SIGNAL was
responsible for the development of the National Public Health Nutrition Strategy 2000
to 2010 (referred to as Eat Well Australia). A complementary strategy for Indigenous
Australians (the National Aboriginal and Torres Strait Islander Nutrition Strategy and
Action Plan) has also been developed by the National Aboriginal and Torres Strait
Islander Nutrition Working Party. 
Eat Well Australia focuses on areas where nutrition can bring the greatest health gain.
These include promoting fruit and vegetable consumption, promoting healthy weight,
promoting good nutrition for mothers and infants, promoting good nutrition for school-
aged children, improving nutrition for vulnerable groups, and addressing structural
barriers to safe and healthy food (SIGNAL 2001). Eat Well Australia links with other
related public health strategies such as the National Breastfeeding Strategy which aims
to encourage and support breastfeeding. The public health nutrition strategy for
Indigenous Australians focuses on nutrition issues and diet-related disease affecting the
health of Aboriginal and Torres Strait Islander peoples. These include food access,
nutrition for mothers and babies, promotion of breastfeeding, infections and childhood
growth, renal disease and dental health (NATSINWP 2001).
Alcohol consumption
Excessive alcohol consumption is a major risk factor for morbidity and mortality in
Australia. The number of deaths attributable to the consumption of alcohol was
estimated to be 3,271 in 1998 (AIHW: Miller & Draper 2001). The number of hospital
episodes attributable to alcohol consumption in 1998 was about 43,000 (AIHW: Ridolfo
& Stevenson 2001).
It has been estimated that the harm caused by excessive alcohol consumption accounts
for 4.9% of the total burden of disease (AIHW: Mathers et al. 1999). Conditions
associated with hazardous and harmful alcohol use include some cancers, liver disease,
pancreatitis, diabetes and epilepsy. Alcohol is a signiÞcant factor in motor vehicle
fatalities and injuries, and is associated with falls, drowning, burns, suicide and
occupational injuries.
However, low to moderate levels of alcohol consumption can protect against
hypertension, ischaemic heart disease, stroke and gallstones. The net harm associated
with alcohol consumption, after taking into account these beneÞts, is around 2.2% of the
total burden of disease. The distribution of harm and beneÞt varies with age. For both
males and females, the harmful burden of disease is highest in the 15Ð24 age group,
mainly due to road trauma and other injury. The largest protective effect is realised in
persons over 65 years of age, because of the increased underlying risk of cardiovascular
disease in this age group.
There are also social costs to the excessive use of alcohol. In 2001, around a quarter of
adult Australians reported being either physically or verbally abused by someone
under the inßuence of alcohol (AIHW 2002). 
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Based on results from the 2001 National Drug Strategy Household Survey, 9 in 10
Australians aged 14 years or more had tried a full serve of alcohol at some time in their
lives, and around 8 in 10 persons reported drinking in the past 12 months (AIHW 2002).
AustraliaÕs drinking pattern has remained largely unchanged over the last decade
(Figure 3.12). In 2001, around 48% of the population aged 14 years and over consumed
alcohol regularly, i.e. on at least one day per week. A further 35% consumed alcohol less
than once per week, and the remaining 17% either no longer drank alcohol or had never
consumed a full glass of alcohol.
Although the drinking pattern has remained fairly constant since 1991, overall levels of
alcohol consumption have decreased. In terms of pure alcohol, consumption decreased
from 9.7 litres per person in 1981 to 8.2 litres in 1991, and then to 7.5 litres in 1998Ð99
(ABS 2000). In 1998, Australia ranked 19th in the world for per capita consumption of
alcohol: 9th for beer consumption, 18th for wine consumption and 35th for spirits
consumption (AIHW: Miller & Draper 2001).
The harm resulting from risky alcohol consumption can be summarised in three
categories (NHMRC 2001c):
¥ alcohol dependence (e.g. loss of control, withdrawal symptoms, social disintegration)
¥ heavy regular-use problems (e.g. cirrhosis of the liver, cognitive impairment,
pancreas damage, heart and blood disorders, ulcers, cancers)
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Source: National Drug Strategy Household Surveys.
Figure 3.12: Alcohol drinking status, 1991 to 2001
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¥ intoxication and acute alcohol-related problems (e.g. alcohol-related violence, risky
behaviour, road trauma, injury).
In the 2001 National Drug Strategy Household Survey, 10% of males and 9% of females
aged 14 years and over reported drinking at levels which put their health at risk in the
long term. Based on Australian alcohol guidelines (NHRMC 2001c, see Box 3.9),
younger females (aged 14Ð19 years) were more likely than their male counterparts to
drink above low-risk levels for long-term alcohol-related harm, with other age groups
about the same or below the male rates (Figure 3.13). 
The 2001 National Drug Strategy Household Survey also showed that 39% of males and
30% of females aged 14 years and over put their health at risk of harm in the short term
during the preceding 12 months (Table 3.6). About 12% of females aged 14Ð19 years and
about 15% of males aged 20Ð29 years consumed alcohol at risky or high-risk levels
during short-term drinking episodes on at least one occasion each week. 
The 2001 drugs survey showed that signiÞcantly higher proportions of Aboriginal and
Torres Strait Islander peoples compared with other Australians drank at levels that put
themselves at risk of harm in the short and long term. For example, 20% of Aboriginal
and Torres Strait Islander peoples drank at levels that were risky or high risk for harm
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(a) For males, the consumption of 29 or more standard drinks per week; for females, the consumption of 15 or more
standard drinks per week.
Note: Includes people aged 14 years and over.
Source: 2001 National Drug Strategy Household Survey.
Figure 3.13: Proportion of the population at risk of alcohol-related harm 
in the long term(a), 2001
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Box 3.9: Australian alcohol guidelines for short-term and long-term patterns of 
drinking.
The following guidelines show the risks for various drinking levels for males and females of
average or larger body size (e.g. above about 60 kg for men and 50 kg for women). Persons
of smaller than average body size should drink within lower levels. 
Risk of alcohol-related harm in the short term (standard drinks per drinking occa-
sion)
Low risk Risky High risk
Males up to 6 7 to 10 11 or more
Females up to 4 5 to 6 7 or more
The short-term risk pattern of drinking assumes that:
• a person drinks on a maximum of three occasions per week and remains within the levels
for long-term harm
• a drinker is not about to drive or operate machinery, is not on medication, does not have
a condition which is exacerbated by drinking, and is not pregnant
• a person is pacing drinks over time to moderate the rate of alcohol consumption (e.g. for
males, no more than two standard drinks in the first hour and one per hour thereafter;
and for females, no more than one standard drink per hour).
Without these qualifications the risk to health is increased.
Risk of alcohol-related harm in the long term (standard drinks)
Low risk Risky High risk
Males
 on an average day up to 4 5 to 6 7 or more
 overall weekly level up to 28 29 to 42 43 or more
Females
 on an average day up to 2 3 to 4 5 or more
 overall weekly level up to 14 15 to 28 29 or more
The long-term risk pattern of drinking presumes the same assumptions for the short-term
risk pattern of drinking, and that:
• a drinker does not have a family history of alcohol-related problems, is not on medica-
tion, does not have a condition that is made worse by drinking, is not pregnant, and is
not in a high-risk category for breast cancer.
Without these qualifications the risk to health is increased.
Source: NHMRC 2001c.
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in the long term, compared with 10% of other Australians. Further, 49% of Aboriginal
and Torres Strait Islander peoples had at least one drinking episode in the past year that
was risky or high risk for short-term harm, compared with 34% of other Australians.
Physical inactivity
Participation in physical activity is an important factor in maintaining good health.
People who participate in moderate to vigorous levels of physical activity have a lower
mortality rate and lower incidence of a number of diseases and conditions than those
who are physically inactive. Physical inactivity ranks second only to tobacco smoking
in terms of the burden of disease from risk factors in Australia. It accounts for 6%
(second highest burden for men) of the total burden of disease and injury among males
and 8% among females (highest burden for women) (AIHW: Mathers et al. 1999). 
The strongest evidence for the beneÞts of physical activity is in reducing the risk of
mortality and morbidity from cardiovascular disease, particularly heart attack and
other forms of coronary heart disease. People who are physically inactive are nearly
twice as likely to have a fatal or non-fatal coronary event than those who do moderate
levels of activity (Blair et al. 1996). 
Physical inactivity is an independent risk factor for cardiovascular disease, and is also
associated with other cardiovascular risk factors such as high blood pressure, high
blood cholesterol levels, and overweight and obesity (Bauman & Owen 1999; USDHHS
1996). 
Table 3.6: Proportion of the population at risk of alcohol-related harm in the short term(a), 2001
Risky and high risk
Age (years) Abstainers(b) Low risk At least yearly At least monthly At least weekly
Males Per cent
14–19 27 30 13 20 10
20–29 8 27 22 28 15
30–39 10 40 22 20 8
40–49 11 51 17 13 8
50–59 12 59 12 8 8
60+ 20 67 6 4 4
Total 14 47 16 15 9
Females
14–19 25 28 13 21 12
20–29 11 32 20 27 9
30–39 16 47 19 13 5
40–49 16 55 15 9 5
50–59 22 62 9 4 3
60+ 33 62 2 1 1
Total 21 50 13 12 5
(a) For males, the consumption of 7 or more standard drinks on one occasion. For females, the consumption of 5 or more 
standard drinks on one occasion.
(b) Alcohol not consumed in the last 12 months.
Source: 2001 National Drug Strategy Household Survey.
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Participation in physical activity is beneÞcial in the prevention and treatment of Type 2
diabetes, especially among people already at risk. It is estimated that appropriate levels
of physical activity could prevent 30Ð50% of new cases of Type 2 diabetes. However, the
beneÞts of physical activity for preventing and treating diabetes occur only with regular
sustained physical activity patterns (Manson & Spelsberg 1994). 
People who are physically inactive are nearly twice as likely to develop colon cancer
(Colditz et al. 1997). Physical activity is also associated with around a 30% reduction in
the risk of women of all ages developing breast cancer (Thune & Furberg 2001). 
Additionally, studies show that participation in physical activity is associated with
improvements in musculoskeletal health and is also beneÞcial to mental health,
reducing symptoms of depression and possibly stress and anxiety (Dunn et al. 2001).
The measurement of physical activity in populations is a challenging task. Physical
activity for health beneÞt comprises several components (e.g. intensity, frequency,
duration) that can be carried out in different settings (e.g. during leisure time, at work,
for daily living or mode of transport). Measurement is further complicated because
there are several dimensions of physical activity related to health, such as energy
expenditure, aerobic intensity, strength and ßexibility. For example, physical activity for
the prevention of cardiovascular disease may be different from that required for
prevention of musculoskeletal problems. 
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Sources: AIHW: Armstrong et al. 2000; Bauman et al. 2001.
Figure 3.14: Proportion of people who were physically inactive, by age, 
1997, 1999 and 2000
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The National Physical Activity Guidelines for Australians (DHAC 1999) recommend the
accumulation of at least 30 minutes of at least moderate-intensity physical activity on
most days of the week (interpreted here as 5 days) as the minimum amount required to
achieve a health beneÞt. This equates to participation in at least 150 minutes of
moderate-intensity activity per week. For this report, anything less than this is deÞned
as physical inactivity. Moderate-intensity physical activity is generally deÞned as
activities that use the large muscle groups and are performed with an intensity of at
least three times the basal or resting metabolic rate. Examples are brisk walking, gentle
swimming, cycling, social tennis and taking the stairs at work. Participation in more
vigorous types of physical activity such as jogging and aerobics (around seven to nine
times the basal or resting metabolic rate) provide further health beneÞts
(AIHW: Armstrong et al. 2000). 
The 2000 Active Australia National Physical Activity Survey was undertaken in
November, about 6 weeks after the close of the Sydney Olympic Games. This survey
indicated that around 5.7 million Australians aged 18Ð75 years (43% of that population)
did not undertake physical activity at the levels recommended to achieve health
beneÞts. Rates of physical inactivity in 2000 were highest among 45Ð59-year-olds (50%)
and lowest among 18Ð29-year-olds (32%) (Figure 3.14). More than 15% of people did no
leisure-time physical activity at all and around 28% did some activity, but not enough to
achieve a sufÞcient level to obtain health beneÞts (AIHW 2001; Bauman et al. 2001). 
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Figure 3.15: Proportion of people who were physically inactive, by sex, 1997, 1999 and 
2000
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Physical inactivity levels appear to have increased in recent years. Between 1997 and
2000, rates of physical inactivity among Australians increased signiÞcantly (from 38% in
1997 to around 43% in 1999 and 2000) (Figure 3.15). This increase in physical inactivity
was seen among men and among all age groups with the exception of those aged 60Ð75
years, among whom activity levels remained constant. Rates of physical inactivity
among women also increased between 1997 (37%) and 1999 (46%) and remained steady
in 2000 (44%). This increase in physical inactivity occurred across all education levels,
most signiÞcantly among people with tertiary qualiÞcations (29% in 1997 to 38% in
2000).
People in the lowest socioeconomic groups and Indigenous Australian adults are more
likely than other Australian adults to report no physical activity in their leisure time.
The National Health Survey in 1995 indicated that 37% of men and 40% of women in
the lowest socioeconomic groups performed no leisure-time physical activity compared
with 27% and 29% of men and women in the highest group. Furthermore, 40% of
Indigenous Australian adults reported no leisure-time physical activity, compared with
34% of other Australians in 1995 (AIHW 2001). Additionally, data from the 1999
Physical Activity Survey showed that people with less than 12 years of education were
almost twice as likely to be physically inactive as people with a Higher School
CertiÞcate or equivalent, or with tertiary qualiÞcations (AIHW: Armstrong et al. 2000). 
Use of illicit drugs
Illicit drugs are drugs that are illegal to possess (such as heroine or cocaine) or drugs
that are not illegal to possess but whose inappropriate use is illicit, such as non-medical
use of prescription drugs, or the use of volatile substances such as glue, solvent or
petrol as inhalants. Illicit drug use is, directly and indirectly, a major cause of death and
ill health. It is through high-risk injecting behaviour that bloodborne viruses are
transmitted. Medical conditions associated with illicit drug use are overdose, HIV/
AIDS, hepatitis C (HCV), low birth weight, malnutrition, infective endocarditis (i.e.
inßammation of lining of the heart), poisoning, suicide and self-inßicted injury. 
The burden of disease attributed to illicit drug use was 1.8% of the total burden of
disease in 1996 (AIHW: Mathers et al. 1999). The age-speciÞc burden of diseases
associated with illicit drug use peaks in the age group 25Ð34 years. About 14,500
hospital separations were related to illicit drug use in 1997Ð98, and over 1,000 people
died in 1998 due to illicit drug use (AIHW: Ridolfo & Stevenson 2001). 
Data from the 2001 National Drug Strategy Household Survey estimate that about
5.7 million Australian people aged 14 years and over have used an illicit drug, with no
clear trend in the use of illicit drugs apparent between 1995 and 2001 (Table 3.7). One-
third of Australians aged 14 years and over have used marijuana in their lifetime.
Amphetamines are the next most common drugs, with 9% of the population aged
14 years and over reporting use in their lifetime. Males are more likely than females to
have used an illicit drug (40% compared with 34% respectively).
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Table 3.7: Summary of illicit drug use, 1995 to 2001
Substance
Ever tried(a) Ever used(a) Recent use(b) 
1995 1998 2001 1995 1998 2001
Per cent
Amphetamines(c) 6 9 9 2 4 3
Barbiturates(c) 1 2 1 0 0 0
Cocaine 3 4 4 1 1 1
Ecstasy/designer drugs 2 5 6 1 2 3
Hallucinogens 7 10 8 2 3 1
Heroin 1 2 2 0 1 0
Inhalants 2 4 3 1 1 0
Injected drugs 1 2 2 1 1 1
Marijuana/cannabis 31 39 33 13 18 13
Pain-killers/analgesics(c) 12 12 6 4 5 3
Steroids(c) 1 1 0 0 0 0
Tranquillisers/sleeping pills(c) 3 6 3 1 3 1
(a) In 1993–98 the question was ‘ever tried’, in 2001 the question was ‘ever used’.
(b) Used in the past 12 months.
(c) For non-medical purposes.
Notes: Includes people aged 14 years and over.
Sources: 1995, 1998 National Campaign Against Drug Abuse Household Survey; 2001 National Drug Strategy 
Household Survey.
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Source: 2001 National Drug Strategy Household Survey.
Figure 3.16: Recent use(a) of selected illicit drugs, 2001
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The data also show that there is a gender difference in the recent use of illicit drugs,
with more males reporting recent use of illicit drugs compared with females (20%
compared with 14%). Males were more likely than females to have used the selected
illicit drugs, with the exception of recent use of pain-killers for non-medical purposes
(Figure 3.16).
Use of illicit drugs varies with age. Males and females aged 20Ð29 years are most likely
to have used any illicit drug in the past 12 months (Figure 3.17). At every age group, the
proportion of males reporting recent use of any illicit drug is higher than for females.
The trend of decreasing recent use with age, after the peak at 20Ð29 years, applies to
both males and females. 
Among Aboriginal and Torres Strait Islander peoples, rates of recent illicit drug use
were higher than for other Australians: 32% of Aboriginal and Torres Strait Islander
peoples aged 14 years and over had used an illicit drug in 2001 compared with 17% of
other Australians. Most of this difference was associated with cannabis use (28% for
Aboriginal and Torres Strait Islander peoples compared with 13% for other
Australians), although recent use of any illicit drug other than cannabis was also
signiÞcantly higher (13% compared with 8% for other Australians).
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(a) Use in the past 12 months.
Note: Includes people aged 14 years and over. 
Source: 2001 National Drug Strategy Household Survey.
Figure 3.17: Recent use(a) of illicit drugs, by age, 2001 
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The data from 2001 NDSHS also show that there is some association between a personÕs
usual area of residence and use of drugs (Table 3.8). Females living in urban areas are
more likely than those living in rural and remote areas to have used an illicit drug in the
past 12 months. When marijuana use is excluded, recent use of other illicit drugs is also
higher in urban areas compared with rural and remote areas, for males and females. 
There is no clear trend for illicit drug use and socioeconomic disadvantage (Table 3.8).
Persons who are in the middle category of socioeconomic status (between those most
and those least disadvantaged) are more likely to have used an illicit drug in the past
12 months.
Table 3.8: Summary of recent illicit drug use by usual area of residence and socioeconomic 
status, 2001
Characteristics
Males Females
Any illicit
drugs
Any illicit
drugs other
than marijuana
Any illicit
drugs
Any illicit
drugs other
than marijuana
Per cent
Usual area of residence
Urban 19.8 10.0 14.6 7.9
Rural/remote 19.2 7.3 12.8 6.1
Socioeconomic status(a)
1st quintile (most disadvantaged) 18.6 7.7 13.4 6.6
2nd quintile 18.9 8.8 13.4 7.1
3rd quintile 21.1 9.9 15.0 8.2
4th quintile 20.9 10.7 14.4 7.5
5th quintile (least disadvantaged) 19.2 9.6 14.6 7.6
(a) Index of socioeconomic disadvantage for usual place of residence.
Note: Includes people aged 14 years and over.
Source: 2001 National Drug Strategy Household Survey.
Table 3.9: Prevalence of HIV or HCV antibodies among injecting drug users(a), by history of 
injecting drug use, 2000
History of injecting 
drug use
Tested positive to HIV antibody Tested positive to HCV antibody
Males Females Persons(b) Males Females Persons(b)
Per cent
Less than 3 years 1.9 — 1.2 25 28 26
3–5 years 1.3 — 0.8 33 48 39
6–10 years 0.5 — 0.3 47 54 50
10 or more years 1.6 — 1.2 73 74 73
History not reported — — — 40 61 47
Total 1.3 — 0.9 52 55 53
(a) Survey of all clients attending 35 needle and syringe program sites during one week in October 2000.
(b) Includes people whose sex was reported as transgender and people whose sex was not reported.
Source: NCHECR 2001.
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Studies of drug use behaviour indicate that the duration of injecting drug use is
associated with the transmission of bloodborne viruses. A survey of injecting drug
users in 2000 showed that more than half tested positive to the HCV antibody, and the
data show a clear association between a history of injecting drug use and the presence
of HCV antibody. The test for HCV antibody was positive for 73% of drug users who
had been injecting drugs for the last 10 years or more, compared with 26% of those
injecting for less than 3 years (Table 3.9).
Vaccination status
Vaccination is the administration of a vaccine to protect children and adults against
some infectious diseases. There are two main purposes of vaccination. First,
immunisation is the most effective way of providing individual protection against
diseases. Second, if enough people are vaccinated at a population level, infections
cannot spread and the disease can be eliminated. For example, through vaccination,
smallpox has been eradicated worldwide and poliomyelitis has been eradicated from
many countries (DHAC 2000). Australia was declared polio-free in October 2000.
Childhood vaccination has been routinely used for over 50 years in Australia and has
had a signiÞcant impact on the morbidity and mortality associated with many diseases
(Gidding et al. 2001). In the late 1800s, vaccines were developed against smallpox,
plague and typhoid and were used extensively throughout Australia. Over time, new
vaccines have been developed for a range of infectious diseases and large-scale
vaccination programs have been implemented. Diseases that can currently be prevented
by childhood vaccination in Australia are diphtheria, tetanus, whooping cough
(pertussis), poliomyelitis, measles, mumps, rubella, Haemophilus influenzae type b (Hib)
and hepatitis B. A schedule of vaccination is provided in the Australian Immunisation
Handbook (NHMRC 2000) and sets out the time frames (from birth) for when a
vaccination provider (usually a local council, health clinic and/or general practitioner)
administers the respective vaccine for each of the above-mentioned diseases. 
In 1997, to improve vaccination coverage in Australia, the Commonwealth Government
initiated the Immunise Australia campaign. The main goals of the program were:
¥ to achieve greater than 90% immunisation coverage of children at 2 years of age for
all diseases speciÞed in the schedule
¥ to achieve near universal coverage at school entry
¥ to achieve near universal coverage of girls and boys under 17 years of age for
measles, mumps and rubella.
To achieve these goals, the Seven Point Plan was implemented which included
initiatives for parents (Maternity Allowance and Childcare Assistance Rebate), a larger
role for general practitioners (through the introduction of the General Practitioner
Immunisation Incentives) and measles eradication. 
Vaccination coverage
Vaccination coverage in Australia is monitored through the Australian Childhood
Immunisation Register (ACIR). The Health Insurance Commission (HIC) has been
operating the ACIR since 1 January 1996, with the cooperation of the State/Territory
health departments. The HIC collects vaccination data for Australian children under
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7 years of age, which forms the basis of the ACIR. The register is updated from
Medicare enrolments to obtain the total number of children in Australia under 7 years
of age. The vaccination status of each child is updated when a vaccination provider
administers the age-appropriate vaccination and notiÞes the ACIR of this vaccination
encounter. Estimates of vaccination coverage are reported as the percentage of a 3-
month cohort of children who are up-to-date for the relevant vaccinations according to
the immunisation schedule by the time they are 12 months and 24 months of age.
Table 3.10 shows that vaccination coverage at one year of age calculated at 31 March
2001 for Australia as a whole was 91.2%. The Northern Territory had the lowest
proportion of children fully vaccinated at one year of age at 88.6% and the Australian
Capital Territory had the highest proportion at 92.7%. Vaccination coverage for
Australia at one year of age was highest for the Hib vaccine (94.6%) and lowest for the
poliomyelitis vaccine (91.4%). Coverage for all individual vaccines was greater than the
90% coverage target.
Vaccination coverage at two years of age for Australia was considerably lower at 84.7%
(Table 3.11). Tasmania had the highest percentage of children fully vaccinated at two
years of age at 89.7% and the Northern Territory the lowest at 78.9%. Coverage for
Table 3.10: Children aged 12Ð15 months(a) fully immunised against specific diseases, by States 
and Territories, 2001
NSW Vic Qld WA SA Tas ACT NT Aust
Number of children 20,721 15,119 11,641 6,074 4,375 1,453 990 778 61,151
Diphtheria, tetanus and 
pertussis (%) 91.0 92.2 91.8 90.1 91.5 93.1 92.9 88.9 91.5
Poliomyelitis (%) 90.9 92.3 91.8 90.0 91.5 93.2 92.8 89.6 91.4
Haemophilus influenzae 
type b (%) 94.3 95.3 94.4 93.6 95.0 95.6 95.4 94.0 94.6
Fully immunised (%)(b) 90.7 92.1 91.4 89.5 91.4 92.6 92.7 88.6 91.2
(a) Aged 12–15 months at 31 December 2000.
(b) Fully immunised = No. children vaccinated/No. children on register x 100.
Source: Australian Childhood Immunisation Register.
Table 3.11: Children aged 24Ð27 months(a) fully immunised against specific diseases, by States 
and Territories, 2001
NSW Vic Qld WA SA Tas ACT NT Aust
Number of children 21,388 15,618 11,504 6,279 4,501 1,609 1,085 781 62,765
Diphtheria, tetanus and 
pertussis (%) 87.2 88.5 90.4 86.4 89.7 91.4 89.6 81.9 88.3
Poliomyelitis (%) 92.1 94.0 93.5 91.9 94.5 95.3 93.9 93.0 93.1
Haemophilus influenzae 
type b (%) 94.4 95.5 94.7 93.5 95.5 95.5 94.9 93.6 94.7
Measles, mumps and
rubella (%) 91.4 93.0 93.3 91.2 94.1 94.3 93.0 91.2 92.4
Fully immunised (%)(b) 82.6 85.1 87.8 82.6 87.5 89.7 87.6 78.9 84.7
(a) Aged 24–27 months at 31 December 2000.
(b) Fully immunised = No. children vaccinated/No. children on register x 100.
Source: Australian Childhood Immunisation Register.
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diphtheria, tetanus and pertussis vaccine at two years of age was the lowest at 88.3%,
whereas coverage was highest for Hib vaccine at 94.7%.
Invasive Hib disease as an example of the effectiveness of 
immunisation 
Haemophilus influenzae is a bacterium that can cause a range of clinical illnesses (see
Chapter 2). The most important are those classiÞed as ÔinvasiveÕ which include
meningitis (infection of the lining of the brain), epiglottitis (infection of the epiglottis in
the windpipe) and septicaemia (blood poisoning). Before the introduction of
immunisation, Hib was the cause of nearly all cases of serious disease caused by
Haemophilus influenzae. 
Hib is predominantly a disease of childhood with over 80% of cases worldwide
occurring in children aged less than 5 years (Peltola 2000). In Australia the case fatality
ratio for invasive Hib disease is estimated to be between 2.5% and 3.5%. In addition,
around 4% of survivors of Hib meningitis suffer profound neurological disability
(Gilbert et al. 1990; Bower et al. 1994). Compared with other Australian children,
Aboriginal children have a higher incidence of this disease and, following Hib
meningitis, have a higher case-fatality ratio and higher rate of disability. 
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Figure 3.18: Observed and expected cases of invasive Hib disease in children under 
5 years
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Vaccines developed from the sugar coat (polysaccharide) of the Hib organism were Þrst
developed in the 1970s but these vaccines did not protect children aged less than 18
months. Linking the polysaccharide to a protein was found to improve the immune
response to the vaccine and Hib vaccines suitable for use in children aged less than 18
months were licensed in Australia in January 1993.
In May 1993, reimbursement for Hib vaccine was introduced for children born after
February 1993 (McIntyre et al. 1995). In July 1993 a fully funded infant Hib vaccination
program was launched and in August 1993 a catch-up vaccination program for all
children aged less than 5 years was funded. 
The introduction of routine immunisation against Hib disease has been followed by a
dramatic reduction in the incidence of this disease. In the target population, children
aged less than 5 years, the immunisation program has resulted in a 94% reduction in the
number of cases (see Figure 3.18).
An unexpected bonus of the Hib immunisation program has been the extent to which
circulation of the organism has been reduced in age groups ineligible for the
immunisation program. Following the introduction of immunisation, there has been a
68% reduction in cases of invasive Hib disease in individuals aged 15 years or older,
even though they are not eligible for the immunisation program (see Figure 3.19).
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data of 91–92 and 92–93 by the person-years at risk for the years 93–94 to 99–00.
Source: National Notifiable Disease Surveillance System.
Figure 3.19: Observed and expected cases of invasive Hib disease in people aged 15 years 
and over
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Overall, if the age-speciÞc incidence rates observed in Þnancial years 1991Ð92 and
1992Ð93 were to have occurred during the period July 1993 to June 2000, 3,602 cases of
invasive Hib disease would have been expected. However, only 572 cases were
reported during this period, 84% less than expected. This means that over the last
7 years, Hib immunisation has prevented more than 3,000 cases of invasive Hib disease.
Of these, it would have been expected that around 90 (3%) children would have died as
a consequence of their infection. Or put another way, Hib immunisation prevents at
least 430 cases and 13 deaths each year in Australia.
3.3 Knowledge, attitudes and beliefs
PeopleÕs knowledge, attitudes and beliefs are among the many inßuences on health-
related behaviour, and therefore on health itself. Documenting and tracking these
cognitive factors among Australians may help to explain overall health levels and
trends. It may also help shed light on differences in the lifestyles and health of different
groups in the population. 
The knowledge, attitudes and beliefs people have regarding certain behaviours (such as
smoking, alcohol consumption, physical activity and diet) are frequently included in
population-based surveys as a means of assessing the impact of health promotion
campaigns or as a way of understanding barriers to behaviour change. Although no
exact formula exists, the likelihood of individuals being motivated to adopt health-
enhancing behaviours, rather than those which are health-compromising, is a function
of the level of knowledge, attitudes and skills which the person possesses in relation to
the health risk. These are inßuenced by factors external to the individual
(environmental factors) and factors intrinsic to the individual (genetic factors) (Egger et
al. 2001). The knowledge, attitudes and beliefs among target populations regarding
secondary prevention services such as cervical and mammographic screening may be
assessed in a similar way.
Knowledge, attitudes and beliefs about specific health 
issues
Data are available on AustraliansÕ knowledge, attitudes and beliefs about major health
issues such as diet, physical activity, alcohol, drug use and childhood immunisation.
For example, a 1988 survey of Australian adults in major urban centres of Western
Australia, South Australia, New South Wales and Queensland found that about two-
thirds were able to link fat intake with heart disease and just under half linked sodium
to hypertension but there appeared to be confusion about the roles of simple
carbohydrate and dietary Þbre and ill health (Crawford & Baghurst 1990). In recent
years there has been considerable effort aimed at increasing the knowledge among
women of child-bearing age of the link between adequate folate intake and neural tube
defects such as spina biÞda. Combined results from three surveys assessed by the
Australia New Zealand Food Authority (ANZFA 2000), as part of their evaluation of the
folate health claim pilot, showed that among women who had heard of folate, about
46% were aware of the association in 1999.
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There is considerable awareness of the beneÞts of physical activity to health among the
Australian population. Results from the 1999 National Physical Activity Survey showed
that 88% of people believe that their health could be improved by being generally more
active, although this belief was not reßected in participation rates (see Section 3.2).
There was also an increase in the overall knowledge of the health beneÞts of physical
activity and awareness of physical activity messages between 1997 and 1999 (AIHW:
Armstrong et al. 2000).
Despite the well-documented and widely promoted adverse health effects of tobacco
use, the 2001 National Drug Strategy Household Survey found that regular use of
tobacco by adults is considered acceptable by 40% of Australians (Table 3.12); about the
same proportion correctly identiÞed tobacco as the leading cause of drug-related
deaths. Over 90% of survey respondents believe that non-smokers who live, work or
socialise with smokers may one day develop health problems themselves because of
other peopleÕs tobacco smoke.
Around 24% of Australians consider the regular use of cannabis/marijuana acceptable.
For other drugs (except tobacco and alcohol), less than 10% of Australians believe that
regular use by adults is acceptable. The legalisation of cannabis/marijuana is supported
by 29% of Australians, whereas less than 5% support the legalisation of heroin, cocaine
or amphetamines. 
Sex and age differences
Although Australian data are limited, differences in attitudes and beliefs relating to
health are evident between males and females, and between younger and older age
groups. For example, men believe that increasing physical activity is an important
Table 3.12: Proportion of people who find regular drug use by adults acceptable, 2001
Drug Males Females Persons
Per cent
Alcohol 81.4 68.0 74.7
Tobacco 42.5 36.8 39.7
Cannabis/marijuana 27.4 20.1 23.8
Pain-killers/analgesics(a) 6.7 5.8 6.3
Ecstasy/designer drugs 5.3 2.6 4.0
Tranquillisers/sleeping pills(a) 4.5 3.2 3.8
Naturally occurring hallucinogens 5.3 2.4 3.8
Amphetamines 4.1 2.3 3.2
LSD/synthetic hallucinogens 3.4 1.6 2.5
Cocaine 2.9 1.5 2.2
Steroids(a) 2.8 0.9 1.8
Barbiturates(a) 1.6 0.7 1.1
Heroin 1.5 0.6 1.1
Inhalants 1.1 0.5 0.8
(a) Non-medical use.
Note: Includes people aged 14 years and over.
Source: 2001 National Drug Strategy Household Survey.
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healthy behaviour, whereas women focus more on social, environmental and dietary
changes (Welsh et al. 1998). Further, older Australian men are more likely to highlight
the importance of Ôkeeping busyÕ and Ôhaving some purpose in lifeÕ. In contrast, older
women appear to share the hope of Ôslowing down moreÕ after being busy with the
multiple roles of paid work, household duties, children and grandchildren. Women are
more likely to see Ôrest and relaxationÕ as important for good health (Brown et al. 1999).
Men are also more likely than women to consider regular use of cannabis/marijuana
and alcohol to be acceptable. Across all illicit substances, acceptability of adult use
mirrored consumption patterns. Approval was strongest among 20Ð29-year-olds, with a
gradual decline in approval occurring with increasing age.
Although most young people are well informed about the transmission of HIV/AIDS,
knowledge about other sexually transmitted diseases (STDs) is low. In a 1997 study of
secondary school students, only 29% of year 10 girls and 42% of year 12 girls knew that
chlamydia could lead to sterility. Knowledge about pelvic inßammatory disease (PID)
was poor, with fewer than half of the students correctly identifying PID as an STD.
Young men in year 12 were least likely to do so (Lindsay et al. 1997).
3.4 Genetic factors
Genetic factors play an important role in human health and disease. A personÕs genetic
make-up (the genome) sets the main features and boundaries within which life is to be
experienced, and provides the blueprint for how the human body interacts with the
environment. In addition, the genome is programmed to protect its own molecular
structure and to repair any damage caused to it by environmental factors.
Human health can also depend on the genetic make-up of other life forms, especially
organisms that infect humans. Therefore, human health may be seen as the outcome of
our environment (including the genetic make-up of other life forms), our genes, our
lifestyle and behaviour, and their interactions.
Genetic basis of disease
Understanding how genetic mechanisms cause disease or provide the basis for
susceptibility to disease requires an understanding of genetic organisation and the way
various genes interact with each other as well as with the environment. For explanation
of various genetic terms and a description of the organisation of the human genetic
material, see Australia’s Health 2000.
Broadly, the major types of genetic diseases/disorders are monogenetic disorders,
chromosomal abnormalities and multifactorial diseases.
Monogenetic (single gene) disorders are genetic defects that result from a change
(mutation) in the structure of the gene and can be traced through families. About 2% of
the population will have a monogenic problem or condition, with some of the problems
showing up at birth and others showing up later in life. Common examples of
monogenic disorders are muscular dystrophy, cystic Þbrosis and haemophilia. 
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Chromosomal abnormalities are caused by structural changes in the chromosomes or
the gain or loss of whole chromosomes (or parts of chromosomes), some of which can
be related to speciÞc clinical syndromes. Chromosomal anomalies are a large source of
chronic disease, disability and premature mortality. These anomalies arise through
changes in the physical structure of the chromosomes (deletion or addition of fragments
of genetic material from/to a chromosome), or changes in the number of chromosomes
(departure from the optimal number, also called aneuploidy). Common examples are
Down syndrome, KlinefelterÕs syndrome, and TurnerÕs syndrome. In 1996 there were
312, 17 and 28 notiÞcations for these chromosomal abnormalities respectively, which
equates to 121, 7 and 11 notiÞcations per 100,000 births respectively. 
There is a genetic component to many of the diseases that are considered to be
multifactorial in origin. A variety of mechanisms lead to these diseases and conditions,
but they result mostly from the effect of environmental factors, such as diet, chemical
exposure and lifestyle, acting on genetically susceptible individuals. Common examples
are cancers and various chronic diseases such as asthma, diabetes and AlzheimerÕs
disease. These particular diseases are responsible for a large burden of disease in
Australia, mainly because of their high prevalence in the population. Various genes
make a contribution to a personÕs susceptibility to these and other chronic diseases.
On their own, genes are rarely the cause of disease levels or trends in populations but
they do affect the chances of individuals having some diseases or risk factors under
certain environmental conditions. 
Genetic basis of health risk factors
Genetic make-up can play a role in the initiation, maintenance and response to some
health risk factors. There are genetic connections to a variety of health risk factors,
including behavioural and biomedical risk factors, that are generally considered
modiÞable:
¥ Some behaviour studies suggest a genetic contribution to some unhealthy behaviours
such as the initiation and cessation of smoking, and emerging Þndings suggest an
inßuence in alcohol-drinking behaviour and chronic alcoholism (Omenn 2000). 
¥ Biomedical risk factors such as high cholesterol and high blood pressure have a
genetic contribution. DietÐgene interactions such as vitamin metabolism and obesity
are of current interest (Rock et al. 2000). 
Factors affecting genetic resistance
A variety of factors may inßuence our inherited resistance to disease, such as age,
nutrition and socioeconomic factors. Variation in the capacity and mechanism for DNA
repair may also lead to differences in the survival of harmful mutations. 
The genetic complexity of the invading organisms is another important factor. The
genetic preparedness of the human host to resist disease is inßuenced by the genetic
ability of the invading organism to bypass the resistance mechanisms. Quite often,
human parasites evolve in step with the disease-resistance mechanisms of the host.
HostÐparasite interactions therefore present a good example of how environmental
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interactions between species inßuence health and disease processes. Many of the
genetic traits observed today, in either host or parasite, are likely to result from this
co-evolution. 
For a fuller description of the factors that increase genetic vulnerability to disease, see
Australia’s Health 2000.
3.5 Environmental factors
AustraliaÕs present social, economic and physical environment generally provides
access to good-quality food and water, housing and places for recreation as well as
education and employment. These contribute to an overall standard of living and
health that compares well with other developed countries (enHealth 1999; AIHW: de
Looper & Bhatia 1998). 
Despite this, some Australians such as many Indigenous peoples have generally poor
social and economic conditions, and poor health. In addition, signiÞcant changes to
AustraliaÕs physical environment since European settlement have been at considerable
cost to natural resources such as soil, rivers and aquifers, and biodiversity (State of the
Environment Advisory Council 1996). Also, material released into AustraliaÕs
atmosphere and the oceans contributes to environmental changes that could have
signiÞcant population health impacts in Australia and worldwide (Epstein 1999;
McMichael & Powles 1999). 
Recently the World Health Assembly endorsed the new International ClassiÞcation of
Functioning, Disability and Health (ICF) which recognises that a personÕs functioning
and disability is a dynamic interaction between health conditions and environmental
and personal factors (WHO 2001b). The ICF recognises that environmental factors may
be either facilitators or barriers to a personÕs functioning.
Unfortunately, although environmental factors are increasingly seen as important and
relevant to health, there are presently insufÞcient data to monitor nationally the levels
and changes in many of these factors or to accurately estimate their effect on current or
future health.
Physical, chemical and biological determinants
Over the past decade there has been growing interest in the links between health and
human surroundings and living conditions. Humans have a large and growing capacity
to affect the life support systems of this planet such as water, agricultural land and
climate, and must use this capacity to manage the environment for better health
outcomes. 
Australia currently has no system of monitoring to provide regular national data about
issues such as the quality of drinking water, food, sewerage, soil health and
biodiversity. The National Environmental Health Strategy 1999 identiÞes the need for
an effective environmental health information system to be established. The types of
information needed for such a system includes:
¥ scientiÞc research on environmental hazards and potential human exposure to them
¥ epidemiological research on the links between exposures and health outcomes
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¥ ongoing surveillance of environmental hazards and health outcomes
¥ information about the processes and practices undertaken by environmental health
managers
¥ evaluation reports of environmental health interventions.
Pressures on the Australian environment continue to grow. Some concerns are the
degradation of lands and waters due in part to increasing salinity, broadacre land
clearing and the overuse of water; the high and increasing per capita energy usage
leading to increase in greenhouse gas emissions; and the high level of (hazardous)
waste (Australian State of the Environment Committee 2001).
Health indicators of environmental effects
The environmentÕs contribution to health is often likely to be indirect, subtle, complex
and delayed. It is therefore very difÞcult to estimate the full range and size of the health
effects that can be linked to the environment, and so to plan and intervene
appropriately. In common with many other countries, AustraliaÕs ability to report on
health-related environmental issues (except for certain communicable diseases) is
poorly developed. This situation is being remedied by a project of the enHealth Council
(a subcommittee of the National Public Health Partnership Group) to develop
indicators of environmental health.
The current lack of environmental health indicators in Australia and elsewhere is due
partly to the difÞculty of determining what constitutes key environmental health issues
and partly to the paucity of data. Five environment-related human health issues for
which data exist are vectorborne diseases, skin cancer, food, air pollution and low-level
lead exposure of children. 
A number of communicable diseases are inßuenced by environmental conditions,
involve environmental agents, or are kept in check by the efforts of environmental
health ofÞcers and other health workers. These diseases include Ross River virus
disease, Murray Valley encephalitis, Japanese encephalitis, dengue fever, Barmah Forest
virus disease, foodborne illnesses and legionellosis. The prevalence of diseases
inßuenced by environmental conditions ßuctuates considerably with changes in the
weather and the prevalence of insect vectors such as mosquitoes. Changes in the
climate and the environment, as may be associated with global warming, may affect the
numbers and geographic distribution of some vectorborne diseases within Australia. 
Development of melanoma and other skin cancers is related to exposure to the
ultraviolet radiation in sunshine. Although the death rate from melanoma has remained
relatively unchanged, the incidence of new cases is growing steadily.
The amount of lead in the atmosphere has been a large concern because of the various
potentially serious health effects associated with exposure to lead, especially for young
children. The introduction of unleaded petrol in the mid-1980s and the banning of lead
in paint sold today have substantially decreased the amount of lead in the environment
(NSW Environment Protection Authority 2000). Research suggests that people who live
in heavily industrialised areas or in older homes (which probably contain deteriorating
lead-based paint) are most likely to have elevated blood lead levels (Australian Institute
of Environmental Health 2000; Kaufman et al. 2000).
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Social, economic, cultural and political determinants
 
The strong association between health and social and economic factors has become
increasingly recognised and documented. However, the mechanisms behind that
association are less clear (Yen & Syme 1999). Much of the research on the social and
economic bases of health focuses on the observation that people in poor circumstances
generally have worse health than those in more advantaged conditions. Social and
economic disadvantages (e.g. poor education, unemployment and few assets) tend to
occur together, and magnify the negative effects on health (WHO 1998; McMichael
2001). Social and economic circumstances can also cause anxiety, low self-esteem and
social isolation which in turn can inßuence health-related behaviours and health itself.
In Australia, men and women with lower socioeconomic status (as measured by
education level, occupation, family income and areas of socioeconomic disadvantage),
including many Indigenous peoples, bear a higher burden of disease (see Chapter 4).
Social, economic and cultural determinants of health are closely related. Social
circumstances affect behaviour, and socioeconomically disadvantaged people may be
inßuenced by economic and cultural reasons in their choice of behaviours that affect
health. In Australia, people in lower socioeconomic groups are more likely to exhibit
behaviours, such as smoking and heavy use of alcohol, that place them at higher risk
(DHAC & AIHW 1999). Other factors leading to unhealthy behaviour include lack of
knowledge, feelings of hopelessness, fatalistic attitudes and the desire for immediate
gratiÞcation in the absence of other rewards.
Cultural factors may inßuence health because of traditions, attitudes, beliefs and
customs. Family life, parental support and social exclusion are other factors that cross
the social and cultural boundaries and may affect health in various ways. There are also
related issues of Ôsocial capitalÕ, a concept developed to explain the apparent beneÞts of
social ties within communities. Migrants, minority groups and refugees may be
susceptible to ill health due to social isolation, and often have few social support
networks (Kawachi et al. 1996; Wilkinson & Marmot 1998). Despite this, overseas-born
Australians, especially those born in southern Europe, generally have lower death rates
than people born in Australia (Giles et al. 1995; Kliewer & Butler 1995).
 
3.6 Determinants and risk factors for NHPA 
diseases and conditions
 
The National Health Priority Areas (NHPA) initiative covers major chronic diseases and
conditions, as well as injuries. Its focus is on those areas that are known to contribute
signiÞcantly to the burden of disease in Australia and for which there is potential for
health gain. The initiative recognises that strategies need to cover the continuum of care
across prevention, treatment and management. Accordingly, the factors that lead up to
and inßuence the NHPA diseases and conditions have been clearly identiÞed. The
determinants and risk factors that broadly relate to the six priority areas are as follows:
¥
 
Cardiovascular health.
 
 Most cardiovascular diseases and conditions follow long-
term exposure to unhealthy factors and disease processes, and often have chronic
outcomes. Both environmental and genetic factors contribute to various harmful
 
AH2002 body 26-6  Page 162  Wednesday, June 26, 2002  7:29 PM
 3
 
 Determinants of health  
 
163
 
TRIM SIZE 175 mm Wide x 250 mm Deep
mechanisms leading to the development of cardiovascular problems. Prominent
among the behavioural and biomedical risk factors are tobacco smoking, unhealthy
diet, physical inactivity, excess weight, hypertension, high blood cholesterol and high
blood sugar. 
¥
 
Cancer control.
 
 Although some cancers have risk factors in common, most cancers
have speciÞc risk factors that may be responsible for their onset. However, the
principal risk factors amenable to primary prevention of the eight NHPA cancers are
smoking, excessive alcohol consumption, physical inactivity, exposure to sunlight
and a high-fat diet. Cancer control can be further advanced through programs such
as screening and early detection, which improve the management of cancer. 
¥
 
Injury prevention and control.
 
 The main focus of injury prevention and control is
injuries caused by exposure to external agents, regardless of intent. This includes
exposure to acute mechanical, thermal, chemical, and radiant energy-related factors
as well as occupational injuries sustained over time through regular use. Factors that
create the situation or environment in which injuries occur, both structural and
personal, also need to be identiÞed. However, unlike cardiovascular diseases and
cancers, the time from exposure to damage is usually short and the factors are more
readily identiÞed.
¥
 
Mental health.
 
 Mental health problems and disorders result from a complex
interplay of biological, genetic, developmental, social and cultural factors, and
identifying precise causes is difÞcult. Prevention and early intervention to identify
and manage the risk factors that increase peopleÕs vulnerability to mental problems
and disorders is important, as is early treatment to decrease the length of illness, and
the identiÞcation of high-risk populations. 
¥
 
Diabetes mellitus
 
.
 
 Diabetes mellitus has a variety of risk factors ranging from genetic
susceptibility to auto-immune mechanisms to behavioural and biomedical risk
factors such as physical inactivity and obesity. Disturbances of fat, protein and
glucose metabolism also mean that diabetes is a risk factor for a variety of diseases
and complications. It is not uncommon to treat risk factors of Type 2 diabetes in
common with cardiovascular diseases, in particular because of its involvement in
coronary heart disease and peripheral vascular disease. However, the ways in which
diabetes and cardiovascular diseases develop are quite different and require speciÞc
strategies.
¥
 
Asthma.
 
 Risk factors for asthma include tobacco smoking and excess weight in
common with other NHPAs, but the triggers for asthma are quite speciÞc. It is a
chronic disease that has a low fatality rate but responds to a variety of different
stimuli through the course of the disease. The triggers that continue to present
regular threats after the initiation of the disease include infectious agents, allergens,
drugs, industrial and occupational chemicals, air pollutants and physical activity.
These stimuli can trigger severe airway narrowing with associated coughing,
wheezing and difÞculty in breathing.
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Most of the risk factors that are relevant to NHPA diseases and conditions and for
which suitable monitoring information is available are described in the preceding
sections of this chapter. It is also important to view these risk factors across the stages of
the life cycle, as well as in the context of social factors and structures that inßuence
health outcomes. This information is provided in Chapter 4.
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4 Population health
4.1 Introduction
This chapter focuses on examining health issues across a number of populations. In
previous chapters, the focus has been mainly on diseases, their risk factors,
complications, management and outcomes. This chapter describes disease patterns
peculiar to population groups and variations from the general community patterns.
This chapter covers the Þrst tier of the National Health Performance Framework,
focusing on its equity issues (NHPC 2001) (described in Chapter 6). It also discusses a
number of the core functions of public health (NPHP 2000).
The population groups identiÞed in this chapter follow a life-course pattern of mothers
and babies, children and young people, and older people. Population groups with some
signiÞcant features are then described: Indigenous peoples, people from rural and
remote locations, overseas-born people and people of various socioeconomic
backgrounds. Veterans and prisoners have also been identiÞed as areas of interest
where there are speciÞc patterns of health and systems dedicated to their particular
needs.
4.2 Mothers and babies
Live births
The annual number of live births in Australia has continued to decline since 1992. There
were 249,636 live births registered in Australia in 2000 (ABS 2001b), a decline from the
peak annual registration of 276,362 live births in 1971, although there was a slight
increase in registered live births between 1979 (223,129) and 1992 (264,151).
The crude birth rate in 2000 was 13.0 live births per 1,000 population compared with
21.7 per 1,000 in 1971.
Age-specific birth rates 
Age-speciÞc birth rates express the number of live births to women in a particular age
group as a proportion of the number of women of the same age group in the population
in a given year.
A very clear trend is emerging in the analysis of age-speciÞc groups of mothers. Among
mothers aged less than 30 years, the birth rates are in a long-term decline. However, this
is partly offset by mothers in their late thirties and early forties whose birth rates are
increasing.
Among teenage mothers aged 15Ð19 years, the birth rate declined from a rate of 55.5
births per 1,000 women in 1971 to a present low of 17.4 in 2000. Even in the last few
years, the decline has been large, down from 22.1 in 1991 to 18.4 in 1998. When
compared with the 1971 rate, the 2000 rate represents an overall decline of 68.5%.
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This trend is more pronounced among women in the 20Ð24 year age group. The birth
rate decreased from 225.8 births per 1,000 women in 1961, 181.9 in 1971, 107.5 in 1981,
75.0 in 1991 to 56.5 in 2000, representing an overall decline of 75.0% in birth rates over
the period 1961Ð2000.
Women aged 35Ð39 years experienced the lowest birth rates in 1978 with 23.5 per 1,000
women giving birth, gradually increasing to a historical high of 49.1 in 2000,
representing an increase of over 100% in the age-speciÞc birth rate for this group.
The birth rate for women aged 40Ð44 years showed a similar trend with rates doubling
over the period 1983Ð2000. In 1983, there were 4.3 births per 1,000 women compared
with 8.8 per 1,000 women in 2000.
In 2000, for the Þrst time since the early 1960s, the peak birth rate among all age groups
shifted from ages 25Ð29 (107.0 births per 1,000 women) to 30Ð34 (110.5). This trend in
delayed child-bearing can be attributed to a number of factors including social,
educational and economic factors, increased access to assisted reproductive technology
and longer reproductive life expectancy (Table S2). 
Multiple births
The increasing incidence of multiple births in Australia continued in 1999. There were
7,642 twin and 329 triplet and higher order multiple births in 1999, representing 3.0%
and 0.1%, respectively, of all births in Australia (AIHW: Nassar et al. 2001). The
associated multiple birth rate in 1999 was 31.0 per 1,000 births, increasing 15.7% from
26.8 per 1,000 births in 1991.
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Source: AIHW National Perinatal Statistics Unit, Perinatal data collection, 2001.
Figure 4.1: Twin birth rate per 1,000 births, 1991 to 1999
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The twin birth rate has steadily increased from 25.8 twins per 1,000 births in 1991 to 29.7
twins per 1,000 births in 1999. This represents a 15.1% increase in the twin birth
proportion over this period (Figure 4.1).
Several factors have inßuenced the rising incidence in multiple births, including the
change in the maternal age distribution (more older mothers) and the increased use of
fertility drugs and assisted conception to treat infertile couples. 
In 1999, assisted conception accounted for 18.5% of twin pregnancies and 42.3% of
triplet pregnancies in Australia. Assisted conception began in Australia in 1979, and in
the 21 years to 1999 nearly 29,000 pregnancies resulted in births. Among these births,
18.8% were twins, 2.1% were triplets and 0.1% were higher order multiple births
(Figure 4.2). These multiple births usually follow transfer of more than one embryo or
egg into the uterus or fallopian tube. In the past decade, there has been a policy of
reducing the number of embryos and eggs transferred during assisted conception
aimed at reducing the incidence of multiple births (AIHW: Hurst & Lancaster 2001). 
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Source: AIHW National Perinatal Statistics Unit, Assisted Conception Database, 2001.
Figure 4.2: Multiple pregnancies of at least 20 weeks gestation after assisted conception, 
Australia, 1979 to 1999
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Termination of pregnancy
Currently, only South Australia, Western Australia and the Northern Territory collect
data on induced abortions and only South Australia publishes its data. In 1999, there
were 5,605 induced abortions reported by South Australia at 17.8 per 1,000 women aged
15Ð44 years. The associated pregnancy rate was 76.0 per 1,000 women and almost one
in four (23.4%) pregnancies resulted in abortions. More than half (54.4%) of all teenage
pregnancies in South Australia were terminated (Chan et al. 1999).
Maternal mortality
Maternal deaths occur infrequently in Australia (approximately 30 per year). Between
1994 and 1996 the maternal mortality rate was 13.0 per 100,000 conÞnements, an
increase on the rate reported in the previous 3-year period (10.9 deaths per 100,000)
(AIHW & NHMRC 2001). The main causes of maternal death include pulmonary
embolism, amniotic ßuid embolism, cardiovascular disease and injury. Deaths from
pregnancy complications accounted for almost half (46%) of all maternal deaths, and
deaths from pre-existing diseases accounted for 20%. In the remaining 34%, the
pregnancy was unlikely to have contributed signiÞcantly to the death, such as in the
case of motor vehicle accidents or unrelated cancer (e.g. melanoma). 
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Note: Perinatal deaths include all babies who died within 28 days of birth and all foetuses weighing at least 400 grams 
or, when birthweight is unavailable, having a corresponding gestational age of at least 20 weeks.
Source: AIHW National Perinatal Statistics Unit, derived from ABS perinatal deaths data, 2001.
Figure 4.3: Foetal, neonatal and perinatal death rates, Australia, 1973Ð1999
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Perinatal mortality
Perinatal deaths include stillbirths (foetal deaths) and deaths of infants within the Þrst
28 days of life (neonatal deaths). In 2000, more than 40% of foetal deaths were not
allocated a speciÞc cause of death. The main causes of perinatal deaths include respiratory
conditions (intra-uterine hypoxia, birth asphyxia and other respiratory conditions)
(21.9%), congenital malformations, deformations and chromosomal abnormalities (19.6%),
and disorders related to length of gestation and foetal growth (12.9%) (ABS 2001c).
Overall, the perinatal death rate has declined markedly in the last decade from 11.3
deaths per 1,000 births in 1990 to 8.3 in 2000 (ABS 2001c) (Figure 4.3). Foetal deaths (5.2
per 1,000 total births) accounted for 62.7% of perinatal deaths, and neonatal deaths (3.1
per 1,000 live births) for 37.3%. The perinatal death rate for males (8.8 per 1,000 total
births) was higher than that for females (7.7 per 1,000 total births).
Perinatal deaths were more likely to occur among babies born to substantially younger
and older mothers. In 2000, the perinatal death rate was 14.3 deaths per 1,000 births
among women aged less than 20 years and 9.2 deaths per 1,000 births among women
aged 40 years or over. In contrast, the perinatal death rates among births to women
aged 25Ð29 and 30Ð34 years were 7.4 and 7.1 deaths per 1,000 births, respectively.
Birthweight
A key indicator of infant health is the percentage of babies having a birthweight of less than
2,500 grams. These low-birthweight babies have a greater risk of dying, require a longer
period of hospitalisation after birth, and are more likely to develop significant disabilities. 
In 1999, the mean birthweight of all liveborn and stillborn babies was 3,360 grams.
There were relatively more male babies (63,613; 48.2%) than females (46,552; 37.2%)
with a birthweight of 3,500 grams or over. The mean birthweight of males (3,420 grams)
was slightly higher than that of females (3,297 grams) (AIHW: Nassar et al. 2001).
In 1999, there were 17,208 low-birthweight babies, representing 6.6% of all births. This
represents an increase of 0.4% from 6.3% in 1991. Low birthweight was more likely
among female babies (7.2%) than males (6.2%). Low birthweight is more common in the
Northern Territory due to the relatively high proportion of Indigenous births. In 1999,
there were 8,930 births to Indigenous mothers, with 13.0% of these classiÞed as being of
low birthweight.
Type of delivery
The method of birth in two-thirds (66.2%) of all conÞnements was spontaneous vaginal
deliveries in 1999, 21.9% involved caesarean section deliveries and 11.8% involved
forceps, vacuum extraction and/or vaginal breech delivery. Obstetric intervention is
implemented if serious complications arise during pregnancy or labour. However, there
is much debate about the most appropriate type of intervention. There was
considerable variation among the States and Territories in the rates of forceps deliveries
and the use of vacuum extraction (Table 4.1). Victoria recorded the highest rate of
forceps delivery (7.9%), and the Northern Territory recorded the lowest (3.9%). The rate
of vacuum extraction varied, ranging from 1.8% of deliveries in the Northern Territory
to 9.2% of deliveries in Western Australia.
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Caesarean birth rates have increased markedly from 17.3% in 1989 (AIHW: Lancaster &
Pedisich 1993) to 21.9% in 1999 (AIHW: Nassar et al. 2001), an increase of 26.6% in the
11-year period. South Australia had the highest caesarean rate (24.9%) in 1999, and the
Australian Capital Territory had the lowest rate (19.6%). The caesarean rate for
Indigenous mothers was 18.4%, slightly less than for all mothers. However, teenage
Indigenous mothers had relatively higher caesarean rates compared with other
Australian mothers. Indigenous mothers aged less than 20 years had a caesarean rate of
16.0% compared with 12.3% of all teenage mothers.
Congenital malformations
Congenital malformations pose a signiÞcant public health problem, and are a major
reason for admission to hospital during infancy and childhood, often resulting in
disabilities, handicaps and, in some cases, death. All States and Territories notify infants
born with major congenital malformations to the national data system. Between 1981
and 1997, the malformation rate was highest in the musculoskeletal structures (49.2 per
10,000 births), the heart and circulatory system (41.8), the genital organs (24.6) and
chromosomal abnormalities (20.6). The high rates in these systems were mainly from
congenital dislocation of the hip (20.8 per 10,000 births), hypospadias (20.2), ventricular
septal defect (16.2), cleft lip/palate (14.9) and Down syndrome (12.4) (Table 4.2) (AIHW:
Hurst et al. 2001).
Table 4.1: Type of delivery, States and Territories, 1999
NSW Vic Qld WA SA Tas(a) ACT NT Aust
Number
Total confinements 85,967 61,587 48,042 25,378 18,233 5,996 4,599 3,550 253,352
Per cent
Spontaneous vaginal 68.6 63.9 67.4 62.1 62.3 70.4 68.9 72.6 66.2
Forceps 4.9 7.9 4.1 4.7 7.1 5.7 6.1 3.9 5.6
Vacuum extraction 6.0 4.7 4.5 9.2 5.2 2.1 4.7 1.8 5.5
Vaginal breech 0.9 0.8 0.5 0.6 0.5 0.6 0.7 0.5 0.7
Caesarean section 19.7 22.8 23.4 23.4 24.9 21.0 19.6 21.2 21.9
Other/unknown — — 0.0 — — 0.2 — — 0.0
(a) Data for Tasmania in 1999 unavailable; 1998 data used as an estimate.
Source: AIHW: Nassar et al. 2001.
Box 4.1 Congenital malformations
Congenital malformations can be grouped into the main anatomical systems, based on the
International Classification of Diseases, or can be tabulated individually.
The main anatomical components in which major malformations occur are the muscu-
loskeletal structures, cardiovascular system and genital organs.
Chromosomal abnormalities, particularly trisomy 21, account for the majority of termina-
tions of pregnancy.
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Anencephalus, spina biÞda and encephalocele are serious malformations of the brain
and spine, known collectively as neural tube defects (NTDs), which often result in
death or major disability and handicap. From 1991 to 1997 the reported malformation
rate for NTDs was 11.5 per 10,000 births. Studies have shown a relationship between
folate deÞciency and NTDs. The National Health and Medical Research Council
(NHMRC) has made a series of recommendations on periconceptional folic acid
supplementation for women likely to become pregnant and for those with a close
family history of NTDs (NHMRC 1993). A validation study on all NTDs was conducted
in 2000. It established baseline Þgures for the years 1991Ð1997 to enable monitoring of
the effects of folate fortiÞcation of foods (AIHW: Lancaster & Hurst 2000).
4.3 Children and young people
Compared with children in many other parts of the world, the majority of Australian
children enjoy good health. Nevertheless, it is important to continue to monitor the
health status of Australian children in order to ensure that their good health is
maintained and to identify groups of children within Australia who are not as healthy
as the majority.
For the purposes of monitoring the health and wellbeing of Australian children, children
are deÞned as those aged 0Ð14 years and young people as those aged 12Ð24 years. The
overlap in ages is intentional, and reßects the fact that the transition from childhood to
adulthood is a gradual process, which does not occur at the same age for all individuals.
Demographic profile
In June 2000, there were around 3.9 million Australian children aged 0Ð14 yearsÑ
2 million boys and 1.9 million girls. Children accounted for 20.5% of the total Australian
population of 19.2 million people. The distribution of children in the three age groups
Table 4.2: Selected congenital malformations, Australia, 1981Ð1997
ICD-9 code Congenital malformation Number
New cases per
10,000 births
740.0 Anencephalus 1,153 2.8
741 Spina bifida 2,294 5.5
742.3 Hydrocephalus 1,609 3.9
745.1 Transposition of great vessels 1,474 3.6
745.4 Ventricular septal defect 6,703 16.2
749 Cleft lip and/or cleft palate 6,180 14.9
750.3 Tracheo-oesophageal fistula, oesophageal atresia and 
stenosis 1,243 3.0
751.2 Atresia and stenosis of large intestine, rectum and anus 1,362 3.3
752.60, 3–5 Hypospadias 8,350 20.2
753.0 Renal agenesis and dysgenesis 1,473 3.6
754.30 Congenital dislocation of hip 8,613 20.8
756.61 Diaphragmatic hernia 1,158 2.8
758.0 Down syndrome 5,123 12.4
Source: AIHW: Hurst et al. 2001.
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0Ð4, 5Ð9 and 10Ð14 years was 32.3%, 33.9% and 33.8% respectively. Infants (i.e. children
under 1 year) made up 6.3%, and 25.9% were aged 1Ð4 years. In the same year there
was an estimated 2.95 million people aged 12Ð24 years who made up 15.2% of the
Australian population. 
The information presented in this section is guided by the National Child and Youth
Health Information Framework. This framework was developed for the management of
national information to improve the monitoring of the health and wellbeing of Australian
children and young people. The framework recognises that the attainment of a healthy
life is a complex process inßuenced by biological, social, cultural and environmental
factors, and knowledge and attitudes to health, as well as access to and availability of
medical services and interventions. It also recognises that health in adulthood is
inßuenced by attitudes and behaviours learnt during childhood. One important outcome
of organising information within the framework is that gaps and deÞciencies in
information become evident, and the national effort to collect data can be improved.
Children
This section covers risk and protective factors among children, measures of health
status and some information on health differentials by subpopulation groups. Most of
the information on children is derived from Australia’s Children: Their Health and
Wellbeing 2002 (AIHW: Al-Yaman et al. 2002). 
Risk and protective factors
As well as monitoring the health status of Australian children, it is important also to
identify health risk factors. Some of these may not cause ill health until later in life.
Information on health risk factors for children is not as easy to obtain as measures of
health status. Risk factors for poor health outcomes, particularly in the years before
school, can include personal factors such as difÞcult temperament and factors related to
the social and family environment such as parental mental illness, harsh parenting,
abuse and neglect, family conßict, low socioeconomic status, poor links with the
community and social isolation. Biological and behavioural risk factors can also
inßuence health and these include low birthweight, lack of breastfeeding, lack of
physical activity and inappropriate nutrition leading to conditions of overweight and
obesity, lack of protection from the sun and not being vaccinated. Safety-related
strategies inßuence the chances of incurring an injury and associated disability and
include policies encouraging fenced swimming pools, car restraints and helmet use for
cyclists. 
The health status of Australian children has generally improved over the last decade.
For example, there has been a decline in the incidence of vaccine-preventable diseases,
which has been associated with an improvement in vaccination coverage. Vaccination
coverage at 1 year of age increased from 74.9% in 1996 to 91.4% in 2000 and at 2 years of
age from 63.8% to 88.0% (Australian Childhood Immunisation Register and Health
Insurance Commission unpublished data). The latest available data on use of sun
protection among children (Australian Bureau of Statistics (ABS) 1995 National Health
Survey) indicate that the majority of Australian children (87%) aged 0Ð14 years usually
or always used some form of sun protection when they were in the sun. This has been
enforced at schools by the Ôno-hat no-playÕ program. 
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Death rates due to motor vehicle accidents and accidental drowning have also fallen
with the compulsory installation and use of child restraints in cars for children of all
ages, legislation to reduce speed limits in speciÞc areas and to enforce existing speed
limits, and the mandatory fencing of private swimming pools. Between 1991 and 2000,
the death rate due to motor vehicle accidents declined from 3.7 to 2.7 per 100,000
children and the death rate from accidental drowning declined from 2.1 to 1.8 per
100,000 children. 
Although these risk factors and their outcomes have shown some improvement, not all
is well. Overweight and obesity among children is on the rise. A recent analysis of the
1995 National Nutrition Survey using age- and sex-speciÞc body mass index cut-off
points indicates that, among children aged 0Ð14 years, 14.3% of boys and 16.4% of girls
are overweight and a further 3.7% of boys and 5.6% of girls are obese. This is of concern,
not only because of the health consequences in these children, but also because of the
greater risk they have of being obese in adulthood (Power et al. 1997). The increased
prevalence of overweight and obesity in Australian children may be attributed to
decreasing physical activity and increasing food energy intake (Magarey et al. 2001).
Health status
In the last decade, the prevalence and seriousness of communicable diseases in children
has continued to decline, particularly those diseases that are preventable by
vaccination. The decline in the incidence of vaccine-preventable diseases has been the
outcome of a number of measures. These include the introduction of new vaccines
(Haemophilus influenzae type b (Hib) in 1993 and hepatitis B vaccine in 2000) and the
modiÞcation of existing vaccination schedules to improve the effectiveness of existing
vaccines (measles and rubella vaccines). The use of more reÞned vaccines which
minimise side effects following vaccination has also led to better compliance with the
vaccination schedule and enhanced vaccination coverage rates. 
For children aged 0Ð4 years between 1993 and 2000, the notiÞcation rate for pertussis
(whooping cough) declined by 42% from 60.7 to 35.3 per 100,000 children, and the
notiÞcation rate for Hib declined by 97% from 27.4 cases to less than 1 case per 100,000
children (Figure 4.4). NotiÞcation rates for other diseases also declined. For all children
aged 0Ð14 years, the notiÞcation rate for measles declined by 99% from 96.8 per 100,000
children in 1993 (during a period in which there was a measles epidemic) to 1.2 cases
per 100,000 children in 2000, and for rubella by 95% from 34.2 cases in 1993 to 1.6 cases
in 2000. In the year 2000, with the exception of pertussis, the notiÞcation rates for all
vaccine-preventable diseases among children aged 0Ð14 years were below 2 per 100,000
children.
Although the incidence of vaccine-preventable diseases has been declining over the
decade, the prevalence of some chronic diseases among Australian children is on the
rise. Asthma is the leading cause of disease burden among children. Over the last two
decades, the prevalence of asthma (measured as a Ôcurrent wheezeÕ) has been estimated
to be increasing at a rate of 1.4% per year (Woolcock et al. 2001). Australia ranks among
the highest prevalence rates for childhood asthma in the world (Robertson et al. 1998).
The latest estimate from the 1995 National Health Survey indicates that the prevalence
of asthma is around 20% in school-age children.
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Childhood diabetes is also on the rise. Data from the New South Wales Diabetes
Register indicate that between 1992 and 1996 the incidence of Type 1 diabetes has
increased at a rate of 3% annually, from 17.1 per 100,000 children in 1992 to 21.6 per
100,000 children in 1996 (Handelsman & Jackson 1999). The latest available national
data on the incidence of Type 1 diabetes in children comes from the National Diabetes
Register (a register of people who use insulin). In 2000, the incidence of Type 1 diabetes
in children was estimated to be 18.6 per 100,000 children (AIHW 2001e).
Type 2 diabetes, which is usually seen only in adults, is increasingly being reported in
children in the United Kingdom, United States and other countries (Ehtisham et al.
2001; American Diabetes Association 2000). The emergence of Type 2 diabetes in
children has been linked to lifestyle factors such as a lack of physical activity and
obesity in children from certain ethnic groups (American Diabetes Association 2000).
Although the incidence and prevalence of Type 2 diabetes in Australian children are
unknown, similar risk factors apply here. 
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Source: Communicable Diseases Network Australia—National Notifiable Diseases Surveillance System, personal 
communication.
Figure 4.4: Notifications of vaccine-preventable diseases in children aged 0Ð14 years, 1993 
to 2000 (per 100,000 children)
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The prevalence of mental health and behavioural problems among children aged 4Ð12
years is also of concern and is estimated to be around 14%. The prevalence of attention-
deÞcit hyperactivity disorder (ADHD), and depressive and conduct disorders is
consistently higher for boys aged 6Ð12 years than for girls of the same age. About 1 in 5
boys (19.3%) were identiÞed to have ADHD compared with a prevalence of 8.8%
among girls. The prevalence of depressive disorder and conduct disorder among boys
was 3.7% and 4.8% respectively. The corresponding prevalence for the same disorders
in girls was 2.1% and 1.9% (Sawyer et al. 2000).
Hospitalisations
In 1999Ð00, there was a total of 542,245 hospitalisations of children aged 0Ð14 years in
Australia, 9.2% of all hospitalisations. Of these, 58% were of boys and 42% of girls. Over
a quarter (26%) of these hospitalisations were of infants. The hospitalisation rate for
infants was 55,667 per 100,000 infants, and the rate for those aged 1Ð14 years was 11,043
per 100,000 children aged 1Ð14. The most common reasons for hospitalisations of
children aged 0Ð14 years were respiratory conditions (chronic tonsillitis and asthma
were the main speciÞc diagnoses) and injury (fracture of lower end of both ulna and
radius). Conditions originating in the perinatal period (pre-term infants born between
28 and 37 weeks of gestation), digestive problems (dental caries) and infectious diseases
(diarrhoea and gastroenteritis of presumed infectious origin, and viral infection) were
also common reasons for hospitalisations.
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Source: AIHW National Mortality Database.
Figure 4.5: Infant mortality rates, 1980 to 2000 (per 1,000 live births)
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Mortality
In 2000 in Australia, 1,931 children aged 0Ð14 years died, accounting for 1.5% of all
deaths in that year. Of these child deaths, 1,290 (66.8%) were infants. 
Despite the decline in the infant mortality rate over the last two decades, AustraliaÕs
infant mortality rate (5.2 per 1,000 live births) is high compared with other developed
countries and, in 1999, ranked nineteenth among OECD countries. In the same year,
Iceland ranked number 1 with an infant mortality rate of 2.4 per 1,000 live births. Infant
mortality in Australia is inßuenced by high death rates among Indigenous infants.
One of the reasons for the decline in post-neonatal mortality has been the decline in
deaths from sudden infant death syndrome (SIDS). In 2000, the SIDS death rate was
51.7 per 100,000 live births, compared with 171.6 in 1980Ña decline of 69.9%
(Figure 4.6). Most of the decline in the SIDS death rate occurred in the 1990s. The
decline followed the 1991 National SIDS Council of AustraliaÕs public education
campaign on the sleeping position of infants.1
1 NHMRC guidelines (1991) suggests that babies be placed on their back or on their side in 
such a way that they cannot roll onto their stomach, to sleep. 
Note: ICD-9 code for SIDS 798.0 (1980 to 1996) and ICD-10 code (1997 to 2000).
Source: AIHW National Mortality Database.
Figure 4.6: Mortality rate from SIDS for infants under 1 year, 1980 to 2000 (per 100,000 live 
births)
1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000
0
50
100
150
200
250
300
350
Males
Females
Year
Deaths per 100,000 live births
AH2002 body 26-6  Page 181  Wednesday, June 26, 2002  6:28 PM
182  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000
0
10
20
30
40
50
60
Males
Females
Year
Deaths per 100,000 children
Source: AIHW National Mortality Database.
Figure 4.7: Mortality rate for children aged 1Ð14 years, 1980 to 2000 (per 100,000 children)
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Source: AIHW National Mortality Database.
Figure 4.8: Injury mortality rate for children aged 0Ð14 years, 1980 to 2000 (rate per 100,000 
children)
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In the last two decades there has also been a large decline in mortality among children
aged 1Ð14 years. Between 1980 and 2000, the mortality rate declined by 52.7% for boys,
from 42.5 to 20.1 per 100,000 boys, and by 49.8% for girls, from 29.7 to 14.9 per 100,000
girls (Figure 4.7). Injury and poisoning remain among the leading causes of deaths of
children aged 1Ð14 years and in 2000 were responsible for 285 deaths (7.8 per 100,000).
Other common causes of deaths in this age group include neoplasms including cancer
(105 deaths, or 2.9 per 100,000), diseases of the nervous system including cerebral palsy
and epilepsy (65 deaths, or 1.8 per 100,000), and congenital malformations (54 deaths,
or 1.5 per 100,000). 
The main causes of death from injury were motor vehicle, bicycle and pedestrian
accidents (38.9%), accidental drowning (20.5%), other accidental threats to breathing
(9.3%) and physical assault (7.8%). However, deaths from injury for both boys and girls
declined between 1980 and 2000, by 55.6% for boys (from 24.3 to 10.8 per 100,000 boys)
and by 58.7% for girls (from 15.0 to 6.2 per 100,000) (Figure 4.8).
Health differentials
Many of the health concerns described above affect particular groups of children more
than others. The health of children is strongly associated with the socioeconomic status
of their family. Children from families with lower socioeconomic status tend to have
poorer health. Aboriginal and Torres Strait Islander children have a higher risk of
disease and injury and have higher death rates than other Australian children. Between
1998 and 2000, the infant mortality rate of Indigenous babies was 14.9 deaths per 1,000
live births, almost three times that of the total infant mortality rate (4.8 per 1,000 live
births). The disparity between the infant mortality rate for the native population and
that of the total population is more pronounced than in the United States and New
Zealand where the infant mortality rates of the native populations in these countries are
substantially lower than in Australia (ABS 2001d). Low socioeconomic status and poor
living conditions associated with higher rates of pre-term and low-birthweight babies
all contribute to the higher mortality rates. There are also regional disparities in health
status. The substantially higher proportion of Indigenous children who live in remote
areas and their generally lower health status mean that the overall health status of
children in remote areas is affected by the health status of Indigenous children.
Young people
Young people in Australia in general enjoy good health, but they are also vulnerable to
particular conditions and diseases.
Risk and protective factors 
There are areas of concern in relation to risk factors among young people. Social and
economic disadvantage (poor education and unemployment) and problems such as
social isolation have been shown to have negative effects on health. There is evidence
from the Mental Health Survey of Young People that among adolescents, mental health
problems and disorders are more prevalent in blended families, one-parent families,
families with low incomes and families where one or both parents are unemployed
(Sawyer et al. 2000). 
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In 1999 only 69% of people aged 18Ð29 years participated at a ÔsufÞcientÕ activity level
to maintain health beneÞts, with 74% of males and 64% of females being sufÞciently
physically active (AIHW: Armstrong et al. 2000).
Tobacco smoking also remains high among young people. National data from the 2001
National Drug Strategy Household Survey (NDSHS) showed that among those aged
14Ð19 years, 14% of males and 16% of females smoked daily. This proportion increased
to 29% and 24% for males and females aged 20Ð29 years respectively.
Alcohol consumption by young people can also be detrimental to their health. The 2001
NDSHS showed that 31% of males and 25% of females aged 14Ð19 years drank alcohol
on a weekly basis. These proportions increase to 55% and 39% for males and females
aged 20Ð29 years respectively. Applying the new NHMRC guidelines on alcohol
consumption in Australia, around 12% of teenagers drank at risky or high-risk levels for
long-term harm, and 45% drank at levels risking short-term harm at least once in the
past year. Among young adults aged 20Ð29 years, 15% were risking harm in the long-
term, and 60% were risking harm in the short term. 
Young people experience a greater risk of developing harmful drug use behaviours and
experiencing drug-related harm. Data from the 2001 NDSHS indicates that about
2.4 million Australians aged 14Ð29 years have used an illicit drug. Marijuana use was
relatively high: 27% of males and 23% of females aged 14Ð19 years recently used the
drug and these proportions increased to 35% for males and 23% for females aged 20Ð29
years. From the 1999 survey of secondary schools, almost 1 in 5 young people aged
12Ð17 years had used inhalants (19% of males and 20% of females) and 1 in 10 had used
tranquillisers (10% of males and 11% of females). Amphetamines use was estimated to
be around 5Ð6% (AIHW: Miller & Draper 2001).
Health status
There is much evidence that young people are in good health compared with
Australians in other age groups. Two-thirds of young Australians rate their own health
as ÔexcellentÕ or Ôvery goodÕ. Mortality rates among young people are lower than those
of all other age groups, with the exception of children aged 1Ð14 years (ABS 2001d).
Disability rates are also low in this age group. In 1998, the proportion of people with a
severe or profound activity restriction needing assistance was lowest among those aged
15Ð19 years and 20Ð29 years: 2.3% and 1.7% respectively (AIHW 2001a). Furthermore,
the health status of young people is improving. Death rates have fallen, due mainly to a
reduction in deaths from motor vehicle accidents. HIV notiÞcation rates for young
people have declined. Among young people aged 12Ð24 years, the number of new HIV
diagnoses in males fell from 10.9 to 3.1 per 100,000 between 1991 and 2000. The female
rate remained much lower at about 1 per 100,000 over the same period (NCHECR 2000,
unpublished data). 
However, areas of concern remain. Young people aged between 12 and 24 years pass
through a period of life characterised by physiological and psychological uncertainty.
Mental health problems, including drug dependence disorders, are the major burden of
disease for this age group. Of people aged 13Ð17 years, 13.4% of males and 12.8% of
females were diagnosed with a mental health problem (Sawyer et al. 2000). In 1997, the
prevalence of a mental disorder among those aged 18Ð24 years was 27% (ABS 1998b).
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NotiÞcations for the main sexually transmitted diseases, except syphilis, increased for
young people in the 1990s. Among people aged 12Ð24 years, notiÞcation rates for
chlamydia increased from 92.6 to 268.2 per 100,000 between 1991 and 1999 and for
gonococcal infections from 47 to 68.8 per 100,000, and for donovanosis from 55.9 to 74.3
per 100,000 (Communicable Diseases Network AustraliaÑNational NotiÞable Diseases
Surveillance System, personal communication 2002).
Hospitalisations
In 1999Ð00, there were 530,347 hospitalisations of young people aged 12Ð24 years (317,109
females and 213,238 males). The higher number of hospitalisations of females was for
pregnancy and childbirth (104,400 hospitalisations). The overall hospitalisation rate for
young people aged 12Ð24 years was 15,414 per 100,000. The hospitalisation rates
increased with ageÑ8,779, 14,681 and 19,675 hospitalisations per 100,000 for those aged
12Ð15, 16Ð18 and 19Ð24 years respectively. The main reasons for hospitalisations of young
people aged 12Ð24 were injury (fracture of nasal bones and head injuries were the main
diagnoses), diseases of the digestive system (impacted teeth, acute appendicitis and non-
infectious gastroenteritis and colitis), and mental and behavioural disorders (depressive
episode, anorexia nervosa, and mental and behavioural disorders due to use of opioids).
Mortality
Mortality rates among young people have declined over the last two decades. Death
rates among those aged 12Ð24 years declined by 37.8% from 83.7 in 1980 to 52.1 per
100,000 in 2000. Throughout this period, the mortality rate was higher for males than
for females. Mortality rates for males declined by 40.7% from 122.5 deaths per 100,000
in 1980 to 72.7 in 2000 compared with a decline for females of 30% from 43.7 deaths per
100,000 in 1980 to 30.6 in 2000 (Figure 4.9). 
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Source: AIHW National Mortality Database.
Figure 4.9: Death rates for people aged 12Ð24 years, 1980 to 2000 (rate per 100,000)
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The highest mortality rates occurred among males aged 19Ð24 and 16Ð18 years (Figure
4.10). In the year 2000, there were 1,795 deaths of people aged 12Ð24 years. The main
causes of death for young people are indicative of the problems of this age group. In
2000, injury was the leading cause of death for people aged 12Ð24 years, with 68.1%
(1,222) of all deaths attributed to some form of injury. The majority of injury cases
(93.4%) were related to motor vehicle accidents. Self-harm was the second leading cause
of death, representing 19.2% of all deaths in this age group.
However, when speciÞc causes of death were considered, suicide by hanging,
strangulation and suffocation was the main leading cause of death for those aged 12Ð24
years (198 deaths, 154 males and 44 females). Vehicle driver killed in collision with a
stationary object (99 deaths) and death from taking opioids (drug dependence, 72
deaths) were also leading speciÞc causes of death in this age group.
Although suicide rates increased between 1980 and 1997, the rate has been declining in
the past few years. The suicide rate declined from 24.5 per 100,000 males aged 12Ð24
years in 1997 to 15.4 in 2000 while that for females of the same age group declined from
6 per 100,000 in 1997 to 4.5 in 2000 (Figure 4.11). In comparison, between 1921Ð1925 and
1996Ð1998, the biggest increases in death rates due to suicide occurred in males aged
15Ð19 and 20Ð24 years, where the rates more than tripled.
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Source: AIHW National Mortality Database.
Figure 4.10: Death rates for people aged 12Ð24 years, 1980 to 2000 (deaths per 100,000 
population)
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Death rates attributed to drug dependence rose sharply between 1993 and 1998, but the
rate declined in the following 2 years. In 2000, drugs were responsible for 108 deaths of
young people aged 12Ð24 years (83 males and 25 females). These accounted for 6% of all
deaths of young people. The rate of deaths related to drug dependence for young males
in 2000 was over 3 times that for young females (Figure 4.11). For males the rate
increased by 200% from 1.6 per 100,000 males aged 12Ð24 years in 1980 to 4.8 in 2000,
compared with an increase of 88% from 0.8 per 100,000 females aged 12Ð24 years in
1980 to 1.5 in 2000.
Considerable differences exist in the health status of male and female young people.
Male deaths outnumber female deaths by almost 3 to 1 with the difference highest in
the age group 20Ð24 years. Car accidents and suicides of males account for most of this
difference. Differences also occur between socioeconomic groups. In males, the
differences in death rates between the lowest socioeconomic group (which has the
highest death rates) and the highest socioeconomic group increased between 1985Ð1987
and 1995Ð1997. Males in the lowest socioeconomic group quintile died at 1.7 times the
rate of males in the highest socioeconomic quintile in the period 1995Ð1997 (AIHW
2000). For females in the same socioeconomic groups, the differences were less marked.
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Source: AIHW National Mortality Database.
Figure 4.11: Suicide and drug dependency mortality rates among young people aged 
12Ð24 years, 1980 to 2000 (rate per 100,000)
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In contrast, females have three times the male rate of depressive illnesses. Females are
hospitalised at higher rates than males in all age groups for parasuicide (self-harm not
resulting in death), although completed suicide rates for males are higher.
Death rates among Aboriginal and Torres Strait Islander young people are of particular
concern. In 2000 the age-speciÞc death rate was 168.1 per 100,000 young Indigenous
people aged 15Ð24 compared with 59.9 per 100,000 other Australians of the same age
group. 
4.4 Older people (aged 65 and over)
The Commonwealth, State and Territory Strategy on Healthy Ageing (Healthy Ageing Task
Force 2000) highlights the improved health and wellbeing of older Australians as a major
goal for the next 5 years. This growing recognition of the concept of healthy ageing goes
hand in hand with a continuing appreciation of the impact of the ageing of the Australian
population. In 2001, there were 2.4 million people aged 65 and over in Australia, and this
number is projected to be 5.4 million in 2031 (AIHW 2001a). Also, declining mortality rates
and increased life expectancy have led to an extended period of life which is spent in Ôold
ageÕ, and greater acknowledgment of the many different activities, opportunities and
contributions which can characterise this phase of the life cycle. 
The strategy suggests that priority should be given to health promotion, prevention of
disease and rehabilitation programs for older people. It also emphasises the importance
of encouraging older people to remain active in their communities and hence to
improve their health and wellbeing. Initiatives to assist groups such as older people
from culturally and linguistically diverse backgrounds, those with disabilities, and the
Indigenous population were identiÞed as important areas for action (Healthy Ageing
Task Force 2000). Broader social factors are also signiÞcant contributors to good health
in old age. A lifetime of higher education, higher labour force participation and income,
supportive personal and social environments, good medical care and good
superannuation entitlements all contribute to better life chances in old age and thus to a
higher likelihood of maintaining good health at advanced ages.
Life expectancy
Life expectancy at birth increased for both men and women throughout the twentieth
century. Whereas most of the gains earlier in the twentieth century resulted from a
reduction in death rates at younger ages, the latter part of the century saw an increase
in life expectancy at older ages. At age 65 in 2000, males can expect to live a further 16.6
years and women 20.2 years.
In recent years, the life expectancy of males has been increasing at a faster rate than that
of females. In the last 20 years, the life expectancy of males at birth has increased from
71.2 in 1980 to 76.5 in 2000 (an increase of 7.4%), and that at age 65 has increased from
78.8 to 81.6 years (an increase of 3.6%). For females, life expectancy at birth has
increased from 78.3 to 81.9 (4.6%) and from 83.0 to 85.2 years (2.7%) at age 65. The faster
increase in life expectancy among men has resulted in an increase in the male to female
sex ratio for people aged 65 and over from 0.73 in 1980 to 0.79 in 2000. The numerical
predominance of older women is declining.
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Disability levels
The proportion of the population with a severe or profound core activity restriction, as
deÞned by the Australian Bureau of Statistics in their 1998 Survey of Disability, Ageing
and Carers (ABS 1999a), is a good indicator of need for assistance. It includes those who
sometimes or always require assistance with self-care, mobility or communication. In
the population aged 65 and over, 83.7% of men and 75% of women did not have a
profound or severe core activity restriction. The proportion of older people with a
severe or profound disability is quite low among older people until age 75. For men, the
proportion with a severe or profound core activity restriction increased from 7.8% at
age 65Ð69 to 19.0% at age 75Ð79, and to 56.0% at age 85 and over. For women the
comparable Þgures at the three ages were 9.2%, 24.9% and 68.8% (AIHW 1999). Women
had higher rates of profound or severe core activity restriction than did men,
particularly at older ages. At age 80 and over, 51.1% of women and 36.5% of men had a
profound or severe core activity restriction. 
Looking at the proportion of people with a ÔdisabilityÕ, as deÞned by the above ABS
survey, it is important to understand the meaning of disability as used in that survey.
Disability is deÞned as having one or more of 17 limitations, restrictions or
impairments. These range from conditions such as Ôloss of speechÕ to ÔanyÉlong-term
condition that restricts everyday activitiesÕ. Importantly, having a ÔdisabilityÕ does not
imply a need for assistance.
Table 4.3: Disability status of primary carers, 1998
Core activity restriction
Age
Profound
or severe Moderate Mild
All with specific
restrictions
All with
disability
Males (number)
Under 65  *4,102       14,970       11,884       30,956       39,243
65 and over    *4,807  *7,285  *7,342       19,434       21,522
Total  *8,909       22,255       19,226       50,390       60,765
Females (number)
Under 65       24,466       15,041       28,056       67,563        84,785
65 and over  *8,500       11,050         9,303       28,853        31,969
Total       32,966       26,091       37,359       96,416       116,754
Males (per cent of all carers with a disability) 
Under 65 *2.3 8.4 6.7 17.4 22.1
65 and over   *2.7 *4.1 *4.1 10.9 12.1
Total *5.0 12.5 10.8 28.4 34.2
Females (per cent of all carers with a disability)
Under 65 13.8 8.5 15.8 38.1 47.8
65 and over *4.8 6.2 5.2 16.3 18.0
Total 18.6 14.7 21.0 54.3 65.8
Note: Estimates marked * have an associated relative sampling error of between 25% and 50%. These estimates should be 
interpreted accordingly. 
Source: AIHW analysis of ABS Survey of Disability, Ageing and Carers confidentialised unit record file.
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It is interesting to note that a signiÞcant proportion of primary carers themselves have a
disability (Table 4.3). Of those carers with a disability, 65.8% were female and 34.2%
were male. The majority of carers with a disability (82.7%) had a speciÞc restriction. Of
carers with a speciÞc restriction, 31.8% had a mild restriction, 27.2% had a moderate
restriction and 23.6% had a severe or profound restriction. The proportion of older
carers who were classiÞed as having a severe or profound core activity restriction was
2.3% for males and 13.8% for females aged under 65, and 2.7% for males and 4.8% for
females aged 65 and over.
Table 4.4: Patients aged 65 and overÑseparations for the most frequently occurring principal 
diagnoses, 1999Ð00
Principal diagnosis Separations
Care involving dialysis 227,902
Other medical care 87,127
Other cataract 74,424
Care involving use of rehabilitation procedures 65,026
Angina pectoris 54,958
Other cancer of skin 38,204
Heart failure 36,229
Other chronic obstructive pulmonary disease 33,939
Senile cataract 30,735
Pneumonia, organism unspecified 26,385
Diverticular disease of intestine 23,192
Acute myocardial infarction 21,282
Pain in throat and chest 20,921
Atrial fibrillation and flutter 20,387
Follow-up examination after treatment for cancer 20,302
Source: AIHW National Hospital Morbidity Database.
Table 4.5: Patients aged 65 and overÑseparations for the most frequently occurring principal 
procedures, 1999Ð00
Principal procedure Separations
Generalised allied health interventions 712,158
Haemodialysis 230,732
Extracapsular crystalline lens extraction by phacoemulsification 93,757
Transfusion of blood and gamma globulin 92,936
Intravenous chemotherapy 81,939
Panendoscopy with excision 70,737
Fibreoptic colonoscopy 67,092
Computerised tomography of brain 59,004
Injection or infusion of therapeutic or prophylactic substance 53,028
Fibreoptic colonoscopy with excision 49,516
Source: AIHW National Hospital Morbidity Database.
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Main reasons for hospitalisation
In 1999Ð00 there were 1.9 million hospital separations for people aged 65 and over
(AIHW 2001b). Tables 4.4 and 4.5 report on the principal diagnoses and the main
procedures performed on the patients while in hospital care. In 1999Ð00, the most
common reason for admission for older Australians was dialysis (227,902 separations),
followed by other medical care (87,127). Diagnoses associated with heart disease
represented one-third of the top 15 principal diagnoses (a total of 153,777 separations).
The most commonly reported procedures for older Australians during hospitalisation
were generalised allied health interventions (712,158 separations), followed by
haemodialysis (230,732) and extraction of eye lens (93,757 separations).
Main causes of death
The main causes of death for both men and women aged 65 and over were diseases of
the circulatory system, cancers and diseases of the respiratory system. Together, these
three categories accounted for about three-quarters of deaths among people aged 65
and over. Among men aged 65 and over, circulatory diseases accounted for 40.7% of all
causes of death, and cancer and respiratory diseases accounted for 30.3% and 10.8%
respectively. The proportion of women aged 65 and over dying from circulatory
diseases was higher than that for men, at 47.5%, whereas deaths from cancer (21.4%)
were fewer and deaths from respiratory diseases (8.8%) differed only slightly. These
patterns were not unlike those appearing in the total population.
Deaths from injury and poisoning are of particular interest, due to the common
occurrence of falls in older people. Female deaths from injury and poisoning were quite
similar in both the 65 and over age group and the total population. For males, however,
there was a marked difference, with the percentage of deaths from injury and poisoning
in the total population being more than three times that of men aged 65 years and over
(Table 4.6).
Table 4.6: Selected major causes of death in the total population and for people aged 65 and 
over, 2000
Cause of death
65 and over Total population
Males Females Males Females
Number
Circulatory disease 19,960 24,466 23,756 25,931
Cancer 14,874 11,003 20,153 15,475
Respiratory disease 5,276 4,509 5,923 4,984
Injury and poisoning 1,128 1,162 5,517 2,581
All causes 49,012 51,462 66,817 61,474
Per cent of all causes
Circulatory disease 40.7 47.5 35.6 42.2
Cancer 30.3 21.4 30.2 25.2
Respiratory disease 10.8 8.8 8.9 8.1
Injury and poisoning 2.3 2.3 8.3 4.2
Source: AIHW National Mortality Database.
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Looking within these broad groupings at more speciÞc causes of death among older
people, falls, cerebrovascular disease (stroke), prostate cancer, breast cancer and
emphysema all account for a high proportion of deaths. Death rates per 100,000 people
aged 65Ð74 show that males have a higher rate from accidental falls, stroke and
emphysema than females. In people aged 75 and over, however, females have a higher
rate of death from stroke, and a slightly lower rate of death from falls. The death rate of
males from emphysema is almost four times that of females (Table 4.7).
The death rate from breast cancer in older females has dropped from 96.4 per 100,000
women aged 65Ð74 in 1991 to 74.4 per 100,000 in 2000, while for females aged 75 and
over the decrease during the same period has been from 143.2 to 132.3. Death rates from
prostate cancer have fallen slightly during this time from 112.9 to 109.8 per 100,000 men
aged 65Ð74. For men aged 75 and over, however, there has been a large increase in
deaths from prostate cancer, from 228.3 in 1991 to 434.6 in 2000. For both men and
women, the death rate from accidental falls is substantially higher in the 75 and over
group, compared with the 65Ð74 age group (Table 4.7).
Falls in older people
One of the major areas of interest in the health of older people is the impact of falls and
their prevention. Falls are responsible not only for pain and suffering in older persons,
but also for a signiÞcant number of deaths. Typically the consequences of falls are cuts,
bruising and occasional burns. The more serious conditions reported are fractures to the
upper limbs, lower limbs, neck and trunk. Death as a result of falls occurred on 1,104
occasions in 1998. It has been reported (AIHW: Cripps & Carman 2001) that there were
45,069 episodes of hospital care as a result of falls in 1997Ð98 in those over age 65.
Analyses show several key factors:
¥ the risk of hospitalisation resulting from a fall increases with age
¥ falls predominantly occur through stumbles or trips on same-level surfaces (39%)
Table 4.7: Selected specific causes of death per 100,000 people aged 65 and over, 1991 and 2000
Cause of death
Males Females
65–74 75+ 65–74 75+
1991
Cerebrovascular disease 198.7 535.0 141.5 1,139.9
Prostate cancer 112.9 228.3 — —
Breast cancer 1.3 0.7 96.4 143.2
Emphysema 30.3 43.0 9.8 20.7
Accidental falls 9.2 18.2 5.4 27.4
2000
Cerebrovascular disease 148.7 853.0 95.5 987.1
Prostate cancer 109.8 434.6 — —
Breast cancer 0.3 1.9 74.4 132.3
Emphysema 22.7 73.2 11.4 19.1
Accidental falls 6.6 32.2 4.4 29.2
Source: AIHW National Mortality Database.
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¥ trends over the period 1993Ð94 to 1997Ð98 show an increased number of hospitalisations
as the aged population increases, but a relatively stable hospitalisation rate
¥ trends in deaths rates have fallen signiÞcantly between the 1980s and 1990s.
It is well recognised that the circumstances leading to falls are complex and varied, but
the main factors contributing to falls are related to the person at risk, taking into
account their physical ability, medical conditions, walking ability, the effect of
medications and alcohol, their familiarity with the activity and the physical
environment (e.g. surfaces, lighting).
Given these contributing factors, the pattern of occurrence is relatively stable. The
majority of falls take place in the home (49%), in public spaces (17%) and in residential
care environments (14.8%) (AIHW: Cripps & Carman 2001). It is this distribution and
the contributing factors described above that drive a number of strategies to prevent
falls in older persons and/or minimise their impact.
4.5 Overseas-born people
Australia is an ethnically diverse nation. The 1999 ABS population estimates show that
about 25% of Australians were born overseas. More than half of these Australian
residents were born in a non-English-speaking country.
Box 4.2: Fall-prevention strategies
There are a number of fall-prevention strategies targeted at older people. The National
Falls Prevention in Older People Initiative (Department of Health and Ageing) seeks to
draw together a number of elements, although there are a number of prevention strategies
implemented by health authorities across all levels of government and non-government
organisations. 
These strategies include interventions such as home assessment and modification, which
have been shown to be beneficial, e.g. installation of hand-rails, improved lighting, non-slip
strips, repair of risk items. These home-based hardware solutions can also be supplemented
by more personal solutions such as walking aids, non-slip footwear, hip protectors, glasses
and hearing aids. Another area of personal intervention relates to the assessment of medi-
cations and their potential contribution to falls. 
Exercise programs are operated by a range of government and non-government organisa-
tions to increase strength, agility and balance in older persons. These programs aim to
improve a person’s ability to avoid falls, minimise the impact of falls or recover from them
more quickly. These programs also have benefits which extend to improving risks of other
health conditions, e.g. heart disease, osteoporosis. Education of older persons is an important
element in the fall-prevention strategy, encouraging awareness of the risks and the conse-
quences of falls. These messages are often incorporated in interactions with community
nurses, doctors, health centres, community activities and broader public health messages.
The activation of strategies in this area has been recent. It is expected that their impact will
be shown over the next 3–5 years, and they will be important as a greater proportion of
Australia’s population moves into this higher risk age group.
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Migrants bring to Australia their own unique health proÞles. The stringent health
requirements for immigration ensure that most migrants enjoy good health, if not better
health than the Australian-born population. This is known as the Ôhealthy migrant
effectÕ. Immigrants generally have lower death rates and hospitalisation rates, as well as
lower prevalence of certain lifestyle-related risk factors. There are also variations in the
health status of migrants according to birthplace, age, socioeconomic status, ßuency in
the English language and satisfaction with their job and life in Australia (Kliewer &
Jones 1998). However, Young (1992) has shown that as length of residence in Australia
increases the relative advantage that migrants have over Australian-born people
decreases. It is important to remove this age effect so that clear comparisons of country
of birth and length of residence can be made.
For purposes of health comparison, immigrants may be grouped into four broad
regional groupsÑthe United Kingdom and Ireland, Other Europe, Asia and Other
(Box 4.3). These regional groups exhibit signiÞcant variation in their age structures,
depending on the period in which they arrived. Migrants from Asia and Other regions,
for example, are mainly young, with large numbers aged between 20 and 44 years,
whereas migrants from the United Kingdom and Ireland and Other Europe have
median ages around 50 years. To enable meaningful comparisons to be made, variation
in the health status among these populations due to different age structures has been
adjusted by age-standardisation.
Mortality and morbidity
Mortality differentials are measured in terms of rate ratios. Table 4.8 compares the death
rates for the overseas-born with the Australian-born for the period 1997Ð1999 using
standardised mortality ratios. The standardised mortality ratios for all causes are lower
for both males and females in all four birthplace categories than in the Australian-born.
Death rates among migrants from the United Kingdom and Ireland were closest to the
rates for Australian-born people. In comparison, migrants from Asia and North Africa
have much lower standardised mortality ratios, with death rates 27% lower among
males and 20% lower among females than their Australian-born counterparts.
Box 4.3: Country of birth categories
Countries classified according to the Australian Standard Classification of Countries for
Social Statistics are grouped here into four birthplace groups:
United Kingdom and Ireland: Form a distinct category that is not easily separated in
population statistics.
Other Europe: Continental Europe including Eastern Europe, former USSR and Baltic
states.
Asia: North-East, South-East and Southern Asia, Middle East and Northern Africa.
Other: Southern Africa, the Americas, New Zealand and the Pacific Region. New Zealand
is the largest source country, constituting around 30% of this group.
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Mortality by cause of death shows signiÞcant variation between overseas-born
population groups. Table 4.8 shows that migrant groups in Australia have lower levels
of cardiovascular mortality compared with the Australian-born population. However,
studies show that rates tend to increase after the migrantsÕ Þrst 10 years of residence in
Australia (NHF 1996). Research also indicates that physical inactivity, a risk factor for
cardiovascular disease, is more common among people from southern, northern and
eastern Europe, Asia, the Middle East and North Africa, in comparison with their
Australian-born counterparts. Exercise levels are reported to increase with length of
stay in Australia (NHF 1996).
Deaths from cancers also show variation. Death rates from lung cancer for both males
and females born in the United Kingdom and Ireland, and for males born in Other
Europe were higher than for males and females born in Australia. Females born in the
Table 4.8: Mortality differentials by birthplace, people aged 15 years and over, 1997Ð1999
Males Females
Standardised mortality ratio(a)
(Australian-born = 1.0)
Standardised mortality ratio(a)
(Australian-born = 1.0)
Cause of death Deaths
UK and
Ireland
Other
Europe Asia Other Deaths
UK and
Ireland
Other
Europe Asia Other
Infectious 1,934 *0.76 1.05 *1.81 1.01 1,989  1.04  *1.27 *1.50 1.07
AIDS(b)  567  *0.74  *0.56  *0.62  *1.80 49  1.37 —  2.61  2.10
Cancers  59,726  *0.95  *0.88  *0.69  *0.85  46,178  *1.04  *0.86  *0.79  *0.94
Lung 13,811 *1.17 1.03 *0.79 *0.87 6,209  *1.43  *0.68  *0.77  1.07
Skin  2,552  *0.41  *0.33  *0.15  *0.53  1,369  *0.52  *0.32  *0.15  *0.72
Prostate  7,522  *0.82  *0.64  *0.45  *0.77  n.a.  n.a.  n.a.  n.a.  n.a.
Breast  n.a.  n.a.  n.a.  n.a.  n.a. 7,648  *1.11  *0.84  *0.71  1.04
Cervix  n.a.  n.a.  n.a.  n.a.  n.a. 772  0.96  0.88  1.28  *1.64
Diabetes mellitus 4,454 *0.84 *1.28 *1.39 0.91  4,344  *0.79  *1.62  *1.66  *1.27
Cardiovascular  75,420  *0.87  *0.85  *0.76  *0.86  80,090  *0.88  *0.83  *0.81  *0.90
Ischaemic  45,527  *0.89  *0.86  *0.75  *0.86  39,198  *0.89  *0.84  *0.76  *0.91
Stroke  14,650  *0.83  *0.83  *0.82  *0.87  22,043  *0.78  *0.78  *0.92  *0.90
Respiratory  16,018  *0.93  *0.62  *0.59  *0.73  13,147  *1.09  *0.49  *0.59  *0.85
Digestive  6,097  *0.87  *0.85  *0.72  *0.70  5,979  1.02 *0.75 *0.71 *0.79
Injury and 
poisoning 16,278  *0.92  *0.82  *0.56 1.01  7,001  *0.87 0.94 *0.81 1.04
Motor vehicle 4,071 0.87 *0.71 *0.60 0.97 1,552  *0.90  1.04  0.94  1.01
Suicide 6,221 0.91 *0.78 *0.40 1.01 1,574  *0.79  1.00 *0.72  1.08
Homicide 561 0.76 1.12 *1.38 1.19 282  0.65  1.29  1.15  0.97
All causes 197,022 *0.90 *0.84 *0.73 *0.85 179035 *0.95 *0.83 *0.80 *0.91
* Significantly different from 1.00 at the 5% level.
(a) The standardised mortality ratio (SMR) is a measure of death from a specific condition in the overseas-born population 
relative to the Australian-born population. The ratio for Australian-born is 1.00, and ratios that exceed 1.00 indicate a 
relatively greater mortality in that population than for the Australian-born. Likewise, ratios less than 1.00 indicate a 
lower death rate for a given cause of death than for the Australian-born.
(b) All deaths where AIDS is mentioned on the death certificate, regardless of whether it is identified as the primary 
cause of death.
Note: Age-standardised to the Australian population at 30 June 1991.
Source: AIHW National Mortality Database.
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United Kingdom and Ireland had higher death rates for breast cancer. Cervical cancer
death rates among women born in Asia and Other countries were higher than among
Australian-born women. However, Australian-born males had higher death rates for
prostate cancer than all other birthplace groups. Immigrants from all regions have
much lower death rates for skin cancer compared with Australian-born persons.
Smoking, diet, sun exposure, alcohol consumption, and utilisation of health care
services such as screening programs all play a role in creating the differentials related to
cancer risk. Development of culturally appropriate models of preventive healthcare
delivery are some of the most effective ways to overcome access and equity concerns
regarding the health of overseas-born people (DHFS & AIHW 1998b).
Table 4.9: Standardised hospital separation ratios by principal diagnosis, people aged 15 years 
and over, 1999Ð00
Males Females
Standardised hospital 
separation ratio(a)
(Australian-born = 1.0)
Standardised hospital 
separation ratio(a)
(Australian-born = 1.0)
Principal 
diagnosis Seps.
UK and
Ireland
Other
Europe Asia Other Seps.
UK and
Ireland
Other
Europe Asia Other
Infectious 62,641  *0.75  *0.70  *0.89  *0.89  23,520  *0.79  *0.68  *0.81  *0.90
Tuberculosis  62,641  *0.75  *0.70  *0.89  *0.89  23,520  *0.79  *0.68  *0.81  *0.90
Cancers  197,173  *0.70  *0.72  *0.53  *0.77  200,670  *0.80  *0.77  *0.67  *0.85
Skin  3,579  *0.42  *0.26  *0.06  *0.61  2,948  *0.50  *0.25  *0.15  *0.53
Lung 10,870 1.02 1.01 *0.71 0.90  5,489  *1.29  *0.69  *0.62  *0.79
Prostate  12,555  *0.68  *0.61  *0.44  *0.80  n.a.  n.a.  n.a.  n.a.  n.a.
Breast  n.a.  n.a.  n.a.  n.a.  n.a. 19,183 0.98 *0.81 *0.70 0.97
Cervix  n.a.  n.a.  n.a.  n.a.  n.a.  2,021  *0.85  *0.83  *1.42  *1.62
Diabetes mellitus  11,682  *0.69  *0.77  *0.60  *0.74  10,294  *0.58  *0.87  *0.66  *0.64
Mental  101,823  *0.66  *0.60  *0.36  *0.61  115,609  *0.79  *0.74  *0.33  *0.70
Cardiovascular  235,536  *0.78  *0.86  *0.75  *0.87  179,975  *0.82  *0.94  *0.76  *0.88
Ischaemic  100,147  *0.79  *0.82  *0.82  *0.90  53,030  *0.82  *0.88  *0.79  *0.94
Stroke  20,490  *0.71  *0.88  *0.81  *0.79 18,488 *0.78 *0.88 0.95 0.93
Respiratory  110,330  *0.77  *0.74  *0.62  *0.78  105,452  *0.81  *0.62  *0.57  *0.77
Asthma 5,234  *0.65  *0.38  *0.58  *0.87 11,238 *0.68 *0.42 *0.66 0.92
Digestive  304,357  *0.78  *0.78  *0.68  *0.79  330,384  *0.82  *0.80  *0.66  *0.80
Injury and 
poisoning  187,953  *0.73  *0.64  *0.45  *0.79 144,344 *0.83 *0.73 *0.56 *0.81
All causes 2,334,979  *0.73  *0.83  *0.73  *0.81 2,854,911  *0.77  *0.82  *0.75  *0.87
* Significantly different from 1.00 at the 5% level.
(a) The standardised hospital separation ratio is a relative measure of hospital use between the overseas-born and 
Australian-born populations. The ratio for Australian-born is 1.00, and ratios that exceed 1.00 indicate relatively greater 
hospital use in that population than for the Australian-born. Likewise, ratios less than 1.00 indicate less hospital use 
due to a given cause than for the Australian-born population.
Note: Age-standardised to the Australian population at 30 June 1991.
Source: AIHW National Morbidity Database.
AH2002 body 26-6  Page 196  Wednesday, June 26, 2002  6:28 PM
4 Population health  197
TRIM SIZE 175 mm Wide x 250 mm Deep
Standardised mortality ratios for diseases of the respiratory system and diseases of the
digestive system among people born overseas are lower than in the Australian-born
population across all regions, except for females born in the United Kingdom and
Ireland. Mortality rates for diabetes are higher for those born in Other Europe, Asia and
Other countries relative to the Australian-born population. The prevalence of diabetes
is high for certain immigrant groups compared with the Australian-born group,
particularly among people of European, PaciÞc Islander and Asian origin (DHAC &
AIHW 1999b). There is a need to provide information and education for effective self-
management of diabetes, since poor glycaemic control is common and more marked
among migrant groups (FECCA 1997).
Motor vehicle accident and suicide death rates are much higher among Australian-born
males compared with their overseas-born counterparts.
Morbidity is presented in terms of hospitalisations for various diseases. Hospitalisation
rates for 1999Ð00 for overseas-born people generally reßect the corresponding mortality
patterns, and indicate lower morbidity compared with Australian-born people for both
males and females (Table 4.9).
Asian-born migrants had the lowest hospitalisation rates in 1999Ð00. However, the
hospitalisation rates for tuberculosis among Asian-born migrants were much higher
than for other population groups. The hospitalisation rates for cancer of the cervix
among females from Asia (rate ratio 1.42) and Other countries (rate ratio 1.62) were also
higher than for the Australian-born females. Lung cancer among females born in the
United Kingdom and Ireland (rate ratio 1.29) was the only other principal diagnosis
among immigrant groups having a signiÞcantly higher rate than the Australian-born
population.
One of the most notable differences was for skin cancer, for which the hospitalisation
rate for the overseas-born population was less than half that of the Australian-born.
Among the overseas-born groups, the Asian-born males and females had less than one-
tenth of the rate of their Australian-born counterparts. Risk factors for skin cancer
include increased exposure to sun early in life, fair complexion, freckles and ease of
sunburn.
Contrary to the usual association between mortality and hospitalisation, there were
some contradictions. For example, for infectious diseases, Asian-born males had a lower
hospitalisation rate but a higher death rate than did Australian-born males. Similarly,
for diabetes mellitus, Asian and Other European-born groups had lower hospitalisation
rates and higher death rates than their Australian-born counterparts.
4.6 Aboriginal and Torres Strait Islander 
Australians
Aboriginal and Torres Strait Islander peoples suffer a greater burden of ill health than
other Australians. Indigenous people are more likely to experience disability and
reduced quality of life due to ill health, and die at younger ages (see ABS & AIHW 2001
for a detailed report). Census data indicate that the Indigenous population is
disadvantaged across a range of socioeconomic factors that have an impact on health
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outcomes. In 1996, Aboriginal and Torres Strait Islander peoples reported lower
incomes than other Australians, higher rates of unemployment, poorer education
outcomes and lower rates of home ownership (ABS 1998a). However, socioeconomic
status alone does not explain the variations in health status that exist between
Indigenous and other Australians. Health risk behaviours (e.g. smoking, alcohol
misuse) and other health risk factors (e.g. poor housing, exposure to violence) are also
important determinants of health, but even these do not fully explain the differential
burden of disease between population groups. Research suggests that the social
environment partially explains health outcomes, including the immediate local or
neighbourhood environment, social connections with friends, family and the
community, the extent of control and perceptions of mastery in the workplace and
wider society (ABS & AIHW 2001). A recent qualitative analysis of the health of the
Yolgnu Indigenous people of north-east Arnhem Land identiÞed the loss of control as
leading to hopelessness, the loss of the will to live and, ultimately, to high levels of
sickness and mortality (Trudgen 2000). Although the incomplete recording of
Indigenous status in administrative records and the experimental nature of Indigenous
population estimates remain barriers to the production of a true picture of Indigenous
health in Australia, an increased emphasis on the inclusion of an Indigenous identiÞer
in a range of surveys and administrative data sets is a key strategy in providing good-
quality information about the health of Indigenous Australians in the future
(ATSIHWIU 1997). Even though a comprehensive picture of Indigenous health is not
yet available, this section provides information on Aboriginal and Torres Strait Islander
peoples where data are of adequate reliability.
Coverage of the Indigenous status of people in birth and death registration is
improving in Australia, but the data collected from deaths registrations is not yet of
high enough quality in all States and Territories, and cannot provide national estimates.
Thus, data from Queensland, Western Australia, South Australia and the Northern
Territory are used to provide indicative information. 
Records of hospital use or general practice encounters cannot provide an understanding
of the prevalence of particular diseases in the Indigenous population, and the extent of
undercounting of Indigenous people in these data sources is not known. However,
information from hospitals and general practitioners provides broad indications of the
burden of chronic conditions and acute illnesses in comparison to the rest of the
Australian population. At present, there is no national data source for conditions
treated by primary healthcare providers such as Aboriginal health workers or nurses.
Other sources of data have the ability to identify Indigenous peoples such as the
Aboriginal Medical Services, disease registers and national household surveys with
supplementary Aboriginal and Torres Strait Islander samples. Such data sources
provide detailed information on speciÞc diseases, risk factors and living conditions.
The Indigenous population
The Indigenous population in Australia is estimated at 386,049, based on 1996 Census
Þgures, representing 2.1% of the total Australian population. Approximately 11% of
Indigenous people counted in the Census reported that they were of Torres Strait
Islander origin. More than half of all Indigenous people live in New South Wales and
Queensland, with the majority residing in urban areas. New South Wales has the
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greatest number of Indigenous people (110,000) and the Northern Territory has the
highest proportion of Indigenous people, at approximately 28% of all residents. Almost
20% of the total Indigenous population live in areas that are classiÞed as very remote,
compared with only 1% of the other Australian population. 
The Indigenous population is much younger than the general population. In 1996, the
median age for Indigenous people was 20 years, compared with a median age of
34 years for the total Australian population. Fertility is higher for the Aboriginal and
Torres Strait Islander populations and Indigenous women give birth at younger ages
than other Australian women. In the period 1996Ð1998, over 80% of Indigenous mothers
had babies before the age of 30. The comparable Þgure for other Australian mothers
was 54%. The estimated life expectancy at birth for Aboriginal and Torres Strait Islander
males and females is 19Ð20 years lower than for other Australians. In the period
1997Ð1999, the life expectancy at birth for the Indigenous population was estimated to
be 56 years for males and 63 years for females. In contrast, the life expectancy at birth
for all Australians was 76 years for males and 82 years for females. The 1997Ð1999
Indigenous life expectancies are similar to life expectancy for the total male population
in the period 1901Ð1910, and for the total female population in the period 1920Ð1922
(ABS 2000c).
Measures of health status
Mortality
In the four jurisdictions where mortality data are reliable, the 1997Ð1999 age-speciÞc
death rates for Aboriginal and Torres Strait Islander peoples were higher than the all-
Australian rates in every age group (Figure 4.12). The largest relative differences in age-
speciÞc death rates occurred for ages 35Ð54, where Indigenous rates were 5Ð6 times
higher than all-Australian rates. There were also substantial differences between the
25Ð34 and 55Ð64 age groups, where the Indigenous age-speciÞc death rates were 3Ð5
times higher than the all-Australian rates.
After adjusting for age difference, death rates were higher for Indigenous people than
for Australians as a whole for almost all causes of death. Diseases of the circulatory
system, deaths resulting from external causes (predominantly accidents, self-harm and
assault), neoplasm (cancers), respiratory diseases, and endocrine/metabolic diseases
accounted for the greatest numbers of deaths among Indigenous people in the period
1997Ð1999 (Table 4.10). These were also the leading causes of death among the
Australian population as a whole, accounting for about 75% of all deaths. However,
both Indigenous males and Indigenous females had higher death rates, and were more
likely to die at younger ages from these causes, than the general population.
Infant mortality rates reported here are produced from data provided by all States and
Territories for the 3-year period 1996Ð1998 (ABS & AIHW 2001). During that period,
babies of Indigenous mothers were twice as likely to die at birth and during the early
post-natal phase than babies born to other Australian mothers (Figure 4.13). Although it
is difÞcult to assess trends due to uncertainties about the extent to which women are
identiÞed as Indigenous in the perinatal collections, the overall infant mortality rate for
this period is similar to that for 1994Ð1996.
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Table 4.10: Deaths from selected causes in Indigenous people, 1997Ð1999(a)
Cause of death
Indigenous males Indigenous females
Number SMR(b) Number SMR(b)
Circulatory disease 750 3.1 568 2.8
External causes 496 2.8 205 3.3
Neoplasms 320 1.4 267 1.4
Respiratory diseases 206 4.1 159 4.0
Endocrine/metabolic conditions 169 7.2 202 9.4
Digestive diseases 119 4.7 96 4.9
Mental disorders 62 2.4 34 2.3
Genitourinary diseases 58 5.8 85 7.6
Infectious/parasitic diseases 58 4.2 45 5.4
Nervous system disorders 55 2.3 39 1.8
Ill-defined causes 76 6.0 43 5.3
All causes 2,515 2.9 1,864 2.9
(a) Data from Queensland, South Australia, Western Australia and the Northern Territory combined, based on year of 
registration.
(b) Standardised mortality ratio (SMR) = observed deaths divided by expected deaths, based on all-Australian age-, sex- 
and cause-specific rates.
Source: ABS Death Registration Database.
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Source: ABS Deaths Registration Database.
Figure 4.12: Age-specific death rates, 1997Ð1999
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The infant mortality rate for babies born to Torres Strait Islander mothers in
Queensland (21.8 per 1,000 births) was similar to that for babies born to Aboriginal
mothers (22.6 per 1,000 births), but twice as high as the rate for babies born to other
Australian mothers (10.6 per 1,000 births) (Perinatal Data Collection, Queensland
Health). A study that examined 10 years of Queensland perinatal data showed a higher
rate of neonatal mortality (death before 28 days) for babies of Torres Strait Islander
mothers, and suggested that this outcome for the babies may be related to the high
prevalence of diabetes among the mothers (Coory 2000).
Common diseases
In 1998 - 99, Indigenous people in every age group were more likely than other people to
be hospitalised for most diseases and conditions, indicating a higher occurrence of
illness at more acute levels (Figure 4.14). Excluding hospital episodes for dialysis, which
is the highest frequency treatment in hospital for Indigenous people, the main reasons
for Indigenous males to be hospitalised during this period were injuries and poisoning
(13% of Indigenous male hospital stays), respiratory disease (12%), digestive diseases
(7%) and mental and behavioural disorders (6%). For Indigenous females, pregnancy
and childbirth were common reasons for hospitalisation (17% of all hospital stays for
Indigenous women), followed by respiratory diseases (9%), injury and poisoning (8%)
and digestive diseases (5%).
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(a) Australian figures include Tasmania and Australian Capital Territory.
Note: Data for Tasmania and the ACT are not presented due to small numbers.
Source: AIHW National Perinatal Statistics Unit, perinatal collection, 2001.
Figure 4.13: Perinatal death rates, 1996Ð1998
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The six most frequent problems managed by GPs for Indigenous patients between April
1998 and December 2000 were upper respiratory infection, diabetes, hypertension,
asthma, acute bronchitis/broncholitis and acute otitis media/myringitis. This compares
with the six most common problems, hypertension, upper respiratory infection,
immunisation, depression, asthma and acute bronchitis/bronchiolitis managed for
other Australian patients (AIHW General Practice Statistics and ClassiÞcation Unit,
unpublished). 
Kidney disease is more prevalent among Indigenous people than among other
Australians. Deaths from kidney failure are eight times greater for Indigenous males
and Þve times greater for Indigenous females than for the general population. The most
common principal diagnosis in Australian hospitals in the period 1998 - 99 for both
Indigenous males and females was for Ôcare involving dialysisÕ, haemodialysis being
the most common procedure. Patients with end-stage renal disease may be admitted to
hospital several times a week for treatment. When compared with all patients receiving
haemodialysis, there were over six times as many procedures for Indigenous males and
eleven times as many for Indigenous females (ABS & AIHW 2001). 
People with end-stage renal disease may also require a kidney transplant for survival,
but Indigenous people are less likely than other people to receive a transplant. In 1999,
46% of all patients registered with the Australian and New Zealand Dialysis and
Transplant Registry had a functioning kidney transplant, but for Indigenous people
< 1 1–4 5–14 15–24 25–34 35–44 45–54 55–64 65–74 75+
0
100
200
300
400
500
600
700
800
900
1,000
1,100
Indigenous males
All Australian males
Indigenous females
All Australian females
Separations per 1,000 population
Age group
Note: Data are from public and most private hospitals.
Source: AIHW National Hospital Morbidity.
Figure 4.14: Hospital separation rates, all causes excluding dialysis, 1997Ð98
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identiÞed on this registry only 18% had functioning transplants. Some of the reasons
Indigenous patients are less likely to receive a transplant include having multiple
illnesses, being less likely to Þnd a suitable donor, or being too ill to undergo the
surgery required (ABS & AIHW 2001). 
Diabetes is a signiÞcant health problem for Aboriginal and Torres Strait Islander
peoples. Indigenous people who have Type 2 diabetes often develop the disease earlier
than other Australians and often die at younger ages. In 1995, the reported rate of
diabetes was four times higher among Indigenous people aged 15 years and over living
in metropolitan and rural areas than for the general population (Figure 4.15) (ABS
1999c). In 1998Ð99, there were 10Ð15 times more hospital separations for Indigenous
patients with Type 2 diabetes than occurred for other patients (ABS & AIHW 2001).
Diabetes can cause serious complications such as cardiovascular disease, kidney
disease, nerve damage, eye damage, ulceration and gangrene. There are a number of
health risk factors associated with diabetes, including obesity, poor nutrition, lack of
physical activity and, as yet, unspeciÞed genetic factors. Type 1 diabetes (early onset
and insulin-dependent) is relatively rare in the Indigenous population, but there is a
very high prevalence of Type 2 diabetes (late onset, non-insulin-dependent). In 1998Ð99
about 75% of Aboriginal and Torres Strait Islander peoples who received hospital
treatment for diabetes had Type 2 diabetes.
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2. Some data values too small to graph.
Source: ABS National Health Survey 1995.
Figure 4.15: Reported diabetes, 1995
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The number of deaths associated with diabetes provides an indication of the differential
burden of the disease in the Indigenous population. Age-speciÞc death rates for
1997Ð1999, where diabetes was recorded as an underlying cause in those jurisdictions
where Indigenous identiÞcation in mortality data is reliable, show that, from age 25
onwards, the death rate for diabetes in the Indigenous population is higher than that
for the total population (Figure 4.16). This reßects the earlier onset of diabetes in this
population group. Causes of death where diabetes was an underlying cause included
ischaemic heart disease (41% of Indigenous deaths where diabetes was an underlying
cause), other forms of heart disease (26%) and renal disease (38%). The earlier onset of
Type 2 diabetes among Indigenous people has serious implications for diabetic
complications (OÕDea 1992).
Mental health
At present, there are no national data sources which provide information about the
incidence or prevalence of mental disorder for Aboriginal and Torres Strait Islander
peoples in the community. Data on hospitalisation and mortality due to serious mental
disorders and illnesses are the main sources of information that can provide an
indication of mental health conditions in the Indigenous population. 
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Source: ABS Deaths Registration Database.
Figure 4.16: Diabetes mellitus age-specific death rates, 1997Ð1999
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In 1998Ð99, Aboriginal and Torres Strait Islander peoples were hospitalised for
conditions classiÞed as Ômental and behavioural disordersÕ at a higher rate than that
experienced by the general population. The rate of hospitalisation for Indigenous
people diagnosed with mental disorders due to psychoactive substance use and organic
disorders such as dementia was three times higher than the rate for the all-Australian
population. The rate for psychotic disorders was twice as high (ABS & AIHW 2001).
Mortality data for 1997Ð1999, from Queensland, Western Australia, South Australia and
the Northern Territory combined, show that there were over twice as many deaths
associated with mental disorders among Indigenous people than for other Australians.
The majority of these deaths in the Indigenous population (78%) were attributed to
mental disorders due to psychoactive substance use. There were Þve times more deaths
from assault for Indigenous males, and ten times as many for Indigenous females, than
for males and females in the general population. 
Rates of intentional injury, whether self-inßicted or caused by assault, may be an
indicator of psychological illness and distress in the community. The rate of
hospitalisation for Indigenous males due to assault was six times higher than the
general population, and for Indigenous females almost 19 times higher. The rate of
hospitalisation due to self-harm for both Indigenous males and Indigenous females was
twice as high as that for the general population. 
Suicide accounted for almost three times as many deaths for Indigenous males and
twice as many deaths for Indigenous females than for the general population. The
highest age-speciÞc death rate from suicide was 108 per 100,000 Indigenous males in
the 15Ð24 age group compared with 27 per 100,000 for males in the same age group in
the general population. In the 25Ð34 age group, deaths by suicide occurred at a rate of
96 per 100,000 Indigenous males compared with 38 per 100,000 for all males. For
Indigenous females, the highest rate was 18 per 100,000 in the 15Ð24 age group
compared with 6 per 100,000 for all females.
Oral health
Information on the oral health of Indigenous adults has been limited to data from the
Commonwealth Dental Health Program which ceased in 1996, and data from a small
sample of Indigenous people in the 1994Ð1996 National Dental Telephone Interview
Surveys (AIHW DSRU 1995; AIHW: Brennan & Carter 1998). While indicative only,
these data suggested that dental problems, tooth extraction and edentulism are more
common among Indigenous people than other Australians. A more recent study of oral
health in the Anangu Pitjantjatjara lands of South Australia found that the children had
a high and increasing prevalence of dental caries in their deciduous teeth, and that
edentulism among adults had increased over the last decade, from no recorded cases in
1987, to ten cases by the year 2000 (Endean et al. forthcoming). There is an association
between periodontal disease and diabetes (Taylor et al. 1996) and all of the edentulous
adults on the Anangu Pitjantjatjara lands also had a diagnosis of diabetes (Endean et al.
forthcoming). 
The oral health of Indigenous children is poorer than that of other children.
Comparative data from the 1998 Child Dental Health Survey for children in the
Northern Territory show that Indigenous children are more likely than other children to
have decayed, missing or Þlled deciduous teeth (ÔbabyÕ teeth). Between the ages of 6
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and 13, there is a decline in the proportion of all children with healthy permanent teeth,
but this decline is more pronounced among Indigenous children than other children.
Data for New South Wales, although based on small numbers of Indigenous children,
show a similar though less marked pattern (AIHW Dental Statistics and Research Unit,
unpublished data). 
Health risk factors
Low birthweight
In the period 1996Ð1998, babies of Indigenous mothers were nearly twice as likely as
babies of other Australian mothers to be of low birthweight (i.e. a weight of less than
2,500 grams at birth). Low birthweight may be a result of premature birth, foetal growth
retardation, or a combination of the two (Alberman 1994). Factors inßuencing a babyÕs
birthweight may include socioeconomic disadvantage, the size and age of the mother,
the number of babies previously carried, the motherÕs nutritional status, smoking and
other risk behaviours, illness during pregnancy, and the duration of pregnancy. Low-
birthweight babies are more prone to ill health during childhood, and may be more
vulnerable to illness, such as kidney disease, in adulthood (Alberman 1994; Barker &
Clark 1997). 
Obesity
There is a greater level of obesity among Aboriginal and Torres Strait Islander adults
than in the general Australian population, based on body mass index, putting this
population group at greater risk for kidney disease, Type 2 diabetes and cardiovascular
disease. Results of two national surveys, the 1994 National Aboriginal and Torres Strait
Islander Survey and the 1995 National Nutrition Survey, provide comparative data on
obesity for Indigenous and other Australian adults (Figure 4.17). Approximately 25% of
adult Indigenous males and 29% of adult Indigenous females were classiÞed as obese
compared to about 19% of both other Australian adult males and adult females.
Poor nutrition
Many Aboriginal and Torres Strait Islander peoples do not have access to a healthy diet.
Indigenous people who live in remote areas do not have the same opportunities as
people living in metropolitan and regional centres to obtain affordable, healthy food. In
areas where healthy food is available, factors such as competing priorities for limited
family incomes, restricted access to traditional foods, lack of knowledge of the
nutritional value of certain foods and lack of culturally appropriate information on
healthy food can lead to inadequate nutrition (Public Health Services 2001). 
The diet of many Aboriginal and Torres Strait Islander peoples has undergone rapid
change, from a Þbre-rich, high protein, low saturated fat ÔtraditionalÕ diet to one which
is high in reÞned carbohydrates and saturated fats. This kind of diet creates a
predisposition to obesity, Type 2 diabetes, cardiovascular disease and renal disease
(NHMRC 2000; OÕDea 1992), conditions which, as noted above, are prevalent in the
Indigenous population. Maternal undernutrition is a factor linked to low birthweight
and a risk factor for infant death and ill health in childhood, and may also predispose
babies to cardiovascular diseases and Type 2 diabetes in later life (Barker & Clark 1997). 
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Alcohol and other drug use
Several surveys have shown that Indigenous people are less likely than other people to
drink alcohol, but those who do so are more likely to consume it at hazardous levels
(ABS & AIHW 2001). The hazardous use of alcohol is related to conditions such as
alcohol-dependence syndrome, alcoholic liver disease, high blood pressure, stroke and
some cancers (Anderson 1996). Alcohol is frequently a contributing factor to injuries,
accidents, assault and self-harm (Unwin et al. 1994), and may contribute to social
problems such as family breakdown, domestic violence, and Þnancial and legal
problems (Davis 1998).
The most recent national data on alcohol consumption among Indigenous people come
from the 2001 National Drug Strategy Household Survey (NDSHS). The survey found
that 20% of Indigenous peoples drank at levels that were risky or high risk for long-
term harm, compared with 10% of other Australians. Further, 49% of Indigenous people
compared with 34% of other Australians had at least one drinking episode in the past
year that was risky or high risk for short-term harm.
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Figure 4.17: Obesity in adults, Australia 1994, 1995
AH2002 body 26-6  Page 207  Wednesday, June 26, 2002  6:28 PM
208  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
Cigarette smoking is associated with the increased incidence of and mortality from
various types of cancer, including lung, cervical, bladder and pancreatic cancers,
coronary heart disease, stroke, chronic respiratory tract diseases, and pregnancy-related
conditions (English et al. 1995). Data from the 2001 NDSHS show that there is a high
prevalence of smoking among Aboriginal and Torres Strait Islander peoples, with the
rate being approximately twice that for other Australians, placing them at an increased
risk for diseases and conditions described above.
Indigenous people are also at risk of ill health through the use of illicit substances such
as marijuana, heroin, amphetamines and inhalants (petrol, glue, aerosols). The 2001
NDSHS found that the rates of recent illicit drug use among Indigenous people were
higher than for other Australians: 32% of Aboriginal and Torres Strait Islander peoples
aged 14 years and over had used an illicit drug in 2001 compared with 17% of other
Australians. Most of this difference was associated with cannabis use (28% for
Aboriginal and Torres Strait Islander peoples compared with 13% for other
Australians), although recent use of any illicit drug other than cannabis was also
signiÞcantly higher (13% compared with 8% for other Australians).
There are no reliable national data collected on petrol snifÞng, but case studies indicate
that the practice continues to be a major problem in some Indigenous communities.
Petrol snifÞng causes confusion, aggression, lack of coordination, hallucinations,
respiratory problems and chronic disability including mental impairment. It is practised
mainly by young people, but the problems associated with it extend to families and the
wider community (dÕAbbs & MacLean 2000).
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One or more bedrooms spare
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Source: Australian Housing Survey, 1999.
Figure 4.18: Housing utilisation, 1999
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Housing and living conditions
Housing has been identiÞed as a major factor affecting the health of Aboriginal and
Torres Strait Islander peoples. Many Indigenous people live in housing which does not
satisfy the basic requirements of shelter, safe drinking water and adequate sewerage
provisionsÑconditions which are considered unacceptable by general Australian
standards (Neutze 1998).
Overcrowded living conditions increase the risk of the spread of infectious diseases
such as meningococcal disease, rheumatic fever, tuberculosis and respiratory infections
(Waters 2001). Aboriginal and Torres Strait Islander peoples experience overcrowded
living conditions more commonly than other Australians. Results from the 1999
Australian Housing Survey showed that 13% of Indigenous households in urban areas
and major regional centres did not have enough bedrooms to meet their needs,
compared with 4% of other Australian households (Figure 4.18) (ABS 2001a).
Results from the 1999 Australian Housing Survey also indicated that Indigenous
households in urban areas and major regional centres were almost three times more
likely than other households to report their homes to be in high need of repair (19%
compared with 7%). A higher proportion of other Australian households reported no
need for repairs (44% compared with 34%) (Figure 4.19). The 1999 Community Housing
and Infrastructure Needs Survey (CHINS) also investigated the number and condition
of houses in discrete Indigenous communities in urban, rural and remote areas.
Findings from the CHINS indicate that the housing conditions of Indigenous people are
generally poorer in rural and remote communities than in urban areas, with a third of
the 14,667 community-owned or managed permanent dwellings in these communities
requiring major repairs (23%) or replacement (10%) (ABS 2000d).
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Source: Australian Housing Survey 1999.
Figure 4.19: Need for repairs to dwelling, 1999
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Inadequate and poorly maintained infrastructure adversely affects many Indigenous
communities, particularly those in remote and rural areas of Australia. It is recognised
that improving basic environmental health conditions, such as access to clean water and
adequate sanitation, are critical issues that need to be confronted if better health
outcomes for Aboriginal and Torres Strait Islander peoples living in these communities
are to be achieved.
Water is a basic necessity, and ready access to safe drinking water is an essential public
health requirement. Regular water testing and treatment are necessary to ensure that
water is free from microorganisms hazardous to human health (NHMRC 2001). The
1999 CHINS collected information on water treatment and testing from a sample of 233
discrete Indigenous communities that were not connected to a town water supply. Of
these, 64 communities (representing a population of approximately 11,100 people) had
not had their water tested in the 12 months before the survey. Of those tested, 58
communities (representing a population of approximately 25,300 people) had failed
water testing at least once in the same period. Chlorination was the most common type
of treatment reported. 
Most discrete Indigenous communities had wastewater and sewerage systems, but a
high proportion reported problems with these systems and a large number of
communities reported unsafe ponding; 204 communities reported sewage overßows or
leakage in the 12 months before the 1999 CHINS, some indicating chronic sewerage
problems. Methods of wastewater disposal from bathrooms, laundries and kitchens were
considered to be undesirable by Australian public health authorities in 41 communities.
Ponding, where large pools of stagnant water collect and remain for more than a week,
is commonly caused by rain, overßow from blocked drains; and sewage overßows and
leakage. It is a major health risk associated with the increased risk of vectorborne
diseases (diseases spread by insects such as mosquitoes). Fifty-six communities,
representing a population of approximately 13,500 people, reported problems with
ponding on Þve or more occasions during the 12 months before the 1999 survey. 
Table 4.11: Water testing, Indigenous communities not connected to town water supply(a)
Water tested
Community population
Total
Reported
population50–199 200 or more
Failed testing 14 44 58 25,322
Did not fail testing 47 53 100 36,918
All communities with water testing(b) 68 101 169 65,829
Water not tested 50 14 64 11,135
Total communities 118 115 233 76,964
(a) Communities with a population of 50 or more.
(b) Includes ‘not stated’.
Source: Community Housing and Infrastructure Needs Survey 1999.
AH2002 body 26-6  Page 210  Wednesday, June 26, 2002  6:28 PM
4 Population health  211
TRIM SIZE 175 mm Wide x 250 mm Deep
Almost all (93%) discrete communities reported some form of organised rubbish
disposal to the 1999 CHINS. Fenced or unfenced tips located on community land were
the most commonly reported form of rubbish disposal (62% of communities). A further
18% used rubbish tips located outside community land, and 10% of communities
incinerated their rubbish.
Health service provision, access and use
In 1998Ð99, an estimated $1,245 million was spent on health services by, and for,
Aboriginal and Torres Strait Islander peoples (AIHW 2001c). This amount represents
2.6% of total health expenditure by Commonwealth, State and local governments as
well as expenditure from private sources such as private health insurance and out-of-
pocket expenses. Per capita, $3,065 was spent on each Indigenous person, compared
with $2,518 for each other Australian.
Indigenous people experienced lower levels of access to health services than the general
population, even though they were twice as likely to be hospitalised. Compared with
the general population, Indigenous people are nearly twice as likely to live outside
urban centres and are therefore more likely to live further from a range of health
services and facilities. A considerable number of the Indigenous communities included
in the 1999 CHINS did not receive visits from a wide range of health professionals.
Other factors which were likely to inßuence the level at which Indigenous people
accessed health services were the socioeconomic status of patients, the availability of
Box 4.4: Ratio of health expenditure for Indigenous and non-Indigenous 
Australians
Examining expenditure on health services is one way of understanding the way in which
health services are delivered and used. Expenditure reflects not only differing client needs,
but differing levels of access and modes of delivery that have developed in response to var-
ious policies and strategies. Most government expenditure on Indigenous health is admin-
istered through local and State governments. 
In 1998–99, an estimated $1,245 million was spent on health services by, and for, Aborig-
inal and Torres Strait Islander peoples (AIHW 2001c). This amount represents 2.6% of
health expenditure for all Australians, but is an estimate only, largely because of the
incomplete identification of Indigenous people in many administrative data sets. However,
patterns of expenditure from available data indicate clear differences between the Indige-
nous and other Australian populations in the way that health services are accessed.
Greater amounts were spent on Aboriginal and Torres Strait Islander peoples in relation to
community and public health services, patient transport, public hospital care (both
admitted and non-admitted patient services), and mental health institutions. Lesser
amounts were spent through Medicare, the Pharmaceutical Benefits Scheme, high-level
residential aged care and private health services than for other Australians. 
Overall, for each dollar spent on health services for other Australians, $1.22 was spent on
health services for Aboriginal and Torres Strait Islander peoples. Per capita, $3,065 was
spent on each Indigenous person, compared with $2,518 for each other Australian. 
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transport, the ability to speak English, and cultural factors such as the availability of
same-sex Indigenous health workers (ABS & AIHW 2001).
4.7 Socioeconomically disadvantaged people
The association between socioeconomic disadvantage and health has been widely
researched in Australia and overseas (AIHW: Mathers 1994b, 1995, 1996; Turrell et al.
1999). The reason for the relationship is not always clear; it varies between speciÞc
conditions and is confounded by other risk factors. The mechanisms by which
socioeconomic status inßuence health status are many and varied. However, those most
often postulated are diet, health behaviour, education, access to health services (both
preventive and treatment), occupational exposures, quality of housing and psychosocial
factors. Regardless of the mechanism, Sainsbury & Harris (2001:117) summarise the
position by stating that Ôwealthy people are healthy people; poor people have poor
healthÕ. But it should be recognised that for some risk factors and some diseases there is
a social gradient. This gradient can be attenuated by adopting healthy behaviours
across all levels.
There are a number of elements that contribute to socioeconomic status, including
income, level of education, employment status and occupation. These elements by
themselves, however, do not provide an ideal measure, and their use often depends on
the age group being analysed. Health information by socioeconomically graded areas of
residence provides a useful way to analyse information. The most common measure of
socioeconomic status by area of residence is the Index of Relative Socioeconomic
Disadvantage, derived by the ABS from population census data (AIHW 2000).
Risk factors
The relationship between socioeconomic disadvantage as a risk factor for ill health and its
interaction with other risk factors has already been discussed in Chapter 3, which points
out that these risk factors are themselves frequently associated with broader social,
economic and cultural determinants. However, it is important to recall that when
compared with people of high socioeconomic status, those from lower socioeconomic
groups are more likely to smoke and smoke regularly, report less physical activity during
their leisure time, and be more overweight or obese, all of which are signiÞcant risk
factors for a number of the major health conditions, e.g. cardiovascular disease,
respiratory diseases. This knowledge is gained from national and State-speciÞc health
surveys such as those conducted in New South Wales which show that in 1997 and 1998
rates of current smoking increased with lower socioeconomic status (Moore & Jorm 2001).
Self-reported health status
The 1995 National Health Survey showed that on average 17% of people rated their
health as fair or poor (rather than good, very good or excellent). This varied with
socioeconomic statusÑ22% of persons in the most disadvantaged quintile reported fair
or poor health, compared with 12% of persons in the least disadvantaged quintile
(ABS 1999b).
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Major illnesses and service use
Of the Þfteen most common major illnesses recorded in the 1995 National Health
Survey, Þve were more common among the most disadvantaged personsÑarthritis,
asthma, bronchitis/emphysema, ulcer and diabetes. The survey also found that the
more socioeconomically disadvantaged made greater use of doctors and outpatient/
casualty services, but were less likely to use preventive health services (ABS 1999b).
Mortality
The relationship between mortality and socioeconomic disadvantage has been well
documented in Australia. Mathers et al. found that people with low socioeconomic
status have higher rates of mortality (AIHW: Mathers et al. 1999). Mortality burden
(years of life lost due to premature mortality) in the most disadvantaged quintile is 41%
higher for males and 26% higher for females compared with the least disadvantaged
quintile. In 1997 and 1998 males in the most disadvantaged quintile had 12% higher
mortality compared to all Australian males, and 30% higher than the males in the least
disadvantaged quintile. For females, those in the most disadvantaged quintile had a
16% higher level of mortality than those in the least disadvantaged quintile
(ABS 1999b).
Turrell and Mathers (2000) also found signiÞcantly higher mortality among males and
females aged 25Ð64 years in the most disadvantaged quintile. Males had more than 40%
excess mortality for diseases of the respiratory system (including chronic lung disease),
and females had more than 70% excess mortality for diseases of the circulatory system
(including coronary heart disease), diseases of the digestive system, and injury (in
particular motor vehicle accidents and suicide).
In interpreting these results, note that the Index of Relative Socioeconomic
Disadvantage relates to the average disadvantage of all people living in a geographic
area and therefore these measures of inequality will, in most cases, be understated. 
Life expectancy and burden of disease
Vos et al. (2001), examining Victorian mortality data, has shown an association between
low socioeconomic status and lower life expectancy at birth. The burden of premature
mortality was also signiÞcantly higher among socioeconomically disadvantaged
people. Years of life lost due to premature mortality among the most disadvantaged
socioeconomic quintile in this study was 30% higher than for the least disadvantaged,
while in women this difference was 19%. Large socioeconomic differences were
observed for such causes of death as ischaemic heart disease, chronic obstructive
pulmonary disease, diabetes, asthma and road trafÞc accidents. 
An earlier study (AIHW: Mathers et al. 1999) found that men in the bottom quintile of
socioeconomic disadvantage had a 40% higher chance of dying between ages 25 and 65
than men in the top quintile. There was a 3.6 year gap in life expectancy at birth for
males between the bottom and top quintiles, and a 1.9 year gap for females. An
especially high inequality was observed for those persons with a mental illness, with
women being slightly more disadvantaged than men.
AH2002 body 26-6  Page 213  Wednesday, June 26, 2002  6:28 PM
214  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
4.8 Rural and remote people
Australia has one of the most urbanised populations in the world, with about 70% of
people living in capital cities or major metropolitan areas. Of the remainder, about 45%
live in regional cities or large country or coastal towns and surrounding agricultural
areas, about 45% live in small country or coastal towns and their surrounding
agricultural areas, and about 10% live in remote areas.
Non-metropolitan areas include not only inland agricultural and remote areas, but also
coastal areas. In fact, of the people who live outside the major cities but not in remote
areas, just under 50% live within 80 km of the coast (Garnaut et al. 2001).
Between 1986 and 1996, population growth across the country was uneven. While the
population of metropolitan areas grew by 15%, that of coastal populations grew by over
20%, and the population of inland Australia grew by less than 8% (larger centres
showed the strongest growth; small centres, especially in remote areas, showed smaller
growth or even a decline) (Garnaut et al. 2001). 
Health service access, health risk factors and health status show differences between
groups in different geographic regions, although they do not apply uniformly to all
groups of people, and the reasons for those differences are not always clear-cut. Changes
in the size of populations, for instance, could affect access to services and opportunities
for employment in some areas, potentially affecting health differentials. This section
further describes some of these differences and the issues associated with them.
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Note: Data presented by ASGC Remoteness category.
Source: AIHW, derived from ABS Statistical Local Area population estimates.
Figure 4.20: Age distribution for people living in Major Cities*, Inner Regional* and 
Very Remote* areas, 1996
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Characteristics of regional and remote populations
The populations in each area differ in various ways, and their characteristics explain, or
provide better insight into, many of the apparent health differences. For example,
people who live in rural and remote areas are more likely to be Indigenous, with about
40% of the Very Remote* area population being Indigenous, compared with 1% in
Major Cities* (Very Remote* and Major Cities* are deÞned according to the ABS, ASGC
Remoteness Structure). Rural populations tend to have proportionally more children
but fewer young adults (Figure 4.20), and remote area populations, with their
signiÞcant Indigenous populations and mining communities, tend to have even more
children, proportionally more people of working age (and more males) but fewer older
people.
People who live in rural and remote areas generally have lower levels of education, at
least in part as a consequence of the relatively low supply of employment requiring
skilled or professional labour. Household incomes in rural and remote areas are also
lower than in metropolitan areas (Garnaut et al. 2001).
Access to commodities and services
Coupled with lower incomes for people in regional and remote areas, the price of
commodities such as food and petrol is higher. In rural and remote communities, the
cost of basic food is frequently up to 10% higher (and sometimes up to 23% higher) than
in metropolitan and regional centres. In addition, stores in remote locations are less
likely to have basic food items or healthy food choices (such as fresh fruit and
vegetables), and are frequently a considerable distance from residents. The price of less
healthy food choices and tobacco increases with remoteness also, but less so than for
healthy choices (ABS 1990; Public Health Services 2001).
Access to health services for people living in regional Australia is inßuenced by the
lower number of GPs (but higher number of nurses), lower rates of bulk billing
(AMWAC 2000), and lower levels of access to specialists and major hospitals as a
consequence of longer travel distances (AIHW: Strong et al. 1998).
Risk factors
Some of the major risk factors for poor health for which rural data are available are
physical inactivity, overweight, smoking, hazardous or harmful alcohol consumption
and high blood pressure. Poor nutrition is also a risk factor, but is not discussed in this
section because little information is available. The geographic areas used here to describe
the prevalence of risk factors are deÞned by the RRMA classiÞcation (see Box 4.5).
In 1995, the rate of physical inactivity during leisure time was higher among people
living in Remote areas of Australia (37%) than for people living in Metropolitan (34%)
and Rural (32%) areas. In the same year, 53% of women from Remote areas were
overweight compared with 47% of women from Metropolitan and Rural areas. The
pattern was the same for men, but the differences were smaller (62% in Metropolitan
and 65% in Rural and Remote areas were overweight). People from Rural and Remote
areas (26%) were more likely to be regular smokers than people from Metropolitan
areas (21%) (AIHW 2001d).
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Box 4.5: Geographic classifications: RRMA, ARIA and ASGC Remoteness
Until recently, rurality had been described almost exclusively by the seven-level Rural,
Remote and Metropolitan Areas (RRMA) classification. This classification is based on the
size of the local population centre as well as a measure of remoteness (DPIE & DHSH
1994).
Work by the National Key Centre for the Social Applications of Geographical Information
Systems (GISCA) from 1996 saw the development of improved measures of remoteness:
the Accessibility/Remoteness Index of Australia (ARIA), a continuous variable with a
remoteness score of 0–12; and its successor, ARIA+ (similar to ARIA, but with a remote-
ness score of 0–15).
From ARIA, the Department of Health and Ageing developed its five-level classification
(also called ARIA), and from ARIA+, ABS developed its six-level classification, the Aus-
tralian Standard Geographic Classification (ASGC) Remoteness Structure (DHAC &
GISCA 1999; ABS 2001e).
Remoteness classifications
RRMA DoHA ARIA ASGC Remoteness
Broad 
category
Fine 
category
Population
(000,000) % Category
Population
(000,000) % Category
Population
(000,000) %
Metropolitan
Capital Cities 11.6 64
Highly 
Accessible 14.9 81
Major 
Cities* 12.1 66
Other
Metropolitan
centres 1.4 8
Rural
Large Rural 
centres 1.1 6 Accessible 2.2 12
Inner 
Regional* 3.8 21
Small Rural 
centres 1.2 7
Outer 
Regional* 2.0 11
Other Rural 
areas 2.4 13
Moderately 
Accessible 0.8 4
Remote
Remote 
centres 0.2 1 Remote 0.2 1 Remote* 0.3 0.3
Other Remote 
areas 0.3 2
Very 
Remote 0.2 1
Very 
Remote* 0.2 0.2
Migratory* < 0.1
Note: This table is a rough guide only; the various classes in each classification are not equivalent.
Source: AIHW Population Estimates.
In this section, both the RRMA and ASGC Remoteness classifications have been used to
describe aspects of rural health. Where terms refer to a formal classification, capital letters
are used (e.g. Capital Cities), otherwise no capitals are used (e.g. cities). To avoid confu-
sion between the similar terms in both the formal classifications, ASGC terms also have
an asterisk (e.g. Remote*).
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Compared with their Metropolitan counterparts, Rural/Remote area males and females
aged 20Ð29 were twice as likely to consume alcohol in hazardous or harmful quantities
(unpublished data from the 1998 National Drug Strategy Household Survey). There
were no clear differences between these areas for people in other age groups.
The prevalence of high blood pressure was similar across geographic areas, with
approximately 22% of women and 29Ð30% of men reporting high blood pressure in all
areas (AIHW 2001d).
With greater prevalence of smoking, lower rates of physical activity and more restricted
access to healthy food, people in rural and remote Australia are likely to be at greater
risk of cardiovascular disease, the leading cause of death in Australia.
On a positive note, it has previously been reported that people living in Rural areas
were substantially less likely to report unhappiness (AIHW: Mathers 1994a), and results
from the Australian longitudinal study on womenÕs health have conÞrmed that women
from Rural and Remote areas report lower levels of stress than women from
Metropolitan areas (Brown et al. 1999).
Health status 
A detailed description of a range of health issues is restricted because some of the rural
populations are small and interpreting data items from some data sets leads to dubious
conclusions. For the purposes of this description, the AIHW National Mortality
Database is currently the most useful. 
Data pertaining to hospital admissions is also a rich source of information, but
differences in admission practices between geographic areas can make interpretation
difÞcult. For example, admission may reßect precaution rather than urgency, especially
if the patient lives a long way from the hospital. In Remote areas, hospital admission for
medical intervention occurs at 1.5 to 1.8 times the rate that it does in Metropolitan areas,
for surgical intervention at 0.9 times the rate, and for Ôother reasonsÕ at 0.7 times the rate
(AIHW: Strong et al. 1998). Although it is clear that differences in hospitalisation exist
across geographic areas, the interpretation of these statistics is ambiguous.
Inequality in life expectancy
Life expectancy is one of the most commonly used summary measures of mortality. It
indicates the number of years a person would live, on average, if subject to prevailing
death rates.
In 1986, the average life expectancy for Australian males was 73 years and for females
79 years. By 1999, life expectancy had risen to almost 76 years for males and 82 years for
females. There is, however, considerable difference according to areas of residence.
Figure 4.21 shows that males and females living in Metropolitan areas have the highest
life expectancy, those in Rural areas the next highest and those in Remote areas the
lowest life expectancy. This pattern remained consistent throughout the period between
1986 and 1999. Differences between Metropolitan and Rural areas were small compared
with the differences between Rural and Remote areas.
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Consistently throughout the period from 1986 to 1999, Metropolitan area males and
females were expected to outlive their counterparts in Remote areas by 3 years and
those in Rural areas by less than a year, suggesting the persistence of inequalities over
time across the three regions. Although this comparison of life expectancy over time is
valid, care should be taken when comparing between regions; the effects of Indigenous
mortality and mortality of older people, discussed in the next section, have not been
excluded from this measure. 
Mortality
Overall, average death rates in rural and especially remote areas are higher than in
metropolitan areas. There is, however, considerable variation within areas (AIHW:
Strong et al. 1998). A large proportion of these higher rates appear to be due to the
substantial inßuence of high Indigenous death rates in these populations.
Uncertainty about the accuracy of identiÞcation of Indigenous deaths prevents in-depth
reporting of Indigenous mortality in rural and remote areas. However, for other
Australians, death rates appear similar or slightly higher in rural areas, and similar or
slightly lower in remote areas compared with metropolitan areas.
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Source: AIHW National Mortality Database.
Figure 4.21: Trends in life expectancy at birth, 1986 to 1999
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This masks differences in certain age groups. For example, death rates for older people
(generally older than 65 years, not including Indigenous people) in remote areas are
lower than those for their less remote (including rural) counterparts. This effect is
strong, appears consistent and has yet to be investigated. It may be that, with declining
health, older people move to larger population centres which have more facilities, and
eventually die there, affecting death rates in both areas. 
For the population younger than 65 years of age (not including Indigenous people), the
reverse is the case. Death rates for males in Regional* and Remote* areas appear to be
10Ð20% higher than in Major Cities*, and for females they appear to be approximately
10% higher.
To disentangle the effect of remoteness from these issues, it may be more informative to
report cause-speciÞc death rates for people (excluding Indigenous people) younger
than 65 years only. The extent to which the mortality of Indigenous people can be
reported is restricted by potential error associated with data quality and small numbers.
For males (excluding Indigenous males) younger than 65 years, mortality for the four
major causes of death shown in Table 4.12 tends to be higher in Regional* areas, with
rates in Remote* areas also higher than in Major Cities* (except for cancer) but not
necessarily higher than in Regional* areas (except for injury, where rates continue to
increase with remoteness). For females (excluding Indigenous females) younger than
65 years, rates for cancer and respiratory disease are largely indistinguishable across
geographic areas, whereas rates for diseases of the circulatory system and injury were
higher in Regional* areas, but not signiÞcantly different between Remote* areas and
Major Cities*.
Table 4.12: Death rates attributed to four major causes, people under 65 (excluding Indigenous 
people) 1997Ð1999
Cause Major City*
Inner
Regional*
Outer
Regional* Remote* Very Remote*
Males
Cancers 62 †71 †71 63 64
Cardiovascular disease 46 †51 †54 †56 †57
Respiratory disease 6 †7 †9 9 †12
Injury 48 †62 †67 †75 †85
Females
Cancers 55 57 56 50 56
Cardiovascular disease 16 †19 †21 20 24
Respiratory disease 5 6 6 †9 9
Injury 15 †20 18 18 19
†
 indicates rates are significantly different from those in Major Cities*.
Note: Indirectly age-standardised to Australian rates for the period 1997–1999.
Source: AIHW National Mortality Database.
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Summary
In summary, rural and remote populations have higher proportions of Indigenous
people, appear to have lower levels of access to employment and services, and have
poorer personal risk proÞles (e.g. people are more likely to smoke). 
Although overall summary measures of mortality reßect common perceptions that
death rates are higher in rural and remote areas than in larger population centres,
distance is not the only factor at play. When the effects of the relatively high mortality
of the Indigenous population are removed from the analysis, the scenario changes from
one where death rates are 5Ð10% higher in Regional* areas and up to 50% higher in
Remote* areas compared with Major Cities*, to one where mortality is 3Ð10% higher in
Regional* areas and similar or lower in Remote* areas compared with Major Cities*.
When the older population is also removed from the analysis, rates increase again to
become 10Ð20% higher in both Regional* and Remote* areas than in Major Cities*. This
means that for people younger than 65 years (excluding Indigenous people), death rates
are indeed higher outside metropolitan areas. Differentiating between these various
population groups, as well as for the whole population, allows for a better
understanding of the issues and more effective targeting of interventions.
Other factors (including socioeconomic status and the environment) which could
potentially affect the analysis have not been examined here. Comparison is far from
simple.
4.9 Health status of veterans
At June 2001, approximately 314,000 of the one-and-a-half million servicemen and
women who enlisted in the Australian Forces over the past century were still alive.
These veterans served in conßicts from World War I (1914Ð1918) through to recent
overseas missions.
In recognition of the special contribution made to the nation by veterans, the Australian
repatriation system provides a wide range of beneÞts to the ex-service community.
The veteran population
Under the Veterans’ Entitlements Act 1986, the Department of VeteransÕ Affairs (DVA)
provides eligible members of the veteran community with access to health care,
assistance in the home and support services through arrangements with registered
health care practitioners, home support agencies and providers, and public and private
hospitals.
Table 4.13: Number of Australian veterans enlisted and estimated survivors at 30 June 2001
Conflict Numbers enlisted or engaged Estimated numbers alive
World War I 416,809 21
World War II 993,000 218,300
Other pre-1972 service 86,480 75,900
Post-1972 service NA 20,300
Total survivors 314,521
Sources: Australian War Memorial/DVA; DVA Survivor Model Summary June 2001.
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Eligible veterans, war widows/widowers and dependants are issued with healthcare
cards that reßect their level of healthcare coverage (Box 4.6).
Veterans aged 75Ð84, largely from the World War II and Korean conßicts, represent the
greatest proportion (58%) of gold and white cardholders. Those aged under 55 are the
next largest group comprising around 16% of veterans.
Box 4.6: Veterans’ entitlement cards
Holders of a gold card (the Repatriation Health Card – For All Conditions) are entitled to
the full range of healthcare services at DVA expense including medical, dental and optical
care. 
Holders of a white card (the Repatriation Health Card – For Specific Conditions) are enti-
tled to the full range of health care services at DVA expense but generally only in respect
of those disabilities or illnesses accepted as service-related. 
An orange card (Repatriation Pharmaceutical Benefits Card) was introduced on 1 January
2002 and provides pharmaceutical benefits under the Repatriation Pharmaceutical Benefits
Scheme to British Commonwealth and Allied veterans who have World War II qualifying
service, are aged 70 years or more and have lived in Australia for 10 years or more.
Table 4.14: Veteran healthcare cardholders, 1 July 2001
Sex
Age group (years)
Under 55 55–59 60–64 65–69 70–74 75–79 80–84
85 and
over Unknown Total
Veterans
Males 34,738 12,074 6,133 5,862 11,537 76,430 51,012 20,513 31 218,330
Females 1,961 57 36 33 260 4,743 2,385 1,252 5 10,732
Dependants
Males 515 21 19 16 11 31 11 3 n.a. 627
Females 2,135 1,143 2,130 5,193 19,834 34,355 25,394 16,639 42 106,865
Other(a)
Persons 8,577
Total  345,131
(a)  British, New Zealand, overseas, miscellaneous and Commonwealth countries’ forces.
Source: DVA Treatment Population Statistics, 1 July 2001.
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Figure 4.22: Veteran healthcare cardholders, 1 July 2001
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Good (31%)
Fair (35%)
Poor (14%)
Very poor (5%)
Source: DVA 1998.
Figure 4.23: Self-assessed health status in veterans and war widows/widowers
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Self-assessments of health status
In a study of veterans and war widows/widowers (DVA 1998), 46% rated their health
as ÔgoodÕ or Ôvery goodÕ (39% of men and 62% of women). Only 43% of wives caring for
veteran husbands and just 33% of Vietnam veterans rated their health as ÔgoodÕ or Ôvery
goodÕ.
Overall, 43% considered there were things they could do to improve their health.
However, although 74% of those aged under 60 believed they could improve their
health, only 24% of those aged 85 years and over believed this. 
Prevalent medical conditions
The most prevalent medical conditions (Figure 4.24) reported by survey participants
were vision problems corrected or alleviated by glasses or contact lenses (85%). Other
prevalent conditions are arthritis or rheumatism (59%) and deafness (49%).
Roughly one-third of cardholders said they had Ôa lot of botherÕ from their medical
conditions, and generally this was greatest in the under 60 age group (55%) and lowest
in the 85 and over age group (30%).
Comparative health status
In an analysis of population-based surveys, nearly half of the veterans with a DVA
healthcare entitlement rated their health as either fair or poor, compared with about
one-third of other males of equivalent age in the general community (Covance & DVA
1999). It was also found that veterans have poorer health and more health problems
than people of the same age in the general community and war widows/widowers. 
Memory loss/dementia
Blindness/serious trouble seeing
Impotence
Anxiety disorders
Depression
Foot problems affecting mobility
Varicose veins
Bronchitis/emphysema/asthma
Skin rash/eczema, dermatitis
Hay fever/sinusitis
Heart disease/angina
Insomnia/sleep disturbance
Have, or have received treatment for, any form of cancer
Non-cancerous skin lesions
High blood pressure
Back trouble
Deafness
Arthritis/rheumatism
Vision problems
0 10 20 30 40 50 60 70 80 90
Percentage of cardholders
Source: DVA 1998.
Figure 4.24: Most prevalent medical conditions in veterans and war widows/widowers
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War widows assess their overall health status in a similar way to other females of the
same age in the community. About one-third rate their health as either fair or poor.
However, compared with the general community, veterans and war widows/widowers
are more likely to:
¥ have a recent illness
¥ have recently taken a health-related action
¥ have recently consulted with doctors and other health professionals
¥ undertake some level of exercise.
Compared with males in the general community, entitled veterans are more likely to
experience the following illnesses:
¥ diseases of the respiratory, circulatory, digestive and musculoskeletal systems, and
the connective tissue
¥ arthritis
¥ mental disorders
¥ neoplasms.
Compared with females in the general community, war widows are more likely to
experience and treat the following illnesses:
¥ diseases of the respiratory system
¥ mental disorders.
Male and female service pensioners and war widow pensioners have a higher average
number of long-term conditions than age pensioners (Covance & DVA 1999). 
These analyses examine a range of health conditions which may or may not be related
to military service, but there are some conditions accepted as being caused by a
personÕs defence service. Statements of Principles (SOPs) are statements of the medical
or scientiÞc evidence connecting injuries, diseases or death with the circumstances of
particular veteransÕ service. The ten most frequent conditions accepted under this
arrangement (covering 63% of all SOP conditions) in 2000Ð01 were sensori-neural
hearing loss, post-traumatic stress disorder, chronic bronchitis and emphysema, solar
keratosis, ischaemic heart disease, tinnitus, acquired cataract, non-melanotic malignant
neoplasm of the skin, osteoarthrosis, and alcohol dependence or alcohol abuse.
Mortality patterns in veterans
A study of the veteran population in the 5 years to 1997 concluded that their death rates
differed substantially from the rest of the community (Covance 2000). The study found
that, on average, male gold cardholders had a death rate around 14% higher than the
community death rate (Table 4.15). In contrast, male white cardholders had death rates
around 7% below the community rate. Similarly, war widows/widowers tended to
have slightly lower death rates than the general community. 
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Death rates also differed substantially between Disability Pension levels. Veterans on
the Extreme Disability Allowance, for example, have a relative death rate two to three
times that of the community.
4.10 Health of prisoners
During 2000, over 40,000 adults were either imprisoned or detained in Australian
prisons. New South Wales had the greatest number of prisoners (8,547), but the
Northern Territory had the highest rate of imprisonment at 458.1 per 100,000
population, followed by Western Australia at 218.4 per 100,000 population (ABS 2000e).
National data on the health status of Australian prisoners is not available (see Chapter 6,
section on information development). However, the limited information available
indicates that many prisoners engage in risk behaviours and have poor health status. 
The most comprehensive data on the health status of prisoners is collected in New
South Wales, via inmate health surveys. The Þrst survey was conducted in 1996 with a
repeat in 2001 (data from this second survey is yet to be released). The 1996 survey
found a high proportion of prisoners tested positive for communicable diseases,
particularly hepatitis C (35% of males and 65% of females), hepatitis B (35% of males
and 45% of females) and herpes simplex virus Type 2 (20% of males and 58% of
females) (Butler et al. 1999, 2000). 
Exposure to bloodborne viruses such as hepatitis C and hepatitis B are strongly
associated with injecting drug use. Two-thirds of female inmates and 40% of male
inmates reported a history of injecting drug use; of these, 49% and 53% (respectively)
reported injecting while in prison (Butler 1997). In the general community, only 2.1%
report a history of injecting drug use (AIHW: Adhikari & Summerill 2000).
The proportion of current smokers in New South Wales prisons was 3 times higher than
that in the general community (80% of prisoners compared with 27% of the general
community) (Butler 1997; AIHW: Adhikari & Summerill 2000). In addition, almost
three-quarters of male prisoners and over 60% of female prisoners reported consuming
harmful/hazardous quantities of alcohol in the year before imprisonment (Butler 1997).
Although a different method of determining consumption levels was applied to the
1998 National Drug Strategy Household Survey, the proportion of the general
community drinking at hazardous or harmful levels was estimated to be much lower, at
10.5% (AIHW: Miller & Draper 2001).
Table 4.15: Number of deaths and expected deaths in the veteran population, 1993Ð1997
Actual deaths Expected deaths
Standardised
mortality ratio
Male gold cardholders 49,501 43,260 1.14
Male white cardholders 12,584 13,45 0.93
Female gold cardholders 18,194 19,125 0.95
Notes
1. The community standardised mortality ratio equals 1.00.
2. Observed deaths, expected deaths and standardised mortality ratio in the DVA treatment population, by sex and card 
type, 1993Ð1997. The expected number of deaths is that expected for other Australians, given the calendar year, ages 
and sex distribution in the DVA treatment population.
AH2002 body 26-6  Page 225  Wednesday, June 26, 2002  6:28 PM
226  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
Mental illness is common among inmates; 33% of males and 50% of females reported
receiving some form of psychiatric treatment. Depression was the most commonly
reported mental illness (7% of males and 16% of females). Prisoners were twice as likely
to rate their health as ÔfairÕ or ÔpoorÕ compared with the general population. Whereas
17% of males and 16% of females in the general community rate their health as ÔfairÕ or
ÔpoorÕ, 28% of male prisoners and 40% of female prisoners rated their health as such
(ABS 2002; Butler 1997).
Data on the HIV status of adults entering prison is collected and published by the
National Centre in HIV Epidemiology and Clinical Research. HIV testing on admission
to prison is not mandatory in all States and Territories in AustraliaÑin 1999 only 58% of
adults admitted to Australian prisons were tested (NCHECR 2000) (Table 4.16). In 1999,
testing was mandatory in Queensland and the Northern Territory. 
Information on the causes of deaths in prison is available nationally and is published by
the Australian Institute of Criminology. Suicide is the leading cause of death in prison,
accounting for approximately half of prisoner deaths in 2000 (Table 4.17). Although
prisoners on remand represent only 17% of the total prison population, they account for
30% of deaths in prison (Collins & Mouzos 2001).
The ABS conducts an annual prison census, which provides information on the
demographic characteristics of prisoners and their crimes. These data demonstrate that,
as is the case with the Australian population, the prisoner population is also ageing.
Table 4.16: Proportion of new prisoners tested for and diagnosed with HIV, 1999
NSW Vic Qld WA SA Tas ACT(a) NT Aust
Number of receptions 15,206 1,994 10,975 5,958 4,016 2,233 254 2,587 43,223
Tested for HIV 
antibody (%) 28.9 68.5 100 55.5 28.5 58.1 5.5 100 58.0
Number (%) with HIV 
infection 38 (0.9) 7 (0.5) 16 (0.1) 0 (0) 3 (0.3) 0 (0) 0 (0) 4 (0.2) 68 (0.3)
(a) The corrections centre in the ACT is a remand centre only. HIV antibody testing is carried out on prisoner request. Data
not available for the first 6 months of 1999.
Source: NCHECR 2000.
Table 4.17: Causes of deaths in Australian prisons, 2000 
Cause of death Indigenous Other Australian Total
Hanging 8 22 30
Natural causes 3 18 21
Injuries 0 5 5
Gunshot 0 0 0
Drugs 0 5 5
Other 1 2 3
Total 12 50 64
Source: Collins & Mouzos 2001.
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The Indigenous population is over-represented in AustraliaÕs prisons, accounting for
20% of prisoners but only 2.1% of the total Australian population. In the general
population, there are health disparities between the health of the Indigenous
population and the rest of the population across a range of health status measures.
There are inadequate national data to determine the applicability of this statement to
the prisoner population. 
4.11 National Health Priority Areas: a population-
based perspective
SigniÞcant interpopulation variation exists in the prevalence and health outcomes of
various National Health Priority Area (NHPA) diseases and conditions and their risk
factors. The risk of a particular disease or condition cannot be considered in isolation
from the health risk of the population as a whole. Nonetheless, speciÞc diseases are
known to have different effects in different population groups.
A major source of this disease-speciÞc variation is the underlying composition of a
population. In the preceding sections of this chapter, population groups of Australian
society have been deÞned using criteria such as stages of life, overseas-born, Aboriginal
and Torres Strait Islander origin, socioeconomic disadvantage, and residence in rural
and remote areas. These population groups are not exclusive, with signiÞcant overlap
between them. Some of these groups correspond with speciÞc causal factors in the
distribution of various determinants of health and disease. Disease-based comparisons
between these population groups enable insights into other factors that affect their
states of health.
Varying effects of NHPA diseases and conditions over the 
lifetime
NHPA diseases and conditions affect all stages of life but the impact is much higher in
the latter half of life. These effects can be usefully viewed through a partitioning of the
life span into three life stages: children and young people (aged 0Ð24), adults (aged
25Ð64), and older people (aged 65 and over).
Children and young persons (aged 0–24)
Among children, adolescents and young adults, the NHPA diseases and conditions
with most impact are injuries, asthma and mental health. In addition, NHPA diseases
with high genetic components, e.g. Type 1 diabetes, contribute signiÞcantly to
morbidity, disability and mortality.
Injury is a leading contributor to the burden of disease in Australian children and
young persons, in particular in terms of the years of life lost prematurely. Much lifelong
disability also results from injuries sustained in this period of life. Injuries accounted for
8.4% of the total disability-adjusted life years (DALYs) in 1996, with the burden peaking
in the age range 15Ð24 (AIHW: Mathers et al. 1999). They continued to be the leading
cause of death among children and young persons in 2000 (ABS 2001c).
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Although not a large cause of mortality, asthma contributes signiÞcantly to years of
healthy life lived with disability. Almost 70% of the total burden of asthma in Australia
falls within childhood (AIHW: Mathers et al. 1999). Asthma ranked sixth for problems
managed by GPs in 2000Ð01, with a large proportion (41.4%) of patients managed aged
less than 25 (AIHW: Britt et al. 2001). In addition, childhood asthma was responsible for
a large number of attendances at emergency departments.
Mental health is a major concern among young people, in particular among those aged
15Ð24 (AIHW: Mathers et al. 1999). Depression is common among young adults,
especially females (see Chapter 2).
Several of the NHPA diseases and conditions taking hold in these early years become
chronic and affect a personÕs whole life. Several risk-taking behaviours such as tobacco
smoking and alcohol misuse are also initiated early in life.
Adults (aged 25–64)
Adulthood is a period of relative stability in health terms. The health changes that
characterise it are often subtle, related to complex behavioural, biomedical and
socioeconomic risk factors. However, adulthood is an extremely large part of the
lifespan and therefore could be split into two broad chronological periods from the
NHPA perspectiveÑthose aged 25Ð44 and those aged 45Ð64. This division usually
marks a shift from greater effects of mental illnesses and injuries to those of
cardiovascular diseases and cancers. The division also usually indicates a change in
health risk behaviours.
The persistence of injuries as a prominent cause of premature mortality and morbidity
among males aged 25Ð44 in some way reßects a continuity of risk-taking behaviours
characteristic of young adulthood. In 1996, injuries accounted for almost 27.6% of
DALYs lost in this age group, followed by mental disorders at 27.3% (AIHW 2000). On
the other hand, cardiovascular diseases and cancers were the leading burden of
diseases among those aged 45Ð64. Dominant cardiovascular diseases were ischaemic
heart diseases and stroke; the leading cancers were lung and colorectal.
Mental disorders dominated the burden of disease among females aged 25Ð44 (33.8% of
all DALYs), followed by cancers (13.1%), in 1996. Depression and breast cancers were
the major single causes of disease and injury. Cancers take over as the leading
contributor to the burden of disease among females aged 45Ð64 (33.1% of all DALYs in
1996), followed by cardiovascular diseases (13.7%) (AIHW 2000). Breast, lung and
colorectal cancer were the leading contributory cancers among females.
Older people (aged 65 and over)
NHPA diseases and conditions play a predominant role in health outcomes among
those aged 65 and over. The health of older people is largely the result of a cumulation
of exposure to a variety of risk factors, in combination with various ageing processes.
Environmental rather than genetic factors are the major sources of disease-speciÞc
variation in this particular stage of life.
Cardiovascular disease dominates the burden of disease for older Australians,
accounting for 37% of total DALYs in 1996. Ischaemic heart disease was the dominant
disease process, responsible for 21.7% of DALYs among males and 20.3% of DALYs
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among females. Stroke was a relatively more prominent cause of death among females
in this age group, accounting for 10.7% of total DALYs. Cancer was responsible for 24%
of DALYs in this age group in 1996. In terms of speciÞc cancers, lung, prostate and
colorectal cancers were the top three DALY contributors among males; breast, colorectal
and lung cancer were the three correspondingly ranked cancers among females (AIHW:
Mathers et al. 1999).
Injuries have serious health implications, both in terms of hospitalisation and mortality,
among the elderly. This is particularly the case for falls. Hospitalisation rates increase
exponentially with age, with the rate among females being much higher than among
males (AIHW: Cripps & Carman 2001).
NHPA diseases and conditions among the overseas-born
As described earlier, the health of Australians born overseas differs markedly from that
of the local Australian population, in terms of hospitalisation and death rates. This
health advantage is often attributed to the Ôhealthy migrant effectÕ, reßecting stringent
health requirements for immigrants. However, this advantage is not consistent across
the board, and shows variations for speciÞc diseases and conditions. In the case of
certain speciÞc diseases, people born overseas reveal disadvantage in comparison to
local residents. Besides, with time, the health risk of immigrants begins to match that of
those born in Australia.
The overseas-born have a lower hospitalisation rate for all NHPA diseases and
conditions than the Australian-born, with the exception of some cancers. Lung cancer
and cervical cancer have higher hospitalisation rates and mortality among women from
the United Kingdom and Ireland and those born in Asia and North Africa, respectively.
Similarly, diabetes is a relatively larger contributor to mortality among those born in
Europe, Asia and North Africa.
NHPAs and Indigenous people
The Indigenous people of Australia experience poorer health than the rest of the
population. This inequality, mainly due to disadvantage and higher psychosocial risk
factors, leads to a wide range of health problems. These health inequalities arise and
accumulate from a lifetime of disadvantage related to inadequate access to appropriate
social, legal and economic support and physical infrastructure. However, these
inequalities vary in their effect through various NHPA diseases and conditions.
Diabetes, for example, is a disproportionately major cause of mortality and morbidity in
Indigenous Australians.
Cardiovascular disease is a large killer in the Indigenous population, with a
standardised mortality ratio (SMR) more than twice that of the rest of the population.
The apparently low risk ratio notwithstanding, the impact of these diseases upon the
health of Indigenous Australians is high because of their high prevalence. The SMR is
much higher (between 7 and 10) among those aged 25Ð64 (AIHW 2001d). 
Indigenous people experience higher death rates for all cancers, 40% higher than the
community in general (ABS & AIHW 2001). This inequality is, however, not consistent
across various types of cancer. Whereas the death rate for lung cancer is much higher
among Indigenous people, it is relatively lower for melanoma and prostate cancers.
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Injuries (accidents, assaults and intentional self-harm) also affect the health of
Indigenous Australians disproportionately compared with that of the general
Australian population. They accounted for 15% of the deaths in 2000 compared with 6%
in the Australian population as a whole (ABS 2001c). This injury-related differential is
also reßected in hospital separation statistics. Hospitalisations due to assault among
Indigenous males were 6 times that of other Australian males in 1998Ð99; the ratio was
much higher among females (ABS & AIHW 2001).
The mental health differential is a complex issue in the case of Indigenous people
because there are many facets to the issue compounded by a recent history of
displacement and disadvantage (DHAC & AIHW 1999a). Taking intentional self-harm
and suicide as an indicator of depression, it becomes evident that Indigenous people are
exposed to greater levels of depression. They also have twice the number of hospital
separations for intentional self-harm than expected on the basis of rates observed in the
Australian population as a whole (ABS & AIHW 2001).
As mentioned earlier, diabetes is a very big concern among Indigenous Australians. The
prevalence of diabetes among Indigenous people is one of the highest in the world. Self-
reported diabetes among Indigenous people aged 25Ð55 is some 7 to 8 times that of the
rest of the Australian population. It is also a large contributor to premature mortalityÑ
diabetes as an underlying cause of death was recorded at three times the rate in the
Australian population in 1997Ð1999 (AIHW 2001d).
Asthma is also a more commonly reported condition among Indigenous people than
the Australian population as a whole (ABS 1999c). Also, over 16,000 people identifying
themselves as Indigenous were admitted to Australian hospitals in 1998Ð99 with a
disease of the respiratory system as the principal diagnosis. This is a rate about twice
the expected rate in the Australian population (ABS & AIHW 2001).
NHPAs and socioeconomically disadvantaged people
The focus of socioeconomic disadvantage in relation to health, in this chapter, has been
on the differences between the Þrst quintile or Q1 (least disadvantaged) and the Þfth
quintile or Q5 (most disadvantaged) of the population grouped by the Index of Relative
Socioeconomic Disadvantage.
In DALY terms, the burden of disease for Q5 in Australia was 37% higher among males
and 27% higher among females than those in the Q1 category (AIHW: Mathers et al.
1999). Given that NHPA conditions account for 70% of the total burden of disease and
injury in Australia in 1996, a signiÞcantly large proportion of these differences is
attributable to NHPAs. However, this difference is not consistent across various NHPAs.
Cardiovascular disease disproportionately affects those in Q5 in comparison to those in
Q1, with a risk ratio of 2 for people aged 25Ð64 (AIHW 2001d). Similarly, diabetes and
motor vehicle accidents were 80% higher in Q5 compared with Q1 (ABS 2001c). The
cancers, however, show a 15% higher death rate among those in Q5 when compared
with those in the Q1 category.
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NHPAs and rural and remote populations
Injuries, cardiovascular disease and mental health constitute important NHPA-related
differentials between those living in the metropolitan areas and rural and remote areas
of Australia.
For residents of rural and remote Australia, injuries are a major concern (DHFS &
AIHW 1998a). Injury-related death rates in rural and remote localities are almost twice
that in the metropolitan areas (AIHW 1998; AIHW: de Looper & Bhatia 2001), and
hospital separations for injuries in rural and remote areas are respectively 2 and 3 times
that of metropolitan areas. Motor vehicle accidents are a major cause of these
differentials. Inter-personal violence and associated health problems are also higher in
rural and remote areas (AIHW 1998).
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5 Health resources and 
use of services
This chapter provides a description of the structure and administration of health
services in Australia, and presents details relating to two of the components of the
conceptual framework for health presented in Chapter 1:
¥ the resources or inputs of the health services
¥ the interventions that are their outputs.
The resources or inputs covered in the chapter include Þnancial, material and human
resources, such as expenditure on health, the nature of hospitals and other healthcare
delivery establishments, and the health labour force. Interventions discussed include
those provided to individual patients by hospitals, general practitioners and
community-based health services, and those provided as population health
interventions. 
The chapter concludes with a focus on health services relating to the National Health
Priority Areas.
5.1 Overview of health services in Australia
The healthcare system in Australia is complex, involving many funders and providers.
Responsibilities are split between different levels of government, and the public and the
for-proÞt and not-for-proÞt non-government sectors all have roles.
Coordination
The Australian Health MinistersÕ Advisory Council (AHMAC) is a committee of the
heads of the Commonwealth, State and Territory health authorities and the
Commonwealth Department of VeteransÕ Affairs (DVA). It is the major decision-making
body on national health issues. AHMAC advises the Australian Health MinistersÕ
Conference on policy, resources and Þnancial issues. SpeciÞc national bodies have been
established by AHMAC or the Ministers to coordinate information, advice and program
implementation, such as: 
¥ the National Health Information Management Group, which coordinates and directs
the implementation of the National Health Information Agreement. The Agreement,
signed by Commonwealth, State and Territory health and statistical authorities, is the
cornerstone of national health information development in Australia.
¥ the National Public Health Partnership, established in 1996 by the Commonwealth,
State and Territory governments. The role of the Partnership is to plan and coordinate
national public health activities, to provide a more systematic and strategic approach
to tackling public health priorities, and to provide a means for assessing and
implementing major initiatives, new directions and best practice.
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¥ the Australian Council for Safety and Quality in Health Care, which leads national
efforts to improve the safety and quality of health care, with a particular focus on
minimising the likelihood and effects of error.
Commonwealth, State and Territory governments
Commonwealth Government
Under the Constitution, the Commonwealth GovernmentÕs health-related powers are
limited mainly to the areas of quarantine; the health needs of veterans; pharmaceutical,
sickness and hospital beneÞts; and medical and dental services. However, the provision
of speciÞc-purpose grants to States under s 96 of the Constitution has enabled the
Commonwealth to have a wider role in the health system by providing health funding
to the States. 
For hospitals, the Australian Health Care Agreements provide the basis for the
Commonwealth GovernmentÕs Þnancial contribution to public hospitals (which are also
funded by the States and Territories). The Agreements are based on the principles that
public hospital services should be provided free of charge to public patients, that access
to these services must be on the basis of clinical need and within a clinically appropriate
period, and that people should have equitable access to public hospital services
regardless of their geographical location.
The Commonwealth operates universal beneÞts schemes for private medical services
(Medicare, see Box 5.9, page 302), and for pharmaceuticals (Pharmaceutical BeneÞts
Scheme (PBS), see Box 5.10, page 321) and other programs, such as for population
health. The Department of Health and Ageing also funds residential aged care and
community aged care packages. These are described in Australia’s Welfare 2001 (AIHW
2001a).
Other Commonwealth health-related activities are undertaken by:
¥ the Therapeutic Goods Administration, which is responsible for carrying out a range
of assessment and monitoring activities to ensure therapeutic goods available in
Australia are of an acceptable standard 
¥ the Health Insurance Commission, a statutory authority which administers Medicare
(for medical services), the PBS and some other beneÞt payment arrangements
¥ the armed services, which provide for the health care of serving personnel
¥ the DVA, which arranges health care for most war veterans, war widows, some other
dependants of deceased veterans and some ex-service personnel
¥ the OfÞce for Aboriginal and Torres Strait Islander Health, which works with
Aboriginal and Torres Strait Islander communities to provide access to primary
healthcare services and population health programs
¥ the Australian Quarantine and Inspection Service, which provides quarantine
inspection services for when international passengers, cargo, mail, and animals and
plants or their products arrive in Australia
¥ the Australia New Zealand Food Authority, a statutory authority that establishes and
maintains uniform food regulations in Australia and New Zealand
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¥ the National Health and Medical Research Council, a statutory authority that
combines the functions of research funding and development of advice. It fosters the
development of consistent health standards among the various States and Territories,
medical and public health research, and consideration of ethical issues relating to
health
¥ the Australian Institute of Health and Welfare (AIHW), a statutory authority, which is
AustraliaÕs national agency for health and welfare statistics and information. It works
with many government and non-government bodies to generate reliable, regular and
current facts and Þgures on the health and welfare of Australians 
¥ the Australian Bureau of Statistics (ABS), which conducts large-scale population
surveys of health and health services on a regular basis. Many of its other surveys
also provide health data. 
State, Territory and local governments
State and Territory governments have the major responsibility for the public provision
of health services, and for public health. The health services usually delivered by State
and Territory health authorities (but sometimes delivered by community service
departments or local government) are public hospital services (acute care and
psychiatric, including admitted-patient services, outpatient clinics and emergency
departments); mental health services; dental health services (including school dental
services); infant health centres; health promotion and prevention activities; community
health centres; ambulance services; and regulation, inspection, licensing and monitoring
of premises, institutions and personnel. Some services are funded by governments but
delivered by non-government organisations or private providers in some States and
Territories. 
Several State and Territory governments have established 24-hour telephone ÔtriageÕ
services in recent years. These are staffed largely by registered nurses who may use
decision support software to answer queries from callers about health problems.
Western AustraliaÕs HealthDirect service, for example, received over 300,000 calls in the
24-month period from May 1999 (Turner et al. 2002).
Most States also provide substantial infrastructure support for medical research
institutes established in association with universities and teaching hospitals.
The health responsibilities of local governments vary from State to State, but are mainly
in environmental control and in a range of community-based and home-care services.
Piped water, sewage disposal and drainage are controlled by local government or by
State-owned or local government-owned water utility corporations. In some
jurisdictions, water quality is monitored independently by health authorities. Other
authorities are responsible for monitoring and regulating air quality. Agencies have
been established in most States to control the disposal of wastes and to administer the
disposal sites in metropolitan areas, leaving local government to be responsible for the
collection and transport of waste material.
The private sector
The private sectorÕs provision of health services includes private medical practitioners
and dentists, community pharmacies, other private practitioners and private hospitals.
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Private hospitals may operate for proÞt, or as not-for-proÞt enterprises, or may be run
by religious or charitable organisations. Funding is usually through private health
insurance, patient payment, Medicare (for in-hospital medical care), government-
contracted services, the DVA, and other insurance including workers compensation,
motor vehicle accident and public liability.
Medical care outside hospitals is based on general practitioners (GPs), mainly in private
practice, who constitute the principal gateway to specialised services, specialist doctors,
pathology, imaging and pharmaceuticals. GPs and other medical practitioners can bill
patients and Medicare provides automatic entitlement to beneÞts for the patients at set
rates. Alternatively, the federal government can be direct-billed (see Box 5.9, page 302).
Box 5.1: Corporatisation in health care
Over the last decade or so, there has been increased corporatisation of private healthcare
services, including private hospitals, general practice, specialist medical practice, medical
centres, pharmaceutical manufacturing and supply, and pathology and imaging services.
In many cases, individual companies have interests in more than one of these activities,
enabling patients to be referred from one activity to another within the corporation’s
group, and sometimes within one physical location. GPs play a gatekeeper role in Aus-
tralia’s healthcare system, and for every dollar of Medicare benefits paid in 2000–01 to
GPs, another $0.83 was paid by Medicare for patients referred by them for specialist
attendances, diagnostic imaging and pathology (including patient episode initiation
items), and another $1.17 was paid for pharmaceuticals through the PBS (DHA, unpub-
lished HIC data). Hence, referral patterns can potentially influence revenue flows for these
corporations from Medicare, the PBS and other funders. 
Further data and analysis are needed to describe corporatisation in health care more com-
pletely, and its effects on service provision. 
General practice
The corporatisation of general practice has involved the formation of larger practices in
attempts to facilitate management and to provide access to capital for the purchase of
equipment and information technology, for example (Power & Aloizos 2000).
Corporatisation of general practice occurs when, for example, GPs assign a proportion of
their gross income to a company in return for management and support services and a
goodwill payment. The number of GPs who work in this type of arrangement with large
corporations is not known, but has been estimated to be about 2,500, or about 10% of the
practising population (Clark 2001). 
Private hospitals
Group for-profit private hospitals (hospitals that either own other hospitals or are owned
by a parent company that owns other hospitals) have increased their share of the private
hospital market over recent years. Between 1991–92 and 1999–00, there was an increase
(continued)
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Box 5.1 (continued): Corporatisation in health care
of 49% in beds for these hospitals (from 7,217 beds to 10,731 beds), compared with falls of
14% for independent for-profit hospitals (from 2,838 beds to 2,430 beds), and 1.7% for
not-for-profit hospitals (from 10,690 beds to 10,504 beds) (ABS unpublished Private
Health Establishments Collection data). Similarly, the number of beds/chairs for group for-
profit private freestanding day hospital facilities increased by 201% between 1991–92 and
1999–00 (from 83 to 250), and numbers for independent for-profit facilities grew by 180%
(from 473 to 1,331).
Over this period, group for-profit hospitals recorded increases of 107% for separations
(to 851,000) (compared with increases of 10% for independent for-profit hospitals and
31% (to 790,000) for not-for-profit hospitals), and 82% for patient-days (to 2,891,000)
(compared with a fall of 16%, to 516,000, and an increase of 5%, to 2,825,000, respec-
tively). This meant that they increased their market share from 35% to 47% of separations,
and from 32% to 46% of patient-days. Group for-profit private freestanding day hos-
pital facilities increased their separations by 200% (from 25,000 to 75,000) but their
market share was similar in 1991–92 (20%) and 1999–00 (21%).
These changes were accompanied by a trend to larger group for-profit private hospitals,
with an increase in the average number of beds from 63 in 1991–92 to 87 in 1999–00
(38%). In comparison, the average size of not-for-profit hospitals increased from 75 beds to
88 beds (17%) and the size of independent for-profit hospitals fell on average by 11%, from
46 beds to 41 beds. 
The main players
In 2001, Mayne Health operated 61 hospitals (including 4 public hospitals) throughout
Australia, large pathology and diagnostic imaging services, medical centres and workplace
health services. It provided over 500,000 hospital admissions, over 1.4 million diagnostic
imaging services and 4.9 million pathology services (Mayne Nickless Ltd 2002). Health-
scope provided services for over 200,000 patients through its 13 hospitals (including one
public hospital) and other health facilities in 2000–01 (Healthscope Ltd 2002). Ramsay
Health Care provided services for over 100,000 patients in 2001 through its 22 hospitals
and centres offering allied health services (Ramsay Health Care 2002). In 2001, Founda-
tion HealthCare Limited had about 1,000 general practitioners and 135 medical centres,
and Primary Healthcare had about 320 general practitioners. Medical Care Services had
12 medical centres in Perth employing about 150 doctors, and owned half of Gribbles, a
pathology company which provides over 2 million pathology tests each year (Catchlove
2001; Gribbles Group 2002). Endeavour Healthcare had 400 general practitioners and was
also involved in radiology and occupational health (Clark 2001). Sonic Healthcare was a
large pathology and radiology provider, which was working with Foundation HealthCare
to locate facilities in the latter’s medical centres, and provided 10 million services in 2001
(Sonic Healthcare 2001).
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Dental care is most commonly delivered by private practitioners. Patients usually pay
direct, with private health insurers providing some rebates.
Non-hospital pharmacy services are provided by private community pharmacists. Most
pharmaceuticals are included in the PBS which subsidises the price to consumers.
Allied health services such as physiotherapy, nursing and optometry can be provided
through private practices, although some are provided through public hospitals,
residential aged care facilities and community health centres. The mix varies depending
on the type of provider. For example, 57% of speech pathologists work in the
government sector but 99% of optometrists work in private practice (AIHW 2001b).
Optometrists are the only allied health professionals covered by Medicare.
Complementary and alternative health services are a growing part of the private sector.
They are funded by patient payments and in some cases part of the funding is through
private health insurance.
5.2 Health services funding and expenditure
Funding for healthcare services comes from a number of government and non-
government sources. Government funding sources include the Commonwealth, State/
Territory and local government agencies. Commonwealth government funds cover
payments for medical services, high-level residential aged care, pharmaceuticals, health
insurance rebates, population health programs and payments to States and Territories
for hospital services. States and Territories use their own funds to supplement
Commonwealth funding for a wide range of health service provision. Non-government
sources include payments by individuals, health insurance organisations and providers
of motor vehicle third-party and workers compensation insurance. 
The total cost of providing and supporting health services is calculated each year as the
total expenditure on health services in Australia. The total includes expenditure on
health-related activities, such as research and administration, and on health
infrastructure (buildings, high-cost equipment and other capital items).
In this section, health services expenditure is examined in terms of total expenditure
and expenditures on the major types of health services and health-related activities.
Some of the main factors contributing to changes in health services expenditure over
time are described. Comparisons are made of expenditure by the State and Territory
governments in recent years, and with other OECD member countries.
Summary of health funding and expenditure in Australia 
Australia’s Health 2000 reported on health expenditure up to 1997Ð98. Since then, the
following have been noteworthy:
¥ In 1999Ð00 Australia spent 8.5% of its gross domestic product on health services. This
proportion was slightly down on the previous year, but one percentage point higher
than at the beginning of the 1990s.
¥ In 1999Ð00 an estimated 71.2% of the $53.7 billion spent on health services was
funded by governments.
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¥ The Commonwealth Government met 48.0% of total funding (up from 44.2% in
1996Ð97), and non-government sources accounted for 28.8% (down from 32.8%).
State/Territory and local governmentsÕ funding share was 23.2%, up marginally from
1996Ð97 (23.0%).
¥ Much of the shift to Commonwealth funding from non-government sources of
funding was due to the rebates paid to private health insurance members since 1997.
¥ Average spending on health services in 1999Ð00 was $2,817 per person.
¥ Spending on hospital services accounted for 38.0% of all recurrent expenditure in
1998Ð99 (the latest year for which detailed estimates by health service type are
available).
¥ The areas of most rapid growth over the 1990s were pharmaceuticals (7.5% per year)
and private hospitals (7.4%).
Sources of funds for health services in Australia 
Funding is provided by all three levels of governmentÑCommonwealth, State/
Territory and localÑas well as by non-government sources. Funding reported here
refers to funding net of transfers. For example, funding by State and local governments
is net of grants, such as speciÞc-purpose payments provided to the States and
Territories for health purposes by the Commonwealth; the grants are regarded as
Commonwealth funding in this case. In much of the discussion that follows, State and
Territory government and local government sources are combined as ÔState and local
governmentÕ.
Funding of health services by the Commonwealth and by the State and Territory
governments is sourced from the consolidated revenues of those levels of government.
The CommonwealthÕs general revenues include the Medicare levy (see Box 5.2), which
in 1999Ð00 totalled $4,350 million. This was 16.9% of the estimated total
Commonwealth funding for health services of $25,771 million (AIHW 2001c). This
compares with 10.1% of total health funding by the Commonwealth in 1984Ð85, the Þrst
full year in which the levy was collected ($12,104 million).
The share of each of the major sources of funding for health services varies according to
the type of service. For high-level residential aged care and medical services, the
Commonwealth Government provides most of the funding. Community and public
Box 5.2: Medicare levy
Almost all Commonwealth government funding for health services comes from general
revenue. However, one portion of the Commonwealth’s revenue collections is, at least nom-
inally, health-related—the Medicare levy. This levy was originally 1.0% of taxable earn-
ings. It has been increased several times since 1984 and the basic rate is currently set at
1.5% of taxable income. The levy has also been subject to ‘one-off’ surcharges from time to
time to cover the costs of non-health initiatives of the Commonwealth.
From October 1997, high-income earners who do not have private insurance cover for hos-
pital care have been required to pay an additional surcharge of 1.0% of taxable income.
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health services are largely funded by the State and Territory governments, and funding
for pharmaceuticals is shared between Commonwealth and non-government sources.
Private hospitals are funded largely by non-government sources (Figure 5.1). 
Table 5.1: Government and non-government sector expenditure as a proportion of total health 
services expenditure, 1989Ð90 to 1999Ð00, current prices (per cent)
Government Non-
government(a)Year Commonwealth(a) State and local Total Total
1989–90 42.2 26.1 68.3 31.7 100.0
1990–91 42.2 25.5 67.7 32.3 100.0
1991–92 42.8 24.6 67.4 32.6 100.0
1992–93 43.7 23.4 67.1 32.9 100.0
1993–94 45.3 21.4 66.7 33.3 100.0
1994–95 45.0 21.7 66.7 33.3 100.0
1995–96 45.5 22.2 67.6 32.4 100.0
1996–97 44.2 23.0 67.2 32.8 100.0
1997–98 45.4 23.9 69.3 30.7 100.0
1998–99 46.8 23.2 70.1 29.9 100.0
1999–00(b) 48.0 23.2 71.2 28.8 100.0
(a) Commonwealth and non-government expenditure has been adjusted for tax expenditures (see Table S41).
(b) Based on preliminary AIHW and ABS estimates.
Source: AIHW Health Expenditure Database.
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Source: AIHW Health Expenditure Database.
Figure 5.1: Recurrent health expenditure by health service type and source of funds, 
current prices, 1998Ð99
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In 1999Ð00 the Commonwealth Government provided 48.0% of the funding for health 
services, State and local governments provided 23.2% and non-government sources 
provided the remaining 28.8% (Table 5.1).
Commonwealth Government funding
In 1998Ð99 most of the CommonwealthÕs funding was applied to medical services
(30.9%) and public non-psychiatric hospitals (27.8%) (calculated from Table S42). High-
level residential aged care and pharmaceuticals were also large consumers of
Commonwealth funding.
State and local government funding
Almost all the health funding by State and local governments is provided by the State and
Territory governments. The contribution by local governments is largely conÞned to some
high-level residential aged care and public/community health services. The funding by
State and Territory governments is that part of total expenditure on health services that
comes from their own revenue sources. It includes speciÞc-purpose payments from the
State governments to local governments for health expenditure purposes.
Nationally, most funding by State and local governments is directed to services in
public hospitals. In 1998Ð99, $6,516 million or 55.0% of their total funding for health
services went to public hospitals. In addition, a large proportion of the capital
formation funded by State and local governments was for public non-psychiatric
hospitals (Table S42).
Non-government funding
Most of the recurrent funding provided by non-government sources is in the form of
out-of-pocket payments by individuals. In 1998Ð99 these payments accounted for 58.1%
of the $14,583 million spent by non-government sources (Table S42). This was more
than double the contribution by private health insurance funds from their own
resources ($4,061 million). Other sourcesÑmainly compulsory motor vehicle third-
party and workers compensation insurersÑmet the balance. 
Real growth in funding, by sources
Between 1989Ð90 and 1999Ð00, real growth in funding by the Commonwealth
Government averaged 5.7% per year (Table 5.2). At the same time, contributions by State
and local governments grew by 3.0% per year, and non-government funding by 2.5%. 
The State and Territory governmentsÕ main health funding responsibilities are often in
areas of health expenditure that had relatively low rates of growth during the 1990s.
These include public hospitals (both psychiatric and non-psychiatric hospitals).
Between 1989Ð90 and 1998Ð99 expenditure on public non-psychiatric hospitals grew at
2.9% per year in real terms, compared with 4.0% for total recurrent health expenditure
(Table S43). At the same time, real expenditure on public psychiatric hospitals fell by an
average of 5.2%. In contrast, growth in expenditure was high in areas where the
Commonwealth had the major responsibility for fundingÑfor example, expenditure on
medical services and pharmaceuticals grew at 4.5% and 7.5%, respectively, during the
1990s. Expenditure on private hospitals, which, although largely funded from non-
government sources, involves third-party payments regulated by the Commonwealth,
grew rapidly (7.4%) over the decade.
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Influence of Commonwealth–State health service funding agreements 
During the life of Medicare, the Commonwealth and the State and Territory
governments have entered into a number of 5-yearly agreements for the funding of
speciÞed health services in the States and Territories concerned (Box 5.3). In this
publication, focus on the impact of the agreements on funding for health services has
been limited to the latest two periods and to part of the second period from 1989Ð90.
Between 1989Ð90 and 1992Ð93, the CommonwealthÕs share of health funding increased
from 42.2% to 43.7% and the proportion met by State and local governments fell from
26.1% to 23.4%. The share of funding borne by non-government sources increased from
31.7% to 32.9% (Table 5.1).
Table 5.2: Funding of health services, constant prices(a) and annual growth rates, 1989Ð90 to 
1999Ð00
Year
Government
Non-government(b) TotalCommonwealth(b)  State and local
Amount
($m)
Growth
(%)
Amount
($m)
Growth
(%)
Amount
($m)
Growth
(%)
Amount
($m)
Growth
(%)
1989–90 14,720 . . 9,107 . . 11,520 . . 35,347 . .
1990–91 14,917 1.3 9,216 1.2 12,003 4.2 36,136 2.2
1991–92 15,833 6.1 9,175 –0.4 12,395 3.3 37,403 3.5
1992–93 16,824 6.3 9,144 –0.3 13,075 5.5 39,043 4.4
1993–94 18,212 8.3 8,704 –4.8 13,696 4.8 40,613 4.0
1994–95 18,921 3.9 9,234 6.1 14,159 3.4 42,314 4.2
1995–96 20,094 6.2 9,803 6.2 14,432 1.9 44,329 4.8
1996–97 20,637 2.7 10,759 9.8 15,361 6.4 46,757 5.5
1997–98 22,205 7.6 11,684 8.6 14,959 –2.6 48,849 4.5
1998–99 23,892 7.6 11,852 1.4 15,266 2.1 51,011 4.4
1999–00(c) 25,556 7.0 12,191 2.9 14,788 –3.1 52,535 3.0
Average annual growth rates
1989–90 to 1992–93 4.6 0.1 4.3 3.4
1992–93 to 1997–98 5.7 5.0 2.7 4.6
1997–98 to 1999–00 7.3 2.1 –0.6 3.7
1989–90 to 1999–00 5.7 3.0 2.5 4.0
. . Not applicable.
(a) See Box 5.4 for explanation of constant price estimating method.
(b) Commonwealth government and non-government sector funding adjusted for tax expenditures (see Table S41).
(c) Based on preliminary AIHW and ABS estimates.
Source: AIHW Health Expenditure Database.
Box 5.3: Commonwealth–State health funding agreement periods
First Medicare (Compensation) Agreement: 1984 to June 1988
Second Medicare Agreement: 1 July 1988 to 30 June 1993
Third Medicare Agreement: 1 July 1993 to 30 June 1998
First Australian Health Care Agreement: 1 July 1998 to June 2003
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The CommonwealthÕs proportion of funding for health services rose from 43.7% in
1992Ð93 to 45.3% at the beginning (1993Ð94) of the third Medicare agreement period.
That was offset by a fall in the State and local governmentsÕ share (from 23.4% to
21.4%). Over the remainder of that agreement period, the CommonwealthÕs proportion
ßuctuated slightly to Þnish the period at 45.4% in 1997Ð98. At the same time, the State
and local governmentsÕ share of funding increased to 23.9%. The proportion of funding
met by non-government sources decreased marginally between 1993Ð94 and 1996Ð97,
from 33.3% to 32.8%, and fell further, to 30.7%, in 1997Ð98.
In the latest agreement period, the funding share met by the Commonwealth increased
each year, to an estimated 48.0% in 1999Ð00. The share met by State and local
governments fell marginally, to 23.2% in 1999Ð00, and the non-government share
continued its fall, to 28.8%. 
Expenditure on health services in Australia, 1989–90 to 1999–00
Estimated total expenditure on health services in Australia in 1999Ð00 was $53,657
million (Table 5.3). This represented 8.5% of AustraliaÕs estimated gross domestic
product (GDP) in that year and compares with 7.5% in 1989Ð90 and 8.6% in 1998Ð99.
Estimates for recent years are subject to revisions as data are progressively reÞned by
the various data provider agencies.
Between 1989Ð90 and 1999Ð00, total expenditure on health services grew at a real
average annual rate of 4.0% (Table 5.4) (6.4% in current prices; Table S44). The period of
most rapid real growth was between 1992Ð93 and 1997Ð98, when expenditure growth
averaged 4.6% per year.
AustraliaÕs expenditure on health services as a proportion of GDP grew slowly for most
of the 1990s. This was because nominal growth (current prices) in health expenditure
over the period (6.4% per annum) was greater than the nominal growth in GDP (5.1%
per annum) (AIHW 2001c).
Table 5.3: Total health services expenditure and GDP, current prices, 1989Ð90 to 1999Ð00
Year
Total health services
expenditure ($m) GDP ($m)
Ratio of health services
expenditure to GDP (%)
1989–90 28,800 384,238 7.5
1990–91 31,270 396,684 7.9
1991–92 33,087 405,961 8.2
1992–93 34,993 426,746 8.2
1993–94 36,787 449,416 8.2
1994–95 38,967 473,381 8.2
1995–96 41,783 506,975 8.2
1996–97 44,851 532,170 8.4
1997–98 47,648 564,653 8.4
1998–99 51,011 595,417 8.6
1999–00(a) 53,657 632,416 8.5
(a) Based on preliminary AIHW and ABS estimates.
Sources: AIHW Health Expenditure Database; ABS Australian National Accounts—National Income, Expenditure and 
Product, June quarter, various years (Cat. No. 5206.0). 
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Average per person expenditure on health services 
In 1999Ð00, the average expenditure on health services was $2,817 per person
(Table 5.5). After adjusting for inßation, it grew over the 1990s at an average of 2.8% per
year. This growth reßects the combined effects of changes in the intensity of use of
health services by individuals and the nature of those services.
Table 5.4: Total health services expenditure and GDP, constant prices(a), 1989Ð90 to 1999Ð00
Year 
Total health services expenditure GDP
Amount ($m) Growth rate (%) Amount ($m) Growth rate (%)
1989–90 35,347 . . 441,385 . .
1990–91 36,136 2.2 440,389 –0.2
1991–92 37,403 3.5 442,023 0.4
1992–93 39,043 4.4 457,985 3.6
1993–94 40,613 4.0 476,989 4.1
1994–95 42,314 4.2 498,550 4.5
1995–96 44,329 4.8 520,261 4.4
1996–97 46,757 5.5 539,088 3.6
1997–98 48,849 4.5 565,126 4.8
1998–99 51,011 4.4 595,417 5.4
1999–00(b) 52,535 3.0 621,186 4.3
Average annual growth rates
1989–90 to 1992–93 3.4 1.2
1992–93 to 1997–98 4.6 4.3
1997–98 to 1999–00 3.7 4.8
1989–90 to 1999–00 4.0 3.5
. . Not applicable.
(a) See Box 5.4 for explanation of constant price estimating method.
(b) Based on preliminary AIHW and ABS estimates.
Sources: AIHW Health Expenditure Database; ABS Australian National Accounts—National Income, Expenditure and 
Product, June quarter, various years (Cat. No. 5206.0).
Box 5.4: Constant price estimates and current prices
Wherever ‘constant price’ estimates are shown they are intended to reflect changes in
volume expressed in terms of prices in the reference year—1998–99 in this publication.
Most constant price estimates are calculated using the annually reweighted chain price
indexes produced by the ABS. In some cases, however, chain price indexes are not avail-
able, and implicit price deflators derived by the ABS have had to be used to calculate the
constant price estimates. 
A full discussion of chain volume measures can be found in the 1997 ABS publication
Chain Volume Measures in the Australian National Accounts, ABS Cat. No. 5248.0. 
The term ‘current prices’ is used to refer to amounts as reported for the reference year,
unadjusted for inflation. Current price amounts are therefore less comparable between
reporting years.
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Between 1996Ð97 and 1998Ð99, the fastest growth in average per person expenditure by
State and Territory occurred in Western Australia (13.0%) and the Australian Capital
Territory (11.8%), whereas in Tasmania it fell by 3.6%. This was largely inßuenced by
growth in expenditure on public (non-psychiatric) hospitals in those jurisdictions (see
Table 5.6).
Expenditure on health services for Aboriginal and Torres Strait Islander peoples
Aboriginal and Torres Strait Islander peoples have much poorer health status (as
described in Chapter 4), and a far greater proportion of the population live in remote
areas where the costs of delivering health services are higher. Despite this, the average
expenditure per person on health services for Aboriginal and Torres Strait Islander
peoples was similar to that for the rest of the population in 1998Ð99 (AIHW 2001d).
Total recurrent expenditures on Indigenous people were estimated at $1,245 million, or
2.6% of expenditure for the whole population. That translates into an average of $3,065
per Indigenous person, compared with $2,518 per person for other Australians, giving a
ratio (Indigenous people to other Australians) of 1.22:1 (Table S45).
There were signiÞcant differences in the patterns of expenditure between Aboriginal
and Torres Strait Islander peoples and other Australians. The former were much higher
users of State- and Territory-funded health services, in particular admitted patient
services in public hospitals and community health services (Figure 5.2). The per person
expenditure ratio for all State and Territory programs combined was 2.40:1.
Table 5.5: Health services expenditure per person, current and constant prices(a), and annual 
growth rates, 1989Ð90 to 1999Ð00
Year 
Amount ($) Growth rate over previous year (%)
Current Constant Current Constant
1989–90 1,700 2,087 . . . .
1990–91 1,820 2,104 7.1 0.8
1991–92 1,902 2,150 4.5 2.2
1992–93 1,990 2,220 4.6 3.2
1993–94 2,071 2,286 4.1 3.0
1994–95 2,170 2,356 4.8 3.1
1995–96 2,296 2,436 5.8 3.4
1996–97 2,434 2,538 6.0 4.2
1997–98 2,557 2,621 5.0 3.3
1998–99 2,706 2,706 5.8 3.2
1999–00(b) 2,817 2,758 4.1 1.9
Average annual growth rates
1989–90 to 1992–93 5.4 2.1
1992–93 to 1997–98 5.1 3.4
1997–98 to 1999–00 5.0 2.6
1989–90 to 1999–00 5.2 2.8
. . Not applicable.
(a) See Box 5.4 for explanation of constant price estimating method.
(b) Based on preliminary AIHW and ABS estimates.
Source: AIHW Health Expenditure Database.
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Table 5.6: Average per person expenditure on public (non-psychiatric) hospital and total 
health services, 1996Ð97 to 1998Ð99, constant prices(a) ($)
State/Territory 1996–97 1997–98 1998–99
Change 1996–97
to 1998–99 (%)
Public (non-psychiatric) hospitals
NSW 758 780 814 7.5
Vic 659 684 695 5.4
Qld 586 604 607 3.5
WA 641 712 705 9.8
SA 658 701 707 7.4
Tas 629 596 613 –2.5
ACT 780 856 885 13.4
NT 856 891 924 8.0
Australia 679 708 725 6.8
Total health services
NSW 2,660 2,715 2,755 3.6
Vic 2,479 2,550 2,674 7.9
Qld 2,444 2,533 2,640 8.0
WA 2,303 2,561 2,602 13.0
SA 2,595 2,658 2,740 5.6
Tas 2,840 2,680 2,737 –3.6
ACT 2,495 2,636 2,790 11.8
NT 2,731 2,972 2,855 4.5
Australia 2,537 2,621 2,706 6.6
(a) See Box 5.4 for explanation of constant price estimating method.
Source: AIHW Health Expenditure Database.
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Source: AIHW 2001d.
Figure 5.2: Estimated health expenditures per person for Aboriginal and Torres Strait 
Islander peoples and other Australians, 1998Ð99
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Aboriginal and Torres Strait Islander peoples were lower users of the two major
Commonwealth health services funding programs, Medicare and the PBS. Average
expenditure through these programs was just over one-third (37%) that for other
Australians. After including spending on Indigenous-speciÞc Commonwealth
programs (consisting of grants to Aboriginal Community Controlled Health Services)
and other nationwide Commonwealth health services, the Aboriginal and Torres Strait
Islander:other Australian per person ratio was 0.74:1.
Average expenditure on privately funded services provided to Aboriginal and Torres
Strait Islander peoples, such as private hospital and dental services and services
provided by other allied heath professionals was also much lower than for the other
Australian population. The per person expenditure ratio for all non-government
services combined was 0.23:1.
Expenditure on veterans
In 2000Ð01, the DVA spent a total of $2,960 million on the health care of the veteran
community, most notably on eligible veterans and war widows/widowers with gold or
white DVA healthcare cards (Table 5.7). The largest components were for private
hospitals and for local medical ofÞcers (GPs) and specialists. Note that elsewhere in this
chapter, DVA expenditure is included in expenditure of the Commonwealth
Government but not separately identiÞed.
DVA health expenditure on eligible gold cardholders rose from an average of $5,800 per
gold cardholder in 1996Ð97 to $8,400 in 2000Ð01 (Table 5.8).
Recurrent expenditure by type of health service 
Recurrent expenditure on health services in 1998Ð99 was $47,481 million. This
represented 93.1% of the total expenditure on health services in that year ($51,011
million). 
In 1998Ð99 recurrent expenditure on hospitals, the largest category, was $18,031 million,
made up of $13,675 million on public non-psychiatric hospitals, $3,959 million on
private hospitals, and $397 million on public psychiatric hospitals (Table S42). Spending
on high-level residential aged care was $4,066 million (8.6% of recurrent expenditure),
medical services $9,001 million (19.0%), pharmaceuticals $5,819 million (12.3%) and
dental services $2,566 million (5.4%). A further $1,860 million (3.9%) was spent on
services provided by other health professionals, such as physiotherapists, chiropractors
and podiatrists. 
The proportion of recurrent expenditure directed to hospital services in 1998Ð99 (38.0%)
was lower than at the beginning of the 1990s (40.6% in 1989Ð90) (Table S46). Much of
this decline occurred in the public hospital systems. Expenditure on public non-
psychiatric hospitals in 1998Ð99 was 28.8%, down from 32.3% in 1989Ð90, and public
psychiatric hospital expenditure was 0.8%, down from 2.0% in 1989Ð90. This was, to
some extent, offset by growth in expenditure on private hospitals, which grew from
6.3% to 8.3% over the same period.
Expenditure on pharmaceuticals represented 12.3% of recurrent health expenditure in
1998Ð99, up three percentage points from 1989Ð90. There were also marginal increases
in medical services, dental services and other health professional services.
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The changes in proportions of recurrent expenditure were due to the different growth
rates for particular types of health services over the period. Expenditure on public
hospitals had relatively low average growth between 1989Ð90 and 1998Ð99 of 2.9% per
year. Expenditure on private hospitals and pharmaceuticals, on the other hand, had
relatively high rates of growth over the period of 7.4% and 7.5%, respectively, per year
(Table S43).
Expenditure on hospitals
Just over three-quarters (75.8%) of all spending on hospital services during 1998Ð99 was
for services provided in public non-psychiatric hospitals operated by, or on behalf of,
State and Territory governments (calculated from Table S42). The remainder was for
services in private hospitals (22.0%) and public psychiatric hospitals (2.2%).
Table 5.7: Department of VeteransÕ Affairs health expenditure(a), 2000Ð01
Type of health service $ million
Private hospitals 676(a)
Local medical officers and specialists 587
Public hospitals 516
Residential aged care subsidy 418
Pharmaceuticals 326
Allied health 99
Rehabilitation appliances 75
Dental services 60
Community nursing 52
Veterans’ Home Care and respite 23
Transport 48
Other 80
Total 2,960
(a) The figures reflect accrual expenditure (e.g. private hospitals $676m = $669m cash + 
$7m accrued expense). 
Source: DVA unpublished data.
Table 5.8: Department of VeteransÕ Affairs health expenditure per eligible gold and white 
cardholder(a), 1996Ð97 to 2000Ð01
Year
DVA-administered health
expenditure(a) ($ million)
Eligible veteran population(b)
at 30 June (number)
Expenditure per gold
cardholder ($)
1996–97 1,600 340,327 5,800
1997–98 1,800 339,310 6,600
1998–99 2,000 353,840 6,900
1999–00 2,300 348,996 7,600
2000–01 2,500 345,131 8,400
(a) Excludes residential aged care subsidy, salaries and administration and certain minor items not directly related to 
veteran health care (e.g. health research). These expenditures are included in Table 5.7.
(b) Includes gold and white cardholders.
Sources: DVA Annual Reports and DVA unpublished data.
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Because most expenditure on hospital services is directed to public non-psychiatric
hospitals, it is greatly inßuenced by the CommonwealthÐState health funding
agreements. In 1989Ð90, which was the second year of the second Medicare agreement
period (see Box 5.3, page 247), the Commonwealth GovernmentÕs share of funding for
expenditure on hospitals was 36.4%, the State and local governmentsÕ was 40.1% and
non-government sources met the remaining 23.5% (Table 5.9). By the end year of that
agreement (1992Ð93), the respective shares were 37.5%, 37.7% and 24.8%.
Table 5.9: Shares of recurrent expenditure on hospitals, current prices, 1989Ð90 to 1998Ð99 
(per cent)
Year
Government
Non-government TotalCommonwealth State and local  Total
1989–90 36.4 40.1 76.5 23.5 100.0
1992–93 37.5 37.7 75.2 24.8 100.0
1993–94 40.5 33.4 73.8 26.2 100.0
1996–97 36.4 37.0 73.5 26.5 100.0
1997–98 37.9 37.7 75.6 24.4 100.0
1998–99 41.9 36.1 78.0 22.0 100.0
Source: AIHW Health Expenditure Database.
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Source: AIHW 2001c.
Figure 5.3: Expenditure on public non-psychiatric hospitals, constant prices, 1989Ð90 to 
1999Ð00
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In the Þrst year of the third Medicare agreement period (1993Ð94) the Commonwealth
and non-government shares increased markedly, to 40.5% and 26.2% respectively. The
State and local governmentsÕ share, on the other hand, fell to 33.4%. This was largely
due to an increase in funding by the Commonwealth for public non-psychiatric
hospitals under the new agreements, which coincided with a reduction in funding by
State and local governments (Figure 5.3). By 1997Ð98, the share of funding met by the
Commonwealth had reduced to 37.9%. The share of funding met by State and local
governments had increased to 37.7% but this was still lower than in 1989Ð90 (40.1%).
The proportion met by non-government funding sources was higher at 24.4% compared
with 23.5% in 1989Ð90.
In the Þrst year of the current agreement period, 1998Ð99, the CommonwealthÕs share of
funding for hospitals increased markedly, to 41.9%. This was due, in part, to the impact
of its subsidies on private health insurance for hospital and other health services.
BeneÞt payments for private hospital services are the main type of expenditure by
registered health beneÞts organisations (health insurance funds; see Box 5.5, page 262).
Because the CommonwealthÕs subsidy on premiums has been allocated across the
different areas of expenditure according to the spread of beneÞts paid by the funds,
there has been a marked movement of funding for hospitals from non-government
sources to the Commonwealth. 
Expenditure on pharmaceuticals
Total expenditure on all pharmaceuticals was $7,563 million in 1999Ð00. This included
$1,084 million on pharmaceuticals used in the provision of hospital services.
Total expenditure on non-hospital pharmaceuticals was $6,480 million in 1999Ð00Ñ
$4,174 million on beneÞt-paid pharmaceuticals and $2,306 million on other non-hospital
pharmaceuticals. The Commonwealth Government contributed $3,522 million in
beneÞts under the PBS and the Repatriation Pharmaceutical BeneÞts Scheme (RPBS).
Individuals paid $652 million in co-payments under the PBS and $2,262 million in
payments for non-beneÞt pharmaceuticals (Table 5.10).
Public hospital expenditure on drugs reported to the AIHW National Public Hospital
Establishments Database was $719 million and expenditure on drugs by private hospitals
was $126 million. In addition, the Commonwealth Government paid $214 million for highly
specialised drugs for use in public hospitals and $25 million for use in private hospitals.
Expenditure on beneÞt-paid items under the PBS was the largest single contributor to
total expenditure on pharmaceuticals. Under the PBS, Commonwealth expenditure on
prescriptions was $3,177 million in 1999Ð00 and increased in nominal terms by 19.9% to
$3,810 million in 2000Ð01 (Table 5.11). The total cost of the scheme both to the
Commonwealth, in terms of beneÞts, and to patients, by way of co-payments, has risen
each year in recent years with the proportion met by beneÞts rising from 81.5% of the
total cost in 1996Ð97 to 83.7% in 2000Ð01.
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Table 5.10: Expenditure on pharmaceuticals(a), current prices, 1999Ð00 ($ million)
Benefit-paid
pharmaceuticals
All other pharmaceuticals Total
pharmaceuticalsNon-hospital Hospital
Public sector
Commonwealth Department of 
Veterans’ Affairs 272 . . . . 272
Commonwealth Department of Health 
and Ageing(b)(c) 3,249 12 . . 3,261
Public acute care and psychiatric 
hospitals(d) . . . . 933 933
Total public sector 3,522 12 933 4,466
Private sector
Health insurance funds . . 32 . . 32
Individuals 652 2,262 . . 2,914
Private hospitals(e) . . . . 151 151
Total private sector 652 2,294 151 3,097
Total 4,174 2,306 1,084 7,563
. . Not applicable
(a) Excludes complementary and alternative medicines.
(b) Excludes $239 million in payments for highly specialised drugs.
(c) Includes $73 million in payments for human growth hormones, IVF and other subsidised 
pharmaceuticals.
(d) Includes $214 million in Commonwealth government payments for highly specialised drugs.
(e) Includes $25 million in Commonwealth government payments for highly specialised drugs.
Source: AIHW Health Expenditure Database.
Table 5.11: Cost of PBS items to the Commonwealth and patients, 1996Ð97 to 2000Ð01 
($ million)
Benefit category 1996–97 1997–98 1998–99 1999–00 2000–01
Patient contributions
General patients 278 294 318 346 407
Concessional patients 252 276 283 306 337
Total patient contributions 530 570 601 652 744
Government benefits
General patients—no safety net 392 412 469 521 662
General patients—safety net 73 99 107 107 128
Total general patients 465 511 576 628 790
Concessional patients—no safety net 1,466 1,576 1,740 2,001 2,360
Concessional patients—safety net 402 440 467 548 660
Total concessional patients 1,868 2,016 2,207 2,548 3,020
Total cost to government 2,333 2,527 2,783 3,177 3,810
Total cost of PBS benefit-paid items(a) 2,863 3,097 3,384 3,828 4,554
(a) Excludes payments for human growth hormones, IVF and other non-PBS subsidised pharmaceuticals.
Source: DHAC 2001c.
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Expenditure on public health activities
Expenditure on public health activities has been described through the National Public
Health Expenditure Project, an initiative of the National Public Health Partnership
(AIHW 2001e, 2001f). In 1998Ð99, public health expenditure by Commonwealth, State
and Territory health departments, based on eight agreed core public health activity
categories, was $880 million (Table S48). This amounted to 1.9% of total recurrent health
expenditure in Australia.
Total spending by the States and Territories was $613 million, of which $192 million was
funded through Commonwealth grants; total direct spending by the Commonwealth
was $267 million.
Selected health promotion aimed at promoting healthy lifestyles was the largest public
health category, accounting for 21% ($187 million) of total public health expenditure in
1998Ð99 (Figure 5.4). The next largest areas of expenditure on public health were
immunisation ($178 million) and communicable disease control ($145 million), which
included HIV/AIDS, hepatitis C and sexually transmitted infections programs, and
needle and syringe programs. Total spending on breast cancer screening in 1998Ð99 was
$91 million and on cervical screening, $81 million. 
The 1998Ð99 data collection represents expenditure by Commonwealth, State and
Territory health departments. Work is currently under way to develop methods for
extending the National Public Health Expenditure Project to cover public health
expenditures by local government authorities and the contributions made by non-
government organisations.
Communicable disease control (17%)
Selected health promotion (21%)
Immunisation (20%)
Environmental health (8%)
Food standards and hygiene (3%)
Breast cancer screening (10%)
Cervical screening (9%)
Research (2%)
All other core public health (10%)
Total expenditure: $880 million
Source: AIHW 2001e.
Figure 5.4: Expenditure on public health by category, 1998Ð99
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Expenditure on health research
The expenditure reported below relates to research activities that have health as the
area of expected national beneÞt. Health research can include research and
development activities directed at understanding the inßuences on population health,
fundamental biological processes, and disease and injury mechanisms. It can also
include developing and testing health promotion activities, disease prevention
strategies, medical instrumentation, human pharmaceutical products, and other clinical
interventions for treatment, rehabilitation, palliation and other health care. 
Total expenditure on health research and development undertaken in Australia in
1998Ð99 was $972 million (Table 5.12), an increase of 25.7% over the previous year.
General government sources invested 37.3% of this funding ($363 million). A further
$316 million came from institutes of higher education, while businessÑincluding
government business enterprisesÑprovided $149 million and private non-proÞt
organisations and overseas sources funded the remaining $144 million.
Between 1996Ð97 and 1998Ð99 the share of funding of health research and development
by institutes of higher education increased from 31.4% to 32.5%, with a marginal
increase recorded for private non-proÞt organisations and overseas sources. These
increases were largely offset by a fall in the share of general government funding, from
38.3% in 1996Ð97 to 37.3% in 1998Ð99, and business enterprise decreased its share from
15.7% to 15.3% over the same period.
Capital formation
The roles of the various sectors in the funding of capital formation are quite different.
The CommonwealthÕs spending on capital is often by way of grants and subsidies to
other levels of government or to non-government organisations to help them provide
facilities for health service delivery. In contrast, the States and Territories are the owners
of large-scale assetsÑsuch as hospitals, community health centres and residential aged
care facilitiesÑand use their own resources and Commonwealth money to purchase
Table 5.12: Expenditure on health research and development, current prices, 1996Ð97 to 1998Ð99 
($ million)
Source 1996–97 1997–98 1998–99
Higher education institutions 268 239 316
Private non-profit and other 101 99 116
Overseas(a) 22 38 28
Business enterprises(b) 134 142 149
Commonwealth Government 196 159 223
State and Territory governments(c) 127 92 133
Government (not elsewhere classified) 4 4 7
All funding sources 853 773 972
(a) Expenditure by overseas financing sources is not included in the research expenditure in Table S42, which records 
expenditure by Australian sources of funding. 
(b) Includes government business enterprises. This expenditure is not included as research in Table S42 as it is assumed 
to have been already captured in expenditure on the services provided by the enterprises.
(c) Includes expenditure on research undertaken in public hospitals and included in Table S42 as hospital expenditure.
Source: AIHW Health Expenditure Database.
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new and replacement health capital. Non-government organisations invest largely in
private hospitals and residential aged care facilities using money funded by the private
sector and by government. 
Total capital outlays in 1998Ð99 were $2,677 million (in current prices) (Table S42).
Almost 60% of these were sourced from State and local government, with non-
government and Commonwealth sources accounting for 37.7% and 2.7% respectively in
that year (Table 5.13).
From 1989Ð90 to 1998Ð99, State and local governmentsÕ share of funding rose 12
percentage points, from 47.7% to 59.7%, as acquisitions of new and replacement capital
for government health service providers increased over the decade. The non-
governmentsÕ share of funding fell by 5.2 percentage points and the CommonwealthÕs
share fell by 6.8 percentage points over the same period. A signiÞcant proportion of the
latter occurred in the early 1990s due to the disposal of the DVA (repatriation) hospitals
to the other service provider sectors.
Australian and international health services expenditure 
This section compares AustraliaÕs health services expenditure during the 1990s with
that of seven other members of the OECDÑCanada, France, Germany, Japan, New
Zealand, the United Kingdom and the United States. The comparison gives an
indication of the relative efforts made to meet the need for health services in countries
with similar economic and social structures or with which Australia has important
economic and social links. Differences between countries, in terms of what is included
as Ôhealth servicesÕ, complicate the comparison to some extent, and caution is therefore
necessary when making comparisons.
The average for health expenditures as a proportion of GDP across all eight selected OECD
countries increased to 10.7% in 1998, from 9.3% in 1989. Australia ranked fifth at 8.6% in
1998, up from 7.5% in 1989 (Table S49 and Figure 5.5). The United States, Canada, France
and Germany were consistently higher spenders compared with Australia. The United States
was by far the highest spender on health care, spending 12.9% of GDP on health in 1999. 
Table 5.13: Shares of outlays on health capital, current prices, 1989Ð90 to 1998Ð99 (per cent)
Year
Government
Non-government TotalCommonwealth State and local  Total
1989Ð90 9.5 47.7 57.1 42.9 100.0
1990Ð91 12.5 53.5 66.0 34.0 100.0
1991Ð92 12.9 50.7 63.6 36.4 100.0
1992Ð93 8.8 49.4 58.1 41.9 100.0
1993Ð94 5.3 48.5 53.9 46.1 100.0
1994Ð95 0.5 54.6 55.1 44.9 100.0
1995Ð96 4.4 49.6 54.0 46.0 100.0
1996Ð97 2.7 52.1 54.8 45.2 100.0
1997Ð98 2.8 56.8 59.7 40.3 100.0
1998Ð99 2.7 59.7 62.3 37.7 100.0
Source: AIHW Health Expenditure Database.
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Health expenditure per person has been calculated after adjusting for differences in the
purchasing powers of the national currencies. This has been done using purchasing
power parities to convert expenditures in each of the countries Þrst into United States
dollars and then into Australian dollars. The purchasing power parities used are for the
whole of the GDP.
In 1999, AustraliaÕs average health expenditure per person was, at $2,817, just under
half that of the United States (Table 5.14). In each year to 1997, Australia had the Þfth
highest average, above Japan, United Kingdom and New Zealand. In 1998, the latest
year for which data are available for all eight countries, its ranking had moved past that
of France to be the fourth highest in the group. This was still well below the eight
country mean (A$3,774) but it was marginally higher than the six country mean
(excluding the United States and Japan), A$2,685. 
Factors contributing to nominal increases in health services expenditure are inßation
(both general inßation and excess health inßation) and changes in the level of services
used, either from population growth or from more intensive per person use of services.
The general rate of inßation is an indication of price pressures that apply throughout
the economy, and the rate of excess health inßation indicates additional price rises
1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
4
6
8
10
12
14
Australia
Canada
France
Germany
Japan
New Zealand
UK
USA
Per cent
Year
Sources: AIHW Health Expenditure Database; OECD 2001.
Figure 5.5: Health expenditure as a proportion of GDP, Australia and other selected 
OECD countries, 1989 to 1999
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speciÞc to the health services sector. The ability of a nationÕs health Þnancing system to
control health prices is an important factor in controlling growth in total expenditure on
health services. 
During the 1990s Australia recorded an excess health inßation rate of 0.7%, the fourth
lowest of the group of selected OECD countries (Table S50). A number of factors have
contributed to AustraliaÕs lower than average excess health inßation rate. The increased
use of fringe beneÞts tax exemption for public benevolent institutions to supplement
the salary packages of hospital employees is one of these. It results in lower growth in
apparent cost of inputs to hospital services and was estimated to have cost the
Commonwealth budget $230 million in 1999-00. Even allowing for this, salaries of
health workers in Australia are lower compared with average weekly earnings (AWE)
than in high inßation countries. For example, remuneration for GPs in Australia is twice
AWE, compared with about three times AWE in the United States.
Had AustraliaÕs excess health inßation rate been similar to that of the United States over
the 1980s and 1990s, its expenditure to GDP ratio would have been 11.3% instead of
8.6% in 1998Ð99.
Table 5.14: Health services expenditure per person, Australia and other selected OECD 
countries, current prices, 1989 to 1999(a) (A$)
Year(a) Aust Canada France Germany(b) Japan NZ UK USA
Eight
country
mean(c)
Seven
country
mean(d)
Six
country
mean(e)
1989 1,700 2,129 1,960 . . 1,397 1,177 1,239 3,413 2,422(f) 1,562(f) 1,689(f)
1990 1,820 2,332 2,113 . . 1,504 1,302 1,346 3,806 2,675(f) 1,690(f) 1,831(f)
1991 1,902 2,485 2,256 2,192 1,595 1,362 1,392 4,062 2,765 1,876 2,018
1992 1,990 2,607 2,421 2,506 1,745 1,462 1,602 4,361 3,004 2,068 2,232
1993 2,071 2,646 2,456 2,483 1,841 1,473 1,608 4,567 3,116 2,109 2,245
1994 2,170 2,680 2,484 2,644 1,959 1,558 1,671 4,738 3,247 2,207 2,332
1995 2,296 2,745 2,558 2,810 2,105 1,605 1,678 4,761 3,324 2,316 2,423
1996 2,434 2,740 2,582 2,974 2,214 1,647 1,833 5,000 3,489 2,423 2,528
1997 2,557 2,878 2,598 3,082 2,387 1,777 1,857 5,300 3,678 2,529 2,600
1998 2,706 3,092 2,665 3,093 2,353 1,886 1,978 5,456 3,774 2,575 2,685
1999 2,817 3,202 2,750 n.a. n.a. 1,957 2,040 5,665    n.a.    n.a.    n.a.
n.a. Not available.
. . Not applicable.
(a) Australian data relate to the year ending 30 June in the following year; data for France and Germany relate to the 
calendar year indicated; data for New Zealand before 1990 relate to the year commencing 1 April in the year indicated, 
and data for 1990 onwards refer to the year ending 30 June in the following year; data for Canada, Japan and the 
United Kingdom relate to the year beginning 1 April in the year indicated; United States data relate to the year ending 
30 September in the year indicated. 
(b) Data for 1991 onwards refer to the unified Germany.
(c) Mean weighted by population.
(d) Weighted mean excluding the United States.
(e) Weighted mean excluding the United States and Japan.
(f) Excludes Germany in 1989 and 1990.
Note: Expenditures converted to Australian dollar (A$) values using GDP purchasing power parities.
Sources: AIHW Health Expenditure Database; OECD 2001.
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Of the selected OECD countries, Australia also recorded the third highest average real
growth in per person expenditure (2.8%), behind that of Japan (5.9%) and Germany
(4.1%) over this period.
5.3 Private health insurance
All Australians are eligible to choose to receive public hospital treatment at no direct
cost to themselves. Private health insurers provide cover for people who wish to be
treated by the doctor of their choice in a hospital and may provide a range of other
beneÞts (Box 5.5).
Funding of health services by health insurance funds
Total expenditure by health insurance funds includes beneÞts for non-health services,
such as funerals, sickness beneÞts and lifestyle activities. These are excluded from the
deÞnition of expenditure on health services used in this analysis. 
Total direct recurrent expenditure on health services funded through private health
insurance funds was $4,843 million in 1998Ð99 (Table 5.15). This was 9.5% of total health
expenditure in that year. In addition, the funds had made an adjustment to their
accumulated provision for outstanding claims of $10 million. At the same time the
Box 5.5: Private health insurance arrangements
Since the introduction of Medicare in 1984, health insurance funds operated by registered
health benefits organisations have offered hospital insurance (‘hospital tables’) for approved
services provided in both public and private hospitals. They have also offered ancillaries
insurance (‘ancillary tables’) for a wide range of non-hospital health and health-related
services. There are four categories of health insurance membership—singles, couples
without children, sole parents, and couples with children. (Registered health benefits
organisations are organisations registered under the National Health Act 1953 for the
purpose of conducting a health benefits fund.)
The funds are able to tailor hospital insurance to meet particular needs of different groups of
contributors. They can, for example, offer ‘exclusionary’ tables that exclude benefits for
obstetrics or hip replacements. The premiums for such insurance reflect the particular exclu-
sion(s) and are lower than for similar insurance that does not contain such exclusion(s).
‘Front-end deductible’ tables are also available. This allows contributors to meet a set amount
of the charge for hospital care from their own pockets whilst paying a reduced premium.
Health insurance arrangements changed substantially on 1 July 2000, with the introduc-
tion of lifetime health cover incentives. These incentives encourage people to take out and
retain private health insurance cover throughout their lives. From that date, people who
join a health insurance fund before their thirtieth birthday and maintain their hospital
cover pay lower premiums throughout their lives compared with someone who joins later
in life. People over 30 years old who take out hospital cover pay a loading of 2% for each
year that their entry age is over 30. Fund members who had hospital cover at 1 July 2000
and maintain it are exempt from the loading. People who were aged 65 years and over at
1 July 1999 are also exempt from the loading. 
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Commonwealth Government, through its 30% rebate of premiums, provided a subsidy
of $962 million to private health insurance. This, in effect, represented a subsidy of $960
million for the direct expenditure on health services, and $2 million for the adjustment
to the provisions for outstanding and unpresented claims.
In its 1999Ð00 budget the Commonwealth Government announced its intention to
introduce lifetime health cover incentives (see Box 5.5).
Direct recurrent expenditure funded through private health insurance increased by
$342 million to $5,185 million in 1999Ð00. The Commonwealth subsidy, on the other
hand, increased by almost 70%, to $1,634 million. Of this, $1,606 million related to the
direct recurrent expenditure and $28 million to the provision adjustment. This rapid
growth in the subsidy was partly due to the effect of the phasing in of lifetime health
cover over the year.
In the following year, 2000Ð01, which was the Þrst full year of the lifetime health cover
policy, direct recurrent expenditure through the funds grew to $6,190 million and the
subsidy payments by the Commonwealth to $2,125 million. The CommonwealthÕs subsidy
of direct recurrent expenditure on health services through private health insurance ($2,052
million) in that year represented just under one-third (33.2%).
The net funding of health services out of income generated by the funds themselves (i.e.
premiums and other income, less the Commonwealth subsidy) fell from $3,883 million
in 1998Ð99 to $3,579 million in 1999Ð00, before rising to $4,138 million in 2000Ð01. The
large increase in membership induced by the potential penalties to people who failed to
join a fund before 1 July 2000 meant the net income received by health insurance funds
during 2000Ð01 exceeded the beneÞts paid out during that year by $1.1 billion.
Accordingly, operating proÞts before abnormals and extraordinary items of the funds
(in current prices) increased almost Þvefold between 1998Ð99 and 2000Ð01, from $176
million to $852 million (Table 5.15).
In 2000Ð01, beneÞts paid for private hospital services accounted for $1,999 million, or
48.3% of the net funding for health by private health insurance. Expenditure on
administration ($564 million, 13.6%) and dental beneÞts ($517 million, 12.5%) were the
next largest areas of funding by private health insurance.
Trends in private health insurance coverage, membership and 
premiums
At the end of June 2001 there were 8.7 million Australians or 44.9% of the population
covered by private health insurance (PHIAC 2002). This was a fall of 0.9% from the
peak of 8.8 million (45.8%) that was reached at the end of September 2000, after an
accelerating upward trend in coverage that had begun in the March 1999 quarter
(Figures 5.6 and 5.7). 
From the introduction of Medicare in 1984, when the level of coverage was just over
50%, to December 1998, the general trend in coverage had been downward. At the end
of December 1998, 30% of the population were covered by health insurance.
AH2002 body 26-6  Page 263  Wednesday, June 26, 2002  6:28 PM
264  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
Ta
bl
e 
5.
15
: E
xp
en
di
tu
re
 o
n 
he
al
th
 s
er
vi
ce
s 
fu
nd
ed
 th
ro
ug
h 
he
al
th
 in
su
ra
nc
e 
fu
nd
s, 
cu
rr
en
t p
ri
ce
s, 
19
98
Ð9
9 
to
 2
00
0Ð
01
 ($
m
ill
io
n)
A
re
a 
of
 e
x
pe
nd
itu
re
19
98
–9
9
19
99
–0
0
20
00
–0
1
G
ro
ss
be
ne
fit
s
pa
id
Pr
em
iu
m
 re
ba
te
s(
a)
N
et
be
ne
fit
s
pa
id
G
ro
ss
be
ne
fit
s
pa
id
Pr
em
iu
m
 re
ba
te
s(
a)
N
et
be
ne
fit
s
pa
id
G
ro
ss
be
ne
fit
s
pa
id
Pr
em
iu
m
 re
ba
te
s(
a)
N
et
be
ne
fit
s
pa
id
D
ire
ct
Ta
xa
tio
n
D
ire
ct
Ta
xa
tio
n
D
ire
ct
Ta
xa
tio
n
Ex
pe
nd
itu
re
H
os
pi
ta
ls
2,
81
3
45
3
10
4
2,
25
5
2,
90
0
77
7
12
1
2,
00
2
3,
31
2
99
7
10
1
2,
21
4
 
 
Pu
bl
ic
 (n
on
-ps
yc
hia
tric
)
28
9
47
11
23
2
28
7
77
12
19
8
32
2
97
10
21
5
 
 
Pr
iva
te
2,
52
4
40
7
94
2,
02
4
2,
61
2
70
0
10
9
1,
80
3
2,
99
0
90
0
91
1,
99
9
Am
bu
la
nc
e
12
5
20
5
10
0
13
5
36
6
93
18
0
54
5
12
0
M
ed
ica
l s
er
vi
ce
s
25
3
41
9
20
3
28
1
75
12
19
4
42
7
12
9
13
28
5
O
th
er
 h
ea
lth
 
pr
of
e
ss
io
na
ls
23
5
38
9
18
8
26
2
70
11
18
1
33
3
10
0
10
22
3
Ph
ar
m
a
ce
u
tic
al
s
36
6
1
29
43
12
2
30
53
16
2
35
Ai
ds
 a
nd
 a
pp
lia
nc
es
18
6
30
7
14
9
21
0
56
9
14
5
26
8
81
8
17
9
Co
m
m
u
n
ity
/p
ub
lic
 h
ea
lth
1
—
—
1
1
—
—
1
1
—
—
1
D
en
ta
l s
er
vi
ce
s
60
3
97
22
48
3
63
6
17
0
27
43
9
77
4
23
3
24
51
7
To
ta
l h
ea
lth
 s
er
v
ic
es
4,
25
2
68
5
15
8
3,
40
9
4,
46
8
1,
19
7
18
6
3,
08
4
5,
34
7
1,
61
0
16
3
3,
57
4
H
ea
lth
 a
dm
in
ist
ra
tio
n
59
1
95
22
47
4
71
7
19
2
30
49
5
84
3
25
4
26
56
4
D
ire
ct
 e
x
pe
nd
itu
re
4,
84
3
78
0
18
0
3,
88
3
5,
18
5
1,
39
0
21
6
3,
57
9
6,
19
0
1,
86
4
18
8
4,
13
8
O
ut
st
an
di
ng
 c
la
im
s
10
2
—
8
91
24
4
63
22
0
66
7
14
7
To
ta
l e
x
pe
nd
itu
re
4,
85
3
78
2
18
0
3,
89
1
5,
27
6
1,
41
4
22
0
3,
64
2
6,
41
0
1,
93
0
19
5
4,
28
5
R
ev
en
u
e
Co
nt
rib
u
tio
ns
 in
co
m
e(
b)
3,
96
5
3,
82
8
5,
00
6
O
th
er
 re
ve
n
u
e
14
9
21
4
22
6
To
ta
l r
ev
e
n
u
e
4,
11
4
4,
04
2
5,
23
2
O
pe
ra
tin
g 
pr
ofi
t/l
os
s 
be
fo
re
 a
bn
or
m
a
ls
 a
nd
 e
xt
ra
o
rd
in
ar
y 
ite
m
s
17
6
38
1
85
2
(a)
Pr
em
iu
m
 re
ba
te
 is
 p
ro
-ra
te
d 
ac
ro
ss
 a
ll 
ca
te
go
rie
s 
(in
clu
din
g c
ha
ng
e i
n p
rov
is
io
ns
 fo
r 
o
u
ts
ta
nd
in
g 
cla
im
s).
(b)
Ad
jus
ted
 to
 re
mo
ve
 
th
e 
Co
m
m
on
we
a
lth
 re
im
bu
rs
e
m
e
n
t t
o 
th
e 
fu
nd
s 
fo
r 
th
e 
30
%
 re
ba
te
 o
n 
pr
em
iu
m
s.
So
ur
ce
s: 
PH
IA
C 
qu
ar
te
rly
 re
po
rts
 a
nd
 A
nn
u
a
l R
ep
or
t: 
O
pe
ra
tio
ns
 o
f t
he
 R
eg
ist
er
ed
 H
ea
lth
 B
en
efi
ts
 O
rg
an
isa
tio
ns
 1
99
7–
98
 to
 1
99
9–
00
. D
ep
ar
tm
en
t o
f t
he
 T
re
a
su
ry
,
 
Ta
x 
Ex
pe
nd
itu
re
s 
St
at
em
en
t, 
va
rio
us
 y
e
a
rs
.
AH2002 body 26-6  Page 264  Wednesday, June 26, 2002  6:28 PM
5 Health resources and use of services  265
TRIM SIZE 175 mm Wide x 250 mm Deep
Events which have contributed to the growth in coverage during recent years include
the following:
¥ In 1995, funds were enabled to provide cover that excluded beneÞts for some types of
treatment (e.g. obstetrics). 
¥ The Private Health Insurance Incentives Scheme was introduced in 1997. This
provided a reimbursement of part of the premiums charged by private health
insurance funds to low- and middle-income earners.
¥ In October 1997 the government introduced an additional levy of 1% of taxable
income on single people with taxable incomes exceeding $50,000 and couples with
combined taxable incomes exceeding $100,000 who did not have private health
insurance that covered hospital services.
¥ The Private Health Insurance Incentives Scheme was replaced by a non-means-tested
30% reimbursement of private health insurance premiums in 1999. 
¥ Lifetime health cover arrangements were introduced. This requires funds to charge a
loading on premiums of 2% for each year that the age of a new member exceeds 30 at
the time of joining a fund. Legislation to give effect to this policy initiative was
passed in 1999 and people who wanted to avoid having to pay the loading were
required to join a fund before 1 July 2000 or before they turned 31 years of age.
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Sources: PHIAC 2001, 2002 and PHIAC unpublished data. 
Figure 5.6: Proportion of population covered by basic health insurance, 1985 to 2001
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The greatest immediate inßuence on the level of coverage was the lifetime health cover
provision. Coverage increased from 32.3% at the end of March 2000, to 45.8% at
30 September 2000, reßecting the full implementation of the Commonwealth
GovernmentÕs lifetime health cover arrangements during the September quarter.
Growth in premiums income, expenditure and reserves
From the introduction of Medicare in 1984 until June 2001, real growth in premiums
income averaged 6.5% per year. Most of this occurred during the 1980s when premiums
rose by an average of 8.0% per year. From 1989Ð90, with falling coverage of health
insurance in the population (44.5% in June 1990; 33.6% in June 1996), the average rate of
growth was much lower, at 6.3% per year. However, since 1996Ð97 when the
Commonwealth Government began to provide incentives in the form of rebates on
premiums, premiums have averaged a 10.6% real increase each year (Table S51).
Real growth in the total amount of beneÞts (including ambulance levies paid to State
and Territory governments) through health insurance funds averaged 5.8% per year
between 1984 and 2001. However, the major growth in these expenditures was during
the 1980s. From 1984Ð85 to 1988Ð89, expenditures grew at an average of 10.5% per year
and from 1989Ð90 to 2000Ð01 at an average of 4.3% per year (Table S51). 
The total reserves, or net assets, of the registered health beneÞts funds in 2000Ð01 were
$2,387 million. This represents a real increase of 51.6% in the level of the reserves
between 1999Ð00 and 2000Ð01 (Table S52). 
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(a) Front-end deductible insurance.
Source: PHIAC annual reports, various years.
Figure 5.7: Hospital insurance coverage, 1995Ð96 to 2000Ð01
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5.4 Health workforce
This section provides information relating to the workforce in health industries and
occupations in Australia. Information of this nature assists in health workforce planning,
which in turn is critical to providing an adequate and suitably distributed workforce
around Australia. The health workforce is large and diverse, covering many occupations,
ranging from highly qualiÞed professionals to support staff and volunteers. 
This section covers the size and composition of and recent changes to three of the major
health occupations, namely medical practitioners, nurses and pharmacists, although
some comparative data are also provided for other health occupations. These
occupations were selected because they are the largest and the ones for which there is
relatively recent good data coverage. The numbers of students who commenced
undergraduate courses in health-related Þelds in 1995 and 2000, and key components of
migration for employment of people in major health occupations are also described.
Finally, an international comparison is given of medical practitioners, nurses and
dentists in terms of numbers per 1,000 population in Australia, New Zealand, Canada,
the United States and the United Kingdom, and changes between 1981 and 1998. 
Health industry employees
In 2000, there were an estimated 643,500 people employed in the health industry
(excluding veterinary services), comprising 7.1% of the total civilian workforce in
Australia (Table 5.16). Of these, 386,500 (60.1%) were full-time employees, and 256,500
(39.9%) were part time. Part-time employees represented a higher than average
percentage, compared with the total civilian workforce (26.3%). This is because the
health industry tends to attract female workers, who make up 78.1% of the health
workforceÑmuch higher than in the total civilian workforce (43.8%). Females (43.7%)
are more likely than males (12.8%) to work part time in general, and in the health
industry, 47.1% of female workers are part time, compared with 14.1% of males. In fact,
92.3% of part-time health employees in 2000 were female. 
In comparison to the workforces of other industries, the health industry is relatively
fast-growing. Between 1995 and 2000, it increased by 12.1%, compared with a 9.6%
increase in the total civilian workforce. Over this period, the increase in part-time
employment (19.2%) was much greater than that for full-time employment (7.5%).
These increases were greater than the percentage increases in the civilian workforce
(17.5% and 7.1% respectively).
Across the broad industry groups within the health industry, the increase in
employment for medical and dental services (16.9%) was greater than those for
hospitals and nursing homes (12.0%) and other health services (excluding veterinary
services) (7.1%), with the increases in part-time employment being much greater than
for full-time employment in each industry.
Health occupations
Health occupations comprise professionals who diagnose and treat physical and mental
illnesses and conditions and recommend, administer, dispense and develop
medications and treatment to promote or restore good health. In this section, only the
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following are discussed: medical practitioners, nurses, dental practitioners,
pharmacists, physiotherapists and medical imaging professionals.
Of the 328,800 employees in health occupations in 2000Ð01, over three quarters (76.3%)
were females (Table 5.17), but this varied widely across occupations, from 95.5% for
enrolled nurses and 91.0% for registered nurses, to 17.2% for dentists. Of the females,
44.1% worked part time compared with 9.6% of males. 
Between 1996Ð97 and 2000Ð01, the number of health professionals increased by 8.2%,
with males up by 4.0% and females up 9.6%. The overall increase in the female
workforce was reßected in almost all occupations, with enrolled nurses (down 22.9%)
being the only occupation to fall.
Advances in medical technology may account for the rapid increase in the medical
imaging occupation (up 27.6%), with more widespread use of magnetic resonance
imaging, ultrasound and computerised tomography scanning. This occupation
recorded the greatest increase between 1996Ð97 and 2000Ð01, with marked increases
also recorded for physiotherapists and pharmacists. The largest decreases occurred in
the number of enrolled nurses, down 24.1%, but this was accompanied by an increase of
11.6% in registered nurses.
Table 5.16: Health industry employees, 2000
Industry
Males Females Persons Per cent
femaleFull-time Part-time Full-time Part-time Full-time Part-time Total
Hospitals and nursing homes
2000 (’000) 65.5 10.3 184.0 148.3 249.5 158.5 408.5 81.4
Increase from 
1995 (%) 1.9 17.1 11.2 17.0 8.6 17.0 12.0 . .
Medical and dental services
2000 (’000) 30.3 4.3 43.3 52.3 73.5 56.5 129.5 73.4
Increase from 
1995 (%) 8.0 30.8 12.3 27.4 10.5 27.7 16.9 . .
Other health services (excluding veterinary services)
2000 (’000) 24.8 5.3 38.8 36.3 63.5 41.5 105.5 71.1
Increase from 
1995 (%) –9.2 31.3 7.6 15.1 0.4 16.9 7.1 . .
Health services (excluding veterinary services)
2000 (’000) 120.5 19.8 266.0 236.8 386.5 256.5 643.5 78.1
Increase from 
1995 (%) 0.8 23.4 10.8 18.8 7.5 19.2 12.1 . .
Total civilian workforce 
2000 (’000) 4,414.5 647.8 2,222.5 1,724.5 6,637.0 2,372.3 9,009.3 43.8
Increase from 
1995 (%) 6.0 26.5 9.3 14.4 7.1 17.5 9.6 . .
. . Not applicable.
Note: Annual figures are the average of the four quarters.
Source: ABS Labour Force Survey data, from AUSTATS.
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Table 5.17: Workforces in selected health occupations, 2000Ð01 
Occupation
Males Females Persons
Per cent
female
Full-
time
Part-
time Total
Full-
time
Part-
time Total
Full-
time
Part-
time Total
Generalist medical practitioners
Workforce (’000) 21.3 2.0 23.0 7.5 3.8 11.5 28.8 5.8 34.5 33.3
Change since 
1996–97 (%) n.a. n.a. –4.2 n.a. n.a. — n.a. n.a. –2.8 . .
Specialist medical practitioners
Workforce (’000) 10.3 0.8 11.3 2.8 1.5 4.0 13.0 2.3 15.3 26.2
Change since 
1996–97 (%) n.a. n.a. –10.0 n.a. n.a. 6.7 n.a. n.a. –6.2 . .
Registered nurses(a)
Workforce (’000) 15.0 1.3 16.5 91.0 76.0 166.8 106.0 77.3 183.3 91.0
Change since 
1996–97 (%) n.a. n.a. 22.2 n.a. n.a. 10.6 n.a. n.a. 11.6 . .
Enrolled nurses
Workforce (’000) 1.0 0.3 1.0 11.3 10.0 21.0 12.3 10.3 22.0 95.5
Change since 
1996–97 (%) n.a. n.a. –42.9 n.a. n.a. –22.9 n.a. n.a. –24.1 . .
Dental practitioners
Workforce (’000) 5.5 0.8 6.0 1.0 0.3 1.3 6.5 1.0 7.3 17.2
Change since 
1996–97 (%) n.a. n.a. –4.0 n.a. n.a. — n.a. n.a. –3.3 . .
Pharmacists
Workforce (’000) 5.5 1.0 6.8 6.0 3.3 9.0 11.5 4.3 15.8 57.1
Change since 
1996–97 (%) n.a. n.a. — n.a. n.a. 50.0 n.a. n.a. 23.5 . .
Physiotherapists
Workforce (’000) 2.0 0.5 2.0 5.5 4.8 10.0 7.5 5.3 12.0 83.3
Change since 
1996–97 (%) n.a. n.a. 14.3 n.a. n.a. 25.0 n.a. n.a. 23.1 . .
Medical imaging professionals
Workforce (’000) 3.5 — 3.5 3.3 2.5 5.8 6.8 2.5 9.3 62.2
Change since 
1996–97 (%) n.a. n.a. 55.6 n.a. n.a. 15.0 n.a. n.a. 27.6 . .
Total(b)
Workforce (’000) 70.5 7.5 77.8 141.0 110.8 251.0 211.5 118.3 328.8 76.3
Change since 
1996–97 (%) 6.0 11.1 4.0 11.0 7.5 9.6 9.3 7.7 8.2 . .
n.a. Not available.
. . Not applicable.
(a) Includes nurse managers, educators, researchers, registered midwives, registered mental health nurses and 
developmental disability nurses. 
(b) Excludes veterinary surgeons; includes other health professionals not individually shown.
Note: Data compiled by averaging rounded quarterly data. Figures showing per cent changes between 1996–97 and 
2000–01 should be treated with caution, due to rounding of numbers and sampling variability.
Source: ABS Labour Force Survey data, from AUSTATS.
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Geographical distribution 
The distribution of the health workforce across Australia does not match the population
distribution. This is true of the three occupations examined hereÑmedical practitioners,
nurses and pharmacists. Moreover, these health workers are distributed differently from
each other. For example, there was a marked variation in the distribution of medical
practitioners, but less variation for nurses, as discussed in the following sections.
Medical practitioners
In 1999, there were higher percentages of medical practitioners in capital cities (76.8%)
and large rural centres (6.2%) than the percentages of population residing in those areas
(63.9% and 6.0% respectively) (Table 5.18). For other areas, the percentage of medical
Table 5.18: Medical practitioners: characteristics by geographic location (RRMA) of main job, 
1999
Geographic location of main job
Capital
city
Other
metropolitan
centre
Large
rural
centre
Small
rural
centre
Other
rural area
Remote
centres
and areas Total
Number 39,165 3,619 3,135 2,035 2,343 672 50,969
Practitioner 
distribution (%) 76.8 7.1 6.2 4.0 4.6 1.3 100.0
Population 
distribution (%) 63.9 7.6 6.0 6.5 13.2 2.7 100.0
Practitioners per 
100,000 population 322 248 277 165 94 8 268
Males 27,067 2,736 2,370 1,555 1,780 462 35,970
Females 12,098 882 765 480 563 210 14,999
Per cent female 30.9 24.4 24.4 23.6 24.0 31.2 29.4
Type of medical practitioner
Primary care 
practitioners 14,900 1,526 1,193 1,185 1,987 440 21,232
Hospital non-
specialists 3,694 413 390 142 77 85 4,801
Specialists 13,903 1,207 1,306 599 203 89 17,306
Specialists-in-training 4,179 334 128 27 11 14 4,694
Non-clinicians 2,489 139 118 81 66 44 2,937
Age (years) Per cent
Under 35 23.1 21.8 17.2 13.3 12.4 30.4 21.8
35–44 28.2 28.8 32.9 32.3 34.1 38.4 29.1
45–54 24.8 25.7 28.3 30.0 27.8 18.4 25.4
55–64 14.6 14.7 14.6 15.0 13.9 9.0 14.6
65 and over 9.2 8.9 7.0 9.3 11.9 3.7 9.1
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Average age (years) 46.0 45.8 45.7 47.5 47.4 42.6 46.1
Note: Based on the Rural, Remote and Metropolitan Classification of the Department of Primary Industries and Energy and 
the Department of Human Services and Health (1994).
Source: AIHW (in press).
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practitioners was lower than the percentage of population. The greatest imbalance was
in other rural areas, where 13.2% of AustraliaÕs population resided, but only 4.6% of
medical practitioners had their main practice.
Medical practitioners in remote areas were generally much younger (average 42.6 years
in 1999) than those in metropolitan and rural areas, with 3.7% of them aged 65 years or
more, compared with 9.1% Australia-wide. Temporary resident doctors (recruited from
overseas for periods less than 1 year) (2,224 in 1998Ð99) were generally at the younger
end of the age range for doctors, and many worked in remote areas, particularly in
Queensland, Western Australia and Victoria (AIHW 1999). This could partly explain the
relatively high percentage (30.4%) of medical practitioners aged under 35 years
practising in remote areas. Medical practitioners in small rural centres (average age 47.5
years) and other rural areas (47.4 years) were marginally older than those in
metropolitan areas. This lower average age for metropolitan doctors may reßect the
numbers of younger doctors undertaking training in teaching hospitals, which are
located mainly in metropolitan areasÑthis acts to reduce the average age in
metropolitan areas. The introduction in the 1999Ð00 Commonwealth Budget of
scholarships such as the Rural Australia Medical Undergraduate Scholarship Scheme,
to assist students from rural and remote areas to undertake medical courses, would not
yet have had a discernible impact on the doctor numbers in non-metropolitan areas.
Table 5.19: Employed registered and enrolled nurses: characteristics by geographic location 
(RRMA) of main job, 1997
Geographic location of main job
Capital
city
Other
metropolitan
centre
Large
rural
centre
Small
rural
centre
Other
rural area
Remote
centre
Other
remote
area Total
Number 139,363 15,385 19,177 17,004 24,630 2,687 3,964 222,211
Per cent registered 83.3 77.5 77.8 71.9 65.1 72.0 72.1 79.2
Nurse distribution (%) 62.7 6.9 8.6 7.7 11.1 1.2 1.8 100.0
Population 
distribution (%) 63.9 7.6 6.0 6.5 13.2 1.2 1.5 100.0
Employed nurses per 100,000 population
Registered nurses 984 853 1,348 1,013 652 875 847 950
Enrolled nurses 198 247 386 397 350 340 328 250
All nurses 1,182 1,100 1,734 1,410 1,001 1,214 1,175 1,200
Age (years) Per cent
Under 30 17.9 15.7 15.5 12.2 9.2 19.5 17.3 16.1
30–39 31.3 34.4 33.4 33.6 31.7 36.6 34.6 32.0
40–49 31.8 34.0 34.2 35.9 37.0 29.3 29.1 33.0
50–59 16.2 13.7 14.8 16.2 18.7 12.4 15.4 16.1
60 and over 2.8 2.2 2.2 2.1 3.4 2.3 3.6 2.8
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Average age (years) 40.1 39.9 40.1 40.9 42.1 38.8 40.0 40.3
Note: Based on the Rural, Remote and Metropolitan Classification of the Department of Primary Industries and Energy and 
the Department of Human Services and Health (1994).
Source: AIHW 2001g.
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There was a higher percentage of female medical practitioners in 1999 in remote areas
(31.2%) and capital cites (30.9%) than in other areas, where the percentages were around
24%.
Nurses
Unlike other health occupations, the percentage of employed nurses in metropolitan
areas was lower than the percentage of AustraliaÕs population in those areas (although
only slightly so). In other areas, nurses tended to be concentrated in cities and towns
with hospitals (mainly large rural centres), where the percentage of nurses exceeded the
population share (Table 5.19). In terms of number per 100,000 population, large and
small rural centres were better served with both registered and enrolled nurses than all
other areas. 
The age distribution of nurses across geographic areas was fairly even, with those in
other rural areas slightly older on average (42.1 years) and those in remote centres
slightly younger (38.8 years).
Table 5.20: Employed pharmacists(a): characteristics by geographic location (RRMA) of main 
job, 1996
Geographic location of main job
Capital
city
Other
metropolitan
centre
Large
rural
centre
Small
rural
centre
Other
rural area
Remote
centre
Other
remote
area Total
Number 9,889 933 801 785 1,243 89 94 13,833
Pharmacist 
distribution (%) 71.5 6.7 5.8 5.7 9.0 0.6 0.7 100.0
Population 
distribution (%) 63.9 7.6 6.0 6.5 13.2 1.2 1.5 100.0
Pharmacists per 
100,000 population 84.9 67.8 73.1 65.7 50.9 40.9 27.9 75.6
Males 5,175 577 491 472 796 51 57 7,619
Females 4,714 356 310 313 447 38 37 6,215
Type of pharmacist
Community 7,635 815 673 672 1,173 77 82 11,126
Hospital/clinic 1,518 108 123 104 63 12 12 1,940
Other 736 10 5 9 7 — — 767
Age (years) Per cent
Under 30 16.5 12.6 13.0 11.6 7.6 16.7 9.0 14.8
30–44 34.2 28.9 31.4 35.9 32.5 46.7 29.9 32.9
45–64 44.1 49.6 48.1 46.3 50.9 31.7 55.2 45.8
65 and over 5.2 9.0 7.5 6.1 9.0 5.0 6.0 6.5
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Average age (years) 42.5 46.4 45.8 44.5 47.7 37.8 45.0 43.7
(a) Includes self-employed.
Note: Based on the Rural, Remote and Metropolitan Classification of the Department of Primary Industries and Energy and 
the Department of Human Services and Health (1994).
Source: AIHW 2000a.
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Pharmacists
Populations in the capitals were better served with pharmacists than all other
geographical areas (Table 5.20). This was reßected in the number of employed
pharmacists per 100,000 population, with the rate of 84.9 in capital cities and 50.9, 40.9
and 27.9 in other rural areas, remote centres, and other remote areas, respectively. 
Of the 13,833 pharmacists in Australia, the great majority (11,126 or 80.4%) were
community pharmacists. The average age for employed pharmacists was 46.7 years. 
The proÞle of pharmacists in capital cities differed from other geographic areas, with
77.2% being community pharmacists, 15.3% hospital/clinic pharmacists and 7.5% other
pharmacists (mainly working in government and research organisations). In every
other area, community pharmacists constituted over 84% of all pharmacists. The
percentage of pharmacists who were working in hospitals (14.0%) was much the same
in all areas (between 11.6% and 15.4%) except for other rural areas (5.1%). Pharmacists
tend to work in large hospitals, few of which are located in other rural areas.
As was the case for medical practitioners, the percentage of pharmacists who were
female was higher in capital cities (47.7%) and remote centres (43.1%) than other areas,
with the percentage in other rural areas being a relatively low 35.9%. 
Dental practitioners
Data collected by the AIHW Dental Statistics and Research Unit in the last quarter of
2000 in cooperation with the State and Territory dental boards and health departments
show that, compared with 1994, the number of dental practitioners practising in
Australia increased by 17.3% to 8,991 in 2000 (Table 5.21). Nationally, the percentage of
female practitioners increased from 18.4% in 1994 to 22.9% in 2000.
Table 5.21: Practising dentists, 1994 and 2000
Dentists per 100,000 population
State or
Practising 
dentists Per cent female Capital city
Rest of State or 
Territory Total
Territory 1994 2000 1994 2000 1994 2000 1994 2000 1994 2000
NSW 2,733 3,126 17.5 22.7 54.8 58.4 29.6 31.2 45.2 48.4
Vic 1,867 2,204 20.1 25.5 48.2 52.4 25.5 29.9 41.7 46.3
Qld 1,314 1,564 16.6 20.6 50.2 52.2 33.5 36.9 41.1 43.9
SA 731 821 19.3 22.7 59.4 64.5 23.4 28.3 49.7 54.8
WA 675 913 17.9 21.6 45.8 55.6 23.4 29.0 39.7 48.5
Tas 119 119 19.3 16.8 31.9 33.9 20.5 19.2 25.2 25.3
NT 55 60 27.3 27.5 42.3 48.7 20.5 15.0 32.1 30.5
ACT 173 184 21.4 25.7 57.5 59.2 . . . . 57.5 59.3
Australia 7,667 8,991 18.4 22.9 51.2 55.6 28.7 31.5 43.0 46.9
. . Not applicable.
Source: AIHW Dental Statistics and Research Unit.
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The number of dentists per 100,000 population had increased in all States and
Territories, except in the Northern Territory, where the rate had declined since 1994.
There was a relatively large variation around the national average rate of 46.9, ranging
from 25.3 dentists per 100,000 population in Tasmania to the highest rate of 59.3 in the
Australian Capital Territory. There was a substantial difference in the rates per 100,000
population in the capital cities (overall rate 55.6) compared with other areas (31.5). The
increase in the rate for capital cities since 1994 was marginally greater than the increase
for other areas.
Tertiary education entrants to the workforce 
In 2000, the highest numbers of students commencing health-related courses were in
the Þelds of nursingÑbasic (6,954), nursingÑpost-basic, including bachelor level
(4,134), medicine (1,303), medical science (1,031) and health science/technology (1,013)
(Table 5.22).
Table 5.22: Australian citizens/residents commencing undergraduate study, 1995 and 2000 
Field of study
1995 2000
% change
1995 to 2000Number % female Number % female
Dental therapy 20 85.0 33 87.9 65.0
Dentistry 199 40.2 264 48.5 32.7
Health—general 172 44.2 325 60.3 89.0
Health administration 357 73.9 336 79.8 –5.9
Health counselling 165 78.2 96 85.4 –41.8
Health support—general 373 81.2 270 74.1 –27.6
Health support—other 341 23.8 835 50.5 144.9
Health surveying/environmental 
health 173 43.9 198 57.6 14.5
Medical radiography 567 64.2 658 67.5 16.0
Medical science 454 61.5 1,031 68.0 127.1
Medical technology 333 65.2 320 66.6 –3.9
Medicine 856 47.4 1,303 53.6 52.2
Nursing—basic 7,099 84.6 6,954 86.6 –2.0
Nursing—post-basic 6,577 89.7 4,134 89.3 –37.1
Bachelor level 3,778 90.0 1,224 89.1 –67.6
Nutrition & dietetics 92 81.5 270 91.9 193.5
Occupational therapy 618 87.5 799 87.2 29.3
Optometry 181 61.3 230 68.7 27.1
Pharmacy 568 57.0 768 67.1 35.2
Physiotherapy 651 60.5 759 63.0 16.6
Podiatry 101 59.4 180 60.6 78.2
Rehabilitation 175 80.0 458 71.0 161.7
Health science/technology 651 71.4 1,013 66.4 55.6
Speech pathology/audiology 352 94.3 429 96.7 21.9
Indigenous total 312 79.2 308 72.7 –1.3
Total 18,276 77.4 18,753 75.9 2.6
Source: AIHW analysis of Department of Education, Science and Training data.
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Between 1995 and 2000, the largest percentage increases in course commencements
were courses with small numbers of commencing students, namely nutrition/dietetics
(up 193.5%), rehabilitation (up 161.7%), health supportÑother (up 144.9%) and medical
science (up 127.1%).
Of the large disciplines (those with more than 500 commencements), all had increases in
enrolments except nursing. Enrolments in basic nursing courses fell by 2.0%, and those
in post-basic nursing courses fell by 37.1%. The fall in post-basic nursing
commencements was mainly due to substantial decreases in those commencing a
bachelor-level course (down 67.6% between 1995 and 2000). Between 1988 and 1993,
nurse education transferred from hospitals to the higher education sector. This resulted
in a very large rise in commencements of bachelor degrees during the following few
years, when many hospital-trained nurses took up the option to upgrade their
qualiÞcations. Commencements reached a maximum of 3,778 in 1995, making up 57%
of all post-basic nursing commencements in that year, and have declined steadily since
then.
Decreases in commencements were also recorded in health counselling (down 41.8%),
health supportÑgeneral (down 27.6%), health administration (down 5.9%) and medical
technology (down 3.9%). 
The number of Indigenous people commencing undergraduate health courses hardly
changed (from 312 to 308) between 1995 and 2000. Most of these students were
commencing courses in nursingÑbasic (82), health supportÑgeneral (81) and health
supportÑother (72), and 19 commenced in medicine.
Migration of health professionals
In 1999Ð00, migration of health professionals to and from Australia comprised 9,427
arrivals and 7,743 departures of a permanent or long-term nature, a net gain of 1,684
(Table 5.23). Note, however, that these Þgures represent arrivals and departures for all
purposes, not just employment, and therefore do not equate with additions to the
workforce. For example, some people arriving will be required to fulÞl the
requirements of professional bodies, some may not obtain employment in their stated
occupation, and some arrive to visit relatives, to holiday or for study or business.
Of permanent and long-term arrivals into and departures from Australia during
1999Ð00, the largest categories of occupation by far were nurses, with 4,092 arrivals and
3,625 departures, resulting in a net gain of 467. There was also a large movement of
general practitioners, with 2,276 arriving and 1,684 leaving, resulting in a net gain of
592. There was a net gain of 172 medical specialists. 
In addition to long-term and permanent migration into and out of the country, there are
quite large numbers of short-term visitors (for a period of 1 year or less), arriving and
leaving. A total of 2,089 short-term visitors arrived in Australia in 1999Ð00 for
employment in a health occupation. Over half of these were general practitioners
(1,376), 395 were nurses and a further 156 were medical specialists. General
practitioners are brought into Australia to work as Temporary Resident Doctors in areas
of need, for periods of up to 12 months. 
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Although it is not known how many Temporary Resident Doctors left Australia during
the year, the number is likely to be fairly similar to the number arriving, as there is a
fairly steady turnover. Their visa conditions are that they cannot stay indeÞnitely, and
their average intended length of stay is just under 12 months (48.5 weeks in 1999Ð00).
Nevertheless, there is always a stock of around 1,000 overseas doctors temporarily
working in various parts of AustraliaÑat any point in time during 1999Ð00 they
numbered approximately 1,275. 
Private sector practices and employment
Private sector employment makes up an important and substantial proportion (60%)
(ABS Census of Population and Housing, 1996, unpublished data) of all workers in the
health industry, as the Þrst point of contact for many patients is often a visit to a local
practitioner in their rooms. The ABS series of surveys of private sector health businesses
and the practitioners who work in them provide relevant information.
Table 5.23: Migration of health professionals: overseas arrivals and departures, 1999Ð00
Permanent and long-term arrivals and departures Short-
term
arrivalsArrivals Departures
Occupation
Residents
returning
after long-
term stay
Perm-
anent
settlers
Visitors,
for long-
term stay Total
Resid-
ents
leaving
perm-
anently
Resid-
ents
leaving
for long-
term stay
Long-
term
visitors
leaving Total
Net
perma-
nent and
long-term
arrivals
Visitors,
for
employ-
ment
Medical 
practitioners
   General 642 439 1,195 2,276 279 715 690 1,684 592 1,376
   Specialist 46 105 160 311 17 35 87 139 172 156
Nurses(a) 1,866 1,158 1,068 4,092 752 2,039 834 3,625 467 395
Dental 
practitioners 111 108 92 311 44 96 62 202 109 21
Pharmacists 133 155 137 425 47 168 109 324 101 24
Occupational
therapists 160 39 28 227 26 194 19 239 –12 10
Optometrists 104 134 114 352 54 96 134 284 68 22
Physio-
therapists 334 90 113 537 82 369 77 528 9 15
Speech  
pathologists 58 17 19 94 15 73 7 95 –1 4
Chiropractors/
osteopaths 46 14 16 76 16 41 18 75 1 0
Podiatrists 11 16 6 33 3 15 7 25 8 2
Medical imaging
professionals 113 56 88 257 28 106 55 189 68 31
Other health 122 177 137 436 68 130 136 334 102 33
Total 3,746 2,508 3,173 9,427 1,431 4,077 2,235 7,743 1,684 2,089
(a) Includes midwives.
Source: AIHW analysis of Department of Immigration and Multicultural and Indigenous Affairs data.
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Dental practitioners (7,368) were the most commonly reported type of professional
(Table 5.24). They were employed in 5,099 dental practices, implying that many worked
in single-person practices.
Dentists also had by far the highest percentage of their number who were males
employed full time (64.1%), with audiologists/audiometrists (22.7%) the lowest.
Relatively high percentages of physiotherapists and chiropractic/osteopathic
practitioners were female part-timers (41.3% and 39.9%, respectively).
Data from the ABS private health business surveys are not comparable with the AIHW
Labour Force Survey data (Tables 5.18 to 5.20), because their methodologies and scope
are different. For some occupations, such as physiotherapists, the difference is
considerable.
Australian and international health workforces 
This section compares the full-time equivalent numbers and rates per 1,000 population
of medical practitioners, dentists and nurses in Þve selected OECD countries: Australia,
New Zealand, Canada, the United States and the United Kingdom (Table 5.25). Growth
in the number of those practitioners in the Þve countries between 1981 and 1998 is also
discussed. Care must be taken, however, when making comparisons between the
countries shown, as their occupational classiÞcations differ.
Table 5.24: Practices and employment of health professionals in private practice, June 1998
Employment
Health 
profession
Males Females Persons
Practices
Full-
time
Part-
time Total
Full-
time
Part-
time Total
Full-
time
Part-
time Total
Number
Dental practice 5,099 4,720 1,073 5,793 730 845 1,575 5,450 1,918 7,368
Physiotherapy 3,242 1,297 644 1,941 1,385 2,336 3,721 2,682 2,980 5,662
Chiropractic/
osteopathic 2,132 1,772 385 2,157 1,369 2,344 3,713 3,141 2,729 5,870
Optometry/
optical 
dispensing 1,557 1,480 237 1,717 637 348 985 2,117 585 2,702
Audiology/
audiometry 146 114 22 136 225 142 367 339 164 503
Per cent
Dental practice . . 64.1 14.6 78.6 9.9 11.5 21.4 74.0 26.0 100.0
Physiotherapy . . 22.9 11.4 34.3 24.5 41.3 65.7 47.4 52.6 100.0
Chiropractic/
osteopathic . . 30.2 6.6 36.7 23.3 39.9 63.3 53.5 46.5 100.0
Optometry/
optical 
dispensing . . 54.8 8.8 63.5 23.6 12.9 36.5 78.3 21.7 100.0
Audiology/
audiometry . . 22.7 4.4 27.0 44.7 28.2 73.0 67.4 32.6 100.0
. . Not applicable.
Sources: ABS 1999a, 1999b, 1999c, 1999d, 1999e. 
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Practising medical practitioners
The number of practising physicians (medical practitioners) per 1,000 population in 1998
in the Þve selected countries ranged from 1.7 for the United Kingdom, 2.1 for Canada,
2.2 for New Zealand, 2.5 for Australia, up to 2.7 for the United States (Table 5.25). 
The number of practising physicians per 1,000 population increased in all countries
between 1993 and 1998, except for Canada. Australia maintained its position of having
the second highest rate behind the United States in 1981, 1993 and 1998.
Table 5.25: Health professionals, selected OECD countries, 1981, 1993 and 1998
Australia
New
Zealand Canada
United
States
United
Kingdom
Practising physicians 1981
FTE professionals 27,127 5,037 45,542 463,330 73,958
FTE per 1,000 population 1.8 1.6 1.8 2.0 1.3
1993
FTE professionals 42,300 6,872 61,877 652,240 87,721
FTE per 1,000 population 2.4 1.9 2.2 2.5 1.5
1998
FTE professionals 46,078 8,491 62,977 725,357 101,732
FTE per 1,000 population 2.5 2.2 2.1 2.7 1.7
Nurses 1981
FTE professionals 106,565 20,341 161,269 1,326,700 256,921
FTE per 1,000 population 7.1 6.4 6.5 6.5 4.6
1993
FTE professionals 147,238 33,429 235,117 1,975,800 295,245
FTE per 1,000 population 8.3 9.4 8.2 7.7 5.1
1998
FTE professionals (a)149,202 36,763 227,651 2,238,800 299,010
FTE per 1,000 population (a)8.1 9.7 7.5 8.3 5.0
Dentists 1981
FTE professionals 6,380 (b)1,145 11,484 124,400 18,163
FTE per 1,000 population 0.4 (b)0.4 0.5 0.6 0.4
1993
FTE professionals 7,618 1,306 15,024 151,400 21,440
FTE per 1,000 population 0.4 0.4 0.5 0.6 0.4
1998
FTE professionals (a)8,000 1,496 16,507 157,900 23,409
FTE per 1,000 population (a)0.4 0.4 0.5 0.6 0.4
(a) 1997 data.
(b) 1980 data.
Note: FTE = full-time equivalent.
Source: OECD 2001.
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Nurses
In 1998 the number of nurses per 1,000 population was higher for New Zealand (9.7)
than the rates for the other selected countries, with the United Kingdom having the
lowest rate of 5.0. The numbers of nurses per 1,000 population increased in each of the
selected countries between 1981 and 1993; after 1993 the rates decreased for Australia
(down 0.2 per thousand), Canada (down 0.7) and the United Kingdom (down 0.1).
Between 1993 and 1998, the increase in the number of nurses was greater in the United
States (up 13.3%) than in the other selected countries. The numbers in Australia (1993 to
1997) and the United Kingdom rose slightly (each up 1.3%), and the number in Canada
fell by 3.2%.
Dentists
The number of dentists per 100,000 population in each of the countries selected appears
to have remained stable for many years, with rates for each country being the same in
1998 as they had been both in 1981 and in 1993. In all 3 years, there were 0.4 dentists per
1,000 population in Australia, New Zealand and the United Kingdom, with slightly
higher rates for Canada (0.5) and the United States (0.6).
The increase between 1993 and 1998 in the number of dentists was higher in New
Zealand (up 14.5%) than in the other selected countries, with the United States having
the lowest increase (up 4.3%). In Australia, the number of dentists increased marginally
between 1993 and 1997 (up 5.0%), which appears to contradict the decline of 3.3%
depicted in Table 5.17. This decline, however, occurred in a subsequent period (1996Ð97
to 2000Ð01).
5.5 Provision and use of health services
Hospitals
In 1999Ð00, there were 726 public acute care hospitals and 302 private hospitals other
than freestanding day hospital facilities, numbers not much changed over recent years
(Table 5.26). Acute care hospitals provide at least minimal medical, surgical or obstetric
services for admitted patient treatment and/or care, and provide 24-hour nursing
service as well as other necessary professional services. Private hospitals in this
category include acute care and psychiatric hospitals.
In contrast, there was a marked change in the number of private freestanding day
hospital facilities, with numbers nearly doubling from 111 in 1993Ð94, to 207 in 1999Ð00.
These facilities provide investigation and treatment services for admitted patients on a
day-only basis.
The number of public psychiatric hospitals declined by 40% from 37 in 1993Ð94 to 22 in
1999Ð00. These hospitals are devoted mainly to the treatment and care of admitted
patients with psychiatric, mental or behavioural disorders. Reforms under the National
Mental Health Strategy have meant that their role has declined in recent years, with
more services provided in acute care hospitals and community settings. 
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Public acute hospitals can be described in terms of peer groups (Table 5.32), as
developed to explain variability in the average cost per casemix-adjusted separation
and to group hospitals in terms of their volume of admitted patient activity and
geographical location (AIHW 2000b). These peer groups also demonstrate some of the
attributes of the State and Territory hospital systems arising from differing geographical
characteristics, for example. Thus, small rural and remote hospitals had an average of
23 beds in 1999Ð00, and were most numerous in Queensland and Western Australia.
Principal referral hospitals averaged 468 beds each nationally.
Bed numbers
Changes in the numbers of hospitals are often due to changes in administrative or
reporting arrangements and not necessarily to changes in the number of hospital
campuses or buildings. For this reason, numbers of hospital beds are regarded as a
more reliable indicator of the availability of hospital services. 
Table 5.26: Hospitals and available beds, 1993Ð94 to 1999Ð00
Hospitals 1993–94 1994–95 1995–96 1996–97 1997–98 1998–99 1999–00
Public acute(a) 702 727 704 704 734 726 726
Public psychiatric 37 35 34 23 24 21 22
Public total 739 762 738 727 758 747 748
Private freestanding day hospital 
facilities 111 125 140 153 175 190 207
Private other(b) 329 328 323 319 317 312 302
Private total 440 453 463 472 492 502 509
All hospitals 1,179 1,215 1,201 1,199 1,250 1,249 1,257
Available beds(c)
Public acute(a) 56,140 54,211 54,579 53,410 52,606 50,851 50,188
Public psychiatric 5,360 4,685 3,992 3,426 3,112 2,943 2,759
Public total 61,500 58,896 58,571 56,836 55,718 53,794 52,947
Private freestanding day hospital 
facilities 917 939 1,023 1,163 1,348 1,460 1,581
Private other(b) 21,241 22,370 22,757 22,966 23,019 23,746 23,665
Private total 22,158 23,309 23,780 24,129 24,367 25,206 25,246
All hospitals 83,658 82,205 82,351 80,965 80,085 79,000 78,193
Available beds per 1,000 population(d)
Public acute(a) 3.1 3.0 3.0 2.9 2.8 2.7 2.6
Public psychiatric 0.3 0.3 0.2 0.2 0.2 0.2 0.1
Public total 3.4 3.2 3.2 3.1 3.0 2.8 2.7
Private freestanding day hospital 
facilities 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Private other(b) 1.2 1.2 1.2 1.2 1.2 1.2 1.2
Private total 1.2 1.3 1.3 1.3 1.3 1.3 1.3
All hospitals 4.7 4.5 4.5 4.3 4.3 4.1 4.1
(a) Includes DVA hospitals.
(b) Includes private psychiatric hospitals, excludes private freestanding day hospital facilities.
(c) Average available beds where possible, otherwise available beds at 30 June.
(d) Rates are calculated as crude rates using the December population for each year. 
Sources: AIHW National Public Hospital Establishments Database; National Survey of Mental Health Services; ABS 1995, 
2001a.
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Hospitals vary in size from small community facilities that may have fewer than 10
beds to large metropolitan hospital campuses that can have more than 500 beds. 
Between 1993Ð94 and 1999Ð00, there was a 3.7% reduction in available beds in hospitals
other than public psychiatric hospitals, resulting in a decrease in the overall number of
available beds from 4.7 to 4.1 beds per 1,000 population (Table 5.26). The change in
available beds was not evenly distributed between the public and private sectors, with
the number of private sector beds increasing by 13.9% and public acute hospital beds
decreasing by 10.6% (calculated from Table 5.26).
The number of beds per 1,000 population in hospitals is a useful indicator of the
comparative supply of hospital services across States and Territories. For example, there
is a different mix between public and private beds across the States and Territories. In
1999Ð00, the national average for public acute hospitals was 2.6 beds per 1,000
population, ranging from 2.2 per 1,000 population in Tasmania and the Australian
Capital Territory, to 3.1 per 1,000 population in South Australia. For the private sector,
there was a range from 1.1 beds per 1,000 population in New South Wales to 1.6 beds
per 1,000 population in Queensland, Western Australia and Tasmania (Table 5.27).
Admitted patients, patient-days and length of stay
There were 5,898,804 separations from public acute, public psychiatric and private
hospitals reported to the AIHW National Hospital Morbidity Database for 1999Ð00
(Tables S30 and S31), or 298 separations per 1,000 population (Table 5.28). There were
3,854,865 separations from public acute hospitals (65%), 17,950 separations from public
psychiatric hospitals (0.3%) and 2,025,989 separations from private hospitals (34%).
These separations accounted for 22,604,114 patient-days, 67% in public hospitals, 5% in
public psychiatric hospitals and 28% in private hospitals (Tables S32 and S33).
Between 1995Ð96 and 1999Ð00, there was an 8% increase in separations from public
acute hospitals and a 28% increase in separations from private hospitals. There was a
Table 5.27: Available beds per 1,000 population(a), States and Territories, 1999Ð00
Hospital type NSW Vic Qld WA SA Tas ACT NT Aust
Public acute 2.6 2.5 2.7 2.7 3.1 2.2 2.2 2.8 2.6
Public psychiatric 0.2 0.0 0.2 0.2 0.3 0.2 . . . . 0.1
Total public 2.8 2.6 2.9 2.8 3.4 2.4 2.2 2.8 2.8
Private freestanding day 
hospital facilities(b) 0.1 0.1 0.1 0.1 0.1 0.0 n.a. . . 0.1
Private other(c) 1.0 1.3 1.5 1.5 1.4 1.6 n.a. n.a. 1.2
Total private 1.1 1.4 1.6 1.6 1.5 1.6 n.a. n.a. 1.3
All hospitals 3.9 3.9 4.5 4.4 4.9 4.1 2.2 2.8 4.1
n.a. Not available.
. . Not applicable.
(a) Rates are calculated as crude rates using the December 1999 population.
(b) Australian Capital Territory included with New South Wales.
(c) Includes private acute and psychiatric hospitals. Australian Capital Territory included with New South Wales; Northern 
Territory included with South Australia.
Sources: AIHW National Public Hospital Establishments Database; ABS 2001a. 
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decrease of 3% in patient-days for public acute hospitals over this period and an
increase of 8% for private hospitals. 
After adjusting for changes in the age and size of the population, between 1995Ð96 and
1999Ð00 the number of separations per 1,000 population increased by 6.7% overall, by
1.7% for public acute hospitals, and 19.2% for private hospitals (calculated from Table
5.28). The number of patient-days per 1,000 population fell by 7.0% over the 4-year
Table 5.28: Hospital use by admitted patients, 1995Ð96 to 1999Ð00
1995–96 1996–97 1997–98 1998–99 1999–00
Separations per 1,000 population(a)
Public hospitals 196.3 195.8 199.9 199.7 197.4
   Public acute hospitals(b) 193.2 193.1 197.0 198.7 196.5
   Public psychiatric hospitals(c) 1.7 1.1 1.2 1.1 1.0
Private hospitals 85.1 89.2 93.2 95.5 101.4
   Private freestanding day hospital facilities n.a. 11.8 12.9 13.3 14.1
   Other private hospitals n.a. 77.5 80.2 82.2 87.3
Total 279.1 282.7 290.6 294.5 298.0
Patient-days per 1,000 population(a)
Public hospitals 878.3 861.7 848.8 817.8 799.6
   Public acute hospitals(b) 827.1 789.4 774.1 751.3 740.2
   Public psychiatric hospitals(c) 89.8 72.3 74.7 66.6 59.3
Private hospitals 311.6 302.0 303.8 299.4 307.7
   Private freestanding day hospital facilities n.a. 11.7 12.8 13.2 14.1
   Other private hospitals n.a. 288.3 289.0 284.2 293.7
Total 1,187.9 1,161.7 1,150.6 1,115.3 1,105.3
Same-day separations as a percentage of total
Public acute hospitals(b) 39.8 42.0 43.3 44.7 45.8
Private hospitals 48.9 51.0 53.1 54.8 56.2
   Other private hospitals n.a. 43.7 45.6 47.6 49.3
Total(d) 42.4 44.7 46.3 47.9 49.2
Average length of stay (days)
Public acute hospitals(b) 4.4 4.2 4.0 3.9 3.9
Other private hospitals n.a. 3.8 3.7 3.6 3.5
Total(d) 4.3 4.2 4.1 3.9 3.8
Average length of stay, excluding same-day separations (days)
Public acute hospitals(b) 6.6 6.5 6.4 6.3 6.4
Other private hospitals n.a. 6.0 6.0 5.9 5.9
Total(d) 6.8 6.8 6.7 6.6 6.6
n.a. Not available.
(a) Figures are rates per 1,000 population directly age-standardised to the Australian population at 30 June 1991. For 
private hospitals, rates were derived using populations of the reporting States and Territories only, without adjustment 
for incomplete reporting.
(b) Includes DVA hospitals.
(c) In 1995–96 Queensland was unable to report. Victoria was not able to provide patient-days data for all separations in 
1995–96 and for 407 separations in 1996–97.
(d) Public psychiatric hospitals included in these totals.
Source: AIHW 2001h.
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Box 5.6: Statistics and data sources relating to the use of hospitals
Admitted patient statistics
Statistics on admitted patients, although sometimes referred to as admission statistics, are
more correctly referred to as separation statistics. This is because most of the data on the
use of hospitals by admitted patients are based on information collected at the end of
patients’ episodes of care, rather than at the beginning. The reason for this is that the
actual length of stay and the procedures carried out are known and the diagnostic informa-
tion is more accurate.
Admitted patient means a patient who undergoes a hospital’s formal admission process.
Patient-day means the occupancy of a hospital bed (or chair in the case of some same-day
patients) by an admitted patient for all or part of a day.
Separation is the term used to refer to the episode of care, which can be a total hospital
stay (from admission to discharge, transfer or death), or a portion of a hospital stay begin-
ning or ending in a change of type of care (for example, from acute to rehabilitation). ‘Sep-
aration’ also means the process by which an admitted patient completes an episode of care
by being discharged, dying, transferring to another hospital or changing type of care.
For each separation, patients are assigned a principal diagnosis or the diagnosis estab-
lished after study to be chiefly responsible for occasioning the patient’s episode of admitted
patient care. The principal diagnosis recorded for each separation is usually a disease,
injury or poisoning, but can also be specific treatment of an already diagnosed condition,
such as dialysis for renal disease, or other reasons for hospitalisation. If applicable, one or
more procedures are also reported. These can be therapeutic or diagnostic. Diagnoses and
procedures were reported using the ICD-10-AM classification in 1999–00 (see Box 5.7,
page 287).
The State and Territory health authorities compile information on separations and supply
it to the AIHW for collation into the National Hospital Morbidity Database. This database
is an electronic record for each separation from almost every hospital in Australia,
including public acute and psychiatric hospitals (public sector) and private hospitals,
which include private freestanding day hospital facilities (private sector).
As indicators of community morbidity, hospital separation data have limitations. Sick
people who are not admitted to hospital are not counted and those who are admitted more
than once, or to more than one hospital, are counted on each occasion. Hospital separation
data also reflect differing admission practices, and availability of and access to hospitals.
Non-admitted patients
Hospitals provide services to non-admitted patients through emergency departments, out-
patient clinics and a range of other specialised services. Summary information on these
services is collated nationally for public hospitals by the AIHW and for private hospitals
by the ABS.
(continued)
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period, 10.5% for public acute hospitals and 1.3% for private hospitals. Thus there was
a slight shift from the use of public acute to private sector hospitals during the 4-year
period. In 1995Ð96, 69% of separations and 70% of patient-days were in public acute
hospitals, whereas in 1999Ð00, these percentages had fallen to 65% and 67%
respectively. Within public acute hospitals, the proportion of patients admitted as
public (Medicare) patients increased, from 83% in 1995Ð96 to 87% in 1999Ð00.
Although some categories of patients are not admitted for acute care services, such as
those requiring rehabilitation, some specialised mental health services or palliative care,
most patients require a relatively short stay in hospital. There is an increasing trend
towards day surgery and procedures for this group of patients, with improvements in
medical technology (anaesthetics and microsurgery, for example) enabling a wider
range of procedures to be performed on a same-day basis (Duckett 2002; Productivity
Commission 1999). Improved drug treatments and efforts to increase hospital
productivity have also tended to result in decreased length of stay. With potentially the
opposite effect on average length of stay, however, some treatments that have
previously required admission are being provided in outpatient clinics and day-care
facilities or by community health services.
The average length of stay in hospital decreased from 4.3 days in 1995Ð96 to 3.8 days in
1999Ð00. The average length of stay excluding same-day separations also decreased, but
less markedly, from 6.8 days in 1995Ð96 to 6.6 days in 1999Ð00. These Þgures are within
the range of those reported for other OECD countries, for which same-day separations
are excluded for average length of stay calculations.
With public psychiatric hospitals excluded, the average length of stay in 1999Ð00 was
3.8 days overall, 3.9 days in public acute hospitals and 3.1 days in private hospitals. The
difference between public and private hospitals at least in part reßects the different
range of patients cared for and treatments undertaken (casemixes) in the two hospital
sectors. For example, public acute hospitals had more children under the age of 5 years
as patients (4.5% of separations) compared with private hospitals (0.9% of separations)
(Tables S30 and S31), and procedures were more commonly reported for patients of
private hospitals (89%) than patients of public acute hospitals (73%).
Same-day separations
In 1999Ð00, there were 2,903,966 same-day separations, 1,764,127 from public acute
hospitals, 2,379 from public psychiatric hospitals and 1,137,460 from private hospitals
Box 5.6 (continued): Statistics and data sources relating to the use of hospitals
An occasion of service for a non-admitted patient is defined as any examination, consul-
tation, treatment or other service provided to a patient in each functional unit of a health
service establishment on each occasion such service is provided. National data are catego-
rised into broad clinic or service-based groupings.
Use of the national definition and categorisation for non-admitted patients is not com-
pletely uniform among the States and Territories and has varied over time, and this affects
data quality. Existing national systems for counting and classifying non-admitted patient
services are being revised.
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(277,774 in private freestanding day hospital facilities). There was a marked upward
trend over the period 1995Ð96 to 1999Ð00 in the proportion of separations that were
day-only. In 1995Ð96, 42% of separations were same-day separations, but by 1999Ð00
this had increased to 49% of all separations. 
Although the number of private freestanding day hospitals has increased markedly
over recent years (from 111 in 1993Ð94 to 207 in 1999Ð00; Table 5.26, page 280), private
acute and psychiatric hospitals accounted for 79.1% of the increase in same-day
separations in the private sector between 1996Ð97 and 1999Ð00. The number of same-
day separations increased by 34.4% for these hospitals, compared with an increase of
26.5% for private freestanding day hospitals. 
Area of usual residence of the patients
Figures 5.8 and 5.9 show age-standardised separation rates per 1,000 population by
statistical division of the usual residence of the patient, for public and private hospitals.
In the public sector, the highest rates were reported for residents of the statistical
divisions of Kimberley in Western Australia and Darwin in the Northern Territory. In
the private sector, highest rates were reported for the Moreton statistical division in
Queensland and the South-West statistical division in Western Australia (AIHW 2001h).
Separations per
1,000 population
290 or greater
260 to < 290
230 to < 260
200 to < 230
less than 200
Note: Rates were age-standardised to the 1991 Australian population.
Source: AIHW 2001h.
Figure 5.8: Separations per 1,000 population, by statistical division of usual residence, 
public hospitals, 1999Ð00
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Diagnoses, procedures and diagnosis-related groups for admitted 
patients
The conditions that hospitals treat are of interest to health service managers, planners,
funders and epidemiologists. These conditions, the procedures that patients undergo in
hospital and the consequent casemix of hospitals are detailed in the National Hospital
Morbidity Database using the classiÞcation systems described in Box 5.7.
For patients with a disease, injury or poisoning recorded as a principal diagnosis, the
broad diagnosis groups (ICD-10-AM chapters) with the highest number of separations
in Australian hospitals (public acute, public psychiatric and private hospitals) in
1999Ð00 were diseases of the digestive system, followed by pregnancy, childbirth and
the puerperium, and diseases of the circulatory system (Tables S34 and S35).
At a more detailed level (three-character ICD-10-AM categories), the most common
disease or injury principal diagnoses (excluding diagnoses described as symptoms or
types of care) in public hospitals were angina pectoris (66,378 separations) and
pneumonia, organism unspeciÞed (42,173 separations) (AIHW 2001h). In private
hospitals, the most common diagnoses were other cataract (55,645 separations), and
embedded and impacted teeth (39,068 separations).
Separations per
1,000 population
90 or greater
80 to < 90
60 to < 80
40 to < 60
less than 40
Note: Rates were age-standardised to the 1991 Australian population.
Source: AIHW 2001h.
Figure 5.9: Separations per 1,000 population, by statistical division of usual residence, 
private hospitals, 1999Ð00
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A procedure was reported for 78% of separations in Australian hospitals in 1999Ð00. Of
these, 61% were in public hospitals, although public hospitals accounted for 66% of
separations overall. Similarly, although 72% of overall patient-days were in public
hospitals, only 69% of patient-days associated with procedures were in public hospitals
(11,901,596). This reßects the higher proportion of separations in the private sector that
were reported with a procedure, compared with the public sector, 89% and 73%
respectively. 
At the broad group (ICD-10-AM chapter) level, if miscellaneous diagnostic and
therapeutic procedures are not included (i.e. procedures that are not ÔoperationsÕ or
obstetrical procedures), operations on the urinary system accounted for the largest
proportion of public hospital separations for which a procedure was reported (584,819
separations) (Table S36). Haemodialysis accounted for 93% (541,388) of these
separations. The most commonly reported procedure group for the private sector was
Box 5.7: Classification of diseases, procedures and separations for admitted 
patients
Diseases and procedures
Hospital patient records contain a great deal of information about a patient’s diagnosis and
about procedures performed during the hospital stay. To allow efficient storage and anal-
ysis of this information, detailed classification and coding systems are used to describe and
record diagnoses and procedures. The classification used in 1999–00 in Australia was the
first edition of the International Statistical Classification of Diseases and Related Health
Problems, 10th Revision, Australian Modification (ICD-10-AM), developed by the
National Centre for Classification in Health (NCCH 1998). It comprises classifications of
diseases and external causes of injuries and poisoning, based on the World Health Organ-
ization version of ICD-10, and a classification of procedures based on the Australian Medi-
care Benefits Schedule. These ICD-10-AM codes can be a source of information on the
diseases treated in hospitals and the operations performed, at very detailed levels or aggre-
gated into broad groupings such as the ICD-10-AM chapters. The second edition of
ICD-10-AM has been in place since 1 July 2000.
Diagnosis-related groups
Australian Refined Diagnosis Related Groups (AR-DRGs) is a classification system used
mainly for acute admitted patient episodes. This classification provides a means of summar-
ising and relating the number and type of acute admitted patients treated in a hospital (i.e.
its casemix) to the resources required by the hospital. This classification groups episodes
with similar clinical conditions and similar usage of hospital resources using information
in the hospital morbidity record such as diagnoses, procedures, and age of the patients.
Each AR-DRG is associated with information on the average length of stay and estimated
average cost for patients in the group in the public and private sectors. This classification,
therefore, has use in measuring outputs and performance of hospitals and in planning and
funding hospital service provision.
AH2002 body 26-6  Page 287  Wednesday, June 26, 2002  6:28 PM
288  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
operations on the digestive system (432,460 separations) (Table S37). Within that
grouping, panendoscopy with excision was reported for 48% of the separations, and
Þbre-optic colonoscopy with excision for 30%.
Procedures were reported for varying proportions of separations within the broad
groups of principal diagnoses. High proportions of separations for diseases of the eye
and adnexa (98%), neoplasms (94%), and diseases of the blood and blood-forming
organs (93%) had procedures reported. In contrast, there were fewer reported for
separations with principal diagnoses of mental and behavioural disorders (36%), certain
infectious and parasitic diseases (40%), and diseases of the respiratory system (55%).
Using the AR-DRGs classiÞcation of acute care separations (see Box 5.7), the Major
Diagnostic Categories for which there were the most separations were kidney and
urinary tract in public hospitals and digestive system in private hospitals (Tables S38
and S39). The AR-DRGs with the highest numbers of separations in 1999Ð00 featured
several for which same-day separations dominated (Table 5.29). Among these were the
top two groups in public hospitals, admit for renal dialysis (466,793 public sector
separations) and chemotherapy (117,705 public sector separations), and the top two
groups in the private sector, other colonoscopy, same-day (136,449 private sector
separations) and other gastroscopy for non-major digestive disease, same-day (95,482
private sector separations).
Vaginal delivery without complicating diagnosis was the most common AR-DRG that
was not usually a same-day hospitalisation. This group was the third most common in 
Table 5.29: Top 12 AR-DRGs (version 4.1), 1999Ð00(a)
AR-DRG Separations
Per cent
same-day
separations
Patient-
days
Average
length of
stay (days)
L61Z Admit for renal dialysis 529,104 99.9 529,503 1.0
R63Z Chemotherapy 207,141 99.7 207,917 1.0
G44C Other colonoscopy, same-day 197,028 100.0 197,028 1.0
G45B Other gastroscopy for non-major 
digestive disease, same-day 154,995 100.0 154,995 1.0
O60D Vaginal delivery without complicating 
diagnosis 144,352 2.9 492,860 3.4
C08Z Major lens procedures 105,064 81.1 109,787 1.0
D40Z Dental extractions and restorations 79,930 89.6 81,953 1.0
I18Z Knee procedures 79,785 66.0 105,161 1.3
Z40Z Follow-up after completed treatment 
with endoscopy 74,989 96.8 76,285 1.0
J11Z Other skin, subcutaneous tissue and 
breast procedures 71,877 87.9 88,873 1.2
U60Z Mental health treatment, same-day, 
without electroconvulsive therapy 69,499 100.0 69,499 1.0
O40Z Abortion with D&C, aspiration 
curettage or hysterotomy 61,326 84.0 64,044 1.0
(a) Includes separations with acute or unspecified type of episode of care only. 
Source: AIHW National Hospital Morbidity Database.
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public hospitals (111,208 separations) and the eighth most common in private hospitals
(33,376 separations). This category does not include deliveries by caesarean section or
complicated deliveries.
Same-day procedures
There were marked increases between 1993Ð94 and 1999Ð00 in the proportions of
separations from both public acute and private hospitals that were same-day, 34.2% and
43.3% to 45.8% and 56.2%, respectively. In addition, the proportion of same-day
separations for which a procedure was reported rose from 83.5% to 87.1%, so there was
an increase of 78.6% (to 2.5 million) same-day separations for which procedures were
reported. 
In contrast with the 78.6% increase for same-day separations, there was a 26% increase
in overnight separations with procedures. Thus the proportion of all separations for
which procedures were reported that were same-day separations rose from 45% to 52%
in public hospitals, and from 49% to 60% in private hospitals. 
Whilst about half of these same-day separations with procedures were for
haemodialysis (529,692 separations in 1999Ð00), Þbre-optic colonoscopies (280,330
separations), panendoscopies (250,187 separations) or intravenous chemotherapy
(186,629 separations), which have historically been undertaken largely on a same-day
basis, some of the increases in these same-day separations relate to other procedures for
which there have been increased proportions undertaken on a same-day basis
(Table 5.30). For example, the proportion of coronary angiographies performed on a
same-day basis rose from 22.0% in 1993Ð94 to 33.1% in 1999Ð00.
Table 5.30: Separations and same-day separations for selected procedures, 1993Ð94 to 1999Ð00
Procedure 1993–94 1996–97 1999–00
Extracapsular crystalline lens extraction by phacoemulsification
 Separations 22,972 78,983 108,957
 % same-day 39.4 64.3 80.5
Release of carpal and tarsal tunnel
 Separations 17,902 21,484 23,650
 % same-day 54.3 70.3 80.8
Procedures for haemorrhoids
 Separations 19,320 24,073 24,850
 % same-day 36.0 50.9 59.5
Coronary angiography
 Separations 45,239 66,923 74,174
 % same-day 22.0 26.6 33.1
Examination procedures on ventricle
 Separations 25,418 56,895 63,099
 % same-day 22.6 26.1 34.0
Source: AIHW National Hospital Morbidity Database.
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Procedures in private hospitals
Over recent years there has been an increase in the activity of private hospitals, as
described above, accompanied by a widening of the types and complexity of services
they provide. Intensive care, cardiac surgery, neurosurgery, renal dialysis and oncology
are among the services that have become increasingly available in private hospitals
(Productivity Commission 1999). 
Between 1991Ð92 and 1999Ð00 the number of private hospitals with an oncology unit
increased from 8 to 51, and the number of hospitals with separate coronary intensive
care units increased from 3 to 29. Renal dialysis units were available in 22 hospitals in
1999Ð00 compared with 3 hospitals in 1991Ð92, and neurosurgical units were available
in 8 hospitals in 1999-00 compared with only 1 hospital in 1991Ð92 (ABS 1993, 2001a).
The expansion in the type and complexity of services available in private hospitals is
also reßected in changes in the procedures undertaken in the private sector. For
example, high-cost procedures such as bone marrow transplants and tracheostomies are
increasingly being undertaken in the private sector. In 1993Ð94, there were 10 bone
marrow transplants reported for private hospitals (1.6% of the total of 621 for all
hospitals), but by 1999Ð00 this had increased to 200 (15% of the total of 1,295). For
tracheostomies, 5% of separations were in private hospitals in 1993Ð94 (134 of a total of
2,863), compared with 12% in 1999Ð00 (559 of a total of 4,627). 
Complex procedures such as coronary artery bypass grafts are also increasingly being
undertaken in private hospitals. For example, in 1993Ð94, 32% of separations for
coronary artery bypass grafts were in private hospitals compared with 41% in 1999Ð00.
Over this period, the number of separations for coronary artery bypass graft increased
by 35% in the private sector, from 5,254 to 7,068. In the public sector the number of
separations for coronary artery bypass graft decreased by 6%, from 10,917 separations
in 1993Ð94 to 10,234 separations in 1999Ð00.
Other procedures that are being increasingly undertaken in the private sector include
chemotherapy and haemodialysis. Between 1993Ð94 and 1999Ð00, the number of
separations for chemotherapy increased from 20,117 to 91,328 (354%) in the private
sector; they increased from 113,585 to 123,024 (8%) in public hospitals. Hence, the
proportion of separations for chemotherapy that were in private hospitals increased
from 15% to 43% over this period. For haemodialysis, 8% of separations were in private
hospitals in 1993Ð94, but by 1999Ð00 this had risen to 12%. The number of separations
for haemodialysis in the private sector increased from 18,005 to 63,346 (252%),
compared with an increase of 210,743 to 478,042 (127%) in public hospitals.
In 1999Ð00, private hospitals reported separations for all but 4 of the 661 AR-DRGs:
liver, lung, heart and multiple organ transplants.
AR-DRGs for veterans
The number of separations has increased substantially over recent years for veterans
(AIHW 2001h), reßecting the increased hospital requirements of an ageing population
and an extension of DVA gold card eligibility on 1 January 1999. As reported by State
and Territory governments to the National Hospital Morbidity Database, the most
frequently reported AR-DRGs in 1999Ð00 were for renal dialysis, major lens procedures
and chemotherapy (Table 5.31). Eligibility to receive hospital treatment as a DVA
patient may not necessarily have been conÞrmed by DVA for these separations.
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The DVA paid for 223,480 private hospital separations and 130,059 public hospital
separations for entitled veterans and war widows in 2000Ð01 (DVA, unpublished data). 
Non-admitted patients 
There were 32,426,272 non-admitted patient occasions of service reported for public
acute and psychiatric hospitals in 1999Ð00, or about 1,859 per 1,000 population (AIHW
2001h). In 1999Ð00, 5,220,290 or 15% of these occasions of service were provided in
accident and emergency departments and 2,844,684 or 8.0% were provided as radiology
or organ imaging. The largest group of non-admitted occasions of service was other
medical/surgical/obstetric services (11,516,364 or 33%). Note that there is considerable
variation in practices among States and Territories in the way in which data on non-
admitted patient occasions of service are collected, and this may affect the numbers of
non-admitted patient occasions of service assigned to each category by different
jurisdictions.
Private hospitals also contribute to the provision of non-admitted patient services, with
a different mix of types compared with the public hospitals. In 1999Ð00, private
hospitals reported 1,819,600 occasions of service (ABS 2001a), with the largest numbers
reported for accident and emergency (486,100 or 26.7%) and allied health services
(474,900 or 26.1%).
Hospital performance indicators
The National Health Performance Framework (see Chapter 6, page 344) includes nine
dimensions that can be used to assess how well the health system is performing in
delivering quality health actions to improve the health of Australians. For several of
Table 5.31: Top 10 AR-DRGs (version 4.1) for veterans, 1999Ð00(a)
AR-DRG
Public
hospitals
Private
hospitals Total
L61Z Admit for renal dialysis 19,434 4,875 24,309
C08Z Major lens procedures 1,911 13,072 14,983
R63Z Chemotherapy 3,849 6,827 10,676
G44C Other colonoscopy, same-day 1,363 6,923 8,286
U60Z Mental health treatment, same-day, without 
electroconvulsive therapy 2,981 3,637 6,618
G45B Other gastroscopy for non-major digestive disease, 
same-day 1,318 5,030 6,348
J11Z Other skin, subcutaneous tissue and breast 
procedures 1,269 3,820 5,089
Z40Z Follow-up after completed treatment with endoscopy 1,035 3,468 4,503
F62B Heart failure and shock without catastrophic cc(b) 2,533 1,629 4,162
E65A Chronic obstructive airways disease with catastrophic 
or severe cc(b) 2,403 1,673 4,076
Total(c) 119,234 159,517 278,751
(a) Includes separations with acute or unspecified type of episode of care only.
(b) cc = complications and co-morbidities.
(c) Includes all other AR-DRGs.
Source: AIHW National Hospital Morbidity Database.
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these dimensions, indicators have been identiÞed that relate to the performance of the
acute care or hospital component of the health system (NHPC 2002). They include:
¥ the cost per casemix-adjusted separation, as an indicator of efÞciency
¥ waiting times for elective surgery, as an indicator of access
¥ hospital separations with an adverse event, as an indicator of safety. 
Table 5.32: Cost per casemix-adjusted separation by public hospital peer group(a), 1999Ð00
NSW Vic Qld WA SA Tas ACT NT Aust
Principal referral and specialist women’s & children’s hospitals                 
Number of hospitals(b) 23 12 15 4 4 2 1 1 62
Average beds per hospital(b) 372 752 351 567 418 364 503 268 468
Average cost weight(c) 1.10 1.03 1.08 1.02 1.06 1.08 0.93 0.80 1.06
Cost per casemix-adjusted 
separation ($) 2,846 2,537 2,683 3,343 2,601 2,518 n.p. n.p. 2,747
Large hospitals
Number of hospitals(b) 17 6 7 2 3 1 1 1 38
Average beds per hospital(b) 146 143 173 117 198 131 162 162 153
Average cost weight(c) 1.01 0.90 0.87 0.87 0.99 1.16 1.14 0.71 0.95
Cost per casemix-adjusted 
separation ($) 2,503 2,422 2,077 2,669 2,545 n.p. n.p. n.p. 2,443
Medium hospitals
Number of hospitals(b) 40 21 16 11 14 0 0 0 102
Average beds per hospital(b) 58 59 68 104 58 . . . . . . 65
Average cost weight(c) 0.91 0.81 0.79 0.81 0.88 . . . . . . 0.85
Cost per casemix-adjusted 
separation ($) 2,847 2,331 2,148 3,116 2,425 . . . . . . 2,632
Small rural and remote hospitals
Number of hospitals(b) 29 17 37 34 15 4 0 3 139
Average beds per hospital(b) 25 20 22 23 25 15 . . 37 23
Average cost weight(c) 0.82 0.83 0.79 0.81 0.84 0.82 . . 0.85 0.81
Cost per casemix-adjusted 
separation ($) 2,532 2,370 2,196 3,785 2,317 15,675 . . 3,394 2,945
Total selected public acute care hospitals
Number of hospitals(b) 109 56 75 51 36 7 2 5 341
Average beds per hospital(b) 129 205 112 87 96 131 333 108 129
Average cost weight(c) 1.05 0.99 1.00 0.94 1.00 1.08 0.98 0.78 1.01
Cost per casemix-adjusted 
separation ($) 2,777 2,511 2,528 3,299 2,552 2,842 3,120 3,410 2,701
n.p. Not published because there was only one hospital in the peer group.
. . Not applicable.
(a) Psychiatric hospitals, drug and alcohol hospitals, mothercraft hospitals, hospices, rehabilitation and other non-acute 
facilities and multipurpose facilities have been excluded. For details, see AIHW 2001h. 
(b) Hospital counts refer to the lowest level of establishment with available financial data. Some relate to hospital networks 
which can include a mix of large, small, specialised and non-acute hospitals. As a result, the numbers of hospitals and 
beds will be different from those reported in Table 5.26.
(c) The average cost weight is a measure of the relative costliness of the separations, based on AR-DRG data from the 
National Hospital Morbidity Database, and 1999–00 AR-DRG v. 4.1 cost weights (DHAC 2001c).
Sources: AIHW National Hospital Morbidity Database and AIHW National Public Hospital Establishments Database.
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Cost per casemix-adjusted separation
The cost per casemix-adjusted separation is a measure of the average cost of providing
care for an admitted patient, adjusted for the relative complexity of the patientÕs
condition and hospital services provided (AIHW 2001h). It is calculated for selected
public acute care hospitals as the proportion of the recurrent expenditure that is
estimated to have been associated with treating admitted patients, divided by the total
separations adjusted using AR-DRG cost weights for their relative costliness.
Table 5.32 presents cost per casemix-adjusted separation data by hospital peer group.
These groups are designed to explain variability in the average cost per casemix-
adjusted separation and to group hospitals in terms of their volume of admitted patient
activity and geographical location (AIHW 2000b). 
For 1999Ð00, the overall cost per casemix-adjusted separation was $2,701. This varied
from $3,410 for the Northern Territory to $2,511 for Victoria, and from $2,945 for small
rural and remote hospitals to $2,443 for large hospitals.
Waiting times for elective surgery
Waiting times for elective surgery are an indicator of access to hospital services, i.e. an
indicator of the provision of timely care according to need. Waiting times are the focus,
rather than waiting lists, because, without knowledge of the rate of turnover of patients
on a waiting list, its size is not a reliable indicator of access to the hospital system or the
amount of time that a patient would be likely to have to wait, or to have waited, for
surgery.
Waiting times for patients admitted during a particular period are generally used as the
main summary measures of elective surgery waiting times, although they provide
measures of waiting times only for patients who complete their wait and are admitted.
Most patients are admitted after waiting, but 10% to 20% of patients are removed from
waiting lists for other reasons (e.g. they were admitted as an emergency patient for the
awaited procedure, or they were not contactable, had died, had been treated elsewhere,
or had declined the surgery).
In 1999Ð00, the AIHW National Elective Surgery Waiting Times Data Collection
included data for an estimated 85% of public hospital elective surgery (AIHW 2002a);
data were not available for smaller hospitals in several States, and for the Australian
Capital Territory.
Overall, the median waiting time for elective surgery was 27 days in 1999Ð00
(Table 5.33), ranging from 22 days in Queensland to 36 days in Tasmania. The shortest
median waiting time was for patients admitted from waiting lists in hospitals in the
ÔPrincipal referral and womenÕs and childrenÕs hospitalsÕ peer group. The longest
median waiting time was for patients admitted from waiting lists in hospitals in the
ÔLarge hospitalsÕ peer group.
In the ÔPrincipal referral and womenÕs and childrenÕs hospitalsÕ peer group, 3.4% of
patients were admitted after waiting more than 12 months. In the ÔLarge hospitalsÕ peer
group 2.7% of patients waited more than 12 months and in the ÔMedium hospitalsÕ peer
group 2.4% of patients waited more than 12 months. Overall, the proportion of patients
admitted after waiting more than 12 months varied among the States and Territories,
ranging from 1.6% in the Northern Territory to 6.7% in Tasmania.
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Adverse events
Adverse events are deÞned as incidents in which harm resulted to a person receiving
health care. They include infections, falls and other injuries, and medication problems,
some of which may be potentially preventable. The Australian Council for Safety and
Quality in Health Care estimates that about 10% of hospital separations in Australia
and other developed countries are likely to be associated with an adverse event
(ACSQHC 2001).
Data are not available to measure accurately the number of adverse events in Australian
hospitals. However, hospital separations data can be used as an indication, as they
include information on diagnoses and external causes of injury and poisoning that
indicate that an adverse event has occurred. Adverse events as recorded in hospital
separations data have been identiÞed as an indicator of safety for the National Health
Performance Framework (NHPC 2002). 
Table 5.33: Patients admitted from waiting lists, by public hospital peer group(a), 1999Ð00
Peer group NSW Vic Qld WA SA Tas ACT NT Aust
Principal referral and women’s & children’s hospitals                 
Number of admissions(b) 113,346 87,076 85,580 26,042 22,806 10,896 n.p. 3,731 349,477
Estimated coverage (%) 100 100 98 100 100 100 n.p. 100 100
Median waiting time (days) 22 27 21 33 26 36 n.p. n.p. 24
% waited more than 
12 months 2.3 4.0 3.0 7.6 2.3 6.0 n.p. n.p. 3.4
Large hospitals
Number of admissions(b) 39,800 24,842 17,474 . . 9,877 2,702 n.p. 1,409 96,104
Estimated coverage (%) 100 52 100 0 100 100 n.p. 100 77
Median waiting time (days) 31 33 27 . . 40 n.p. n.p. n.p. 31
% waited more than 
12 months 2.8 1.7 3.3 . . 1.9 n.p. n.p. n.p. 2.7
Medium hospitals
Number of admissions(b) 41,766 4,398 9,201 18486 . . . . n.p. . . 73,851
Estimated coverage (%) 100 15 92 72 0 . . n.p. . . 58
Median waiting time (days) 28 22 29 29 . . . . n.p. . . 28
% waited more than 
12 months 1.9 4.1 2.5 2.9 . . . . n.p. . . 2.4
Total(c)
Number of admissions(b) 202,281 116,316 112,718 44,528 32,683 13,598 n.p. 5,786 527,910
Estimated coverage (%) 100 71 95 75 67 99 n.p. 100 85
Median waiting time (days) 26 28 22 31 30 36 n.p. 23 27
% waited more than 
12 months 2.4 3.6 3.0 5.7 2.2 6.7 n.p. 1.6 3.1
n.p. Not published because there was only one hospital in the peer group.
. . Not applicable.
(a) Psychiatric hospitals, drug and alcohol hospitals, mothercraft hospitals, hospices, rehabilitation and other non-acute 
facilities and multipurpose facilities have been excluded. For details, see AIHW 2002a. 
(b) Admissions for elective surgery reported to the National Elective Surgery Waiting Times Data Collection.
(c) Includes data for hospitals not included in the specified hospital peer groups.
Source: AIHW 2002a.
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The number of separations reported to the AIHW National Hospital Morbidity
Database which included a diagnosis and/or external cause code for an adverse event
increased each year between 1993Ð94 (182,858 separations) and 1997Ð98 (264,347
separations) (Table 5.34). The proportion of total separations which included adverse
events also increased each year, from 3.97% in 1993Ð94 to 4.75% in 1997Ð98. Similarly,
the number of separations with adverse events per 1,000 patient-days increased, from
8.70 per 1,000 patient-days in 1993Ð94 to 11.71 per 1,000 patient-days in 1997Ð98. 
Although the rates reported increased over this period, there are several reasons that it
should not be concluded that there was an increase in actual adverse events occurring
or treated in Australian hospitals. There were slight changes in scope and coverage of
the database and likely improvements in the quality of data recording associated with
the introduction of Australian editions of ICD-9-CM and, in some States and Territories,
of casemix-based funding arrangements. Some of the ICD-9-CM disease and external
cause categories (e.g. falls and accidental poisonings) can be used for both adverse
events and other occurrences, so the number of adverse events is likely to have been
underestimated (AIHW: Hargreaves 2001).
Mental health services
Each year, approximately 18% of Australian adults experience mental illness and 38% of
these people use a health service for a mental health-related problem (ABS 1998a).
Those with severe mental health-related disabilities were more likely to use a health
service (57%). 
Historically, stand-alone psychiatric hospitals were the main focus of specialised mental
health care. However, the availability of effective anti-psychotic drugs, changes in
clinical practice and the emergence of the human rights movement provided the setting
for reform of mental health care which, in recent years, has been outlined in the
National Mental Health Strategy. The StrategyÕs Þrst National Mental Health Plan
(1993Ð98) included reducing or closing existing psychiatric hospitals; providing
sufÞcient acute hospital, accommodation and community-based services; integrating
the management and delivery of psychiatric services within general healthcare services;
and establishing effective links between mental health, general health and non-health
services. The second plan (1998Ð2003) has focused on improving quality of care,
increasing consumer participation and developing models of best practice. 
Table 5.34: Hospital separations with an adverse event, 1993Ð94 to 1997Ð98
Year
Mis-
adventures
Compli-
cations
Drug
adverse
effects
Iatrogenic
disease Total(a)
Total per
100
separations
Total per
1,000
patient-days
1993–94 2,898 133,516 28,890 143,647 182,858 3.97 8.70
1994–95 3,582 152,584 35,816 164,063 209,305 4.29 9.98
1995–96 3,928 164,181 41,714 174,242 226,563 4.38 10.09
1996–97 4,532 178,837 48,202 189,792 246,948 4.64 11.04
1997–98 4,877 190,739 53,388 200,264 264,347 4.75 11.71
(a) Categories do not necessarily sum to the totals, as shown, because multiple diagnoses and external causes can be 
recorded for each separation.
Source: AIHW National Hospital Morbidity Database.
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Australians therefore now use a variety of public and private health service providers
for mental health care, including psychiatric and acute care hospitals, public
community-based services, private psychiatrists and general practitioners.
Hospitals and beds
For both public and private hospitals, specialised mental health care is provided in
psychiatric units and wards in acute care hospitals and in stand-alone psychiatric
hospitals. This care is provided to patients formally admitted to the hospital and to
those who attend, or are visited by, the hospitalÕs outpatient services and community-
based services. Most national data on mental health-related hospital services relate to
the care of admitted patients, with only limited data available on non-admitted patient
care.
The reforms of the last decade have seen a reduction in the proportion of resources
devoted to public psychiatric hospitals and a corresponding increase in resources for
psychiatric units in acute care hospitals and community-based mental health services.
Between 1993Ð94 and 1999Ð00, the number of public psychiatric hospitals fell from 37 to
22, and bed numbers fell 48.5%, from 5,360 to 2,759 (Table 5.26, page 280). This decline
has been accompanied by a 31% increase in the number of available psychiatric unit
beds in public acute care hospitals wards between 1992Ð93 and 1997Ð98 (DHAC 2000).
Between 1992Ð93 and 1997Ð98 there was a decrease in spending per capita on public
psychiatric hospitals (from $32 to $21 per capita) and a corresponding increase in
spending on psychiatric units co-located with acute care hospitals (from $14 to $19 per
capita) (DHAC 2000). 
In 1999Ð00, the recurrent expenditure for public psychiatric hospitals, including non-
admitted patient and community services managed by the hospital, was $423.8 million.
The majority of this expenditure was for the salaries and wages of the 6,274 full-time
equivalent staff. The available beds per capita were comparable across the six States,
with the exception of Victoria, which manages most of its psychiatric hospital services
as components of acute care hospitals. 
In 1999Ð00, there were 45 private hospitals with one or more psychiatric units or wards
(ABS 2001a). Of these, 24 were designated as private psychiatric hospitals. These
private psychiatric hospitals had an expenditure of $122.5 million, employed an
average of 1,572 full-time equivalent staff and had 1,369 available beds. 
Admitted patients
Hospitalisation is comparatively infrequent, with less than 1% of adults with a mental
illness hospitalised each year (ABS 1998a). There were 177,789 mental health-related
separations involving specialised psychiatric care and/or a mental health-related
principal diagnosis in public hospitals during 1999Ð00, associated with 2.6 million
patient-days (Table 5.35). Public acute hospitals accounted for 89.9% of public
hospitalisations but only about 55.5% of the days spent in hospital. The majority of
public psychiatric and public acute hospitalisations were overnight (86.7% and 73.8%,
respectively). For private hospitals, there were 88,873 mental health-related
hospitalisations in 1999Ð00, the majority of which were same-day (69.3%). There were
579,327 patient-days associated with these hospitalisations.
AH2002 body 26-6  Page 296  Wednesday, June 26, 2002  6:28 PM
5 Health resources and use of services  297
TRIM SIZE 175 mm Wide x 250 mm Deep
Involuntary hospitalisation was more frequent in public psychiatric hospitals, where
over half of the separations were involuntary, compared with 24.5% of mental health-
related separations in public acute hospitals and 5.6% in private hospitals (AIHW
2002b).
For public psychiatric hospitals, the most frequently recorded principal diagnosis, in
terms of the number of separations and patient-days, was schizophrenia. Principal
diagnoses of depressive disorders were reported most frequently for public acute
hospitalisations with specialised psychiatric care, with principal diagnoses of
schizophrenia accounting for the greatest number of patient-days. Mental and
behavioural disorders due to use of alcohol were the most frequently reported principal
diagnoses for separations from public acute hospitals without specialised psychiatric
care, and separations for dementia accounted for the most patient-days.
In private hospitals, the most frequently recorded principal diagnoses, for separations
with and without specialised psychiatric care, and for patient-days (for separations
with specialised psychiatric care), were depressive disorders. The most patient-days
without specialised psychiatric care were recorded for separations with principal
diagnoses of dementia. 
Table 5.35: Mental health-related separations and patient-days by hospital type, 1999Ð00
Public acute
Public
psychiatric Private Total
Same-day separations
With specialised psychiatric care 24,316 2,379 45,524 72,219
Without specialised psychiatric care 17,622 0 9,552 27,174
Total 41,938 2,379 55,076 99,393
Overnight separations
With specialised psychiatric care 63,635 15,568 20,126 99,329
Without specialised psychiatric care 54,266 3 13,671 67,940
Total 117,901 15,571 33,797 167,269
Total mental health-related separations
With specialised psychiatric care 87,951 17,947 65,650 171,548
Without specialised psychiatric care 71,888 3 23,223 95,114
Total 159,839 17,950 88,873 266,662
Receiving specialised psychiatric 
care (%) 55.1 100.0 73.9 64.3
Patient-days for overnight separations
With specialised psychiatric care 927,332 1,153,859 341,265 2,422,456
Without specialised psychiatric care 475,439 12 182,986 658,437
Total 1,402,771 1,153,871 524,251 3,080,893
Total patient-days for mental 
health-related separations
With specialised psychiatric care 951,648 1,156,238 386,789 2,494,675
Without specialised psychiatric care 493,061 12 192,538 685,611
Total 1,444,709 1,156,250 579,327 3,180,286
Receiving specialised psychiatric 
care (%) 65.9 99.9 66.8 78.4
Source: AIHW 2002b.
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The top twelve most frequent AR-DRGs for mental health-related separations are
presented in Table 5.36. For same-day separations, mental health treatment without
electroconvulsive therapy was the most frequently recorded AR-DRG (54,335
separations). Major affective (mood) disorders without catastrophic or severe
complications or co-morbidities was the AR-DRG most frequently recorded for
overnight separations (20,208 separations). 
Public community mental health services
Public community mental health services include community-based services such as
child and adolescent community mental health services, mobile treatment teams and
community residential services that are staffed either 24 hours a day or on a part-time
basis. The category also includes hospital-based services such as psychiatric outpatient
services, day programs and community outreach services. Reßecting the general move
Table 5.36: Top 12 AR-DRGs (version 4.1) for mental health-related separations(b), all 
hospitals, 1999Ð00
AR-DRG Separations
Per cent
same-day
separations
Patient-
days
Average
length of
stay (days)
U60Z Mental health treatment, same-day, 
without electroconvulsive therapy 54,335 100.0 54,335 1.0
U63B Major affective disorders without 
catastrophic or severe cc (age less than 
70 years) 20,208 0.0 318,173 15.7
U67Z Personality disorders and acute 
reactions 15,511 0.0 126,697 8.2
U61A Schizophrenia disorders with mental 
health legal status 12,204 0.0 370,263 30.3
U61B Schizophrenia disorders without mental 
health legal status 10,875 0.0 247,689 22.8
U64Z Other affective and somatoform 
disorders 5,997 0.0 67,450 11.2
U40Z Mental health treatment, same-day, with 
electroconvulsive therapy 4,036 100.0 4,036 1.0
U63A Major affective disorders with 
catastrophic or severe cc or without 
catastrophic or severe cc and aged 70 
or over 3,904 0.0 109,613 28.1
V61B Drug intoxication and withdrawal 
without cc 2,569 8.6 17,939 7.0
V60Z Alcohol intoxication and withdrawal 2,464 34.8 20,133 8.2
B63Z Dementia and other chronic 
disturbances of cerebral function 2,365 11.6 156,387 66.1
U62A Paranoia and acute psychiatric disorder 
with catastrophic or severe cc or with 
mental health legal status 2,344 0.0 37,864 16.2
(a) Includes separations with acute or unspecified type of episode of care only.
Note: cc = complications or co-morbidities.
Source: AIHW 2002b.
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of mental health services to community settings, between 1992Ð93 and 1997Ð98
expenditure on these services increased, particularly for ambulatory services ($15 to $26
per capita) (DHAC 2000). 
During 1999Ð00, these services had a recurrent expenditure of $631.4 million and an
average of 8,570 full-time-equivalent staff. They had 1,171 available beds, in relation to
which 1,545 overnight stays were reported.
Vietnam Veterans Counselling Service
The prevalence of anxiety disorders, depression and post-traumatic stress disorder were
found to be higher in male Vietnam veterans than would be expected in the community
(DVA 1998). In a survey conducted in 1997, anxiety disorders were reported by 41% of
veterans, higher than that expected based on prevalence of anxiety disorders in the
general community (31%). Depression (45%) and post-traumatic stress disorder (31%)
were also more common than expected (36% and 8% respectively). 
The DVA recognises these conditions as consequences of war-related service and has
put in place the Vietnam Veterans Counselling Service (VVCS) to help veterans cope
with them. 
The VVCS offers free services to veterans of all conßicts, including those from
peacekeeping missions. Partners are also eligible, as are the sons and daughters of
Vietnam veterans. The service operates from 15 centres across Australia and provides
outreach services with more than 380 contracted counsellors in rural, remote and outer
metropolitan areas.
Services include counselling, therapeutic and educational group programs, community
development and health promotion. There are specialist projects such as one aimed at
promoting cardiovascular Þtness, and another aimed at sons and daughters to combat
signiÞcantly elevated suicide rates in this group. VVCS also provides an after-hours
telephone crisis counselling service known as Veterans Line.
Contact counselling session numbers grew from fewer than 3,000 ten years ago to over
28,000 in 2000Ð01 (Table 5.37). Increases similarly occurred in other counselling
activities, group programs, community development and liaison work (which includes
support for self-help ventures), linkages with the Department of Defence, involvement
in education of general practitioners and allied health professionals, and support of ex-
service organisations.
Table 5.37: Vietnam Veterans Counselling Service activity, 1999Ð00 and 2000Ð01
Service 1999–00 2000–01
Contact counselling sessions 26,880 28,063
Veterans Line calls 5,887 6,372
Centre-based counselling
   Hours 24,077 25,958
   Clients 12,000 12,300
   Services 27,421 29,360
Source: DVA, unpublished data.
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Alcohol and other drug treatment services 
In Australia, alcohol and other drug treatment services are provided in a variety of
settings, mainly through partnerships involving government and community-based
organisations, or private practices. Treatment services range from early, brief
interventions designed to prevent clients progressing to harmful drug use, to long-term
residential treatment designed to rehabilitate clients with an alcohol or drug
dependence. The goals of treatment can vary from complete abstinence to reduced or
controlled use. Alcohol and other drug treatment services also work with family
members of people with a drug or alcohol problem, as well as with other service
providers to resolve additional health and social problems confronting their clients. 
In March 1990, the Þrst national census of Clients of Treatment Service Agencies in
Australia was conducted to identify the characteristics of clients attending drug and
alcohol treatment services. The census was subsequently repeated in 1992, 1995 and
most recently in May 2001. 
The 2001 client census reported that 5,304 clients were treated on census day in the 458
agencies that responded (90.3% of the total) (Shand & Mattick in press). Although the
majority of clients were in treatment for their own substance use (93.8%), a small
proportion of clients (6.2%) were relatives or friends of substance users. The mean age
was 33 years for substance users and 39 years for relatives/friends. Overall, the majority
of substance users were male (64.8%), had been born in Australia (88.8%), spoke English
at home (95.0%), and were in unpaid employment or unemployed (82.1%). Alcohol and
opiates were the substances most commonly reported (35.1% and 39.1% respectively),
followed by cannabis (9.3%) and amphetamines (8.8%). Polydrug use was reported for
12.6% of substance users. Just under half the substance users (47.0%) were reported to
have injected illicit drugs in the 12 months preceding the census.
Box 5.8: The National Drug Strategy
The National Drug Strategy (NDS) and its forerunner, the National Campaign Against
Drug Abuse (NCADA), have been operating since 1985. Both NCADA and NDS were
created with strong bipartisan political support as cooperative ventures between the Com-
monwealth and State/Territory governments as well as the non-government sector. The
common aim from the outset was ‘to minimise the harmful effects of drug use in Aus-
tralian society’. Drugs affect virtually every Australian family. Each year the use of
alcohol, tobacco and illicit drugs is a significant factor in many deaths and hospitalisations
and contributes enormous economic costs to the healthcare system, law enforcement and
private industry in Australia.
The National Drug Strategic Framework 1998–99 to 2002–03 has been developed under
the direction of the Ministerial Council on Drug Strategy to outline policy principles and
priority areas for reducing harm arising from the use of licit and illicit drugs. The Frame-
work presents a shared vision and a basis for cooperation and coordinated action to reduce
the harm caused by drugs in Australia over a 5-year period until the year 2003. The mis-
sion for the National Drug Strategic Framework 1998–99 to 2002–03 is to improve health,
social and economic outcomes by preventing the uptake of harmful drug use and reducing
the harmful effects of licit and illicit drugs in Australian society.
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Table 5.38 shows that the proportions of clients presenting to specialist treatment
agencies with alcohol problems and opiate problems has changed since the Þrst census
in 1990. Whereas the proportion of clients presenting with alcohol-related problems has
substantially decreased, treatment for other drug problems (opiates, cannabis,
amphetamines and polydrug use) has increased since 1990. 
The Clients of Treatment Service Agencies census, however, does not record methadone
dosing. Given that the number of people registered for methadone maintenance
treatment increased from approximately 10,000 in 1990 (Ward et al. 1992) to over 30,000
in 2000 (Degenhardt 2001), overall treatment for opiates has increased far more
markedly than the census indicates. Further, the census captures only clients in
treatment at specialist drug and alcohol treatment agencies. It does not capture
treatment by general practitioners, which may be one of the factors behind the decline
in alcohol treatment observed (e.g. since 1999, two new prescribed
pharmacotherapiesÑacamprosate and naltrexoneÑhave become available to treat
alcohol dependence). In addition, it is a one-day sample and therefore may not be
representative of the total substance user community in treatment.
Medicare services
Data on the operation of Medicare, AustraliaÕs universal system of health insurance,
provide an overview of the use of private medical services. These include services
provided outside hospitals as well as medical services for private patients in public and
private hospitals. Note, however, that Medicare data do not provide a complete view of
the use of medical services (see Box 5.9).
In 2000Ð01, Medicare provided beneÞts for 213.9 million services (DHA 2002a). This
represents a 2-year increase of 3.7% over the 206.3 million services in 1998Ð99. This
increase was in part due to the effects of population growth (2.4%), a rise in the number
of items per person and the inclusion of additional items in the Medicare BeneÞts
Schedule (MBS). Medicare items cover a range of different services, from a single doctor
Table 5.38: Principal drug problems of substance users in treatment, 1990, 1992, 1995 and 
2001(a)
Proportion of substance users (per cent)
Drug problem 1990 1992 1995 2001
Alcohol 55.2 51.7 49.3 35.1
Opiates 33.7 33.2 33.6 39.1
Tobacco 7.9 8.5 4.8 2.2
Benzodiazepines 3.7 4.1 4.0 2.4
Cannabis 4.1 6.0 6.7 9.3
Amphetamines 3.9 4.3 6.5 8.8(b)
Polydrug(c) 10.9 11.2 12.2 12.6
Injected drugs in last 12 months 34.4 32.1 38.2 47.0
(a) Figures reflect more than one drug problem nominated for some participants.
(b) The 2001 figure includes amphetamine-related substances (e.g. ecstasy).
(c) These figures reflect clients reported by agencies as polydrug (including opiates) users, polydrug (excluding opiates) 
users, and those clients for whom more than three drugs (excluding tobacco) had been nominated.
Source: Shand & Mattick (in press).
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Box 5.9: Medicare and Medicare benefits
Medicare, Australia’s universal health insurance scheme, came into operation on 1 Feb-
ruary 1984. Administered by the Health Insurance Commission (HIC), the scheme pro-
vides people with access to free treatment as public (Medicare) patients in hospitals, and
free or subsidised treatment by medical practitioners, participating optometrists and, for
certain services, eligible dentists. All Australian residents are eligible for Medicare, except
diplomats and their dependants. Short-term visitors are not eligible unless they are covered
by a reciprocal healthcare agreement and the services are of immediate medical necessity.
Medicare is funded through taxation, which includes the Medicare levy (see Box 5.2). 
The Australian Health Care Agreements between the Commonwealth Government and the
State and Territory governments provide for all persons eligible for Medicare to obtain care
as an admitted patient, outpatient or emergency department patient at public hospitals
without charge. Doctors appointed by the hospitals provide medical care for such ‘public’
patients (at no cost to the patient). Patients who choose to be treated in private hospitals or
as private patients in public hospitals are liable for hospital accommodation and other
charges, and for medical fees charged by private practitioners. Private health insurance can
be purchased to cover these private hospitalisation costs (see Section 5.3 and Box 5.5).
Medicare benefits provide financial assistance to people who incur medical expenses in
respect of professional services rendered by qualified medical practitioners, participating
optometrists and, for certain services, eligible dentists. A schedule of fees has been estab-
lished, and Medicare benefits for services provided by private practitioners are based on
those fees. 
Practitioners are not obliged to adhere to the schedule fees, except in the case of partici-
pating optometrists. However, if they direct-bill the HIC for any service rather than
issuing patients with accounts, the amount payable then is the Medicare benefit, and addi-
tional charges cannot be raised for the service. About 71% of services were direct-billed in
2000–01.
Some types of medical services do not qualify for Medicare benefits. These include services
provided to entitled veterans and their dependants for the DVA. Interim Medicare benefits
may be paid for services for which claims may be lodged under motor vehicle third-party
insurance and workers compensation schemes. These benefits are covered by the HIC at the
time when claims are settled. Other services which do not qualify for Medicare benefits
include services provided by public authorities and most government-funded community
health services, as well as services not necessary for patient care (e.g. examinations for
employment purposes). To attract benefits, services must be ‘clinically relevant’, i.e. rea-
sonably required for the treatment of the patient’s condition. 
For private patients who are admitted in hospitals or day-hospital facilities, the Medicare
benefit is 75% of the schedule fee, but the gap between the benefit and the schedule fee is
insurable with private health insurance organisations. Insurance to cover amounts paid in
excess of the schedule fee is prohibited unless the services are the subject of a private health
insurance contract or no-gaps arrangement. 
(continued)
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consultation to multiple pathology tests for a single patient episode, each of which is
counted as a separate item. Consequently, it is not possible to directly compare different
types of services based on of the number of Medicare claims. Also for this reason, the
terms ÔitemsÕ or Ôitems of serviceÕ are generally used when referring to Medicare claims.
Box 5.9 (continued): Medicare and Medicare benefits
For non-hospital services, a benefit of up to 85% of the schedule fee is payable. The patient
is responsible for the gap between the benefit paid and the schedule fee, up to a maximum
amount, which is indexed annually. From 1 November 2001, that amount was $55.60.
Patients are responsible for payments of amounts charged above the schedule fee. 
For all beneficiaries (individuals and registered families), if the sum of the gaps between
benefits and schedule fees exceeds a specified amount in any year for non-hospital services,
an amount up to the level of the schedule fee is reimbursed for services during the
remainder of the year. The level of this ‘safety net’ threshold is linked to the Consumer
Price Index, and is adjusted each year.
Unreferred attendances (35.0%)
Specialist attendances (13.7%)
Obstetrics (0.9%)Anaesthetics (2.1%)
Pathology (15.8%)
Diagnostic imaging (15.8%)
Operation (9.4%)
Assistance at operation (0.4%)
Optometry (2.2%)
Radiotherapy & therapeutic nuclear medicine (0.9%)
Other (3.9%)
Note: Based on the amount paid in benefits ($), not the number of services.
Source: DHA 2002a.
Figure 5.10: Medicare benefits paid by broad type, 2000Ð01 
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In 2000Ð01, a total of $7,326 million was paid in Medicare beneÞts, of which $2,561
million (35.0%) was for unreferred attendances, i.e. GP services, emergency attendances
after hours, other prolonged attendances, group therapy and acupuncture. A further
$1,159 million (15.8%) was paid for diagnostic imaging, $1,156 million (15.8%) for
pathology tests and $1,005 million (13.7%) for specialist attendances (Figure 5.10).
The largest increase in items of service between 1998Ð99 and 2000Ð01 were in
anaesthetics (15.4%), with growth coinciding with higher levels of private health
insurance following the introduction of the lifetime health cover initiatives (see Section
5.3). There were also large increases for radiotherapy and therapeutic nuclear medicine
(13.5%) and pathology (11.7%), reßecting decreases for hospital patients and larger
increases for out-of-hospital services. 
In 2000Ð01, each person in Australia received, on an average, 11.0 services under
Medicare (or 10.0 services, if patient episode initiation (PEI) items, which cover the
administrative costs associated with collection of specimens for pathology, are
excluded). These services included 5.2 unreferred attendances, 1.0 specialist attendance
and 3.2 pathology items.
Between 1998Ð99 and 2000Ð01, the annual number of services per person (including
PEI) increased from 10.9 to 11.3, or an average annual increase of 0.7% (Table 5.39). As
for numbers of services overall, the largest increase was for anaesthetics. 
The number of services used per person varied considerably. For example, in 2000Ð01,
2.5% of the population received 51 or more services each, and these accounted for 18.4%
of total beneÞts paid. Between 1 and 5 services were received per person by 34.5% of
the population, and these accounted for 8.5% of the total beneÞts (DHA, unpublished
Medicare data).
Table 5.39: Medicare items processed per capita, by broad type, 1998Ð99 and 2000Ð01
Type of item 1998–99 2000–01
Total change
(per cent)
Annual change
(per cent)
Unreferred attendances(a) 5.42 5.19 –4.1 –2.1
Specialist attendances 0.98 1.00 1.5 0.7
Obstetrics 0.08 0.08 –8.3 –4.2
Anaesthetics 0.09 0.11 12.7 6.3
Pathology PEI items(b) 0.97 1.02 4.7 2.4
Other pathology 1.97 2.18 4.4 2.2
Total pathology 2.94 3.20 9.1 4.6
Diagnostic imaging 0.60 0.63 5.6 2.8
Operations 0.29 0.30 4.2 2.1
Optometry 0.21 0.22 6.1 3.1
Other(c) 0.29 0.26 4.7 2.4
Total including PEI items 10.90 11.03 1.3 0.7
Total excluding PEI items 9.93 10.02 0.9 0.5
(a) Includes general practitioner attendances, emergency attendances, attendances after hours, other prolonged 
attendances, group therapy and acupuncture.
(b) Patient episode initiation items. These items cover the administrative costs associated with the collection of 
specimens.
(c) Includes assistance at operations, radiotherapy and therapeutic nuclear medicine, and miscellaneous services.
Source: DHA 2002a.
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The average number of consultations with GPs and specialists per person increased
steadily from 1986Ð87 to 1995Ð96, and has since declined slightly (Figure 5.11). The data
exclude obstetrics, pathology, radiology, anaesthetics, optometry and surgery.
In 1988Ð89, males consulted a GP or specialist on average 4.5 times per year and the
female population averaged 6.6 times per year. In 2000Ð01, these rates increased to 5.2
and 7.2 respectively. The increase in consultation rates may be in part due to improved
access to doctors, as there was a 30% increase in the number of full-time-equivalent
Medicare providers of general practice services between 1988Ð89 and 2000Ð01 (DHA,
unpublished Medicare data). Increased promotion and awareness of steps which people
can take to maintain their own health and that of their families, such as immunisation,
Pap smears, blood pressure measurements and general health check-ups, may have also
contributed to the increased consultation rates. 
Use of private medical services by State
Variations in the use of medical items occur among the States and Territories. In
2000Ð01, the highest number of services was recorded in New South Wales with 11.7
services per person. This was followed by Victoria and South Australia (11.1) and
Queensland (10.8). The Northern Territory recorded the lowest per person use of
medical services with 5.9 (DHA 2002a). This is partly offset by services being provided
to Aboriginal and Torres Strait Islander peoples through programs other than Medicare,
and these services are not included in the data reported here. 
1988–89 1990–91 1992–93 1994–95 1996–97 1998–99 2000–01
0
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Number
Year
Females
Males
Note: Rates are age-adjusted to the Australian population at 30 June 1991.
Source: AIHW, derived from DHA 2002a.
Figure 5.11: GP and specialist consultations per person, 1988Ð89 to 2000Ð01
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Use of DVA-funded medical services
The DVA funds medical services provided by local medical ofÞcers (GPs who are
registered with DVA) and specialists for eligible veterans, war widows/widowers and
their dependants. DVA issues each eligible veteran with a gold or white health card.
The gold card is issued to veterans who are entitled to the full range of healthcare
services funded by DVA. The white card provides access to the services for service-
related conditions only.
In 2000Ð01, 11.7 million medical services were provided under these arrangements
(Table 5.40). 
Of the DVA healthcare cardholder population of approximately 345,000 people, 22%
(nearly 73,000 people) receive some form of mental health treatment in any given year.
Whereas some receive specialist treatment from mental health practitioners, for the
majority, treatment is provided through their GP. 
General practice
The continuous national study of general practice activity in Australia, known as the
BEACH (Bettering the Evaluation and Care of Health) program provides insight into
the patients and problems managed in general practice and the ways in which GPs
manage the problems. For BEACH, a random sample of about 1,000 GPs provides
details of a total of around 100,000 GPÐpatient encounters each year. These encounters
represent more than 100 million such encounters occurring across the country each
year. The study is conducted by the General Practice Statistics and ClassiÞcation Unit
(an AIHW collaborating unit within the Family Medicine Research Centre, University
of Sydney). This section provides a summary of the results from the third year of the
program, covering the period April 2000 to March 2001 inclusive (AIHW: Britt et al.
2001).
The general practitioners and encounters
GPs sampled for BEACH have the equivalent of at least 1,500 Medicare claims a year, so
the majority of part-time GPs are included and those who claim for only a few
consultations a year are excluded. The source population for 2000Ð01 included over
17,000 practitioners, the majority (68.0%) of whom were male (Table 5.41). Almost
one-quarter (23.9%) were aged 55 years or more and only 12.4% were under 35 years
Table 5.40: DVA healthcare cardholder use of local medical officer and specialist services, 
2000Ð01
Consultations/
services
Cardholders
who received
services
Items per
cardholder
Users as
proportion of
treatment
population (%)(a)
Local medical officer consultations 3,888,029 312,133 12 90
Specialist consultations 1,657,725 231,948 7 67
Other local officer and specialist 
services 6,115,527 284,579 21 82
(a) Using treatment population at 30 June 2001 of 345,131.
Source: DVA Treatment Accounts System, unpublished.
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old. Three-quarters of the GPs had graduated in Australia and the majority (66.4%)
were practising in capital cities. Those in New South Wales and Victoria accounted for
58.4% of the total. A total of 999 GPs took part in BEACH for 2000Ð01.
In most (98.1%) of the 99,307 encounters reported, the patient was seen by the GP. By far
the majority (94.6%) were claimable from Medicare and 83.9% of these were standard
surgery consultations. 
The encounters involved 149,962 reasons for encounter (RFEs), 143,528 problems
managed, 107,400 medications, 49,072 non-pharmacological treatments, 10,366 referrals,
29,225 pathology test orders and 8,227 orders for imaging.
The patients
Children accounted for 14.0% of encounters, 10.3% were with young adults, and 23.0%
with older patients. The majority of the patients were female (57.1%). The patient held a
healthcare card at 36.7% of encounters, and came from a non-English-speaking
background at 7.1%. The patients identiÞed themselves as an Aboriginal and/or a
Torres Strait Islander at less than 1%. 
For every 100 encounters an average of 151 patient RFEs were recorded. More than half
related to the respiratory, musculoskeletal, skin, circulatory and digestive systems. The
ten most commonly recorded RFEs accounted for 35.5% of all RFEs. The need for a
Table 5.41: The 2000Ð01 BEACH source population: all active recognised GPs in Australia 
Australia(a) Australia(a)
Variable Number % of GPs Variable Number % of GPs
Sex State
Males 11,730 68.0 New South Wales 5,849 34.1
Females 5,514 32.0 Victoria 4,170 24.3
Age Queensland 3,136 18.3
< 35 2,143 12.4 South Australia 1,521 8.9
35–44 5,438 31.6 Western Australia 1,590 9.3
45–54 5,536 32.1 Tasmania 485 2.8
55+ 4,112 23.9 Australian Capital Territory 282 1.6
Geographical location Northern Territory 137 0.8
Capital city 11,454 66.4 Graduated
Other metropolitan centre 1,287 7.5 Australia 12,928 75.0
Large rural centre 1,055 6.1 Overseas 4,316 25.0
Small rural centre 1,148 6.7
Other rural area 1,953 11.3
Remote centre 151 0.9
Other remote area 196 1.1
(a) Data provided by GP Branch, DHA. All GPs who claimed at least 375 A1 Medicare items during the most recent 
3-month HIC data period. Missing data removed.
Note: Based on the Rural, Remote and Metropolitan Classification of the Department of Primary Industries and Energy and 
the Department of Human Services and Health (1994).
Source: AIHW: Britt et al. 2001.
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check-up was the most common RFE (13.2 per 100 encounters) and requests for
medication were also frequent (9.2). Visits were also often related to the need for
immunisation or vaccination (4.4 per 100 encounters) (Table 5.42).
The problems managed
On average there were 145 problems managed per 100 encounters. Problems related to
the respiratory system, the skin and the musculoskeletal and circulatory systems
accounted for just over half of all problems managed. Of the 143,528 problems
managed, 32.8% were problems new to the patient. Problems regarded by the GP as
likely to be work-related (irrespective of whether the encounter was covered by
workers compensation) occurred at a rate of 3.3 per 100 encounters. The 20 problems
most frequently managed accounted for 39.4% of all problems managed. Hypertension
was the most common (8.6 per 100 encounters) followed by upper respiratory tract
infection (6.9 per 100), immunisation/vaccination (4.6 per 100) and depression (3.7 per
100) (Table 5.43).
Between 1998Ð99 and 2000Ð01 there was a statistically signiÞcant increase in the rate of
management of problems related to the endocrine and metabolic system, partly
explained by an increase in the rate of management of lipid disorders. There was a
signiÞcant decrease in the rate of management of respiratory problems, in particular of
asthma and acute bronchitis. There were also marginal decreases in the rates of
management of problems related to the ear, the eye and the neurological system.
Management
There was no speciÞc treatment recorded for 13.6% of problems managed. The most
common treatment was medication alone (40.9% of problems) followed by clinical
treatments only (9.6%) and then by medication and clinical treatment (8.6%).
Table 5.42: GP consultations: 10 most frequent patient reasons for 
encounter, 2000Ð01
Patient reason for encounter
Per cent of total
RFEs(a)
Rate per 100
encounters(a)
Check-up 8.8 13.2
Prescription 6.1 9.2
Cough 4.6 7.0
Immunisation/vaccination 2.9 4.4
Test results 2.8 4.3
Throat complaint 2.7 4.0
Back complaint 2.5 3.8
Rash 1.9 2.9
Upper respiratory tract infection 1.7 2.6
Fever 1.5 2.3
Total 100.0 151.0
(a) Figures do not total 100 as more than one RFE can be managed at each encounter. Also 
only the 10 most frequent problems are listed.
Note: Based on 149,962 RFEs at 99,307 encounters.
Source: AIHW: Britt et al. 2001.
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GPs undertook management activities at a rate of 205 per 100 encounters and 142 per
100 problems. The most common was the prescription, advice (for over-the-counter
purchase) or supply of medication (108.2 per 100 encounters or 74.8 per 100 problems).
Other treatments of a clinical or procedural nature were provided at 49.4 per 100
encounters, referrals at 10.4, pathology orders at 29.4 and imaging at 8.3 per 100
encounters (Table 5.44).
One or more medications were given for 58.7% of problems and at least one non-
pharmacological treatment was used in the management of 29.7% of problems. A
referral was made for 7.2% of problems and orders for pathology tests were made for
10.6% of problems. Orders for imaging were less frequent, being made for 5.2% of
problems managed.
Between 1998Ð99 and 2000Ð01 there were statistically signiÞcant increases in rates of
treatment with drugs such as non-steroidal anti-inßammatory drugs, and lipid-
lowering agents (such as statins). There was a decrease for asthma inhalants.
Table 5.43: GP consultations: 20 most frequently managed problems, 
2000Ð01
Problems managed
Per cent of total
problems(a)
Rate per 100
encounters(a)
Hypertension 6.0 8.6
Upper respiratory tract infection 4.8 6.9
Immunisation/vaccination 3.2 4.6
Depression 2.5 3.7
Lipid disorder 2.0 2.9
Asthma 2.0 2.8
Diabetes 1.9 2.8
Acute bronchitis/bronchiolitis 1.9 2.7
Back complaint 1.8 2.6
Osteoarthritis 1.7 2.5
Dermatitis, contact/allergic 1.4 2.1
Sprain/strain 1.4 2.0
Anxiety 1.2 1.7
Prescription 1.1 1.7
Viral disease, other/not otherwise specified 1.1 1.6
General check-up 1.1 1.6
Sleep disturbance 1.1 1.6
Urinary tract infection 1.1 1.5
Acute otitis media/myringitis 1.0 1.5
Sinusitis acute/chronic 1.0 1.5
Total 100.0 144.5
(a) Figures do not total 100 as more than one problem can be managed at each encounter. Also 
only the 20 most frequent problems are listed.
Note: Based on 143,528 problems managed at 99,307 encounters.
Source: AIHW: Britt et al. 2001.
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Dental services
This section focuses on access to dental care using data from National Dental Telephone
Interview Surveys (NDTISs) conducted in the period 1994 to 1999. Data are also
presented on trends in dental practice, using data from a longitudinal study of dentistsÕ
practice activity.
Child and adolescent access to dental care
NDTIS data collected in 1999 show that, for more than 70% of primary school children
(aged 6Ð12 years) in Queensland, South Australia, Western Australia, Tasmania and the
Northern Territory (Figure 5.12), their last visit to a dentist was to a school dental
service. In the Australian Capital Territory, the corresponding Þgure was 52% and it
was less than 50% in New South Wales and Victoria.
Over 50% of adolescents aged 13Ð16 years reported having visited a school dental
service for their last visit in 1999 in Queensland, South Australia, Western Australia,
Tasmania and the Northern Territory. In Victoria and the Australian Capital Territory,
substantially fewer than 50% had used a school dental service for their last visit.
In 1999, over two-thirds of children aged 6Ð12 years in all States and Territories had
made a dental visit in the previous 12 months (Figure 5.13), although this proportion
varied, from 68% in New South Wales to 92% in Tasmania. In the 13Ð16 age group, a
similar proportion of children had made a dental visit in the previous 12 months, the
proportion varying from 67% in the Northern Territory to 91% in Tasmania. 
Table 5.44: GP consultations: management activities, 2000Ð01
Management type
Rate per 100
encounters
Rate per 100
problems
Per cent of total
problems(a)
Medications 108.2 74.8 58.7
Prescribed 92.3 63.9 51.3
Advised 9.0 6.2 5.6
GP supplied 6.9 4.8 3.8
Other treatments 49.4 34.2 29.7
Clinical 37.2 25.8 22.7
Procedural 12.2 8.4 8.0
Referrals 10.4 7.2 7.2
Specialist 7.4 5.1 5.1
Allied health 2.3 1.6 1.6
Pathology 29.4 20.4 10.6
Imaging 8.3 5.7 5.2
(a) The percentage of total problems for which at least one of the specified management types was initiated by the GP.
Note: Based on 143,528 problems managed at 99,307 encounters.
Source: AIHW: Britt et al. 2001.
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Figure 5.12: Children whose last visit to a dentist was to a school dental service, 
1999 (per cent)
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Source: National Dental Telephone Interview Survey 1999.
Figure 5.13: Children who made a dental visit in the previous 12 months, 1999 (per cent)
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Figure 5.14: Dentate adults making a dental visit within the previous 12 months, by 
income and reason for last visit, 1999 (per cent)
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Source: National Dental Telephone Interview Survey 1999.
Figure 5.15: Dental services received by dentate adults within the previous 12 months, 
1999 (per cent)
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Adult access to dental care
This section focuses on adult access to dental services with a particular emphasis on
problem-oriented dental-visiting behaviour and the subsequent differences in the type
of care received.
Dental visits are prompted by some form of stimulus, which may vary between a
regular check-up and a perceived dental problem. The potential beneÞts of the visit are
assessed and balanced against the costs or possible disadvantages, which may include
money, time, pain, inconvenience of travel and fear of dentists (dental anxiety). These
factors inßuence whether or not care is avoided or delayed, and are associated with the
type of care received, which may vary from timely preventive services to invasive
procedures for advanced disease. 
In 1999 just over half of dentate Australian adults (i.e. persons with at least one natural
tooth) made a dental visit in the previous 12 months, and in the majority of cases the
last visit was made in response to a problem or for relief of pain (Figure 5.14). The most
obvious difference between low and higher income groups was the dominance of visits
for relief of pain and problems among those with the lowest annual household income.
The proportion of people last visiting for a check-up increased steadily with income,
with the proportion for the highest income group just over double that of the lowest.
Less variation occurred in the percentage last visiting for relief of pain, and all problem
visits were less prevalent among groups with a household income above $30,000 per
annum. 
The proportion of government beneÞt cardholders last visiting for a problem or relief of
pain was higher than that for non-cardholders, with the proportion of visits that were
for check-ups and the proportion that made a dental visit in the previous 12 months
noticeably lower than for non-cardholders.
The differences in the services received by cardholders receiving public-funded care,
those receiving private care at their own expense, and non-cardholders are evident in
Figure 5.15. The group with the highest extraction rateÑcardholders who last had
public-funded careÑalso had the lowest Þlling rate. This group consistently had a high
proportion of problem visits, in excess of 70%. Non-cardholders and cardholders whose
last dental visit was in the private sector were more likely to receive Þllings and less
likely to have extractions. The group with the lowest extraction rateÑnon-cardholders
whose last visit was to a private practiceÑhad a lower proportion of problem-oriented
visiting.
Time since last making a dental visit indicates contact with services, with people who
avoid or delay dental visits less likely to receive ongoing preventive care. The
differences between dentate adults from the Ômost disadvantagedÕ and Ôleast
disadvantagedÕ groups in the time since their last dental visit are demonstrated in
Figure 5.16. Adults living in the most disadvantaged areas (lowest quintile based on the
SEIFA Index of Relative Socio-Economic Disadvantage) whose annual household
income was below $20,000 and who did not have private dental insurance were deÞned
as Ômost disadvantagedÕ. The Ôleast disadvantagedÕ were deÞned as people who had an
income greater than $40,000, dental insurance and a residential postcode in an afßuent
area (highest SEIFA quintile). Less than half of the participants from Ômost disadvantagedÕ
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Figure 5.16: Years since last dental visit for dentate adults, 1994 to 1996
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Figure 5.17: Mean number of services per year for dentate adults making a dental visit 
within the previous 12 months, 1994 to 1996
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households had visited in the previous year, compared with almost 70% of the Ôleast
disadvantagedÕ. A greater percentage of the Ômost disadvantagedÕ had not visited for 2
or more years, with a Þvefold difference between the two groups (16.3% compared with
3.1%) when the time elapsed was 5 or more years.
Problem-oriented visiting behaviour may lead to more advanced disease and less
favourable treatment, such as extraction. Longer periods between dental visits reported
by Ômost disadvantagedÕ persons, particularly among those who usually visited for a
problem, were likely to be followed by more invasive procedures when dental care was
sought. 
ÔMost disadvantagedÕ persons had three times as many teeth extracted as Ôleast
disadvantagedÕ persons (0.60 per person per year compared with 0.20), and fewer
Þllings than Ôleast disadvantagedÕ persons who last visited for a problem (Figure 5.17).
Those visiting for a check-up had fewer Þllings and extractions than those last
attending for a problem, with Ômost disadvantagedÕ persons more likely to have a tooth
extracted. These differences between Ômost disadvantagedÕ and Ôleast disadvantagedÕ
persons indicate that the treatment received was inßuenced by socioeconomic factors as
well as the reason for visit.
Trends in dental practice
Trends in dental practice have been measured at 5-year intervals in Australia since 1983.
These trends are established among a random sample of dentists from each State and
Territory, with a sample supplementation procedure at each wave of the study to ensure
representative cross-sectional estimates over time.
Measures of practice activity show a pattern of stable numbers of hours worked per
year by dentists in private general practice between 1983Ð84 and 1998Ð99 (Table 5.45).
However, over the same period the number of patient visits per hour declined, with a
consequent decrease in the number of patient visits per year. These changes reßect
longer term trends towards increased length of appointment time observed between
1960Ð61 and 1982Ð83 (Spencer & Lewis 1986).
In contrast to the reduction in number of patient visits, the number of services per visit
provided by dentists in private general practice increased between 1983Ð84 and
1998Ð99. However, the total number of services provided by dentists per year remained
stable, reßecting a counterbalancing of the decline in patient visits and the increase in
services supplied per visit. Demographic trends towards increased numbers of older
adults in the population are also being observed among dental patients, with the
proportion of adult patients increasing between 1983Ð84 and 1998Ð99 from 20% to 34%
for 45Ð64-year-olds and from 5% to 14% for patients aged 65 years and over. Oral health
trends in the population have indicated a decline in tooth loss over recent decades, with
the percentage of people with no natural teeth among those aged 65 years and over
decreasing from 66.6% in 1979 (ABS 1979) to 40.0% in 1994 (AIHW: Carter et al. 1994).
With increasing numbers of older patients who are retaining their teeth, these patients
may have complex treatment needs that require more services that take longer to
complete.
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The population trends towards declining tooth loss and increased numbers of older
adults are likely to affect service patterns. The increase in total number of services
provided per visit reßects changes in a range of service areas (Figure 5.18). Service
provision was dominated by restorative, diagnostic and preventive services in each of
the survey years. However, diagnostic, preventive and endodontic (root canal
treatment) services each showed increases over the 1983Ð84 to 1998Ð99 period. These
trends in service provision reßect a service pattern oriented towards retention of natural
teeth through diagnosis and disease prevention, restoration through Þllings, and
avoidance of extraction through endodontic treatment. 
Table 5.45: Practice activity and service provision for private general dental practitioners, 
1983Ð84 to 1998Ð99
Hours per year
Patients per
hour
Patients per
year
Total services
per visit
Annual
services per
dentist
1983–84 1,726 1.95 3,405 1.78 5,832
1988–89 1,756 1.78 3,097 1.84 5,607
1993–94 1,752 1.61 2,816 2.10 5,766
1998–99 1,740 1.49 2,589 2.14 5,463
Source: AIHW DSRU Longitudinal Study of Dentists’ Practice Activity.
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Figure 5.18: Main types of service provision by private general dental practitioners, 
1983Ð84 to 1998Ð99
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Primary health care services for Aboriginal and Torres 
Strait Islander peoples
Section 4.6 of this report provides data on health status, hospitalisation rates and the
use of GPs for Aboriginal and Torres Strait Islander peoples, demonstrating that the
pattern of usage of these mainstream services is different for Indigenous peoples
compared with the rest of the Australian population. Health expenditure data (Section
5.2) also indicate that Aboriginal and Torres Strait Islander peoples have different
patterns of use of healthcare services compared with other Australians. 
Mainstream services are not always accessible or the most appropriate provider for
Aboriginal and Torres Strait Islander peoples, due to a mix of geographic, social and
cultural reasons. Combined with the relatively poorer health status of Aboriginal and
Torres Strait Islander peoples compared with the rest of the population, this has led to
State, Territory and Commonwealth governments providing funds for healthcare
services speciÞcally to meet the needs of Aboriginal and Torres Strait Islander peoples.
The State and Territory governments provide funding mainly through hospitals and
community clinics. The Commonwealth Government, through the OfÞce for Aboriginal
and Torres Strait Islander Health (OATSIH), provides funding for a range of
Indigenous-speciÞc health and substance misuse services, which are largely delivered
in community-based settings. In 2000Ð01 OATSIH provided $162 million for the
provision of these services from 211 primary service sites and 81 secondary service sites
(including outreach services) distributed throughout Australia (DHAC 2001a).
The OATSIH-funded Aboriginal primary healthcare services (which may also receive
funding from other sources such as State and Territory governments) are also known as
Aboriginal Community-Controlled Health Services and Aboriginal Medical Services.
They operate in urban, rural and remote locations and offer a wide range of services,
including management of acute and chronic health conditions, preventive health (such
as immunisation and screening) and promotion activities, transport services and
advocacy and assistance in accessing other appropriate community and health services.
A small number provide speciÞc programs only, such as substance misuse, health
promotion or counselling.
In 1999Ð00, approximately 1,200,000 episodes of health care were reported to have been
provided by 117 services (98% of the total) (DHA and NACCHO unpublished). This
compared with 1,060,000 services in 1998Ð99 and 860,000 services in 1997Ð98. These
services covered an estimated total health service population of 600,000 Aboriginal and
Torres Strait Islander peoples in 1999Ð00 (the population Þgure reßecting some overlap
between services) compared with 515,000 in 1998Ð99 and 410,000 in 1997Ð98.
Approximately 90% of services in 1999Ð00 were provided to Aboriginal and Torres
Strait Islander clients (DHAC 2001b). Of these clients, 61% were female.
The services had 2,100 full-time-equivalent staff positions funded by OATSIH and State
and Territory governments in 1999Ð00. Of these, 65% were Aboriginal or Torres Strait
Islander staff members. This did not include 200 full-time-equivalent visiting health
professionals and Community Development Employment Program staff. Nearly all
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Aboriginal health workers and substance misuse workers were Indigenous people,
whereas most nurses and almost all doctors, dentists and specialists were other
Australians. 
Hearing services
The loss of hearing can hamper learning and acquisition of speech by children and can
contribute to social isolation, particularly for older Australians. An estimated 17% of the
Australian population have hearing loss (AIHW: Mathers et al. 1999), making it the
second most prevalent health condition, after dental caries.
In Australia, public hearing services are provided through a voucher system
coordinated by the Commonwealth GovernmentÕs OfÞce of Hearing Services. People in
need of these services are referred by their medical or hearing services practitioner.
Those assessed as eligible (e.g. sickness allowance recipients, pensioner concession card
and some DVA healthcare cardholders) are sent a voucher and a list of accredited
hearing services providers (including private providers and Australian Hearing
Services, the public provider) who are contracted with the OfÞce of Hearing Services to
provide services under the voucher system. Clients present their voucher to a listed
provider to access services such as hearing assessment; audiological rehabilitation and
maintenance; prescription, selection and Þtting of hearing devices; and subsidised
battery supply and device repair.
During 2000Ð01, the voucher system expenditure was $127.8 million compared with
$71.9 million for 1997Ð98, when the system commenced (DHAC 2001a). In 2000Ð01,
124,630 adult clients were issued with a voucher, an increase of around 4,000 vouchers
on the previous year. In total, there were 479,906 voucher hearing services provided by
Australian Hearing Services and the other private service providers in 2000Ð01, a slight
Table 5.46: Hearing services provided through the voucher system and 
community service obligation arrangements, Australia, 1999Ð00 and 2000Ð01
Type of service 1999–00 2000–01
Assessments
New                 57,867                 57,555
Return                 55,171                 53,750
Total 113,038 111,305
Hearing aid fitted
New monaural fit                 19,073                 17,381
New binaural fit                 30,921                 29,277
Subsequent binaural                  9,636                  9,416
Return monaural fit                 18,018                 15,997
Return binaural fit                 22,291                 18,869
Total 99,939 90,940
Replacements                 12,969                 14,689
Maintenance               257,744               262,972
Total 483,690 479,906
Source: Office of Hearing Services.
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decrease on the previous 12 months (483,690) (Table 5.46). The majority of these were
maintenance (55%) and assessment services (23%). About 73% of clients receiving an
assessment in 2000Ð01 were Þtted with a device compared with 80% for 1999Ð00
(DHAC 2001a).
In addition to the voucher system, Australian Hearing Services also receives funding
from the Commonwealth Government for community service obligations and research
($28.7 million in 2000Ð01). All Australians under the age of 21 and adults with special
needs (e.g. those with complex hearing rehabilitation needs, Aboriginal and Torres
Strait Islander peoples, those living in remote locations) are eligible to receive services
from Australia Hearing Services as part of its community service obligations. Services
were provided in 2000Ð01 to around 34,909 children and young adults under the age of
21, and around 11,044 adults with special needs.
Family planning organisations
Family planning organisations provide a range of clinical, community education and
professional training services in sexual and reproductive health. The clinical services
provided to individuals include contraceptive services, counselling and information
services, and the management of sexual and reproductive health. Family planning
organisations provide these services to many clients who choose not to use or do not
have access to mainstream health services, including young people, migrant
populations, the homeless and people with disabilities. 
During 2000Ð01, 126,720 client visits were made to family planning organisations
(excluding those in South Australia) (Family Planning Australia 2001). This compares
with 151,338 client visits recorded for 1998Ð99 and was a 27% decline from the 173,036
visits recorded for 1996Ð97.
When clients visit a family planning organisation they may access a single service or a
combination of services. Following the trend reported for client visits, there was a 21%
reduction in the number of services provided in 2000Ð01 compared with 1996Ð97
(calculated from Table 5.47). The majority of this reduction occurred for early
intervention and health promotion services. In contrast, the number of reproductive
Table 5.47: Client visits and services provided by family planning organisations(a), selected 
years, 1996Ð97 to 2000Ð01
Type of service provided 1996–97 1998–99 2000–01
Contraceptive services 72,463 62,040 70,584
Reproductive and sexual health management(b) 31,159 23,866 44,061
Early intervention/health promotion services(c) 127,807 107,554 68,541
Total services 231,429 193,460 183,186
Number of client visits 173,036 151,338 126,720
(a) Excludes South Australia.
(b) Includes management of menstrual irregularity, sexually transmitted infections and menopause, antenatal checks, 
postnatal checks and post-termination checks.
(c) Includes Pap smears, breast checks, pregnancy tests, tests for sexually transmitted infections, rubella tests and 
hepatitis tests.
Source: Family Planning Australia national database.
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and sexual health management services provided during 2000Ð01 represented a 41%
increase on the number of those services provided during 1996Ð97. Data on
reproductive health counselling and information services to clients were not available
for 2000Ð01.
During 2000Ð01, 37% of services were delivered to clients who were aged less than 25
years and 21% to clients aged 40 years and over. Males made 3% of client visits,
although the number of males who attended with their female partners (i.e. as couples)
is unknown. About 23% of client visits were made by people born outside Australia. 
Family planning organisations also provide education and training programs. In
2000Ð01, about 13,500 people (mainly health and education professionals) attended
training sessions, and over 100,000 attended general, community or school education
programs.
Complementary and alternative health services
A range of services complement or provide alternatives to mainstream healthcare
services. The 1995 National Health Survey estimated that 1.6% of Australians consulted
a chiropractor in the 2 weeks before the survey, with smaller proportions visiting
acupuncturists, herbalists, naturopaths, hypnotherapists and osteopaths (ABS 1997b).
The extent to which these services have been incorporated into the general healthcare
system differs. Only acupuncture performed by a medical practitioner attracts a
Medicare rebate; rebates totalled $15.2 million in 2000Ð01, for 719,000 acupuncture
Medicare items. Some private health ancillary insurance covers some of these services,
such as those provided by naturopaths, osteopaths and chiropractors.
5.6 Use of medications
The use of medications is the most common health-related action taken by Australians
(ABS 1997b). Prescription medications are provided through community pharmacies
and hospitals, whereas non-prescription medicines and complementary and alternative
medicines are available from pharmacies and other retail outlets. 
The National Health Survey in 1995 estimated that 10.7 million Australians (59.1% of
the population) used some form of orthodox medication (medications other than
homeopathic, herbal, nutritional, and other complementary and alternative medicines)
in the 2 weeks before interview. There were 4.6 million (25.8%) who had used vitamins
or minerals and 1.7 million (9.4%) who had used herbal or natural medications. 
Prescribed medicines
In the 1995 National Health Survey, it was estimated that 6.54 million Australians used
medications that had been prescribed by a medical practitioner in the 2 weeks before
interview. The types of prescribed medication most commonly used were ßuid, heart
and blood pressure medications (1.93 million people), asthma medications (1.01 million
people) and pain relievers (752,000 people).
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Information on the use of prescription medicine compiled by the Health Insurance
Commission relates to prescriptions submitted for subsidy payment under the PBS or
the RPBS (Box 5.10). Data are not available on use of prescribed medicines in public
hospitals and most private hospitals. Recent data are also not available on prescriptions
issued from community pharmacies that were not covered by the PBS or the RPBS; data
for 1998 were summarised in Australia’s Health 2000. 
In 2000Ð01, there were 148.1 million community PBS prescriptions, 22.9 million to
general patients and 124.8 million to concessional patients (DHA 2002b). This was an
increase of 7.2% over the 138.1 million in 1999Ð00 and of 18.4% over the 125.1 million in
1998Ð99. There were 13.1 million RPBS prescriptions in 2000Ð01, an increase of 8.7%
over the 12.0 million RPBS prescriptions in 1999Ð00.
Box 5.10: The Pharmaceutical Benefits Scheme
The PBS subsidises the cost of a wide range of prescription medications, providing Aus-
tralians with access to necessary and cost-effective medicines at an affordable price. As at
1 November 2001, 589 generic drugs available in 1,458 forms and strengths (items) mar-
keted as 2,459 different drug products (brands) were covered by the scheme. The items that
attract benefits are reviewed frequently, and the price of every item covered is negotiated
with the supplier.
Australian residents and visitors from those countries with which Australia has a Recip-
rocal Health Care Agreement are eligible for PBS benefits. To access the benefits under the
scheme, patients are grouped into two classes. General patients pay the first $22.40 (from
1 January 2002) for each prescription item. Concessional cardholder patients (people with
low incomes and sickness beneficiaries who hold a healthcare card) make a copayment of
$3.60 per prescription item. Surcharges apply for some alternative brands and medicines.
Individuals and families are protected from large overall expenses for PBS-listed medicines
by safety nets. Once a general patient and/or immediate family has spent $686.40 in a cal-
endar year (excluding surcharges), the patient copayment per item decreases to the conces-
sional rate of $3.60 per item. 
For concessional patients, the $3.60 copayment is not required once their expenditure on
PBS items exceeds $187.20 in a calendar year (excluding surcharges). These copayments
and safety net thresholds are indexed according to movements in the Consumer Price
Index from 1 January each year.
Patients may pay more than the standard copayment where a PBS item is priced above the
benchmark price for different brands of the same drug, or the benchmark price for a partic-
ular therapeutic group of drugs. These additional payments do not count towards safety
nets and any difference in price must be met by the patient.
The Commonwealth also helps in the provision and purchase of drugs through the RPBS,
which provides assistance to eligible war veterans and dependants. It is generally similar
to the PBS for concessional beneficiaries but covers some additional medicines. 
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The top three generic medications by PBS prescription volume in 2000Ð01 were
atorvastatin and simvastatin (both serum lipid-reducing agents; both about 4.5 million
prescriptions), followed by paracetamol (an analgesic; 4.3 million prescriptions). The
number of prescriptions for atorvastatin in 2000Ð01 was 24% higher than in 1999Ð00,
and there was a marked increase also for simvastatin (Table 5.48). Simvastatin and
atorvastatin were also the highest cost drugs for the PBS in 2000Ð01, with PBS
expenditure on them totalling $237.0 million and $226.2 million, respectively. The next
most costly were omeprazole (an anti-ulcerant, $161.4 million) and celecoxib (an anti-
inßammatory/anti-rheumatic drug, $160.6 million). 
Celecoxib, for which there were 3.3 million prescriptions, was newly listed on the PBS
in 2000Ð01. For Zyban (bupropion, an anti-smoking drug), another newly listed drug,
there were 274,382 prescriptions between February and June and PBS expenditure of
$65.6 million.
Table 5.48: Top 10 generic medications by volume, Pharmaceutical Benefits Scheme, 2000Ð01
Generic drug Action
Total volume
2000–01
Total volume
1999–00 % change
1 Atorvastatin Serum lipid-reducing 4,512,127 3,442626 23.7
2 Simvastatin Serum lipid-reducing 4,498,294 4,124,508 8.3
3 Paracetamol Analgesic 4,344,529 4,267,035 1.8
4 Ranitidine 
hydrochloride
Anti-ulcerant 3,567,592 3,688,406 –3.4
5 Salbutamol Bronchodilator 3,392,527 3,456,617 –1.9
6 Celecoxib Anti-inflammatory 3,312,211 . . . .
7 Codeine with 
paracetamol
Analgesic 2,833,716 2,880,507 –1.7
8 Temazepam Sedative hypnotic 2,562,287 2,541,297 0.8
9 Omeprazole Anti-ulcerant 2,529,186 2,167,644 14.3
10 Atenolol Beta-blocker 2,460,249 2,319,294 5.7
. . Not applicable.
Source: DHA 2002b.
Table 5.49: GP consultations: 10 most frequently prescribed medications, 2000Ð01
Generic medication Action
Per cent of
prescriptions
Prescriptions per
100 encounters
Paracetamol Analgesic 4.2 3.9
Amoxycillin Antibiotic 3.5 3.2
Cephalexin Antibiotic 2.4 2.2
Paracetamol & codeine Analgesic 2.4 2.2
Celecoxib Anti-inflammatory 2.3 2.1
Salbutamol Bronchodilator 2.3 2.1
Amoxycillin & potassium clavulanate Antibiotic 1.8 1.7
Cefaclor monohydrate Antibiotic 1.8 1.6
Roxithromycin Antibiotic 1.7 1.6
Influenza virus vacinne Vaccine 1.6 1.5
Source: AIHW: Britt et al. 2001.
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The BEACH survey of general practice activity collects information on drugs prescribed
by GPs (AIHW: Britt et al. 2001). In 2000Ð01, medications were prescribed at a rate of
92.3 per 100 encounters. Antibiotics were the most commonly prescribed group,
accounting for 17.2% of all prescriptions. This was followed by cardiovascular (14.7%),
central nervous system (12.0%), psychological (8.1%), musculoskeletal (7.3%) and
respiratory medications (6.8%). 
The most frequently prescribed individual generic medications are listed in Table 5.49.
Five of the top ten drugs are from the antibiotic group. Simple analgesics were
relatively frequently prescribed. This reßects their prescription for healthcare
cardholders for whom they are a cheaper option than over-the-counter purchases. 
Non-prescribed medicines
The 1995 National Health Survey estimated that, in the 2 weeks before interview, 6.3
million people (34.6% of the population) used orthodox medications that were not
prescribed, and 178,900 Australians (1.0%) used medications provided by a doctor or
hospital (ABS 1997b). The most commonly used types of non-prescribed drugs were
pain relievers (used by 3.6 million people), and skin ointments and creams (1.1 million
people). 
The BEACH survey collects and reports information on drugs that GPs advise patients
to purchase over the counter, and those that the GPs supply directly (AIHW: Britt et al.
2001). 
In 2000Ð01, 8.5% of medications were advised for over-the-counter purchase and 6.3%
were supplied by the GP. Extrapolated, this represented about 9 million
recommendations for purchase of drugs, and 7 million supplies of drugs by GPs. The
drugs most commonly advised for over-the-counter purchase were paracetamol and
ibuprofen (an anti-inßammatory drug). The most common medications supplied by
GPs were vaccines (principally inßuenza virus vaccine) and celecoxib (an anti-
inßammatory drug). 
Complementary and alternative medicines
In addition to the prescribed pharmaceuticals and other orthodox drugs, some
Australians use a range of complementary and alternative medicines, including
homeopathic, herbal and nutritional medications. The 1995 National Health Survey
estimated that in the 2 weeks before interview, 25.8% Australians used vitamin or
mineral supplements and 9.4% used herbal or natural medications (ABS 1997b). 
5.7 Public health interventions
Public health is an integral component of the Australian health system but is commonly
differentiated from the treatment system. Activities widely deÞned as public health
represent the organised response by society to protect and promote health and to
prevent illness, injury and disability. Public health interventions focus on prevention,
promotion and protection rather than on treatment; on populations or population
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groups rather than on individuals; and on the factors and behaviours that affect health
and cause illness and injury. Health promotion and prevention are the key public health
services and activities. 
Many modern diseases and illnesses are encouraged by social, economic, behavioural,
environmental and lifestyle choices (Egger et al. 1990). Public health interventions
include a wide range of activities to monitor, assess, promote and protect the
populationÕs health and to reduce the level and impact of those factors that inßuence ill
health. They encompass education of target groups on health risk behaviours and harm
minimisation, community development, development of legislation, and community-
wide campaigns and services including immunisation, and improving water quality
and food standards. These activities aim to prevent or reduce those modiÞable risk
factors that result in diseases and injuries and may result in a reduced life expectancy or
quality of life.
Well-structured public health priorities and interventions have the ability to reduce
illness, cut healthcare costs and improve quality of life. Studies have demonstrated the
value to the community of such interventions, in particular the substantial beneÞts,
relative to costs, ßowing from both measles immunisation and tobacco control (Abelson
2001). 
National public health interventions include those in areas such as cancer screening and
immunisation, as described below.
Cancer screening
Breast, cervical and bowel cancers are three of a small group of cancers where there is
evidence that illness and death can be reduced through population-based screening and
effective follow-up treatment. National screening programs for breast cancer (via
mammography) and cervical cancer (via Pap smears) have been implemented in
Australia with the aim of achieving this reduction. These programs are called
BreastScreen Australia and the National Cervical Screening Program. Pilot tests for a
population-based screening program for bowel cancer are currently being developed,
with screening expected to commence in mid-2002.
BreastScreen Australia
The BreastScreen Australia program is jointly funded by the Commonwealth and State
and Territory governments. It consists of a network of dedicated screening and
assessment services throughout metropolitan, rural and remote areas of all Australian
States and Territories. These services can be Þxed or mobile and provide free two-yearly
mammographic screening and follow-up of any suspicious lesions identiÞed at
screening to the point of diagnosis of breast cancer. The program is aimed speciÞcally at
women aged 50Ð69 years of age without symptoms, although women aged 40Ð49 years
and 70 years and older may attend for screening. Women may attend without a doctorÕs
referral. 
In addition, recruitment and reminder systems are used to promote screening and
rescreening among women in the target group once every 2 years.
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A comprehensive system of accreditation is used to ensure that all BreastScreen
Australia services operate under a common set of standards. Each service is assessed on
a regular basis by an independent team to ensure that the service provided complies
with national standards.
The proportion of women in the target age group who were screened under the
BreastScreen Australia program in a 2-year period rose from 51.4% in the period
1996Ð97 to 55.9% in the period 1998Ð99 (Table 5.50). Participation rates in 1998Ð99 in
non-capital city metropolitan areas, large and small rural centres, other rural areas and
remote centres were all statistically signiÞcantly higher than the rates for capital cities
and other remote areas (Figure 5.19). These higher rates reßect policies aimed at
encouraging participation in country areas, for example through the use of mobile
mammography units. There was no consistent pattern in participation rates by relative
socioeconomic disadvantage, with no statistically signiÞcant difference in participation
between the most and the least disadvantaged groups (Figure 5.20).
National Cervical Screening Program
Screening to detect abnormalities of the cervix has been available for Australian women
since the 1960s. Until the early 1990s this screening was largely unstructured, with no
agreement on the screening target group or the best interval between screens. Since
then it has become progressively more organised and in 1995 the program became
known as the National Cervical Screening Program.
Unlike breast screening, cervical screening in Australia does not operate through a
separate dedicated screening and assessment service. Instead, screening services are
provided as part of mainstream health services, with approximately 80% of Pap smears
performed by GPs. Cervical screening is funded mainly by Medicare (61%) with the
remainder funded by Commonwealth government contributions through special-
purpose payments to State and Territory governments (23%), and these governmentsÕ
own revenue sources (16%). 
Table 5.50: Women screened in each 2-year period, 1996 to 1999
1996 & 1997 1997 & 1998 1998 & 1999
BreastScreen Australia
All ages 40 years and over 1,240,885 1,367,759 1,452,263
Target population (ages 50–69) 844,607 921,283 975,258
Participation rate for target population (%) 51.4 54.3 55.9
National Cervical Screening Program
All ages 20 years and over 2,630,235 2,721,650 2,777,324
Target population (ages 20–69) 2,563,108 2,653,504 2,716,364
Participation rate for target population (%) 62.3 63.9 64.8
Notes
1. Participation rates are age-standardised to the 1991 total Australian population.
2. The Queensland Health Pap Smear registry commenced in February 1999. Hence the data presented here for cervical 
screening exclude screening in Queensland.
Sources: AIHW analysis of State and Territory Cervical Cytology Registry data and BreastScreen Australia data.
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Figure 5.19: Participation of women aged 50Ð69 years in BreastScreen Australia by region, 
1998Ð99
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Source: AIHW analysis of BreastScreen Australia data.
Figure 5.20: Participation of women aged 50Ð69 years in BreastScreen Australia by 
socioeconomic status, 1998Ð99
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The National Cervical Screening Program has both national and State and Territory
components. Although policy is usually decided at a national level, coordination of
screening activity mainly happens at a State and Territory level. 
Cervical cytology registries operate in all States and Territories. The major functions of
the registries are to:
¥ remind women to attend for screening
¥ ensure the follow-up of women with abnormal Pap smears
¥ provide cervical screening histories to laboratories and clinicians to aid reporting and
management
¥ monitor the effects of initiatives to improve participation by women in screening. 
The current Australian recommendation is for all women who have been sexually
active at any stage in their lives to have a Pap smear every 2 years until they reach the
age of 70 years. Screening may cease at the age of 70 for women who have had two
normal Pap smears within the last 5 years. Women over 70 years who have never had a
Pap smear or who request a Pap smear are also screened. However, for reporting
purposes the target group is taken to be all women aged between 20 and 69 years who
have not had a hysterectomy.
The proportion of women in the target age group who were screened under the
National Cervical Cancer Screening Program in a 2-year period rose from 62.3% in the
period 1996Ð97 to 64.8% in the period 1998Ð99 (Table 5.50). 
Childhood immunisation
The purchase of vaccines in the Australian Standard Vaccination Schedule is funded by
the Commonwealth and delivery of vaccines and program implementation is the
responsibility of the States and Territories. The schedule includes vaccines
recommended for children against diseases such as measles, diphtheria, tetanus,
pertussis and hepatitis B (see Chapter 3).
The national childhood vaccination activities include the Australian Childhood
Immunisation Register (ACIR), which is administered by the Health Insurance
Commission and records details of vaccinations given to children under the age of 7
who live in Australia. Providers are paid a fee for reporting each completed schedule
milestone; the cost of this is shared equally by the Commonwealth and the States. For
the Þnancial year 2000Ð01, ACIR information payments totalled $8.6 million with the
majority ($6.2 million) being paid to GP providers (Table 5.51).
Table 5.51: ACIR information payments, 2000Ð01
Provider type Benefits paid
General practice $6.2 million
Council/State health $1.5 million
Community health centres $0.64 million
Other $0.22 million
Total $8.6 million
Source: Australian Childhood Immunisation Register.
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Nationally, GPs are the major childhood vaccine providers but there is considerable
variation between jurisdictions in the proportion of vaccines delivered in the private
and public sectors. In 2000Ð01, there were 3.8 million vaccinations recorded by the ACIR
(Table 5.52). The majority (69.4%) were provided by GPs, although this varied from
State to State. Local government councils (15.6%) and community health centres (8.0%)
administered a substantial proportion of vaccinations, particularly in Victoria for the
former, and in the Australian Capital Territory and the Northern Territory for the latter.
Before the introduction of the current national child immunisation program and the
establishment of the ACIR in January 1996, the percentage of children immunised was
regarded as unacceptably low. The national program has put in place a range of
funding arrangements and Þnancial incentives to increase the proportion of children
immunised. The level of immunisation (which has risen over recent years; see Chapter 3)
has been regularly monitored using ACIR data, and appropriate modiÞcations have
been made to the program and payments.
The incentives for increased immunisation and reporting have included the General
Practice Immunisation Incentives Scheme, which was introduced by the
Commonwealth Government in 1998. The scheme includes service incentive payments,
which are paid on the completion of each immunisation schedule in accordance with
the approved standards. In addition, outcomes payments are paid quarterly to general
practices that achieve target levels of immunisation for children who attend the
practice. In 1999Ð00, $18.5 million was paid in service incentive payments, and $13.3
million in outcome payments. 
Two incentives for parents were introduced in 2000. The means-tested Maternity
Immunisation Allowance is payable for children from 18 months of age either when all
immunisations due by that age have been recorded on the ACIR, or there is a
documented medical contraindication or conscientious objection to immunisation. The
Table 5.52: Immunisation episodes by State and Territory and provider type, 2000Ð01
Provider type NSW Vic Qld SA WA Tas ACT NT Aust(a)
Local government 
council 74,007 403,867 50,378 36,826 24,127 10,739 0 0 599,944
State/Territory 
health department 0 0 81 127 15,262 0 1,860 45 17,375
Flying Doctor 
Service 577 0 2,526 348 7 0 0 0 3,458
General practice 1,054,629 520,237 590,113 174,516 228,259 75,042 22,571 2,111 2,667,359
Public hospital 21,264 1,736 19,762 10,913 16,026 199 561 1,663 72,450
Private hospital 793 19 24 0 0 0 0 627 1,463
Aboriginal health 
service or health 
worker 5,022 2,042 7,397 2,234 1,527 0 198 5,675 19,417
Community health 
centre 81,485 7,967 39,049 24,039 62,483 532 39,584 54,800 310,176
Total(a) 1,237,777 935,937 709,330 249,003 347,691 86,512 64,774 64,921 3,841,373
(a) Both totals include other.
Source: HIC 2002.
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Child Care BeneÞt, which is available to partially reimburse expenditure on approved
or registered child care, is also available only with evidence of either up-to-date
immunisation on the ACIR, or contraindication or conscientious objection.
5.8 Health resources and use of health services 
for the National Health Priority Areas 
This section provides an overview of the health resources and use of health services for
the six National Health Priority Areas (NHPAs). Information is included on health
system expenditure on the NHPAs, and provision and use of health services, including
general practitioners, hospitals, mental health services and the National Diabetic
Services Scheme. Information is also included on use of medications.
Expenditure
Estimates of disease costs give an indication of the Þnancial burden of NHPAs on the
Australian health system. In 1993Ð94, the total health system costs of NHPAs was
estimated at over $12.6 billion or 40% of total health expenditure (Table 5.53).
Cardiovascular disease placed the largest Þnancial burden on the health system,
especially ischaemic heart disease and hypertension. Mental disorders, injury and
poisoning and cancer were other large contributors to health system expenditure.
About $5.9 billion of the NHPA related expenditure (47%) was spent on NHPAs in the
hospital sector, with over 60% of health expenditure for cancer and injury and
poisoning in the hospital sector, in contrast to 20% for asthma. 
Table 5.53: Health system expenditure on National Health Priority Areas, $m, 1993Ð94
NHPA diseases and conditions Hospital(a) Medical(b) Pharmaceuticals Other(c) All sectors
Cardiovascular disease 1,663 546 849 861 3,919
Mental disorders 941 438 199 1,444 3,022
Injury and poisoning 1,663 393 127 418 2,601
Cancer 1,327 261 53 263 1,904
Diabetes 201 98 136 247 681
Asthma 94 102 199 82 478
All NHPAs 5,889 1,838 1,563 3,315 12,605
All diseases and injuries 14,062 5,640 4,042 7,654 31,397
(a) Includes public and private acute hospitals, repatriation hospitals, and psychiatric hospitals. Excludes public hospital 
non-admitted services.
(b) Medical services for private patients in hospitals are included under Hospital.
(c) Includes nursing homes, dental and allied health services, certain cancer prevention programs (national screening 
programs for breast and cervical cancer, and lung and skin cancer prevention programs), National Drug Strategy 
funding for prevention, health and medical research, and administration and other institutional and non-institutional 
health expenditure. In addition, for mental health specifically, hospital non-admitted patient services, specialised 
community mental health services, residential and non-residential treatment services run by non-government 
organisations, and allied health services.
Source: AIHW: Mathers et al. 1999.
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A large proportion of expenditure for asthma was on pharmaceuticals (42%). Asthma
drugs cost the Commonwealth Government more than $274 million in 2000Ð01. The
cost of diabetes drugs was over half that, at about $130 million (DHA 2002b). Well-
managed asthma costs considerably less than poorly managed asthma ($2,094 and
$4,909 per person with asthma per year, respectively). The majority of savings that arise
from asthma being well-managed are in the hospital system, with fewer people
presenting at emergency departments or requiring readmission. There are also
considerable savings in indirect costs, such as absenteeism from the workplace
(National Asthma Campaign 1992).
Provision and use of health services
Hospitals 
Principal diagnoses within the six NHPAs accounted for 30% of hospital separations
(1,762,624) and 41% of patient days (9,302,554) in Australian hospitals in 1999Ð00
(Table 5.54). Cancers accounted for the largest number of these (583,220 separations),
followed by cardiovascular disease (443,369 separations). Mental disorders accounted
for the highest number of patient-days (2,942,961), followed by cardiovascular disease
(2,413,204).
The average length of hospital stay for NHPA diseases and conditions in 1999Ð00 was
5.3 days, compared with 3.8 days for all hospital separations. Average lengths of stay
were highest for mental disorders and diabetes, with lengths of stays averaging
12.0 days and 6.6 days respectively. Asthma had the shortest average length of stay at
2.7 days.
Table 5.54: Hospital separations for National Health Priority Areas(a), all hospitals(b), 1999Ð00
NHPA diseases and 
conditions Separations
Same-day
separations
Separations
per 1,000
population(c) Patient-days
Average
length of
stay (days)
Cancer 583,220 404,866 30.6 1,866,899 3.2
Cardiovascular disease 443,369 91,853 23.3 2,413,204 5.4
Injury and poisoning 419,681 121,416 22.0 1,788,466 4.3
Mental disorders 244,858 94,075 12.9 2,942,961 12.0
Asthma 47,008 7,240 2.5 128,771 2.7
Diabetes 24,488 4,713 1.3 162,253 6.6
Total NHPA separations 1,762,624 724,163 92.5 9,302,554 5.3
All separations 5,898,804 2,903,966 152.1 22,604,114 3.8
(a) Only separations for which the principal diagnosis corresponds to one of the priority areas have been included. These 
conditions will also have been reported as additional diagnoses for separations with principal diagnoses not within 
these priority areas. The figures also include family history, observation/screening and follow-up care and treatment for 
the NHPAs. The ICD-10-AM codes associated with the priority areas are as follows: Cancer C00–C97, Z08–Z09, 
Z51.0–1, Z54.1–2, Z80, Z85–Z86; Cardiovascular disease G45–G46, I00–I99, Z01.3, Z03.4–5, Z13.6, Z82.3–4, Z86.7, 
Z95; Injury and poisoning V01–Y98; Mental disorders F00-F99, Z03.2, Z81, Z86.5; Asthma J45–J46, Diabetes 
E10–E14, Z13.1, Z83.3.
(b) Includes public psychiatric hospitals.
(c) Crude rates.
Source: AIHW National Hospital Morbidity Database.
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About 41% of hospital separations for NHPAs in 1999Ð00 were same-day separations,
lower than the average of 49% for all hospital separations. Cancer was the NHPA
condition for which the greatest proportion of separations were same-day (69%),
followed by mental disorders (38%) and injury and poisoning (29%). Separations for
chemotherapy were a large contributor to the high number of same-day separations for
cancer.
Overall about 68% of hospital separations for NHPA diseases and conditions were in
public hospitals (1,196,504). However, over 85% of hospital separations for asthma and
diabetes were in public hospitals. The largest proportion of private hospital separations
were for cancers (44%) and mental disorders (34%).
Mental health services
In the Australian healthcare system, mental health care is provided by both hospital-
based and community-based services (as discussed on page 295). Community-based
services are dedicated to the assessment, treatment and rehabilitation or care of people
whose mental illness can be managed in the community, sometimes as an alternative to
hospitalisation. Information on the use of and expenditure on mental health services is
provided in more detail earlier in the chapter.
General practitioners
According to the 1995 National Health Survey, overall about 23% of persons consulted
a doctor (GP or specialist) in relation to their health in the 2 weeks before interview
(ABS 1997b). However, almost 46% of people with diabetes consulted a doctor in the
2 weeks before the survey, as did 40% of people with a cardiovascular condition and
31% of people with asthma (ABS 1997c, 1997d, 1998b).
The BEACH survey of general practice activity collects information on problems
managed by GPs (see page 306). Selected NHPA conditions accounted for about 28% of
all problems managed in general practice in 2000Ð01. Circulatory and psychological
problems were the most common NHPA diseases and conditions managed in general
practice, at a rate per 100 encounters of 16.0 and 10.8 respectively in 2000Ð01 (AIHW:
Britt et al. 2001). A simple extrapolation based on approximately 103 million Medicare-
claimed general practice consultations would suggest there are approximately
16.5 million encounters per year in which GPs manage cardiovascular diseases and
11.1 million in which GPs manage mental disorders. The management rate per 100
encounters did not vary signiÞcantly over the period 1998Ð99 to 2000Ð01 for most of the
selected NHPA diseases and conditions (Figure 5.21). However, the management rate of
asthma decreased signiÞcantly (p = 0.007) from 3.2 contacts per 100 encounters in
1999Ð00 to 2.8 per 100 encounters in 2000Ð01. This represents an estimated drop in
annual asthma encounters of about 400,000 per year (AIHW: Britt et al. 2001).
National Diabetic Services Scheme 
Under the National Diabetic Services Scheme (NDSS), the Commonwealth Government
subsidises the supply of insulin syringes and diagnostic agents to persons with diabetes
(DHA 2002b). There were 493,919 persons with diabetes registered with the NDSS in
2000Ð01, an increase of over 10% from the previous year. The increase in registrants has
been associated with an increase in the use of and expenditure on both syringes and
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diagnostic agents used for urine and blood testing. The number of products used for
urine testing decreased and the number of products used for blood testing increased
between 1999Ð00 and 2000Ð01.
The total government expenditure on NDSS for products supplied in 2000Ð01 was
$57 million, with expenditure on diagnostic agents totalling $52.9 million and syringes
$4.1 million.
Use of medications
The 1995 National Health Survey found that the use of medications was the most
common health-related action taken by Australians (ABS 1997b), being reported for the
2 weeks before interview by 12.5 million people, or 69% of the population. Heart and
blood pressure medications (1.93 million people, or 11%) and asthma medications (1.01
million people, or 6%) were the most commonly used prescribed medications.
Medications for diabetes, heart and blood pressure medications, and medications for
anxiety, depression or nervous conditions were used on a daily basis in over 90% of
cases (ABS 1998c). 
Two-thirds (67%) of adults with a cardiovascular condition took medications for heart
problems/blood pressure. Other medication types used for cardiovascular conditions
were pain relievers (24%) and ßuid tablets/diuretics (11%) (ABS 1997d). For people
with diabetes, the most common types of medication were diabetes medication (58%)
and heart/blood pressure medication (44%) (ABS 1997c).
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Figure 5.21: National Health Priority Area-related problems managed by general 
practitioners per 100 encounters, 1998Ð99 to 2000Ð01
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The BEACH survey of general practice activity collects information on both prescribed
and non-prescribed medications, such as those supplied or advised for over-the-counter
purchase by GPs (AIHW: Britt et al. 2001). In 2000Ð01, cardiovascular drugs were the
second most commonly prescribed drug group, accounting for 14.7% of all
prescriptions. Psychological drugs (8.1%) and respiratory drugs were the fourth and
sixth most common drug groups prescribed, with asthma preventives (2.4%) the second
most common respiratory drugs prescribed after bronchodilators (3.5%). In terms of
drugs supplied by GPs, cardiovascular drugs were the third most common, accounting
for 9.1% of all supplied drugs, and psychological drugs (6.1%) were the Þfth most
common drug group supplied. Cardiovascular and psychological medications were less
commonly advised for over-the-counter purchase. Asthma preventives were generally
not supplied or advised for over-the-counter purchase by GPs.
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6 Health monitoring and 
information 
development
The previous chapters illustrate the amount and quality of information now collected in
Australia on health and health-related issues. 
Substantial improvements in national health information have occurred since the
signing of the National Health Information Agreement (the Agreement) in 1993 by
Commonwealth, State and Territory health authorities, the Australian Bureau of
Statistics (ABS) and the Australian Institute of Health and Welfare (AIHW). The Health
Insurance Commission became a signatory to the Agreement in 1999. The Agreement
put in place the national infrastructure of cooperative structure and processes needed to
improve the quality, collection and dissemination of health information across
Australia.
Management and development of national health information under the Agreement is
the responsibility of the National Health Information Management Group (NHIMG),
which reports to the Australian Health MinistersÕ Advisory Council (AHMAC). The
National Advisory Group for Aboriginal and Torres Strait Islander Health Information
and Data, the Expert Group on Health ClassiÞcation and the National Health Data
Committee (NHDC), report to NHIMG. The NHDC produces the National Health Data
Dictionary.
When the National Public Health Partnership was established in 1997 to develop a joint
Australian intergovernmental agenda for public health, a related information group, the
National Public Health Information Working Group, was set up.
The AgreementÕs focus on consistent information across Australia has been a large force
in the improvement of consistent health information in the different parts of the health
system. The push by government for measuring performance in the health sector has
also resulted in increased work on both the conceptual and information development
needed to cater for issues such as efÞciency, effectiveness, equity, responsiveness and
accountability. A conceptual framework for the measurement of health status and the
performance of health system has been developed.
The rapid global growth of information technology has given rise to opportunities to
harness new technologies to enable better communication to support clinical decisions,
program management and policy development. In 2001 Commonwealth, State and
Territory Ministers initiated the Healthconnect project to investigate the concept of and
to develop plans for a national network of electronic health records. The establishment
of such a network has the potential to improve the timeliness and connectivity of health
statistics as well as information for clinical management. International reporting on
health of countries by bodies such as the World Health Organization (WHO) and OECD
has also affected health information development. Not only do international reports
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need reliable and comparable data from member countries, but also international
analysis and debate on such aspects as the responsiveness of the health system and the
structure of health Þnancing require new data that need to be developed and collected.
These developments are described in this chapter.
6.1 Recent information developments and 
emerging issues
Even with the improvements in the quality and quantity of data now available there
remain signiÞcant challenges in answering questions about how well our health system
is performing. To a large degree this should be seen as a natural ongoing process.
Although Australia has reliable data on a number of broad measures of health such as
death rates and infant mortality, prevalence of disease and life expectancy, these broad
measures often fail to explain the whole story. These measures are population averages
and may mask important variations within the population and, in particular, how
disadvantaged groups compare with the overall population, although information on
population groups is improving.
Increasingly, people want to know how healthy they are, whether it is the same for
everyone, what the effects of disease and injury are on the quality of life, what the
factors are that determine health, whether those factors are changing for the better,
whether we are investing in the areas of health that will have the most beneÞcial effect,
and how well the healthcare system performs in improving the health of Australians.
There has been a steady growth of public and private sector activities in the healthcare
industry that require reliable, consistent and timely information. In some cases these
activities have been built on good-quality data, but in many cases the activities have
themselves provided the catalyst and momentum for the development of the necessary
data. 
One major driving force has been the push by governments to reform government
services with special emphasis on the effectiveness and efÞciency of government-
funded human services. Health and community services have been important focuses
for the reviews of government services undertaken by the Steering Committee for the
Review of Commonwealth/State Service Provision (SCRCSSP 2002). For these reviews
to be valid, the underlying data need to have a high degree of consistency across
jurisdictions and programs. The reviews have noted the difÞculties in obtaining good-
quality data and have provided an incentive to improve the quality of data available.
Strategies and plans
As health information has become more complex, government, the major source and
user of health data in Australia, has responded with a range of health information
development plans. Although this report covers the national plans, it is important to
recognise that State and Territory health authorities also have a number of plans and
strategies to achieve their own information needs and to implement aspects of national
plans. The States and Territories are the major sources of administrative health data.
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In 1995 the NHIMG, after extensive consultation, published the National Health
Information Development Plan (AIHW & AHMAC 1995). This plan, which listed eight
priority areas for information development, has provided the foundation for recent and
current developments in national health information. 
Other information plans include the National Public Health Information Development
Plan, focusing on the development needs in relation to public and population health,
and the National Indigenous Health Information Plan, which recommended strategies
and actions needed to achieve improvements in data about the health of Aboriginal and
Torres Strait Islander peoples. 
There are also a range of health information developments that underlie activities of
other bodies such as the National Health Priorities Action Council and the National
Health Performance Committee, both reporting to AHMAC. 
In 2001Ð02, NHIMG reviewed the implementation of the 1995 National Health
Information Development Plan, and has developed an updated plan currently before
AHMAC for endorsement. 
Progress with the 1995 National Health Information 
Development Plan
The 1995 plan listed eight priority areas for information development. These priority
areas were information development in relation to Aboriginal and Torres Strait Islander
health, national health and welfare information model, record linkage, health outcomes,
severe mental illness, non-institutional healthcare data, improving cost-effectiveness of
collections, and potentially modiÞable major disease risk factors. Efforts have been
made in all these areas, and the progress that has not been covered in previous chapters
is described below. 
There has been considerable progress in improving Indigenous health statistics. An
Indigenous sample was added to the 2001 ABS National Health Survey and plans have
been made to include a larger Indigenous sample in the forthcoming 2004 survey. The
ABS will also introduce a regular 6-yearly Indigenous social survey (including health
topics), the Þrst of which is to be undertaken in 2002.
Indigenous data from births and deaths registers and from hospital administration
records have improved. Birth data are of sufÞcient quality to be published nationally,
and death data from most States and the Northern Territory are now considered of
sufÞcient quality to be publishable.
Every two years since 1997, the ABS and AIHW have jointly published a comprehensive
report, The Health and Welfare of Australia’s Aboriginal and Torres Strait Islander Peoples
(ABS & AIHW 2001). As well, AHMAC has endorsed a set of indicators of Aboriginal
and Torres Islander health, and an annual report on these indicators is published
(NHIMG 2001).
The 1996 National Health Information Model has been reviewed and updated by the
AIHW (AIHW 2002). It has been used to organise the content of the recent versions of
the National Health Data Dictionary.
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Linkage of health records for research has progressed. The AIHW National Death Index
and the Cancer Register are available to users for speciÞc health research that requires
data linkages, and have been used to study cancer survival rates. An AHMAC-
approved protocol for record linkage for research into diabetes services and outcomes
has been agreed between Western Australia, the Health Insurance Commission, the
Department of Health and Ageing and the AIHW. A pilot study linking hospital
separations and admission to aged care homes has started at AIHW as part of a large
AHMAC-auspiced research program on the interface between aged care and hospital
services.
Developing health outcome measures has received a great deal of attention. The
NHIMG-developed health outcomes indicators framework has been adopted for data
development and reporting for National Health Priorities Areas such as injury, diabetes
and asthma. These are reported in previous chapters of this publication. Health status
and outcomes indicators developed for the National Health Performance Framework
and used in the 2001 report on health performance by the National Health Performance
Committee are discussed later in this chapter. 
 
National information development priorities
 
The NHIMG paper before AHMAC includes the following priority areas for
information development:
 
Indigenous health
 
—
 
Reinforce efforts to implement the National Indigenous Health
Information Plan, implement the ABS survey strategy for Indigenous statistics, improve
Indigenous population estimates for the Indigenous population, and develop data to
support the national performance indicators for Indigenous health. 
 
Integration of services
 
—
 
Develop and expand national minimum data sets to cover
emergency, rehabilitation and community services, and work with the National
Community Services Information Management Group to implement a consistent
approach to data development in National Data Dictionaries in the health, community
services and housing Þelds.
 
Safety and quality in health care
 
—
 
Review existing data collections and establish new
collections where necessary to monitor health system safety, and improve
measurements of health outcomes, including survival analysis, using ethically
approved data linkage.
 
Information technology and health
 
—
 
Develop consistent coding and classiÞcation
systems for use within the national health information network.
 
Population health
 
—
 
Develop data collection on a range of health risk factors, develop
and implement national surveys that include biological measurements of risk factors,
and continue the collection of data on public health expenditure.
 
Equity and access
 
—
 
Further develop analytical techniques for measuring health
inequality, and use emerging geo-coding capability to analyse locational aspects of
inequality.
 
Health labour force
 
—
 
Review and improve health labour force collections for planning
use, including geographic distribution, skill levels and consumer demand.
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Performance of health system
 
—
 
Undertake data development to facilitate reporting
under the National Health Performance Framework, and develop summary measures
to enable valid international comparison.
 
Standards and classification
 
—
 
Review the 
 
National Health Data Dictionary
 
, including the
upgrading of the AIHW Knowledgebase as a national health data repository, and
establish and maintain national classiÞcation systems and links with coding systems in
all health settings.
 
Management of health information
 
—
 
Regularly review national minimum data sets,
negotiate reduction of duplication in health meta-data collections, implement best
practice guidelines, and advocate statistical best practice in information privacy
regimes.
A number of the current information development activities have their source in one of
the plans or current programs, and when brought together it is apparent there is
considerable activity. That this high level of activity will continue is also evident from
the plans of organisations like the ABS, the Department of Health and Ageing and the
AIHW over the next 3 years. The National Health Survey will now be conducted every
3 years. Plans for the survey incorporate an Indigenous health component. A pilot
survey is planned for the Þrst Australian Health Measurement Survey, which will
include a range of physical and biomedical measures. There is increased State and
Territory population health surveillance activity, including on-going programs of
computer-assisted telephone interviews. These programs are supported by health
survey module manuals on chronic disease and common risk factors. A number of
other data collections are also being planned, including the establishment of national
minimum data sets on drugs and alcohol and palliative care.
 
6.2 Health system performance measurement
 
As outlined in the introduction, measurement of health system performance is now
seen as an important issue at not only national but also international levels. WHO and
the OECD have both signalled their intention not only to focus on the development of
performance measures but also to publish comparative reports of national performance. 
This represents a major change in approach resulting to some extent from the improved
health data in many countries which allows some limited comparison because of the
increasing consistency in both the data and the information concepts underlying the
data. 
The measuring of performance of a system or service requires an understanding of the
objectives of the system or service and of the context within which the system operates.
The National Health Performance Committee (NHPC) Report (NHPC 2001) notes:
 
when measuring performance of a system or program it is important to consider the
process involved in turning inputs into outputs and evaluating the outcomes.
 
Consistent with the conceptual framework outlined in Chapter 1 of this report, system
performance can be measured taking the following approach:
¥ monitoring of inputs to the health system 
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¥ measurement of outputs 
¥ monitoring of outcomes. 
Both equity and quality are integral components of performance measurement;
performance cannot be validly measured without regard to both equity and quality.
These two elements in themselves signiÞcantly raise the complexity of measurement.
Establishing valid measures for both concepts requires a clear understanding of
objectives and unambiguous outcome measures. 
National Health Performance Framework 
In 1999 Australian Health Ministers set up the NHPC, to report on the national health
system encompassing the acute, community health care and public health sectors. The
committee is to develop, establish and maintain a national performance measurement
framework and appropriate indicators as a basis for its reporting. 
The NHPC developed the National Health Performance Framework, largely derived
from the Indicators Framework published as part of the Canadian Health Information
Roadmap Initiative (CIHI 2000: Appendix A). The NHPC framework has also drawn on
the conceptual framework for health presented by the AIHW in Australia’s Health 2000.
It has been endorsed by Australian Health Ministers for reporting the performance of
the Australian health system at a national level. 
The Australian framework has three basic tiers of information:
¥ health status and outcomes
¥ determinants of health
¥ health system performance.
This three-tier framework acknowledges that inßuences on population health status
and outcomes can come from the health systemÕs interventions as well as determinants
from outside the health system. It also allows monitoring on how health system
interventions can focus on managing determinants, as in public health programs, as
well as those that directly relate to the treatment of diseases. 
The close correspondence with the Canadian framework has contributed to a growing
international consensus on frameworks for health performance indicators. 
The framework provides a structured approach to the appraisal of the health system,
particularly on assessing how well the system is performing. Although the three tiers of
the framework are not hierarchical, the relationships between the tiers and the
dimensions are important.
The inclusion of questions in relation to each tier and set of dimensions clearly provides
a performance emphasis to the framework. The question ÔIs it the same for everyone?Õ
integrates equity into the framework and establishes the information requirements. It is
intended that data on the indicators will reßect differentials by age, sex, geographic
location, Indigenous status and socioeconomic status. The data on performance
collected in accordance with this framework will help in reporting on inequities, and in
highlighting possible scope for improvement.
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National Health Performance Framework
Health status and outcomes
How healthy are Australians? Is it the same for everyone? Where is the most opportunity 
for improvement? 
Health Conditions Human Function
Life Expectancy 
and Wellbeing Deaths
Prevalence of disease, 
disorder, injury or trauma 
or other health-related 
states.
Alterations to body 
structure or function, 
activities and 
participation.
Broad measures of 
physical, mental, and 
social wellbeing of 
individuals and other 
derived indicators.
Age and/or condition 
specific mortality rates.
Determinants of health
Are the factors determining health changing for the better? Is it the same for everyone? 
Where and for whom are they changing?
Environmental 
Factors
Socioeconomic 
Factors 
Community 
Capacity
Health 
Behaviours
Person-related 
Factors
Physical, chemical 
and biological 
factors such as air, 
water, food and soil 
quality.
Socioeconomic 
factors such as 
income, education, 
employment, per 
capita expenditure 
on health.
Characteristics of 
communities and 
families such as 
population density 
and structure, 
health, literacy, 
housing, and 
community support.
Attitudes, knowledge 
and behaviours, e.g. 
eating patterns, 
physical activity, 
alcohol consumption 
and smoking.
Genetic-related 
susceptibility to 
disease and other 
factors such as 
blood pressure, 
cholesterol levels 
and body weight.
Health system performance
How well is the health system performing in delivering quality health actions to 
improve the health of all Australians? Is it the same for everyone?
Effective Appropriate Efficient
Care/intervention/action achieves 
desired outcome.
Care/intervention/action provided is 
relevant to the client’s needs and 
based on established standards.
Achieving desired results with most 
cost-effective use of resources.
Responsive Accessible Safe
Service provides respect for 
persons and is client-orientated. 
Includes respect for dignity, 
confidentiality, promptness, quality 
of amenities, access to social 
support networks and choice of 
provider.
Ability of people to obtain health 
care at the right place and right 
time irrespective of income, 
physical location and cultural 
background.
The avoidance or reduction to 
acceptable limits of actual or 
potential harm from healthcare 
management or the environment in 
which health care is delivered.
Continuous Capable Sustainable
Ability to provide uninterrupted, 
coordinated care or service across 
programs, practitioners, 
organisations and levels over time.
An individual’s or service’s capacity 
to provide a health service based 
on skills and knowledge.
Capacity to provide infrastructure 
such as workforce, facilities and 
equipment, and be innovative and 
respond to emerging needs 
(research, monitoring).
Source: NHPC (2001).
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The framework can be applied at all levels and in all sectors of the health system,
including at the individual program level and for particular regions. A validated and
endorsed structure on how to approach the appraisal of health system performance that
supports benchmarking for improvement will minimise the risks of a proliferation of
conceptual frameworks, each associated with data collections for which limited
comparisons can be made.
Wider application of the framework
It is expected the framework will help the integration of other national performance
measurement and reporting activities, including, for example, those of the Steering
Committee for the Review of Commonwealth/State Service Provision. 
A number of bodies whose focus is on particular programs or population groups have
begun implementing or trialling the framework for their own applications,
demonstrating a robustness in the underlying structure of the framework. For instance,
the National Health Priority Performance Advisory Group, a body charged with
advising the National Health Priority Action Council on monitoring the performance of
the National Health Priority Areas initiative, sees the framework as useful for assessing
the range of indicators already determined for individual health priority areas. It
recognises a basic consistency with the health outcomes framework developed in 1997
by the NHIMG and adopted for National Health Priority Areas indicators. Additionally,
a workshop on chronic disease monitoring, conducted in November 2001 under the
auspices of the National Public Health Information Working Group, has recommended
that the NHPC framework become the basis for indicators for chronic disease
monitoring. Indicators for child and youth health, and rural health, are also being
developed using the NHPC framework as a guide. 
6.3 Health indicators
Health indicators, like frameworks, are derived and used in a number of different ways.
Indicators may provide a measure of a relatively straightforward event such as the
death rate for the population as a whole, or by age, population group or condition.
Indicators may also be measures of more complex concepts such as healthy life
expectancy (HALE). An important characteristic of indicators is that they can be used to
facilitate comparisons and highlight and clarify relationships, for example of the health
impact of various conditions or the effect of factors such as socioeconomic status on
health. The selection and use of indicators must be customised to their speciÞc purpose
and the context in which they are being used. The indicators must be robust and
capable of adapting to change and reßecting trends.
The development of health indicators that can be used to measure performance is a
major thrust both internationally and in Australia. Keeping some consistency between
these measures, in terms of comparability, use of uniform data deÞnitions and data
standards, presents a challenge to the health information sector. This challenge will
grow as the need for patient-level data and increased uniformity in clinical data
increases. 
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Hierarchy of indicators
Indicators need to reßect the level from which they are drawn. Indicators at the national
level may have little relevance at the regional or local level, but may still provide a
useful benchmark in the absence of detailed local data. There is a hierarchy of indicators
that will vary according to context. System-level indicators are generally related to a
discrete system within a jurisdiction, such as a State health system or the national
health system. Indicators at this level are used by international organisations such as
the WHO and OECD to monitor and compare the performance of health systems of
different countries. Below the system level is the program level, which relates
particularly to identiÞed public sector programs within a State or jurisdiction and
allows comparison between programs and potentially across jurisdictions. Program-
level indicators remain at a fairly high level, for example measuring trends across
speciÞc conditions or population groups. The provider level is the level of indicator that
most directly relates to the provision of services and activities, and may be part of
funding arrangements and reporting. This level usually does not feature in national
performance indicators.
Currently, there are extensive sets of indicators being developed at a national level to
shape and monitor programs and activities including the six National Health Priority
Areas, chronic diseases and health outcomes. Sets of speciÞc performance measures
include not only those being developed by the NHPC but also the Aboriginal and
Torres Strait Islander Health Performance Indicators. 
IdentiÞcation of a parsimonious set of indicators suitable for monitoring key elements
of health at a national level is a continuing task for the NHPC. The committee has
adopted deÞned criteria to help it to identify the indicators that best summarise the
overall performance of the Australian health system.
The NHPC has proposed several criteria (Box 6.1) to be applied in selecting health
performance indicators (NHPC 2001). 
In addition the NHPC agreed to Þve selection criteria for sets of performance indicators.
Sets of indicators or composite indices should:
1. cover the spectrum of the health issue
2. reßect a balance of indicators for all appropriate parts of the framework
3. identify and respond to new and emerging issues
4. be capable of leading change
5. provide feedback on where the system is working well, as well as areas for
improvement.
The NHPC notes the need to use existing data where possible and appropriate, the
difÞculty in linking the efforts of the health sector directly with observable health
outcomes, and the long-term nature of the research and conceptual and information
development necessary to develop Ômeaningful measures of the efÞciency and
effectiveness of health outputs and the impact on health outcomesÕ (NHPC 2001:20).
AH2002 body 26-6  Page 346  Wednesday, June 26, 2002  6:28 PM
6 Health monitoring and information development  347
TRIM SIZE 175 mm Wide x 250 mm Deep
The NHPC thus recognises the need for care in selection and use of indicators, noting
that indicators are an indication of organisational achievement and not an exact
measure.
The NHPC 2001 report gave examples of a number of illustrative indicators that could
be used in measuring the dimensions of the three tiers. Further development of these
and other indicators provides the basis of the NHPC 2001 national report on health
sector performance indicators (NHPC 2002). Examples of the indicators used to
measure the dimensions in the three tiers are given below. 
Although these indicators have generally been chosen by the NHPC in accordance with
the selection criteria outlined, their developmental nature must be recognised together
with the difÞculties caused by data limitations. 
Box 6.1: Selection criteria for health performance indicators 
1. Be worth measuring.
The indicators represent an important and salient aspect of the public’s health or the per-
formance of the health system.
2. Be measurable for diverse populations.
The indicators are valid and reliable for the general population and diverse populations
(i.e. Indigenous populations, sex, rural/urban, socioeconomic etc.).
3. Be understood by people who need to act.
People who need to act on their own behalf or that of others should be able to readily com-
prehend the indicators and what can be done to improve health.
4. Galvanise action.
The indicators are of such a nature that action can be taken at the national, State, local or
community level by individuals, organised groups, and public and private agencies. 
5. Be relevant to policy and practice.
Actions that can lead to improvement are anticipated and feasible—they are plausible
actions that can alter the course of an indicator when widely applied.
6. Reflect results of actions when measured over time.
If action is taken, tangible results will be seen, indicating improvements in various aspects
of the nation’s health.
7. Be feasible to collect and report.
The information required for the indicator can be obtained at reasonable cost in relation to
its value and can be collected, analysed and reported on in an appropriate time frame.
8. Comply with national processes of data definitions.
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Tier 1 Health status and outcomes
Indicator Dimension
Non-fatal burden of disease (years of life lived with
disability) for disease groups 
Health condition
Core activity restriction Human function
Proportion of disease in targeted National Health
Priority Areas of the total burden of disease and
injury
Life expectancy and wellbeing
Standardised mortality ratios for Indigenous
Australians
Life expectancy and wellbeing
International comparison of life expectancy at birth
by sex
Life expectancy and wellbeing
Cause-speciÞc death rates Deaths
Suicide and self-inßicted injury deaths Deaths
Tier 2 Determinants of health
Indicator Dimension 
Environmental tobacco smoke Environmental factors
NotiÞcation rates of Ross River virus Environmental factors
Differentials in death rates across socioeconomic
quintiles
Socioeconomic factors
Carer activity Community capacity
Voluntary work participation rates Community capacity
Proportion of adults and adolescent smokers Health behaviours
Proportion of adults insufÞciently physically active Health behaviours
Proportion of persons overweight Health behaviours
Proportion of persons with high blood pressure Person-related factors
Low-birthweight babies Person-related factors
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Tier 3 Health system performance
Indicator Dimension 
Separation rates with asthma as principal diagnosis Effective
Five-year survival rates for cancer Effective
Breast and cervical cancer screening: proportion of
females screened
Effective
Immunisation: children fully vaccinated Effective
Hospital separation rates for caesarean sections Appropriate
Hospital separation rates for myringotomies and
tonsillectomies
Appropriate
Prescription of oral antibiotics for upper respiratory
tract infection
Appropriate
Cost per casemix-adjusted separation EfÞcient
Average length of stay for hospital admissions EfÞcient
Per capita fee-for-service expenditure on primary
and secondary health services
EfÞcient
Emergency department waiting times Responsive
Number of full-time workload equivalent GPs 
by location
Responsive
Days waited for admission for elective surgery
(50th percentile)
Accessible
Number of residential care places and community
aged care packages per 1,000 persons aged 70 years
and over
Accessible
Hospital separations with an adverse event Safe
Uptake of Medicare BeneÞts Schedule items for
enhanced primary care 
Continuous
Proportion of workload carried by vocationally
registered GPs and other medical practitioners aged
over 50 years 
Sustainable
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6.4 A national network for electronic health 
records
In 1996, the Minister for Health and Family Services requested the House of
Representatives to conduct an inquiry into health information management and tele-
medicine. In its report, Health On-line, the Inquiry recommended a major pilot trial
designed to evaluate the costs and beneÞts of deploying Ôtelehealth and health
informaticsÕ throughout the health system (Commonwealth of Australia 1997).
In 1998, Health Ministers established the National Health Information Management
Advisory Council (NHIMAC) to advise on plans for the development of an electronic
health information system. In July 2000, the National Electronic Health Records
Taskforce recommended to NHIMAC the establishment of a general approach to a
health information exchange or network for Australia. The Taskforce identiÞed four
components for the network: privacy and conÞdentiality, standards (including data
standards), telecommunication infrastructure, and uptake and use of information
technology (National Electronic Health Records Taskforce 2000).
In 2001, the Healthconnect ofÞce was established by Commonwealth, State and Territory
Health Ministers to undertake a two-year research and development program to test
the potential of a national electronic health records network. The Healthconnect ofÞce
has released a draft statement of business requirements, called Healthconnect Business
Architecture, for general consultation. Work is also proceeding to establish sites for
Healthconnect trials.
The development of an electronic health record system aims to provide on-line
information for clinical use and may contribute to improving the timeliness and quality
of statistical information that would ßow from health services delivery.
6.5 International work on health measurement
WHO Health System Performance Assessment Framework
The WHO Health System Performance Assessment Framework deÞnes the functions
and goals of the health system (WHO 2000).
Goals of the health system
The goals are health, responsiveness and fair Þnancing contribution. 
For the health goal, both the level of health and the inequality of health are considered
important. The WHO are measuring the level of health by the HALE measure.
Responsiveness refers to non-health goals of the system such as respect for people and
client orientation. This is measured by, among other things, examining how the health
system deals with conÞdentiality of information, how it respects the dignity of the
person, whether it allows access to social support networks and whether the patient
receives prompt attention. It is proposed to measure the distribution of responsiveness
as well as the level. 
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The WHO also proposes to measure fairness in Þnancial contribution. This focuses on
the risks that are faced by households in Þnancing health care, and on catastrophic costs
that may be incurred by some households in paying for health care.
 
Functions of the health system
 
The WHO deÞned four basic functions of a health system which contribute to
determining observed levels of goal attainmentÑÞnancing, service provision, resource
generation and stewardship (WHO 2001a).
 
Health system financing
 
 is the process by which revenues are collected, accumulated in
fund pools and allocated to speciÞc health actions. It can be subdivided into three sub-
functions: revenue collection, fund pooling and purchasing. 
 
Service provision
 
 
 
refers to the way inputs are combined to allow the delivery of a
series of interventions or health actions. It includes personal and non-personal health
services. The former are services consumed directly by an individual (preventive,
diagnostic, therapeutic or rehabilitative). The latter are actions that are applied either to
collectivities (e.g. mass health education, legislation) or to the non-human components
of the environment (e.g. basic sanitation).
Health systems are not limited to the institutions that Þnance or provide services, but
include organisations that produce inputs to those services, particularly human
resources, physical resources such as facilities and equipment, and knowledge.
Included are educational institutions, research centres, construction Þrms, and the vast
array of organisations producing technologies such as pharmaceutical products, devices
and equipment. Strategies for 
 
resource generation
 
, the third function, can be critical to
the performance of the system.
 
Stewardship
 
 
 
is a neglected function in most health systems, extending beyond the
conventional notion of regulation. It involves setting, implementing and monitoring the
business rules for the health system; assuring a level playing Þeld among all people in
the system (particularly purchasers, providers and patients); and deÞning strategic
directions for the health system as a whole.
 
OECD health framework and reporting
 
The OECD published a report 
 
Health at a Glance 
 
in October 2001 which includes
indicators of health status, healthcare resources, healthcare utilisation and health
expenditures, using information from its OECD Health Data database provided by
member countries. In 2001 the OECD also started a new 3-year health project. The
project focuses on measuring and analysing the performance of healthcare systems in
member countries and the factors affecting performance. 
 
Components for assessment Average level Distribution
Goals
 
Health 
 
3 3
 
Responsiveness 
 
3 3
 
Fairness in financial contribution —
 
3
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In this project, the OECD has proposed a framework for reporting on health system
performance that has a focus on three broad goals: health improvement/outcomes,
responsiveness and access, and Þnancial contribution/health expenditure. A broad
comparison shows much in common with frameworks used by the WHO, AustraliaÕs
NHPC, Canada and other countries.
The pace of international health information development is a major challenge for
Australia. Fortunately, the robust and, at times, innovative national health information
infrastructure that has been established in Australia since 1993 has also enabled
Australia to be an inßuential participant in international health information
developments through a range of European, American and international health,
informatics and standards bodies. Australia has made an important contribution to the
recent review of the WHO Health System Performance Assessment Framework,
through the participation in the Peer Review Group. Australia has also been a
signiÞcant contributor to the international development of welfare and social indicators
and associated performance indicators.
6.6 Health classifications
ClassiÞcations are a basic statistical building block. They provide a logical structure to
information, enabling concepts and data to be aggregated into manageable
understandable information.
The 54th WHO World Health Assembly in May 2001 endorsed the International
ClassiÞcation of Functioning, Disability and Health (ICF) as a companion classiÞcation
to the long-established International ClassiÞcation of Disease (ICD). The ICD is used for
the classiÞcation of health conditions (diseases, disorders, injuries, etc.) and is generally
based on an etiological perspective. The ICF is intended for the classiÞcation of
functioning and disability associated with health conditions. Under the ICF, disability is
conceptualised as multidimensional, relating to body functions and structures of
people, their activities, the life areas in which they participate, and the factors in their
environment that affect these experiences (WHO 2001b; AIHW 2001: 258Ð9). Work is
under way to develop implementation plans for the ICF, including the development of
user guides and generally promoting the classiÞcation for use in national data systems. 
The ICD and the ICF are now the two reference classiÞcations in the WHO family of
health classiÞcations. Other health classiÞcations that are derived from the reference
classiÞcations or are related to them will also belong to the family and will be able to be
linked to the reference classiÞcations. 
Work is under way to develop a structure for the WHO family of health classiÞcations
to better link the various classiÞcations. Australia participates actively in these
international developments through the NHIMGÕs Expert Group on Health
ClassiÞcations and through the AIHW as the WHO Collaborating Centre for Health
ClassiÞcation in Australia. These classiÞcations serve as an additional standardising
inßuence on health system performance reporting as they are the basis of
measurements describing health status and functioning in frameworks proposed by the
NHPC, WHO and other organisations.
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6.7 Future directions in health information
This report has beneÞted from the range of health data being collected in Australia. 
Arrangements under the National Health Information Agreement have been effective in
ensuring information priority areas are covered and data gaps are identiÞed. The
NHIMG, with representation from the policy departments of all jurisdictions, has
ensured that data collected meet the requirements of policy and program
administrators.
Further improvements in Australian health statistics can be expected with the recent
decision to increase the frequency of the National Health Survey to every 3 years. The
National Health Survey will provide up-to-date data on health status and the use of
health services, and will also collect some information on mental health and nutrition,
areas where current data are limited.
Plans are being developed to conduct a health measurement survey in 2004 that collects
biomedical specimens to give information on health risks in the population.
Information on health risks is an important guide for the targeting of early intervention
programs to populations that are exposed to risks. The Department of Health and
Ageing, the AIHW and ABS will conduct a pilot test of this survey in 2003.
There is also increased emphasis in the joint use of data from different sources for the
analysis of issues that cut across health sectors, e.g. the use of aged care homes and
hospitals by older Australians. The issues involved in such joint use of data, e.g.
technical and privacy considerations in the creation and use of linked data sets, are
being given attention by the NHIMG. The development of data on the various primary
and community health services is also progressing to help monitor the various
community-based services and understand the interface between institutional and
community care.
The 2001 publication of the National Health Performance Framework will assist in the
development of indicators in the various health subsectors, e.g. hospital services, child
and youth health, rural health, and particular health areas such as chronic diseases. 
At the AIHW, work has progressed on exploring a range of issues that arise in
developing a measurement framework for welfare needs, interventions and outcomes
(AIHW 2001). A conceptual framework for welfare information has been described
which includes components of welfare (outcome measures), inßuential factors
(analogous to determinants in the health sector) and interventions, services and
assistance. Despite the differences of language, the parallels to the National Health
Performance Framework are evident.
Australia’s Welfare 2001 also sets out an indicative list of welfare indicators. Combined
with the several sets of performance indicators developed in recent years for different
community service sectors, the aim is to produce a parsimonious set of indicators for
the welfare sector in Australia’s Welfare 2003.
In both the health and welfare sectors, the scene is set for the production of indicator
sets, based on consistent models for each sector. With moves towards statistical
integration now being initiated by NHIMG and National Community Services
Information Management Group, indicator development is paralleling policy moves
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towards the integration of health and community services used by an individual, family
or household. The AIHW will report on these substantial aims in its 2004 report on
AustraliaÕs health.
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Statistical tables
 
1.1 Population
 
Table S1: Estimated resident population, selected years, 1901 to 2001 (number)
 
Age group 1901 1921 1941 1961 1981 1991 2001
 
(a)
 
Males
 
0–4 172,957 307,300 299,900 573,700 583,218 652,302 644,853
5–14 450,067 570,800 575,300 1,056,600 1,321,340 1,290,729 1,367,178
15–24 366,146 457,900 627,900 776,100 1,320,618 1,405,897 1,403,747
25–34 320,455 451,800 593,900 728,000 1,244,663 1,416,512 1,463,465
35–44 279,558 369,500 496,000 737,900 931,360 1,319,366 1,474,375
45–54 156,674 281,300 432,400 627,800 772,879 960,260 1,330,222
55–64 99,170 208,400 307,600 427,800 661,984 734,081 911,623
65–74 64,716 90,900 173,100 266,300 426,174 548,636 626,897
75–84 18,731 29,300 70,900 102,300 158,247 243,406 350,853
85+ 2,207 4,700 7,500 15,800 27,784 44,220 82,209
 
All ages 1,977,928 2,771,900 3,584,500 5,312,300 7,448,267 8,615,409 9,655,422
Females
 
0–4 168,836 296,300 288,700 546,400 556,400 619,401 612,618
5–14 441,003 557,300 556,000 1,008,300 1,264,582 1,223,098 1,298,569
15–24 365,792 462,800 614,900 729,300 1,278,293 1,354,941 1,340,767
25–34 293,424 458,400 573,300 664,400 1,212,261 1,408,886 1,451,173
35–44 216,135 353,200 471,900 706,100 891,517 1,303,292 1,477,932
45–54 118,574 257,400 436,400 595,700 737,394 915,819 1,316,973
55–64 80,302 179,300 307,600 435,500 691,752 728,737 891,056
65–74 48,935 82,000 186,400 333,100 511,502 633,509 674,584
75–84 14,757 31,000 79,700 149,200 256,487 370,917 487,120
85+ 2,038 5,500 10,500 27,900 74,805 110,027 180,449
 
All ages 1,795,873 2,683,200 3,525,400 5,195,900 7,474,993 8,668,627 9,731,241
 
(a) Preliminary data.
 
Note:
 
 Population estimates are for 30 June of each year.
 
Sources:
 
 Commonwealth Statistician 1925; ABS Cat. No. 3201.0; AIHW National Population Database.
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Fertility and pregnancy
 
Table S2: Age-specific birth rates
 
(a)
 
 and total fertility rates
 
(b)
 
, 1921 to 2000 (live births per 1,000 
females)
 
Age group of mother (years) Total
fertility
rate
Less
than 20 20–24 25–29 30–34 35–39 40–44
45 and
over
Annual averages
 
1921–1925 27.3 133.7 167.0 137.0 96.9 40.4 4.2 3,032
1941–1945 23.9 126.9 152.8 114.3 66.3 21.1 1.7 2,535
1961–1965 46.5 204.0 207.2 122.4 59.2 17.5 1.2 3,289
1981–1985 25.7 100.8 144.5 82.0 25.4 4.4 0.3 1,915
1991–1995 21.2 71.6 128.3 104.2 39.3 6.4 0.3 1,857
 
Annual rates
 
1996 20.1 65.2 117.1 105.7 43.7 7.5 0.3 1,797
1997 19.5 62.3 113.8 106.7 44.9 7.5 0.3 1,775
1998 18.5 60.0 111.2 107.2 45.7 8.0 0.3 1,755
1999 18.1 58.7 108.5 108.8 47.1 8.5 0.3 1,751
2000 17.4 56.5 107.0 110.5 49.1 8.8 0.4 1,749
 
(a) Age-specific birth rates are the live births registered during the calendar year, according to age of mother, per 1,000 of 
the female resident population of the same age as estimated for 30 June.
(b) Total fertility rate is obtained by summing the 5-year age-specific birth rates and multiplying by 5. It represents the 
number of children 1,000 women would bear during their lifetimes if they experienced the rates of the year shown.
 
Sources: 
 
ABS 1977; ABS Cat. No. 3301.0.
 
Table S3: Age-specific birth rates
 
(a)
 
 and total fertility rates
 
(b)
 
, States and Territories, 2000 (live 
births per 1,000 females)
 
Age group of mother (years) Total
fertility
rateState/ Territory
Less
than 20 20–24 25–29 30–34 35–39 40–44
45 and
over
 
NSW 16.7 59.5 110.2 113.6 51.7 9.7 0.5 1,809
Vic 10.8 41.4 98.3 113.1 52.2 8.8 0.4 1,625
Qld 22.7 66.3 112.9 103.9 43.5 7.3 0.3 1,784
WA 20.9 61.6 108.3 109.8 46.5 8.1 0.3 1,777
SA 15.2 54.0 104.8 110.7 48.2 9.2 0.6 1,713
Tas 25.7 80.5 113.3 95.9 36.3 6.5 0.4 1,792
ACT 10.9 38.5 100.4 111.5 53.0 8.2 0.3 1,614
NT 69.6 98.6 111.3 99.4 49.7 13.7 0.8 2,216
Australia
 
17.4 56.5 107.0 110.5 49.1 8.8 0.4 1,749
 
(a) Age-specific birth rates are the live births registered during the calendar year, according to age of mother, per 1,000 of 
the female resident population of the same age as estimated for 30 June.
(b) Total fertility rate is obtained by summing the 5-year age-specific birth rates and multiplying by 5. It represents the 
number of children 1,000 women would bear during their lifetimes if they experienced the rates of the year shown.
 
Source: 
 
ABS 2001a.
 
AW2002 end matter  Page 356  Wednesday, June 26, 2002  5:43 PM
 Statistical tables  
 
357
 
TRIM SIZE 175 mm Wide x 250 mm Deep
 
Table S4: Total fertility rates
 
(a)
 
, crude birth rates
 
(b)
 
 and male:female birth ratio, selected 
countries (latest available year)
 
Total fertility rate Crude birth rate M:F birth ratio
Country Year Rate Year Rate Year ratio
Australia 2000 1,749 2000 13.0 2000 105.6
 
Australia 1999 1,751 1999 13.1 1999 104.8
 
Canada 1997 1,552 1997 11.6 1997 105.5
China 1995–2000 1,800 1995–2000 16.2 1994 112.0
Denmark 1996 1,747 1999 12.4 1996 106.1
France 1996 1,712 1999 12.6 1996 105.5
Germany 1997 1,368 1999 9.5 1997 105.5
Greece 1998 1,292 1999 10.9 1998 106.3
Ireland 1997 1,920 1999 14.2 1997 105.5
Israel 1997 2,933 1999 21.2 1997 105.8
Italy 1995 1,187 1998 9.3 1995 106.4
Japan 1998 1,384 1999 9.3 1998 105.4
Korea, Republic of 1998 1,478 1998 13.6 1998 110.1
Malaysia 1998 3,290 1998 25.0 1998 107.1
Netherlands 1998 1,628 1999 12.7 1998 105.0
New Zealand 1998 1,910 1998 14.6 1998 106.8
Norway 1998 1,814 1999 13.3 1998 104.9
Philippines 1995–2000 3,620 1995–2000 28.6 1996 108.2
Poland 1997 1,508 1999 9.9 1997 106.0
Russian Federation 1995 1,344 1999 8.3 1997 106.0
Singapore 1998 1,500 1999 11.1 1998 106.5
Spain 1997 1,157 1998 9.3 1997 106.3
Sweden 1997 1,525 1999 10.0 1997 105.7
Switzerland 1998 1,470 1999 10.3 1998 105.0
United Kingdom 1997 1,720 1999 11.9 1997 105.1
United States 1998 2,060 1998 14.6 1997 104.8
 
(a) Total fertility rate is obtained by summing the 5-year age-specific birth rates and multiplying by 5. It represents the 
number of children 1,000 women would bear during their lifetimes if they experienced the rates of the year shown.
(b) Live births per 1,000 mid-year population.
 
Sources:
 
 UN 2001; WHO 2002; ABS 2001a.
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Table S5: Birthweight distribution of total births
 
(a)
 
, States and Territories, 1999
 
Births/birthweight NSW Vic Qld WA SA Tas
 
(b)
 
ACT NT Australia
Births Number
 
Less than 2,500 g 5,541 4,340 3,286 1,720 1,218 415 332 356 17,208
All births 87,289 62,689 48,747 25,771 18,519 6,092 4,688 3,599 257,394
 
Birthweight (g) Per cent
 
Less than 500 0.2 0.4 0.4 0.3 0.3 0.3 0.4 0.3 0.3
500 to 999 0.4 0.5 0.5 0.5 0.6 0.4 0.8 1.2 0.5
1,000 to 1,499 0.6 0.6 0.7 0.7 0.6 0.7 0.9 0.8 0.6
1,500 to 1,999 1.2 1.3 1.3 1.3 1.2 1.4 1.2 2.4 1.3
2,000 to 2,499 3.8 4.1 3.8 3.9 3.9 4.0 3.8 5.3 3.9
Less than 2,500 6.3 6.9 6.7 6.7 6.6 6.9 7.1 10.0 6.7
2,500 to 2,999 14.8 15.9 14.2 15.8 15.3 15.0 13.8 19.3 15.1
3,000 to 3,499 35.5 35.5 34.6 36.4 35.7 33.6 34.0 35.2 35.3
3,500 to 3,999 31.1 30.2 31.9 30.4 30.6 31.6 31.1 25.6 30.9
4,000 to 4,499 10.3 9.9 10.7 9.1 10.0 10.8 12.0 8.3 10.2
4,500 and over 1.9 1.7 1.9 1.6 1.9 2.1 1.9 1.6 1.8
 
(a) Includes live births and foetal deaths (stillbirths) with known birthweight. Totals include births with unstated 
birthweights.
(b) Data for Tasmania unavailable; 1998 data used as an estimate.
 
Source: 
 
AIHW NPSU 2001.
 
Table S6: Infant mortality rates, States and Territories, selected years, 1901 to 2000 (per 1,000 
live births)
 
Year NSW Vic Qld WA SA Tas ACT NT Australia
 
1901 103.7 102.9 101.9 128.9 100.1 89.0
 
(a)
 
62.5 103.6
1921 62.6 72.5 54.2 78.3 65.5 78.0 74.1 63.3 65.7
1941 43.8 36.2 39.1 35.3 32.5 49.0 16.4 83.3 39.7
1961 20.8 17.8 20.0 19.7 20.0 16.8 15.6 23.9 19.5
1981 10.2 9.3 10.4 8.9 8.0 12.3 8.9 23.5 10.0
1993 6.2 5.4 7.0 5.9 5.2 5.9 4.3 15.3 6.1
1994 6.3 5.1 6.2 5.6 4.7 7.5 4.7 11.3 5.9
1995 5.7 4.9 6.3 5.1 5.8 5.8 4.8 13.3 5.7
1996 5.8 5.0 6.4 6.5 4.9 4.5 5.7 11.5 5.8
1997 5.2 4.9 5.8 5.3 4.7 6.5 3.8 12.5 5.3
1998 4.3 4.7 6.4 5.0 4.0 5.7 6.0 12.4 5.0
1999 5.8 5.6 5.7 4.7 4.3 7.6 5.6 11.7 5.7
2000 5.2 4.5 6.2 4.3 4.6 5.8 4.2 11.7 5.2
 
(a) Part of New South Wales prior to 1911.
 
Source:
 
 ABS Cat. No. 3302.0.
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Table S7: Perinatal mortality rates
 
(a)
 
, by age group of mother, 1991 to 2000 (per 1,000 
live births plus foetal deaths)
 
Age group of mother (years)
Year
Less
than 20 20–24 25–29 30–34 35–39
40 and
over Aust
 
1991 15.2 11.0 9.0 10.3 11.3 20.8 10.6
1992 14.1 11.1 9.2 9.8 11.6 18.0 10.7
1993 12.7 9.6 8.1 8.1 10.4 13.1 9.2
1994 12.0 9.3 7.6 8.4 10.8 14.8 9.1
1995 14.2 10.2 8.0 7.9 9.5 13.4 9.4
1996 14.0 10.9 8.4 8.9 9.9 17.3 10.0
1997 15.0 9.6 8.0 7.6 10.7 12.1 9.2
1998 13.0 8.9 7.4 6.9 9.6 12.6 8.3
1999 13.8 9.6 7.5 7.3 8.6 13.4 8.5
2000 14.3 9.4 7.4 7.1 8.4 9.2 8.3
 
(a) Perinatal deaths consist of foetal deaths (stillbirths) and neonatal deaths (within 28 days of birth). The 
perinatal mortality rate is defined as the number of deaths per 1,000 live births and foetal deaths 
combined.
 
Note: 
 
Data are based on year of registration and use the ABS definition for perinatal deaths of at least 400 
grams birthweight or, where birthweight is unknown, at least 20 weeks gestation. Editions of 
 
Australia’s Health
 
 
prior to the year 2000 used the WHO definition of 500 grams birthweight and 22 weeks gestation.
 
Source:
 
 ABS Cat. No. 3303.0.
 
Table S8: Perinatal mortality rates
 
(a)
 
, States and Territories, 1991 to 2000 (per 1,000 live births 
plus foetal deaths)
 
Year NSW Vic Qld WA SA Tas ACT NT Aust
 
1991 11.0 9.8 11.1 10.3 9.0 11.9 12.5 18.2 10.6
1992 11.8 9.4 10.6 9.8 9.9 9.1 9.4 19.3 10.7
1993 9.5 8.5 9.4 8.3 8.8 10.0 7.7 21.1 9.2
1994 9.2 9.3 8.9 8.3 8.5 8.4 6.9 16.9 9.1
1995 8.9 9.2 9.8 9.3 9.9 9.7 9.2 16.3 9.4
1996 11.0 8.8 10.0 10.2 8.6 9.5 8.8 12.6 10.0
1997 9.8 8.5 9.1 8.1 8.2 11.6 6.6 15.5 9.2
1998 8.1 7.7 9.6 7.5 7.2 9.8 12.2 13.1 8.3
1999 8.1 9.2 8.2 8.3 6.6 10.7 11.7 16.1 8.5
2000 7.7 7.9 8.9 8.4 8.2 10.6 8.3 14.5 8.3
 
(a) Perinatal deaths consist of foetal deaths (stillbirths) and neonatal deaths (within 28 days of birth). The perinatal 
mortality rate is defined as the number of deaths per 1,000 live births and foetal deaths combined.
 
Note:
 
 Data are based on year of registration and use the ABS definition for perinatal deaths of at least 400 grams 
birthweight or, where birthweight is unknown, at least 20 weeks gestation. Editions of 
 
Australia’s Health
 
 prior to the year 
2000 used the WHO definition of 500 grams birthweight and 22 weeks gestation.
 
Source: 
 
ABS Cat. No. 3303.0.
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Table S9: Neonatal, postneonatal and infant mortality rates
 
(a)
 
, selected countries (latest 
available year) (per 1,000 live births)
 
Males Females
Neonatal
Post-
neonatal Infant Neonatal
Post-
neonatal Infant
Australia (2000) 3.8 1.8 5.7 3.1 1.6 4.7
 
Australia (1998) 3.7 1.8 5.5 3.0 1.5 4.5
 
Canada (1997) 4.2 2.2 6.0 3.6 1.4 5.0
China (1997) n.a. n.a. 28.8 n.a. n.a. 37.1
Denmark (1996) 4.7 1.6 6.3 3.0 1.7 4.7
France (1996) 3.3 2.1 5.4 2.7 1.4 4.1
Germany (1997) 3.2 2.2 5.4 2.5 1.7 4.3
Greece (1998) 4.8 2.3 7.1 4.4 1.8 6.2
Ireland (1997) 3.9 2.5 6.4 3.5 2.4 5.9
Israel (1997) 4.1 2.4 6.5 3.8 2.4 6.3
Italy (1995) 5.2 1.8 7.0 3.9 1.4 5.4
Japan (1998) 2.1 1.7 3.8 1.8 1.6 3.4
Korea, Republic of (1997) n.a. n.a. 2.5 n.a. n.a. 2.4
Malaysia (1998) 8.4 2.3 10.7 6.6 2.2 8.8
Netherlands (1998) 4.3 1.7 6.0 3.3 1.0 4.3
New Zealand (1998) 3.4 3.1 6.5 2.7 1.7 4.4
Norway (1998) 2.9 1.6 4.6 2.2 1.2 3.4
Philippines (1996) 11.4 10.0 21.3 8.5 7.9 16.5
Poland (1997) 8.2 2.8 11.0 6.6 2.8 9.3
Russian Federation (1995) 12.8 7.9 20.7 9.1 6.5 15.6
Singapore (1997) 2.5 1.5 4.0 1.8 1.6 3.4
Spain (1997) 3.6 2.0 5.5 2.9 1.6 4.5
Sweden (1997) 2.7 1.4 4.1 2.0 1.2 3.1
Switzerland (1998) 4.0 1.5 5.5 2.9 1.0 4.0
United Kingdom (1997) 4.2 2.2 6.4 3.5 1.7 5.3
United States (1997) 5.2 2.8 8.0 4.3 2.1 6.5
 
(a) Neonatal: less than 28 days. Postneonatal: 28 to 364 days. Infant: less than 1 year.
 
Sources:
 
 ABS 2001b; UN 2001; WHO 2002.
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Mortality 
 
Table S10: Life expectancy (years) at selected ages, 1901 to 1998Ð2000
 
At birth At age 15 At age 65
Year Males Females Males Females Males Females
Annual averages
 
1901–10 55.2 58.8 49.0 51.9 11.3 12.9
1920–22 59.2 63.3 51.4 54.6 12.0 13.6
1946–48 66.1 70.6 54.3 58.3 12.3 14.4
1960–62 67.9 74.2 55.1 61.0 12.5 15.7
1980–82 71.2 78.3 57.4 64.3 13.8 18.0
 
Annual rates
 
1990 73.9 80.1 59.8 65.8 15.2 19.0
1991 74.4 80.4 60.2 66.0 15.4 19.1
1992 74.5 80.4 60.3 66.1 15.4 19.2
1993 75.0 80.9 60.8 66.5 15.7 19.5
1994 75.0 80.9 60.8 67.0 15.7 19.7
1994–1996
 
(a)
 
75.2 81.1 60.9 66.7 15.8 19.6
1995–1997
 
(a)
 
75.6 81.3 61.3 66.9 16.1 19.8
1996–1998
 
(a)
 
75.9 81.5 61.5 67.1 16.3 20.0
1998–2000
 
(a)
 
76.6 82.0 62.2 67.6 16.8 20.4
 
(a) The methodology used to calculate this table has changed since 1995. Data on population and deaths averaged over 
3 years are now used to minimise year-to-year statistical variations.
 
Sources:
 
 ABS Cat. No. 3302.0; ABS unpublished data.
 
Table S11: Life expectancy (years) at selected ages, States and Territories, 1998Ð2000
 
At birth At age 15 At age 65
State/Territory Males Females Males Females Males Females
 
New South Wales 76.4 81.9 62.0 67.5 16.7 20.3
Victoria 77.1 82.3 62.7 67.8 17.1 20.5
Queensland 76.4 81.9 62.2 67.6 16.9 20.4
Western Australia 76.9 82.6 62.5 68.0 17.1 20.8
South Australia 76.6 82.3 62.2 67.7 16.8 20.6
Tasmania 75.7 81.2 61.4 66.9 16.3 19.8
Australian Capital Territory 78.3 82.3 63.8 68.0 17.6 20.5
Northern Territory 70.3 75.2 56.6 61.5 15.0 17.2
 
Australia 76.6 82.0 62.2 67.6 16.8 20.4
 
Note:
 
 The methodology used to calculate this table has changed since 1995. Data on population and deaths averaged over 
3 years are now used to minimise year-to-year statistical variations.
 
Sources:
 
 ABS Cat. No. 3302.0; ABS unpublished data.
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Table S12: Life expectancy (years) at selected ages, selected countries, latest year
 
At birth At age 15 At age 65
Country/year Males Females Males Females Males Females
Australia (1998–2000) 76.6 82.0 62.2 67.6 16.9 20.4
 
Australia (1997–1999) 76.2 81.8 61.9 67.4 16.6 20.2
 
Canada (1995) 75.2 81.2 61.0 66.9 16.1 20.1
China (1990) 66.8 70.5 55.4 59.2 12.2 14.7
Denmark (1996–1997) 73.3 78.4 58.9 63.9 14.5 17.9
France (1996) 74.2 82.0 59.8 67.5 16.1 20.7
Germany (1994–1996) 73.3 79.7 58.9 65.3 14.8 18.5
Greece (1998) 75.3 80.5 61.1 66.2 16.2 18.7
Ireland (1990–1992) 72.3 77.9 58.2 63.6 13.4 17.1
Israel (1997) 76.0 80.4 61.8 66.2 16.4 19.1
Italy (1995) 74.6 81.0 60.4 66.7 15.5 19.4
Japan (1998) 77.2 84.0 62.7 69.5 17.1 22.0
Korea, Republic of (1997) 70.6 78.1 56.5 64.0 13.6 17.3
Malaysia (1998) 69.6 74.6 55.9 60.8 13.1 15.0
Netherlands (1997–1998) 75.4 80.7 61.0 66.2 15.2 19.3
New Zealand (1995–1997) 74.3 79.6 55.4 60.5 15.5 19.0
Norway (1998) 75.5 81.3 61.0 66.7 15.7 19.6
Philippines (1991) 63.1 66.7 53.5 56.3 12.3 13.7
Poland (1997) 68.4 77.0 54.5 62.9 13.1 16.8
Russian Federation (1995) 58.3 71.7 45.1 58.4 10.8 14.9
Singapore (1998) 75.2 79.3 60.7 64.7 15.3 17.8
Spain (1994–1995) 74.3 81.6 60.0 67.3 16.1 20.0
Sweden (1997) 76.7 81.8 62.2 67.2 16.2 19.9
Switzerland (1995–1996) 75.7 81.9 61.3 67.4 16.3 20.3
United Kingdom (1997) 74.7 79.6 60.3 65.2 15.1 18.5
United States (1997) 73.6 79.2 59.4 63.0 15.8 19.0
 
Sources:
 
 UN 2001; ABS 2001b.
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Table S13: Age-specific, crude and age-standardised death rates, selected years, 1921 to 2000 
(per 100,000 population)
 
Sex/age group (years) 1921 1941 1961 1981 1991 2000
Males
 
0–4 2,213 1,289 564 281 191 136
5–9 200 139 49 34 20 15
10–14 172 108 52 29 22 18
15–19 219 159 123 124 88 73
20–24 321 205 161 153 128 101
25–29 373 199 146 133 127 124
30–34 442 232 169 123 133 131
35–39 584 339 229 165 161 149
40–44 730 461 380 261 198 186
45–49 994 737 588 455 313 241
50–54 1,299 1,161 992 790 517 383
55–59 1,895 1,775 1,614 1,294 885 627
60–64 2,878 2,774 2,619 1,983 1,543 1,041
65–69 4,199 4,251 4,117 3,231 2,489 1,789
70–74 6,199 6,479 6,252 5,195 3,927 3,097
75–79 10,076 10,054 9,312 8,018 6,547 5,162
80–84 15,368 15,264 14,084 12,112 10,548 8,493
85+ 26,213 29,453 23,772 20,814 17,571 16,530
 
Crude rate 1,106 1,099 946 815 744 700
ASR
 
(a)
 
1,733 1,578 1,358 1,109 885 713
Females
 
0–4 1,771 1,022 443 216 151 110
5–9 192 103 38 18 14 11
10–14 128 73 30 20 15 12
15–19 205 104 47 45 37 33
20–24 290 155 61 48 45 37
25–29 377 202 74 51 54 44
30–34 426 234 92 57 54 53
35–39 535 311 146 87 77 76
40–44 563 374 209 143 111 102
45–49 690 565 347 265 187 158
50–54 943 780 542 378 307 242
55–59 1,289 1,103 785 617 484 397
60–64 1,915 1,805 1,298 971 797 590
65–69 3,112 2,884 2,178 1,568 1,305 996
70–74 5,041 4,789 3,652 2,552 2,187 1,704
75–79 8,295 8,275 6,271 4,426 3,797 2,907
80–84 13,136 12,704 10,241 7,597 6,487 5,572
85+ 22,345 25,457 20,670 16,035 14,351 13,790
 
Crude rate 873 901 745 646 635 639
ASR
 
(a)
 
1,394 1,225 875 633 537 451
 
(a) Age-standardised rate. Age-standardised to the total Australian population at 30 June 1991.
 
Source:
 
 AIHW National Mortality Database.
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Table S14: Age-specific, crude and age-standardised death rates, State or Territory of usual 
residence, 2000 (per 100,000 population)
 
Sex/age group (years) NSW Vic Qld WA SA Tas ACT NT Aust
Males
 
0–4 142 116 141 131 144 140 122 266 136
5–9 13 14 19 16 12 17 9 22 15
10–14 20 15 15 17 23 28 9 37 18
15–19 71 61 71 76 81 114 39 275 73
20–24 102 89 96 109 113 100 105 212 101
25–29 113 123 125 129 146 107 115 268 124
30–34 124 125 122 153 142 159 118 283 131
35–39 149 142 145 162 151 155 116 299 149
40–44 198 154 180 180 196 254 120 528 186
45–49 250 219 243 228 248 276 123 611 241
50–54 378 374 398 321 472 393 199 682 383
55–59 643 577 679 575 622 656 420 1,255 627
60–64 1,118 975 1,019 951 1,034 1,135 743 1,821 1,041
65–69 1,827 1,737 1,776 1,685 1,789 2,085 1,801 2,672 1,789
70–74 3,148 2,948 3,121 3,014 3,155 3,574 2,642 5,837 3,097
75–79 5,177 5,024 5,102 5,154 5,484 5,840 4,170 6,968 5,162
80–84 8,656 8,306 8,603 7,923 8,366 9,422 8,007 12,245 8,493
85+ 16,774 16,634 16,305 16,021 16,726 16,040 14,179 13,000 16,530
 
Crude rate 729 694 674 602 827 832 415 553 700
ASR
 
(a)
 
724 688 712 687 732 780 599 1,081 713
Females
 
0–4 113 92 140 88 75 134 87 270 110
5–9 10 13 12 12 4 18 19 24 11
10–14 11 12 12 13 14 12 9 – 12
15–19 26 36 34 45 28 35 35 85 33
20–24 38 35 33 48 31 35 8 115 37
25–29 34 44 57 46 51 32 23 129 44
30–34 54 47 48 59 59 50 57 124 53
35–39 66 83 72 81 73 94 32 309 76
40–44 97 101 104 103 114 88 56 254 102
45–49 153 159 142 149 191 177 166 340 158
50–54 245 223 245 218 254 302 258 565 242
55–59 400 382 407 367 423 432 273 802 397
60–64 611 574 530 603 560 686 617 1,838 590
65–69 1,015 930 1,018 968 1,018 1,146 978 2,021 996
70–74 1,750 1,684 1,671 1,633 1,620 1,896 1,683 2,678 1,704
75–79 2,972 2,862 2,808 2,624 3,017 3,484 2,865 3,947 2,907
80–84 5,726 5,371 5,609 5,274 5,513 5,962 5,756 9,199 5,572
85+ 14,177 13,826 13,617 12,549 13,824 13,659 13,926 8,136 13,790
 
Crude rate 676 650 584 529 756 747 421 367 639
ASR
 
(a)
 
458 441 447 425 451 490 438 701 451
 
(a) Age-standardised rate. Age-standardised to the total Australian population at 30 June 1991.
 
Source:
 
 AIHW National Mortality Database.
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Table S15: Age-specific, crude and age-standardised death rates, selected countries, latest year 
(per 100,000 population)
 
Age group (years)
Country/year 0
 
(a)
 
1–4 5–14 15–24 25–34 35–44
Males
Australia (2000) 566 30 16 87 127 167
 
Australia (1997) 576 39 17 105 131 168
 
Canada (1997) 601 31 20 87 102 170
Denmark (1996) 626 30 19 72 108 245
Finland (1996) 437 17 22 88 147 293
France (1996) 536 32 19 91 149 274
Germany (1997) 542 31 16 84 103 214
Greece (1997) 673 35 21 94 124 191
Ireland (1996) 641 29 23 102 132 170
Israel (1996) 663 41 21 74 90 151
Italy (1995) 696 29 22 91 140 192
Japan (1997) 395 38 15 58 73 141
Netherlands (1997) 551 31 18 56 75 146
New Zealand (1996) 775 44 22 134 143 158
Norway (1995) 503 25 20 86 100 162
Poland (1996) 1,342 46 27 106 180 435
Portugal (1998) 661 59 38 139 227 338
Russian Federation (1997) 1,965 109 57 286 523 908
Spain (1995) 587 36 21 86 209 259
Sweden (1996) 401 23 12 48 81 149
United Kingdom (1997) 643 30 17 76 96 159
United States (1997) 795 40 24 124 160 266
 
(continued)
 
(a) Infant mortality per 100,000 births.
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Table S15 (continued): Age-specific, crude and age-standardised death rates, selected 
countries, latest year (per 100,000 population)
 
Age group (years)
Crude rate ASR
 
(b)
 
Country/year 45–54 55–64 65–74 75+
Males
Australia (2000) 310 812 2,405 8,234 700 549
 
Australia (1997) 342 961 2,736 8,884 735 610
 
Canada (1997) 376 1,057 2,826 9,212 754 634
Denmark (1996) 523 1,390 3,796 11,320 1,160 796
Finland (1996) 579 1,342 3,501 10,962 972 792
France (1996) 551 1,260 2,800 9,373 974 672
Germany (1997) 527 1,280 3,262 10,723 996 733
Greece (1997) 447 1,055 2,718 9,498 1,015 632
Ireland (1996) 427 1,318 3,917 12,208 926 829
Israel (1996) 342 1,080 2,715 9,316 630 608
Italy (1995) 402 1,147 3,051 9,973 1,030 673
Japan (1997) 378 956 2,341 8,527 813 556
Netherlands (1997) 372 1,096 3,257 10.690 871 695
New Zealand (1996) 406 1,194 3,107 9,883 793 706
Norway (1995) 410 1,134 3,266 10,852 1,068 711
Poland (1996) 993 2,338 4,786 12,695 1,083 1,089
Portugal (1998) 597 1,343 3,458 11,974 1,165 889
Russian Federation (1997) 1,658 3,382 6,269 13,489 1,500 1,530
Spain (1995) 496 1,212 2,873 9,656 962 698
Sweden (1996) 361 944 2,747 9,927 1,075 614
United Kingdom (1997) 408 1,184 3,387 10,388 1,036 705
United States (1997) 551 1,337 3,191 9,120 881 723
 
(continued)
 
(b) Age-standardised rate. Reference population is the WHO standard population. Standard death rates in this table are 
different from the rates in other tables because of the use of a different reference population.
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Table S15 (continued): Age-specific, crude and age-standardised death rates, selected 
countries, latest year (per 100,000 population)
 
Age group (years)
Country/year 0
 
(a)
 
1–4 5–14 15–24 25–34 35–44
Females
Australia (2000) 465 23 12 35 48 89
 
Australia (1997) 487 24 13 39 52 91
 
Canada (1997) 502 27 15 33 43 95
Denmark (1996) 472 30 14 26 50 136
Finland (1996) 345 23 14 28 42 114
France (1996) 414 23 13 34 59 117
Germany (1997) 428 25 11 30 43 110
Greece (1997) 613 25 16 31 40 83
Ireland (1996) 551 33 9 29 48 94
Israel (1996) 599 36 10 26 41 86
Italy (1995) 537 29 15 27 52 91
Japan (1997) 343 35 11 24 37 81
Netherlands (1997) 454 26 11 27 45 106
New Zealand (1996) 674 39 22 57 62 96
Norway (1995) 318 25 11 30 39 92
Poland (1996) 1,092 38 18 33 52 152
Portugal (1998) 539 51 26 45 69 131
Russian Federation (1997) 1,471 92 31 88 134 248
Spain (1995) 509 33 16 30 63 103
Sweden (1996) 363 15 10 23 38 80
United Kingdom (1997) 526 23 12 30 43 105
United States (1997) 647 32 17 46 70 141
 
(continued)
 
(a) Infant mortality per 100,000 births.
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Table S15 (continued): Age-specific, crude and age-standardised death rates, selected 
countries, latest year (per 100,000 population)
 
Age group (years)
Crude rate ASR
 
(b)
 
Country/year 45–54 55–64 65–74 75+
Females
Australia (2000) 198 484 1,342 6,575 639 344
 
Australia (1997) 215 549 1,512 7,030 662 377
 
Canada (1997) 232 619 1,589 6,958 684 391
Denmark (1996) 354 924 2,331 8,686 1,148 516
Finland (1996) 230 520 1,610 8,371 947 425
France (1996) 236 493 1,192 7,312 865 345
Germany (1997) 269 592 1,711 8,450 1,099 430
Greece (1997) 190 468 1,510 8,494 887 414
Ireland (1996) 266 719 2,221 9,247 824 512
Israel (1996) 211 661 1,865 7,956 590 439
Italy (1995) 216 515 1,471 7,768 916 388
Japan (1997) 192 415 1,043 5,557 652 295
Netherlands (1997) 264 628 1,638 7,959 869 422
New Zealand (1996) 299 744 1,878 7,715 735 462
Norway (1995) 231 607 1,707 7,935 1,006 414
Poland (1996) 364 891 2,444 10,530 918 602
Portugal (1998) 256 600 1,688 9,343 980 504
Russian Federation (1997) 532 1,250 3,149 11,414 1,273 767
Spain (1995) 198 463 1,283 7,463 808 379
Sweden (1996) 237 558 1,517 7,613 1,048 384
United Kingdom (1997) 270 715 2,057 8,398 1,097 459
United States (1997) 316 815 1,959 7,534 849 463
 
(b) Age-standardised rate. Reference population is the WHO standard population. Standard death rates in this table are 
different from the rates in other tables because of the use of a different reference population.
 
Sources:
 
 WHO 2002; AIHW National Mortality Database.
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Table S16: Age-standardised death rates
 
(a)
 
, selected years, 1921 to 2000 (per 100,000 population)
 
ICD-10 chapter or disease 1921 1941 1961 1971 1981 1991 1998 1999 2000
Males
 
Infectious and parasitic
 
(b)
 
210 93 17 10 5 6 9 9 9
Neoplasms 157 179 197 222 242 237 224 219 216
Endocrine, nutritional
 
(c)
 
16 24 16 23 18 24 23 22 23
Blood diseases 10 6 4 3 3 3 2 2 2
Mental disorders 7 4 5 9 9 13 16 14 15
Nervous system diseases 47 26 15 12 13 16 20 20 20
Circulatory diseases 387 635 759 763 565 381 290 276 256
Respiratory diseases 207 149 108 124 98 78 62 59 64
Digestive diseases 59 57 39 31 36 29 22 23 22
Genitourinary diseases 126 138 44 24 16 14 14 14 13
Skin diseases 5 3 2 1 1 1 1 1 1
Musculoskeletal diseases 7 5 4 4 3 3 3 3 3
Congenital diseases 9 10 10 8 7 5 4 4 4
Perinatal diseases 54 43 20 17 7 5 4 4 4
Ill-defined conditions 315 103 15 7 6 5 4 4 4
Injury and poisoning 117 104 104 105 81 65 63 63 58
 
All causes 1,733 1,577 1,358 1,361 1,109 885 760 739 713
Females
 
Infectious and parasitic
 
(b) 158 58 9 6 4 4 5 6 6
Neoplasms 159 163 139 138 136 144 135 132 131
Endocrine, nutritional(c) 26 40 20 22 15 15 16 16 15
Blood diseases 13 6 5 3 3 2 2 2 2
Mental disorders 3 3 2 6 6 9 10 10 11
Nervous system diseases 36 22 9 9 8 12 15 15 16
Circulatory diseases 345 523 514 509 347 246 192 183 173
Respiratory diseases 160 115 45 43 32 34 33 32 36
Digestive diseases 58 40 23 18 20 19 15 16 15
Genitourinary diseases 67 76 20 17 12 10 11 11 10
Complications of pregnancy 24 14 2 1 — — — — —
Skin diseases 5 3 2 1 — 1 1 1 1
Musculoskeletal diseases 9 6 4 5 4 5 4 4 4
Congenital diseases 7 9 8 8 6 4 3 4 3
Perinatal diseases 40 33 15 13 5 4 3 3 3
Ill-defined conditions 250 74 14 6 4 3 2 2 3
Injury and poisoning 34 40 42 46 30 25 23 23 23
All causes 1,394 1,225 875 848 633 537 470 461 451
(a) Age-standardised to the total Australian population at 30 June 1991.
(b) From 1996, includes AIDS and AIDS-related deaths.
(c) Prior to 1996, includes AIDS and AIDS-related deaths.
Source: AIHW National Mortality Database.
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Table S17: Age-standardised death rates(a), State or Territory of usual residence, 2000 
(per 100,000 population)
ICD-10 chapter or 
disease NSW Vic Qld WA SA Tas ACT NT Aust
Males
Infectious and parasitic(b) 11 9 7 7 8 8 6 19 9
Neoplasms 209 215 226 215 218 235 217 260 216
Blood diseases 2 2 2 1 2 3 3 1 2
Endocrine, nutritional 19 27 23 22 22 21 13 67 23
Mental disorders 17 17 9 16 12 8 7 14 15
Nervous system diseases 21 20 19 22 14 19 16 17 20
Circulatory diseases 269 235 256 235 266 279 245 358 256
Respiratory diseases 66 59 63 56 76 76 50 102 64
Digestive diseases 23 19 20 21 25 24 19 58 22
Skin diseases 1 1 1 1 1 2 0 3 1
Musculoskeletal diseases 3 3 3 3 2 6 6 9 3
Genitourinary diseases 12 16 10 11 14 14 5 27 13
Perinatal diseases 4 4 4 3 5 5 6 10 4
Congenital diseases 3 4 4 3 5 2 3 6 4
Ill-defined conditions 2 3 3 7 2 18 9 34 4
Injury and poisoning 54 54 67 63 62 58 57 115 58
All causes 717 689 719 688 734 776 663 1100 713
Females
Infectious and parasitic(b) 6 6 4 5 6 4 5 21 6
Neoplasms 128 134 126 131 128 149 154 195 131
Blood diseases 2 2 2 1 2 2 0 0 2
Endocrine, nutritional 13 17 16 16 18 11 11 50 15
Mental disorders 12 13 7 11 13 8 16 12 11
Nervous system diseases 16 16 14 20 12 16 14 14 16
Circulatory diseases 181 160 181 148 172 186 206 205 173
Respiratory diseases 38 33 32 31 41 42 32 73 35
Digestive diseases 14 14 16 16 17 16 14 25 15
Skin diseases 1 1 1 1 1 1 1 1 1
Musculoskeletal diseases 4 4 4 4 5 7 5 7 4
Genitourinary diseases 10 11 9 8 11 8 11 55 10
Pregnancy — — — — — — — — —
Perinatal diseases 4 2 4 3 2 3 4 8 3
Congenital diseases 3 3 4 2 3 1 3 6 3
Ill-defined conditions 2 2 3 4 2 11 3 9 3
Injury and poisoning 19 23 28 26 23 18 20 43 23
All causes 454 441 450 426 454 483 497 722 451
(a) Age-standardised to the total Australian population at 30 June 1991.
(b) Includes AIDS and AIDS-related deaths.
Source: AIHW National Mortality Database.
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Table S18: Age-standardised death rates(a), selected countries, latest year 
(per 100,000 population)
ICD-10 chapter
Infectious
& parasitic
Malignant
neoplasms Circulatory Respiratory
External
causes All causes
Males
Australia (2000) 7 164 188 46 54 549
Australia (1997) 8 171 226 61 56 610
Canada (1997) 5 176 221 58 55 634
Denmark (1996) 10 204 278 67 64 796
Finland (1996) 7 170 329 72 102 792
France (1996) 9 213 179 48 77 672
Germany (1997) 6 192 308 49 51 733
Greece (1997) 5 167 277 33 57 632
Ireland (1996) 4 196 353 115 57 829
Israel (1996) 10 148 217 38 47 608
Italy (1995) 4 199 248 46 50 673
Japan (1997) 11 179 159 76 55 556
Netherlands (1997) 8 207 247 73 36 695
New Zealand (1996) 4 185 282 76 65 706
Norway (1995) 6 172 296 67 55 711
Poland (1996) 8 228 505 47 104 1,089
Portugal (1998) 14 186 300 84 70 889
Russian Federation (1997) 34 226 722 94 286 1,530
Spain (1995) 9 201 216 73 54 698
Sweden (1996) 5 145 280 47 48 614
United Kingdom (1997) 5 185 283 102 38 705
United States (1997) 11 176 271 66 76 723
(continued)
(a) Reference population is the WHO standard population. Standard death rates in this table are different from the rates in 
other tables because of the use of a different reference population.
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Table S18 (continued): Age-standardised death rates(a), selected countries, latest year 
(per 100,000 population)
ICD-10 chapter
Infectious
& parasitic
Malignant
neoplasms Circulatory Respiratory
External
causes All causes
Females
Australia (2000) 4 103 123 26 21 344
Australia (1997) 4 109 143 35 20 377
Canada (1997) 4 118 131 32 21 391
Denmark (1996) 4 155 162 48 29 516
Finland (1996) 4 95 180 30 31 425
France (1996) 5 97 101 22 32 345
Germany (1997) 4 116 193 20 19 430
Greece (1997) 4 90 210 21 17 414
Ireland (1996) 3 133 210 73 18 512
Israel (1996) 9 121 155 28 20 439
Italy (1995) 2 105 162 17 19 388
Japan (1997) 6 87 96 33 22 295
Netherlands (1997) 5 124 141 32 17 422
New Zealand (1996) 4 139 173 48 24 462
Norway (1995) 5 117 159 40 21 414
Poland (1996) 3 121 311 18 28 602
Portugal (1998) 6 96 208 37 21 504
Russian Federation (1997) 7 108 446 27 69 767
Spain (1995) 5 92 146 26 16 379
Sweden (1996) 3 108 159 27 20 384
United Kingdom (1997) 4 130 169 66 15 459
United States (1997) 8 121 172 42 27 463
(a) Reference population is the WHO standard population. Standard death rates in this table are different from the rates in 
other tables because of the use of a different reference population.
Sources: WHO 2002; AIHW National Mortality Database.
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Table S19: Age-standardised death rates(a), States and Territories, 1997Ð2000 and changes from 
1993Ð1996 to 1997Ð2000
Cause of death NSW Vic Qld WA SA Tas ACT NT
Ischaemic heart disease
Males 171.8 155.4 181.2 154.8 172.8 175.2 156.7 207.5
% change 93–96 to 97–00 –15.4 –21.7 –17.2 –23.9 –18.7 –20.2 –16.4 1.8
Females 95.0 85.4 103.2 81.5 91.9 93.2 88.6 106.8
% change 93–96 to 97–00 –19.2 –19.3 –15.1 –24.0 –18.9 –20.7 –16.6 13.9
Cerebrovascular disease (stroke)
Males 60.6 51.5 57.0 53.4 55.3 65.9 54.3 68.3
% change 93–96 to 97–00 –8.1 –14.9 –11.5 –17.1 –19.7 –8.1 –9.9 –10.3
Females 54.4 47.0 52.0 47.3 49.3 52.3 62.0 69.3
% change 93–96 to 97–00 –12.0 –12.6 –11.9 –12.9 –17.0 –16.7 3.1 –0.3
Lung cancer
Males 49.0 48.7 53.6 51.8 50.6 54.1 43.8 64.0
% change 93–96 to 97–00 –5.5 –13.9 –3.3 –8.2 –4.0 –10.0 4.4 –30.6
Females 18.5 19.4 18.7 20.8 17.3 20.4 24.0 34.0
% change 93–96 to 97–00 1.6 –1.6 10.6 4.5 5.4 –0.6 42.1 6.9
Chronic obstructive pulmonary disease
Males 38.8 38.2 40.9 34.4 33.7 52.6 33.4 72.3
% change 93–96 to 97–00 –7.1 –16.7 –4.9 –15.1 –16.9 –4.7 –13.2 –15.3
Females 17.8 16.7 16.1 14.3 14.4 25.1 17.7 49.2
% change 93–96 to 97–00 1.2 –3.7 8.7 –3.7 5.1 15.3 3.5 –12.4
Colorectal cancer
Males 26.4 28.3 27.7 28.7 26.2 28.4 28.0 18.0
% change 93–96 to 97–00 –1.9 –8.3 –1.8 0.6 –10.1 –17.1 –22.9 –30.4
Females 16.8 18.9 17.9 17.9 18.6 23.5 21.3 14.6
% change 93–96 to 97–00 –6.6 –10.3 –1.8 –7.7 0.4 2.1 –3.4 –43.0
All causes
Males 754.6 727.9 760.5 729.2 751.2 806.8 731.8 1067.7
% change 93–96 to 97–00 –6.9 –11.4 –9.1 –11.0 –10.5 –12.7 –11.2 –7.8
Females 469.1 463.0 470.9 448.3 463.3 509.2 518.5 770.5
% change 93–96 to 97–00 –8.6 –8.6 –7.5 –9.2 –8.7 –9.7 –0.9 –5.1
(a) Age-standardised to the total Australian population at 30 June 1991.
Note: A small proportion of the difference between the 1993–1996 and the 1997–2000 rates is due to the classification 
change from ICD-9 to ICD-10 and the introduction of automated coding in 1997.
Source: AIHW National Mortality Database.
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Infectious diseases 
Table S20: Selected notifiable diseases, 1996 to 1999
Notifications Rate per 100,000 population
Disease 1996 1997 1998 1999 1996 1997 1998 1999
Bloodborne
Hepatitis B—incident 213 268 262 307 1.2 1.4 1.4 1.6
Hepatitis B—unspecified(a) 5,911 7,044 6,620 8,091 32.3 38.0 35.3 42.7
Hepatitis C—incident 75 154 345 385 0.5 1.0 2.3 2.5
Hepatitis C—unspecified(a) 9,712 19,331 19,006 21,244 53.0 104.4 101.4 112.0
Hepatitis D 14 17 10 21 0.1 0.1 0.1 0.1
Hepatitis (NEC) 16 5 4 0 0.1 0.0 0.0 0.0
Gastrointestinal
Campylobacteriosis(b) 12,117 11,742 13,282 12,643 100.1 95.8 107.0 100.7
Haemolytic uraemic syndrome — 4 13 24 — 0.0 0.1 0.1
Hepatitis A 2,112 3,069 2,443 1,557 11.5 16.6 13.0 8.2
Hepatitis E 4 7 1 2 0.0 0.0 0.0 0.0
Listeriosis 68 73 55 63 0.4 0.4 0.3 0.3
Salmonellosis 5,791 7,089 7,489 7,154 31.6 38.3 39.9 37.7
Shigellosis(b) 677 796 594 547 5.6 6.5 4.8 4.4
SLTEC,VTEC(c) — 20 14 43 — 0.2 0.1 0.3
Typhoid 79 81 63 72 0.4 0.4 0.3 0.4
Yersiniosis(b) 272 246 190 143 2.2 2.0 1.5 1.1
Quarantinable
Cholera 5 2 4 3 0.0 0.0 0.0 0.0
Sexually transmissible
Chancroid 1 1 1 0 0.0 0.0 0.0 0.0
Chlamydial infection 8,445 9,242 11,339 14,082 46.1 49.9 60.5 74.2
Donovanosis 49 48 27 16 0.3 0.3 0.2 0.1
Gonococcal infection(d) 4,175 4,692 5,398 5,676 22.8 25.3 28.8 29.9
Syphilis(e) 1,510 1,355 1,677 1,979 8.2 7.3 8.9 10.4
Vaccine preventable
Haemophilus influenzae type b 49 52 34 40 0.3 0.3 0.2 0.2
Measles 481 858 290 230 2.6 4.6 1.5 1.2
Mumps 126 191 182 184 0.7 1.0 1.0 1.0
Pertussis 4,384 10,941 5,739 4,396 23.9 59.1 30.6 23.2
Rubella(f) 2,556 1,389 745 376 14.0 7.5 4.0 2.0
Tetanus 3 7 8 2 0.0 0.0 0.0 0.0
(continued)
(a) Unspecified hepatitis includes cases with hepatitis in whom the duration of illness can not be determined.
(b) Notified as ‘foodborne disease’ or ‘gastroenteritis in an institution’ in New South Wales.
(c) Infections with Shiga-like toxin (verotoxin) producing E.coli (SLTEC/VTEC).
(d) Northern Territory, Queensland, South Australia, Victoria and Western Australia: includes gonococcal neonatal 
ophthalmia.
(e) Includes congenital syphilis.
(f) Includes congenital rubella.
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Table S20 (continued): Selected notifiable diseases, 1996 to 1999
Notifications Rate per 100,000 population
Disease 1996 1997 1998 1999 1996 1997 1998 1999
Vectorborne
Arbovirus infection nec 47 21 83 62 0.3 0.1 0.4 0.3
Barmah Forest virus infection 859 696 531 639 4.7 3.8 2.8 3.4
Dengue 123 175 509 131 0.7 0.9 2.7 0.7
Malaria 866 751 647 724 4.7 4.1 3.5 3.8
Ross River virus infection 7,853 6,643 3,128 4,416 42.9 35.9 16.7 23.3
Zoonoses
Brucellosis 39 40 43 52 0.2 0.2 0.2 0.3
Hydatid infection 44 61 40 29 0.2 0.3 0.2 0.2
Leptospirosis 215 128 189 318 1.2 0.7 1.0 1.7
Ornithosis 86 35 64 84 0.6 0.2 0.4 0.9
Q fever 554 580 560 518 3.0 3.1 3.0 2.7
Other bacterial infections
Legionellosis 201 157 262 249 1.1 0.8 1.4 1.3
Leprosy 7 12 4 6 0.0 0.1 0.0 0.0
Meningococcal infection 421 484 453 568 2.3 2.6 2.4 3.0
Tuberculosis 971 1,043 972 1,153 5.3 5.6 5.2 6.1
Total 71,131 89,550 83,321 88,229
nec Not elsewhere classified.
(a) Unspecified hepatitis includes cases with hepatitis in whom the duration of illness can not be determined.
(b) Notified as ‘foodborne disease’ or ‘gastroenteritis in an institution’ in New South Wales.
(c) Infections with Shiga-like toxin (verotoxin) producing E.coli (SLTEC/VTEC).
(d) Northern Territory, Queensland, South Australia, Victoria and Western Australia: includes gonococcal neonatal 
ophthalmia.
(e) Includes congenital syphilis.
(f) Includes congenital rubella.
Note: In the period 1996–1999 there were no reported cases of the following notifiable diseases: diphtheria, plague, 
poliomyelitis, rabies, viral haemorrhagic fever, yellow fever, lymphogranuloma venereum. There was 1 case of botulism in 
1998.
Source: DHAC 2001a.
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Table S21: Characteristics of AIDS cases
Description £ 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
Total cases 3,428 791 845 955 807 664 376 308 176 207
Median age (years)
Males 37 38 37 37 37 37 39 39 39 40
Females 32 32 37 31 35 34 32 35 34 33
Per cent males 96.7 95.1 94.6 94.9 95.3 95.0 91.8 93.2 88.6 90.3
State/Territory (per cent)
NSW 60.9 54.6 57.0 57.9 58.3 54.8 52.1 54.2 58.0 49.0
Vic 20.4 21.1 21.3 19.9 20.1 20.6 20.5 19.8 15.9 26.7
Qld 8.3 11.4 10.8 10.4 12.5 11.6 16.0 12.0 17.6 16.5
WA 4.6 5.8 3.8 4.3 3.7 5.7 4.0 4.2 2.3 3.4
SA 3.8 4.2 5.3 5.2 3.7 4.7 6.1 6.2 5.1 2.4
Tas 0.5 1.3 0.1 0.5 0.2 1.1 0.5 1.0 0.0 0.5
ACT 1.2 1.0 1.1 1.5 1.1 1.3 0.0 1.6 0.0 1.0
NT 0.3 0.6 0.6 0.3 0.4 0.2 0.8 1.0 1.1 0.5
Exposure category (per cent)
Male homosexual/bisexual 
contact 86.9 82.1 81.1 83.4 81.2 80.0 74.9 67.5 63.3 68.7
Male homosexual/bisexual 
contact and ID use 3.3 5.0 7.0 5.0 5.4 5.9 3.7 3.1 6.3 4.2
ID use (female and 
heterosexual male) 2.2 2.2 3.3 3.1 3.6 3.8 5.6 8.4 6.3 7.3
Heterosexual contact 2.5 6.5 6.3 5.7 6.5 8.3 14.1 18.5 22.8 17.7
Haemophilia/coagulation 
disorder 1.7 1.7 1.3 1.1 2.0 1.1 1.1 0.3 0.6 1.6
Receipt of blood/tissue 3.1 2.0 1.0 1.0 0.8 1.0 0.3 1.4 0.6 0.5
Mother with/at risk for HIV 
infection 0.3 0.5 0.0 0.7 0.5 0.0 0.3 0.7 0.0 0.0
Other/undetermined 2.3 3.2 3.8 3.6 4.3 5.3 5.6 7.1 10.2 6.8
AIDS-defining condition (per cent)
Pneumocystis carinii 
pneumonia (PCP) 35.3 26.8 22.1 22.4 19.8 22.6 25.5 22.4 19.9 29.6
Kaposi’s sarcoma (KS) 13.9 12.2 11.1 9.8 10.9 11.7 9.3 9.7 8.0 5.8
PCP and other (not KS) 6.1 6.1 3.7 2.5 4.1 4.4 7.2 7.1 8.5 6.3
Oesophageal candidiasis 6.3 8.7 11.8 14.6 16.5 14.3 10.1 9.7 11.9 13.1
Other(a) 38.4 46.2 51.3 50.7 48.7 47.0 47.9 51.0 51.7 45.1
(a) Includes Mycobacterium avium and HIV wasting disease.
Source: NCHECR 2001.
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Cancer   
Table S22: Leading cancers(a), 1998
New cases Deaths
Cancer Number Per cent ASR(b)
Lifetime
risk(c) Number Per cent ASR(b) PYLL(d)
Males
Prostate 9,869 22.6 109.5 1 in 11 2,544 13.1 29.5 6,128
Colorectal 6,131 14.1 66.7 1 in 17 2,475 12.8 27.4 18,128
Lung 5,307 12.2 58.2 1 in 20 4,817 24.8 53.2 30,660
Melanoma 4,398 10.1 46.4 1 in 26 635 3.3 6.9 7,315
Bladder 2,068 4.7 22.9 1 in 57 564 2.9 6.4 1,985
NHL(e) 1,742 4.0 18.7 1 in 65 750 3.9 8.3 6,835
Unknown primary 1,629 3.7 18.0 1 in 71 1,198 6.2 13.3 8,075
Kidney 1,333 3.1 14.1 1 in 78 495 2.6 5.4 4,158
Stomach 1,238 2.8 13.5 1 in 91 765 3.9 8.5 5,235
Pancreas 860 2.0 9.4 1 in 130 814 4.2 8.9 6,333
All cancers 43,595 100.0 474.6 1 in 3 19,400 100.0 215.3 141,030
Females
Breast 10,665 28.6 101.3 1 in 11 2,526 17.0 22.8 29,255
Colorectal 5,158 13.8 46.3 1 in 26 2,159 14.5 18.5 13,310
Melanoma 3,493 9.4 34.1 1 in 36 344 2.3 3.0 3,740
Lung 2,488 6.7 23.0 1 in 47 2,076 14.0 18.8 14,458
Unknown primary 1,538 4.1 13.1 1 in 105 1,102 7.4 9.2 6,038
NHL(e) 1,466 3.9 13.4 1 in 90 759 5.1 6.6 5,020
Uterus 1,399 3.8 13.2 1 in 78 246 1.7 2.1 1,130
Ovary 1,216 3.3 11.5 1 in 99 769 5.2 6.9 6,548
Pancreas 869 2.3 7.5 1 in 175 805 5.4 6.9 4,058
Cervix 868 2.3 8.6 1 in 143 264 1.8 2.4 3,795
All cancers 37,269 100.0 346.5 1 in 4 14,870 100.0 130.1 119,010
(a) Rankings are based on the number of new cases; excludes non-melanocytic skin cancers.
(b) Age-standardised rate. Per 100,000 population, age-standardised to the Australian population at 30 June 1991.
(c) Lifetime risk—a measure which approximates the risk of contracting a particular cancer in a lifetime if the risks at the 
year of estimation remained throughout a person’s life. For the purposes of this table, ‘lifetime’ is defined as ages 0–74.
(d) Potential years of life lost between the ages of 0 and 74 years.
(e) Non-Hodgkin’s lymphoma.
Sources: AIHW & AACR 2001; AIHW National Mortality Database.
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Table S23: Major cancers, age-standardised incidence rates(a), 1990 to 1998 
(per 100,000 population)
Cancer 1990 1991 1992 1993 1994 1995 1996 1997 1998
Males
Prostate 85.3 92.4 104.2 140.9 158.3 144.0 117.4 110.9 109.5
Colorectal 64.3 67.4 66.0 66.3 67.4 68.1 69.2 68.4 66.7
Lung 68.5 66.0 64.9 62.7 64.8 60.6 60.1 59.8 58.2
Melanoma 39.0 39.1 42.4 43.8 43.7 46.4 48.0 50.1 46.4
Bladder 21.9 20.5 22.1 22.4 23.9 23.7 22.4 22.6 22.9
NHL(b) 17.3 18.2 19.0 18.7 17.7 17.6 19.4 18.6 18.7
Stomach 16.4 15.3 15.2 15.3 14.7 15.1 13.8 13.4 13.5
Kidney 12.0 13.3 13.0 12.8 13.1 13.7 13.7 13.5 14.1
Pancreas 10.0 9.6 9.7 9.5 10.2 9.3 9.4 9.2 9.4
Testis 4.8 5.2 5.6 5.5 6.0 5.7 6.0 6.2 6.1
All cancers 448.4 457.9 476.5 507.5 530.6 510.4 489.1 482.7 474.6
Females
Breast 83.2 88.2 85.7 92.7 100.3 101.1 95.5 97.9 101.3
Colorectal 44.5 47.2 47.3 46.0 47.5 46.1 46.0 46.6 46.3
Melanoma 30.5 30.7 32.5 32.7 32.6 34.4 35.0 37.0 34.1
Lung 21.0 21.5 21.3 22.4 22.5 22.7 23.0 23.5 23.0
NHL(b) 11.1 12.2 12.6 12.3 12.7 13.4 13.3 13.5 13.4
Uterus 12.0 12.6 13.2 13.1 13.9 13.6 12.9 13.5 13.2
Cervix 12.3 12.4 11.2 11.0 11.9 9.9 9.4 8.0 8.6
Kidney 6.8 7.4 8.1 7.4 7.2 7.3 7.6 7.7 8.0
Pancreas 6.8 7.1 7.3 7.2 7.0 7.2 7.2 7.4 7.5
Stomach 6.5 6.8 6.4 6.1 5.9 6.4 6.0 6.5 5.8
Bladder 5.9 5.3 5.3 5.9 6.1 6.1 5.7 6.2 6.5
All cancer 314.2 327.0 327.9 332.2 342.1 345.7 338.8 344.2 346.5
(a) Age-standardised to the Australian population at 30 June 1991.
(b) Non-Hodgkin’s lymphoma.
Source: AIHW & AACR 2001.
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Table S24: Major cancers, average annual age-standardised incidence rates(a), States and 
Territories 1994-1998 and Australia 1998 (per 100,000 population)
Cancer NSW Vic Qld WA SA Tas ACT NT Aust(b)
Males
Prostate 130.1 124.3 115.3 132.6 144.7 147.5 169.6 84.0 109.5
Colorectal 67.0 70.2 69.2 65.0 68.2 65.1 63.0 54.4 66.7
Lung 59.6 60.8 63.0 62.1 60.9 68.0 41.6 79.5 58.2
Melanoma 47.3 35.0 68.0 49.1 40.3 37.1 43.7 29.4 46.4
Bladder 18.5 30.2 29.9 14.3 16.4 28.7 18.7 12.5 22.9
NHL(c) 18.8 19.5 17.6 16.6 18.3 17.7 18.8 12.4 18.7
Stomach 13.8 15.3 13.3 13.8 13.7 14.7 12.7 11.4 13.5
Kidney 13.9 13.4 14.9 9.8 14.6 15.0 12.6 11.8 14.1
Pancreas 9.4 9.9 9.7 9.4 9.3 9.7 9.2 6.8 9.4
Testis 6.1 5.9 5.9 5.5 6.5 6.3 7.5 3.5 6.1
Females
Breast 100.0 100.9 96.7 100.2 100.5 94.9 104.0 71.5 101.3
Colorectal 45.0 47.2 49.4 43.6 48.1 51.3 41.9 42.0 46.3
Melanoma 31.2 30.4 48.3 35.3 34.7 34.0 30.1 17.8 34.1
Lung 22.8 23.4 22.1 24.5 21.8 25.8 25.2 42.5 23.0
NHL(c) 13.3 13.8 12.3 11.9 15.1 14.5 15.9 10.2 13.4
Uterus 12.2 15.2 13.6 11.4 15.1 12.5 14.4 9.7 13.2
Cervix 9.5 9.5 10.3 10.2 7.1 11.0 8.5 18.0 8.6
Kidney 8.2 7.1 8.6 6.0 6.9 6.9 6.3 6.2 8.0
Pancreas 7.3 7.2 7.0 7.6 7.6 8.5 7.3 9.4 7.5
Stomach 5.8 6.7 5.7 6.5 6.0 6.6 6.9 4.5 5.8
Bladder 5.2 7.5 8.4 3.4 4.2 6.9 3.6 2.8 6.5
(a) Age-standardised to the Australian population at 30 June 1991.
(b) State and Territory averages for 1994–1998 do not equate to a single-year average for Australia.
(c) Non-Hodgkin’s lymphoma.
Source: AIHW & AACR 2001.
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Table S25: Major cancers, age-standardised incidence rates(a), selected countries 1988Ð1992 and 
Australia 1992 and 1998 (per 100,000 population)
Males Colorectal Lung Melanoma Prostate Stomach All cancers(b)
Australia 1992 46.6 44.3 32.4 63.4 10.4 327.2
Australia 1998 47.5 40.3 36.1 73.6 9.4 340.9
Canada 43.0 65.4 7.7 64.7 10.6 322.1
England and Wales(c) 33.9 62.4 4.6 28.0 16.1 261.1
Italy (Venice) 35.4 81.9 6.1 26.8 19.9 355.9
Japan (Osaka) 34.2 43.5 0.2 6.8 65.0 272.8
Netherlands 36.4 73.0 6.9 39.6 15.4 288.4
New Zealand (non-Maori) 51.3 46.5 25.0 37.8 11.0 290.3
United States (black) 46.4 99.1 0.7 137.0 14.5 454.5
United States (white) 42.4 61.3 13.1 100.8 7.5 370.9
Females Colorectal Lung Melanoma Breast Stomach All cancers(b)
Australia 1992 32.6 15.0 26.3 69.4 4.1 247.2
Australia 1998 33.2 16.7 28.0 83.2 3.9 268.7
Canada 30.5 28.0 6.9 76.8 4.5 252.8
England and Wales(c) 23.7 22.8 6.6 68.8 6.3 225.5
Italy (Venice) 24.3 13.9 7.0 72.6 8.8 230.6
Japan (Osaka) 19.9 12.4 0.2 24.3 27.3 154.8
Netherlands 27.8 13.0 9.8 79.6 6.1 225.0
New Zealand (non-Maori) 40.8 18.2 29.8 77.2 4.8 274.6
United States (black) 35.3 38.5 0.5 79.3 5.9 271.6
United States (white) 29.5 33.8 10.2 90.7 3.1 280.9
(a) Age-standardised to the World Standard Population.
(b) Excludes non-melanocytic skin cancer.
(c) 1988–1990.
Sources: Parkin et al. 1997; AIHW & AACR 2001.
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Table S26: Primary teeth with caries experience(a), 5- to 10-year-old school children, 
1991 to 1998 (mean number of teeth)
Age (years)
5 6 7 8 9 10
1991 1.78 1.94 2.13 2.24 2.22 1.81
1992 1.80 1.95 1.93 2.21 2.11 1.74
1993 1.76 1.90 2.01 2.15 2.13 1.73
1994 1.56 1.79 1.95 2.13 2.01 1.71
1995 1.49 1.73 1.87 2.05 1.97 1.61
1996 1.26 1.45 1.66 1.68 1.72 1.47
1997 1.28 1.50 1.63 1.78 1.75 1.47
1998 1.37 1.51 1.62 1.81 1.70 1.40
(a) As measured by dmft index (number of decayed, missing and filled primary teeth).
Source: AIHW Dental Statistics and Research Unit Child Dental Health Survey.
Table S27: Permanent teeth with caries experience(a), 6- to 12-year-old school children, 1991 to 
1998 (mean number of teeth)
Age (years)
6 7 8 9 10 11 12
1991 0.09 0.24 0.40 0.56 0.83 0.91 1.29
1992 0.09 0.21 0.38 0.53 0.69 0.90 1.22
1993 0.08 0.22 0.36 0.51 0.66 0.90 1.10
1994 0.11 0.23 0.37 0.47 0.65 0.88 1.09
1995 0.10 0.20 0.36 0.46 0.57 0.79 1.01
1996 0.07 0.18 0.30 0.38 0.49 0.66 0.90
1997 0.07 0.17 0.30 0.42 0.52 0.65 0.86
1998 0.07 0.21 0.32 0.41 0.58 0.64 0.83
(a) As measured by DMFT index (number of decayed, missing and filled permanent teeth).
Source: AIHW Dental Statistics and Research Unit Child Dental Health Survey.
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Table S28: Dental caries experience(a) of 6-year-old and 12-year-old school children, States and 
Territories, 1991 to 1998 (mean number of teeth)
NSW Vic Qld WA SA Tas ACT NT Aust
6-year-olds (dmft)
1991 2.05 2.04 2.48 1.29 1.98 1.57 1.14 1.96 1.94
1992 2.00 2.05 2.37 1.32 1.53 1.48 1.09 1.99 1.95
1993 2.04 1.81 2.18 1.48 1.38 1.35 1.33 1.81 1.90
1994 1.93 1.67 2.27 1.37 1.17 (b) 1.17 1.99 1.79
1995 1.75 1.78 1.99 1.39 1.47 1.48 1.39 1.99 1.73
1996 0.94 1.61 2.25 1.30 1.17 1.37 0.89 1.79 1.45
1997 0.97 1.92 1.97 1.45 1.39 1.45 1.05 1.81 1.50
1998 0.90 2.08 2.04 1.43 1.24 1.40 1.40 2.00 1.51
12-year-olds (DMFT)
1991 1.18 1.38 1.54 1.43 1.06 1.18 0.91 1.26 1.29
1992 1.19 1.77 1.50 1.22 1.04 0.98 0.76 0.91 1.22
1993 1.04 1.52 1.44 1.20 0.64 0.96 0.77 0.85 1.10
1994 1.11 1.28 1.37 1.07 0.59 (b) 0.69 0.81 1.09
1995 0.93 1.02 1.37 1.04 0.64 0.86 0.61 0.82 1.01
1996 0.64 1.09 1.30 0.99 0.47 0.96 0.56 0.71 0.90
1997 0.64 1.04 1.14 0.87 0.58 0.97 0.82 0.78 0.86
1998 0.49 1.15 1.22 0.77 0.52 1.39 0.68 0.79 0.83
(a) As measured by dmft or DMFT index (number of decayed, missing and filled primary or permanent teeth).
(b) Data not available for Tasmania in 1994.
Source: AIHW Dental Statistics and Research Unit unpublished data.
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Cardiovascular risk factors
Table S29: Cardiovascular disease risk factors by age, 1999 to 2001 (per cent)
Age group
Risk factor Sex 18–24 25–34 35–44 45–54 55–64 65–74 75+ 25+ (a)
Diabetes type 2 Male n.a. * 2.7 7.0 14.6 19.5 24.1 7.8
Female n.a. * 2.3 5.5 9.4 15.5 22.4 6.2
High blood cholesterol(b) Male n.a. 31.0 54.2 60.7 61.8 54.1 49.2 49.9
Female n.a. 30.1 39.8 54.7 71.6 74.0 65.2 49.7
High blood pressure(c) Male n.a. 7.9 16.2 30.5 46.5 69.7 75.1 30.7
Female n.a. 4.1 7.9 22.8 42.3 66.7 77.2 25.6
Overweight(d) Male n.a. 60.2 65.5 72.5 74.0 73.7 64.3 67.3
Female n.a. 35.8 45.6 58.1 67.2 70.7 56.4 51.7
Smoking(e) Male 24.5 29.0 26.7 22.0 15.2 11.0 4.8 22.0 (f)
Female 23.7 23.8 23.8 17.5 13.5 6.6 4.4 18.4 (f)
Physical inactivity(g) Male 18.1 46.7 44.5 47.6 50.1 45.8 (h) n.a 42.0 (i)
Female 32.4 40.1 46.3 52.0 46.9 46.1 (h) n.a 43.5 (i)
n.a. Not available.
* Not included as the relative standard error is greater than 50%.
(a) Age-standardised to the Australian population at 30 June 1991.
(b) High blood cholesterol is defined as above 5.5 mmol/L.
(c) High blood pressure is defined as systolic blood pressure ‡  140 mmHg and/or diastolic blood pressure ‡  90 mmHg 
and/or receiving treatment for high blood pressure.
(d) Overweight is defined as body mass index (BMI) ‡  25.
(e) The daily smoking of tobacco products, including packet cigarettes, roll-your-own cigarettes, pipes and cigars.
(f) Data for ages 18 and over.
(g) Physical inactivity is defined as less than 150 minutes of physical activity for recreation or exercise (including walking 
for transport) in the previous week.
(h) Data for ages 65–75.
(i) Data for ages 18–75.
Sources: AIHW analysis of 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab); 2000 National Physical 
Activity Survey; 2001 National Drug Strategy Household Survey.
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Use of hospitals
Table S30: Separations from public hospitals, States and Territories, 1999Ð00
Age group NSW Vic Qld WA SA Tas ACT NT Total
Males
Under 1 23,656 17,115 11,206 5,343 6,136 1,200 1,122 1,563 67,341
1–4 31,021 19,578 16,820 9,076 7,802 1,585 1,437 1,567 88,886
5–14 35,545 23,127 21,461 10,413 8,435 1,835 1,496 1,450 103,762
15–24 40,179 28,497 27,728 11,513 10,365 2,406 1,982 1,757 124,427
25–34 47,889 40,726 32,962 18,282 14,736 3,440 2,833 3,275 164,143
35–44 56,421 48,700 38,674 20,640 16,831 3,993 3,734 4,771 193,764
45–54 66,539 55,973 43,613 21,336 21,312 4,240 4,417 5,212 222,642
55–64 76,656 68,823 49,969 23,576 22,303 5,160 4,947 2,746 254,180
65–74 104,986 94,183 56,087 28,205 30,012 6,563 5,280 2,775 328,091
75+ 99,357 73,623 39,379 22,368 29,953 5,880 3,005 869 274,434
Total 582,249 470,346 337,899 170,752 167,885 36,302 30,253 25,987 1,821,673
Females
Under 1 16,980 12,093 8,287 3,899 4,453 938 868 1,346 48,864
1–4 21,414 13,003 11,952 6,059 5,427 1,153 836 1,173 61,017
5–14 24,231 16,772 15,169 7,892 6,579 1,381 1,248 1,066 74,338
15–24 65,860 49,737 45,257 20,350 21,216 4,570 3,182 4,525 214,697
25–34 115,309 98,429 66,180 32,862 34,872 6,628 5,528 6,290 366,098
35–44 75,317 67,160 47,069 25,030 24,052 5,040 4,158 5,232 253,058
45–54 61,727 58,841 42,429 22,144 20,179 4,570 3,857 5,516 219,263
55–64 67,488 58,283 40,027 20,376 19,399 4,258 4,006 4,398 218,235
65–74 89,991 71,206 44,999 23,074 24,619 4,750 4,013 1,420 264,072
75+ 125,246 87,725 48,646 27,956 31,339 6,350 3,324 865 331,451
Total 663,564 533,250 370,015 189,642 192,135 39,638 31020 31,832 2,051,096
Total 
separations 1,245,814 1,003,609 707,914 360,394 360,020 75,951 61,273 57,840 3,872,815
Note: Totals include separations for which age and/or sex was not reported.
Source: AIHW National Hospital Morbidity Database.
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Table S31: Separations from private hospitals, States and Territories, 1999-00
Age group NSW Vic Qld WA SA Tas ACT NT Total
Males
Under 1 4,436 3,355 2,487 1,959 511 635 571 n.a. 13,954
1–4 5,052 3,257 4,194 2,581 1,337 543 330 n.a. 17,294
5–14 7,477 5,530 5,475 3,441 1,689 849 389 n.a. 24,850
15–24 15,078 13,889 10,506 7,231 4,486 1,193 739 n.a. 53,122
25–34 19,090 16,352 12,205 8,076 5,024 1,494 590 n.a. 62,831
35–44 27,996 23,921 19,197 10,818 6,897 2,347 937 n.a. 92,113
45–54 41,278 33,447 32,524 14,340 11,405 3,123 1,524 n.a. 137,641
55–64 46,895 36,400 33,671 14,838 11,532 3,183 1,700 n.a. 148,219
65–74 51,799 43,754 39,785 15,628 14,081 3,879 1,897 n.a. 170,823
75+ 54,677 47,236 49,469 16,943 13,215 4,381 1,831 n.a. 187,752
Total 273,778 227,141 209,513 95,855 70,177 21,627 10,508 n.a. 908,599
Females
Under 1 2,861 2,238 1,576 1,378 312 486 467 n.a. 9,318
1–4 3,147 2,185 2,943 1,803 951 324 187 n.a. 11,540
5–14 6,439 4,709 4,381 3,027 1,489 693 276 n.a. 21,014
15–24 23,410 17,667 12,956 11,395 4,919 2,252 860 n.a. 73,459
25–34 49,786 42,137 32,597 19,998 9,730 4,830 1,971 n.a. 161,049
35–44 47,458 42,953 33,172 17,723 10,573 4,238 2,131 n.a. 158,248
45–54 49,218 44,574 37,194 18,493 14,666 4,487 2,203 n.a. 170,835
55–64 44,238 37,555 34,509 15,361 12,784 3,725 1,649 n.a. 149,821
65–74 48,242 44,178 38,926 13,878 13,700 3,716 1,253 n.a. 163,893
75+ 55,695 54,492 44,643 16,183 20,493 5,110 1,576 n.a. 198,192
Total 330,498 292,688 242,897 119,239 89,617 29,861 12,573 n.a. 1,117,373
Total separations 604,276 519,838 452,410 215,095 159,794 51,495 23,081 n.a. 2,025,989
n.a. Not available.
Note: Totals include separations for which age and/or sex was not reported.
Source: AIHW National Hospital Morbidity Database.
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Table S32: Patient-days in public hospitals, States and Territories, 1999Ð00
Age 
group NSW Vic Qld WA SA Tas ACT NT Total
Males
Under 1 111,416 82,663 63,041 28,829 31,286 7,527 7,283 9,874 341,919
1–4 59,287 36,219 30,040 18,128 13,841 2,710 2,365 5,827 168,417
5–14 73,696 45,731 42,282 22,988 16,663 3,780 2,930 5,364 213,434
15–24 172,386 94,710 118,219 41,999 38,864 8,095 7,927 7,162 489,362
25–34 213,195 126,864 141,899 61,545 56,207 10,565 8,889 11,654 630,818
35–44 230,010 146,214 168,663 64,119 53,024 12,183 11,227 14,215 699,655
45–54 292,524 168,742 149,516 66,279 63,893 14,924 12,394 12,327 780,599
55–64 333,102 222,592 224,134 76,729 78,136 21,475 15,626 11,500 983,294
65–74 548,798 364,225 271,747 110,865 137,342 32,411 20,556 9,812 1,495,756
75+ 707,178 467,951 297,330 135,109 213,278 46,251 16,588 4,922 1,888,607
Total 2,741,592 1,756,007 1,506,871 626,590 702,534 159,921 105,785 92,660 7,691,960
Females
Under 1 89,149 64,049 50,032 22,824 23,746 6,902 5,120 10,309 272,131
1–4 43,669 24,061 21,187 12,369 10,900 2,038 1,720 6,415 122,359
5–14 55,955 36,694 32,905 18,853 13,839 2,741 2,453 4,399 167,839
15–24 188,427 129,766 121,372 63,437 54,507 12,923 9,868 14,201 594,501
25–34 349,475 264,317 205,027 98,544 94,965 19,538 19,063 19,138 1,070,067
35–44 276,946 183,237 125,970 72,807 67,386 15,959 13,135 14,023 769,463
45–54 227,635 167,660 150,238 63,875 57,194 14,012 13,751 11,451 705,816
55–64 262,029 180,021 139,111 66,911 64,934 17,191 12,619 11,247 754,063
65–74 450,864 306,213 209,872 87,009 115,130 26,371 15,333 4,889 1,215,681
75+ 1,083,475 716,955 478,056 217,115 273,752 78,761 24,457 5,839 2,878,410
Total 3,027,625 2,073,679 1,533,770 723,744 776,353 196,436 117,519 101,915 8,551,041
Total 
patient- 
days 5,769,219 3,829,729 3,040,641 1,350,334 1,478,887 356,373 223,304 194,628 16,243,115
Note: Totals include separations for which age and/or sex was not reported.
Source: AIHW National Hospital Morbidity Database.
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Table S33: Patient-days in private hospitals, States and Territories, 1999Ð00
Age 
group NSW Vic Qld WA SA Tas ACT NT Total
Males
Under 1 19,337 13,673 12,311 7,830 2,208 2,670 2,562 n.a. 60,591
1–4 6,277 3,684 5,431 3,384 1,420 671 427 n.a. 21,294
5–14 12,661 7,448 7,900 4,439 2,040 1,159 558 n.a. 36,205
15–24 24,840 29,094 16,956 13,104 8,363 2,239 1,263 n.a. 95,859
25–34 34,303 36,947 21,113 14,069 9,480 2,964 1,261 n.a. 120,137
35–44 51,846 46,838 36,700 19,124 13,989 4,817 2,305 n.a. 175,619
45–54 90,372 70,130 73,323 30,274 25,404 7,581 5,522 n.a. 302,606
55–64 108,913 91,349 84,494 35,495 29,778 8,220 5,156 n.a. 363,405
65–74 149,485 136,166 126,120 53,677 46,773 14,523 7,571 n.a. 534,315
75+ 243,069 235,181 267,289 96,958 62,742 24,197 10,142 n.a. 939,578
Total 741,103 670,510 651,637 278,354 202,197 69,041 36,767 n.a. 2,649,609
Females
Under 1 16,083 10,579 9,846 6,262 2,045 1,868 2,238 n.a. 48,921
1–4 4,224 2,563 4,221 2,434 997 406 238 n.a. 15,083
5–14 11,204 6,536 6,374 4,117 1,937 940 345 n.a. 31,453
15–24 43,972 35,664 27,012 21,348 10,229 5,081 2,328 n.a. 145,634
25–34 136,698 120,400 91,348 60,901 30,638 13,827 7,782 n.a. 461,594
35–44 110,677 107,233 78,100 48,353 29,554 11,137 7,551 n.a. 392,605
45–54 111,628 106,119 87,266 45,105 36,242 11,986 6,550 n.a. 404,896
55–64 110,422 97,214 84,615 40,430 37,019 10,916 5,210 n.a. 385,826
65–74 155,323 151,627 135,493 51,393 49,713 16,044 6,252 n.a. 565,845
75+ 303,741 336,862 334,529 106,653 132,275 33,454 11,915 n.a. 1,259,429
Total 1,003,976 974,797 858,804 386,996 330,649 105,659 50,409 n.a. 3,711,290
Total 
patient- 
days 1,745,079 1,645,396 1,510,441 665,353 532,846 174,708 87,176 n.a. 6,360,999
n.a. Not available.
Note: Totals include separations for which age and/or sex was not reported.
Source: AIHW National Hospital Morbidity Database.
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Table S34: Separations, same-day separations, patient-days and average length of stay by 
principal diagnosis, grouped into ICD-10-AM chapters, public hospitals, 1999Ð00
Principal diagnosis Separations
Per cent
same-day
separations
Patient-
days
ALOS
(days)
ALOS
(days)
excluding
same-day
A00–B99 Infectious and parasitic 72,863 22.2 268,523 3.7 4.5
C00–D48 Neoplasms 240,852 44.5 1,191,798 4.9 8.1
D50–D89 Blood, blood forming organs, 
immunological 48,663 62.7 121,284 2.5 5.0
E00–E90 Endocrine, nutritional, metabolic 49,030 28.7 268,886 5.5 7.3
F00–F99 Mental disorders 160,475 25.3 2,386,714 14.9 19.6
G00–G99 Nervous system diseases 81,068 35.9 448,728 5.5 8.1
H00–H59 Eye diseases 60,692 74.4 84,714 1.4 2.5
H60–H95 Ear diseases 32,951 61.9 51,612 1.6 2.5
I00–I99 Circulatory diseases 296,513 18.8 1,696,889 5.7 6.8
J00–J99 Respiratory diseases 251,160 13.5 1,100,123 4.4 4.9
K00–K93 Digestive diseases 352,973 47.4 998,143 2.8 4.5
L00–L99 Skin diseases 73,253 37.2 334,030 4.6 6.7
M00–M99 Musculoskeletal diseases 145,784 40.2 602,220 4.1 6.2
N00–N99 Genitourinary diseases 208,758 48.3 577,382 2.8 4.4
O00–O99 Pregnancy, childbirth, 
puerperium 324,839 22.6 955,616 2.9 3.5
P00–P96 Perinatal diseases 39,718 7.3 368,633 9.3 9.9
Q00–Q99 Congenital anomalies 24,161 46.8 90,462 3.7 6.2
R00–R99 Symptoms, signs, abnormal 
findings 229,808 39.8 604,053 2.6 3.7
S00–T98 Injuries and poisoning 333,258 30.3 1,336,980 4.0 5.3
Z00–Z99 Factors influencing health status 
and contact with health services 844,156 87.5 2,733,863 3.2 18.9
Not reported 1,840 56.6 22,462 12.2 26.8
Total 3,872,815 45.6 16,243,115 4.2 6.9
ALOS = average length of stay.
Source: AIHW National Hospital Morbidity Database.
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Table S35: Separations, same-day separations, patient-days and average length of stay by 
principal diagnosis, grouped into ICD-10-AM chapters, private hospitals, 1999Ð00
Principal diagnosis Separations
Per cent
same-day
separations
Patient-
days
ALOS
(days)
ALOS
(days)
excluding
same-day
A00–B99 Infectious and parasitic 13,815 29.6 59,076 4.3 5.7
C00–D48 Neoplasms 182,246 55.0 657,459 3.6 6.8
D50–D89 Blood, blood forming organs, 
immunological 15,414 60.9 37,828 2.5 4.7
E00–E90 Endocrine, nutritional, metabolic 14,555 26.0 71,642 4.9 6.3
F00–F99 Mental disorders 84,242 63.5 555,845 6.6 16.3
G00–G99 Nervous system diseases 45,976 31.2 149,177 3.2 4.3
H00–H59 Eye diseases 107,427 78.2 116,944 1.1 1.4
H60–H95 Ear diseases 22,850 73.7 29,791 1.3 2.2
I00–I99 Circulatory diseases 134,391 25.5 659,296 4.9 6.2
J00–J99 Respiratory diseases 74,704 12.5 346,810 4.6 5.2
K00–K93 Digestive diseases 347,048 72.0 622,087 1.8 3.8
L00–L99 Skin diseases 32,191 57.9 119,691 3.7 7.5
M00–M99 Musculoskeletal diseases 184,638 40.5 656,433 3.6 5.3
N00–N99 Genitourinary diseases 146,105 57.4 333,905 2.3 4.0
O00–O99 Pregnancy, childbirth, 
puerperium 102,494 28.5 400,578 3.9 5.1
P00–P96 Perinatal diseases 9,949 5.5 71,598 7.2 7.6
Q00–Q99 Congenital anomalies 9,629 51.1 20,456 2.1 3.3
R00–R99 Symptoms, signs, abnormal 
findings 92,862 56.7 221,950 2.4 4.2
S00–T98 Injuries and poisoning 81,447 23.9 405,506 5.0 6.2
Z00–Z99 Factors influencing health status 
and contact with health services 320,738 84.6 814,235 2.5 11.0
Not reported 3,268 66.8 10,692 3.3 7.8
Total 2,025,989 56.1 6,360,999 3.1 5.9
ALOS = average length of stay.
Source: AIHW National Hospital Morbidity Database.
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Table S36: Separations, same-day separations, patient-days and average length of stay by 
procedure, grouped into ICD-10-AM chapters, public hospitals, 1999Ð00
Procedure Separations
Per cent
same-day
separations
Patient-
days
ALOS
(days)
ALOS
(days)
excluding
same-day
1–86 Operations on the nervous 
system 77,452 31.2 554,140 7.2 9.9
110–129 Operations on the endocrine 
system 5,939 2.8 29,386 4.9 5.1
160–256 Operations on the eye 61,366 74.4 102,849 1.7 3.6
300–333 Operations on the ear 30,148 66.9 52,134 1.7 3.2
370–422 Operations on the nose, mouth 
and pharynx 52,475 27.0 105,555 2.0 2.4
450–490 Dental services 29,454 83.3 217,219 7.4 39.1
520–569 Operations on the respiratory 
system 58,671 22.7 126,416 2.2 16.7
600–767 Operations on the 
cardiovascular system 142,670 22.7 1,235,790 8.7 10.9
800–817 Operations on the blood and 
blood-forming organs 24,846 31.0 204,310 8.2 11.5
850–1011 Operations on the digestive 
system 378,433 53.5 1,544,670 4.1 7.6
1040–1128 Operations on the urinary 
system 584,819 88.2 1,100,135 1.9 8.5
1160–1203 Operations on the male genital 
organs 41,535 54.2 118,802 2.9 5.1
1230–1299 Gynaecological procedures 171,662 65.1 342,954 2.0 3.9
1330–1347 Obstetric procedures 174,490 5.8 676,694 3.9 4.1
1360–1579 Operations on the 
musculoskeletal system 206,070 30.4 1,082,831 5.3 7.1
1600–1718 Dermatological and plastic 
procedures 164,924 47.5 901,242 5.5 9.5
1740–1759 Operations on the breast 20,397 44.9 57,247 2.8 4.3
1780–1799 Chemotherapeutic and 
radiation oncology procedures 144,631 81.1 360,412 2.5 8.9
1820–1899 Miscellaneous procedures 368,259 40.1 2,499,363 6.8 10.7
1940–2016 Imaging services 268,101 12.9 2,699,609 10.1 11.4
2050–2140 Allied health interventions 638,776 4.1 7,439,380 11.6 12.1
No procedure or not reported 1,052,862 29.8 4,341,519 4.1 5.4
Total 3,872,815 45.6 16,243,115 4.2 6.9
ALOS = average length of stay.
Note: As more than one procedure can be reported for each separation, the totals are not the sums of the rows of the table.
Source: AIHW National Hospital Morbidity Database.
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Table S37: Separations, same-day separations, patient-days and average length of stay by 
procedure, grouped into ICD-10-AM chapters, private hospitals, 1999Ð00
Procedure Separations
Per cent
same-day
separations
Patient-
days
ALOS
(days)
ALOS
(days)
excluding
same-day
1–86 Operations on the nervous 
system 68,194 42.0 342,373 5.0 7.9
110–129 Operations on the endocrine 
system 3,991 1.6 14,448 3.6 3.7
160–256 Operations on the eye 105,967 78.2 118,706 1.1 1.6
300–333 Operations on the ear 24,567 71.8 30,313 1.2 1.8
370–422 Operations on the nose, 
mouth and pharynx 47,812 29.6 66,961 1.4 1.6
450–490 Dental services 60,974 87.0 65,259 1.1 1.5
520–569 Operations on the respiratory 
system 16,553 33.3 148,584 9.0 13.0
600–767 Operations on the 
cardiovascular system 86,745 22.5 473,828 5.5 6.8
800–817 Operations on the blood and 
blood-forming organs 12,514 29.2 73,301 5.9 7.9
850–1011 Operations on the digestive 
system 432,460 75.0 925,949 2.1 5.6
1040–1128 Operations on the urinary 
system 146,613 71.7 364,853 2.5 6.3
1160–1203 Operations on the male genital 
organs 36,354 45.9 108,576 3.0 4.7
1230–1299 Gynaecological procedures 133,896 71.4 265,512 2.0 4.4
1330–1347 Obstetric procedures 59,577 2.9 328,293 5.5 5.6
1360–1579 Operations on the 
musculoskeletal system 204,463 40.0 736,555 3.6 5.3
1600–1718 Dermatological and plastic 
procedures 127,598 63.3 322,221 2.5 5.2
1740–1759 Operations on the breast 24,724 39.7 58,007 2.3 3.2
1780–1799 Chemotherapeutic and 
radiation oncology procedures 104,290 88.6 176,338 1.7 7.1
1820–1899 Miscellaneous procedures 157,428 42.5 881,564 5.6 9.0
1940–2016 Imaging services 79,184 13.4 717,547 9.1 10.3
2050–2140 Allied health interventions 230,810 14.5 2,344,822 10.2 11.7
No procedure or not reported 231,686 26.2 1,091,849 4.7 6.0
Total 2,025,989 56.1 6,360,999 3.1 5.9
ALOS = average length of stay.
Note: As more than one procedure can be reported for each separation, the totals are not the sums of the rows of the table.
Source: AIHW National Hospital Morbidity Database.
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Table S38: Separations(a), same-day separations, patient-days, average length of stay and cost 
by Major Diagnostic Category, public hospitals, 1999Ð00
Major Diagnostic Category(b) Separations
Per cent
same-day
separations
Patient-
days
ALOS
(days)
ALOS
(days)
excluding
same-day
Estimated
cost
($’000)(c)
01 Nervous system 183,544 30.4 1,127,585 6.1 8.4 660,481
02 Eye diseases, disorders 70,837 72.0 105,739 1.5 2.8 134,937
03 Ear, nose, mouth, throat 169,482 45.2 285,162 1.7 2.2 272,287
04 Respiratory system 229,017 13.8 1,151,221 5.0 5.7 738,691
05 Circulatory system 315,510 21.3 1,379,382 4.4 5.3 1,224,173
06 Digestive system 407,032 47.8 1,086,870 2.7 4.2 851,018
07 Hepatobiliary, pancreas 72,423 17.6 307,135 4.2 4.9 264,904
08 Musculoskeletal system 
and connective tissue 294,422 34.9 1,240,296 4.2 5.9 1,106,118
09 Skin, subcutaneous 
tissue and breast 155,107 50.8 467,725 3.0 5.1 333,569
10 Endocrine, nutritional and 
metabolic 43,467 21.5 203,260 4.7 5.7 142,172
11 Kidney and urinary tract 591,462 87.3 882,396 1.5 4.9 516,836
12 Male reproductive 46,103 54.4 111,027 2.4 4.1 92,101
13 Female reproductive 135,633 62.2 276,709 2.0 3.8 254,985
14 Pregnancy, childbirth and 
puerperium 336,929 23.4 981,946 2.9 3.5 732,512
15 Newborns, neonates 51,217 9.4 417,561 8.2 8.9 301,924
16 Blood, blood-forming 
organs, immunological 55,800 62.9 132,078 2.4 4.8 96,816
17 Neoplastic disorders 164,880 87.5 301,239 1.8 7.6 217,810
18 Infectious and parasitic 
diseases 46,463 18.3 222,907 4.8 5.6 159,706
19 Mental diseases and 
disorders 124,234 27.1 1,301,406 10.5 14.0 444,293
20 Alcohol/drug use and 
disorders 26,902 21.8 113,901 4.2 5.1 51,630
21 Injury, poison, toxic 
effects of drugs 106,958 36.9 302,401 2.8 3.9 268,368
22 Burns 6,108 24.6 38,330 6.3 8.0 38,880
23 Factors influencing health 
status, other contacts 96,349 71.1 269,702 2.8 7.2 144,215
ED Edit DRG(d) 11,791 30.4 102,391 8.7 12.0 79,835
PR Pre-MDC(d) 9,226 2.7 265,230 28.7 29.5 440,491
Total 3,750,896 46.2 13,073,599 3.5 5.6 9,568,752
(a) Separations for acute and unspecified episodes of care only.
(b) Major Diagnostic Categories are groupings of AR-DRGs within the AR-DRG (casemix) classification.
(c) The estimated total hospital cost is the sum of the estimated costs for each AR-DRG within the Major Diagnostic 
Category, calculated using the estimated average cost for each AR-DRG in public hospitals in 1999–00.
(d) ‘Pre-MDC’ is a group of particularly resource-intensive AR-DRGs such as transplants. Separations in the ‘Edit DRG’ 
grouping did not have a valid AR-DRG.
Note: Abbreviations: ALOS = average length of stay; MDC = Major Diagnostic Category; DRG = diagnosis-related group.
Source: AIHW National Hospital Morbidity Database.
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Table S39: Separations(a), same-day separations, patient-days, average length of stay and cost, 
by Major Diagnostic Category, private hospitals, 1999Ð00
Major Diagnostic Category(b) Separations
Per cent
same-day
separations
Patient-
days
ALOS
(days)
ALOS
(days)
excluding
same-day
Estimated
cost
($’000)(c)
01 Nervous system 53,798 33.2 302,493 5.6 7.9 158,138
02 Eye diseases, disorders 112,755 78.3 124,799 1.1 1.5 151,991
03 Ear, nose, mouth, throat 139,967 60.8 183,108 1.3 1.8 148,383
04 Respiratory system 62,308 7.3 365,800 5.9 6.3 165,320
05 Circulatory system 122,841 19.0 567,175 4.6 5.5 466,119
06 Digestive system 366,061 73.8 717,050 2.0 4.7 439,578
07 Hepatobiliary, pancreas 28,171 9.5 113,834 4.0 4.4 81,837
08 Musculoskeletal system 
and connective tissue 239,276 37.9 925,364 3.9 5.6 741,833
09 Skin, subcutaneous 
tissue and breast 118,972 62.0 284,543 2.4 4.7 189,784
10 Endocrine, nutritional and 
metabolic 15,022 20.9 65,570 4.4 5.3 41,134
11 Kidney and urinary tract 123,317 75.6 226,940 1.8 4.4 116,340
12 Male reproductive 36,261 50.2 97,970 2.7 4.4 59,091
13 Female reproductive 109,069 66.1 230,439 2.1 4.3 162,782
14 Pregnancy, childbirth and 
puerperium 105,466 28.9 411,476 3.9 5.1 222,962
15 Newborns, neonates 14,581 11.0 89,384 6.1 6.8 50,518
16 Blood, blood-forming 
organs, immunological 17,211 62.9 40,081 2.3 4.6 22,463
17 Neoplastic disorders 110,702 91.4 158,881 1.4 6.1 72,628
18 Infectious and parasitic 
diseases 10,035 11.6 61,680 6.1 6.8 29,309
19 Mental diseases and 
disorders 63,745 66.5 361,281 5.7 14.9 108,504
20 Alcohol/drug use and 
disorders 8,903 48.2 51,099 5.7 10.1 14,059
21 Injury, poison, toxic 
effects of drugs 17,558 26.9 65,916 3.8 4.8 35,407
22 Burns 436 20.0 2,384 5.5 6.6 1,339
23 Factors influencing health 
status, other contacts 70,905 82.7 147,553 2.1 7.3 81,866
ED Edit DRG(d) 11,233 59.2 49,261 4.4 9.3 40,083
PR Pre-MDC(d) 1,294 4.5 34,936 27.0 28.2 42,749
Total 1,959,887 56.4 5,679,017 2.9 5.4 3,644,217
(a) Separations for acute and unspecified episodes of care only.
(b) Major Diagnostic Categories are groupings of AR-DRGs within the AR-DRG (casemix) classification.
(c) The estimated total hospital cost is the sum of the estimated costs for each AR-DRG within the Major Diagnostic 
Category, calculated using the estimated average cost for each AR-DRG in public hospitals in 1999-00.
(d) ‘Pre-MDC’ is a group of particularly resource-intensive AR-DRGs such as transplants. Separations in the ‘Edit DRG’ 
grouping did not have a valid AR-DRG.
Note: ALOS = average length of stay; MDC = Major Diagnostic Category; DRG = diagnosis related group.
Source: AIHW National Hospital Morbidity Database.
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Health expenditure
Table S40: Commonwealth government receipts from the Medicare levy and total taxation 
revenue, current prices, 1984Ð85 to 2000Ð01 ($ million)
Revenue type 1984–85 1989–90 1990–91 1992–93 1994–95 1996–97 1998–99 2000–01
Medicare levy 1,223 2,545 2,480 2,415 3,030 3,664 4,100 4,580
Total taxation revenue 53,208 91,343 93,225 89,435 105,687 125,815 139,202 144,255
Medicare levy as a 
proportion of total 
taxation revenue 2.3% 2.8% 2.7% 2.7% 2.9% 2.9% 2.9% 3.2%
Source: Commonwealth of Australia Budget Papers, various years.
Table S41: Health-related taxation expenditures, current and constant(a) prices, 1989Ð90 to 
1999Ð00 ($ million)
Year Current prices Constant prices
1989–90 61 76
1990–91 85 101
1991–92 82 95
1992–93 91 104
1993–94 95 106
1994–95 91 100
1995–96 105 113
1996–97 125 131
1997–98 290 297
1998–99 325 325
1999–00 345 338
(a) See Box 5.4 for explanation of constant price estimating method.
Source: AIHW Health Expenditure Database.
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Table S42: Total health services expenditure (current prices), by source of funds(a), 1998Ð99 
($ million)
Government sector Non-government sector
Total all 
sectorsHealth service type
Common-
wealth
State
and
local Total
Health
insurance
funds
Indi-
viduals Other(b) Total
Total hospitals 7,555 6,516 14,071 2,358 664 938 3,960 18,031
Public (non-psychiatric 
hospitals 6,638 6,146 12,784 242 288 361 891 13,675
Public psychiatric 
hospitals 7 369 376 — 9 13 21 397
Private hospitals 911 — 911 2,116 367 565 3,048 3,959
High-level residential aged 
care 3,011 244 3,255 — 789 22 811 4,066
Ambulance 37 322 359 105 179 52 336 694
Total institutional 10,604 7,081 17,685 2,463 1,632 1,012 5,107 22,792
Medical services 7,372 — 7,372 212 936 480 1,628 9,001
Other professional services 232 — 232 197 1,191 240 1,628 1,860
Pharmaceuticals 3,092 — 3,092 30 2,697 — 2,727 5,819
Benefit paid 
pharmaceuticals 3,086 — 3,086 — 601 — 601 3,688
All other items 6 — 6 30 2,096 — 2,126 2,132
Aids and appliances 118 — 118 156 301 58 515 634
Other non-institutional 
services 1,534 2,262 3,796 1,002 1,716 138 2,856 6,652
Community/public 
health(c) 879 1,775 2,654 1 76 84 161 2,815
Dental services 104 305 408 506 1,640 11 2,157 2,566
Health administration 551 182 733 495 — 43 538 1,271
Research 510 93 603 — — 122 122 725
Total non-institutional 12,859 2,355 15,214 1,597 6,841 1,037 9,476 24,689
Total recurrent 
expenditure 23,462 9,436 32,899 4,061 8,473 2,049 14,583 47,481
Capital expenditure 71 1,597 1,668 n.a. n.a. n.a. 1,009(d) 2,677
Capital consumption 34 819 853 .. .. .. ..(e) 853
Total health expenditure(f) 23,567 11,852 35,420 n.a n.a n.a 15,591 51,011
nec Not elsewhere classified.
(a) This table shows funding provided by the Commonwealth Government, State and Territory governments, local 
government authorities and by the major non-government sources of funding for health services. It does not show 
gross outlays on health services by the different service provider sectors.
(b) ‘Other’ includes expenditure on health services by providers of workers compensation and compulsory motor vehicle 
third party insurance cover as well as other sources of income (e.g. interest earned) of service providers.
(c) Includes expenditure that was previously classified as ‘other non-institutional (nec)’ as well as expenditure on 
community and public health services.
(d) Capital outlays for the non-government sector cannot be allocated according to source of funds.
(e) Non-government capital consumption (depreciation) is included as part of recurrent expenditure.
(f) Not adjusted for tax expenditure.
Source: AIHW Health Expenditure Database.
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Table S44: Total health services expenditure, current and constant prices(a), and annual growth 
rates, 1989Ð90 to 1999Ð00
Amount ($ million) Growth rate (%)
Year Current Constant Current Constant
1989–90 28,800 35,347 . . . .
1990–91 31,270 36,136 8.6 2.2
1991–92 33,087 37,403 5.8 3.5
1992–93 34,993 39,043 5.8 4.4
1993–94 36,787 40,613 5.1 4.0
1994–95 38,967 42,314 5.9 4.2
1995–96 41,783 44,329 7.2 4.8
1996–97 44,851 46,757 7.3 5.5
1997–98 47,648 48,849 6.2 4.5
1998–99 51,011 51,011 7.1 4.4
1999–00(b) 53,657 52,535 5.2 3.0
Average annual growth rates
1989–90 to 1992–93 6.7 3.4
1992–93 to 1997–98 6.4 4.6
1997–98 to 1999–00 6.1 3.7
1989–90 to 1999–00 6.4 4.0
(a) See Box 5.4 for explanation of constant price estimating method.
(b) Based on preliminary AIHW and ABS estimates.
Source: AIHW Health Expenditure Database.
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Table S45: Estimated health expenditures for Aboriginal and Torres Strait Islander Australians 
and other Australians, total and per person, 1998Ð99
Total ($m) Per person ($) Ratio
Indigenous/
other AustralianDelivery Indigenous
Other
Australian Indigenous
Other
Australian
Through State programs
Admitted patient expenditure 453 10,096 1,115 548 2.04
Other through State program 
expenditure 443 6,850 1,090 372 2.93
Total through State programs 896 16,947 2,205 920 2.40
Through Commonwealth 
programs
Indigenous-specific 
Commonwealth programs 121 10 298 1 . .
Medicare/PBS 91 11,071 224 601 0.37
Other Commonwealth 
programs 69 6,196 169 336 0.50
Total through Commonwealth 
programs 281 17,277 691 938 0.74
Through local government 
programs 8 206 20 11 1.78
Services through private 
sector programs 60 11,982 148 650 0.23
Total recurrent expenditure 1,245 46,412 3,065 2,518 1.22
Source: AIHW 2001a.
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Table S46: Recurrent expenditure on health services (current prices), 1989Ð90 to 1998Ð99 
(per cent)
Health service type
1989–
90
1990–
91
1991–
92
1992–
93
1993–
94
1994–
95
1995–
96
1996–
97
1997–
98
1998–
99
Total institutional 50.5 50.3 49.8 48.3 47.2 46.6 46.7 46.5 47.2 48.0
Hospitals 40.6 40.1 39.7 38.6 37.7 37.6 37.5 37.6 37.8 38.0
Public (non-psychiatric) 
hospitals 32.3 31.3 30.7 29.8 28.8 28.5 28.3 28.3 28.8 28.8
Public psychiatric 
hospitals 2.0 1.9 1.8 1.6 1.4 1.3 1.1 1.0 0.9 0.8
Private hospitals 6.3 6.9 7.2 7.3 7.5 7.8 8.1 8.3 8.2 8.3
High-level residential aged 
care 8.3 8.6 8.4 8.1 7.8 7.5 7.5 7.6 7.9 8.6
Ambulance 1.5 1.4 1.4 1.4 1.4 1.2 1.3 1.2 1.4 1.5
Other institutional (nec) 0.2 0.2 0.2 0.2 0.3 0.3 0.4 — — —
Total non-institutional 49.5 49.7 50.2 51.7 52.8 53.4 53.3 53.5 52.8 52.0
Medical services 18.4 18.7 19.0 19.6 20.0 20.2 20.0 19.4 19.1 19.0
Other health professionals 3.7 3.9 3.7 3.7 3.6 3.6 3.4 3.8 3.7 3.9
Pharmaceuticals 9.3 9.5 9.9 10.4 11.0 11.6 11.8 12.0 12.0 12.3
Benefit-paid items 5.4 5.0 5.2 6.0 6.6 7.0 7.6 7.7 7.6 7.8
All other items 3.9 4.5 4.7 4.5 4.4 4.6 4.2 4.2 4.4 4.5
Aids and appliances 2.1 2.2 2.2 2.2 2.2 2.1 2.0 2.0 1.8 1.3
Other non-institutional 
services(a) 14.4 13.8 13.8 14.4 14.4 14.3 14.5 14.7 14.7 14.0
Community/public 
health(b) 5.6 4.7 4.4 4.9 5.2 4.7 5.1 5.6 5.7 5.9
Dental services 5.1 5.3 5.3 5.9 6.0 5.9 6.0 6.0 5.8 5.4
Health administration 3.7 3.8 4.1 3.6 3.2 3.6 3.3 3.0 3.2 2.7
Research(c) 1.5 1.5 1.5 1.5 1.6 1.6 1.6 1.6 1.5 1.5
Total recurrent 
expenditure 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
nec Not elsewhere classified
(a) ‘Other non-institutional services’ is a summary of community and public health, dental services and administration.
(b) Includes expenditure that was previously classified as ‘other non-institutional (nec)’ as well as expenditure on 
community and public health services.
(c) Health services research expenditure has been allocated according to the level of government or the private sector 
organisation that actually undertakes the research activity, not according to source of funds.
Source: AIHW Health Expenditure Database.
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Table S47: Total recurrent expenditure on health services, constant prices(a), 1989Ð90 to 1998Ð99 
($ million)
Health service type
1989–
90
1990–
91
1991–
92
1992–
93
1993–
94
1994–
95
1995–
96
1996–
97
1997–
98
1998–
99
Total institutional 16,624 17,118 17,546 17,749 18,048 18,642 19,652 20,538 21,702 22,792
Hospitals 13,334 13,622 14,003 14,186 14,432 15,024 15,802 16,624 17,368 18,031
Public (non-psychiatric) 
hospitals 10,614 10,647 10,845 10,948 11,042 11,385 11,924 12,539 13,216 13,675
Public psychiatric 
hospitals 642 652 640 574 546 522 484 429 390 397
Private hospitals 2,078 2,323 2,518 2,663 2,844 3,117 3,394 3,656 3,761 3,959
High-level residential aged 
care 2,733 2,933 2,961 2,969 2,965 2,993 3,158 3,385 3,676 4,066
Ambulance 488 487 503 517 521 487 544 529 659 694
Other institutional (nec) 71 76 79 78 130 138 148 — — —
Total non-institutional 16,679 16,976 17,880 19,052 20,073 21,173 22,295 23,501 24,088 24,689
Medical services 6,020 6,087 6,709 7,125 7,553 7,986 8,381 8,612 8,808 9,001
Other health professionals 1,215 1,280 1,275 1,338 1,364 1,420 1,436 1,691 1,707 1,860
Pharmaceuticals 3,028 3,198 3,400 3,713 4,047 4,436 4,786 5,112 5,350 5,819
Benefit-paid items 1,665 1,584 1,674 2,002 2,325 2,585 3,028 3,294 3,396 3,688
All other items 1,363 1,613 1,726 1,711 1,721 1,851 1,758 1,818 1,954 2,132
Aids and appliances 732 778 816 837 873 848 836 856 821 634
Other non-institutional 
services(b) 5,188 5,125 5,158 5,517 5,655 5,844 6,184 6,520 6,735 6,652
Community/public 
health(c) 1,873 1,619 1,538 1,763 1,944 1,858 2,127 2,460 2,583 2,815
Dental services 2,081 2,177 2,184 2,476 2,514 2,551 2,668 2,738 2,676 2,566
Health administration 1,234 1,330 1,435 1,278 1,197 1,435 1,388 1,321 1,476 1,271
Research(d) 496 508 522 522 581 639 672 710 668 725
Total recurrent 
expenditure 33,304 34,094 35,426 36,802 38,121 39,815 41,947 44,039 45,790 47,481
nec Not elsewhere classified
(a) See Box 5.4 for explanation of constant price estimating method.
(b) ‘Other non-institutional services’ is a summary of community and public health, dental services and administration.
(c) Includes expenditure that was previously classified as ‘other non-institutional (nec)’ as well as expenditure on 
community and public health services.
(d) Health services research expenditure has been allocated according to the level of government or the private sector 
organisation that actually undertakes the research activity, not according to source of funds.
Source: AIHW Health Expenditure Database.
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Table S48: Expenditure by Commonwealth, States and Territories on core public health 
categories including overheads and program-wide expenditure ($), 1998Ð99
Category
Total direct and
overhead expenditure
by the Commonwealth
(excluding grants to
States and Territories)
Total direct and overhead
expenditure by States and
Territories (including
Commonwealth grants to
States and Territories)
Total expenditure
through States,
Territories &
Commonwealth
Communicable disease 
control 24,193,170 120,953,126 145,146,296
Selected health promotion 
activities 40,128,117 147,116,876 187,244,993
Immunisation 72,493,136 105,943,194 178,436,330
Environmental health 31,670,639 39,988,676 71,659,314
Food standards & hygiene 9,006,112 13,350,594 22,356,706
Breast cancer screening 5,133,327 85,679,611 90,812,938
Cervical screening 59,652,592 21,271,644 80,924,235
Research (Commonwealth 
only) 16,993,750 — 16,993,750
All other core public health 6,602,095 78,722,505 85,324,600
Administration of public 
health grants(a) 840,156 . . 840,156
Total expenditure 266,713,095 613,026,225 879,739,320
Percentage of total 30% 70% 100%
. . Not applicable.
(a) This represents the overheads associated with administering the grants to States and Territories by the Commonwealth 
Department of Health and Ageing. It is made up of $498,300 in population health running costs, and $341,856 in non-
grant program costs. The grants to States and Territories of $192m help to fund the expenditure of the States and 
Territories of $613m.
Source: AIHW 2001b.
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Table S49: Health services expenditure as a proportion of GDP(a), Australia and other selected 
OECD countries, 1989 to 1999 (per cent)
Year(b) Aust Can Fra Ger(c) Jpn NZ UK USA
Eight-
country
mean(d)
Seven-
country
mean(e)
Six-
country
mean(f)
1989 7.5 8.6 8.5 . . 6.2 6.6 5.9 11.2 9.3(g) 7.0(g) 7.5(g)
1990 7.9 9.0 8.6 . . 6.1 7.0 6.0 11.9 9.6(g) 7.0(g) 7.7(g)
1991 8.2 9.8 8.9 9.1 6.1 7.5 6.4 12.6      10.0      7.6  8.5
1992 8.2 10.1 9.1 9.7 6.3 7.6 6.9 13.0      10.3      8.0 8.9
1993 8.2 9.9 9.5 9.7 6.6 7.2 6.9 13.2      10.6      8.1 8.9
1994 8.2 9.6 9.4 9.8 6.9 7.3 7.0 13.2      10.6      8.2 8.9
1995 8.2 9.3 9.6 10.2 7.2 7.3 6.9 13.2      10.7      8.4 9.1
1996 8.4 9.1 9.5 10.6 7.1 7.3 7.0 13.2      10.7      8.4 9.2
1997 8.4 9.0 9.4 10.5 7.4 7.6 6.7 13.0      10.7      8.4 9.0
1998 8.6 9.3 9.3 10.3 7.5 8.1 6.8 12.9      10.7      8.5 9.0
1999 8.5 9.3 9.3 n.a. n.a. 8.1 6.9 12.9       n.a.      n.a. n.a
(a) Some of these ratios have changed since Health Expenditure Bulletin 17 due to changes in the OECD estimates of 
gross domestic product (GDP).
(b) Australian data relate to the year commencing 1 July; data for France and Germany relate to the calendar year 
indicated; data for New Zealand prior to 1990 relate to the year commencing 1 April, and data for 1990 onwards refer 
to the year commencing 1 July; data for Canada, Japan and the United Kingdom relate to the year commencing 1 April; 
United States data relate to the year ending 30 September. 
(c) Data for 1991 onwards refer to the unified Germany.
(d) Mean weighted by GDP.
(e) Weighted mean excluding the United States.
(f) Weighted mean excluding the United States and Japan.
(g) Excludes Germany in 1989 and 1990.
Sources: AIHW Health Expenditure Database; OECD 2001.
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Table S50: Components of growth in health services expenditure, Australia and other selected 
OECD countries, 1989 to 1999(a) (per cent)
Aust Can Fra Ger(b) Jpn(c) NZ(d) UK(e) USA
Nominal growth in health 
services expenditure 6.4 6.0 4.5 7.9 7.8 8.2 7.0 6.9
Health services inflation 2.3 2.2 1.5 3.2 1.5 3.8 5.3 3.7
General inflation 1.6 1.6 1.8 2.8 0.7 1.9 4.0 2.4
Excess health inflation(f) 0.7 0.6 -0.2 0.3 0.8 1.9 1.2 1.3
Real growth in health 
services expenditure 4.0 3.7 2.9 4.6 6.2 4.2 1.6 3.1
Population growth 1.2 1.1 0.4 0.5 0.3 1.6 0.4 1.0
Per person real growth 2.8 2.6 2.5 4.1 5.9 2.6 1.3 2.1
(a) Australian data relate to the year commencing 1 July; data for France and Germany relate to the calendar year 
indicated; data for New Zealand prior to 1990 relate to the year commencing 1 April, and data for 1990 onwards refer 
to the year commencing 1 July; data for Canada, Japan and the United Kingdom relate to the year commencing 1 April; 
United States data relate to the year ending 30 September.
(b) Germany from 1991 to 1996.
(c) Japan to 1997.
(d) New Zealand to 1995.
(e) UK to 1996.
(f) Excess health inflation rate is the rate by which changes in the prices of health services exceed changes in prices 
throughout the general community. A positive excess health inflation rate indicates that health prices are rising faster 
than the general rate of inflation; a negative rate indicates that health prices are falling or not rising as fast as the 
general rate of inflation.
Sources: AIHW Health Expenditure Database; OECD 2001.
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Table S51: Contributions income and direct health expenditure by Registered Health Benefits 
Funds, Australia, constant prices(a), 1984Ð85 to 2000Ð01 ($ million)
Year
Contributions
income
Annual growth
rate (%) Benefits paid(b)
Annual growth
rate (%)
1984–85 2,494 . . 2,061 . .
1985–86 2,701 8.3 2,399 16.4
1986–87 3,094 14.5 2,782 15.9
1987–88 3,379 9.2 3,021 8.6
1988–89 3,396 0.5 3,069 1.6
1989–90 3,502 3.1 3,230 5.3
1990–91 3,833 9.5 3,559 10.2
1991–92 4,308 12.4 3,778 6.2
1992–93 4,496 4.4 3,918 3.7
1993–94 4,535 0.9 3,963 1.2
1994–95 4,458 –1.7 3,994 0.8
1995–96 4,449 –0.2 4,129 3.4
1996–97 4,559 2.5 4,317 4.6
1997–98 4,814 5.6 4,229 –2.0
1998–99 5,027 4.4 4,336 2.5
1999–00 5,462 8.7 4,468 3.0
2000–01 6,825 24.9 5,117 14.5
Average annual growth rates
1984–85 to 2000–01 6.5 5.8
1984–85 to 1988–89 8.0 10.5
1989–90 to 2000–01 6.3 4.3
1996–97 to 2000–01 10.6 4.3
. . Not applicable.
(a) Constant price estimates have been derived using the implicit price deflator for household expenditure on hospital 
services, referenced to 1999–00.
(b) Benefits paid include levies paid to State and Territory Governments for ambulance services; excludes administration 
expenditure.
Source: AIHW Health Expenditure Database.
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Table S52: Net assets of registered health benefits funds, current and constant(a) prices, 1989Ð90 
to 2000Ð01 ($ million)
Net assets of funds
Year Current prices Constant prices(a) Annual real growth rate (%)
1989–90 862 549 . .
1990–91 851 573 4.3
1991–92 991 685 19.5
1992–93 1,205 841 22.8
1993–94 1,350 950 13.0
1994–95 1,409 1,009 6.2
1995–96 1,295 1,004 –0.5
1996–97 1,174 1,014 1.1
1997–98 1,173 1,099 8.3
1998–99 1,304 1,245 13.3
1999–00 1,662 1,662 33.5
2000–01 2,387 2,521 51.6
(a) Constant price estimates have been derived using the implicit price deflator for household expenditure on hospital 
services, referenced to 1999–00.
Source: PHIAC 2002.
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Table S53: Employment in the health industry, August 1981 to August 2001
Year
Employed in
health industry
(’000)
All employed
persons (’000)
Proportion of
all employed
persons (%)
Civilian labour
force(a) (’000)
Proportion of
civilian labour
force(a) (%)
1981 406.1 6,393.7 6.4 6,774.3 6.0
1982 424.5 6,379.3 6.7 6,840.7 6.2
1983 440.6 6,241.1 7.1 6,927.9 6.4
1984 453.6 6,466.1 7.0 7,070.1 6.4
1985 461.6 6,675.6 6.9 7,248.3 6.4
1986 489.2 6,918.6 7.1 7,516.2 6.5
1987 510.5 7,092.3 7.2 7,694.4 6.6
1988 530.7 7,353.4 7.2 7,892.1 6.7
1989 520.3 7,727.6 6.7 8,197.0 6.3
1990 557.9 7,825.0 7.1 8,412.5 6.6
1991 580.0 7,669.2 7.6 8,475.2 6.8
1992 575.3 7,679.3 7.5 8,585.7 6.7
1993 561.4 7,621.0 7.4 8,537.0 6.6
1994 547.2 7,885.7 6.9 8,683.5 6.3
1995 591.9 8,217.7 7.2 8,939.6 6.6
1996 590.2 8,319.7 7.1 9,090.8 6.5
1997 610.2 8,315.5 7.3 9,080.1 6.7
1998 598.7 8,537.2 7.0 9,261.5 6.5
1999 600.4 8,731.6 6.9 9,384.4 6.4
2000 656.9 9,070.8 7.2 9,645.3 6.8
2001 669.2 9,124.2 7.3 9,768.2 6.9
1991 to 2001 
increase (%) 15.4 19.0 15.3
(a) Includes unemployed persons.
Sources: ABS Cat No. 6203.0; ABS Labour Force Survey estimates on microfiche.
AW2002 end matter  Page 406  Wednesday, June 26, 2002  5:43 PM
Statistical tables  407
TRIM SIZE 175 mm Wide x 250 mm Deep
Use of professional services
Table S54: Medical and optometrical services, fees and benefits under Medicare, 1994Ð95 to 
2000Ð01
Year
 Number of
services (million)
Fees charged
($ million)
 Schedule fees
($ million)
Benefits paid
($ million)
GP attendances
1994–95  98.4  2,361.5  2,582.7  2,195.6
1995–96  102.1  2,484.4  2,722.3  2,314.4
1996–97  102.5  2,517.8  2,752.6  2,339.7
1997–98  103.1  2,564.5  2,786.6  2,367.8
1998–99  102.6  2,605.0  2,818.6  2,395.4
1999–00 101.5 2,675.3 2,884.3 2,452.3
2000–01 100.6 2,811.0 3,014.2 2,561.1
Special attendances
1994–95  17.5  1,031.2  1,005.7  847.3
1995–96  18.1  1,084.0  1,053.5  887.8
1996–97  18.2  1,109.3  1,066.6  897.7
1997–98  18.2  1,133.1  1,078.9  907.5
1998–99  18.6  1,183.3  1,119.2  941.3
1999–00 18.9 1,231.4 1,152.8 969.2
2000–01 19.3 1,303.8 1,197.5 1,005.3
Obstetrics
1994–95  0.7  93.9  70.8  55.0
1995–96  1.3  100.7  74.1  58.7
1996–97  1.6  98.9  70.7  56.8
1997–98  1.6  97.4  68.2  54.9
1998–99  1.6  101.3  71.9  57.7
1999–00 1.5 106.3 75.2 60.0
2000–01 1.5 120.1 78.5 62.5
Anaesthetics
1994–95  1.7  184.0  152.1  115.0
1995–96  1.7  201.6  160.6  121.6
1996–97  1.7  218.6  166.0  125.7
1997–98  1.7  225.2  168.9  127.9
1998–99  1.8  235.2  175.5  132.9
1999–00 1.8 249.6 182.3 138.0
2000–01 2.1 294.5 206.4 156.2
Pathology
1994–95  47.0  869.9  926.3  778.3
1995–96  48.6  901.4  966.7  812.8
1996–97  50.3  945.3  1,020.2  857.8
1997–98  52.4  1,014.5  1,099.6  924.2
1998–99  55.6  1,096.3  1,199.0  1,008.4
1999–00 58.8 1,173.9 1,292.7 1,087.6
2000–01 62.1 1,246.7 1,375.6 1,156.8
 (continued)
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Table S54 (continued): Medical and optometrical services, fees and benefits under Medicare, 
1994Ð95 to 2000Ð01
Year
 Number of
services (million)
Fees charged
($ million)
 Schedule fees
($ million)
Benefits paid
($ million)
Diagnostic imaging
1994–95  9.9  904.2  925.9  797.1
1995–96  10.5  983.7  1,016.1  875.9
1996–97  10.4  992.2  1,029.9  880.1
1997–98  10.8  1,063.8  1,105.6  938.2
1998–99  11.4  1,199.9  1,250.9  1,064.7
1999–00 11.7 1,257.5 1,296.7 1,105.0
2000–01 12.3 1,346.8 1,361.2 1,159.5
Operations
1994–95  5.2  761.6  679.6  537.2
1995–96  5.3  799.6  708.6  560.7
1996–97  5.4  841.2  736.2  682.1
1997–98  5.4  861.4  744.7  587.2
1998–99  5.5  898.0  770.6  607.8
1999–00 5.6 951.3 803.8 634.3
2000–01 5.8 1,074.7 875.9 688.9
Optometry
1994–95  3.3  131.5  152.7  129.8
1995–96  3.6  143.2  166.9  141.9
1996–97  3.7  147.3  172.0  146.2
1997–98  3.8  144.2  167.8  142.7
1998–99  3.9  147.9  171.7  146.1
1999–00 4.1 156.8 182.3 155.1
2000–01 4.2 164.6 191.5 162.9
All other services(a)
1994–95  4.4  257.9  255.0  216.4
1995–96  4.5  283.3  280.9  238.2
1996–97  4.7  301.2  292.9  247.6
1997–98  4.8  321.0  309.8  260.7
1998–99  5.5  394.8  377.7  314.9
1999–00 5.6 429.4 410.9 343.5
2000–01 5.9 476.0 447.3 373.6
Total services
1994–95  188.1  6,633.3  6,784.2  5,696.4
1995–96  196.0  7,022.4  7,185.0  6,038.4
1996–97  198.8  7,209.1  7,339.5  6,158.0
1997–98  202.2  7,460.7  7,560.1  6,333.5
1998–99  206.3  7,861.8  7,955.2  6,669.1
1999–00 209.6 8,231.4 8,281.0 6,945.0
2000–01 213.9 8,838.0 8,748.1 7,326.8
(a) Includes radiotherapy and nuclear medicine therapy, assistance at operations and other miscellaneous services. 
Source: DHAC 2001b.
AW2002 end matter  Page 408  Wednesday, June 26, 2002  5:43 PM
Statistical tables  409
TRIM SIZE 175 mm Wide x 250 mm Deep
Table S55: Medicare services, age-specific rates, 1993Ð94 to 2000Ð01 (services per person)
Sex/age group 1993–94 1994–95 1995–96 1996–97 1997–98 1998–99 1999–00 2000–01
Males
0–4 9.85 9.60 9.80 9.60 9.47 9.27 9.05 8.79
5–9 5.43 5.24 5.30 5.31 5.25 5.12 4.75 4.59
10–14 4.60 4.50 4.54 4.48 4.53 4.44 4.25 4.16
15–19 4.68 4.67 4.86 4.83 4.77 4.73 4.74 4.60
20–24 5.00 5.02 5.32 5.26 5.12 5.02 4.92 4.75
25–34 5.58 5.77 5.97 5.93 5.84 5.75 5.66 5.53
35–44 6.60 6.91 7.11 7.07 7.05 7.08 7.10 7.17
45–54 8.82 9.23 9.48 9.45 9.54 9.61 9.70 9.78
55–64 13.35 14.01 14.41 14.42 14.59 14.74 14.99 14.83
65–74 15.82 17.11 18.35 19.07 20.11 21.09 22.10 22.94
75+ 19.85 20.38 20.69 20.54 20.66 20.26 19.77 19.8
Crude rate 8.07 8.35 8.68 8.71 8.81 8.87 8.91 8.95
ASR(a) 8.20 8.45 9.01 9.01 8.79 8.81 8.81 8.86
Females
0–4 9.01 8.80 8.98 8.82 8.67 8.52 8.29 8.02
5–9 5.44 5.23 5.26 5.21 5.23 5.15 4.75 4.57
10–14 4.79 4.67 4.66 4.60 4.64 4.62 4.38 4.24
15–19 8.27 8.37 8.64 8.43 8.26 8.28 8.22 8.05
20–24 11.43 11.64 12.12 11.72 11.35 11.16 10.87 10.54
25–34 12.62 13.05 13.57 13.51 13.36 13.30 13.09 12.98
35–44 11.61 12.11 12.23 12.17 12.13 12.21 12.19 12.35
45–54 13.52 14.00 14.06 14.02 14.04 14.19 14.31 14.46
55–64 15.54 16.20 16.67 16.87 17.19 17.56 17.99 17.88
65–74 18.57 19.21 20.08 20.45 20.97 21.60 22.31 22.76
75+ 22.87 23.43 24.10 24.36 24.63 24.88 25.46 25.38
Crude rate 12.14 12.49 12.84 12.85 12.89 13.01 13.07 13.10
ASR(a) 11.88 12.19 12.28 12.24 12.46 12.53 12.53 12.57
(a) Age-standardised rate. Age-standardised to the Australian population at 30 June 1991.
Sources: HIC 1994, 1995, 1996, 1997, 1998, 1999, 2000, 2001.
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Table S56: Medicare services, age-specific rates, States and Territories, 2000Ð01 (services per 
person)
Sex/age group NSW Vic Qld WA SA Tas ACT NT Aust
Males
0–4 9.27 8.83 8.91 7.64 8.89 7.27 7.68 4.98 8.77
5–9 4.91 4.84 4.37 3.83 4.61 3.77 4.04 2.58 4.58
10–14 4.44 4.17 4.22 3.78 4.12 3.48 3.78 2.19 4.17
15–19 4.90 4.60 4.54 4.16 4.75 4.16 3.90 2.27 4.60
20–24 5.16 4.83 4.66 3.95 5.01 4.65 3.69 2.19 4.77
25–34 5.97 5.67 5.38 4.68 5.64 5.33 4.75 2.82 5.55
35–44 7.84 7.20 6.97 6.12 7.07 6.21 6.14 4.54 7.18
45–54 10.67 9.65 9.87 8.68 9.49 8.50 8.61 6.84 9.85
55–64 16.54 14.83 15.16 13.39 14.29 13.21 13.12 10.45 15.19
65–74 24.67 22.92 22.49 20.47 21.64 20.04 20.83 13.91 22.98
75+ 21.08 21.19 18.97 19.47 20.16 15.18 18.77 12.43 20.31
Crude rate 9.75 9.06 8.76 7.69 9.12 8.00 7.28 4.52 9.00
ASR(a) 9.51 8.89 8.69 7.80 8.68 7.67 7.75 5.35 8.86
Females
0–4 8.42 7.99 8.17 7.04 8.17 6.51 6.96 4.53 7.99
5–9 4.83 4.84 4.36 3.90 4.59 3.75 4.06 2.53 4.56
10–14 4.43 4.30 4.28 3.94 4.33 3.68 4.00 2.37 4.26
15–19 8.22 7.76 8.53 7.84 8.00 8.14 7.25 5.13 8.06
20–24 11.04 10.25 10.97 9.80 10.34 11.15 9.21 7.38 10.57
25–34 13.43 13.26 12.91 12.50 12.47 12.24 11.78 8.84 13.02
35–44 13.00 12.48 12.23 11.60 11.85 11.27 11.13 8.78 12.38
45–54 15.33 14.42 14.86 13.56 13.91 13.60 13.03 10.43 14.60
55–64 19.43 17.98 18.46 16.65 17.33 16.84 16.82 12.45 18.30
65–74 23.96 22.55 23.09 20.76 21.44 20.16 21.21 14.27 22.78
75+ 26.08 26.45 25.98 24.42 25.42 22.56 24.14 15.92 25.82
Crude rate 13.83 13.29 13.07 11.97 13.12 12.22 11.37 7.53 13.18
ASR(a) 13.11 12.56 12.66 11.69 12.13 11.56 11.39 8.34 12.57
(a) Age-standardised rate. Age-standardised to the Australian population at 30 June 1991.
Source: HIC 2001.
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Table S57: Medicare services, percentage of enrolled persons by number of items, 2000Ð01
Number of services
Sex/age group 0 1 2 3 4 5 or more
Males
0–4 9.48 6.50 7.23 7.50 7.28 62.01
5–9 14.88 13.26 11.94 10.22 8.54 41.16
10–14 21.67 15.90 12.94 10.33 8.04 31.12
15–19 21.30 15.18 11.95 9.55 7.58 34.44
20–24 22.84 14.16 10.93 8.63 6.90 36.54
25–34 26.18 13.88 10.25 7.85 6.33 35.51
35–44 23.61 12.46 9.20 7.11 5.96 41.66
45–54 17.70 10.58 7.78 6.13 5.35 52.46
55–64 12.81 6.84 5.34 4.46 4.19 66.36
65–74 10.04 3.44 3.01 2.79 2.77 77.95
75+ 31.47 3.54 2.94 2.29 2.44 57.32
All ages 19.93 11.03 8.67 7.00 5.92 47.45
Females
0–4 10.30 7.37 7.96 8.07 7.88 58.42
5–9 15.27 13.69 12.13 10.30 8.58 40.03
10–14 21.40 16.11 13.06 10.27 7.93 31.23
15–19 15.07 12.36 10.80 8.89 7.26 45.62
20–24 8.56 6.71 6.73 6.41 6.08 65.51
25–34 10.37 6.06 5.58 5.53 5.36 67.10
35–44 11.31 6.85 5.77 5.86 5.59 64.62
45–54 8.86 5.93 5.06 4.91 4.85 70.39
55–64 7.16 4.08 3.67 3.68 3.77 77.64
65–74 8.08 2.62 2.57 2.52 2.68 81.53
75+ 19.97 1.80 1.88 1.82 2.01 72.52
All ages 11.91 7.07 6.30 5.83 5.39 63.50
Source: HIC 2001.
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National Health Priority Areas
Table S58: Indicators for cardiovascular health
Baseline Most recent data
Descriptor Year Value Year Value
Incidence rate for myocardial infarction, ages 30–79(a) (events per 100,000 population)
Males 1993–1994 441 1997–1998 377
Females 1993–1994 144 1997–1998 119
Hospital separation rate for principal diagnosis of unstable angina pectoris, ages 0–79 (per 100,000 
population)
Males 1993–94 178 1999–00 312
Females 1993–94 101 1999–00 153
Hospital separation rate for principal diagnosis of congestive heart failure, ages 0–79 (per 100,000 
population)
Males 1993–94 102 1999–00 90
Females 1993–94 63 1999–00 52
Death rate for coronary heart disease, ages 0–79 (per 100,000 population)(b)
Males 1986 203 2000 88
Females 1986 89 2000 36
Death rate for coronary heart disease among rural and remote area residents, ages 0–79 (per 100,000 
population)(b)(c)
Males, remote 1988–1990 202 1998–2000 133
Males, rural 1988–1990 184 1998–2000 102
Males, metropolitan 1988–1990 176 1998–2000 93
Females, remote 1988–1990 101 1998–2000 61
Females, rural 1988–1990 82 1998–2000 43
Females, metropolitan 1988–1990 74 1998–2000 37
Prevalence rate for people whose main/underlying disabling condition is stroke, ages 25 or more(d) 
(per 100,000 population)
Males 1993 297 1998 474
Females 1993 268 1998 490
Death rate for stroke, ages 0–79 (per 100,000 population)(b)
Males 1986 46 2000 25
Females 1986 35 2000 17
(continued)
(a) Currently, data are available only for ages 35–69. Rates are standardised to the 1993 Australian population.
(b) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
(c) Rural Remote and Metropolitan Area (RRMA) classification aggregated to three categories: metropolitan, rural and 
remote.
(d) Although the prevalence of stroke may have increased between 1993 and 1998, a change in the data collection method 
may also have contributed to the increased reported rate. In 1993, it was based on the underlying cause of the main 
disabling condition, whereas in 1998, survey participants were asked directly whether they had had a stroke.
Note: Except for the incidence of myocardial infarction, rates have been age-standardised to the 1991 Australian population.
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Table S58 (continued): Indicators for cardiovascular health
Baseline Most recent data
Descriptor Year Value Year Value
Death rate for stroke among rural and remote area residents, ages 0–79 (per 100,000 population)(b)(c)
Males, remote 1988–1990 48 1998–2000 35
Males, rural 1988–1990 41 1998–2000 26
Males, urban 1988–1990 40 1998–2000 25
Females, remote 1988–1990 37 1998–2000 25
Females, rural 1988–1990 31 1998–2000 19
Females, urban 1988–1990 30 1998–2000 18
Hospital separation rate for major amputation for peripheral vascular disease, ages 0–79 (per 100,000 
population)
Males 1993–94 1 1999–00 4
Females 1993–94 0 1999–00 2
Hospital separation rate for emergency and elective surgery for abdominal aortic aneurysm, ages 
0–79 (per 100,000 population)
Males 1993–94 19 1999–00 16
Females 1993–94 3 1999–00 3
(a) Currently data are available only for ages 35–69. Rates are standardised to the 1993 Australian population.
(b) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
(c) Rural Remote and Metropolitan Area (RRMA) classification aggregated to three categories: urban, rural and remote.
(d) Although the prevalence of stroke may have increased between 1993 and 1998, a change in the data collection method 
may also have contributed to the increased reported rate. In 1993, it was based on the underlying cause of the main 
disabling condition, whereas in 1998, survey participants were asked directly whether they had had a stroke.
Note: Except for the incidence of myocardial infarction, rates have been age-standardised to the 1991 Australian population.
Sources: AIHW National Mortality Database; AIHW National Hospital Morbidity Database; DHAC & AIHW 1999a.
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Table S59: Indicators for health risk factors
Baseline Most recent data
Descriptor Year Value Year Value
Proportion of adults who smoke regularly, ages 18 or more (per cent)
Males 1991 33 1998 31
Females 1991 27 1998 25
Proportion of secondary school students who smoke, age 15 (per cent)
Males 1984 29 1996 24
Females 1984 34 1996 29
Proportion of adults not engaged in regular physical activity, ages 18–75 (per cent)
Males 1997 37 2000 42
Females 1997 39 2000 44
Proportion of adults who are overweight, ages 25–64 (per cent)(a)
Males 1989 53 1999–2000 65
Females 1989 36 1999–2000 45
Proportion of adults with high blood pressure and/or on antihypertensive treatment, ages 25–64 
(per cent)(a)(b)
Males 1989 33 1999–2000 22
Females 1989 21 1999–2000 16
Mean blood pressure levels, ages 25–64 (mm Hg)(a)
Males, systolic BP 1989 130 1999–2000 128
Males, diastolic BP 1989 83 1999–2000 75
Females, systolic BP 1989 123 1999–2000 121
Females, diastolic BP 1989 78 1999–2000 68
Proportion of adults with high blood cholesterol, ages 25–64 (per cent)(a)(c)
Males 1989 51 1999–2000 47
Females 1989 43 1999–2000 44
Contribution of saturated fat as a proportion of total energy intake, ages 25–64 (per cent)(a)
Males 1983 16 1995 13
Females 1983 16 1995 13
(a) Baseline sample conducted in capital cities.
(b) Hypertension is defined as systolic blood pressure ‡  140 mmHg and/or diastolic blood pressure ‡  90 mmHg and/or 
receiving treatment for high blood pressure.
(c) High blood cholesterol is defined as a level equal to or greater than 5.5 mmol/L.
Note: Age-standardised to the Australian population at 30 June 1991.
Sources: AIHW analysis of 1983 National Dietery Survey of Adults (NHF 1986, 1987); 1989 NHF Risk Factor Prevalence 
Survey; 1995 ABS National Nutrition Survey; 1997, 1999, 2000, Physical Activity Surveys; 1999–2000 Australian Diabetes, 
Obesity and Lifestyle Study; DHAC & AHIW 1999a; Hill & White 1995; Hill et al. 1990; Hill et al. 1987.
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Table S60: Indicators for cancer control
Baseline Most recent data
Descriptor Year Value Year Value
Incidence of cervical cancer among women aged 20–74 years (new cases per 100,000 population)
Females 1988 18 1998 12
Death rate for cervical cancer among women aged 20–74 years (deaths per 100,000 population)(a)
Females 1991 4 2000 3
Five-year relative survival proportions for cervical cancer (per cent)
Females 1982–1986 70 1992–1997 75
Proportion of females aged 20–69 years screened within intervals for cervical cancer (per cent)
Females 1996–1997 62 1997–1998 64
Incidence of breast cancer among women aged 50–74 years (new cases per 100,000 population)
Females 1988 202 1998 297
Death rate for breast cancer among women aged 50–74 years (deaths per 100,000 population)(a)
Females 1992 67 2000 59
Five-year relative survival proportions for breast cancer (per cent)
Females 1982–1986 72 1992–1997 84
Proportion of females aged 50–69 years screened for breast cancer (per cent)
Females 1996–1997 51 1997–1998 54
Incidence of prostate cancer (new cases per 100,000 population)
Males 1988 71 1998 110
Death rate for prostate cancer (deaths per 100,000 population)(a)
Males 1992 33 2000 29
Five-year relative survival proportions for prostate cancer (per cent)
Males 1982–1986 59 1992–1997 83
Incidence of colorectal cancer (new cases per 100,000 population)
Males 1988 62 1998 67
Females 1988 43 1998 46
Death rate for colorectal cancer (deaths per 100,000 population)(a)
Males 1992 29 2000 27
Females 1992 19 2000 18
Incidence of melanoma of the skin (new cases per 100,000 population)
Males 1991 39 1998 46
Females 1991 31 1998 34
Death rate for melanoma of the skin (deaths per 100,000 population)(a)
Males 1991 6 2000 6
Females 1991 3 2000 3
Five-year relative survival proportions for melanoma of the skin (per cent)
Males 1982–1986 83 1992–1997 90
Females 1982–1986 91 1992–1997 95
Incidence of non-melanocytic skin cancer (new cases per 100,000 population)
Males 1990 1,187 1995 1,374
Females 1990 769 1995 857
(continued)
(a) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
Note: Age-standardised to the Australian population at 30 June 1991.
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Table S60 (continued): Indicators for cancer control
Baseline Most recent data
Descriptor Year Value Year Value
Death rate for non-melanocytic skin cancer (deaths per 100,000 population)(a)
Males 1991 2 2000 3
Females 1991 1 2000 1
Incidence of cancer of the trachea, bronchus and lung (new cases per 100,000 population)
Males 1983 73 1998 58
Females 1983 16 1998 23
Death rate for cancer of the trachea, bronchus and lung (deaths per 100,000 population)(a)
Males 1986 63 2000 48
Females 1986 16 2000 20
(a) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
Note: Age-standardised to the Australian population at 30 June 1991.
Sources: AIHW National Mortality Database; AIHW National Hospital Morbidity Database; National Cancer Statistics 
Clearing House.
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Table S61: Indicators for diabetes mellitus
Baseline Most recent data
Descriptor Year Value Year Value
Prevalence rates for Type 1 and Type 2 diabetes in the general population, in the Indigenous 
population, and among people from non-English-speaking backgrounds (NESB) (per 100,000 
population)
Self-reported diabetes, all ages
Males, Type 1 diabetes, general population 1995 283
Males, Type 2 diabetes, general population 1995 2,772
Females, Type 1 diabetes, general population 1995 245
Females, Type 2 diabetes, general population 1995 2,461
Males, Type 2 diabetes, NESB(a) 1995 4,174
Females, Type 2 diabetes, NESB(a) 1995 3,565
Males, all diabetes, Indigenous population 1994 7,597
Females, all diabetes, Indigenous population 1994 9,763
Measured diabetes, age 25 and over
Males, Type 2 diabetes, general population 1999–2000 7,753
Females, Type 2 diabetes, general population 1999–2000 6,156
Incidence rates for Type 1 diabetes in the general population (per 100,000 population 
aged less than 15)
Males, Type 1 diabetes, general population 2000 19
Females, Type 1 diabetes, general population 2000 19
Prevalence rates for obesity (BMI ‡  30) and overweight (25 £ BMI <30) in the general population, and 
among persons with Type 2 diabetes (per 1,000 persons aged 25 and over)(b)
Males, Type 2 diabetes, overweight 1999–2000 266
Males, Type 2 diabetes, obese 1999–2000 622
Females, Type 2 diabetes, overweight 1999–2000 216
Females, Type 2 diabetes, obese 1999–2000 428
Males, general population, overweight 1999–2000 480
Males, general population, obese 1999–2000 187
Females, general population, overweight 1999–2000 294
Females, general population, obese 1999–2000 214
Rates for non-participation(c) in regular, sustained, moderate aerobic exercise in the general 
population, and among persons with Type 2 diabetes (per 1,000 persons aged 25 and over)(b)
Males, Type 2 diabetes, insufficient 1999–2000 292
Males, Type 2 diabetes, sedentary 1999–2000 282
Females, Type 2 diabetes, insufficient 1999–2000 553
Females, Type 2 diabetes, sedentary 1999–2000 124
(continued)
(a) NESB is based on a country of birth other than Australia, New Zealand, United Kingdom or Ireland.
(b) Measured diabetes.
(c) Sedentary persons reported undertaking no leisure-time physical activity in the week prior to interview. Insufficient 
activity is defined as reporting some leisure-time physical activity, but less than 150 minutes total, in the week prior to 
interview.
(d) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
(e) NESB is based on a country of birth other than Australia, New Zealand, United States of America, Canada, South 
Africa, United Kingdom or Ireland.
(f) Mortality and population data is based on Queensland, Western Australia, South Australia & the Northern Territory.
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Table S61 (continued): Indicators for diabetes mellitus
Baseline Most recent data
Descriptor Year Value Year Value
Rates for non-participation(c) in regular, sustained, moderate aerobic exercise in the general 
population, and among persons with Type 2 diabetes (per 1,000 persons aged 25 and over)(b)
Males, general population, insufficient 1999–2000 282
Males, general population, sedentary 1999–2000 140
Females, general population, insufficient 1999–2000 357
Females, general population, sedentary 1999–2000 168
Prevalence rates for high blood pressure among persons with Type 2 diabetes, aged 25–59, 60 and 
over (per 1,000 persons)(b)
Males, aged 25–59 years 1999–2000 607
Males, aged 60 years and over 1999–2000 528
Females, aged 25–59 years 1999–2000 322
Females, aged 60 years and over 1999–2000 552
Prevalence rates for high levels of lipoproteins in the general population, and among persons with 
Type 1 and Type 2 diabetes (per 1,000 persons aged 25 and over)(b)
Males, Type 1 diabetes, total cholesterol 1999–2000 n.a.
Males, Type 2 diabetes, total cholesterol 1999–2000 577
Males, general population, total cholesterol 1999–2000 502
Males, Type 1 diabetes, HDL cholesterol 1999–2000 n.a.
Males, Type 2 diabetes, HDL cholesterol 1999–2000 224
Males, general population, HDL cholesterol 1999–2000 177
Females, Type 1 diabetes, total cholesterol 1999–2000 n.a.
Females, Type 2 diabetes, total cholesterol 1999–2000 692
Females, general population, total cholesterol 1999–2000 496
Females, Type 1 diabetes, HDL cholesterol 1999–2000 n.a.
Females, Type 2 diabetes, HDL cholesterol 1999–2000 241
Females, general population, HDL cholesterol 1999–2000 52
Prevalence rates for fasting hypertriglyceridaemia in the general population and among among 
persons with Type 1 and Type 2 diabetes (per 1,000 persons aged 25 and over)(b)
Males, Type 1 diabetes 1999–2000 n.a.
Males, Type 2 diabetes 1999–2000 77
Males, general population 1999–2000 38
Females, Type 1 diabetes 1999–2000 n.a.
Females, Type 2 diabetes 1999–2000 65
Females, general population 1999–2000 15
(continued)
(a) NESB is based on a country of birth other than Australia, New Zealand, United Kingdom or Ireland.
(b) Measured diabetes.
(c) Sedentary persons reported undertaking no leisure-time physical activity in the week prior to interview. Insufficient 
activity is defined as reporting some leisure-time physical activity, but less than 150 minutes total, in the week prior to 
interview.
(d) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
(e) NESB is based on a country of birth other than Australia, New Zealand, United States of America, Canada, South 
Africa, United Kingdom or Ireland.
(f) Mortality and population data is based on Queensland, Western Australia, South Australia & the Northern Territory.
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Table S61 (continued): Indicators for diabetes mellitus
Baseline Most recent data
Descriptor Year Value Year Value
Rate of new cases of persons with end-stage renal disease with diabetic nephropathy as a causal 
factor (per 1,000 persons aged 25–84 years)
Total 1991 130 2000 229
Prevalence rate for foot problems among clinically diagnosed persons with diabetes (per 1,000 
persons)
Current foot ulcer 1999 14 2000 17
Previous foot ulcers 1999 30 2000 33
Incidence rate for myocardial infarction or stroke among clinically diagnosed persons with diabetes 
(per 1,000 persons)
Myocardial infarction 1999 12 2000 10
Stroke 1999 10 2000 8
Hospital separation rate for end-stage renal disease (ICD-9-CM 584–585, ICD-10-AM N17–N18) as the 
principal diagnosis with diabetes (ICD-9-CM 250, ICD-10-AM E10–E14) as an associated diagnosis 
(per 100,000 persons)
Males 1993–94 7 1999–00 15
Females 1993–94 6 1999–00 12
Hospital separation rate for coronary heart disease (ICD-9-CM 410–414, ICD-10-AM I20–I25) or stroke 
(ICD-9-CM 430–438, ICD-10-AM G45, G46 & I10–I69) as the principal diagnosis with diabetes as an 
associated diagnosis (per 100,000 persons)
Males 1993–94 156 1999–00 244
Females 1993–94 93 1999–00 131
Hospital separation rate for diabetes both as the principal diagnosis and as an associated diagnosis 
with conditions other than end-stage renal disease and coronary heart disease/stroke as the 
principal diagnosis (per 100,000 persons)
Males 1993–94 858 1999–00 1,606
Females 1993–94 703 1999–00 1,265
Death rates for diabetes (ICD-9 250, ICD-10 E10–E14) in the general population, in the Indigenous 
population, and among people from non-English-speaking backgrounds (NESB) (per 100,000 
population)
Males, general population(d) 1991 16 2000 17
Females, general population(d) 1991 11 2000 11
Males, NESB(d)(e) 1991 22 2000 21
Females, NESB(d)(e) 1991 19 2000 15
Males, Indigenous population(f) 1998–2000 117
Females, Indigenous population(f) 1998–2000 152
(continued)
(a) NESB is based on a country of birth other than Australia, New Zealand, United Kingdom or Ireland.
(b) Measured diabetes.
(c) Sedentary persons reported undertaking no leisure-time physical activity in the week prior to interview. Insufficient 
activity is defined as reporting some leisure-time physical activity, but less than 150 minutes total, in the week prior to 
interview.
(d) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
(e) NESB is based on a country of birth other than Australia, New Zealand, United States of America, Canada, South 
Africa, United Kingdom or Ireland.
(f) Mortality and population data is based on Queensland, Western Australia, South Australia & the Northern Territory.
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Table S61 (continued): Indicators for diabetes mellitus
Baseline Most recent data
Descriptor Year Value Year Value
Death rates for coronary heart disease (ICD-9 410–414, ICD-10 I20–I25) and stroke (ICD-9 430–438, 
ICD-AM G45, G46 & I10–I69) as the underlying cause of death where diabetes (ICD-9 250, ICD-10 
E10–E14) was an associated cause in the general population, and among people from non-English-
speaking backgrounds (NESB) (per 100,000 population)
Coronary heart disease
Males, general population 1997 16 2000 15
Females, general population 1997 10 2000 8
Males, NESB(e) 1997 20 2000 17
Females, NESB(e) 1997 13 2000 11
Stroke
Males, general population 1997 5 2000 4
Females, general population 1997 3 2000 3
Males, NESB(e) 1997 5 2000 6
Females, NESB(e) 1997 4 2000 4
Self-assessed health status of persons with and without diabetes (per 1,000 persons aged 25 
and over)
Good, very good or excellent
Males, with diabetes 1999–2000 657
Males, without diabetes 1999–2000 859
Females, with diabetes 1999–2000 684
Females, without diabetes 1999–2000 870
Fair or poor
Males, with diabetes 1999–2000 343
Males, without diabetes 1999–2000 141
Females, with diabetes 1999–2000 316
Females, without diabetes 1999–2000 130
(a) NESB is based on a country of birth other than Australia, New Zealand, United Kingdom or Ireland.
(b) Measured diabetes.
(c) Sedentary persons reported undertaking no leisure-time physical activity in the week prior to interview. Insufficient 
activity is defined as reporting some leisure-time physical activity, but less than 150 minutes total, in the week prior to 
interview.
(d) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
(e) NESB is based on a country of birth other than Australia, New Zealand, United States of America, Canada, South 
Africa, United Kingdom or Ireland.
(f) Mortality and population data is based on Queensland, Western Australia, South Australia & the Northern Territory.
Note: Age-standardised to the Australian population at 30 June 1991.
Sources: AIHW National Mortality Database; AIHW National Hospital Morbidity Database; AIHW National Diabetes Register; 
AIHW analysis of 1999–2000 Australian Diabetes, Obesity and Lifestyle Study; 1995 National Health Survey, 1995 National 
Nutrition Survey; 1994 National Aboriginal and Torres Strait Islander Survey; Disney 1992; Russ 2001; NADC National 
Diabetes Clinical Data Collection Project.
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Table S62: Indicators for injury prevention and control(a)(b)
Baseline Most recent data
Descriptor Year Value Year Value
Death rate for injury and poisoning (per 100,000 population)(c)
Persons 1992 44 2000 40
Hospital separation rate for injury and poisoning in the total population (per 100,000 population)
Persons 1991–92 1,714 1999–00 2,300
Death rate ratio comparing the injury status of males and females
Male:female 1992 2.6 2000 2.6
Death rate ratio comparing the injury status among people living in rural and remote areas 
with the general population
Males, capital cities 1991–1995 0.9 1997–2000 0.9
Males, other metropolitan areas 1991–1995 1.0 1997–2000 1.0
Males, large rural centres 1991–1995 1.1 1997–2000 1.0
Males, small rural centres 1991–1995 1.1 1997–2000 1.2
Males, other rural areas 1991–1995 1.3 1997–2000 1.3
Males, remote centres 1991–1995 1.5 1997–2000 1.6
Males, other remote areas 1991–1995 1.9 1997–2000 1.9
Females, capital cities 1991–1995 0.9 1997–2000 0.9
Females, other metropolitan areas 1991–1995 1.0 1997–2000 1.0
Females, large rural centres 1991–1995 1.0 1997–2000 1.1
Females, small rural centres 1991–1995 1.0 1997–2000 1.1
Females, other rural areas 1991–1995 1.2 1997–2000 1.2
Females, remote centres 1991–1995 1.3 1997–2000 1.7
Females, other remote areas 1991–1995 2.0 1997–2000 1.7
Death rate for road transport-related injury in the total population and among males aged 15–24 
years (per 100,000 population)(c)
Total population 1992 11 2000 9
Males aged 15–24 years 1992 30 2000 27
Hospital separation rate for road transport-related injury in the total population and among males 
aged 15–24 years (per 100,000 population)
Total population 1990 232 1999–00 241
Males aged 15–24 years 1990 858 1999–00 567
Death rate due to falls among people aged 65 years and over (per 100,000 population)
Persons aged 65 years and over 1992 40 1998 39(d)
(continued)
(a) All indicators: case selection for most recent data is in terms of the ranges of ICD-10 External Cause codes considered 
to be most comparable to the ranges of ICD-9 External Cause in terms of which the indicators were originally defined. 
(b) All indicators based on hospital data: case inclusion and calculation follow the NHPA Report Injury Prevention and 
Control 1997. The values reflect numbers of separation events included in the Australian Hospital Morbidity Data 
collection. They should not be interpreted as valid measures of levels or trends in the population incidence of injury.
(c) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
(d) Accidental falls categories under ICD-9 (E880–E888) and ICD-10 (W00–W19) are not comparable without re-
specification of the indicator. The reported value is for the last year coded to ICD-9. The (non-comparable) value for 
ICD-10 range W00–W19 in 2000 is 15 deaths per 100,000 population.
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Table S62 (continued): Indicators for injury prevention and control(a)(b)
Baseline Most recent data
Descriptor Year Value Year Value
Hospital separation rate due to falls among people aged 65 years and over (per 100,000 population)
Males aged 65–74 years 1991–92 668 1999–00 1,087
Males aged 75 years and over 1991–92 2,242 1999–00 4,364
Females aged 65–74 years 1991–92 1,225 1999–00 1,599
Females aged 75 years and over 1991–92 4,554 1999–00 6,758
Hospital separation rate due to falls among children aged 0–4 and 5–9 years (per 100,000 population)
Children aged 0–4 years 1991–92 502 1999–00 630
Children aged 5–9 years 1991–92 868 1999–00 800
Death rate for homicide among people aged 20–39 years (per 100,000 population)(c)
Males 1992 3 2000 3
Females 1992 2 2000 2
Death rate for homicide among children aged 0–9 years (per 100,000 population)(d)
Children aged 0–9 years 1992 1 2000 1
Death rate for injury resulting from fire, burns and scalds among people aged 55 years and over 
(per 100,000 population)(c)
Persons aged 55 years and over 1992 2 2000 1
Hospital separation rate for injury resulting from fire, burns and scalds among children aged 0–4 years 
(per 100,000 population)
Boys 1991–92 167 1999–00 221
Girls 1991–92 127 1999–00 167
Hospital separation rate due to poisoning among children aged 0–4 years (per 100,000 population)
Children aged 0–4 years 1991–92 302 1999–00 267
Death rate for drowning in the total population and among children aged 0–4 years 
(per 100,000 population)(c)
Total population 1992 2 2000 1
Children aged 0–4 years 1992 6 2000 4
Hospital separation rate for near drowning among children aged 0–4 years (per 100,000 population)
Children aged 0–4 years 1991–92 30 1999–00 25
Incidence rate for persistent spinal cord injury from traumatic causes (per 100,000 population)
Persons 1995–96 1 1999–2000 1
(a) All indicators: case selection for most recent data is in terms of the ranges of ICD-10 External Cause codes considered 
to be most comparable to the ranges of ICD-9 External Cause in terms of which the indicators were originally defined. 
(b) All indicators based on hospital data: case inclusion and calculation follow the NHPA Report Injury Prevention and 
Control 1997. The values reflect numbers of separation events included in the Australian Hospital Morbidity Data 
collection. They should not be interpreted as valid measures of levels or trends in the population incidence of injury.
(c) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
(d) Accidental falls categories under ICD-9 (E880–E888) and ICD-10 (W00–W19) are not comparable without re-
specification of the indicator. The reported value is for the last year coded to ICD-9. The (non-comparable) value for ICD-
10 range W00–W19 in 2000 is 15 deaths per 100,000 population.
Note: Age-standardised to the Australian population at 30 June 1991.
Sources: DHFS & AIHW 1998; AIHW National Mortality Database; AIHW National Hospital Morbidity Database; AIHW NISU 
unpublished data.
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Table S63: Indicators for mental health, focusing on depression
Baseline Most recent data
Descriptor Year Value Year Value
Prevalence rate for depressive disorders (per 100,000 population)
Males 1997 4 n.a. n.a.
Females 1997 7 n.a. n.a.
Prevalence rate for anxiety disorders (per 100,000 population)
Males 1997 7 n.a. n.a.
Females 1997 12 n.a. n.a.
Hospital separation rate for suicide and self-inflicted injury among young adults aged 15–24 years, 
and older people aged 65 years and over (per 100,000 population)
Males, aged 15–24 years 1993–94 142 1999–00 193
Females, aged 15–24 years 1993–94 236 1999–00 337
Males, aged 65 years and over 1993–94 38 1999–00 44
Females, aged 65 years and over 1993–94 30 1999–00 44
Death rate for suicide among young adults aged 15–24 years and people aged 65 years and over (per 
100,000 population)(a)
Males, aged 15–24 years 1986 21 2000 19
Females, aged 15–24 years 1986 5 2000 6
Males, aged 65 years and over 1986 30 2000 22
Females, aged 65 years and over 1986 7 2000 6
Death rate for suicide in urban, rural and remote areas among young adults aged 15–24 years 
(per 100,000 population)(a)
Males, 15–24 years, capital cities 1986–1996 22 1990–2000 22
Males, 15–24 years, other metropolitan 
areas 1986–1996 24 1990–2000 26
Males, 15–24 years, large rural centres 1986–1996 27 1990–2000 29
Males, 15–24 years, small rural centres 1986–1996 31 1990–2000 29
Males, 15–24 years, other rural areas 1986–1996 33 1990–2000 35
Males, 15–24 years, remote centres 1986–1996 30 1990–2000 38
Males, 15–24 years, other remote areas 1986–1996 41 1990–2000 57
Females, 15–24 years, capital cities 1986–1996 5 1990–2000 5
Females, 15–24 years, other 
metropolitan areas 1986–1996 4 1990–2000 5
Females, 15–24 years, large rural 
centres 1986–1996 4 1990–2000 6
Females, 15–24 years, small rural 
centres 1986–1996 4 1990–2000 5
Females, 15–24 years, other rural areas 1986–1996 5 1990–2000 5
Females, 15–24 years, remote centres 1986–1996 5 1990–2000 6
Females, 15–24 years, other remote 
areas 1986–1996 6 1990–2000 7
(continued)
(a) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
AW2002 end matter  Page 423  Wednesday, June 26, 2002  5:43 PM
424  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
Table S63 (continued): Indicators for mental health, focusing on depression
Baseline Most recent data
Descriptor Year Value Year Value
Death rate for suicide in urban, rural and remote areas among people aged 65 years and over 
(per 100,000 population)(a)
Males, 65+ years, capital cities 1986–1996 26 1990–2000 24
Males, 65+ years, other metropolitan 1986–1996 30 1990–2000 28
Males, 65+ years, large rural centres 1986–1996 28 1990–2000 26
Males, 65+ years, small rural centres 1986–1996 30 1990–2000 27
Males, 65+ years, other rural areas 1986–1996 33 1990–2000 31
Males, 65+ years, remote centres 1986–1996 50 1990–2000 46
Males, 65+ years, other remote areas 1986–1996 39 1990–2000 36
Females, 65+ years, capital cities 1986–1996 8 1990–2000 7
Females, 65+ years, other metropolitan 1986–1996 5 1990–2000 6
Females, 65+ years, large rural centres 1986–1996 7 1990–2000 5
Females, 65+ years, small rural centres 1986–1996 5 1990–2000 5
Females, 65+ years, other rural areas 1986–1996 4 1990–2000 4
Females, 65+ years, remote centres 1986–1996 0 1990–2000 0
Females, 65+ years, other remote areas 1986–1996 7 1990–2000 6
(a) Comparability factor applied to enable comparison between ICD-9 (baseline) and ICD-10 (most recent) coded data.
Note: Age-standardised to the Australian population at 30 June 1991.
Sources: AIHW National Mortality Database; AIHW National Morbidity Database; DHAC & AIHW 1999b.
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Methods and conventions 
Methods
Details of methods used in particular sections of the report are included in the text and
boxes, and in footnotes to Þgures and tables. Entries in columns of tables may not add
to the totals shown, due to rounding.
Age standardisation has been used to facilitate the comparison of populations with
differing age compositions, either different populations at one time or the same
population at different times. The 1991 Australian population (ABS 1993) has been used
as the standard population for all intra-Australia comparisons. The 1988 Australian
population was used for these comparisons in editions of Australia’s Health prior to the
1996 edition; some statistics may thus differ slightly from those in previous editions.
The European and the World Standard Populations have been used for some
international comparisons. Details of these standard populations are provided.
Table A1: Age composition of the Australian population at 30 June 1991, and of European and 
World Standard Populations
Age group (years) Australia, 30 June 1991 European Std World Std
0 259,085 1,600 2,400
1–4 1,012,618 6,400 9,600
5–9 1,272,208 7,000 10,000
10–14 1,241,619 7,000 9,000
15–19 1,364,074 7,000 9,000
20–24 1,396,764 7,000 8,000
25–29 1,399,663 7,000 8,000
30–34 1,425,735 7,000 6,000
35–39 1,328,387 7,000 6,000
40–44 1,294,271 7,000 6,000
45–49 1,029,145 7,000 6,000
50–54 846,934 7,000 5,000
55–59 725,950 6,000 4,000
60–64 736,868 5,000 4,000
65–69 671,390 4,000 3,000
70–74 510,755 3,000 2,000
75–79 384,495 2,000 1,000
80–84 229,828 1,000 500
85 and over 154,247 1,000 500
Total 17,284,036 100,000 100,000
Sources: ABS 1993; WHO 1996.
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Within Australia, most regional comparisons are among States and Territories. For
within-State comparisons, Australian Bureau of Statistics sources use capital city
statistical areas and the rest of each State. DeÞnitions for regional comparisons from
other sources are not consistent, and are stated at appropriate places in the text.
Average annual rates of change or growth rates have been calculated as geometric rates:
Average rate of change 
where Pn = value in later time period
Po = value in earlier time period
N = number of years between the two time periods.
The classiÞcation of deaths follows the Tenth Revision of the International ClassiÞcation
of Diseases (WHO 1992). Diseases treated in hospitals and the procedures performed
during a hospital stay are classiÞed using the Þrst edition of the International Statistical
ClassiÞcation of Diseases and Related Health Problems, 10th Revision, Australian
ModiÞcation (ICD-10-AM) (NCCH 1998).
Symbols
$ Australian dollars, unless otherwise speciÞed
Ñ nil or rounded to zero
% per cent
g gram
kg kilogram
kJ kilojoule
km 2 square kilometres
Õ000 thousands
m million
mm millimetre
mm Hg millimetres of mercury
mmol/L millimoles per litre
n.a. not available
. . not applicable
nec not elsewhere classiÞed
n.p. not published by the data source
npr not previously reported
wk week
Pn Po⁄( )1 N⁄ 1–( ) 100·=
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> more than
< less than
‡ more than or equal to
£ less than or equal to
* value subject to sampling variability too high for most practical
purposes and/or the relative standard error is 25% to 50%.
** value subject to sampling variability too high for most practical
purposes and/or the relative standard error is more than 50%.
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Abbreviations
ABS Australian Bureau of Statistics
ACIR Australian Childhood Immunisation Register
AHMAC Australian Health MinistersÕ Advisory Council 
AIDS Acquired immune deÞciency syndrome
AIHW Australian Institute of Health and Welfare
AN-DRG Australian National Diagnosis Related Group
ANZDATA Australian and New Zealand Dialysis and Transplant Registry
AR-DRG Australian ReÞned Diagnosis Related Group
AusDiab Australian Diabetes, Obesity & Lifestyle Study 
BEACH Bettering the Evaluation And Care of Health
BMI Body mass index
CABG Coronary artery bypass grafting
CHD Coronary heart disease
COPD Chronic obstructive pulmonary disease
CVD Cardiovascular disease
DALY Disability-adjusted life years
DMFT Decayed, missing or Þlled permanent teeth
dmft Decayed, missing or Þlled primary teeth
DTP Diphtheria, tetanus, pertussis (triple antigen vaccine)
DVA Department of VeteransÕ Affairs 
GIFT Gamete intra-fallopian transfer
GP General practitioner
GPSCU General Practice Statistics and ClassiÞcation Unit
Hib Haemophilus inßuenzae type b
HDL high-density lipoprotein
HIC Health Insurance Commission
HIV Human immunodeÞciency virus
ICD-10 International ClassiÞcation of Diseases, 10th Revision
ICD-10-AM International ClassiÞcation of Diseases, 10th Revision, Australian
ModiÞcation
ICD-9 International ClassiÞcation of Diseases, 9th Revision
ICD-9-CM International ClassiÞcation of Diseases, 9th Revision, Clinical
ModiÞcation
ICF International ClassiÞcation of Functioning, Disability and Health
ICIDH International ClassiÞcation of Impairments, Disabilities and Handicaps
ID Intravenous drug
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Abbreviations of places
ACT Australian Capital Territory
Aust Australia
Can Canada
Fra France
Ger Germany
Jpn Japan
NSW New South Wales
NT Northern Territory
NZ New Zealand
Qld Queensland
SA South Australia
IRSD Index of relative socioeconomic disadvantage
LDL low-density lipoprotein
MMR Measles, mumps and rubella (vaccine)
NACCHO National Aboriginal Community Controlled Health Organisation
NADC National Association of Diabetes Centres
NDSHS National Drug Strategy Household Survey
NESB Non-English-speaking background
NHIA National Health Information Agreement
NHIMAC National Health Information Management Advisory Committee
NHIMG National Health Information Management Group
NHMRC National Health and Medical Research Council
NHPA National Health Priority Area
NHPC National Health Performance Committee
NMSC Non-melanocytic skin cancer
NNDSS National NotiÞable Diseases Surveillance System
OECD Organisation for Economic Co-operation and Development
RPBS Repatriation Pharmaceutical BeneÞts Scheme
RRMA Rural, Remote and Metropolitan Areas classiÞcation
RRV Ross River virus
SAAP Supported Accommodation Assistance Program
SBP Systolic blood pressure
SCRCSSP Steering Committee for the Review of Commonwealth/State Service
Provision
SEIFA Socio-Economic Indexes for Areas
SMR Standardised mortality ratio
UN United Nations
WHO World Health Organization
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Tas Tasmania
UK United Kingdom
USA United States of America
USSR Former Union of Soviet Socialist Republics
Vic Victoria
WA Western Australia
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Glossary
Aboriginal: A person of Aboriginal descent who identiÞes as an Aboriginal and is
accepted as such by the community in which he or she lives.
accommodation (of eye): How the eye automatically adjusts so it can focus at various
distances, mainly by changing the shape of its lens.
acute: Coming on sharply and often brief, intense and severe.
acute hospitals: Public, Department of VeteransÕ Affairs (repatriation) and private
hospitals which provide services primarily to admitted patients with acute or
temporary ailments. The average length of stay is relatively short.
Addiction/addictive use: A condition marked by repeated and compulsive activity in a
manner or at a level that is harmful or dangerous. Term is most often applied to
addictive drug use, such as with alcohol, tobacco or other drugs, but could be applied
to gambling or many other practices.
admission: Admission to hospital. In this report, the number of separations has been
taken as the number of admissions. Hence an admission rate is the same as a separation
rate.
admitted patient: A patient who undergoes a hospitalÕs formal admission process. See
Box 5.6, page 283.
affective disorders: Mood disorders such as depression, mania and bipolar affective disorder.
(Do not include anxiety disorders, which are classiÞed as a separate group.)
age-specific death rate: See Box 2.6, page 68.
age-specific rate: A rate for a speciÞc age group. The numerator and denominator relate
to the same age group.
age standardisation: A method of removing the inßuence of age when comparing
populations with different age structures. This is usually necessary because the rates of
many diseases vary strongly (usually increasing) with age. The age structures of the
different populations are converted to the same ÔstandardÕ structure, then the disease
rates that would have occurred with that structure are calculated and compared.
age-standardised death rate: See Box 2.6, page 68.
agoraphobia: Fear of being in public places from which it may be difÞcult to escape.
Alzheimer’s disease: A disease (named after a German physician) in which there is
progressive loss of brainpower shown by worsening short-term memory, confusion and
disorientation. A form of dementia. 
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ambulatory care: Care provided to hospital patients who are not admitted to the hospital,
such as patients of emergency departments and outpatients clinics. The term is also
used to refer to care provided to patients of community-based (non-hospital) healthcare
services.
anaemia: A reduced level of haemoglobin, the protein that carries oxygen in the red
blood cells. Has many causes, including bleeding (loss of red blood cells), low
production of red blood cells and processes that damage them. Can cause paleness,
tiredness and even breathlessness.
AN-DRGs: See DRGs.
angina: Temporary chest pain or discomfort when the heartÕs own blood supply is
inadequate to meet extra needs, as in exercise. See also cardiovascular disease.
anencephalus: A congenital condition with partial or complete absence of the skull and
hemispheres of the brain.
angioplasty: A method of reducing a blockage in an artery by opening out a balloon
placed inside the artery at the point of narrowing. If the artery is a coronary artery the
procedure is technically known as percutaneous transluminal coronary angioplasty
(PTCA).
anxiety disorders: A group of mental disorders marked by excessive feelings of
apprehension, worry, nervousness and stress. Includes panic disorder, various phobias,
generalised anxiety disorder, obsessive–compulsive disorder and post-traumatic stress disorder.
arrhythmia: A disturbed rhythm of the heart beatÑeither too fast, too slow or irregular.
arthritis: A group of disorders in which there is inßammation of the joints, which can
become stiff, painful, swollen or deformed. The two main types of arthritis are
osteoarthritis and rheumatoid arthritis.
asthma: An inßammatory disease of the air passages that makes them prone to narrow
too easily and too much, causing episodes of shortness of breath and wheezing or
coughing. The narrowing is due to many ÔtriggersÕ which include the house dust mite,
exercise, pollens, cold weather, throat and chest infections, tobacco smoke and other
factors.
atherosclerosis: A process that gradually clogs arteries, through fatty and Þbre-like
deposits that build up on the inner walls of the arteries. It is the main underlying
condition in heart attack, angina, stroke and peripheral vascular disease.
atrial fibrillation: A condition marked by an irregular rapid heart beat. Arises because the
heartÕs collecting chambers (atria) stop beating rhythmically and quiver uselessly
(Þbrillate).
auto-immune diseases: Diseases, such as rheumatoid arthritis and Type 1 diabetes, in which
the immune system reacts against body tissues, damaging them.
available beds: Beds immediately available for use by admitted patients.
average length of stay (ALOS): The average of the length of stay for admitted patient
episodes.
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benchmark: A standard or point of reference for measuring quality or performance. See
also benchmarking.
benchmarking: A continuous process of measuring quality or performance against the
highest standards. See also benchmark.
bipolar affective disorder: A mental disorder where the person may be depressed at one
time and manic at another. Formerly known as manic depression.
blood cholesterol: Fatty substance produced by the liver and carried by the blood to
supply the rest of the body. Its natural function is to supply material for cell walls and
for steroid hormones, but if levels in the blood become too high this can lead to
atherosclerosis and heart disease.
body mass index (BMI): The most commonly used method of assessing whether a person
is normal weight, underweight, overweight or obese. Calculated by dividing the
personÕs weight (in kilograms) by their height (in metres) squared, i.e. . Also
known as QueteletÕs Index. For both men and women, underweight is a BMI below
18.5, acceptable weight is from 18.5 to less than 25, overweight is 25 and above but less
than 30, and obese is 30 and over. 
bronchitis: Inßammation of the main air passages (the bronchi). May be acute (due to
infection) or chronic (most often due to tobacco smoking).
campylobacteriosis: A disease usually marked by diarrhoea, abdominal pain, fever,
nausea and vomiting for a few days, caused by some types of Campylobacter bacteria
and often food-borne.
cancer: A range of diseases where some of the bodyÕs cells begin to multiply out of
control, can invade and damage the area around them, and can also spread to other
parts of the body to cause further damage.
cardiovascular disease: Any disease of the heart (cardio) or blood vessels (vascular).
Includes heart attack, angina, stroke and peripheral vascular disease. Also known as
circulatory disease. 
capital expenditure: Expenditure on large-scale Þxed assets (for example, new buildings
and equipment with a useful life extending over a number of years).
casemix: The range and types of patients (the mix of cases) treated by a hospital or other
health service. This provides a way of describing and comparing hospitals and other
services for planning and managing health care. Casemix classiÞcations put patients
into manageable numbers of groups with similar conditions that use similar healthcare
resources, so that the activity and cost-efÞciency of different hospitals can be compared.
See DRGs—diagnosis related groups.
cause of death: From information reported on the medical certiÞcate of cause of death,
each death is classiÞed by the underlying cause of death according to rules and
conventions of the 10th revision of the International ClassiÞcation of Diseases. The
underlying cause is deÞned as the disease that initiated the train of events leading
directly to death. Deaths from injury or poisoning are classiÞed according to the
circumstances of the violence which produced the fatal injury, rather than to the nature
of the injury.
kg m2‚
AW2002 end matter  Page 435  Wednesday, June 26, 2002  5:43 PM
436  Australia’s Health 2002
TRIM SIZE 175 mm Wide x 250 mm Deep
cerebrovascular disease: See stroke.
chemotherapy: The use of drugs (chemicals) to prevent or treat disease, with the term
usually being applied to treatment for cancer rather than for other uses.
cholesterol: see blood cholesterol.
chronic: Persistent and long-lasting.
chronic bronchitis: Long-term condition with inßammation of the bronchi, the lungÕs
main air passages, causing frequent coughing attacks and coughing up of mucus. 
chronic diseases: Term applied to a diverse group of diseases, such as heart disease,
cancer and arthritis (to name a few), that tend to be long-lasting and persistent in their
symptoms or development. Although these features also apply to some communicable
diseases (infections), the general term chronic diseases is usually conÞned to non-
communicable diseases.
chronic obstructive pulmonary disease (COPD): Serious, progressive and disabling long-
term lung disease where damage to the lungs, usually due to both emphysema and
chronic bronchitis, obstructs oxygen intake and causes increasing shortness of breath. By
far the greatest cause is cigarette smoking.
circulatory disease: See stroke.
cirrhosis: Permanently damaged structure of the liver due to extensive death of its cells
with resultant scarring. Main causes are chronic alcohol abuse and hepatitis C.
cohort: A group of individuals being studied who have experienced the same event at a
speciÞed period in time, e.g. Ôbirth cohortÕ refers to people born in the same year.
colonoscopy: A procedure whereby the inside of the large bowel (colon) is viewed using
a long ßexible tube inserted through the anus.
colorectal cancer: Cancer of the colon (the lower 1.5 to 2 metres of the intestine) or of the
rectum (the Þnal 15 cm at the end of the colon, ending with the anus).
communicable diseases (infectious diseases): Diseases or illnesses due to infectious
organisms or their toxic products. Communication to a person may occur directly or
indirectly via contact with other humans, animals or other environments that harbour
the organism.
co-morbidity: When a person has two or more health problems at the same time.
complication: A secondary problem that arises from or occurs with a disease or its
treatment (such as surgery), worsening the patientÕs condition and making treatment
more complicated.
confidence interval: A statistical term describing a range (interval) of values within which
we can be ÔconÞdentÕ that the true value lies, usually because it has a 95% or higher
chance of doing so.
congenital: A condition that is recognised at birth, or that is believed to have been
present since birth, including conditions which are inherited or caused by
environmental factors.
coronary heart disease: See ischaemic heart disease.
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crude death rate: See Box 2.6, page 68.
cryptosporidiosis: A disease usually marked by diarrhoea with cramping abdominal pain
and other symptoms, caused by Cryptosporidiosis parvum, a protozoan parasite and
transmitted directly from person to person, or foodborne.
dementia: A general and worsening loss of brain power such as memory, understanding
and reasoning.
dentate: Having one or more natural teeth.
depression: A mood disorder with prolonged feelings of being sad, hopeless, low and
inadequate, with a loss of interest or pleasure in activities and often with suicidal
thoughts or self-blame.
diabetes (diabetes mellitus): A chronic condition in which the body makes too little of the
hormone insulin or cannot use it properly. This raises the blood level of the bodyÕs
major energy source, the sugar glucose, and causes other widespread disturbance of the
bodyÕs energy processes. For the three main types of diabetes see Type 1 diabetes, Type 2
diabetes and gestational diabetes.
dialysis/haemodialysis: A process used to treat kidney failure. A machine is connected to
the patientÕs bloodstream so it can take on the role of the kidneys by removing excess
substances and waste from the blood.
diphtheria: A bacterial infection that usually starts with soreness of the throat and tonsils
but which can also affect other parts of the body and become severe enough to block
breathing. Preventable by vaccine.
direct bill: The process by which a medical practitioner or optometrist sends the bill for
services direct to Medicare, often referred to as bulk billing.
disability: A concept of several dimensions relating to an impairment in body structure
or function, a limitation in activities (such as mobility and communication), a restriction
in participation (involvement in life situations such as work, social interaction and
education), and the affected personÕs physical and social environment.
disability-adjusted life year (DALY): Years of healthy life lost through premature death or
living with disability due to illness or injury.
donovanosis: Donovanosis which was previously called granuloma inguinale, is caused
by the bacteria Chlamydia granulomatis. It features painless genital ulcers with tissue
destruction, and can result in secondary infection and scarring.
DRGs (diagnosis related groups): A widely used type of casemix classiÞcation system. In
the case of Australian acute hospitals, AN-DRGs (Australian National Diagnosis
Related Groups) classify admissions into groups with similar clinical conditions (related
diagnoses) and similar resource usage. This allows the activity and performance of
hospitals to be compared on a common basis. See also casemix.
dysthymia: A disorder characterised by constant or constantly recurring chronic
depression of mood, lasting at least 2 years.
emphysema: A long-term lung disease where over expansion or destruction of the lung
tissue blocks oxygen intake, leading to shortness of breath and other problems.
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endoscopy: The viewing of internal parts of the body, such as the inside of the lower
bowel (the colon) with a colonoscope.
encephalitis: Inßammation of the brain.
encephalocele: An abnormal protrusion of the brain through a congenital opening in the
skull. Encephaloceles can occur with spina biÞda or as a separate condition.
enterohaemorrhagic E. coli infection: A disease marked by diarrhoea that can be mild or
severe and bloody, and sometimes also the haemolytic-uraemic syndrome (sudden
kidney failure and anaemia in children) and other symptoms. It is caused by some
types of E. coli bacteria and is usually food-borne.
epidemic: An outbreak of a disease or its occurrence at a level that is clearly higher than
previously existed.
epidemiology: The study of the patterns and causes of health and disease in populations,
and the application of this study to improve health.
expectation of life: See life expectancy.
external cause: Environmental event, circumstance and/or condition as the cause of
injury, poisoning and/or other adverse effect. Used in disease classiÞcation.
foetal death: Birth of a foetus weighing at least 400 grams (or, where birthweight is
unavailable, of at least 20 weeks gestation), which shows no signs of life. Commonly
referred to as stillbirth.
foetal death rate: Number of foetal deaths per 1,000 total births (foetal deaths plus live
births).
freestanding day hospital facility: A private hospital where only minor operations and
other procedures not requiring overnight stay are performed, not forming part of any
private hospital providing overnight care.
gastroscopy: A procedure whereby the inside of the stomach is viewed using a ßexible
tube passed down into it via the mouth.
generalised anxiety disorder: A mental disorder where a person is overly and
unrealistically anxious and worried about many things over a long period. One of the
group of anxiety disorders.
gestational diabetes: Diabetes which is Þrst diagnosed during pregnancy (gestation). It
may disappear after pregnancy but signals a high risk of diabetes occurring later on.
gross domestic product (GDP): A statistic commonly used to indicate national wealth. It is
the total market value of goods and services produced within a given period after
deducting the cost of goods and services used up in the process of production but
before deducting allowances for the consumption of Þxed capital.
haemodyalisis: See dialysis.
handicap: A disadvantage resulting from impairment or disability that limits or prevents
the fulÞlment of a role that is normal.
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health: Term relating to whether the body (which includes the mind) is in a good or bad
state. With good health the state of the body and mind are such that a person feels and
functions well, given their circumstances, and can continue to do so for as long as
possible. See also public health.
health indicator: See indicator.
health outcome: A change in the health of an individual or population due to a
preventive or clinical intervention.
health promotion: Activities to improve health and prevent disease.
health status: An individualÕs or populationÕs overall level of health, taking account of
various aspects such as life expectancy, amount of disability, levels of disease risk
factors and so forth.
heart attack: Life threatening emergency that occurs when a vessel supplying blood to
the heart muscle is suddenly blocked completely by a blood clot. The medical term
commonly used for a heart attack is myocardial infarction. See also cardiovascular disease.
heart failure: When the heart cannot pump strongly enough to keep the blood circulating
around the body at  adequate rate.
hepatitis: Inßammation of the liver, which can be due to certain viral infections, alcohol
excess or a range of other causes.
Hib (Haemophilus influenzae type b): A bacterial infection of infants and children that can
cause meningitis, pneumonia and other serious effects. Preventable by vaccine.
Highly specialised drugs: Under Section 100 of the National Health Act, certain drugs (for
example, Cyclosporin) can only be supplied to community patients through hospitals
because the hospitals can provide the facilities or staff necessary for the appropriate use
of the drugs. These drugs are funded by the Commonwealth separately from the PBS.
Hodgkin’s disease (Hodgkin’s lymphoma): A cancer marked by progressive painless
enlargement of lymph nodes throughout the body. A form of lymphoma. Named after
the English physician who described it.
hostel: Establishment for people who cannot live independently but who do not need
nursing care in a hospital or nursing home. Hostels provide board, lodging or
accommodation and cater mostly for the aged, distressed or disabled. Residents are
generally responsible for their own provisions but may be given domestic assistance
such as help with meals, laundry and personal care. 
hypertensive disease: Occurs when blood pressure is high long term, especially when this
leads to damage of the heart, brain or kidneys.
hypomania: A lesser degree of mania characterised by a persistent mild abnormal
elevation of mood and increased activity lasting at least 4 days.
hypospadias: A congenital abnormality of the penis, where its opening is on the
underside rather than at the end.
immunisation: Inducing immunity against infection by the use of antigen to stimulate
the body to produce its own antibodies. See vaccination.
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impairment: Any loss or abnormality of psychological, physiological or anatomical
structure or function. 
incidence: The number of new cases (of an illness or event etc.) occurring during a given
period. Compare with prevalence.
indicator (health indicator): A key statistic that indicates an aspect of population health
status, health determinants, interventions, services or outcomes. Indicators are designed
to help assess progress and performance, as a guide to decision making. They may have
an indirect meaning as well as a direct one; for example, AustraliaÕs overall death rate is
a direct measure of mortality but is often used as a major indicator of population health.
Indigenous: A person of Aboriginal and/or Torres Strait Islander descent who identiÞes
as an Aboriginal and/or Torres Strait Islander and is accepted as such by the
community with which he or she is associated.
inflammation: Local response to injury or infection, marked by local redness, heat,
swelling and pain. Can also occur when there is no clear external cause and the body
reacts against itself, as in the auto-immune disorders.
International Classification of Diseases: The World Health OrganizationÕs internationally
accepted classiÞcation of death and disease. The 10th Revision (ICD-10) is currently in
use. In this report, causes of death classiÞed before 1979 under previous revisions have
been reclassiÞed to ICD-10 by the AIHW.
intervention (for health): Any action taken by society or an individual which Ôsteps inÕ
(intervenes) to improve health, such as medical treatment and preventive campaigns.
insulin: Hormone that is produced by the pancreas and regulates the bodyÕs energy
sources, most notably the sugar glucose.
ischaemia: Reduced or blocked blood supply. See also ischaemic heart disease.
ischaemic heart disease: Heart attack and angina (chest pain). Also known as coronary heart
disease.
length of stay: Duration of hospital stay, calculated by subtracting the date the patient is
admitted from the day of separation. All leave days, including the day the patient went
on leave, are excluded. A same-day patient is allocated a length of stay of 1 day.
life expectancy: An indication of how long a person can expect to live. Technically it is the
number of years of life remaining to a person at a particular age if death rates do not
change.
listeriosis: A disease which normally appears in otherwise healthy people as an acute,
mild fever, sometimes with inßuenza-like symptoms, caused by the bacteria Listeria
monocytogenes and usually foodborne. It can cause more severe symptoms in
newborns, the elderly, people with poor immunity and pregnant women (in whom it
can also cause abortion).
low birthweight: Birth of a baby weighing less than 2,500 grams.
lymphoma: A cancer of the lymph nodes. Lymphomas are divided into two broad types,
Hodgkin’s disease/lymphoma and non-Hodgkin’s lymphoma (NHL).
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major diagnostic categories (MDCs): A high level of groupings of patients used in the AN-
DRG classiÞcation.
malignancy: See cancer.
mammogram: X-ray of the breast. May be used to assess a breast lump or as a screening
test in women with no evidence of cancer.
mania: A mental disorder where the person is overexcited, overactive and excessively
and unrealistically happy and expansive. It is the opposite of depression and can
alternate with it in the same person in what is known as bipolar affective disorder
(formerly known as manic depression). 
manic depression; manic depressive disorder: See bipolar affective disorder; mania; and
depression.
measles: A highly contagious infection, usually of children, that causes ßu-like
symptoms, fever, a typical rash and sometimes serious secondary problems such as
brain damage. Preventable by vaccine. 
median: The midpoint of a list of observations ranked from the smallest to the largest.
Medicare: A national, government-funded scheme that subsidises the cost of personal
medical services, and that covers all Australians to help them afford medical care.
melanoma: A cancer of the bodyÕs cells that contain pigment (melanin), mainly affecting
the skin.
meningitis: Inßammation of the brainÕs covering (the meninges), as can occur with some
viral or bacterial infections.
mental disorders: Disturbances of mood or thought that can affect behaviour and distress
the person or those around them, so the person cannot function normally. Includes
anxiety disorders, depression and schizophrenia.
metastasis: The spread of a cancer from its original site to other parts of the body.
morbidity: Refers to ill health in an individual and to levels of ill health in a population
or group.
mortality: Death. 
motor neurone disease: A disease of the nervous system with progressive wasting of
muscles, weakness and paralysis.
multiple sclerosis: One of the most common nervous system disorders, with varied
symptoms such as loss of control of limbs, sudden vision problems and disturbed
sensations.
mumps: A contagious viral disease marked by acute and painful swelling of the saliva-
producing glands, often similarly affecting the testicles and sometimes other parts.
musculoskeletal: Relating to the muscles, joints and bones.
myocardial infarction: Term still commonly used to mean a heart attack, but more correctly
refers only to those heart attacks which have caused some death of heart muscle.
neonatal death: Death of an infant within 28 days of birth.
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neonatal mortality rate: Number of neonatal deaths per 1,000 live births.
neural tube defects: Defects such as spina biÞda and anencephalus that have arisen in the
neural tube, the part of the embryo that develops into the brain and spinal cord.
neurosis/neurotic disorders: A broad category of mental disorders with anxiety as their
main feature and whose symptoms are mostly exaggerations of normal emotions or
behaviour. Includes anxiety disorders, obsessive–compulsive disorder, stress reactions and
other problems.
non-Hodgkin’s lymphoma: A range of cancers of the lymphatic system (lymph glands and
the channels they are linked to) which are not of the HodgkinÕs variety.
non-admitted patient: A patient who receives care from a recognised non-admitted
patient service/clinic of a hospital.
nursing homes: Establishments which provide long-term care involving regular basic
nursing care to chronically ill, frail, disabled or convalescent people or senile inpatients.
obesity: Marked degree of overweight, deÞned as body mass index 30 and over. See also
overweight.
obsessive–compulsive disorder: A form of anxiety disorder where repeated and unwanted
thoughts and impulses disturb and dominate a person. Often involves rituals such as
excessive-hand washing, checking and counting, which in turn cause anxiety if they are
prevented or out of control. 
occasion of service: Occurs when a patient receives some form of service from a functional
unit of the hospital, but is not admitted.
ophthalmology: A medical specialty dealing with eye diseases.
Organisation for Economic Co-operation and Development (OECD): An organisation of 24
developed countries, including Australia.
osteoarthritis: A chronic and common form of arthritis, affecting mostly the spine, hips,
knees and hands. It Þrst appears from the age of about 30 and is more common and
severe with increasing age.
osteoporosis: Thinning and weakening of the bone substance, with a resulting risk of
fracture.
outcome (health outcome): A health-related change due to a preventive or clinical
intervention or service. (The intervention may be single or multiple and the outcome
may relate to a person, group or population or be partly or wholly due to the
intervention.)
overweight: DeÞned as a body mass index 25 and over but less than 30. See also obesity.
panic disorder: Marked by panic attacks (episodes of intense fear or discomfort) that
occur suddenly and unpredictably.
Pap smear: Papanicolaou smear, a procedure to detect cancer and pre-cancerous
conditions of the female genital tract.
parasuicide: The deliberate or ambivalent act of self-damage which is potentially life-
threatening, but not resulting in death.
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pathology: General term for the study of disease, but often used more speciÞcally for
diagnostic services which examine specimens, such as samples of blood or tissue.
patient-days: The number of full or partial days of stay for patients who were admitted
for an episode of care and who underwent separation during the reporting period. A
patient who is admitted and separated on the same day is allocated 1 patient-day.
performance indicators: Measures of the efÞciency and effectiveness of health services
(hospitals, health centres, etc.) in providing  health care.
perinatal: Pertaining to or occurring in the period shortly before or (usually 28 days)
after birth.
perinatal death: Foetal or neonatal death.
perinatal mortality rate: Number of perinatal deaths per 1,000 total births (foetal deaths
plus live births).
peripheral vascular disease: Pain in the legs due to an inadequate blood supply to them.
pertussis (whooping cough): A highly infectious bacterial disease of the air passages
marked by explosive Þts of coughing and often a whooping sound on breathing in.
Preventable by vaccine.
Pharmaceutical Benefits Scheme (PBS): A national, government-funded scheme that
subsidises the cost of a wide range of pharmaceutical drugs, and that covers all
Australians to help them afford standard medications.
phobia: A form of anxiety disorder in which there is persistent, unrealistic fear of an
object or situation and which interferes with the personÕs life as they seek to avoid the
object of their fear. Different phobias include fear of heights, ßying, open spaces, social
gatherings, animals such as spiders and snakes, etc.
poliomyelitis (polio): Muscle paralysis, wasting and deformity of limbs after infection by
a common virus (poliovirus) that can damage the so-called motor nerves in the spinal
cord. Preventable by vaccine.
post-traumatic stress disorder (PSD): A form of anxiety disorder in which a person has a
delayed and prolonged reaction after being in an extremely threatening or catastrophic
situation such as a war, natural disaster, terrorist attack, serious accident or witnessing
violent deaths.
potential years of life lost (PYLL): Number of potential years of life lost in a population as
a result of premature death.
prescription drugs: Pharmaceutical drugs available only on the prescription of a
registered medical practitioner and available only from pharmacies.
prevalence: The number or proportion (of cases, instances, etc.) present in a population at
a given time. Compare with incidence.
prevention (of disease): Action to reduce or eliminate the onset, causes, complications or
recurrence of disease.
principal diagnosis: The diagnosis describing the problem that was chießy responsible for
the patientÕs episode of care in hospital.
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principal procedure: The most signiÞcant procedure that was performed for treatment of
the principal diagnosis.
private health insurance: See Box 5.5, page 262.
private hospital: A privately owned and operated institution, catering for patients who
are treated by a doctor of their own choice. Patients are charged fees for
accommodation and other services provided by the hospital and relevant medical and
paramedical practitioners. Includes private freestanding day hospital facilities.
private patients: Persons admitted to a private hospital; or persons admitted to a public
hospital who decide to choose the doctor(s) who will treat them and to have private
ward accommodation. This means they will be charged for medical services, food and
accommodation. 
prostate cancer: Cancer of the prostate, the male organ that sits next to the urinary
bladder and contributes to the semen (sperm ßuid).
psychiatric hospitals: Establishments devoted primarily to the treatment and care of
inpatients with psychiatric disorders.
psychosis: A broad grouping for a more severe degree of mental disturbance, often
involving Þxed, false beliefs known as delusions.
public health: Term variously referring to the level of health in the population, to actions
that improve that level or to related study. Activities that aim to beneÞt a population
tend to emphasis prevention, protection and health promotion as distinct from
treatment tailored to individuals with symptoms. Examples include provision of a clean
water supply and good sewerage, conduct of anti-smoking education campaigns and
screening for diseases such as cancer of the breast and cervix.
public hospital: A hospital controlled by a State or Territory health authority. In Australia
public hospitals offer free diagnostic services, treatment, care and accommodation to all
who need it. 
public patient: A patient admitted to a public hospital who has agreed to be treated by
doctors of the hospitalÕs choice and to accept shared ward accommodation. This means
the patient is not charged. 
quintile: A group derived by ranking the population according to speciÞed criteria and
dividing it into Þve equal parts.
radiology: The use or study of X-rays and other rays to help view internal parts of the
body as a guide to diagnosis as well as to treatment and its progress.
real expenditure: Expenditure expressed in terms which have been adjusted for inßation
(for example, in 1989Ð90 dollars). This enables comparisons to be made between
expenditures in different years.
recurrent expenditure: Expenditure on goods and services which are used up during the
year, for example, salaries. It may be contrasted with capital expenditure, such as
expenditure on hospital buildings and large-scale diagnostic equipment, the useful life
of which extends over a number of years.
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refraction: The eyeÕs ability to bend light rays that enter it, to form an image at the back
of the eye.
renal dialysis: A treatment for kidney failure where the patient is connected to a machine
which does the kidneysÕ work by Þltering the blood to control its contents.
revascularisation (‘re-vesseling’): Restoring adequate blood ßow to the heart or other part
of the body, usually after the supply has been reduced or blocked, as in angina or a heart
attack. Revascularisation  includes methods such as angioplasty and bypass graft surgery.
rheumatic fever: An acute, serious disease that affects mainly children and young adults
and can damage the heart valves, the heart muscle and its lining, the joints and the
brain. Is brought on by a reaction to a throat infection by a particular bacterium. Now
very rare in the non-Indigenous population but is still at unacceptably high levels
among Indigenous Australians living in remote areas. See rheumatic heart disease.
rheumatic heart disease: Disease from damaged heart valves caused by childhood attack
of rheumatic fever.
rheumatoid arthritis: A chronic, multi-system disease whose most prominent feature is
joint inßammation, most often affecting the hand joints in symmetrical fashion. Can
occur in all age groups but most commonly appears between ages 20 to 40 years.
Causes not certain but involve auto-immune processes.
risk factor: Any factor which represents a greater risk of a health disorder or other
unwanted condition or event. Some risk factors are regarded as causes of disease,
others are not necessarily so.
rubella (German measles): A contagious viral disease of children and young adults which
has mild symptoms but which often causes serious birth defects if it occurs in a mother
during the Þrst 3 months of pregnancy. Preventable by vaccine.
salmonellosis: a disease commonly marked by sudden onset of headache, abdominal
pain, fever, diarrhoea, nausea and sometimes vomiting, caused by some types of
Salmonella bacteria and often food-borne.
same-day patients: Admitted patients who are admitted and separated on the same day.
schizophrenia: A group of serious mental disorders where imagined and disordered
thoughts are key features, often with problems of behaviour, mood and motivation, and
a retreat from social life.
separation: The formal process by which a hospital records the completion of treatment
and/or care for an admitted patient. See Box 5.6, page 283.
SF-36: Short Form 36Ñwidely used questionnaire to measure general health and
wellbeing.
shigellosis: A disease characterised by acute diarrhoea with fever, nausea and sometimes
other symptoms, usually transmitted directly from person to person via the faecalÐoral
route. It is caused by Shigella species bacteria, including Shigella dysenteriae 1, the
cause of dysentery.
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sign (clinical): An indication of a disorder that is detected by a clinician or other observer
who examines the person affected. Unlike with symptoms, a patient does not necessarily
notice or complain of a sign and many signs are detected only with special techniques
used by the person doing the examination.
social phobia: A persistent, irrational fear of being the focus of attention, or fear of
behaving in a way that will be embarrassing or humiliating.
statistical significance: An indication from a statistical test that an observed difference or
association may be signiÞcant or ÔrealÕ because it is unlikely to be just due to chance. A
statistical result is usually said to be ÔsigniÞcantÕ if it would occur by chance only once
in twenty times or less often.
stent: A metal mesh tube that is expanded within an artery at a point of narrowing and
left there to hold the artery open.
stillbirth: See foetal death.
stroke: When an artery supplying blood to the brain suddenly becomes blocked or
bleeds. Often causes paralysis of parts of the body normally controlled by that area of
the brain, or speech problems and other symptoms.
substance use disorders: Result from harmful use and/or dependence on illicit or licit
drugs, including alcohol, tobacco and prescription drugs. 
suicide: Deliberately ending oneÕs own life.
symptom: Any indication of a disorder that is apparent to the person affected. Compare
with sign (clinical). 
tetanus: A serious infection with a bacterial nerve poison causing spasm of the jaw
muscles (lockjaw) and body muscles generally, from a bacterium entering through a
wound. The disease is preventable by vaccine.
thrombolysis: Emergency Ôclot-bustingÕ drug treatment for a heart attack.
TIA, transient ischaemic attack: A ÔminiÕ stroke, with temporary problems in speech or
paralysis that last for 24 hours or less, often only minutes. A strong warning sign of a
more severe stroke.
Torres Strait Islander: A person of Torres Strait Islander descent who identiÞes as a Torres
Strait Islander and is accepted as such by the community in which he or she lives.
Type 1 diabetes: A form of diabetes usually arising in childhood or youth (Ôjuvenile onsetÕ),
marked by a complete lack of insulin and needing insulin replacement for survival.
Type 2 diabetes: The most common form of diabetes, occurring mostly in people aged
40 years and over and marked by reduced or less effective insulin.
tuberculosis: A bacterial disease that affects the lungs especially, with serious fever-like
symptoms and destruction of tissue. It can spread to other parts of the body, causing
secondary problems and often death if not treated.
underweight: DeÞned as a body mass index less than 18.5.
AW2002 end matter  Page 446  Wednesday, June 26, 2002  5:43 PM
Glossary  447
TRIM SIZE 175 mm Wide x 250 mm Deep
unstable angina: A form of angina that is more dangerous than normal angina but less so
than a heart attack. It can feature chest pain that occurs at rest; and in someone who
already has angina it can be marked by new onset of chest pain with exertion or pain
that accelerates by coming on more easily, more often or for longer than previously.
vaccination: The process of administering a vaccine to a person to produce immunity
against infection. See immunisation.
ventricular septal defect: A congenital defect of the heart that occurs as an abnormal
opening in the wall that separates the left and right main pumping chambers (the
ventricles).
whooping cough: See pertussis.
yersiniosis: a disease typically involving acute diarrhoea, fever, and other abdominal
symptoms, caused by the bacteria Yersinia pseudotuberculosis and Yersinia
enterocolitica and often food-borne.
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Index
Aboriginal Community Controlled 
Health Services, 317
Aboriginal Medical Services, 317
Aboriginal peoples, see Indigenous 
peoples
abortions, 26, 28, 173, 288
ABS, see Australian Bureau of Statistics
abuse, see violence and aggression
accident (emergency) departments, 74, 
291
accidents, see injuries; road trafÞc 
accidents
ACIR, 20Ð1, 152Ð3, 327Ð9
acupuncture, 320
acute bronchitis/bronchiolitis, 92, 202, 
308, 309
see also chronic obstructive pulmonary 
disease
acute care hospitals, see public hospitals
acute epiglottitis, 101
acute myocardial infarction, 190
acute otitis media/myringitis, 202, 309
acute respiratory infections, see 
respiratory diseases/infections 
ADHD, 63, 180
administration, see health administration
admissions, see hospitalisation
adolescents, see young people
adverse events, 61, 294Ð5
adverse reactions to vaccination, 20, 21
affective disorders, 61, 64, 65, 298
age, 170Ð93, 227Ð9, 355
alcohol and drug treatment service 
clients, 300
alcohol consumption, 143, 145
asthma, 72Ð3, 74
attitudes and beliefs, 157Ð8
cancers, 37, 48, 50
cardiovascular diseases, 38, 39
chronic obstructive pulmonary 
disease, 77Ð8
dental (oral) health, 15Ð19, 381Ð2
diabetes, 67Ð8, 383
health workforce, 270, 271, 272, 273, 
274, 306Ð7
hepatitis, 95
Hib disease, 155Ð6
high blood cholesterol, 130, 383
high blood pressure, 127, 128, 383
hospital use, 384Ð7
illicit drug users, 150
impaired glucose tolerance, 132Ð3
Indigenous population, 199, 203, 207
injury-related hospital separations, 60, 
61, 421, 422
kidney failure, 86, 88
at marriage, 25
Medicare services, use of, 409Ð11
meningococcal disease, 99
mothers, 170Ð1, 175, 199, 356, 359
musculoskeletal disorders, 80, 81, 82, 
83
physical inactivity, 146, 147, 383, 414
private health insurance coverage, 265
respiratory infections, 91, 92, 93
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rural and remote people, 214
self-reported health, 13Ð14
tobacco smokers, 134, 135, 383, 414
vaccine-preventable diseases, 99, 100, 
101, 102
veteran healthcare cardholders, 221Ð2
weight, 121Ð2, 123, 124, 139, 178, 207, 
383, 414
see also children; life expectancy; older 
people; young people
age, at death, 36Ð7, 363Ð8
AlzheimerÕs disease, 90
asthma, 75Ð6
cancer, 48, 50, 51, 53
cardiovascular diseases, 45
diabetes, 204
Indigenous peoples, 199, 200, 204
kidney failure, 87
respiratory infections, 91, 92
suicide, 58Ð9, 205, 423Ð4
tetanus, 100
age-standardised death rates, 33
aged people, see older people
aggressive behaviour, see violence and 
aggression
AHMAC, 6, 238Ð9
AIDS, see HIV/AIDS
aids and appliances, 253, 264, 395Ð6, 
399Ð400
AIHW, 240, 338, 340, 341, 352
alcohol and drug treatment services, 
300Ð1
alcohol consumption, 47, 84, 141Ð5, 301
Indigenous peoples, 207
liver disease, 83
mental problems and disorders, 64, 
65, 297, 298
osteoporosis, 82
prisoners, 225
public attitudes, 157, 158
rural and remote people, 217
veterans and war widows/widowers, 
224
young people, 64, 184
allergies, 22
allied health services, 243, 274, 291, 
390Ð1
expenditure on, 252, 253
general practitioner referrals to, 310
alternative medicine, 243, 320
AlzheimerÕs disease, 88Ð90
see also dementia
ambulance services, 264, 395Ð6, 399Ð400
amoxycillin, 322
amphetamines, 149, 157, 184, 301
anaesthetics, 303, 304, 407
analgesic kidney disease, 85
analgesics/pain-killers, 149, 157, 320, 
322, 323, 332
anencephalus, 176
angina, 38, 69, 190, 286, 412
angiograms, 42, 289
angioplasty, 42, 43
antibiotics, 322, 323
anxiety disorders, 61, 62, 63, 65, 223, 423
general practitioner patients, 309
Vietnam veterans, 299
Arab origin, people of, 68
arbovirus infection, 375
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AR-DRGs, 287, 288, 291, 298, 392Ð3
arteries, arterioles and capillaries, 
diseases of, 32
arthritis, 23Ð4, 30, 80Ð1, 213, 223, 224
osteoarthritis, 70, 80Ð1, 224, 309
see also musculoskeletal disorders
assisted conception, 25, 172
asthma, 22, 71Ð6, 104Ð110, 178, 213
burden of disease, 108Ð9, 228
with depressive symptoms, 64
determinants and risk factors, 163
general practitioner patients, 74, 309, 
331, 332
health system costs, 110, 329Ð30
hospitalisation, 73, 230, 329, 330Ð1
Indigenous peoples, 202, 230
medications, 74, 309, 320, 322, 329Ð30, 
332
overseas-born people, 196
atenolol, 322
atherosclerosis, 129
atorvastatin, 322
atresia, 176
attempted suicide, 60, 188
attention-deÞcit hyperactivity disorder 
(ADHD), 63, 180
attitudes, knowledge and beliefs, 156Ð8
audiology/audiometry practices, 277
Australia New Zealand Food Authority, 
239
Australian Bureau of Statistics (ABS), 
240, 338, 340, 341
constant price estimates, 249
Australian Capital Territory, see States 
and Territories
Australian Childhood Immunisation 
Register (ACIR), 20Ð1, 152Ð3, 327Ð9
Australian Council for Safety and 
Quality in Health Care, 239
Australian Health Care Agreements, 
239, 247
Australian Health MinistersÕ Advisory 
Council, 6, 238Ð9
Australian Health MinistersÕ 
Conference, 238
Australian Hearing Services, 318Ð19
Australian Institute of Health and 
Welfare (AIHW), 240, 338, 340, 341, 
352
Australian ReÞned Diagnosis Related 
Groups (AR-DRGs), 287, 288, 291, 298, 
392Ð3
Australian Quarantine and Inspection 
Service, 239
Australian Standard Vaccination 
Schedule, 22, 99, 152
auto-immunity, 23Ð4
babies, see births and pregnancy
back complaints/problems, 81, 223, 308, 
309
barbiturates, 149, 157
Barmah Forest virus, 97, 161, 375
bed numbers, 242, 280Ð1, 292, 296, 299
beer consumption, 142
behaviour, see lifestyle
beliefs, knowledge and attitudes, 156Ð8
benzodiazepines, 301
beta-blockers, 322
biological determinants of health, 160Ð1
biomedical risk factors, 121Ð34
bipolar affective disorder, 64
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birth defects, 102, 158Ð60, 175Ð6, 388Ð9
birthplace, 162, 194Ð7
births and pregnancy, 25Ð6, 28, 170Ð6, 
288Ð9, 356Ð60, 388Ð93
congenital rubella, 102
diabetes during pregnancy, 66, 68, 69
diet and nutrition, 138, 139, 141, 156, 
176
family planning organisations, 319Ð20
Indigenous, 199, 201, 201, 340
Medicare beneÞts, 303, 304, 407
birthweight, 174, 206, 358
bladder cancer, 49, 50, 51, 52, 377Ð9
blended families, 183
blood-borne diseases, 91, 93Ð6, 225, 374
see also HIV/AIDS
blood cholesterol, 40, 129Ð32, 383, 414
blood diseases, 288, 369Ð70, 388Ð93
blood glucose, see diabetes
blood lead levels, 161
blood pressure, see high blood pressure
blood transfusions and gamma globulin, 
190
blood vessel diseases, 32
body weight, 81, 121Ð4, 139, 178, 383
at birth, 174, 206, 358
health indicators, 414, 417
Indigenous peoples, 123Ð4, 206, 207
rural and remote people, 215
Bone and Joint Decade, 79
bone marrow transplants, 290
bones, see musculoskeletal disorders
bovine spongiform encephalopathy, 103
bowel cancer, see colorectal cancer
brain cancer, 51, 52
brain damage and head injuries, 30, 31, 
61
breast cancer, 48, 49, 50, 54Ð5, 377Ð80
health indicators, 415
older people, 192
overseas-born people, 195, 196
physical activity and, 146
screening, 324Ð5, 326, 415: 
expenditure on, 257, 401
survival following diagnosis, 51, 52, 
415
breast cancer, as cause of death, 32, 35, 
36, 51, 54, 55, 377, 415
health indicators, 415
overseas-born people, 195, 196
breast diseases, 28, 390Ð1
breastfeeding, 138, 141
BreastScreen Australia, 324Ð5, 326
bronchitis/bronchiolitis, 92, 202, 308, 
309
see also chronic obstructive pulmonary 
disease
brucellosis, 375
BSE, 103
burden of disease
alcohol consumption, 141
asthma, 108Ð9, 228
auto-immune diseases, 23
cancers, 108Ð9, 228, 229
cardiovascular disease, 23, 46Ð7, 
108Ð9, 125, 228Ð9
diabetes, 23, 71, 108Ð9
fruit and vegetables, inadequate 
consumption of, 140
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high blood cholesterol, 129
high blood pressure, 125
illicit drug use, 148
injuries, 108Ð9, 227, 228, 229
mental disorders, 108Ð9, 213, 228
physical inactivity, 145
socioeconomically disadvantaged 
people, 230
tobacco smoking, 134
see also disability; health system costs; 
mortality
burns, 392Ð3
business R&D expenditure, 258
bypass operations, 42, 43
caesarean section deliveries, 171Ð2
campylobacteriosis, 96, 374
cancers (neoplasms), 47Ð57, 104Ð10, 
377Ð80
burden of disease, 108Ð9, 228, 229
determinants and risk factors, 140, 
162Ð3
general practitioner patients, 105, 332
health expenditure, 110, 257, 325, 329
hospitalisation, 105Ð6, 196, 197, 329, 
330Ð1, 388Ð9: procedures reported, 
288, 390Ð1
indicators, 415Ð16
Indigenous peoples, 229
medications, 329: chemotherapy, 190, 
288, 289, 290, 291, 331, 390Ð1
physical activity and, 146
private hospital procedures, 290
screening, 257, 324Ð7, 415
veterans and war widows/widowers, 
223, 224
see also breast cancer; cervical cancer; 
colorectal cancer; lung cancer; 
prostate cancer
cancers, as cause of death, 31, 32, 34Ð7, 
47, 51Ð7, 107Ð8, 369Ð73, 377
by age, 37, 48, 50
children, 183
data linkages, 341
diabetes associated with, 71
indicators, 415Ð16
Indigenous peoples, 200
older people, 191
overseas-born people, 195Ð6
record linkage, 341
rural and remote people, 219
socioeconomically disadvantaged 
people, 230
cannabis/marijuana, 149, 150, 301
mental disorders, deaths attributed to, 
65
public attitudes, 157, 158
young users, 184
capital formation, 258Ð9
cardiovascular (circulatory) diseases, 11, 
30, 38Ð47, 104Ð10, 127
burden of disease, 23, 46Ð7, 108Ð9, 
125, 228Ð9
determinants and risk factors, 162Ð3
diabetes associated with, 69, 70, 419
general practitioner consultations, 40, 
70, 202, 308, 309, 331, 332, 333
health system costs/expenditure, 47, 
109Ð10, 329
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hospitalisation, 40Ð1, 105Ð6, 329, 330, 
388Ð93: indicators, 412, 413, 419
indicators, 412Ð13, 419
Indigenous peoples, 39, 200, 229
medications, 320, 322, 332Ð3
overseas-born people, 196
rural and remote people, 217
socioeconomically disadvantaged 
people, 230
ÔstressÕ as risk factor, 126
veterans and war widows/widowers, 
223, 224
see also heart disease/attack; high 
blood pressure; stroke
cardiovascular diseases, as cause of 
death, 37, 44Ð6, 107Ð8, 369Ð73
in hospital, 41Ð2
indicators, 420
Indigenous peoples, 200
older people, 191
overseas-born people, 195
rural and remote people, 219
socioeconomically disadvantaged 
people, 213
carers of people with disability, 189, 190
caries, see dental health
carotid endarterectomies, 42, 43
carpal and tarsal tunnel, release of, 289
casemix (diagnosis related groups), 284, 
287, 288, 291, 292Ð3, 298, 392Ð3
casualty (emergency) departments, 74, 
291
cataracts, 190, 224, 286
causes of death, 31Ð7, 369Ð72
AIDS, 95, 195
alcohol consumption, 141
AlzheimerÕs disease, 90
asthma, 75Ð6, 107Ð8
auto-immune diseases and conditions, 
23Ð4
children, 37, 174, 178, 181Ð3
chronic obstructive pulmonary 
disease, 32, 34, 35, 36, 75, 78, 79, 373
diabetes, 23Ð4, 32, 71, 107Ð8, 195, 197, 
204
digestive system diseases, 37, 195, 197, 
200, 213, 369Ð70
drugs, 65, 148, 187, 226
Hib disease, 100, 156
Indigenous peoples, 198, 200, 204, 205
infectious and parasitic diseases, 90, 
91, 195, 197, 200, 369Ð72
inßuenza and pneumonia, 95
kidney failure, 87
listeriosis, 97
liver disease, 84
meningococcal disease, 99
mental problems and disorders, 37, 
58, 65Ð6, 107Ð8, 200, 369Ð70
mothers, 173
nervous system disorders, 183, 200, 
369Ð70
older people, 191Ð2, 193
osteoporisis, 82
overseas-born people, 195Ð6
prisoners, 226
psychoactive substances, 65Ð6
rural and remote people, 219
socioeconomically disadvantaged 
people, 213
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tobacco smoking, 134
tuberculosis, 97Ð8
vaccine-preventable diseases, 100, 101, 
102, 156
young people, 186Ð8
see also cancers; cardiovascular 
diseases; injuries and poisoning; 
respiratory diseases/infections
cefaclor monohydrate, 322
celecoxib, 322, 323
central nervous system drugs, 323
cephalexin, 322
cerebrovascular disease, see stroke
cervical cancer, 48, 49, 50, 52, 377Ð9, 415
overseas-born people, 195, 196, 197
screening, 325, 327, 415, expenditure 
on, 257, 401
chancroid, 374
check-ups, 27, 308, 309
dental consultations, 312, 314
chemical determinants of health, 160Ð1
chemists, see pharmacists
chemotherapy, 190, 288, 289, 290, 291, 
331, 390Ð1
Child Care BeneÞt, 329
children, 176Ð83, 227Ð8, 345
asthma, 72Ð3, 74, 75, 178
dental (oral) health, 15Ð16, 205Ð6, 
310Ð11, 381Ð2
diet and nutrition, 139
general practitioner patients, 307
hearing services, 319
hospital patients, 284, 388Ð9
Indigenous, 39, 205Ð6
infectious and parasitic diseases, 90
injuries, 60, 61, 422
mental problems and disorders, 62Ð3, 
180
weight, 122, 139, 178
see also age; births and pregnancy; 
vaccination
children, mortality, 37, 173Ð4, 178, 180Ð3, 
358Ð60, 369Ð70
Indigenous, 183, 199, 201
Chinese origin, people of, 68
chiropractors/osteophaths, 276, 277, 320
chlamydia, 26, 27, 96, 158, 185, 374
cholera, 374
cholesterol, 40, 129Ð32, 383, 414
chromosomal abnormalities, 159, 175
chronic obstructive pulmonary disease 
(COPD), 76Ð9, 190, 213, 224, 291
cause of death, 32, 34, 35, 36, 78, 79, 
192, 373: asthma associated with, 75
cigarettes, see tobacco smoking
circulatory diseases, see cardiovascular 
diseases
circumcision of females, 28
cirrhosis of liver, 83
CJD, 103
classiÞcations, 57, 351Ð2
cleft lip/palate, 176
climate, 2, 161
cocaine, 65, 149, 157
codeine with paracetamol, 322
colds and coughs, 22, 79, 308
colon cancer, 52, 146
colonoscopies, 190, 288, 289, 291
colorectal (bowel) cancer, 48, 49, 56Ð7, 
377Ð80, 415
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cause of death, 32, 34, 35, 51, 56, 373, 
377, 415
screening for, 324
survival following diagnosis, 52, 415
common cold, 22, 79
Commonwealth Government, 239Ð40
see also Department of Health and 
Ageing; Department of VeteransÕ 
Affairs
Commonwealth government 
expenditure, 244Ð8, 258Ð9, 395, 401
cervical screening, 325, 401
Department of VeteransÕ Affairs, 252, 
253, 256
hospitals, 245, 246, 253, 254Ð5, 395
Indigenous health services, 251, 252, 
317, 398
pharmaceuticals, 245, 253, 255Ð6, 395
private health insurance rebate, 263, 
266
public health activities, 257
research and development, 258, 395, 
401
Commonwealth government receipts, 
244, 394
Commonwealth, State and Territory 
Strategy on Healthy Ageing, 188
communicable (infectious/parasitic) 
diseases, 90Ð103, 161, 369Ð72, 374Ð5, 
388Ð9, 392Ð3
expenditure on control programs, 257, 
401
Indigenous peoples, 96, 200
overseas-born people, 195, 196, 197
prisoners, 225
procedures reported, 288
sexually transmitted, 26Ð7, 91, 96, 158, 
185, 374
see also vaccination
communication restriction, 29
community health services, 298Ð9, 327, 
328
community pharmacists, 272, 273
complementary medicine, 243, 320
co-morbidity, 63Ð5
asthma, 73, 75
chronic obstructive pulmonary 
disease, 79
diabetes, 69Ð71
computerised tomographic scans, 42, 43, 
190
computers and computing, 338
conception, assisted, 25, 172
concession cardholders
dental (oral) health, 16Ð17, 312, 313Ð14
hearing service, 318Ð19
general practitioner patients, 307
Pharmaceutical BeneÞts Scheme 
(PBS), 256, 321, 323
see also veterans
condoms, 26
conduct disorder, 63
congenital anomalies/malformations, 
102, 158Ð60, 175Ð6, 183, 369Ð70, 388Ð9
congenital rubella infection, 102
constant price estimates, 249
consultations, see general practitioners; 
specialist medical practitioners
contact dermatitis, 309
contagious diseases, see communicable 
diseases
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contraception, 25Ð6, 319
COPD, see chronic obstructive 
pulmonary disease
coronary angiography, 42, 43, 289
coronary angioplasty, 42, 43
coronary artery bypass grafting, 42, 43
coronary heart disease, see heart 
disease/attack
coronary intensive care units, 290
coronary stenting, 42, 43
corporatisation in health care, 241Ð2
corticosteroid drug treatments, 82
cost of diseases, see health system costs
cost per casemix-adjusted separation, 
292Ð3
coughs and colds, 22, 79, 308
counselling, 274, 299
country of birth, 162, 194Ð7
Creutzfeldt-Jakob disease, 103
CT scans, 42, 43, 190
cultural health determinants, 162
day hospital facilities, 242, 279Ð85
deafness, 318Ð19
see also ear diseases/disorders
death, see causes of death; mortality
deÞnitions
disability, 189
health, 3Ð4
high blood pressure, 125
recommended dietary intakes (RDIs), 
140
delinquent behaviour, 63
delivery method (births), 171Ð2, 288Ð9
dementia, 32, 64, 205, 297, 298
AlzheimerÕs disease, 88Ð90
veterans and war widows/widowers, 
223
dengue fever, 97, 161, 375
dental (oral) health, 15Ð20, 310Ð17, 381Ð2
expenditure on, 245, 252, 253, 395Ð6, 
399Ð400: private health insurance 
funds, 263, 264, 395
hospital separations, 286, 390Ð1
Indigenous peoples, 205Ð6
dental practitioners, 243, 269, 278, 279, 
273Ð4
migration, 276
in private practice, 277
students commencing courses, 274
dental therapists, 274
Department of Health and Ageing, 97, 
239, 256, 341
Department of VeteransÕ Affairs (DVA), 
220, 238, 239, 259
expenditure by, 252, 253, 256
see also veterans
depression/depressive disorders, 63, 64, 
65, 296
children and adolescents, 63
diabetes and, 70
general practitioner patients, 309
immunity and, 22
indicators, 423Ð4
Indigenous peoples, 230
prisoners, 226
veterans and war widows/widowers, 
223, 299
young people, 188
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see also suicide
dermatitis, 309
designer drug use, 149, 157
determinants of health, 3Ð5, 119Ð69, 198, 
348
see also risk factors
diabetes, 66Ð71, 104Ð10, 213, 383
burden of disease, 23, 71, 108Ð9
cause of death, 23Ð4, 32, 71, 107Ð8, 
195, 197, 419
in childhood, 179
dental (oral) health, 18Ð20
depression, 64
determinants and risk factors, 163
general practitioner patients, 70, 202, 
309, 331, 332
health system costs, 71, 110, 329
hospitalisation, 23Ð4, 70Ð1, 105Ð6, 203, 
329, 330Ð1: indicators, 419
impaired glucose tolerance, 132Ð4
indicators, 417Ð20
Indigenous peoples, 18Ð20, 68, 69, 202, 
203Ð4, 230
medication and syringes, 329, 331Ð2
migrants and overseas-born people, 
68, 195, 196, 197
record linkage protocol, 341
socioeconomically disadvantaged 
people, 230
diabetic kidney disease, 85
diagnoses, see diseases
diagnosis related groups, 284, 287, 288, 
291, 292Ð3, 298, 392Ð3
diagnostic imaging, see medical imaging
dialysis, 86, 87Ð8, 190, 202, 287, 288, 289, 
290, 291
diaphragmatic hernia, 176
diastolic blood pressure, 125
diet and nutrition, 47, 137Ð41
eating disorders, 64
foodborne disease, 96Ð7, 161, 374
food standards and hygiene, 239, 257, 
401
Indigenous peoples, 141, 206
low salt products, 128
students commencing courses, 274
digestive system diseases, 190, 288, 291, 
388Ð93
cause of death, 37, 195, 197, 213, 
369Ð70
Indigenous peoples, 201
overseas-born people, 195, 196, 197
socioeconomically disadvantaged 
people, 213
veterans and war widows/widowers, 
224
diphtheria, 20, 21, 22, 100, 153, 154
disability, 4, 28Ð31
asthma, 74, 106Ð7
auto-immune diseases/conditions, 
23Ð4
cardiovascular disease, 106Ð7
chronic obstructive pulmonary 
disease, 77Ð8
diabetes, 71, 106Ð7
Ôhealthy life expectancyÕ (HALE), 
12Ð13
injuries and poisoning, 106Ð7
mental problems and disorders, 65, 
106Ð7
older people, 31, 189Ð90
after stroke, 39
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young people, 184
disadvantage, see Indigenous peoples; 
socioeconomic status
diseases, 3Ð5, 15Ð20, 26Ð103, 286Ð91
Indigenous peoples, 201Ð6
socioeconomically disadvantaged 
people, 213
veterans and war widows/widowers, 
223
see also cancers; cardiovascular 
diseases; causes of death; 
communicable diseases; digestive 
system diseases; disability; ear 
diseases/disorders; eye diseases; 
health system costs; hospitalisation; 
injuries and poisoning; mental 
health/disorders; respiratory 
diseases; risk factors
doctors, see medical practitioners
donovanosis, 96, 185, 374
Down syndrome, 159, 176
drinking water, 210
drowning, 60, 178, 183
drug adverse effects, 293Ð4
drug scripts and treatments 
(medications), 307, 308, 309Ð10, 320Ð3, 
329, 332Ð3
asthma, 74, 309, 320, 322, 329Ð30, 332
mental problems and disorders, 63, 
329, 323
musculoskeletal disorders, 81, 83, 322, 
323
drug treatment services, 300Ð1
drugs and drug use, 148Ð52
dependence/drug use disorders, 64, 
65, 187, 225, 226, 298, 300Ð1, 392Ð3
Indigenous peoples, 208
medication non-compliance, 64
osteoporosis, 82
prisoners, 225, 226
public attitudes and beliefs, 157, 158
young people, 64, 184, 187
see also alcohol consumption; 
pharmaceuticals; tobacco smoking 
DVA, see Department of VeteransÕ 
Affairs
dwellings, 208Ð9
ear diseases/disorders, 30, 388Ð93
audiology/audiometry practices, 277
general practitioner patients, 202, 308, 
309
hearing services, 318Ð19
veterans and war widows/widowers, 
223
Eat Well Australia, 141
eating disorders, 64
economic health determinants, 162
see also socioeconomic status
ecstasy, use of, 149, 157
edentulism, 16Ð17, 205, 315Ð17
education and training, 2
family planning, 320
health and medical, 271, 274Ð5, 307
schooling or employment restriction, 
30
see also socioeconomic status
elective surgery waiting times, 293Ð4
electronic health records, 338
emergency departments, 74, 291
emotional stress, 22
see also depression
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emphysema, see chronic obstructive 
pulmonary disease
employment, 2
occupations associated with 
osteoarthritis, 81
schooling or employment restriction, 
30
self-reported health status, 14
see also health workforce; 
socioeconomic status
encephalocele, 176
end-stage renal disease, 84Ð8, 202Ð3, 419
endocrine disorders, 37, 200, 308, 
369Ð70, 388Ð93
energy intake, 139Ð40, 414
environmental determinants of health, 
4Ð5, 160Ð2
environmental health, 210Ð11, 240, 257, 
274, 401
epiglottitis, 101
equity and access, 341
see also socioeconomic status
erectile dysfunction/impotence, 28, 69, 
70, 223
ethnicity, see Indigenous peoples; 
migrants
exercise, see physical activity/inactivity
expenditure, see health expenditure; 
health system costs
external causes, see injuries
eye diseases/disorders, 30
diabetes-related complications, 69, 70
general practitioner patients, 308, 309
hospital separations, 286, 190, 191, 
388Ð93: procedures reported, 288, 289, 
291
veterans and war widows/widowers, 
223, 224, 291
see also optometry
falls, 60, 81, 82, 192Ð3, 421Ð2
family planning, 28, 319Ð20
farming, 81
fat intakes, 130, 137Ð8, 140, 140, 156, 414
fatalities, see mortality
fatty liver, 83
females, see births and pregnancy; sex of 
population
fertility, 25, 170Ð1, 199, 356Ð7
see also births
Þbreoptic colonoscopies, 190, 288, 289
Þnance, see health expenditure; health 
system costs
Þrearm deaths, 60, 226
ßuid tablets, 332
Flying Doctor Service, 328
foetal deaths (stillbirths), 173Ð4
folate, 138, 156, 176
food, see diet and nutrition
foot problems, 223, 419
for-proÞt private hospitals, 241Ð2
forceps delivery, 171Ð2
fractures, 81Ð3
fruit and vegetable consumption, 139Ð40
full-time employment, 267, 268, 269, 277
functioning, see disability
funding, see health expenditure; health 
system costs
gamete intra-fallopian transfer (GIFT), 
172
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gastrointestinal infections, 91, 96Ð7, 374
gastroscopy, 288, 291
gay men, 94, 95, 96, 376
General Practice Immunisation 
Incentives Scheme, 328
general practitioners (GPs), 269, 270
corporatisation, 241, 242
migration, 271, 276
general practitioners, consultations 
with, 306Ð10, 322Ð3, 407
asthma, 74, 309, 331, 332
cancers, 105, 332
cardiovascular (circulatory) diseases, 
40, 70, 202, 308, 309, 323, 331, 332, 333
chronic obstructive pulmonary 
disease, 77
diabetes and complications, 70, 202, 
309, 331, 332
Indigenous peoples, 202
injuries, 105, 332
mental problems and disorders, 63, 
309, 331, 332, 333
musculoskeletal disorders, 80, 309, 
323
Pap smears, 325
respiratory infections, 92, 308, 309, 323
sexual health problems, 27Ð8
vaccination/ immunisation, 308, 309, 
327Ð8
genetic disorders, 102, 158Ð60, 175Ð6, 
369Ð70, 388Ð9
genital herpes, 96
genitals, 27Ð8, 175, 390Ð3
testis, cancer of, 50, 52, 378Ð9
genitourinary diseases, 37, 200, 287, 
369Ð70, 388Ð91
see also prostate cancer
gestational diabetes, 66, 68, 69
GIFT, 172
global warming, 161
glomerulonephritis, 85, 88
glucose, see diabetes
gonococcal infection, 26Ð7, 96, 185, 374
government concession cardholders, see 
concession cardholders
government expenditure, see 
Commonwealth government 
expenditure; State and local 
government expenditure; State and 
Territory expenditure
gross domestic product (GDP), and 
health services expenditure, 248Ð9, 
259Ð60, 261, 402
group for-proÞt private hospitals, 241Ð2
gum diseases, 15, 18Ð20
gun deaths, 60, 226
haemodialysis, 86, 87Ð8, 190, 202, 287, 
288, 289, 290, 291
haemolytic uraemic syndrome, 374
Haemophilus influenzae type b, see Hib 
disease
haemorrhoids, 289
HALE, 12Ð13
hallucinogens, 149, 157
hanging, strangulation and suffocation, 
60, 186, 226
hay fever, 22
HDL cholesterol, 129
head injuries and brain damage, 30, 31, 
61
health administration, 395Ð6, 399Ð400
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health insurance funds costs, 263, 264
students commencing courses, 274
health classiÞcations, 57, 351Ð2
health counselling, 274, 299
health determinants, see determinants of 
health; risk factors
health expenditure, 243Ð62, 329Ð30, 
394Ð405
cancer screening, 257, 325
childhood immunisation, 257, 327
Indigenous peoples, services for, 
211Ð12, 317, 398
National Diabetic Services Scheme, 
332
private health insurance funds, 262Ð3, 
264, 266, 395, 404
private hospital psychiatric units/
wards, 296
public community mental health 
services, 299
research and development, 257, 258, 
395Ð6, 399Ð401
residential aged care, 245, 252, 253, 
395Ð6, 399Ð400
see also health system costs
health indicators, 291Ð5, 344, 345Ð9, 
412Ð24
health information, see statistical 
developments, gaps and deÞciencies
health insurance, 255, 256, 262Ð6, 320, 
395, 404Ð5
see also Medicare
Health Insurance Commission, 152Ð3, 
239, 302, 338, 341
health promotion and prevention, 257, 
323Ð9, 401
see also vaccination
health research and development, 257, 
258, 395Ð6, 399Ð401
health resources, 238Ð337, 384Ð411
health risk factors, see risk factors
health services provision and use, 
279Ð320, 407Ð11
Indigenous peoples, 211Ð12
rural and remote people, 215
see also general practitioners; 
hospitalisation; specialist medical 
practitioners
health status, 9Ð118, 348
children, 178Ð80
Indigenous peoples, 199Ð208
rural and remote people, 217
socioeconomically disadvantaged 
people, 212Ð13
veterans and war widows/widowers, 
222Ð4
young people, 184Ð5
health support courses, 274, 275
health system, 6Ð8
health system costs, 47, 71, 57, 109Ð10, 
329Ð30
musculoskeletal disorders, 81
health workforce, 241Ð3, 267Ð79, 341, 406
Indigenous, 275, 316, 317
private hospital psychiatric units/
wards, 296
public community mental health 
services, 299
rural and remote areas, 215
healthcare cards, see concession 
cardholders
Healthconnect project, 338, 350
Ôhealthy life expectancyÕ (HALE), 12Ð13
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hearing services, 318Ð19
see also ear diseases/disorders
heart disease/attack, 38, 40Ð2, 190
diabetes and, 69, 70, 71
indicators, 412, 419
overseas-born people, 196
private hospital procedures, 290
public knowledge, attitude and 
beliefs, 156
rheumatic, 23Ð4, 39, 40Ð2, 44
ÔstressÕ as risk factor, 126
veterans and war widows/widowers, 
223, 224
heart disease/attack, as cause of death, 
31, 32, 34, 35, 44Ð6, 373, 412
asthma associated with, 75
diabetes associated with, 71, 204
in hospital, 42
indicators, 412, 412, 420
Indigenous peoples, 204
overseas-born people, 195
socioeconomically disadvantaged 
people, 213
heart failure, 40Ð2, 44, 190, 291, 412
diabetes associated with, 71
heart rhythm disorders, 40
hepatitis, 83, 95Ð6, 374
hepatitis B, 95, 179, 374
vaccination against, 20, 21, 99: 
suppression of immune response to, 
22
hepatitis C, 95Ð6, 225, 374
herbal medications, 320
herpes, 96, 225
heroin, 149, 157
Hib disease, 20, 21, 22, 153
cases, 101, 154Ð6, 178, 179, 374
high blood cholesterol, 40, 129Ð32, 383, 
414
high blood pressure (hypertension), 
40Ð2, 44, 125Ð9, 383
diabetes and, 69, 70
general practitioner patients, 40, 70, 
202, 309
indicators, 414, 418
Indigenous peoples, 129, 202
kidney failure caused by, 85
public knowledge, attitude and 
beliefs, 156
rural and remote people, 217
veterans and war widows/widowers, 
223
higher education, 271, 274Ð5
R&D expenditure, 258
hips, 61, 81, 176
HIV/AIDS, 90, 93Ð5, 376
injecting drug users, 94, 151Ð2
overseas-born people, 195
prisoners, 226
young people, 184
HodgkinÕs lymphoma, 51, 52
home assessment and modiÞcation, 193
home care, 253
homicide, 195, 422
homosexual men, 94, 95, 96, 376
hormone replacement therapy, 83
hospitalisation, 110, 242, 281Ð91, 341, 
384Ð93
alcohol caused, 141
asthma, 73, 230, 329, 330Ð1
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auto-immune diseases and conditions, 
23Ð4
cancers, 105Ð6, 196, 197, 329, 330Ð1, 
388Ð9: procedures reported, 288, 390Ð1
cardiovascular disease, 40Ð1, 105Ð6, 
329, 330, 388Ð93: indicators, 412, 413, 
419
children, 180
chronic obstructive pulmonary 
disease, 77
diabetes, 23Ð4, 70Ð1, 105Ð6, 203, 329, 
330Ð1: indicators, 419
drug users, 64, 148
Indigenous peoples, 201Ð2, 203, 205, 
230
infectious and parasitic diseases, 90, 
98, 99, 100, 101, 102
kidney failure, 87Ð8
liver disease, 83
meningococcal disease, 99
multiple sclerosis, 23Ð4
musculoskeletal disorders, 81
older people, 190Ð1
overseas-born people, 196, 197
respiratory infections, 91, 92, 93, 230
rural and remote people, 217, 231
sexual health problems, 28
smoking as cause, 134
tuberculosis, 98
vaccine-preventable diseases, 100, 101, 
102
young people, 185, 188
see also injuries; mental health/
disorders
hospitals, 259, 279Ð95
medical practitioners, 270
see also public hospitals; private 
hospitals
hospitals, expenditure on, 244, 253Ð5, 
329, 395Ð6, 399Ð400
pharmaceuticals used, 255, 256
private health insurance funds, 264, 
395
housing and living conditions, 208Ð11
HRT, 83
human papillomavirus, 96
hydatid infection, 375
hydrocephalus, 176
hyperactivity (ADHD), 63, 180
hypertension, see high blood pressure
hypogonadism, 83
hypospadias, 176
iatrogenic disease, 295
ibuprofen, 323
ICD, 57
ICF, 351Ð2
ICSI, 172
illicit drugs, see drugs and drug use
illness, see diseases
imaging, see medical imaging
immigrants, see migrants and overseas-
born people
immunisation, see vaccination
Immunise Australia campaign, 152
immunodeÞciency, 24
immunological health, 20Ð4
see also vaccination
impaired glucose tolerance (IGT), 132Ð4
impotence/erectile dysfunction, 28, 69, 
70, 223
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in-vitro fertilisation (IVF), 25, 172
inactivity, see physical activity/inactivity
income
Commonwealth Government receipts, 
244, 394
private health insurance funds, 263, 
264, 266, 404
see also socioeconomic status
independent for-proÞt private hospitals, 
242
Index of Relative Socioeconomic 
Disadvantage, 213
Indian origin, people of, 68
Indigenous peoples, 197Ð212, 229Ð30, 
239, 317Ð18
birth delivery methods, 175
birthweight, 174, 206
cardiovascular diseases, 39, 200, 229
childhood immunisation, 99, 328
dental (oral) health, 17Ð20
diabetes, 18Ð20, 68, 69, 202, 203Ð4, 230
diet and nutrition, 141, 206
general practitioner patients, 307
health expenditure, 211, 250Ð2, 398
health workforce entrants, 275
Hib disease, 154
high blood cholesterol, 132
high blood pressure (hypertension), 
129, 202
illicit drug users, 150
information developments relating to, 
198, 338, 340, 341
kidney failure, 88, 202Ð3, 204
life expectancy, 11, 199
physical inactivity, 148
prisoners, 227
sexually transmitted diseases (STDs), 
95, 96
tobacco smoking, 20, 136
weight, 123Ð4, 206, 207
see also rural and remote people
Indigenous peoples, mortality, 198, 
199Ð201
children, 183, 199Ð201
diabetes, 204, 230
from injuries, 230
prisoners, 226
young people, 188
industrial lead, 161
infants, see children
infectious agents, 47
infectious diseases, see communicable 
diseases
infertility treatment, 25
inßation, 261, 403
inßuenza and pneumonia, 32, 79, 92Ð3, 
190, 286
vaccination, 93, 322, 323
Inßuenza Vaccine Program for Older 
Australians, 93
information, see statistical developments
information technology, 338
inhalants, 149, 157, 184, 208
injecting drugs and drug users, 94, 95, 
96, 149, 151Ð2
alcohol and drug treatment service 
clients, 301
prisoners, 225
injuries and poisoning (external causes), 
57Ð61, 104Ð10
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burden of disease, 108Ð9, 227, 228, 229
children, 60, 61, 178, 182, 183
determinants and risk factors, 163
general practitioner patients, 105, 332
health system costs, 57, 109Ð10, 329
indicators, 421Ð2
Indigenous peoples, 201, 205, 230
medications, 329
older people, 191, 229
overseas-born people, 195, 196, 197
socioeconomically disadvantaged 
people, 230
young people, 186Ð7, 227
see also road trafÞc accidents; suicide
injuries and poisoning, as cause of 
death, 37, 57Ð60, 107Ð8, 369Ð72
adverse events, 61
indicators, 421
Indigenous peoples, 200
older people, 192, 193
overseas-born people, 195, 197
prisoners, 226
rural and remote people, 219
socioeconomically disadvantaged 
people, 213
young people, 186Ð8
injuries and poisoning, hospitalisation 
for, 60Ð1, 105Ð6, 330Ð1, 388Ð9, 392Ð3
expenditure, 329
indicators, 421, 422
Indigenous peoples, 205
rural and remote people, 231
insomnia/sleep disturbance, 223, 309
institutional care, see hospitals; 
residential aged care
intellectual disabilities, people with, 30
see also mental health/disorders
intentional injuries/self-harm, 60, 186Ð8, 
205, 230, 423
see also suicide
International ClassiÞcation of Diseases 
(ICD), 57
International ClassiÞcation of 
Functioning, Disability and Health 
(ICF), 351Ð2
international comparisons, 338Ð9
alcohol consumption, 142
asthma prevalence among children, 73
cancer incidence, 380
death rates, 45Ð6, 365Ð8, 371Ð2: 
children, 181, 183, 360
disability prevalence among older 
people, 31
fertility and pregnancy, 357, 181, 360
health expenditure, 259Ð62, 402Ð3
health workforce, 277Ð9
life expectancy, 11Ð13, 362
mental health problems and 
disorders, 62
suicide, 60
international health measurement work, 
350Ð1
international research and development 
expenditure, 258
interpersonal violence, see violence and 
aggression
intracytoplasmic sperm injection, 172
invasive meningococcal disease, 98Ð9
in-vitro fertilisation (IVF), 25, 172
involuntary hospitalisation, 297
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ischaemic heart disease, see heart 
disease/attack
joint injuries, 61, 81, 288
kidney diseases, 84Ð8, 392Ð3, 419
cancer, 49, 50, 51, 52, 377Ð9
diabetes and, 69, 70, 71, 204
dialysis, 86, 87Ð8, 190, 202, 287, 288, 
289, 290, 291
Indigenous peoples, 88, 202Ð3, 204
renal agensesis and dysgenesis, 176
KlinefelterÕs syndrome, 159
knees, 81, 288
knowledge, attitudes and beliefs, 156Ð8
labour force, see health workforce
land transport accidents, see road trafÞc 
accidents
language spoken, 300
LDL cholesterol, 129
lead, health effects of, 161
legalisation of illicit drugs, 157
legionellosis, 161, 375
length of hospital stay, 242, 282, 284Ð5, 
388Ð93
asthma, 73
cardiovascular diseases, 40Ð1, 42, 
388Ð93
chronic obstructive pulmonary 
disease, 77
diabetes, 70Ð1
injuries, 60
kidney failure, 87Ð8
liver disease, 83
mental disorders, 105, 296Ð7, 388Ð9, 
392Ð3
musculoskeletal disorders, 81, 388Ð93
see also same-day patients
leprosy, 375
leptospirosis, 375
leukaemia, 50, 52
life expectancy, 9Ð13, 188, 361Ð2
Indigenous peoples, 11, 199
rural and remote people, 217Ð18
socioeconomically disadvantaged 
people, 11, 213
lifestyle and behaviour, 120, 129, 134Ð56, 
257, 414
see also alcohol consumption; body 
weight; diet and nutrition; physical 
activity/inactivity; tobacco smoking
lifetime health cover, 262, 263, 265Ð6
lipid disorders, 40, 70, 308, 309, 322
listeriosis, 97, 374
liver diseases, 83Ð4
living conditions, 208Ð11
see also socioeconomic status
local government, 240, 328
see also State and local government 
expenditure
longevity, see life expectancy
LSD, 157
lung cancer, 48, 49, 50, 53Ð4, 377Ð80
indicators, 416
overseas-born people, 196, 197
survival following diagnosis, 52
long cancer, as cause of death, 32, 34, 35, 
51, 53, 54, 373, 377
indicators, 416
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overseas-born people, 195
malaria, 97, 375
males, see prostate cancer; sex of 
population
male homosexuals, 94, 95, 96, 376
manic episodes, 64
marijuana, see cannabis/marijuana
maternal mortality, 173
Maternity Immunisation Allowance, 328
measles, 20, 21, 22, 152, 153
cases, 101Ð2, 178, 179, 374
medical imaging, 80, 242, 307, 309, 310, 
390Ð1
Medicare beneÞts, 303, 304, 408
medical imaging professionals, 268, 269, 
276
medical practitioners, 7, 269, 270Ð2, 278
consultations with, 303, 304, 305, 
306Ð10
Department of VeteransÕ AffairsÕ 
health expenditure, 253
migration and, 271, 276
students commencing courses, 274
see also general practitioners; specialist 
medical practitioners
medical radiography, 274
medical science, 274
medical services, expenditure on, 245, 
246, 252, 329, 395Ð6, 399Ð400
private health insurance funds, 264, 
395
medical technology, 268, 274
medical treatment, adverse effects of, 61, 
293Ð4
Medicare, 239, 247Ð8, 301Ð6, 320, 407Ð11
cervical screening, 325
Indigenous peoplesÕ use, 252
sexual health, beneÞts paid for, 25, 26
Medicare agreements, 247Ð8, 254Ð5
Medicare levy, 244, 265, 394
medications, see drug scripts and 
treatments
medicine (Þeld of study), 274
melanoma, 48, 49, 50, 52, 229, 377Ð80, 
415
men, see prostate cancer; sex of 
population
men who have sex with men, 94, 95, 96, 
376
meningococcal disease, 98Ð9, 375
menopausal problems, 27
mental health/disorders, 30, 61Ð6, 
104Ð10
burden of disease, 108Ð9, 213, 228
cause of death, 37, 58, 65Ð6, 107Ð8, 
200, 369Ð70
children, 62Ð3, 180
determinants and risk factors, 163
general practitioner patients, 63, 309, 
331, 332, 333
health system costs, 109Ð10, 329
immune system and, 22
indicators, 423Ð4
Indigenous peoples, 200, 201, 204Ð5, 
230
medications, 63, 329, 333
prisoners, 226
procedures reported, 288, 291
rural and remote people, 217
socioeconomically disadvantaged 
people, 213
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veterans and war widows/widowers, 
223, 224
young people, 62Ð3, 64, 183, 184, 228
see also depression; suicide
mental health/disorders, hospitalisation 
for, 63, 64, 105Ð6, 296Ð8, 329, 330Ð1, 
388Ð9, 392Ð3
Indigenous peoples, 205, 230
young people, 188
mental health services, 246, 295Ð9
see also public psychiatric hospitals
mental retardation, 64
metabolic and endocrine disorders, 37, 
200, 308, 369Ð70, 388Ð93
Metabolic Syndrome, 133, 134
methadone, 149
migrants and overseas-born people, 97, 
162, 193Ð7, 229
diabetes, 68, 195, 196, 197, 419
family planning organisation clients, 
320
general practitioner patients, 307
health professionals, 271, 275Ð6
mineral supplements, 320
minimum data sets, 341, 342
monogenetic disorders, 158
mood (affective) disorders, 61, 64, 65, 
298
morbidity, see disability; diseases
mortality, 31Ð7, 358Ð73
auto-immune diseases and conditions, 
23Ð4
after hip fracture, 81
maternal, 173
overseas-born people, 162, 194Ð6
rural and remote people, 218Ð19
socioeconomically disadvantaged 
people, 213
veterans and war widows/widowers, 
224Ð5
young people, 37, 58, 59, 184, 185Ð8
see also causes of death; children; 
Indigenous peoples; life expectancy
mosquito-borne diseases, 97, 161, 375
mothers, see births and pregnancy
motor vehicle accidents, see road trafÞc 
accidents
multifactoral diseases, 159
multiple births, 171Ð2
multiple sclerosis (MS), 23Ð4
mumps, 20, 21, 22, 152, 153
cases, 102, 179, 374
musculoskeletal disorders, 30, 79Ð83, 
309, 369Ð70, 388Ð93
congenital malformations, 175
drug treatment and prescriptions, 81, 
83, 322, 323
veterans and war widows/widowers, 
223, 224
see also arthritis
myocardial infarction, 190, 412, 419
myringitis/otitis media, 202, 309
National Aboriginal and Torres Strait 
Islander Nutrition Working Party, 141
National Advisory Group for Aboriginal 
and Torres Strait islander Health 
Information and Data, 338
National Cancer Statistics Clearing 
House, 47
National Cervical Screening Program, 
325, 327
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National Child and Youth Health 
Information Framework, 177
National Childhood Immunisation 
Program, 21
National Death Index, 341
National Diabetes Register, 68, 69
National Diabetic Services Scheme 
(NDSS), 331Ð2
National Falls Prevention in Older 
People Initiative, 193
National Health and Medical Research 
Council, 137, 138, 140, 240
National Health Data Committee, 338
National Health Data Dictionary, 338, 
340, 342
National Health Information 
Agreement, 338
National Health Information 
Development Plan, 340Ð1
National Health Information 
Management Group (NHIMG), 338, 
340, 341, 345, 352
National Health Information Model, 340
National Health Performance 
Committee (NHPC), 343, 343, 346Ð7
National Health Performance 
Framework, 6, 291Ð5, 343Ð5
National Health Priority Areas 
(NHPAs), 38Ð76, 103Ð110, 162Ð4, 
227Ð31, 329Ð33
indicators, 345, 412Ð24
see also asthma; cancers; 
cardiovascular diseases; diabetes; 
injuries; mental health/disorders
National Health Priority Performance 
Advisory Committee, 345
National Mental Health Strategy, 295
national minimum data sets, 342
National Physical Activity Guidelines 
for Australians, 147
National Public Health Expenditure 
Project, 257
National Public Health Information 
Working Group, 345
National Public Health Nutrition 
Strategy 2000 to 2010 (Eat Well 
Australia), 141
National Public Health Partnership, 238, 
257
natural medications, 320
neonatal deaths, 173Ð4
neoplasms, see cancers
nerve damage, 69, 70
nervous system diseases/disorders, 30, 
88Ð90, 388Ð93
cause of death, 37, 369Ð70: children, 
183
drug prescriptions, 323
Indigenous peoples, 200
see also dementia
neural tube defects, 138, 156, 176
neurosurgery, 290
neurotic disorders, 64
New South Wales, see States and 
Territories
non-admitted patients, 283Ð4, 291
non-HodgkinÕs lymphoma, 49, 50, 52, 
377Ð9
non-prescribed medicines, 323
Northern Territory, see States and 
Territories
not-for-proÞt private sector, 242, 258
notiÞable diseases, see cancers; 
communicable diseases
nuclear medicine and radiotherapy, 303
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nurses, 268, 269, 278, 279, 271, 272
community, DVA health expenditure 
on, 253
migration, 276
students commencing courses, 274, 
275
nursing homes, see residential aged care
nutrition, see diet and nutrition
obesity, see body weight
obstetrics, see births
occupational therapists/therapy, 274, 
276
occupations, see employment; health 
workforce; socioeconomic status
OECD countries, see international 
comparisons
OECD health framework and reporting, 
361
oesophagus, cancer of, 50
oestrogen replacement, 83
OfÞce for Aboriginal and Torres Strait 
Islander Health, 239, 317
OfÞce of Hearing Services, 318
older people, 31, 188Ð93, 219, 228Ð9
dental patients, 315
falls, 81, 82, 192Ð3, 421Ð2
general practitioner patients, 307
mental health indicators, 424
private health insurance, 265
see also residential aged care
omeprazole, 322
oncology units, 290
see also cancers
online information, 338
operations, 303, 304, 390Ð1, 408
elective surgery waiting times, 293Ð4
joint replacement, 81
sterilisation, 25, 26
see also procedures
opiates, 65, 149, 157, 186, 301
optometry, optometrists and opticians, 
243, 274, 276, 277
Medicare beneÞts, 303, 304, 408
see also eye diseases/disorders
oral contraceptives, 26
oral glucose tolerance test (OFTT), 67, 
133
oral health, see dental health
ornithosis, 375
osteoarthritis, 70, 80Ð1, 224, 309
osteopaths/chiropractors, 276, 277
osteoporosis, 81Ð3
otitis media, 202, 309
ovarian cancer, 48, 49, 52, 377
over-the-counter medicines, 323
overseas-born people, see migrants
overseas R&D expenditure, 258
overseas-trained general practitioners, 
307
overweight, see body weight
OzFoodNet, 97
pain-killers (analgesics), 149, 157, 320, 
322, 323, 332
pancreas, 392Ð3
cancer, 49, 50, 52, 377Ð9
panendoscopies, 190, 288, 289
Pap smears, 27, 325, 327
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papillomavirus, 96
paracetamol, 322, 323
paranoia, 298
parasitic diseases, see communicable 
diseases
part-time employment, 267, 268, 269, 277
pathology tests, 40, 242, 307, 310, 407
Medicare beneÞts, 303, 304
patient-days, 281Ð4, 288, 330, 386Ð93
adverse effects, 295
injuries, 60Ð1
liver disease, 83
mental health services, 296, 297Ð8
NHPA diseases and conditions, 105
pelvic inßammatory disease, 158
pensioners, see concession cardholders
per person expenditure, 249Ð50, 251, 
252, 260, 261, 262
performance indicators, 291Ð5, 344, 
345Ð9, 412Ð24
performance measurement, 291Ð5, 
342Ð51
perinatal diseases, 388Ð9
perinatal mortality, 37, 173Ð4, 358Ð60, 
369Ð70
Indigenous, 199Ð201
peripheral vascular disease, 40Ð2, 44, 
413
personality disorders, 64, 298
pertussis (whooping cough), 99Ð100, 
178, 179, 374
vaccination against, 20, 21, 22, 153, 154
petrol snifÞng, 208
Pharmaceutical BeneÞts Scheme (PBS), 
255Ð6, 321Ð3, 395Ð6, 399Ð400
Indigenous peoplesÕ use, 252
pharmaceuticals, expenditure on, 244, 
245, 252, 253, 255Ð6, 395Ð6, 399Ð400
National Health Priority Areas, 
329Ð30
PBS prescriptions, 322
private health insurance funds, 264, 
395
see also drug scripts
pharmacists (chemists), 243, 268, 269, 
272Ð3
migration and, 276
students commencing courses, 274
physical activity/inactivity, 66, 82, 145Ð8
indicators, 414, 417Ð18
overseas-born people, 195
public beliefs and attitudes, 157
rural and remote people, 215
young people, 184
physical disabilities, people with, 30
physical environmental health 
determinants, 160Ð1
physical stress, 22
physicians, see medical practitioners
physiotherapists, 268, 269, 274, 275, 277
PID, 158
plant food, 137Ð8, 139Ð40, 141
plasma glucose sampling, 67, 133
pneumonia, see inßuenza
pneumococcal disease, 99
podiatrists, 274, 276
polio, 20, 21, 22, 100, 153
population, 2, 176Ð7, 198Ð9, 214, 355
private health insurance coverage, 
263Ð6
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see also age; sex of population
post-traumatic stress disorder, 224, 299
pregnancy, see births
prevention and promotion, 257, 323Ð9, 
401
see also vaccination
prisoners, 225Ð7
private health insurance, 255, 256, 262Ð6, 
320, 395, 404Ð5
Private Health Insurance Incentives 
Scheme, 265
private hospitals, 7, 241Ð2, 279Ð95, 331
childhood immunisation episodes, 
328
dialysis procedures, 88, 290, 291
expenditure on, 244, 245, 252, 253, 
395Ð6, 399Ð400: private health 
insurance funds, 263, 264, 395
length of stay, 389, 391
mental health services, 296Ð7
patient-days, 387, 389, 391
pharmaceuticals, beneÞt-paid, 256
separations from, 385, 389, 391
see also day hospital facilities
private patients, 302
private (non-government) sector, 240Ð3, 
276Ð7, 395
dental services, 312, 315Ð16
pharmaceuticals, beneÞt-paid, 256
research and development 
expenditure, 258, 395
private sector, expenditure by, 244, 
245Ð8, 395Ð6
hospitals, 245, 254Ð5
Indigenous programs, 251, 251
procedures, 284, 287Ð9
cardiovascular, 42Ð3
dialysis, 86, 87Ð8, 190, 202, 287, 288, 
289, 290, 291
older people, 190
transplants, 86, 202Ð3, 290
see also operations
promotion and prevention, 257, 323Ð9, 
401
see also vaccination
prostate cancer, 48, 49, 50, 55Ð6, 377Ð80, 
415
cause of death, 32, 34, 36, 51, 55, 192, 
377, 415
Indigenous peoples, 229
older people, 192
overseas-born people, 195, 196
survival following diagnosis, 51, 52, 
415
PSA testing, 56
psychiatric disability, people with, 30
see also mental health/disorders
psychiatric hospitals, see public 
psychiatric hospitals
psychoactive drugs, 64, 65, 205
psychological development, disorders 
of, 64
psychological drugs, 323
psychological problems, 63
psychotic disorders, 62, 64, 65, 205, 297, 
298
public attitudes, 156Ð8
public community mental health 
services, 298Ð9
public dental care, 312
public health, 7Ð8, 238, 323Ð9, 401
expenditure on, 245, 257
AW2002 end matter  Page 472  Wednesday, June 26, 2002  5:43 PM
Index  473
TRIM SIZE 175 mm Wide x 250 mm Deep
public hearing services, 318Ð19
public (non-psychiatric/acute) 
hospitals, 239, 242, 279Ð89, 291, 331
childhood immunisation episodes, 
328
dialysis procedures, 88, 287, 288, 291
expenditure on, 245, 246, 251, 252, 
253Ð5, 395Ð6, 399Ð400: private health 
insurance funds, 264, 395
length of stay, 388, 390, 392
mental health services, 296Ð7
patient days, 386, 388, 388, 390, 392
performance indicators, 291Ð5
separations from, 384, 388, 390, 392
public psychiatric hospitals, 279Ð84, 
296Ð7
expenditure on, 246, 252, 253, 395Ð6, 
399Ð400
pulmonary diseases, see chronic 
obstructive pulmonary disease
Q fever, 375
qualiÞcations, see socioeconomic status
quality of health services, 341
see also adverse events
quarantine, 239
Queensland, see States and Territories
radiation, 47, 161
radiography, 274
radiotherapy and nuclear medicine, 303
ranitidine hydrochloride, 322
rashes, 308
recommended dietary intakes (RDIs), 
137, 138, 140
record linkage, 341
recurrent expenditure, 245, 252Ð4, 263, 
296, 299, 396, 399Ð400
referrals, 74, 307, 309, 310
regulatory framework, 7
rehabilitation appliances, 253, 264, 
395Ð6, 399Ð400
rehabilitation students, 274
rehabilitation procedures, hospital care 
involving, 190
remote people, see rural and remote 
people
renal diseases, see kidney diseases
repairs to dwellings, 209
repatriation hospitals, 259
Repatriation Pharmaceutical BeneÞts 
Scheme (RPBS), 321
reproduction, see births and pregnancy
reproductive organs, 27Ð8
see also genitals
research and development, 257, 258, 
395Ð6, 399Ð400
residence in Australia, length of, 194, 
195
residential aged care, 81, 341
expenditure on, 245, 252, 253, 395Ð6, 
399Ð400
resources, 238Ð337, 384Ð411
respiratory diseases/infections, 30, 91Ð3, 
388Ð9, 388Ð93
drug prescriptions, 323
general practitioner patients, 202, 308, 
309
Indigenous peoples, 200, 201, 202
older people, 191
overseas-born people, 195, 196, 197
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procedures reported, 288
rural and remote people, 219
socioeconomically disadvantaged 
people, 213
veterans and war widows/widowers, 
223, 224
see also chronic obstructive pulmonary 
disease
respiratory disease, as cause of death, 
37, 91, 92, 369Ð72
birthplace, 195, 197
Indigenous peoples, 200
older people, 191, 192
remote and rural people, 219
socioeconomically disadvantaged 
people, 213
respite care, 253
retinopathy, 69
rheumatic fever/heart disease, 23Ð4, 39, 
40Ð2, 44
rheumatoid arthritis, 23Ð4
risk factors, 119Ð69, 341, 414
cancers, 47Ð8, 53, 120
cardiovascular diseases, 383
children, 177Ð8
chronic obstructive pulmonary 
disease, 78Ð9
diabetes, 66, 68, 69
Indigenous peoples, 206Ð10
kidney (renal) failure, 85
overseas-born people, 195, 196, 197
osteoarthritis, 81
osteoporosis, 82
rural and remote people, 215Ð17
socioeconomically disadvantaged 
people, 212
young people, 183Ð4
see also determinants of health
road trafÞc accidents, 57Ð8, 60, 230, 231, 
421
road trafÞc fatalities, 32, 57Ð8, 421
children, 178, 183
overseas-born people, 195, 197
socioeconomically disadvantaged 
people, 213
young people, 186
Ross River virus, 97, 161, 375
roxithromycin, 322
Royal Flying Doctor Service, 328
RPBS, 321
rubella, 20, 21, 22, 152, 153
cases, 102, 178, 179, 374
rubbish disposal, 211, 240
rural and remote hospitals, 292
rural and remote people, 214Ð20, 231, 
345
breast cancer screening, 325, 326
dental (oral) health, 17Ð18, 19
health indicators, 412, 413, 421, 423Ð4
health workforce, 270Ð3, 307
illicit drug use, 151
safety, 341
see also adverse events
salbutamol, 74, 322
salmonellosis, 96, 374
salt/sodium, 128, 140, 156
same-day patients, 282, 284Ð5, 330, 
388Ð93
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mental health, 297, 298, 330, 331, 
388Ð9, 392Ð3
procedures, 88, 288, 289, 291, 390Ð1
saturated fat intake, 130, 137Ð8, 140, 414
schizophrenia and psychotic disorders, 
62, 64, 65, 205, 297, 298
school dental services, 310
schoolchildren, see children
science students, 274
sedatives, 322
self-care restriction, 29, 65
self-harm, 60, 186Ð8, 205, 230, 423
see also suicide
self-reported health status, 13Ð14, 212, 
222, 223, 226
sensory disorders, see ear diseases/
disorders; eye diseases/disorders
sewage disposal, 210, 240
sex of population, 355, 384Ð7
alcohol and drug treatment service 
clients, 300
alcohol consumption, 143Ð5, 184, 225
AlzheimerÕs disease, 89
asthma, 72, 73, 74
attitudes and beliefs, 157Ð8
auto-immune diseases and conditions, 
23Ð4
birth ratios, 357
birthweight, 174
burden of disease, 228Ð9, 230
cancers, 47Ð57, 228, 229, 369Ð72, 377Ð9, 
415Ð16
cardiovascular (circulatory) diseases, 
38Ð9, 40Ð2, 228Ð9, 369Ð72, 412Ð13, 418, 
419
chronic obstructive pulmonary 
disease, 77Ð9
diabetes, 24, 67Ð8, 69, 70, 383, 417Ð20
diet and nutrition, 139
disability, 29, 30, 189Ð90
family planning clients, 320
general practitioner patients, 307
health workforce, 267, 268, 269, 270, 
272, 273, 277, 307
hepatitis, 95, 225
high blood cholesterol, 130Ð2, 383, 
414, 418
high blood pressure, 127Ð8, 383, 414, 
418
HIV/AIDS, 184, 376
hospitalisation, 180, 185
illicit drug use, 148Ð51, 184
impaired glucose tolerance, 132Ð3
Indigenous peoples, 201Ð2, 205, 207, 
317
injuries, 60, 61, 228, 421Ð2
kidney disease, 86Ð8, 202
life expectancy, 9Ð13, 188, 199, 217Ð18, 
361Ð2
liver disease, 83Ð4
medical practitioner consultations, 
305
Medicare services, use of, 409Ð11
mental problems and disorders, 61, 
62Ð3, 66, 180, 184, 205, 226, 228, 369Ð70
multiple sclerosis, 24
musculoskeletal disorders/diseases, 
80, 81, 82, 83, 369Ð70
older people, 188Ð92
physical inactivity, 145, 146, 147, 148, 
184, 383, 417Ð18
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prisoners, 225Ð6
respiratory infections/diseases, 93, 
369Ð72
rural and remote, 215, 217
salt consumption, 140
self-reported health, 13, 14
sexual health, 25Ð6, 27Ð8
sexually transmitted diseases (STDs), 
96
socioeconomically disadvantaged 
people, 213
tetanus, 100
tobacco smokers, 134Ð6, 184, 383, 414
tuberculosis, 97Ð8
veteran healthcare cardholders, 221, 
223Ð4
weight, 121Ð4, 207, 215, 383, 414
sex of population, and mortality, 31Ð7, 
361Ð73
AlzheimerÕs disease, 90
asthma, 75Ð6
auto-immune diseases and conditions, 
23Ð4
cancers, 47, 50, 51Ð7, 191, 192, 195Ð6, 
377, 415Ð16
cardiovascular diseases, 44Ð6, 191, 
195, 200, 412Ð13, 420
children, 174, 180Ð3, 360
chronic obstructive pulmonary 
disease, 77Ð9, 192
diabetes, 24, 71, 195, 204
Indigenous peoples, 200, 204, 205
infectious and parasitic diseases, 90, 
91, 195
injuries and poisoning, 57Ð60, 369Ð72, 
421, 422: children, 183; Indigenous 
peoples, 205; older people, 191, 192; 
overseas-born people, 195, 197
kidney failure, 87
liver disease, 84
mental problems and disorders, 66, 
200
musculoskeletal disorders, 24
older people, 191Ð2
overseas-born people, 194Ð6
respiratory infections, 91, 92, 191, 195
road trafÞc accidents, 58, 183
rural and remote people, 219
socioeconomically disadvantaged 
people, 213
suicide, 58Ð60, 195, 197, 205
tuberculosis, 97Ð8
veterans and war widows/widowers, 
224
young people, 185Ð8
sexual health/practice, 24Ð8, 158, 185, 
319Ð20
see also births and pregnancy
sexually transmitted diseases, 26Ð7, 91, 
96, 158, 185, 374
see also HIV/AIDS
shigellosis, 374
shooting deaths, 60, 226
sickness, see diseases
SIDS, 37, 181
sight, see eye diseases/disorders
SIGNAL, 141
simvastatin, 322
sinusitis, 309
skin cancers, 48, 105, 161, 332, 377Ð9, 
415Ð16
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melanoma, 48, 49, 50, 52, 229, 377Ð80, 
415
older people, 190
overseas-born people, 195, 196, 197
veterans and war widows/widowers, 
224
skin diseases/disorders, 223, 224, 309, 
369Ð70, 388Ð9, 392Ð3
skin ointments and creams, 323
skin procedures, 288, 291
sleep disturbance/insomnia, 223, 309
sleeping pills/tranquillisers, 149, 157, 
184, 301
SLTEC, VTEC, 374
smoking, see tobacco smoking
social health determinants, 162, 198
socioeconomic status, 162, 212Ð13, 230
alcohol and drug treatment service 
clients, 300
breast cancer screening, 325, 326
children, 183
dental (oral) health, 313Ð14
high blood cholesterol, 131
high blood pressure, 128
illicit drug users, 151
Indigenous peoples, 199
inßuenza vaccination, 93
life expectancy, 11, 213
oral (dental) health, 16Ð17
physical inactivity, 148
rural and remote people, 215
self-reported health status, 14
tobacco smoking, 137
weight, 124
young people, 183, 187
see also concession cardholders
sodium, 156
South Australia, see States and 
Territories
specialist medical practitioners, 269, 270, 
276
attendances, 303, 304, 305, 306, 407
referrals to, 310
speech therapists/pathologists, 243, 274
spina biÞda, 138, 156, 176
spirits consumption, 142
sprains and strains, 309
SSPE, 102
State and local government expenditure, 
244Ð8, 259, 395
childhood vaccination, 327
hospitals, 245, 254Ð5, 395
Indigenous programs, 250, 251
State and Territory expenditure, 258Ð9, 
401
cervical screening, 325
Indigenous services, 317, 398
public health activities, 257
research and development, 258
States and Territories, 7, 240
AIDS cases, 376
births, 171Ð2, 201, 356, 358
cancer incidence, 379
childhood immunisation, 153Ð4, 328
cost per casemix-adjusted separation, 
292Ð3
death rates, 364, 370: perinatal, 358, 
359
dental (oral) health, 310Ð11, 382
dental practitioners, 273Ð4
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general practitioners (GPs), 307
HIV, new prisoners diagnosed with, 
226
hospitals, 280, 281, 285Ð6, 293Ð4, 
384Ð7: mental health services, 296
Indigenous peoples, 19, 96, 198Ð9, 201, 
250, 251
inßuenza vaccination, 93
life expectancy, 11, 361
private medical service use, 305
psychotic disorders, 62
public (non-psychiatric) hospitals, 246
sexually transmitted diseases (STDs), 
96
vectorborne diseases, 97
statistical developments, gaps and 
deÞciencies, 5Ð6, 338Ð54, 412Ð24
AlzheimerÕs disease, 90
biomedical risk factors, 127
constant price estimates, 249
diabetes, 68, 127
environmental health, 160Ð1
functioning and disability, 28Ð9
high blood pressure, 125, 127
hospital use, 283Ð4
Indigenous peoples, 198, 340
infectious and parasitic diseases, 90
injury deaths, 57
STDs, 26Ð7, 91, 96, 158, 185, 374
see also HIV/AIDS
Steering Committee for the Review of 
Commonwealth/State Service 
Provision, 339
stenosis, 176
stenting, 42, 43
sterilisation and sterility, 25, 26, 158
steroids, 82, 149, 157
stillbirths (foetal deaths), 173Ð4
stomach cancer, 49, 50, 52, 377Ð80
students, see children; education and 
training; young people
strains and sprains, 309
Strategic Inter-Governmental Nutrition 
Alliance (SIGNAL), 141
stress, 22, 126, 217
stroke (cerebrovascular disease), 30, 39, 
40Ð2
diabetes and, 69, 70
diagnostic procedures, 42, 43
indicators, 412, 419
overseas-born people, 196
stroke, as cause of death, 31, 32, 34Ð5, 
44Ð6, 373
asthma associated with, 75
diabetes associated with, 71
in hospital, 41, 42
indicators, 412Ð13, 420
older people, 192
overseas-born people, 195
subacute sclerosing panencephalitis 
(SSPE), 102
substance use and abuse, 61, 62, 64, 65Ð6
Indigenous peoples, 205, 208
see also alcohol consumption; drugs 
and drug use; tobacco smoking
sudden infant death syndrome, 37, 181
suicide, 32, 36, 57, 58Ð60, 423Ð4
Indigenous peoples, 205
overseas-born people, 195, 197
prisoners, 226
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socioeconomically disadvantaged 
people, 213
young people, 58, 59, 186Ð7, 188, 423
see also depression
sun protection, by children, 177
surgery, see operations
survival following diagnosis
AlzheimerÕs disease, 89
cancer, 51, 52, 415
HIV/AIDS, 94Ð5
syphilis, 27, 96, 374
systemic lupus erythmatosus, 23, 24
systolic blood pressure, 125
Tasmania, see States and Territories
taxation revenue and expenditure, 394
TB, 97Ð8, 196, 197, 375
technology, 268, 274
teenagers, see young people
teeth, see dental health
temazepam, 322
Temporary Resident Doctors, 271, 275Ð6
termination of pregnancy, 26, 28, 173, 
288
tertiary education, 271, 274Ð5
test results, consultations about, 308
testis, cancer of, 50, 52, 378Ð9
testosterone replacement, 83
tetanus, 100, 374
vaccination against, 20, 21, 22, 153, 154
Therapeutic Goods Administration, 239
throat complaints, 308
thyroid, cancer of, 52
tinnitus, 224
tobacco smoking, 35, 47, 53, 82, 134Ð7, 
301, 414
Indigenous peoples, 20, 136
mental disorders, deaths attributed to, 
65
prisoners, 225
public beliefs and attitudes, 157
rural and remote people, 215
self-reported health status, 14
young people, 136, 184
Zyban prescriptions, 322
see also chronic obstructive pulmonary 
disease; lung cancer
Torres Strait Islanders, see Indigenous 
peoples
tracheo-oesophageal Þstula, 176
tracheostomies, 290
trafÞc accidents, see road trafÞc 
accidents
tranquillisers/sleeping pills, 149, 157, 
184, 301
transfusions, 190
transmissible spongiform 
encephalopathies (TSEs), 103
transplants, 86, 202Ð3, 290
transport services, DVA expenditure on, 
253
transposition of great vessels, 176
triglyceride (TG), 129
triplets, 171, 172
tubal ligations, 25
tuberculosis, 97Ð8, 196, 197, 375
TurnerÕs syndrome, 159
twins, 171Ð2
Type 1 diabetes, 23Ð4, 66, 68, 69, 179, 
203, 417, 418
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Type 2 diabetes, 66, 67, 68Ð9, 179, 203, 
383, 417Ð18
typhoid, 374
ulcers, 213, 322, 419
undergraduate course commencements, 
274Ð5
underweight, 121, 122
unemployment, 2
see also socioeconomic status
unintentional injuries, 60Ð1
see also road trafÞc accidents
university courses, 271, 274Ð5
upper respiratory tract infections, 92, 
202, 308, 309
urinary system, operations on, 287, 
390Ð1
urinary tract infection, 309
uterus, cancer of, 48, 49, 52, 377Ð9
vaccination (immunisation), 20Ð2, 152Ð6, 
177, 327Ð9
diabetes and, 70
expenditure on, 257, 327, 401
general practitioner patients, 308, 309, 
327Ð8
inßuenza, 93, 322, 323
recent changes, 99, 100, 101
vaccine-preventable diseases, 99Ð102, 
178, 179, 374
vacuum extraction deliveries, 171Ð2
vaginal breech deliveries, 171Ð2
variant CJD (vCJD), 103
varicose veins, 223
vasectomies, 25
vectorborne diseases, 97, 161, 375
vegetable consumption, 140
ventricle, examination procedures on, 
289
ventricular septal defect, 176
veterans and war widows/widowers, 
220Ð5, 252, 290Ð1, 299, 306, 321
see also Department of VeteransÕ 
Affairs
Veterans Line, 299
Victoria, see States and Territories
Vietnam veterans, 223, 299
Vietnam Veterans Counselling Service 
(VVCS), 299
Vietnamese origin, people of, 68
violence and aggression, 63, 64, 231
alcohol-caused, 141
deaths from, 183
Indigenous hospitalisation, 205, 230
see also suicide
vision, see eye diseases/disorders
vitamin and mineral supplements, 320
vitamin C intake, 139
waist circumference, 122Ð3, 124
waiting times for elective surgery, 293Ð4
war widows/widowers, see veterans
waste disposal, 210, 211, 240
water and sewage, 210, 240
weather, 2, 161
weight, see body weight
wellbeing, 3Ð5, 13Ð14, 22, 217
Western Australia, see States and 
Territories
whooping cough, see pertussis
wine consumption, 142
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women, see births and pregnancy; sex of 
population
workforce, see health workforce
World Health Organization (WHO), 3Ð4, 
12, 79, 100, 125, 138, 351, 350Ð2
yersiniosis, 374
Yolgnu Indigenous people, 198
young people, 177, 183Ð8, 345
dental (oral) health, 310Ð11
drug use, 64, 184, 187
general practitioner patients, 307
mental problems and disorders, 62Ð3, 
64, 183, 184, 423
mortality, 37, 184, 185Ð8: suicide, 58, 
59, 186Ð7, 188, 423
pregnancies, 173, 175
sexual activity, 26, 185
sexual knowledge, 158
tobacco smoking, 136, 184, 414
vaccine-preventable diseases, 101, 102
weight, 122, 139
zoonoses, 375
Zyban, 322
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